The BLUE BOOK (Cash Flows) - Centrum

Download as pdf or txt
Download as pdf or txt
You are on page 1of 324

Institutional Research l ϭϲ September 2021

Please see Appendix for analyst certifications and all other important disclosures.
The Blue Book ϭϲ September 2021

Foreword
THE BLUE BOOK – Putting 10-year cash flows in perspective
The idea behind this product is that while the future remains uncertain, a deep dive into
past performance can bring to the fore intrinsic strengths and weaknesses of businesses
across economic cycles. Such a study can also help spot structural changes in the businesses
and demonstrate the track record of capital allocation decisions, thus separating the
winners from the laggards within the same sector. It helps us have an analytical framework
to make sense of the hugely varying valuations of various sectors and even of companies
within the same sector. This exercise has made us think harder about how we rate stocks
and we hope we will be able to add value to you as well.
We have analyzed the past 10 years of cash flows and returns for 105 stocks in our coverage
universe spanning a wide gamut of sectors. We have looked into metrics like operating cash
flows, working capital trends, EBITDA to OCF conversion, capex and acquisition intensity,
performance of acquisitions, and finally, free cash flow trends, leverage and return ratios.
Operating cash flows improving, partially led by efficiency but largely by squeezing
suppliers; tougher conditions for MSME/SME sectors: One common observation across
both cyclical and non-cyclical sectors is that working capital levels and operating cash flows
have remained strong or improved for most sectors. Among other drivers, this has also been
led by extracting better credit terms from suppliers. This is especially visible in Automobiles,
Cement, FMCG, Consumer Electricals and in select Pharma stocks. The most prominent
improvement is in Oil & Gas, led by deregulation of fuel prices; in Pharmaceuticals, led by a
greater domestic focus; and in Metals, led by improved capacity utilization and higher
product prices. Construction too has seen an improvement in operating cash flows.
Operating cash flows for Automobiles and Cement & Building Products have been steady,
while FMCG and Consumer Electricals have retained the top slot due to inherent strengths
in their business models. Mining continues to witness elevated working capital levels and
weak cash generation. There are outliers to these general trends, which we discuss in
greater detail inside.
Capex recovering after big trough in FY14-17; recovery led by Cement, Metals & Mining
and Chemicals: Capital expenditure has been on a recovery path since FY18 after plunging
over FY14-17. For our sample set comprising of 12 traditionally capex-intensive sectors,
capital expenditure plummeted 17% from Rs3tn in FY14 to Rs2.5tn in FY16. The decline in
capex levels was prevalent across capex-intensive sectors like Cement, Metals & Mining,
Utilities, and Oil & Gas. Starting FY17, however, there has been a visible uptick in capex in
the Cement and Metals & Mining sectors, while capex has remained muted in Automobiles.
The Auto Components sector is seeing a surge in capex, led by tyre manufacturers.
Chemicals and Telecom have seen a consistent rise in capital expenditure since FY14.
Acquisition intensity in the Pharma sector is coming down, though the sector continues to
invest in R&D. By FY20, the total capital expenditure of the same sample of companies had
recovered to Rs3.6tn.
Indian corporates curtailing overseas ambitions after huge losses; also highlights Indian
corporates not ready to become MNCs yet: The experience of Indian corporates with
overseas acquisitions has been far from remunerative and this highlights that they were ill-
prepared to operate in complex or unfamiliar regulatory and market environments. Large-
ticket acquisitions in Automobiles, Metals & Mining, upstream Oil & Gas are clearly
struggling. Thankfully, Indian corporates have been re-orienting their focus towards the
domestic markets, and in fact have benefitted from increased consolidation in various
sectors in recent years.

Centrum Institutional Research 2


The Blue Book ϭϲSeptember 2021
Free cash flows cyclical but have improved, leading to deleveraging; low risk-taking
appetite: Free cash flows have exhibited a fair amount of cyclicality but have remained
positive for most sectors, leading to reduction in leverage. FMCG, Consumer Electricals,
Automobiles and Pharmaceuticals lead the pack in terms of FCF generation, followed by
Cement, Metals, Refining, and Gas Utility sectors. For Metals, FCFs have been rather cyclical
but have improved, leading to deleveraging in the sector. Upstream Oil & Gas and Mining
have seen weak FCFs, and consequently, leverage remains elevated. Infra asset owners in
Ports and Highways have also seen increased investments in asset creation, though leverage
ratios and liquidity profile remain comfortable.
Return ratios trend mixed; better pricing management and operating leverage helps:
Return ratios have expanded only for a handful of sectors, while for most others, they are
just about maintained or have hovered within their cyclical range. Return ratios for Cement
& Building Materials have expanded due to pricing-led improvement in profitability and
improvement in working capital levels. The Metals sector has seen a strong recovery, led by
higher volumes and higher product prices. CGDs have benefitted from strong penetration-
led volume growth and margin expansion. MNC Pharma has seen improved growth and
improved operating leverage, leading to better margins, which in turn has led to improved
returns. Retail and Upstream witnessed compression in return ratios, led by elevated
working capital levels and increased investments, respectively.
Surprisingly, high cash generators show no improvement in return ratios as they continue
to hoard cash: Corporates in traditionally strong cash generating sectors are in need of a
better strategy on utilization of their excess cash. FMCG, Consumer Electricals and
Automobiles have not seen much improvement in return ratios despite healthy cash flows,
as cash distribution has not kept pace with cash generation. This is evident from the fact
that ROICs for these sectors have improved.
Asset quality of Large Banks improving; stress continues for Midsize Banks and NBFCs:
Large Banks, which had seen a significant worsening in asset quality from FY15 to FY17, have
started seeing an improvement in the last two years. Overall balance sheet stress has
reduced while CASA has remained strong. Increased retail focus and lower credit costs have
helped expand NIMs. Hence, PPOP has improved, except for SBI; return ratios have
increased, led by lower provisions. Meanwhile, asset quality for Midsize Banks and NBFCs
has generally worsened. However, for NBFCs, NIMs are improving, as diversification in their
liability mix has brought down the cost of capital. Return ratios, nevertheless, have
worsened for both.

Nischal Maheshwari
CEO, Centrum Broking Ltd.

Centrum Institutional Research 3


The Blue Book ϭϲ September 2021

Findings of our cash flow analysis at a glance

Consumer Electricals
Building Materials

Overall Pharma
Non-ferrous

Gas Utilities

Big Pharma
MNC Pack
Chemicals

Upstream
Aviation

Cement

Ferrous

Mining
FMCG

Retail

CGDs
Auto

Infra

RIL
Working capital
Operating cash flows
Free cash flows
Leverage
Return ratios
Large Banks

Mid-Banks

Ratings
NBFCs

AMCs
Asset quality Market share Working capital Legend
Asset/Liability mix Operating yields Operating cash flows Improved
NIM Return ratios Free cash flows Neutral
PPoP Distribution Return ratios Worsened
Return ratios

Centrum Institutional Research 4


The Blue Book ϭϲ September 2021

Index
l Auto & Auto Ancillaries
Ashok Leyland (AL) .......................................................................................................7
Bajaj Auto (BJAUT)...................................................................................................... 10
Eicher Motors............................................................................................................. 13
Endurance Technologies (ENDU)................................................................................. 16
Hero Motocorp (HMCL) .............................................................................................. 19
Mahindra & Mahindra (MM) ...................................................................................... 22
Maruti Suzuki (MSIL) .................................................................................................. 25
TVS Motors (TVSL) ...................................................................................................... 28
l Aviation
InterGlobe Aviation (IndiGo) ....................................................................................... 31
SpiceJet ...................................................................................................................... 34
l BFSI
Axis Bank.................................................................................................................... 37
Can Fin Homes (Canfin) .............................................................................................. 40
CARE Ratings (CARE) ................................................................................................... 43
CRISIL ......................................................................................................................... 46
City Union Bank (CUBK) .............................................................................................. 49
DCB Bank (DCB) .......................................................................................................... 52
Federal Bank (FB) ....................................................................................................... 55
HDFC AMC.................................................................................................................. 58
ICICI Bank ................................................................................................................... 61
LIC Housing Finance (LICHF) ........................................................................................ 64
M&M Financial Services (MMFS) ................................................................................ 67
Nippon Life AMC (NAM) ............................................................................................. 70
State Bank of India (SBIN) ........................................................................................... 73
Sundaram Finance (SUF) ............................................................................................. 76
Ujjivan Small Finance Bank (USFB) .............................................................................. 79
UTI AMC..................................................................................................................... 82
l Cement
ACC ............................................................................................................................ 85
Ambuja Cement (ACEM) ............................................................................................. 88
Cera Sanitaryware (CRS) ............................................................................................. 91
Heidelberg Cement India (HEIM) ................................................................................ 94
JK Cement (JKCE) ........................................................................................................ 97
JK Lakshmi Cement (JKLC) ......................................................................................... 100
Kajaria Ceramics (KJC)............................................................................................... 103
Orient Cement (ORCMNT) ........................................................................................ 106
The Ramco Cements (TRCL) ...................................................................................... 109
Shree Cement (SRCM) .............................................................................................. 112
Star Cement (STRCEM) ............................................................................................. 115
Ultratech Cement (UTCEM) ...................................................................................... 118
l Chemicals
Dhanuka Agritech (DAGRI) ........................................................................................ 121
PI Industries (PII) ...................................................................................................... 124
UPL .......................................................................................................................... 127
l Consumer
Asian Paints (APNT) .................................................................................................. 130
Bajaj Consumer Care ................................................................................................ 133
Britannia Industries .................................................................................................. 136
Colgate Palmolive India (CLGT) ................................................................................. 139
Dabur India (DABUR) ................................................................................................ 142
Emami ...................................................................................................................... 145
Godfrey Phillips India (GP) ........................................................................................ 148
Hindustan Unilever (HUVR)....................................................................................... 151
ITC ........................................................................................................................... 154
V-Mart Retail (VMART) ............................................................................................. 157
VST Industries (VST).................................................................................................. 160

Centrum Institutional Research 5


The Blue Book ϭϲ September 2021
l Consumer Electricals
Bajaj Electricals ........................................................................................................ 163
Crompton Greaves Consumer Electricals .................................................................. 166
Havells India ............................................................................................................. 169
Orient Electric .......................................................................................................... 172
Polycab India ............................................................................................................ 175
V-Guard Industries ................................................................................................... 178
l Infrastructure
Adani Ports and SEZ (APSEZ) ..................................................................................... 181
Ahluwalia Contracts (ACIL)........................................................................................ 184
Ashoka Buildcon (ABL) .............................................................................................. 187
G R Infraprojects (GRIL) ............................................................................................ 190
Gujarat Pipavav Port (GPPL)...................................................................................... 193
HG Infra Engineering (HG) ........................................................................................ 196
KEC International (KEC)............................................................................................. 199
KNR Constructions (KNR) .......................................................................................... 202
Larsen & Toubro (L&T).............................................................................................. 205
NCC Ltd (NCC) .......................................................................................................... 208
PNC Infratech (PNC) ................................................................................................. 211
l Metals & Mining
APL Apollo (APAT) .................................................................................................... 214
Coal India (COAL)...................................................................................................... 217
Hindalco (HNDL) ....................................................................................................... 220
Hindustan Zinc (HZ) .................................................................................................. 223
Jindal Stainless (JDSL) ............................................................................................... 226
Jindal Steel and Power (JSP)...................................................................................... 229
JSW Steel ................................................................................................................. 232
NMDC ...................................................................................................................... 235
Steel Authority of India (SAIL) ................................................................................... 238
Tata Steel (TATA) ...................................................................................................... 241
Vedanta (VEDL) ........................................................................................................ 244
l Oil & Gas
BPCL......................................................................................................................... 247
GAIL India (GAIL) ...................................................................................................... 250
Gujarat Gas .............................................................................................................. 253
Gujarat State Petronet (GSPL)................................................................................... 256
HPCL ........................................................................................................................ 259
IOCL ......................................................................................................................... 262
Indraprastha Gas (IGL) .............................................................................................. 265
Mahanagar Gas (MGL) .............................................................................................. 268
ONGC ....................................................................................................................... 271
Oil India (OIL) ........................................................................................................... 274
Petronet LNG (PLNG) ................................................................................................ 277
RIL............................................................................................................................ 280
l Pharmaceuticals
Aarti Drugs (ARTD) ................................................................................................... 283
Abbott...................................................................................................................... 286
Aurobindo Pharma (ARBP) ........................................................................................ 289
Biocon...................................................................................................................... 292
Cipla......................................................................................................................... 295
Dr Reddy’s Laboratories (DRRD)................................................................................ 298
FDC .......................................................................................................................... 301
GlaxoSmithKline Pharmaceuticals (GLXO) ................................................................. 304
Granules India (GRAN) .............................................................................................. 307
Lupin ........................................................................................................................ 310
Pfizer........................................................................................................................ 313
Sanofi India (SANL) ................................................................................................... 316
Sun Pharma (SUNP) .................................................................................................. 319
Annexure ................................................................................................................. 322

Centrum Institutional Research ϲ


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

Ashok Leyland (AL)


AL is in a cyclical business – sale of M&HCVs. Since FY14 (consolidated financials Market data
available from FY14), OCF has been negative on four occasions due to industry Current price: Rs127
slowdowns. Over FY15-19, OCF before WC saw consistent improvement on the back Bloomberg: AL IN
of growth in operations. AL has invested Rs25bn in subsidiaries since FY14, of which 52-week H/L: Rs143/67
Rs11bn was in Hinduja Leyland Finance, mainly in the last three years for capital
Market cap: Rs373.4bn
adequacy. It has incurred cumulative capex of Rs66bn since FY14, of which Rs39bn
was in the last four years, towards BS6, modular platform, Phoenix (LCV) platform Free float: 63.4%
and EVs. Net fixed asset turnover has been 2-5x over the years. Avg. daily vol. 3mth: 20,418,490
Source: Bloomberg

Cyclical cash flows from operations: M&HCVs is a cyclical business. Since FY14, AL’s OCF has been negative in four years –
FY14: industry slowdown, negative PBT; and FY16, FY19 and FY21: negative WC change. It was the worst in FY19, as dealer
advances were lower on a high base, and as inventory was high at the year-end due to sudden slowdown in demand. Over
FY15-19, OCF before WC has seen consistent improvement on the back of growth in operations.
Exhibit 1: Cash flows from operations reflect cyclical nature of M&HCV business
40

20

0
Rs Bn

-20
Lower dealer advances on
-40
high base and higher
-60 inventory due to sudden
slowdown in demand
-80
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF before WC WC Change OCF
Source: Company, Centrum Broking

Analysis of working capital movement: AL has a history of negative cash conversion cycle, similar to the industry. NWC
was also broadly negative over the last 8 years. Debtor and creditor days have been higher in the last few years, given the
industry slowdown and the pandemic. OCF has been negative in FY14, FY16, FY19, and FY21; as a result, the OCF ratios for
these years appear distorted.
Exhibit 2: As is the case with the industry, AL’s NWC has been broadly negative
150

100
Days of Revenue

50

-50

-100
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Creditors NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Ashok Leyland (AL) 16 September 2021

Exhibit 3: OCF/PAT (x) Exhibit 4: OCF/EBITDA (x)

4 3.5 1
0.5
0.5 0.3
3 0.1 0.1
2 0
0.9 1.0
1 -0.5
0.2 0.4
0.2 -0.6
-1
0 -0.9
-1.5 -1.2
-1
-1.1 -2
-2 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -2.0
-1.8 -2.5
-3 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex, investments and FCF: Since FY14, AL has invested Rs25bn in subsidiaries, of which Rs11bn was in Hinduja Leyland
Finance, mainly in the last three years for capital adequacy. It has incurred cumulative capex of Rs66bn, of which Rs39bn was
in the last four years towards BS6, modular platform, Phoenix (LCV) platform, and EVs.
Exhibit 5: Capex intensity was higher in last four years towards BS6, modular platform, Phoenix (LCV) platform, and EVs
20
10
0
-10
Rs. Bn

-20
-30
-40
-50
-60
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF Capex Investments in JVs, Subs and Asso Net FCF
Source: Company, Centrum Broking

Exhibit 6: Net fixed asset turnover


FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Fixed Asset turn (x) 2.2 3.2 4.0 4.0 5.3 5.2 2.6 2.2
Net Debt/Equity (x) 1.7 1.4 1.3 1.4 1.5 1.5 1.8 1.7
Source: Company, Centrum Broking

Exhibit 7: RoE trend mimics cyclical nature of core business – M&HCV


FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
ROE (%) -14.8 6.3 25.2 27.0 23.7 26.3 5.1 -4.2
Investments (Rs Bn) 11.6 15.0 10.3 19.3 43.8 14.9 9.6 10.5
Source: Company, Centrum Broking

Centrum Institutional Research 8


Ashok Leyland (AL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 286,140 172,672 152,292 213,754 288,746 Equity share capital 2,936 2,936 2,936 2,936 2,936
Operating Expense 206,796 123,692 114,033 156,351 205,506 Reserves & surplus 80,389 69,704 66,837 69,693 79,587
Employee cost 20,988 16,151 15,839 16,152 20,347 Shareholders fund 83,324 72,640 69,772 72,628 82,522
Others 31,409 23,096 17,791 27,566 34,881 Minority Interest 0 0 0 0 0
EBITDA 31,357 11,737 5,351 15,291 29,939 Total debt 3,984 31,053 37,463 33,463 26,463
Depreciation & Amortisation 6,210 6,698 7,477 7,653 7,859 Non Current Liabilities 0 0 0 0 0
EBIT 25,147 5,039 (2,126) 7,638 22,080 Def tax liab. (net) 2,497 2,648 1,708 1,708 1,708
Interest expenses 704 1,095 3,068 1,773 1,498 Total liabilities 89,806 106,341 108,943 107,799 110,693
Other income 1,099 1,233 1,195 1,720 2,051 Gross block 75,926 96,199 105,576 113,076 118,076
PBT 25,543 5,177 (3,999) 7,585 22,633 Less: acc. Depreciation (19,791) (28,163) (35,072) (42,725) (50,584)
Taxes 5,136 1,224 (982) 1,896 5,658 Net block 56,135 68,036 70,504 70,351 67,492
Effective tax rate (%) 20.1 23.6 24.6 25.0 25.0 Capital WIP 6,576 5,941 3,719 3,719 3,719
PAT 20,407 3,953 (3,016) 5,688 16,974 Net fixed assets 62,711 73,977 74,222 74,070 71,210
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 20,407 3,953 (3,016) 5,688 16,974 Investments 26,365 27,196 30,687 32,687 35,687
Extraordinary items (575) (1,558) (121) 0 0 Inventories 26,847 12,380 21,423 24,251 23,891
Reported PAT 19,832 2,395 (3,137) 5,688 16,974 Sundry debtors 25,055 11,804 28,163 29,501 23,891
Cash & Cash Equivalents 13,736 13,225 8,230 5,478 10,843
Ratios Loans & advances 542 554 411 411 411
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 26,978 24,760 21,363 21,363 21,363
Growth (%) Trade payables 50,179 26,239 51,647 56,053 51,764
Revenue 18.8 (39.7) (11.8) 40.4 35.1 Other current liab. 31,725 23,261 17,364 17,364 17,364
EBITDA 14.5 (62.6) (54.4) 185.7 95.8 Provisions 10,524 8,055 6,545 6,545 7,475
Adj. EPS 29.2 (80.6) nm nm 198.4 Net current assets 729 5,168 4,033 1,042 3,796
Margins (%) Total assets 89,806 106,341 108,943 107,799 110,693
Gross 29.3 29.5 25.6 27.6 29.5
EBITDA 10.8 6.7 3.5 7.1 10.3 Cashflow
EBIT 8.7 2.9 (1.4) 3.5 7.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 7.0 2.3 (2.0) 2.6 5.8 Profit Before Tax 25,543 5,177 (3,999) 7,585 22,633
Returns (%) Depreciation & Amortisation 6,210 6,698 7,477 7,653 7,859
ROE 26.3 5.1 (4.2) 8.0 21.9 Net Interest 704 1,095 3,068 1,773 1,498
ROCE 25.6 5.0 (0.7) 6.6 16.8 Net Change – WC (29,030) (4,950) (3,861) 239 2,612
ROIC 71.8 7.0 (2.4) 8.4 25.4 Direct taxes (5,623) (1,073) 42 (1,896) (5,658)
Turnover (days) Net cash from operations (1,837) (6,223) 4,637 14,870 27,734
Gross block turnover ratio (x) 3.8 1.8 1.4 1.9 2.4 Capital expenditure (15,167) (17,964) (7,722) (7,500) (5,000)
Debtors 22 39 48 49 34 Acquisitions, net 0 0 0 0 0
Inventory 39 58 54 53 43 Investments 31,661 (831) (3,491) (2,000) (3,000)
Creditors 85 113 125 126 96 Others 0 0 0 0 0
Net working capital 1 11 10 2 5 Net cash from investing 16,495 (18,795) (11,214) (9,500) (8,000)
Solvency (x) FCF 14,658 (25,018) (6,576) 5,370 19,734
Net debt-equity (0.1) 0.2 0.4 0.4 0.2 Issue of share capital 8 0 0 0 0
Interest coverage ratio 44.6 10.7 1.7 8.6 20.0 Increase/(decrease) in debt (1,173) 27,069 6,410 (4,000) (7,000)
Net debt/EBITDA (0.3) 1.5 5.5 1.8 0.5 Dividend paid (9,098) (1,468) (1,761) (2,348) (5,871)
Per share (Rs) Interest paid (704) (1,095) (3,068) (1,773) (1,498)
Adjusted EPS 7.0 1.3 (1.0) 1.9 5.8 Others 0 0 0 0 0
BVPS 28.4 24.7 23.8 24.7 28.1 Net cash from financing (10,966) 24,507 1,581 (8,122) (14,369)
CEPS 9.1 3.6 1.5 4.5 8.5 Net change in Cash 3,692 (511) (4,996) (2,752) 5,365
DPS 3.1 0.5 0.6 0.8 2.0 Source: Company, Centrum Broking
Dividend payout (%) 45.9 61.3 nm 41.3 34.6
Valuation (x)
P/E 18.3 94.2 nm 65.6 22.0
P/BV 4.5 5.1 5.4 5.1 4.5
EV/EBITDA 11.6 33.3 75.2 26.3 13.0
Dividend yield (%) 2.4 0.4 0.5 0.6 1.6
Source: Company, Centrum Broking

Centrum Institutional Research 9


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

Bajaj Auto (BJAUT)


BJAUT’s operating profits have consistently expanded over the last 10 years, but Market data
there have been a few hiccups due to industry downturns. Working capital intensity Current price: Rs3,814
has been low to moderate, enabling it to generate strong OCF. The company has a Bloomberg: BJAUT IN
negative cash conversion cycle, given the nature of its business. It has not done any 52-week H/L: Rs4,361/2,822
greenfield capex in the last decade. In FY13, it increased its stake in KTM AG from
Market cap: Rs1103.5bn
~41% to ~48% for Rs2.3bn. In the last 8 years, KTM’s PAT contribution has improved
from Rs1.5bn to Rs3.1bn. Return ratios have been declining, as more cash is getting Free float: 43.5%
invested in non-core assets (mutual funds, bonds, etc). Avg. daily vol. 3mth: 477,711
Source: Bloomberg

Stable cash flows from operations: Over the last decade, operating profits have improved directionally, but there have been
a few hiccups on the back of industry downcycle. In FY15, the company underperformed the industry due to increasing
competition. In FY19, BJAUT reduced prices of six models to gain market share at the cost of profitability.
Exhibit 8: OCF has improved directionally over the last decade, though there have been hiccups due to downturns
70 Margin impact Industry downcycle;
Industry Domestic sales
due to price war pandemic
downcycle decline; market
50 share loss

30
Rs Bn

10

-10
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-30 Unrealized VAT refund


OCF before WC change WC change OCF
Source: Company, Centrum Broking

Negative cash conversion cycle: The company has a negative cash conversion cycle, given the nature of the
business. Debtors days have increased in the last few years due to industry slowdown and the pandemic.
Exhibit 9: Debtor days increased in the last few years due to industry slowdown, pandemic
80.0
60.0
Days of revenue

40.0
20.0
0.0
-20.0
-40.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Debtors Inventory Creditors NWC


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Bajaj Auto (BJAUT) 16 September 2021

Exhibit 10: OCF/PAT (x) Exhibit 11: OCF/EBITDA (x)

1.2 0.9 0.8


1.1 1.0 0.8 0.8
1.0 0.8
0.8 0.7 0.7
1.0 0.9
0.9 0.7 0.6
0.7 0.8 0.6
0.8 0.7 0.7 0.6
0.5 0.5
0.6 0.5
0.6
0.4
0.4 0.3
0.2
0.2
0.1
0.0 0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex, investments and FCF: The company has not done any greenfield capex in the last decade. In FY13, it increased its
stake in KTM AG from ~41% to ~48% for Rs2.3bn. In the last 8 years, KTM’s PAT contribution has improved from Rs1.5bn to
Rs3.1bn. In the last five years, company has done annual capex of Rs2bn on an average towards debottlenecking and
maintenance of its plants. Capex has been a tad higher in the last two years, as BJAUT spent on BS6 and EV technologies.
Exhibit 12: BJAUT has not done any greenfield capex in the last decade
50
40
30
20
Rs Bn

10
0
-10 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-20 Investment in KTM


Debottlenecking, BS6 and maintenance capex
OCF Capex Investments in Subs and Asso Net FCF
Source: Company, Centrum Broking

Exhibit 13: Net fixed asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Fixed Asset turn (x) 12.5 10.8 9.8 11.0 10.6 10.7 13.2 16.8 17.1 16.3
Source: Company, Centrum Broking

Return ratios declining: Return ratios have been declining, as more cash is getting invested in non-core assets (mutual
funds, bonds, etc).

Exhibit 14: RoE declining, as more cash getting invested in non-core financial assets
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
ROE (%) 57.3 41.8 37.9 32.1 32.8 25.3 22.7 21.2 24.5 20.2
Investments (Rs Bn) 48.8 64.3 85.5 91.5 102.6 147.3 175.9 191.6 182.0 226.3
Source: Company, Centrum Broking

Centrum Institutional Research 11


Bajaj Auto (BJAUT) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 295,673 291,115 271,329 341,521 399,460 Equity share capital 2,894 2,894 2,894 2,894 2,894
Operating Expense 218,243 210,083 196,097 248,143 287,044 Reserves & surplus 214,905 196,361 249,129 255,520 263,362
Employee cost 12,554 13,892 12,860 14,638 17,100 Shareholders fund 217,799 199,255 252,023 258,414 266,256
Others 21,882 24,249 19,170 23,464 27,848 Minority Interest 0 0 0 0 0
EBITDA 52,717 51,455 49,285 62,270 75,162 Total debt 0 0 0 0 0
Depreciation & Amortisation 2,657 2,464 2,593 2,916 3,226 Non Current Liabilities 5,427 3,464 5,221 5,221 5,221
EBIT 50,060 48,990 46,692 59,354 71,936 Def tax liab. (net) 0 0 0 0 0
Interest expenses 45 32 67 50 35 Total liabilities 223,226 202,719 257,244 263,635 271,477
Other income 13,597 16,843 12,765 13,352 13,999 Gross block 42,956 41,573 43,443 48,603 53,763
PBT 63,612 65,802 59,390 72,657 85,900 Less: acc. Depreciation (25,317) (24,583) (26,794) (29,710) (32,936)
Taxes 20,280 14,802 13,844 17,074 20,187 Net block 17,639 16,990 16,649 18,893 20,827
Effective tax rate (%) 31.9 22.5 23.3 23.5 23.5 Capital WIP 480 602 160 160 160
PAT 43,332 51,000 45,546 55,582 65,714 Net fixed assets 18,120 17,592 16,809 19,053 20,987
Minority/Associates 0 0 0 0 0 Non Current Assets 9,229 10,009 10,713 11,785 12,963
Recurring PAT 43,332 51,000 45,546 55,582 65,714 Investments 175,829 154,162 146,028 146,028 146,028
Extraordinary items 3,420 0 0 0 0 Inventories 9,615 10,635 14,939 16,842 19,699
Reported PAT 46,752 51,000 45,546 55,582 65,714 Sundry debtors 25,597 17,251 27,169 32,749 35,021
Cash & Cash Equivalents 24,993 30,880 85,555 92,026 96,294
Ratios Loans & advances 380 386 372 372 372
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 10,042 6,818 13,718 15,089 16,598
Growth (%) Trade payables 37,867 31,997 45,738 56,140 60,193
Revenue 19.7 (1.5) (6.8) 25.9 17.0 Other current liab. 11,159 10,633 10,776 12,393 14,252
EBITDA 4.5 (2.4) (4.2) 26.3 20.7 Provisions 1,552 2,385 1,544 1,775 2,041
Adj. EPS 5.7 17.7 (10.7) 22.0 18.2 Net current assets 20,048 20,955 83,693 86,769 91,499
Margins (%) Total assets 223,226 202,719 257,244 263,635 271,477
Gross 29.5 30.8 30.0 29.4 30.1
EBITDA 17.3 17.2 17.8 17.9 18.5 Cashflow
EBIT 16.4 16.3 16.8 17.0 17.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 14.2 17.0 16.4 15.9 16.1 Profit Before Tax 63,612 65,802 59,390 72,657 85,900
Returns (%) Depreciation & Amortisation 2,657 2,464 2,593 2,916 3,226
ROE 21.2 24.5 20.2 21.8 25.0 Net Interest 45 32 67 50 35
ROCE 21.2 24.5 20.2 21.8 25.1 Net Change – WC (13,023) 4,200 (8,767) 2,324 (1,640)
ROIC 280.1 243.5 206.7 222.6 248.5 Direct taxes (18,087) (16,765) (12,087) (17,074) (20,187)
Turnover (days) Net cash from operations 38,623 55,733 41,196 60,872 67,335
Gross block turnover ratio (x) 6.9 7.0 6.2 7.0 7.4 Capital expenditure (1,429) (1,937) (1,810) (5,160) (5,160)
Debtors 24 26 29 31 30 Acquisitions, net 0 0 0 0 0
Inventory 14 18 24 23 23 Investments (15,711) 9,634 (44,350) (8,000) (5,000)
Creditors 59 61 72 75 74 Others 0 0 0 0 0
Net working capital 25 26 113 93 84 Net cash from investing (17,139) 7,697 (46,160) (13,160) (10,160)
Solvency (x) FCF 21,484 63,430 (4,964) 47,713 57,175
Net debt-equity (0.1) (0.2) (0.3) (0.4) (0.4) Issue of share capital (26) (29,612) 53,809 7,379 8,681
Interest coverage ratio 1,176.7 1,628.3 740.0 1,245.4 2,147.5 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (0.5) (0.6) (1.7) (1.5) (1.3) Dividend paid (45) (32) (67) (50) (35)
Per share (Rs) Interest paid (19,966) (39,932) (46,587) (56,570) (66,553)
Adjusted EPS 149.7 176.2 157.4 192.1 227.1 Others 0 0 0 0 0
BVPS 752.7 688.6 870.9 893.0 920.1 Net cash from financing (20,036) (69,576) 7,155 (49,241) (57,907)
CEPS 158.9 184.8 166.4 202.2 238.2 Net change in Cash 1,448 (6,145) 2,191 (1,529) (732)
DPS 60.0 120.0 140.0 170.0 200.0 Source: Company, Centrum Broking
Dividend payout (%) 37.1 68.1 88.9 88.5 88.1
Valuation (x)
P/E 25.5 21.6 24.2 19.9 16.8
P/BV 5.1 5.5 4.4 4.3 4.1
EV/EBITDA 20.5 20.8 20.7 16.2 13.4
Dividend yield (%) 1.6 3.1 3.7 4.5 5.2
Source: Company, Centrum Broking

Centrum Institutional Research 12


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

Eicher Motors
Riding on strong order book, Eicher’s PAT grew at a CAGR of 39% over CY11-FY18. Market data
Over this time, the company’s operating profits improved significantly. Working Current price: Rs2,860
capital change has been favorable in most years during the last decade. EBITDA to Bloomberg: EIM IN
OCF conversion has been at a decent level of ~1x. Fixed asset turnover has been 52-week H/L: Rs3,037/2,015
impressive owing to high utilization levels, except in FY20 and FY21. The company
Market cap: Rs782bn
has incurred capex of over Rs60bn in the last decade mainly on capacity addition.
Capacity increased from 70,000 units in CY11 to 1.2mn units in FY21. Capacity Free float: 46.5%
utilization has been 90%+ between CY14 and FY19. Net FCF deteriorated in the last Avg. daily vol. 3mth: 898,816
three years, as demand slowed, but committed capex continued. Source: Bloomberg

OCF stagnant for last three years: Riding on strong order book, Eicher’s PAT grew at a CAGR of 39% over CY11-FY18. Over the
same time, the company’s operating profits improved significantly. Working capital change has been favorable every year
during the last decade, except in FY19, when inventory increased after production improvement and the industry slowed
down in the exit quarter. Since then, revenue and profitability have been under pressure; hence, OCF has not improved.
Exhibit 15: After consistent improvement until FY18, OCF has stagnated in the last three years
30 EPPL shut down in FY19; loss
25 of Rs2.2bn incurred
20
15
Rs.Bn

10
5
0
-5
CY11 CY12 CY13 CY14 FY16 FY17 FY18 FY19 FY20 FY21
-10
OCF before WC WC Change OCF
Source: Company, Centrum Broking

Analysis of working capital movement: Eicher has enjoyed a healthy order pipeline until FY18, which explains why its
debtor days and inventory days have been at the lower end. Creditor days have always been high at 45-70 days in the last 10
years. EBITDA to OCF conversion has been around a decent level of 1x. Fixed asset turnover has been impressive owing to
high utilization levels, except in FY20 and FY21.
Exhibit 16: Working capital is negative due to the nature of the business and in line with the industry
100

50
Days of Revenue

0
CY11 CY12 CY13 CY14 FY16 FY17 FY18 FY19 FY20 FY21
-50

-100

-150
Debtors Inventory Creditors NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Eicher Motors 16 September 2021

Exhibit 17: OCF/PAT (x) Exhibit 18: OCF/EBITDA (x)

1.6 1.6
1.4 1.4
1.4 1.3 1.4
1.2 1.2 1.3
1.1 1.1 1.2
1.2 1.2 1.0
0.9 0.9 0.9 0.9
1 1 0.9
0.8 0.8 0.8
0.8 0.7 0.8
0.5
0.6 0.6
0.4 0.4
0.2 0.2
0 0
CY11 CY12 CY13 CY14 FY16 FY17 FY18 FY19 FY20 FY21 CY11 CY12 CY13 CY14 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex, investments and FCF: The company incurred capex of above Rs60bn over the last decade mainly on capacity addition.
Capacity increased from 70,000 units in CY11 to 1.2mn units in FY21. Capacity utilization has been 90%+ between CY14 and
FY19. Net FCF deteriorated in the last three years, as demand slowed, but committed capex continued.
Exhibit 19: Capex of ~Rs60bn in the last decade, mainly towards greenfield capacity addition
30 Set up 3rd plant in Chennai in August 2017; capacity increased
25 to 825,000 units
Bought 50-acre land
20 in Chennai in 2014
15
Eicher Polaris (EPPL) JV set up
Rs. Bn

10
in October 2012
5
0
-5
-10 CY11 CY12 CY13 CY14 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Investments in JVs, Subs and Asso Net FCF


Source: Company, Centrum Broking

Asset turn: Asset turn has been healthy, except in the last couple of years, when it has been hit by industry slowdown.
Return ratios on decline: Return ratios have declined steadily, especially in the last four years. This is majorly due to
slowdown in the industry and lower capacity utilization.
Exhibit 20: RoE has declined steadily in the last four years due to industry slowdown and lower utilization
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Fixed Asset Turnover(x) 5.72 5.27 5.34 5.29 6.94 5.63 4.87 4.19 3.36 3.14
Capacity Utilisation (%) 108.6 75.6 67.9 93.1 80.1 98.8 92.1 93.6 56.7 51.0
ROE (%) 27.0 26.7 42.0 62.5 71.6 62.5 52.2 37.9 27.5 16.2
Source: Company, Centrum Broking

Centrum Institutional Research 14


Eicher Motors 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 97,174 90,736 86,616 113,724 141,363 Equity share capital 273 273 273 273 273
Operating Expense 50,574 49,959 51,128 63,614 77,772 Reserves & surplus 88,914 99,536 114,108 129,528 152,296
Employee cost 7,024 7,958 8,432 9,298 11,292 Shareholders fund 89,187 99,809 114,381 129,801 152,570
Others 11,341 11,815 9,331 14,483 17,178 Minority Interest 0 0 0 0 0
EBITDA 29,031 21,804 18,313 26,898 35,804 Total debt 1,868 2,490 2,193 2,193 2,193
Depreciation & Amortisation 3,003 3,815 4,507 5,129 5,899 Non Current Liabilities 0 0 0 0 0
EBIT 26,028 17,988 13,805 21,769 29,905 Def tax liab. (net) 2,739 2,522 2,215 2,215 2,215
Interest expenses 73 189 165 189 218 Total liabilities 93,794 104,821 118,788 134,209 156,977
Other income 4,434 5,433 4,532 5,574 6,856 Gross block 27,673 36,192 41,257 46,757 51,757
PBT 30,389 23,232 18,173 27,154 36,544 Less: acc. Depreciation (8,927) (12,417) (16,924) (22,054) (27,952)
Taxes 10,770 5,275 4,515 6,788 9,136 Net block 18,746 23,775 24,333 24,704 23,805
Effective tax rate (%) 35.4 22.7 24.8 25.0 25.0 Capital WIP 4,497 3,122 3,143 3,143 3,143
PAT 19,619 17,957 13,658 20,365 27,408 Net fixed assets 23,243 26,897 27,476 27,847 26,948
Minority/Associates 2,584 317 311 1,647 3,600 Non Current Assets 0 0 0 0 0
Recurring PAT 22,203 18,274 13,969 22,012 31,008 Investments 44,537 32,363 28,261 28,261 38,261
Extraordinary items (175) 0 (500) 0 0 Inventories 6,334 5,724 8,746 10,905 11,619
Reported PAT 22,027 18,274 13,469 22,012 31,008 Sundry debtors 903 868 1,582 2,077 1,936
Cash & Cash Equivalents 34,341 54,631 69,064 86,427 96,944
Ratios Loans & advances 13 1 4,592 4,617 4,642
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 4,497 4,014 5,866 6,366 6,866
Growth (%) Trade payables 12,341 10,277 15,358 20,165 17,428
Revenue 8.9 (6.6) (4.5) 31.3 24.3 Other current liab. 6,928 8,426 10,312 10,822 11,332
EBITDA 3.4 (24.9) (16.0) 46.9 33.1 Provisions 807 974 1,128 1,303 1,478
Adj. EPS 1.9 (17.8) (23.6) 57.6 40.9 Net current assets 26,013 45,561 63,052 78,102 91,769
Margins (%) Total assets 93,794 104,821 118,788 134,209 156,977
Gross 48.8 45.8 41.7 44.6 45.5
EBITDA 29.6 23.8 21.0 23.5 25.2 Cashflow
EBIT 26.6 19.7 15.8 19.0 21.1 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 22.7 20.0 16.0 19.3 21.8 Profit Before Tax 30,389 23,232 18,173 27,154 36,544
Returns (%) Depreciation & Amortisation 3,003 3,815 4,507 5,129 5,899
ROE 27.8 19.3 13.0 18.0 22.0 Net Interest 73 189 165 189 218
ROCE 24.2 18.7 12.6 16.5 19.2 Net Change – WC (4,720) 742 (3,057) 2,313 (3,150)
ROIC 209.3 101.2 60.1 89.3 121.7 Direct taxes (9,452) (5,492) (4,822) (6,788) (9,136)
Turnover (days) Net cash from operations 22,670 19,266 21,483 29,644 33,974
Gross block turnover ratio (x) 3.5 2.5 2.1 2.4 2.7 Capital expenditure (7,897) (7,469) (5,086) (5,500) (5,000)
Debtors 3 4 5 6 5 Acquisitions, net 0 0 0 0 0
Inventory 37 44 52 56 53 Investments 6,583 (8,263) 18,466 (20,000) (20,000)
Creditors 87 83 92 102 88 Others 0 0 0 0 0
Net working capital 98 183 266 251 237 Net cash from investing (1,314) (15,732) 13,380 (25,500) (25,000)
Solvency (x) FCF 21,356 3,534 34,863 4,144 8,974
Net debt-equity (0.4) (0.5) (0.6) (0.6) (0.6) Issue of share capital 0 0 0 0 0
Interest coverage ratio 396.1 115.5 111.3 142.2 164.6 Increase/(decrease) in debt 359 622 (298) 0 0
Net debt/EBITDA (1.1) (2.4) (3.7) (3.1) (2.6) Dividend paid (4,109) (4,115) (5,603) (6,592) (8,240)
Per share (Rs) Interest paid (73) (189) (165) (189) (218)
Adjusted EPS 81.4 66.9 51.1 80.5 113.5 Others 0 0 0 0 0
BVPS 327.2 365.6 418.5 474.9 558.2 Net cash from financing (3,824) (3,681) (6,065) (6,781) (8,458)
CEPS 92.5 80.9 67.6 99.3 135.0 Net change in Cash 17,533 (147) 28,798 (2,637) 517
DPS 12.5 12.5 17.0 20.0 25.0 Source: Company, Centrum Broking
Dividend payout (%) 15.5 18.7 34.5 24.8 22.0
Valuation (x)
P/E 35.1 42.7 56.0 35.5 25.2
P/BV 8.7 7.8 6.8 6.0 5.1
EV/EBITDA 25.8 33.5 39.1 25.9 19.2
Dividend yield (%) 0.4 0.4 0.6 0.7 0.9
Source: Company, Centrum Broking

Centrum Institutional Research 15


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

Endurance Technologies (ENDU)


ENDU’s operating cash flows have been improving consistently, with minimal change Market data
in working capital requirement, except in the pandemic year. Over FY16-21, its Current price: Rs1,625
debtor days have hovered at 40-60, inventory days at 30-40, and creditor days at 50- Bloomberg: ENDU IN
60. Net working capital excluding current investments has increased significantly in 52-week H/L: Rs1,830/975
the last couple of years. OCF/EBITDA has been a bit lower than 1x. Since FY16,
Market cap: Rs228.6bn
cumulative capex has been Rs30bn; other than that, there is no major impact on free
cash flows. This is also visible in the fixed asset turnover ratio, which has consistently Free float: 23%
been over 1.5x, except in FY21. Avg. daily vol. 3mth: 120,316
Source: Bloomberg

Consistent improvement in cash flows from operations: Operating cash flows have been improving consistently, with
minimal change in working capital requirement, except in the pandemic year. Over FY16-20 PBT grew consistently at a CAGR
of 15.4%, with EBITDA margin expanding from 12.9% in FY16 to 16.3% in FY20. The company has won new orders worth over
Rs18bn in India and EUR100mn+ in Europe in the last three years. Order inflows have been strong for the last 4-5 years. As
the peak of new order revenue starts coming in from the third year onwards, we have seen high capex in the last four years.
Exhibit 21: Steady improvement in cash flows from operations with minimal working capital movement
12
10
8
6
Rs.Bn

4
2
0
-2
-4
FY16 FY17 FY18 FY19 FY20 FY21

OCF before WC WC Change OCF


Source: Company, Centrum Broking

Analysis of working capital movement: Over FY16-21, ENDU’s debtor days have hovered at 40-60 days, inventory days at
30-40, and creditor days at 50-60. Net working capital excluding current investments has increased significantly in the last
couple of years. OCF/EBITDA has been a bit lower than 1x.
Exhibit 22: Working capital is impacted by higher debtor days, being a tier-1 supplier
80
70
Days of Revenue

60
50
40
30
20
10
0
FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Creditors NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Endurance Technologies (ENDU) 16 September 2021

Exhibit 23: OCF/PAT (x) Exhibit 24: OCF/EBITDA (x)

1.2
1.0
2.5 2.3
1 0.9
0.8 0.8
2 1.8 1.7 1.8 0.8 0.7
1.6
0.6
1.5 0.6
1.2
1 0.4

0.5 0.2

0
0
FY16 FY17 FY18 FY19 FY20 FY21
FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex, investments and FCF: Over the last few years, ENDU’s order inflows have been robust. It has been expanding capacity
to cater to its piling order book. Since FY16, cumulative capex has been Rs30bn. Other than that, there is no major impact on
free cash flows. This is also visible in the fixed asset turnover ratio, which has been consistently over 1.5x, except in FY21.
Exhibit 25: Capex intensity has been high due to the need to fulfil order book and add new products
15

10

5
Rs. Bn

-5
FY16 FY17 FY18 FY19 FY20 FY21
-10
CFO Capex Investments in JVs, Subs and Asso Net FCF
Source: Company, Centrum Broking

Exhibit 26: Net fixed asset turnover


FY16 FY17 FY18 FY19 FY20 FY21
Net Fixed Asset turn (x) 3.30 3.42 3.43 3.47 2.65 2.52
Source: Company, Centrum Broking

Return ratios have been steady


Exhibit 27: RoE (%) trend
FY16 FY17 FY18 FY19 FY20 FY21
ROE (%) 23.2 20.8 21.4 21.8 20.3 16.2
Investments (Rs Bn) 0.5 0.3 0.5 0.4 1.7 4.4
Source: Company, Centrum Broking

Centrum Institutional Research 17


Endurance Technologies (ENDU) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 75,105 69,177 65,470 82,504 95,479 Equity share capital 1,407 1,407 1,407 1,407 1,407
Operating Expense 43,495 37,352 35,706 44,799 51,368 Reserves & surplus 24,240 28,654 34,215 39,759 47,097
Employee cost 6,527 6,773 6,761 7,920 8,880 Shareholders fund 25,647 30,060 35,621 41,166 48,503
Others 13,795 13,744 12,602 16,336 18,618 Minority Interest 0 0 0 0 0
EBITDA 11,288 11,308 10,402 13,448 16,613 Total debt 5,584 5,482 4,242 3,242 1,242
Depreciation & Amortisation 3,762 4,143 3,991 4,391 4,830 Non Current Liabilities 0 0 0 0 0
EBIT 7,526 7,165 6,411 9,058 11,784 Def tax liab. (net) (150) (242) (597) (597) (597)
Interest expenses 257 175 138 120 80 Total liabilities 31,081 35,300 39,266 43,811 49,148
Other income 270 476 307 369 442 Gross block 33,860 42,204 45,793 50,293 54,793
PBT 7,539 7,465 6,580 9,306 12,146 Less: acc. Depreciation (12,229) (16,141) (19,768) (24,158) (28,988)
Taxes 2,381 1,810 1,272 2,327 3,037 Net block 21,631 26,063 26,026 26,135 25,806
Effective tax rate (%) 31.6 24.2 19.3 25.0 25.0 Capital WIP 1,178 1,260 962 962 962
PAT 5,158 5,655 5,308 6,980 9,110 Net fixed assets 22,809 27,323 26,987 27,097 26,767
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 5,158 5,655 5,308 6,980 9,110 Investments 361 1,660 4,431 6,443 8,443
Extraordinary items (208) 0 (112) 0 0 Inventories 5,400 5,501 6,118 7,710 8,923
Reported PAT 4,950 5,655 5,196 6,980 9,110 Sundry debtors 9,251 6,727 10,410 13,118 15,181
Cash & Cash Equivalents 5,379 6,209 5,145 6,532 9,241
Ratios Loans & advances 2,065 1,385 1,956 2,249 2,587
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 2,283 1,573 1,715 1,973 2,268
Growth (%) Trade payables 11,735 10,662 12,783 16,109 18,643
Revenue 18.2 (7.9) (5.4) 26.0 15.7 Other current liab. 3,694 3,305 3,791 4,171 4,588
EBITDA 21.7 0.2 (8.0) 29.3 23.5 Provisions 1,039 1,111 1,032 1,032 1,032
Adj. EPS 23.5 9.6 (6.1) 31.5 30.5 Net current assets 7,911 6,317 7,738 10,270 13,937
Margins (%) Total assets 31,081 35,300 39,266 43,811 49,148
Gross 42.1 46.0 45.5 45.7 46.2
EBITDA 15.0 16.3 15.9 16.3 17.4 Cashflow
EBIT 10.0 10.4 9.8 11.0 12.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 6.9 8.2 8.1 8.5 9.5 Profit Before Tax 7,539 7,465 6,580 9,306 12,146
Returns (%) Depreciation & Amortisation 3,762 4,143 3,991 4,391 4,830
ROE 21.8 20.3 16.2 18.2 20.3 Net Interest 257 175 138 120 80
ROCE 18.2 17.3 14.4 16.8 19.5 Net Change – WC (3) 2,424 (2,484) (1,146) (958)
ROIC 21.8 20.4 17.8 22.0 27.8 Direct taxes (2,428) (1,902) (1,628) (2,327) (3,037)
Turnover (days) Net cash from operations 8,919 12,305 6,376 10,454 13,061
Gross block turnover ratio (x) 2.2 1.6 1.4 1.6 1.7 Capital expenditure (7,374) (8,656) (3,656) (4,500) (4,500)
Debtors 46 42 48 52 54 Acquisitions, net 0 0 0 0 0
Inventory 43 53 59 56 59 Investments 98 (1,299) (2,783) (2,000) (2,000)
Creditors 97 109 120 118 123 Others 0 0 0 0 0
Net working capital 38 33 43 45 53 Net cash from investing (7,276) (9,955) (6,439) (6,500) (6,500)
Solvency (x) FCF 1,643 2,350 (64) 3,954 6,561
Net debt-equity 0.0 0.0 0.0 (0.1) (0.2) Issue of share capital (103) (313) 1,378 0 0
Interest coverage ratio 43.9 64.5 75.6 112.1 207.7 Increase/(decrease) in debt (2) (102) (1,240) (1,000) (2,000)
Net debt/EBITDA 0.0 (0.1) (0.1) (0.2) (0.5) Dividend paid (928) (928) (1,013) (1,435) (1,772)
Per share (Rs) Interest paid (257) (175) (138) (120) (80)
Adjusted EPS 36.7 40.2 37.7 49.6 64.8 Others 0 0 0 0 0
BVPS 182.3 213.7 253.2 292.7 344.8 Net cash from financing (1,291) (1,519) (1,013) (2,555) (3,852)
CEPS 63.4 69.7 66.1 80.8 99.1 Net change in Cash 352 831 (1,076) 1,399 2,708
DPS 5.5 5.5 6.0 8.5 10.5 Source: Company, Centrum Broking
Dividend payout (%) 15.6 13.7 16.2 17.1 16.2
Valuation (x)
P/E 44.3 40.4 43.1 32.7 25.1
P/BV 8.9 7.6 6.4 5.6 4.7
EV/EBITDA 19.8 19.7 21.9 16.8 13.3
Dividend yield (%) 0.3 0.3 0.4 0.5 0.6
Source: Company, Centrum Broking

Centrum Institutional Research 18


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

Hero Motocorp (HMCL)


HMCL’s operating profits have been robust and have consistently expanded over the Market data
last 10 years. Working capital intensity in the business has been low to moderate Current price: Rs2,920
except in the last three years. Overall, OCF trend largely mirrors the cyclical nature of Bloomberg: HMCL IN
the industry. Excluding current investments, working capital has been negative in 52-week H/L: Rs3616/2636
most years. Over the last 10 years, HMCL has incurred capex of Rs98bn towards
Market cap: Rs583.5bn
greenfield projects at three new locations, increasing achievable capacity from
6.2mn units to 11mn units (FY22E onwards). Investments of Rs25bn in subsidiaries Free float: 77.3%
and associates have been mainly towards associates, Hero Fincorp and Ather. Avg. daily vol. 3mth: 595,474
Source: Bloomberg

History of robust cash flows from operations: Operating profits have been robust and have consistently expanded over the
last 10 years. Working capital intensity in the business has been low to moderate except in the last three years. In FY19,
demand was hit by slowdown in Q4, resulting in higher inventory and receivables. Overall, OCF trend largely mirrors the
cyclical nature of the industry. Over FY20-21, HMCL too has been impacted by the industry slowdown and the pandemic.
However, OCF was higher, as debtors declined in FY20 and creditors increased in FY21. OCF before WC improved in FY20,
after the shift to the new corporate tax regime.
Exhibit 28: Barring FY19, cash flows from operations have been robust
60,000 Consistent improvement in OCF High inventory and receivables
due to slowdown in Q4
40,000

20,000
Rs Mn

-20,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-40,000 Strong OCF despite


industry downcycle
OCF before WC WC change OCF and pandemic
Source: Company, Centrum Broking

Analysis of working capital movement: NWC movement reflects the cyclical nature of the industry. Excluding current
investments, working capital has been negative in most years. Debtor days have been 15-20 days on an average, but there
was a spike in FY19 due to sudden slowdown in demand towards the end of year, leaving higher channel inventory in the
system. Inventory days have been hovering around 10 days. Creditors are normally around 30 days, but have been on the
higher side in FY18, FY19 and FY21. During upcycles, OCF/EBITDA improves, but in most years it has been below 1.
Exhibit 29: NWC movement reflects the cyclical nature of the industry
60.0

40.0

20.0

0.0

-20.0

-40.0 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-60.0
Debtors Inventory Creditors NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Hero Motocorp (HMCL) 16 September 2021

Exhibit 30: OCF/PAT (x) Exhibit 31: OCF/EBITDA (x)

1.6 1.5 1.2 1.1


1.3 1.0
1.4
1.2 1.0
1.2 1.1 0.8
1.0 0.7
0.9 1.0 0.8 0.7
1.0 0.7 0.7
0.7 0.5
0.8 0.7 0.6 0.5
x

x
0.6
0.4
0.3 0.2
0.4
0.2
0.2
0.0 0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex, investments and FCF: In FY12, HMCL was manufacturing out of three plants with a utilization of 98%. Over the last 10
years, it has incurred capex of Rs98bn towards greenfield projects at three new locations, increasing achievable capacity from
6.2mn units to 11mn units (FY22 onwards). Its total capacity in FY21 was 9.5mn. The company started manufacturing in
Colombia in FY16 and in Bangladesh in FY18. Capacity utilization has been 80%+ in most years. However, industry slowdown
has affected utilization in the last couple of years. HMCL’s investments in subsidiaries and associates of Rs25bn have been
mainly towards Hero Fincorp and Ather lately, both associates.
Exhibit 32: Capex intensity, acquisitions and free cash flows
60,000 FY14 onwards – Neemrana and FY17 – Andhra greenfield capex started
50,000 Gujarat greenfield capex started
40,000
30,000
Rs Mn

20,000
10,000
0
-10,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20,000
Sudden slowdown in the industry resulted
FCF in line with the cyclical nature of the industry
in overproduction
OCF Capex investments in Subs and Asso Net FCF
Source: Company Centrum Broking

Exhibit 33: Net fixed asset turnover


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Capacity Utilization (%) 98.2 88.0 89.2 86.7 81.9 73.2 83.4 85.9 70.4 60.9
Net Asset Turn (x) 14.5 14.6 15.0 10.1 9.3 7.8 6.4 6.9 5.9 7.1
Net Fixed Asset turn (x) 6.61 6.74 7.07 7.59 6.46 6.15 6.38 7.06 5.66 5.56
Source: Company, Centrum Broking

Muted activity on acquisitions, zero debt; returns healthy, albeit declining: HMCL has a healthy balance sheet, with
no debt and a sizeable investment and cash book. However, we have not seen any significant acquisition or investment in
core operations in the last decade (except Rs8.5bn in Jaipur Tech Center inaugurated in FY16), which is the key reason for its
declining return ratios. However, the ratios are still at respectable levels.
Exhibit 34: Though declining, return ratios are still at respectable levels
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
ROE (%) 131.3 69.2 39.8 41.9 41.1 35.7 33.8 27.5 21.9 20.2
ROCE (%) (before tax) 134.6 101.5 54.3 57.6 57.8 49.2 48.0 40.8 28.9 26.5
Investments (Rs Bn) 39.6 36.2 40.9 31.5 45.8 58.9 75.3 59.7 82.2 105.0
Source: Company, Centrum Broking

Centrum Institutional Research 20


Hero Motocorp (HMCL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 336,505 288,361 308,006 358,299 410,240 Equity share capital 400 400 400 400 400
Operating Expense 233,177 196,974 217,623 253,317 287,988 Reserves & surplus 128,172 140,965 151,585 164,296 179,465
Employee cost 17,302 18,417 18,987 20,781 23,384 Shareholders fund 128,571 141,364 151,984 164,695 179,865
Others 36,725 33,390 31,203 36,905 42,665 Minority Interest 0 0 0 0 0
EBITDA 49,301 39,580 40,192 47,295 56,203 Total debt 0 1,217 1,298 1,298 1,298
Depreciation & Amortisation 6,020 8,180 6,769 7,371 8,385 Non Current Liabilities 0 0 0 0 0
EBIT 43,281 31,400 33,424 39,925 47,818 Def tax liab. (net) 5,365 3,928 4,041 4,041 4,041
Interest expenses 86 220 218 200 200 Total liabilities 133,936 146,509 157,323 170,034 185,204
Other income 6,913 7,783 5,799 6,651 7,386 Gross block 78,538 99,619 102,296 108,296 115,296
PBT 50,107 38,963 39,004 46,376 55,004 Less: acc. Depreciation (33,763) (39,849) (45,314) (52,685) (61,070)
Taxes 16,259 9,404 9,362 11,687 13,861 Net block 44,775 59,770 56,982 55,611 54,226
Effective tax rate (%) 32.4 24.1 24.0 25.2 25.2 Capital WIP 3,607 1,603 1,779 1,779 1,779
PAT 33,849 29,559 29,642 34,689 41,143 Net fixed assets 51,604 64,584 64,250 63,379 62,495
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 33,849 29,559 29,642 34,689 41,143 Investments 28,015 35,282 43,082 48,082 53,082
Extraordinary items 0 6,774 0 0 0 Inventories 10,724 10,920 14,696 15,706 15,735
Reported PAT 33,849 36,333 29,642 34,689 41,143 Sundry debtors 28,216 16,031 24,268 24,541 22,479
Cash & Cash Equivalents 33,036 49,363 64,486 73,915 78,186
Ratios Loans & advances 850 896 892 1,037 1,188
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 23,968 10,417 9,938 9,938 9,938
Growth (%) Trade payables 33,553 30,305 52,046 53,990 44,958
Revenue 4.4 (14.3) 6.8 16.3 14.5 Other current liab. 7,161 7,990 8,913 8,913 8,913
EBITDA (6.6) (19.7) 1.5 17.7 18.8 Provisions 1,762 2,689 3,328 3,661 4,027
Adj. EPS (8.5) (12.7) 0.3 17.0 18.6 Net current assets 54,317 46,644 49,992 58,573 69,627
Margins (%) Total assets 133,936 146,509 157,323 170,034 185,204
Gross 30.7 31.7 29.3 29.3 29.8
EBITDA 14.7 13.7 13.0 13.2 13.7 Cashflow
EBIT 12.9 10.9 10.9 11.1 11.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 10.1 10.3 9.6 9.7 10.0 Profit Before Tax 50,107 38,963 39,004 46,376 55,004
Returns (%) Depreciation & Amortisation 6,020 8,180 6,769 7,371 8,385
ROE 27.5 21.9 20.2 21.9 23.9 Net Interest 86 220 218 200 200
ROCE 27.5 21.9 20.1 21.8 23.8 Net Change – WC (24,871) 24,001 11,775 847 (6,784)
ROIC 53.9 38.0 49.0 66.6 76.2 Direct taxes (16,010) (10,841) (9,249) (11,687) (13,861)
Turnover (days) Net cash from operations 15,333 67,296 46,238 42,607 42,444
Gross block turnover ratio (x) 4.3 2.9 3.0 3.3 3.6 Capital expenditure (7,895) (21,159) (6,435) (6,500) (7,500)
Debtors 24 28 24 25 21 Acquisitions, net 0 0 0 0 0
Inventory 15 20 21 22 20 Investments 15,566 (22,540) (22,770) (14,500) (11,500)
Creditors 52 59 69 76 63 Others 0 0 0 0 0
Net working capital 59 59 59 60 62 Net cash from investing 7,671 (43,699) (29,205) (21,000) (19,000)
Solvency (x) FCF 23,004 23,597 17,033 21,607 23,444
Net debt-equity (0.3) (0.3) (0.4) (0.4) (0.4) Issue of share capital (5,588) (5,562) 1,957 0 0
Interest coverage ratio 573.3 179.7 184.0 236.5 281.0 Increase/(decrease) in debt 0 1,217 81 0 0
Net debt/EBITDA (0.7) (1.2) (1.6) (1.5) (1.4) Dividend paid (17,378) (17,978) (20,979) (21,978) (25,974)
Per share (Rs) Interest paid (86) (220) (218) (200) (200)
Adjusted EPS 169.5 148.0 148.4 173.6 205.9 Others 0 0 0 0 0
BVPS 643.7 707.7 760.7 824.3 900.2 Net cash from financing (23,052) (22,543) (19,159) (22,178) (26,174)
CEPS 199.6 188.9 182.2 210.5 247.9 Net change in Cash (49) 1,054 (2,126) (571) (2,730)
DPS 87.0 90.0 105.0 110.0 130.0 Source: Company, Centrum Broking
Dividend payout (%) 51.3 49.5 70.8 63.4 63.1
Valuation (x)
P/E 17.2 19.7 19.7 16.8 14.2
P/BV 4.5 4.1 3.8 3.5 3.2
EV/EBITDA 11.2 13.5 12.9 10.8 9.0
Dividend yield (%) 3.0 3.1 3.6 3.8 4.5
Source: Company, Centrum Broking

Centrum Institutional Research 21


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

Mahindra & Mahindra (MM)


MM has 167 subsidiaries, 31 JVs, and 28 associates. We have analyzed its Market data
consolidated cash flows in this note. Over the last decade, the company has reported Current price: Rs757
negative OCF on four occasions, driven by higher working capital. In FY18, FY19 and Bloomberg: MM IN
FY20, losses from international subsidiaries dragged OCF. MM has invested heavily in 52-week H/L: Rs952/566
international subsidiaries like SsangYong in the last decade. These investments have
Market cap: Rs941bn
turned out to be the key reason for the company’s poor performance at the
consolidated level. In FY21, MM took a write-off of investments in SsangYong, GenZ, Free float: 86.9%
GippsAero, and MFCS. As a result, we saw a big turnaround in FY21. OCF/PAT and Avg. daily vol. 3mth: 3,077,389
OCF/EBITDA have been inconsistent, driven by loss-making subsidiaries. This has Source: Bloomberg

affected the company’s return ratios as well.

Story of capital mismanagement: Over the last decade, MM has reported negative OCF on four occasions, driven by higher
working capital. In FY18, FY19 and FY20, losses from international subsidiaries dragged OCF. The company has invested
heavily in international subsidiaries in the last decade, which has turned out to be the key reason for its poor performance at
the consolidated level. FY21 marks a stark improvement on the back of the management’s change in strategy to focus on
core business and rationalize capital allocation.
Exhibit 35: Over FY18-20, losses from international subsidiaries dragged OCF
200,000 Rationalizing loss-
making subsidiaries
100,000
Rs Mn

-100,000

-200,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Effect of poor performance of
OCF before WC WC change OCF international subsidiaries
Source: Company, Centrum Broking

Exhibit 36: Impact of subsidiaries/associates on OCF


200

100
OCF Rs Bn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-100
Standalone Consolidated
Source: Company, Centrum Broking

Analysis of working capital movement: MM has a negative working capital cycle, given the nature of its business.
Debtors have been at 20-30 days, inventory at 35-45 days, and creditors at 60-70 days in the last decade. OCF/PAT and
OCF/EBITDA have been inconsistent, driven by loss-making subsidiaries. This impacted return ratios as well.
Exhibit 37: Negative working capital cycle in most years is in line with the nature of the industry
100.0 20
Days of revenue

50.0 0

0.0 -20
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Creditors NWC (RHS)
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Mahindra & Mahindra (MM) 16 September 2021

Exhibit 38: OCF/PAT (x) Exhibit 39: OCF/EBITDA (x)


2.0 1.7
15.0 12.9 FY21: Sharp improvement
FY21: Sharp improvement 1.5
after writing off loss-making after writing off loss-making
10.0
subsidiaries. 1.0 subsidairies.
5.0
0.0 0.5 0.9 0.1 0.2 0.5 0.1 0.2
0.0 0.0 0.1
0.0
0.0

FY16

FY20
FY12

FY13

FY14

FY15

FY17

FY18

FY19

FY21

FY14

FY17
FY12

FY13

FY15

FY16

FY18

FY19

FY20

FY21
-5.0 -0.5
-0.3 -0.1 -1.0 -2.4
-0.1 0.0 -0.3 -0.1
Source: Company, Centrum Broking Source: Company, Centrum Broking

Exhibit 40: Standalone OCF/PAT and OCF/EBITDA


2.5
2
1.5
x

1
0.5
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF/PAT OCF/EBITDA
Source: Company, Centrum Broking

Capex, investments and FCF: MM acquired 70% stake in SsangYong in FY13 for Rs21bn. SsangYong reported a loss of Rs30bn
in FY20, up from Rs3.5bn in FY19. In fact, it reported losses every year except in FY14&17. Total international subsidiary
losses increased progressively from Rs530mn in FY17, to Rs11bn in FY18, to Rs20bn in FY19, and then to Rs53bn in FY20. In
FY21, MM took a write-off of investments in SsangYong, GenZ, GippsAero and MFCS. As a result, we see a big turnaround in
FY21.
Exhibit 41: Capex intensity and acquisitions have impacted free cash flows
200,000
Write-off and shutdown of loss making
150,000 subidiaries like SSangyoung, GenZ, Gipps
FY12: Rs1.75bn FY14: Rs2bn for 51%
100,000 for 49% share in share in Peugeot FY17: Rs9.3bn for controlling stake
Navistar Motorcycles in Hisarlar and Erkunt
50,000
Rs Mn

-50,000

-100,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-150,000 FY13: Rs21bn for 70% Mounting subsidairy losses
share in SSangyong CFO Capex investments in Subs and Asso Net FCF
Source: Company, Centrum Broking

Exhibit 42: SsangYong’s performance over the years have deteriorated significantly
Rs Mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20
M&M Investments 17,396 17,396 21,339 21,339 21,339 21,339 21,339 24,503 24,503
Loans Balance 4,288 4,653
Revenue 122,561 149,746 202,407 182,710 195,196 211,531 204,104 241,844 200,377
PAT -7,175 -5,092 736 -7,095 -1,430 2,332 -4,984 -3,454 -30,386
% Shareholding 70.04% 69.63% 72.85% 72.85% 72.85% 72.46% 72.46% 74.65% 74.65%
Revenue/Investment Turnover 4.0 4.7 6.9 6.3 6.7 7.2 6.9 7.4 6.1
Source: Company, Centrum Broking

Exhibit 43: Net fixed asset turn and RoE trend


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
ROCE (%) 36.2 20.5 19.1 14.8 16.6 15.7 16.2 16.0 9.8 9.7
ROE (%) 32.5 17.4 18.5 9.4 10.2 9.6 12.7 11.5 1.5 3.4
Net Fixed Asset Turn (x) 3.5 3.8 4.0 3.8 3.7 4.0 3.5 3.6 3.2 4.2
D/E (x) 1.0 1.0 1.1 0.9 0.9 1.0 0.9 1.1 1.3 1.3
Source: Company, Centrum Broking

Centrum Institutional Research 23


Mahindra & Mahindra (MM) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21E FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21E FY22E FY23E
Revenues 528,482 448,655 445,744 537,677 618,657 Equity share capital 5,958 5,965 5,974 5,974 5,974
Operating Expense 359,977 298,668 301,766 368,309 417,594 Reserves & surplus 343,979 340,326 347,239 389,190 444,508
Employee cost 32,830 32,237 32,428 38,175 43,925 Shareholders fund 349,937 346,291 353,212 395,164 450,482
Others 60,375 54,245 41,785 51,617 56,916 Minority Interest 0 0 0 0 0
EBITDA 75,301 63,506 69,766 79,576 100,223 Total debt 26,803 31,530 72,143 62,143 52,143
Depreciation & Amortisation 20,030 23,631 23,624 26,591 29,217 Non Current Liabilities 0 0 0 0 0
EBIT 55,271 39,875 46,142 52,985 71,005 Def tax liab. (net) 7,896 15,068 14,497 14,497 14,497
Interest expenses 1,467 1,245 3,957 4,029 3,429 Total liabilities 384,636 392,889 439,852 471,803 517,122
Other income 16,303 15,391 11,973 14,368 17,241 Gross block 138,562 144,142 143,695 188,695 228,695
PBT 70,106 54,021 54,158 63,324 84,818 Less: acc. Depreciation (20,030) (23,631) (23,624) (26,591) (29,217)
Taxes 15,867 18,513 13,183 15,939 21,349 Net block 118,532 120,511 120,070 162,103 199,477
Effective tax rate (%) 22.6 34.3 24.3 25.2 25.2 Capital WIP 26,437 48,582 61,255 61,255 61,255
PAT 54,239 35,509 40,974 47,386 63,469 Net fixed assets 144,969 169,093 181,325 223,358 260,732
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 54,239 35,509 40,974 47,386 63,469 Investments 176,422 153,433 177,977 222,862 242,862
Extraordinary items (227) (28,112) (31,745) 0 0 Inventories 47,631 40,408 47,827 57,690 66,379
Reported PAT 54,012 7,397 9,229 47,386 63,469 Sundry debtors 38,119 29,012 22,012 26,552 30,551
Cash & Cash Equivalents 68,160 64,262 107,440 60,991 56,651
Ratios Loans & advances 8,612 6,511 19,399 19,399 19,399
YE Mar FY19A FY20A FY21E FY22E FY23E
Other current assets 65,257 55,460 63,130 69,443 76,388
Growth (%) Trade payables 103,607 72,006 106,438 128,390 147,727
Revenue 11.1 (15.1) (0.6) 20.6 15.1 Other current liab. 44,775 37,503 57,744 63,519 69,870
EBITDA 6.9 (15.7) 9.9 14.1 25.9 Provisions 16,154 15,781 15,077 16,584 18,243
Adj. EPS 29.5 (34.5) 15.4 15.6 33.9 Net current assets 63,245 70,363 80,550 25,583 13,528
Margins (%) Total assets 384,636 392,889 439,852 471,803 517,122
Gross 31.9 33.4 32.3 31.5 32.5
EBITDA 14.2 14.2 15.7 14.8 16.2 Cashflow
EBIT 10.5 8.9 10.4 9.9 11.5 YE Mar (Rs mn) FY19A FY20A FY21E FY22E FY23E
Adjusted PAT 10.3 7.9 9.2 8.8 10.3 Profit Before Tax 70,106 54,021 54,158 63,324 84,818
Returns (%) Depreciation & Amortisation 20,030 23,631 23,624 26,591 29,217
ROE 16.6 10.2 11.7 12.7 15.0 Net Interest 1,467 1,245 3,957 4,029 3,429
ROCE 15.5 9.6 10.9 11.4 13.8 Net Change – WC (6,822) (11,017) 32,992 8,517 7,715
ROIC 34.8 17.9 23.3 25.3 28.2 Direct taxes (12,528) (11,341) (13,754) (15,939) (21,349)
Turnover (days) Net cash from operations 72,026 28,427 69,231 86,523 103,830
Gross block turnover ratio (x) 3.8 3.1 3.1 2.8 2.7 Capital expenditure (34,930) (47,755) (35,856) (68,624) (66,591)
Debtors 24 27 21 16 17 Acquisitions, net 0 0 0 0 0
Inventory 41 54 53 52 54 Investments (12,263) 30,933 (47,533) (35,000) (30,000)
Creditors 100 107 108 116 121 Others 0 0 0 0 0
Net working capital 44 57 66 17 8 Net cash from investing (47,192) (16,822) (83,389) (103,624) (96,591)
Solvency (x) FCF 24,834 11,605 (14,157) (17,102) 7,239
Net debt-equity (0.1) (0.1) (0.1) 0.0 0.0 Issue of share capital 1,225 (8,231) 8,165 (646) (970)
Interest coverage ratio 51.3 51.0 17.6 19.8 29.2 Increase/(decrease) in debt (5,340) 4,728 40,613 (10,000) (10,000)
Net debt/EBITDA (0.5) (0.5) (0.5) 0.0 0.0 Dividend paid (10,174) (2,813) (10,473) (4,788) (7,181)
Per share (Rs) Interest paid (1,467) (1,245) (3,957) (4,029) (3,429)
Adjusted EPS 45.3 29.7 34.2 39.6 53.0 Others 0 0 0 0 0
BVPS 292.4 289.3 295.1 330.2 376.4 Net cash from financing (15,755) (7,561) 34,348 (19,463) (21,580)
CEPS 62.1 49.4 54.0 61.8 77.4 Net change in Cash 9,079 4,045 20,190 (36,564) (14,341)
DPS 8.5 2.3 8.8 4.0 6.0 Source: Company, Centrum Broking
Dividend payout (%) 18.8 38.0 113.5 10.1 11.3
Valuation (x)
P/E 16.7 25.5 22.1 19.1 14.3
P/BV 2.6 2.6 2.6 2.3 2.0
EV/EBITDA 11.9 14.3 13.0 11.8 9.3
Dividend yield (%) 1.1 0.3 1.2 0.5 0.8
Source: Company, Centrum Broking

Centrum Institutional Research 24


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

Maruti Suzuki (MSIL)


MSIL’s operating profits have been robust and have consistently expanded over Market data
FY11-18. The industry slowed down from Q4FY19, impacting operating profits and Current price: Rs6,931
cash flows. Working capital intensity in the business has been low to moderate and Bloomberg: MSIL IN
positive except in FY19 and FY20, when the industry slowed down. Capex and 52-week H/L: Rs8,400/6270
investments in subsidiaries have been negligible in the last decade. MSIL has
Market cap: Rs2,093.7bn
accumulated cash over the years in the form of investments. Total cash +
investments reached Rs448bn by the end of FY21, not far from the net worth of the Free float: 38.1%
company. We have not seen any significant acquisition or investment in core Avg. daily vol. 3mth: 700,408
operations in the last decade, which is the key reason for its declining return ratios. Source: Bloomberg

OCF improved consistently until FY18, post which industry downturn took a toll: Operating profits have been robust and
consistently expanded until FY18. Industry slowed down from Q4FY19, impacting operating profits and cash flows. Working
capital intensity in the business has been low to moderate and positive except in FY19 and FY20, when the industry slowed
down. In FY19, demand was hit by slowdown in Q4, resulting in higher inventory and receivables. Over FY20-21, demand has
been battered by industry slowdown and the pandemic. However, OCF was better, as creditors increased in FY21.
Exhibit 44: Industry downturn from FY19 broke the trend of consistent improvement in OCF
140,000
Industry downcycle and pandemic
120,000 Consistent improvement in OCF until FY18
100,000
80,000
60,000
Rs Bn

40,000
20,000
0
-20,000
-40,000 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF before WC WC change OCF
Source: Company, Centrum Broking

Analysis of working capital movement: Creditors have always been on the higher end, and hence, NWC has been
negative in most years. Debtor days have been at around 10 days, inventory days at 10-20 days, and creditor days at 30-50
days. Working capital has been in the negative zone in most years due to the nature of the business.
Exhibit 45: High creditors have kept NWC negative in most years
60.0

40.0
Days of revenue

20.0

0.0

-20.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-40.0

-60.0
Debtors Inventory Creditors NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Maruti Suzuki (MSIL) 16 September 2021

Exhibit 46: OCF/PAT Exhibit 47: OCF/EBITDA

2.5 1.8 1.7


2.1 1.6
2.0 1.8 1.8 1.4
1.5 1.6 1.5
1.4 1.4 1.2 1.0 1.0
1.5 0.9 1.0 1.0 1.0
1.0 0.9
x

x
0.9 0.8 0.6
1.0
0.6 0.6 0.5
0.5 0.4
0.2
0.0 0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex, investments and FCF: Capex and investments in subsidiaries have been negligible in the last decade. MSIL has
accumulated cash over the years in the form of investments. Total cash + investments reached Rs448bn by the end of FY21,
which is not far from the net worth of the company.
Exhibit 48: Free cash flows equivalent to cash flows from operations
140,000
120,000
100,000
80,000
Rs Bn

60,000
40,000
20,000
0
-20,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Investments in Subs and Asso Net FCF
Source: Company, Centrum Broking

Exhibit 49: Net fixed asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Fixed Asset turn (x) 6.61 6.74 7.07 7.59 6.46 6.15 6.38 7.06 5.66 5.56
Source: Company, Centrum Broking

Healthy balance sheet with no debt; return ratios declining: MSIL has a healthy balance sheet with no debt and a sizeable
investment and cash book. However, we have not seen any significant acquisition or investment in core operations in the last
decade, which is the key reason for its declining return ratios.
Exhibit 50: RoE declining
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
ROE (%) 25.5 20.2 14.1 18.5 20.0 22.2 19.8 17.1 12.2 8.5
Investments (Rs Bn) 61.5 70.8 101.2 128.1 199.3 282.3 352.9 365.2 364.7 417.9
Source: Company, Centrum Broking

Centrum Institutional Research 26


Maruti Suzuki (MSIL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 830,265 716,904 665,621 835,913 947,379 Equity share capital 1,510 1,510 1,510 1,510 1,510
Operating Expense 595,485 530,316 508,172 633,142 702,095 Reserves & surplus 459,905 482,860 512,158 556,692 617,946
Employee cost 32,549 33,839 34,029 41,503 44,132 Shareholders fund 461,415 484,370 513,668 558,202 619,456
Others 122,176 117,675 107,671 128,924 146,437 Minority Interest 0 0 0 0 0
EBITDA 109,993 74,276 53,453 79,474 110,329 Total debt 1,496 1,613 5,241 2,241 2,241
Depreciation & Amortisation 30,189 35,257 30,315 34,254 42,630 Non Current Liabilities 0 0 0 0 0
EBIT 79,804 39,019 23,138 45,220 67,700 Def tax liab. (net) 5,640 5,984 3,847 3,847 3,847
Interest expenses 758 1,329 1,008 969 1,049 Total liabilities 468,551 491,967 522,756 564,290 625,544
Other income 25,610 34,208 29,464 36,075 42,855 Gross block 263,293 297,969 320,042 365,042 410,042
PBT 104,656 71,898 51,594 80,326 109,505 Less: acc. Depreciation (109,215) (140,157) (170,472) (204,726) (247,356)
Taxes 29,650 14,142 9,297 17,672 24,091 Net block 154,078 157,812 149,570 160,316 162,686
Effective tax rate (%) 28.3 19.7 18.0 22.0 22.0 Capital WIP 16,001 13,374 14,898 14,898 14,898
PAT 75,006 57,756 42,297 62,654 85,414 Net fixed assets 170,079 171,186 164,468 175,214 177,584
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 75,006 57,756 42,297 62,654 85,414 Investments 314,695 352,488 333,710 333,710 333,710
Extraordinary items 0 (1,250) 0 0 0 Inventories 33,257 32,149 30,500 36,289 38,471
Reported PAT 75,006 56,506 42,297 62,654 85,414 Sundry debtors 23,104 21,270 12,766 21,774 21,983
Cash & Cash Equivalents 52,244 12,399 114,521 118,899 191,856
Ratios Loans & advances 162 171 232 232 232
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 35,777 35,858 44,477 46,701 49,036
Growth (%) Trade payables 154,128 126,242 170,055 160,371 178,355
Revenue 6.3 (13.7) (7.2) 25.6 13.3 Other current liab. 0 0 0 0 0
EBITDA (8.8) (32.5) (28.0) 48.7 38.8 Provisions 6,639 7,312 7,863 8,158 8,973
Adj. EPS (2.9) (23.0) (26.8) 48.1 36.3 Net current assets (16,223) (31,707) 24,578 55,366 114,250
Margins (%) Total assets 468,551 491,967 522,756 564,290 625,544
Gross 31.9 31.5 29.3 29.9 31.8
EBITDA 12.8 9.8 7.6 9.0 11.0 Cashflow
EBIT 9.3 5.2 3.3 5.1 6.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 8.7 7.6 6.0 7.1 8.5 Profit Before Tax 104,656 71,898 51,594 80,326 109,505
Returns (%) Depreciation & Amortisation 30,189 35,257 30,315 34,254 42,630
ROE 17.1 12.2 8.5 11.7 14.5 Net Interest 758 1,329 1,008 969 1,049
ROCE 17.1 12.4 8.6 11.7 14.6 Net Change – WC (15,725) (24,361) 45,837 (26,410) 14,073
ROIC 71.0 28.9 19.8 39.5 51.8 Direct taxes (29,599) (13,798) (11,434) (17,672) (24,091)
Turnover (days) Net cash from operations 90,279 69,075 117,320 71,467 143,166
Gross block turnover ratio (x) 3.2 2.4 2.1 2.3 2.3 Capital expenditure (45,419) (36,364) (23,597) (45,000) (45,000)
Debtors 8 11 9 7 8 Acquisitions, net 0 0 0 0 0
Inventory 20 23 22 19 19 Investments (12,248) 474 (53,191) (33,809) (70,000)
Creditors 97 96 106 95 88 Others 0 0 0 0 0
Net working capital (7) (16) 13 24 44 Net cash from investing (57,667) (35,890) (76,788) (78,809) (115,000)
Solvency (x) FCF 32,612 33,185 40,532 (7,342) 28,166
Net debt-equity (0.1) 0.0 (0.2) (0.2) (0.3) Issue of share capital (7,004) (15,431) 591 0 0
Interest coverage ratio 145.1 55.9 53.0 82.0 105.2 Increase/(decrease) in debt 388 117 3,628 (3,000) 0
Net debt/EBITDA (0.5) (0.1) (2.0) (1.5) (1.7) Dividend paid (758) (1,329) (1,008) (969) (1,049)
Per share (Rs) Interest paid (24,160) (18,120) (13,590) (18,120) (24,160)
Adjusted EPS 248.4 191.2 140.1 207.5 282.8 Others 0 0 0 0 0
BVPS 1,527.9 1,603.9 1,700.9 1,848.4 2,051.2 Net cash from financing (31,534) (34,763) (10,379) (22,089) (25,209)
CEPS 348.3 308.0 240.4 320.9 424.0 Net change in Cash 1,078 (1,578) 30,153 (29,431) 2,957
DPS 80.0 60.0 45.0 60.0 80.0 Source: Company, Centrum Broking
Dividend payout (%) 32.2 32.1 32.1 28.9 28.3
Valuation (x)
P/E 27.9 36.2 49.5 33.4 24.5
P/BV 4.5 4.3 4.1 3.7 3.4
EV/EBITDA 18.6 28.0 37.1 24.9 17.3
Dividend yield (%) 1.2 0.9 0.6 0.9 1.2
Source: Company, Centrum Broking

Centrum Institutional Research 27


16 September 2021

Institutional Research
Anish Rankawat
Research Analyst, Auto & Auto Ancillaries
+91 22 4215 9053
[email protected]
SECTOR: AUTO & AUTO ANCILLARIES

TVS Motors (TVSL)


TVSL’s operating cash flows have improved consistently in the past decade, despite Market data
multiple industry disruptions. The company has followed a lean inventory strategy, Current price: Rs545
which yielded benefits during the industry-wide slowdown in FY19. TVSL has a Bloomberg: TVSL IN
history of negative cash conversion cycle, similar to the industry. In FY15, inventory, 52-week H/L: Rs666/407
debtors, and loans and advances increased, impacting working capital, and hence,
Market cap: Rs258.8bn
OCF. Otherwise, OCF to EBITDA has been around 1x, similar to other OEMs. Return
ratios have declined steadily, especially in the last four years. This is majorly due to Free float: 42%
higher investments in subsidiaries such as TVS Singapore, TVS Indonesia, and Avg. daily vol. 3mth: 1,814,973
Sundaram Auto Components starting from FY18. Source: Bloomberg

Consistent improvement in cash flows from operations: OCF has improved consistently in the past decade, despite multiple
industry disruptions. The company followed a lean inventory strategy, which yielded benefits during the industry-wide
slowdown in FY19. In the last three years, payables have seen a sharp rise, leading to better working capital and operating
cash flows.
Exhibit 51: OCF has improved consistently in the last decade
30
Lean inventory
25
strategy, nullifying WC
20 Consistent improvement in OCF generation impact in FY19
15
Rs Bn

10
5
0
-5 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-10
OCF (before WC change) WC Change OCF
Source: Company, Centrum Broking

Analysis of working capital movement: TVSL has a history of negative cash conversion cycle, similar to the industry. Net
working capital has been broadly negative, except in FY15, when short-term loans and advances went up due to VAT
receivables and excise duty dues from the government. Debtor and creditor days have been higher in the last few years,
given the industry slowdown and the pandemic. In FY15, inventory, debtors, and loans and advances increased, impacting
working capital, and hence, OCF. Otherwise, OCF to EBITDA has been around 1x, similar to other OEMs.
Exhibit 52: Working capital has been negative in most years, in line with the industry
100 Negative cash conversion cycle, mirroring the industry
80
60
In Days of Revenue

40
20
0
-20 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-40 FY15 NWC higher due to


increased ST loans &
-60 advances
Debtors Inventory
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
TVS Motors (TVSL) 16 September 2021

Exhibit 53: OCF/PAT (x) Exhibit 54: OCF/EBITDA (x)

4.5 4.2 2 1.8


4 1.8
3.5 1.6
3 1.4
1.1 1.2 1.1
2.3 1.2 1.1 1.0
2.5 2.1 2.0 0.9
1.9 2.0 1
2 1.8 1.6 0.8 0.8
0.8
1.5 1.2
0.6
1 0.4
0.2 0.1
0.5 0.2
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex, investments and FCF: TVSL acquired Norton Motorcycles for GBP16mn in FY20 in an all-cash deal. Investment in
subsidiaries and associates has seen a jump since FY18, with significant uptick in investment in subsidiaries in Singapore and
Indonesia. TVS Credit has seen constant capital infusion from TVSL, reaching Rs1bn by FY21. In the last two years, the
company has invested Rs400mn in Ultraviolet. Over the years, overall capex and investments have slowly moved from
conventional projects to EVs and digital initiatives.
Exhibit 55: Capex intensity and investment in subsidiaries and associates have been high in the last four years
30 Higher investment in subsidiaries since FY18
25
20
Norton acquistion in FY20
15
Rs Bn

10
5
0
-5
-10 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Investment in subs and Associates Net FCF
Source: Company, Centrum Broking

Exhibit 56: Net fixed asset turnover


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Fixed Asset turn (x) 6.61 6.74 7.07 7.59 6.46 6.15 6.38 7.06 5.66 5.56
Source: Company, Centrum Broking

Asset turn: Asset turn has been above a healthy 5x, except in the last couple of years on industry slowdown.
Return ratios declining: Return ratios have been declining steadily, especially in the last four years. This is majorly due to
higher investments in subsidiaries, TVS Singapore, TVS Indonesia, and Sundaram Auto components, starting from FY18; and
slowdown in the industry in last 2 years. This naturally increased the investment base for the company. In FY21, TVS
Indonesia reported annual profits for the first time.
Exhibit 57: RoE on a declining trend
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
ROE (%) 45.9 24.4 19.8 22.7 27.2 28.2 25.1 21.5 17.9 15.7
Investments (Rs Bn) 9.3 8.7 9.0 10.1 12.7 15.9 20.4 23.0 26.1 33.1
Source: Company, Centrum Broking

Centrum Institutional Research 29


TVS Motors (TVSL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22A FY23A YE Mar (Rs mn) FY19A FY20A FY21A FY22A FY23A
Revenues 182,099 164,233 167,505 206,116 238,596 Equity share capital 475 475 475 475 475
Operating Expense 138,423 121,359 127,239 156,236 180,140 Reserves & surplus 32,998 35,706 41,234 47,906 56,810
Employee cost 9,226 9,384 9,485 11,130 12,646 Shareholders fund 33,473 36,181 41,710 48,381 57,285
Others 20,118 20,031 16,497 19,993 21,951 Minority Interest 0 0 0 0 0
EBITDA 14,333 13,459 14,286 18,757 23,860 Total debt 13,779 20,843 11,590 13,090 12,090
Depreciation & Amortisation 3,993 4,890 4,937 6,051 6,681 Non Current Liabilities 597 929 1,163 1,291 1,433
EBIT 10,340 8,568 9,349 12,706 17,179 Def tax liab. (net) 2,126 1,581 1,955 1,955 1,955
Interest expenses 806 1,022 1,416 1,172 1,196 Total liabilities 49,975 59,533 56,417 64,717 72,763
Other income 75 321 329 345 363 Gross block 50,536 58,071 63,232 71,232 77,232
PBT 9,610 7,867 8,262 11,879 16,345 Less: acc. Depreciation (24,743) (29,071) (33,128) (39,179) (45,860)
Taxes 2,908 1,622 2,142 2,990 4,114 Net block 25,793 28,999 30,104 32,053 31,372
Effective tax rate (%) 30.3 20.6 25.9 25.2 25.2 Capital WIP 2,572 2,854 2,787 2,787 2,787
PAT 6,701 6,246 6,120 8,889 12,231 Net fixed assets 28,365 31,854 32,890 34,839 34,158
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 6,701 6,246 6,120 8,889 12,231 Investments 23,007 26,059 33,145 37,145 40,145
Extraordinary items 0 (323) 0 0 0 Inventories 11,759 10,389 11,518 13,553 15,689
Reported PAT 6,701 5,923 6,120 8,889 12,231 Sundry debtors 14,141 12,814 8,700 16,376 18,957
Cash & Cash Equivalents 439 4,192 8,590 1,542 2,245
Ratios Loans & advances 0 0 0 0 0
YE Mar FY19A FY20A FY21A FY22A FY23A
Other current assets 5,982 8,305 7,132 7,132 7,132
Growth (%) Trade payables 29,239 28,864 39,216 39,529 39,221
Revenue 20.4 (9.8) 2.0 23.1 15.8 Other current liab. 3,893 4,381 5,579 5,579 5,579
EBITDA 26.9 (6.1) 6.1 31.3 27.2 Provisions 586 834 762 762 762
Adj. EPS 1.1 (6.8) (2.0) 45.3 37.6 Net current assets (1,397) 1,621 (9,618) (7,268) (1,540)
Margins (%) Total assets 49,975 59,533 56,417 64,717 72,763
Gross 24.0 26.1 24.0 24.2 24.5
EBITDA 7.9 8.2 8.5 9.1 10.0 Cashflow
EBIT 5.7 5.2 5.6 6.2 7.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22A FY23A
Adjusted PAT 3.7 3.8 3.7 4.3 5.1 Profit Before Tax 9,610 7,867 8,262 11,879 16,345
Returns (%) Depreciation & Amortisation 3,993 4,890 4,937 6,051 6,681
ROE 21.5 17.9 15.7 19.7 23.2 Net Interest 75 321 329 345 363
ROCE 16.8 13.5 13.0 17.0 20.1 Net Change – WC (2,405) 1,068 15,871 (9,270) (4,882)
ROIC 33.9 26.9 36.1 55.4 51.7 Direct taxes (2,264) (2,167) (1,768) (2,990) (4,114)
Turnover (days) Net cash from operations 9,009 11,656 27,631 6,015 14,393
Gross block turnover ratio (x) 3.6 2.8 2.6 2.9 3.1 Capital expenditure (7,328) (8,379) (5,973) (8,000) (6,000)
Debtors 24 30 23 22 27 Acquisitions, net 0 0 0 0 0
Inventory 28 33 31 29 30 Investments (2,653) (3,052) (7,086) (4,000) (3,000)
Creditors 72 87 98 92 80 Others 0 0 0 0 0
Net working capital (3) 4 (21) (13) (2) Net cash from investing (9,981) (11,431) (13,060) (12,000) (9,000)
Solvency (x) FCF (972) 225 14,571 (5,985) 5,393
Net debt-equity 0.4 0.5 0.1 0.2 0.2 Issue of share capital (28) (1,274) 1,072 0 0
Interest coverage ratio 17.8 13.2 10.1 16.0 19.9 Increase/(decrease) in debt 3,410 7,064 (9,253) 1,500 (1,000)
Net debt/EBITDA 0.9 1.2 0.2 0.6 0.4 Dividend paid (2,005) (1,940) (1,663) (2,218) (3,327)
Per share (Rs) Interest paid (806) (1,022) (1,416) (1,172) (1,196)
Adjusted EPS 14.1 13.1 12.9 18.7 25.7 Others 0 0 0 0 0
BVPS 70.5 76.2 87.8 101.8 120.6 Net cash from financing 572 2,827 (11,260) (1,890) (5,523)
CEPS 22.5 23.4 23.3 31.4 39.8 Net change in Cash (401) 3,052 3,311 (7,875) (130)
DPS 4.2 4.1 3.5 4.7 7.0 Source: Company, Centrum Broking
Dividend payout (%) 29.9 32.8 27.2 24.9 27.2
Valuation (x)
P/E 38.6 41.4 42.3 29.1 21.2
P/BV 7.7 7.2 6.2 5.3 4.5
EV/EBITDA 19.0 20.5 18.3 14.4 11.3
Dividend yield (%) 0.8 0.7 0.6 0.9 1.3
Source: Company, Centrum Broking

Centrum Institutional Research 30


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Aviation
+91 22 4215 9021
SECTOR: AVIATION [email protected]
Vaibhav Shah
Research Associate, Aviation

InterGlobe Aviation (IndiGo) +91 22 4215 9815


[email protected]

IndiGo has generated strong operating cash flows over the last decade (except for Market data
Covid-impacted FY21), albeit with some amount of cyclicality. This cyclicality is Current price: Rs1,979
caused by higher linkage with crude prices (~1/3rd of the total cost) as well as Bloomberg: INDIGO IN
fluctuations in yield. Demand growth over this period has remained strong by and
52-week H/L: Rs2,024/1,181
large. Working capital levels have been low till FY18, post which there has been an
Market cap: Rs762.3bn
increase due to GST paid under protest and higher levels of restricted cash. IndiGo
has generated total operating cash flows of Rs112bn and FCF of Rs45.4bn over FY12- Free float: 25.2%
21 (FCF of Rs82bn over FY12-20). Free cash balance declined to Rs71bn as at March Avg. daily vol. 3mth: 677,877
2021 from Rs89.2bn in March 2020 and further to Rs56.2bn in June 2021. Source: Bloomberg

Cash generation largely positive, but cyclical: Cash flows from operations have been positive except in the Covid-impacted
FY21. However, given the volatility in the business, especially due to dependence on crude, there is cyclicality in cash
generation. Operating cash flows (net of interest) plunged in FY19 due to higher crude prices and weaker yields and
rebounded in FY20 as the impact reversed. The plunge in FY21 was driven by disruption caused by Covid.
Exhibit 58: Operating cash flows* of Rs112bn over the last 10 years
45,000 Sharp fall in
30,000 traffic amid
Covid
15,000
-
Rs mn

(15,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(30,000)
Robust volume growth Lower yields and Fall in crude prices
(45,000)
and healthy spreads led higher crude price and improved yields
(60,000) to strong CFO led to weak CFO improved CFO

Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO post lease payments (Rs mn)

Source: Company, Centrum Broking; *: net of lease payments

Working capital levels low historically: The Aviation business – driven by forward sales of tickets, minimum inventories,
provisions for future maintenance and deferred payments of supplementary rentals – is typically not a working capital
intensive business. IndiGo’s working capital cycle has been low over large part of the decade in the range of 5 to 15 days.
However, in the recent years, it has increased materially due to GST payments under protest carried as collectibles and
increase in restricted cash levels. FY21 was highly disrupted year amid outbreak of Covid.
Exhibit 59: Working capital levels* largely moderate; have risen materially in last 2-3 years
175 Rise in working capital levels due
150 to GST receivables and rise in
restricted cash levels
125
100
Days

75
50
25
-
(25) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Forward sales and advances (days) Provisions (days) Supplementary rentals (days) NWC ex cash (days)
Source: Company, Centrum Broking; *: including restricted cash balances

Please see Appendix for analyst certifications and all other important disclosures.
InterGlobe Aviation (IndiGo) 16 September 2021

Exhibit 60: EBITDAR to CFO* conversion at 29% in 10 years Exhibit 61: PAT to CFO conversion remained strong

75% 400%

300%
50%

200%

25%
100%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21# FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking *net of lease payments; #: CFO negative and
Source: Company, Centrum Broking
EBITDAR miniscule making the ratio irrelevant in FY21

FCF generation impacted by Covid in FY21: Total operating cash flows of Rs112bn over FY12-21 have adequately supported
capex of Rs86bn. Also, IndiGo generated gain on sale and leaseback of aircraft worth Rs18.8bn in FY21. Overall, FCF of
Rs45.4bn appears modest, as it was impacted by (-ve) FCF of Rs36.6bn in FY21. IndiGo had free cash balance of Rs71bn as at
March 2021 (Rs89.2bn in March 2020), which got further depleted to Rs56.2bn in June 2021.
Exhibit 62: FCF generation modest at Rs45.4bn over FY12-21, impacted by steep cash burn in FY21
40,000

20,000

-
Rs mn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)

(40,000)

(60,000)
CFO post lease payments Capex Proceeds from sale and lease back of aircrafts Net FCF
Source: Company, Centrum Broking

Exhibit 63: FCF used for debt repayment and for dividends; payouts declined since FY19
Rs mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF 5,056 3,434 (12,535) 6,316 21,942 33,132 14,009 (7,305) 17,897 (36,588) 45,358
Inflow from equity raise/dividend outflow (5,700) (6,376) - (16,128) (1,133) (6,515) 10,281 (2,780) (2,073) 93 (30,332)
Increase/ (decrease) in net debt 644 2,943 12,535 9,812 (20,808) (26,618) (24,290) 10,085 (15,823) 36,495 (15,025)
Source: Company, Centrum Broking

Exhibit 64: Return ratios volatile due to accounting issues and inherent volatility in business
Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 81.3% 402.7% 117.0% 307.6% 126.1% 51.0% 41.3% 2.2% -3.9% -196.5%
RoCE pre-tax -0.6% 95.5% 20.0% 48.3% 62.0% 41.6% 44.1% 3.9% 8.5% -12.6%
RoCE -1.1% 75.7% 20.0% 34.1% 43.6% 32.2% 31.7% -4.0% 7.7% -12.6%
Source: Company, Centrum Broking

Centrum Institutional Research 32


InterGlobe Aviation (IndiGo) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 2,84,968 3,57,560 1,46,406 2,37,587 3,71,070 Equity share capital 3,844 3,848 3,849 3,849 3,849
Operating Expense 1,89,667 1,60,400 57,801 1,05,874 1,41,772 Reserves & surplus 65,604 54,776 (3,140) (54,784) (37,233)
Employee cost 31,378 43,954 30,262 32,298 37,466 Shareholders fund 69,448 58,624 709 (50,935) (33,384)
Others 65,977 1,12,825 58,598 81,918 97,905 Minority Interest 0 0 0 0 0
EBITDAR 40,861 50,824 6,101 22,085 99,903 Total debt 21,937 24,343 41,210 65,056 65,056
Depreciation & Amortisation 7,596 39,736 46,987 52,744 52,145 Non Current Liabilities 0 2,02,849 2,57,387 3,11,674 3,70,490
EBIT (9,650) 645 (47,241) (35,246) 41,781 Def tax liab. (net) 644 (2,949) (2,949) (2,949) (2,949)
Interest expenses 5,090 18,759 21,420 23,017 27,165 Total liabilities 92,029 2,82,867 2,96,356 3,22,846 3,99,213
Other income 13,249 15,362 10,363 6,619 8,838 Gross block 86,167 2,12,375 2,73,689 3,56,431 4,46,581
PBT (1,490) (2,751) (58,298) (51,644) 23,455 Less: acc. Depreciation (29,547) (44,593) (85,535) (1,38,234) (1,90,334)
Taxes (3,052) (269) 0 0 5,904 Net block 56,620 1,67,782 1,88,155 2,18,197 2,56,247
Effective tax rate (%) 204.8 9.8 0.0 0.0 25.2 Capital WIP 220 1,402 717 717 717
PAT 1,562 (2,482) (58,298) (51,644) 17,551 Net fixed assets 56,841 1,69,184 1,88,872 2,18,915 2,56,964
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 1,562 (2,482) (58,298) (51,644) 17,551 Investments 65,167 94,994 72,902 42,902 42,902
Extraordinary items 0 0 0 0 0 Inventories 2,114 2,861 3,164 3,374 2,414
Reported PAT 1,562 (2,482) (58,298) (51,644) 17,551 Sundry debtors 3,625 2,596 2,192 1,953 3,050
Cash & Cash Equivalents 7,128 6,760 5,083 34,293 70,606
Ratios Loans & advances 10,509 17,293 17,074 11,717 18,299
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,04,718 1,23,847 1,37,506 1,26,732 1,43,391
Growth (%)
Trade payables 14,552 15,655 15,561 11,592 15,526
Revenue 23.8 25.5 (59.1) 62.3 56.2
Other current liab. 1,39,148 99,530 93,436 90,781 1,12,834
EBITDAR (38.6) 24.4 (88.0) 1039.5 15.2 Provisions 4,372 19,484 21,440 14,665 10,053
Adj. EPS (93.0) nm NM NM 14.6 Net current assets (29,979) 18,689 34,582 61,030 99,347
Margins (%) Total assets 92,029 2,82,867 2,96,356 3,22,846 3,99,213
Gross 33.4 55.1 60.5 55.4 61.8
EBITDAR 14.3 14.2 4.2 9.3 26.9 Cashflow
EBIT (3.4) 0.2 (32.3) (14.8) 11.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 0.5 (0.7) (39.8) (21.7) 4.7 Operating profit bef working capital
6,105 21,902 (40,243) (25,122) 47,466
Returns (%) changes
ROE 2.2 (3.9) NM NM NM Net change - WC 19,844 165 (17,095) 2,762 (2,004)
ROCE (4.0) 7.7 NM NM 11.0 Direct Taxes - (8) - - (5,904)
ROIC 41.6 0.6 NM NM 11.8 Cash flow from operations 25,950 22,059 (57,338) (22,359) 39,558
Turnover (days) Net Capex (18,323) (10,605) 16,795 (2,278) (3,245)
Gross block turnover ratio (x) 3.3 1.7 0.5 0.7 0.8 Long term Investments (1,727) (29,827) 22,092 30,000 -
Debtors 4 3 6 3 2 Others (120) 15,595 (95) 0
Inventory 4 6 19 11 7 Cash flow from investing activities (20,170) (24,837) 38,792 27,723 (3,245)
Creditors 24 34 99 47 35 FCF 7,626 11,454 (40,543) (24,637) 36,313
Net working capital (38) 19 86 94 98 Issue of share capital - 4 1 - -
Solvency (x) Increase/(decrease) in debt (2,591) 2,406 16,867 23,846 -
Net debt-equity 0.2 0.3 50.9 (0.6) 0.2 Dividend (2,768) - - - -
Interest coverage ratio 8.0 2.7 0.3 1.0 3.7 Cash flow from financing (5,358) 2,410 16,868 23,846 -
Net debt/EBITDAR 0.4 0.3 5.9 1.4 (0.1) Net change in cash 422 (367) (1,678) 29,210 36,313
Per share (Rs) Source: Company, Centrum Broking
Adjusted EPS 4.1 NM NM NM 45.6
BVPS 180.7 152.4 1.8 NM NM
CEPS 23.8 96.8 (29.4) 2.9 181.1
DPS 0.0 0.0 0.0 0.0 0.0
Dividend payout (%) 0.0 NM NM NM 0.0
Valuation (x)
P/E 270.8 nm nm nm 42.9
P/BV 6.1 9.7 717.6 nm nm
EV/EBITDAR 14.7 12.9 1,024.2 53.6 11.7
Dividend yield (%) 0.0 0.0 0.0 0.0 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 33


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Aviation
+91 22 4215 9021
SECTOR: AVIATION [email protected]
Vaibhav Shah

SpiceJet Research Associate, Aviation


+91 22 4215 9815
[email protected]

SpiceJet’s cash generation has been poor over the last decade (except for a brief Market data
recovery during FY16-18) due to the distress it went through during FY12-15. Cash Current price: Rs76
flows improved during FY16-18 post restructuring of the company and general Bloomberg: SJET IN
improvement in the industry (lower crude prices and better yields). CFO deteriorated 52-week H/L: Rs108/46
again since FY19, as the pricing could not keep up with the rising crude prices. NWC
Market cap: Rs45.5bn
has remained negative throughout, as SpiceJet was able to delay its payments to
vendors, lessors, etc, consistently. SpiceJet has generated total CFO of only Rs16.4bn Free float: 40.5%
and negative FCF of Rs14.5bn over FY12-21. RoE is immaterial for the company, as its Avg. daily vol. 3mth: 5,264,939
net worth has remained negative for the past 10 years. Source: Bloomberg

Cash generation largely poor: Cash flow from operations was negative during FY12-15 due to low yields, low load factors,
and high crude prices. CFO improved during FY16-18 post restructuring of the company and strong tailwinds of growth and
low/moderate crude prices. In this period, fuel costs declined, SpiceJet rationalized its fleet, and yields remained strong,
leading to strong cash flows. However, with falling yields and rising crude, CFO once again deteriorated over FY19/20. The
decline in CFO in FY21 was restricted by deferment of lease payments.
Exhibit 65: Operating cash flows* weakened again after a brief recovery
12,000 Low yields, over-capacity/low load factors and
High crude
high crude prices led to negative CFO in FY12-15
9,000 prices led to
contraction in
6,000
CFO in FY19-20
3,000
Rs mn

-
(3,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(6,000)
(9,000) Despite Covid impact, fall in
Improved volumes and rationalization of fleet
CFO was not material, led by
along with falling crude led to strong CFO
deferrals of lease payments
Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking *net of lease payments

Working capital has remained negative: SpiceJet’s WC cycle has been negative throughout the decade, in line with the
inherent characteristics of the industry (forward ticket sales, future maintenance provisions, deferred incentives, etc) and
also owing to delay in payments to vendors and lessors. During FY20 and FY21, the build-up in receivables is due to accruing
of claims worth Rs12.3bn from Boeing.
Exhibit 66: WC remained negative, aided by delayed payments; recent deterioration due to rise in Boeing receivables
180 Elongated payables and increase in Claims of Rs12.3bn
provision for aircraft maintenance Unwinding of payables, (cumulative) from Boeing
120 aided by improved CFO

60
Days

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-60

-120 Deferral of
lease payments
Payables (days) Provisions (days) Receivables days NWC ex cash (days)

Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
SpiceJet 16 September 2021

Exhibit 67: EBITDAR to CFO^ conversion at 16% in 10 years Exhibit 68: PAT to CFO^ conversion negative due to losses

75% 200%

50% 150%

100%
25%

50%
0%
FY12* FY13 FY14 FY15* FY16 FY17 FY18 FY19 FY20 FY21
0%
-25% FY12*FY13*FY14*FY15* FY16 FY17 FY18 FY19*FY20*FY21*

Source: Company, Centrum Broking; ^: net of lease payments; *: CFO or EBITDAR Source: Company, Centrum Broking; *: company has made losses in these years;
negligible in these years ^: net of lease payments

FCF generation largely weak, except for a brief period of FY16-18: Total operating cash flow of Rs16.4bn over FY12-21 could
not even suffice capex requirements of Rs27bn. Over and above, deposits of Rs5.8bn made with Delhi HC over FY18-20
further deteriorated FCF. Consequently, SpiceJet has reported negative FCF of Rs14.5bn over this period. SpiceJet could
generate strong FCF only for a brief period of FY16-18, when the aviation industry performed well. Otherwise, FCF generation
has been largely negative.
Exhibit 69: Negative FCF of Rs14.5bn over FY12-21 accentuated by steep cash burn in FY21
10,000

5,000
Rs mn

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(5,000)

(10,000)
CFO Capex Investments in subs/Deposits with Delhi HC Net FCF
Source: Company, Centrum Broking

Exhibit 70: Negative FCF has been funded through capital raise and incremental debt proceeds over FY12-21
Rs mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF (7,564) (9,096) (1,253) (5,386) 4,328 1,898 4,579 375 (367) (1,987) (14,473)
Inflow from capital raise 1,315 1,130 990 4,254 500 - - 3 4 9 8,204
Increase/ (decrease) in net debt 6,249 7,966 263 1,132 (4,828) (1,898) (4,579) (378) 364 1,978 6,269
Source: Company, Centrum Broking

Centrum Institutional Research 35


SpiceJet 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 91,133 123,586 51,334 77,274 127,949 Equity share capital 5,997 6,001 6,009 6,009 6,009
Operating Expense 69,983 82,955 35,460 58,462 80,361 Reserves & surplus (9,504) (21,793) (31,725) (46,932) (42,530)
Employee cost 10,570 15,258 6,762 7,777 12,443 Shareholders fund (3,507) (15,793) (25,715) (40,923) (36,520)
Others 10,678 20,410 7,368 10,940 12,581 Minority Interest 0 0 0 0 0
EBITDAR 12,868 15,313 9,832 9,035 28,912 Total debt 11,098 10,967 7,072 7,072 7,072
Depreciation & Amortisation 2,562 17,339 15,580 13,454 13,617 Non Current Liabilities 0 89,532 84,462 78,139 56,744
EBIT (2,661) (12,375) (13,837) (13,359) 8,946 Def tax liab. (net) 0 0 0 0 0
Interest expenses 1,313 5,450 6,021 5,929 5,661 Total liabilities 7,591 84,706 65,818 44,288 27,295
Other income 1,448 8,478 9,874 4,080 1,117 Gross block 24,890 112,074 109,573 107,605 107,870
PBT (2,526) (9,348) (9,983) (15,207) 4,402 Less: acc. Depreciation (8,852) (25,265) (39,513) (52,967) (66,584)
Taxes 0 0 0 0 0 Net block 16,038 86,810 70,060 54,639 41,286
Effective tax rate (%) 0.0 0.0 0.0 0.0 0.0 Capital WIP 0 0 0 0 0
PAT (2,526) (9,348) (9,983) (15,207) 4,402 Net fixed assets 16,038 86,810 70,060 54,639 41,286
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT (2,526) (9,348) (9,983) (15,207) 4,402 Investments 4 5 26 26 26
Extraordinary items (635) 0 0 0 0 Inventories 1,373 1,776 1,558 1,768 1,767
Reported PAT (3,161) (9,348) (9,983) (15,207) 4,402 Sundry debtors 7,144 15,458 20,398 11,602 10,997
Cash & Cash Equivalents 779 402 320 331 757
Ratios Loans & advances 14,286 15,102 13,981 13,996 13,996
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 8,326 10,115 7,412 7,412 7,412
Growth (%)
Trade payables 10,591 17,371 17,106 15,921 15,718
Revenue 16.9 35.6 (58.5) 50.5 65.6
Other current liab. 23,310 16,545 20,407 18,705 22,200
EBITDAR (28.1) 19.0 (35.8) (8.1) 220.0 Provisions 6,459 11,047 10,423 10,860 11,029
Adj. EPS nm 269.8 6.6 52.3 nm Net current assets (8,451) (2,109) (4,267) (10,376) (14,017)
Margins (%) Total assets 7,591 84,706 65,818 44,288 27,295
Gross 23.2 32.9 30.9 24.3 37.2
EBITDAR 14.1 12.4 19.2 11.7 22.6 Cashflow
EBIT (2.9) (10.0) (27.0) (17.3) 7.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT (2.8) (7.6) (19.4) (19.7) 3.4 Operating profit bef working capital
36 164 3,618 (6,597) (3,375)
Returns (%) changes
ROE 128.3 96.9 48.1 45.6 (11.4) Trade and other receivables (6,293) (8,314) (4,940) 8,796 604
ROCE (13.1) (8.4) (5.3) (16.9) 28.1 Trade payables 3,558 6,780 (265) (1,186) (202)
ROIC (34.9) (27.2) (18.5) (24.4) 25.4 Net change - WC 1,713 5,345 2,077 6,120 4,066
Turnover (days) Direct Taxes - - - - -
Gross block turnover ratio (x) 3.7 1.1 0.5 0.7 1.2 Cash flow from operations 1,749 5,509 5,695 (477) 691
Debtors 16 33 127 76 32 Net Capex (2,623) (3,395) (1,921) 487 (265)
Inventory 7 7 17 10 8 Long term Investments 1,009 (1) (21) - -
Creditors 46 62 177 103 72 Others (554) (2,364) 52 - -

Net working capital (34) (6) (30) (49) (40) Cash flow from investing activities (2,168) (5,760) (1,889) 487 (265)
Solvency (x) FCF (419) (251) 3,806 11 426
Net debt-equity (2.9) (0.7) (0.3) (0.2) (0.2) Issue of share capital 3 4 9 - -
Interest coverage ratio 9.8 2.8 1.6 1.5 5.1 Increase/(decrease) in debt (263) (131) (3,896) - -
Net debt/EBITDAR 0.8 0.7 0.7 0.7 0.2 Dividend - - - - -
Per share (Rs) Cash flow from financing (260) (127) (3,887) - -
Adjusted EPS (4.2) (15.6) (16.6) (25.3) 7.3 Net change in cash (679) (377) (81) 11 426
BVPS (5.8) (26.3) (42.8) (68.1) (60.8) Source: Company, Centrum Broking
CEPS 0.1 13.3 9.3 (2.9) 30.0
DPS 0.0 0.0 0.0 0.0 0.0
Dividend payout (%) nm nm nm nm 0.0
Valuation (x)
P/E nm nm nm nm 10.4
P/BV nm nm nm nm nm
EV/EBITDAR 13.2 17.2 23.8 26.7 8.1
Dividend yield (%) 0.0 0.0 0.0 0.0 0.00
Source: Company, Centrum Broking

Centrum Institutional Research 36


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

Axis Bank
Axis Bank has done well on building up its retail franchise, with the share of RTD and Market data
retail loans growing over FY12-21. Though stress to average assets peaked in FY18, Current price: Rs803
credit costs remained elevated post FY18, driven by a miss on asset quality, which Bloomberg: AXSB IN
resulted in sub-optimal returns profile. NIM, which saw a declining trend mainly led 52-week H/L: Rs819/400
by interest reversals, improved over FY18-21. Fee income performance has been
Market cap: Rs2,461bn
weaker as the share of corporate declined while operating leverage played out well
as the bank increased its reach. ALM profile suggests a negative mismatch in the <1- Free float: 85.7%
year bucket, which exposes the bank to interest rate risk in a rising interest rate Avg. daily vol. 3mth: 7,275,114
scenario. Over FY19-21, this negative imbalance has reduced. Source: Bloomberg

Wholesale funding reduced in favour of RTD: CASA contribution to total deposits has been rather volatile for Axis; FY12-18
saw CASA ratio rising from 41.5% to 53.8% (stagnant over FY13-15 at 44.5%). FY18-21 saw the CASA ratio reverting to 44%
levels. Its strategy of concentrating on building a granular and sticky deposit franchise has worked well for Axis. The share of
RTD has consistently risen from 22% to 40% of total deposits, while the share of bulk deposits has reduced from 32% to 14%
over FY12-21. On loan mix, the share of retail has increased from 32% in FY12 to 54% in FY21. The other positive has been the
reduction of overseas loan contribution, which declined from 15% to 7% over FY12-21.

Exhibit 71: RTD share improved consistently Exhibit 72: Retail share improved; overseas share declined

Deposit mix Advances mix


100% 100%

80% 80%

60% 60%

40% 40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RTD Savings Current Wholesale Overseas Retail Corporate SME Overseas
Source: Company, Centrum Broking Source: Company, Centrum Broking

Stress recognized over FY13-18; improvement slower post FY18 compared to ICICI: Total stress, defined as NNPA +
restructuring + net SR, rose over FY13-18 from 1.6% to 3.4%, led by stress in the infrastructure space. This was also reflected
in a rise in industry GNPA from 1.7% in FY15 to 15.2% in FY18. Overall stress declined drastically over FY18-21 from 3.4% to
1.3%. Compared to ICICI, Axis saw lower stress recognition over FY16-18; however, post FY18, ICICI saw a sharper improvement
in asset quality as also reflected in lower delinquencies in terms of slippage ratio for ICICI compared to Axis. Led by the
pandemic-related lockdown, overall stress rose slightly in FY21. FY21 saw personal loan GNPA rising from 0.7% to 1.5%.

Exhibit 73: Stress has reduced post FY18 Exhibit 74: FY21 saw a spike in personal loan GNPA

Balance sheet stress Segment-wise GNPA


4% 40% 16%
14%
3% 30% 12%
10%
2% 20% 8%
6%
1% 10% 4%
2%
0% 0% 0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Agri Industry Services Personal Overall
Stress to avg. assets Stress to equity (RHS) FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Axis Bank 16 September 2021

Exhibit 75: Weak NIM profile; opex has improved Exhibit 76: Elevated credit cost cycle depressed RoE

Du pont % (to avg. assets) Return ratios (%)


3.5 2.8 1.8 21
3.0 2.4 1.5 18
2.0 1.2 15
2.5
1.6 12
2.0 0.9
1.2 9
1.5 0.6 6
0.8
1.0 0.4 0.3 3
0.5 0.0 0.0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM Opex PPoP Fees (RHS) Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

NIM performance over FY12-21 has been weak; opex has done better: Despite a rise in retail share over FY12-21, NIM has
remained stagnant, which means market share gains may have happened by diluting pricing. Although NIM improved from
2.91% to 3.35% over FY12-16, it declined over FY17-20, also led by interest reversals and CASA decline. Fees to average assets
has been at 1.2-1.3% over FY16-21, down from ~1.6% over FY12-13, as corporate share shifted in favour of retail. Opex leverage
played out, with opex to assets declining over FY12-20 from 227bp to 200bp. Provisioning costs spiked from 43bp in FY12 to
239bp in FY18 and remained at elevated levels, which led to a RoE decline (peak 20% in FY12, bottom 0.5% in FY18).

Exhibit 77: Shift from borrowings to deposits Exhibit 78: Balance sheet liquidity increased recently
Liability mix Asset mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Deposits Borrowings Capital Other Liabilities Advances Investments Cash Other assets Fixed assets
Source: Company, Centrum Broking Source: Company, Centrum Broking

Liability mix shifting from borrowings to deposits; increased liquidity recently: Over FY12-18, Axis relied more on borrowings,
which increased from 12% of total liabilities to 21%. Since it started focusing on RTD, the share of borrowings reduced from
21% in FY18 to 14% in FY21. In the last decade, the bank raised equity thrice, in FY13, FY18 and FY21, leading to an improvement
in CET-1 ratio. As at FY21, CET-1 ratio stood at 15.4%. On assets, liquidity declined over FY12-18, while the share of advances
rose from 59% to 64%. However, from FY19 to FY21, the bank again increased liquidity buffers, as asset quality issues were not
completely resolved till FY20.

Exhibit 79: ALM profile stabilized only recently Exhibit 80: Mismatch in the <1-year bucket has reduced
Asset (A) Liability (L) Maturity pattern ALM mismatch (%)
100% 0

80% -5
60%
-10
40%
20% -15

0% -20
A L A L A L A L A L A L A L A L A L A L
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -25
<1yr 1-3yr 3-5yr >5yr FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile was unbalanced, with a negative gap; it improved only recently: Over FY12-19, the bank’s ALM profile was more
volatile with a negative drift. The <1-year bucket saw a largely negative gap ranging from -10% to -26%, indicating that liabilities
matured faster than assets. A more unbalanced ALM mix suggests NIM would also be sensitive to systemic interest rate
movements. Post FY19, the bank’s ALM profile became more balanced, led by a focus on retail term deposits. Share of >5-year
deposits rose from 36% in FY19 to 63% in FY21. A more balanced ALM profile would lead to more dependence on loan and
deposit mix rather than systemic interest rates.

Centrum Institutional Research 38


Axis Bank 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest earned 549,858 626,352 636,453 686,118 799,050 Share capital 5,143 5,643 6,128 6,128 6,128
Interest expended 332,776 374,290 344,062 362,904 435,851 Reserves & surplus 661,620 843,835 1,009,903 1,106,722 1,231,990
Net Interest Income 217,082 252,062 292,391 323,214 363,199 Deposits 5,484,714 6,401,050 7,073,061 7,921,828 8,872,447
Other income 131,303 155,369 148,382 178,077 197,800 Borrowings 1,527,758 1,479,541 1,428,732 1,508,920 1,689,990
Total Income 348,385 407,431 440,773 501,291 560,999 Other Liabilities 330,731 421,579 443,362 445,444 481,004
Operating Expenses 158,334 173,046 183,752 215,555 237,864 Total liabilities 8,009,966 9,151,649 9,961,184 10,989,041 12,281,559
Employees 47,473 51,508 61,640 70,886 81,519 Cash balances with RBI 350,987 849,593 518,086 471,537 528,122
Others 110,861 121,538 122,111 140,428 161,492 Balances with banks 321,059 123,090 99,213 100,998 102,816
Operating profit 190,051 234,385 257,022 285,736 323,135 Investments 1,749,693 1,567,343 2,261,193 2,376,549 2,661,734
Provisions 120,310 185,339 168,963 141,485 135,913 Advances 4,947,980 5,714,242 6,237,202 6,985,666 7,900,789
Profit before tax 69,741 49,046 88,058 144,251 187,222 Fixed Assets 40,366 43,129 42,450 43,299 44,165
Taxes 22,975 32,772 22,173 36,351 47,180 Other Assets 599,880 854,252 803,041 1,010,992 1,043,933
Net Profit 46,766 16,274 65,885 107,900 140,042 Total assets 8,009,965 9,151,649 9,961,184 10,989,041 12,281,559

Ratios Ratios
YE Mar FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Growth (%) Balance Sheet (%)
Loans 12.5 15.5 9.2 12.0 13.1 Loans / Deposits 90.2 89.3 88.2 88.2 89.0
Deposits 20.9 16.7 10.5 12.0 12.0 Investments / Deposits 31.9 24.5 32.0 30.0 30.0
RWA growth 6.6 11.1 4.0 12.0 15.2 CASA 44.4 41.2 44.9 44.0 43.0
NII 16.6 16.1 16.0 10.5 12.4 Assets/equity (x) 12.0 10.8 9.8 9.9 9.9
Other income 19.7 18.3 (4.5) 20.0 11.1 RWA / Total assets 68.9 67.0 64.0 65.0 67.0
Opex 13.2 9.3 6.2 17.3 10.3 Capital ratios (%)
PPoP 21.9 23.3 9.7 11.2 13.1 CET-1 11.3 13.3 15.4 15.1 14.7
Provisions (22.2) 54.1 (8.8) (16.3) (3.9) Tier-1 12.5 14.5 16.5 16.1 15.5
Net profit 1,596.4 (65.2) 304.9 63.8 29.8 Tier-2 3.3 3.0 2.6 2.8 3.0
Profitability (%) CRAR 15.8 17.5 19.1 18.9 18.5
Yield on assets 8.4 8.7 8.0 7.6 7.9 Asset quality ratios (%)
Cost of funds 5.1 5.0 4.2 4.0 4.4 GNPA (Rs mn) 297,896 302,346 253,148 258,280 284,227
NIM 3.3 3.5 3.7 3.6 3.6 NNPA (Rs mn) 114,389 93,602 69,935 77,484 90,953
Other income / Total inc. 37.7 38.1 33.7 35.5 35.3 GNPA 5.8 5.1 3.9 3.6 3.5
Other inc. / avg assets 1.8 1.8 1.6 1.7 1.7 NNPA 2.3 1.6 1.1 1.1 1.2
Cost/Income 45.4 42.5 41.7 43.0 42.4 PCR 61.6 69.0 72.4 70.0 68.0
Employee 13.6 12.6 14.0 14.1 14.5 Slippage 3.0 3.7 2.9 2.8 2.5
Other 31.8 29.8 27.7 28.0 28.8 NNPA / Equity 17.2 11.0 6.9 7.0 7.3
Opex/ Avg assets 2.1 2.0 1.9 2.1 2.0 Per share
Provisioning cost 2.6 3.5 2.8 2.1 1.8 EPS 18.2 5.8 21.5 35.2 45.7
Tax rate 32.9 66.8 25.2 25.2 25.2 BVPS 259.3 301.1 331.6 363.2 404.1
RoE 7.2 2.1 7.1 10.1 11.9 ABVPS 214.8 267.9 308.8 337.9 374.4
RoA 0.6 0.2 0.7 1.0 1.2 Valuation (x)
RoRWA 0.9 0.3 1.1 1.6 1.8 P/E 33.2 123.6 24.6 22.8 17.6
Du-pont (%) P/BV 2.3 2.4 1.6 2.2 2.0
Interest income 7.4 7.3 6.7 6.5 6.9 P/ABV 2.8 2.7 1.7 2.4 2.1
Interest expenses 4.5 4.4 3.6 3.5 3.7 Source: Company, Centrum Broking
NII 2.9 2.9 3.1 3.1 3.1
Other income 1.8 1.8 1.6 1.7 1.7
Total income 4.7 4.7 4.6 4.8 4.8
Operating expenses 2.1 2.0 1.9 2.1 2.0
Employee 0.6 0.6 0.6 0.7 0.7
Other 1.5 1.4 1.3 1.4 1.4
PPOP 2.5 2.7 2.7 2.7 2.8
Provisions 1.6 2.2 1.8 1.4 1.2
PBT 0.9 0.6 0.9 1.4 1.6
Tax 0.3 0.4 0.2 0.3 0.4
RoA 0.6 0.2 0.7 1.0 1.2
Source: Company, Centrum Broking

Centrum Institutional Research 39


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
[email protected]
SECTOR: BFSI

Can Fin Homes (Canfin)


Canfin has seen improved performance on the back of controlled asset quality, better Market data
operating leverage and NIM enhancement over FY15-21, supported by lower funding Current price: Rs624
cost driven by sovereign holding, affordable home focus, favourable interest rate Bloomberg: CANF IN
regime, and conducive ALM profile. Share of individual housing has consistently 52-week H/L: Rs653/390
stayed near 90% over FY15-21 and developer exposure has been negligible, leading
Market cap: Rs83.1bn
to superior credit quality. Share of self-employed rose over FY15-21, leading to
increase in GNPA over FY18-21 from 0.2% to 0.9%. NIM/CASA could have done better. Free float: 68.6%
Single product concentration exposes Canfin to interest rate risk since ALM profile Avg. daily vol. 3mth: 1,216,788
suggests a negative mismatch in the <1-year bucket. Source: Bloomberg

Bank funding mix in FY21 similar to FY12 levels; home loans dominate credit: Borrowing mix broadly saw two cycles. Over
FY12-17, the share of banks decreased from 68% to 19%, which was replaced by NCD/NHB/CP. As systemic rates eased post
FY17, funding mix shifted back towards banks and NHB in FY21. Share of banks increased back to 51% in FY17. Affordable
housing focus, asset quality control and sovereign holding allowed access to relatively lower cost bank and NHB funding. Hence,
Canfin has the lowest funding cost among peers. On the loan mix side, share of individual housing has consistently improved
over FY15-21 from 86% to 90%. From the customer segmentation perspective, the share of salaried declined over FY15-21
from 84% to 73.3% while the share of self-employed increased.

Exhibit 81: Lower rates led to increase in bank funding Exhibit 82: Housing share consistently rose from 85% to 90%
Borrowings mix Advances mix
100% 100%

80% 80%

60% 60%
40% 40%
20% 20%
0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0%
FY15 FY16 FY17 FY18 FY19 FY20 FY21
Bank NCD NHB CP Deposits Home LAP Builder Others
Source: Company, Centrum Broking Source: Company, Centrum Broking

Overall GNPA controlled; rise in GNPA led by increase in self-employed share: Over the last 10 years, Canfin’s asset quality
has been broadly controlled. Its GNPA has been best-in-class and has not crossed 1%. However, owing to a rise in self-employed
share, overall GNPA rose from 0.4% in FY13 to 0.9% in FY21. Against 0.5% in the salaried customer segment, GNPA in the self-
employed segment is 1.6%. The rise in overall, housing and non-housing GNPA can be attributed to the rise in the share of self-
employed customers. The overall proportion of stage-2 assets increased over FY18-20 from 4.4% to 6% and improved a bit to
5.4% in FY21. Stage 1&2 provisioning, indicating a buffer, remained largely stable over FY18-21.

Exhibit 83: Non-housing NPA a concern Exhibit 84: Stage 1+2 provisioning adequate for likely stress
Segment-wise GNPA Stage-2 + provision cover
1.5% 6% 55

1.2% 5% 51

0.9% 4% 47

0.6% 3% 43

0.3% 2% 39

0.0% 1% 35
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21
Housing Non Housing Overall Stage 2 Assets Stage 1+ Stage 2 (Bps)
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Can Fin Homes (Canfin) 16 September 2021

Exhibit 85: Rise in stress with increase in self-employed Exhibit 86: Leverage reduced sharply over FY16-21
Debt/Equity (x)
Balance sheet stress 12.0
1.0% 10%
10.0
0.8% 8%
8.0
0.6% 6%
6.0
0.4% 4%
4.0
0.2% 2%
2.0
0.0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Stress to AuM Stress to Equity
Source: Company, Centrum Broking Source: Company, Centrum Broking

Stress rose over the last four years, though still controlled compared to peers: With a rise in the share of self-employed,
overall balance sheet stress increased over FY17-21 from 0% to 0.5%. The spike in FY21 was mainly led by increase in the
restructured pool (0.35% of loans), which could further increase in the coming quarters. Debt to equity consistently declined
for Canfin over FY16-21 from 11x to 7.4x, which also supported the decline in funding cost over the same period. Increase in
equity outpaced debt growth, led by reduction in payout ratio and declining loan growth.

Exhibit 87: Control over credit costs has been the mainstay Exhibit 88: Rising NIM, lower opex /credit costs drove RoE
Du pont % (to avg. assets) Return ratios (%)
4.0 1.2 2.1 23
3.5 1.1
3.0 0.9 1.7 19
2.5 0.8 1.3 15
2.0 0.6
1.5 0.5 0.9 11
1.0 0.3
0.5 7
0.5 0.2
0.0 0.0 0.1 3
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM PPoP Opex Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Controlled provisions and operating leverage led to a strong RoE profile: Over a 10-year cycle, NIMs have remained a tad
volatile. FY12-15 saw margins contracting since the focus was on growth and gaining market share. Over FY16-18, NIMs
improved, as focus shifted to pricing over growth. Margins dipped in FY19, but improved over FY19-21 owing to a favourable
interest rate cycle coupled with a favourable ALM. Return ratios dipped over FY12-15 in tandem with margins. From FY15 to
FY21, RoA improved from 1.2% to 2.1%, mainly led by improving opex and controlled credit costs. Opex to assets has declined
from 77bp to 57bp while provisions have remained under 30bp.

Exhibit 89: Share of short-term liabilities has increased Exhibit 90: Negative ALM mismatch has increased
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
0
100%
-5
80%
-10
60%
-15
40% -20
20% -25
0% -30
A L A L A L A L A L A L A L A L A L A L
-35
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
<1yr 1-3yr 3-5yr >5yr
Source: Company, Centrum Broking Source: Company, Centrum Broking

Negative mismatch in the portfolio has increased: After FY15, negative mismatch increased in the <1-year bucket since share
of less than 1-year liabilities increased at the expense of 1-3 year and 3-5 year buckets. ~80% of assets had a maturity of 3 years
and above, since housing loans are generally longer term. Hence, the ALM profile for an HFC is generally negative in the less
than 1-year bucket. This also exposes them to interest rate risk in case of a rising rate environment, as liabilities would mature
faster than assets. Currently, as systemic rates are at historic lows, HFCs are exposed to interest rate risk, which coupled with
competition from banks may pressurize NIMs.

Centrum Institutional Research 41


Can Fin Homes (Canfin) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest income 17,134 20,189 20,064 18,138 21,910 Financial assets 186,735 209,457 219,670 248,185 287,960
Interest expense 11,693 13,442 12,083 10,317 13,097 Cash 4,015 3,723 8 1,261 1,463
NII 5,441 6,747 7,980 7,821 8,812 Bank balance 187 201 208 303 351
Other income 179 115 121 141 161 Loans 182,342 205,257 218,915 246,321 285,797
Total income 5,621 6,862 8,101 7,962 8,974 Investment 163 243 496 252 293
Operating expenses 915 1,075 1,240 1,339 1,470 Other financial assets 28 33 44 48 56
Employee 414 565 700 772 851 Non-financial assets 560 979 1,067 908 1,053
Others 501 511 540 567 620 Current tax assets 206 240 183 156 181
PPOP 4,706 5,787 6,861 6,623 7,504 Deferred tax assets 240 339 455 319 417
Provisions 11 603 685 525 480 Fixed Assets 99 379 378 390 405
PBT 4,695 5,184 6,176 6,098 7,024 Other Non-fin. assets 15 20 51 44 51
Tax 1,728 1,422 1,615 1,616 1,861 Total Assets 187,295 210,436 220,737 249,093 289,013
PAT 2,967 3,762 4,561 4,482 5,163 Financial liabilities 169,059 188,114 193,480 218,038 253,054
Debt securities 56,347 38,096 48,913 43,298 50,253
Ratios Borrowings 111,425 148,360 142,987 173,193 201,013
YE Mar FY19A FY20A FY21A FY22E FY23E
Subordinated Debt 1,029 1,029 1,029 854 991
Growth (%) Other financial liabilities 258 630 551 693 797
AUM 16.8 12.7 6.7 14.1 16.0 Non-financial liabilities 414 821 1,159 1,082 1,206
Borrowings 21.3 11.1 2.9 12.2 16.1 Provisions 266 662 1,023 955 1,064
NII 6.8 24.0 18.3 (2.0) 12.7
Other Non-fin liabilities 148 159 137 128 142
Other income (42.9) (35.6) 4.5 16.8 14.5
Total equity 17,822 21,501 26,098 29,973 34,753
Opex 4.2 17.6 15.3 8.0 9.8
Share capital 266 266 266 266 266
PPoP 3.8 23.0 18.6 (3.5) 13.3 Other equity 17,556 21,235 25,832 29,706 34,487
Provisions (95.1) 5,422.4 13.6 (23.4) (8.5) Total Liabilities 187,295 210,436 220,737 249,093 289,013
PAT 3.7 26.8 21.2 (1.7) 15.2 Balance Sheet ratios (%)
Profitability (%) Debt / Equity 9.5 8.7 7.4 7.3 7.3
Yield on advances 10.0 10.3 9.3 7.6 8.0 Assets / Equity 10.5 9.8 8.5 8.3 8.3
Cost of funds 7.6 7.5 6.4 5.0 5.6
Cash / Borrowings 2.5 2.1 0.1 0.7 0.7
NIM (on AuM) 3.2 3.4 3.7 3.3 3.2
Capital Adequacy (%)
Other Income/ Total Income 3.2 1.7 1.5 1.8 1.8
CRAR 19.2 22.3 25.6 25.8 25.6
Other Income / Total Assets 0.1 0.1 0.1 0.1 0.1 Tier-1 17.4 20.5 23.8 23.9 23.7
Cost/Income 16.3 15.7 15.3 16.8 16.4 Tier-2 1.8 1.8 1.8 1.9 1.8
Employee 7.4 8.2 8.6 9.7 9.5 Asset quality (%)
Others 8.9 7.4 6.7 7.1 6.9 GNPA (Rs mn) 1,135 1,571 2,021 2,453 2,788
Opex/ Avg AuM 0.5 0.5 0.6 0.6 0.5 NNPA (Rs mn) 795 1,118 1,338 1,618 1,859
Provisions 0.0 0.3 0.3 0.2 0.2
GNPA 0.6 0.8 0.9 1.0 1.0
Tax Rate 36.8 27.4 26.2 26.5 26.5
NNPA 0.4 0.5 0.6 0.6 0.6
RoA 1.6 1.8 2.1 1.8 1.8
PCR 30.0 28.8 33.8 34.0 33.3
RoE 18.2 19.1 19.2 16.0 16.0 NNPA / Equity 4.5 5.2 5.1 5.4 5.3
Per share (Rs)
DuPont (% avg assets)
EPS 22.3 28.3 34.2 33.7 38.8
YE Mar FY19A FY20A FY21A FY22E FY23E
BVPS 133.8 161.5 196.0 225.1 261.0
Interest income 9.9 10.1 9.3 7.6 8.0
ABVPS 127.9 153.1 185.9 212.9 247.0
Interest expense 6.8 6.7 5.6 4.3 4.8 Valuation (x)
NII 3.2 3.4 3.7 3.3 3.2 P/E 11.1 11.4 12.2 18.5 16.1
Other income 0.1 0.1 0.1 0.1 0.1 P/BV 1.9 2.0 2.1 2.8 2.4
Total income 3.3 3.4 3.7 3.4 3.3 P/ABV 2.1 2.1 2.0 2.9 2.5
Operating expenses 0.5 0.5 0.6 0.6 0.5 Source: Company, Centrum Broking
Employee 0.2 0.3 0.3 0.3 0.3
Others 0.3 0.3 0.2 0.2 0.2
PPOP 2.7 2.9 3.2 2.8 2.7
Provisions 0.0 0.3 0.3 0.2 0.2
PBT 2.7 2.6 2.9 2.6 2.6
Tax 1.0 0.7 0.7 0.7 0.7
PAT 1.7 1.9 2.1 1.9 1.9
Source: Company, Centrum Broking

Centrum Institutional Research 42


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

CARE Ratings (CARE)


CARE was a significant player in the ratings space, with 10% revenue CAGR over FY12- Market data
18. Over the same time frame, its cash flows improved, led by better EBITDA. Current price: Rs737
However, revenue declined sharply over FY18-20, leading to a fall in market share due Bloomberg: CARE IN
to the SEBI enquiry in FY20. In line with the ratings business model, working capital 52-week H/L: Rs791/296
was largely negative, while capex requirement was immaterial. During the last
Market cap: Rs21.7bn
decade, total OCF/FCF generated was Rs10.2bn/Rs9.5bn, which was mainly a function
of low debt and capex requirements. However, compared to CRISIL, it was less Free float: 97.7%
efficient in converting profits to cash. CARE’s return ratios were comparable to CRISIL Avg. daily vol. 3mth: 465,019
over FY14-18, but were marred thereafter due to the NBFC crises. Source: Bloomberg

Cash generation good, but impacted by NBFC crises: Cash flows from operations saw a consistent rise over FY12-18, but declined
over FY18-21, mainly led by a sharp decline in revenue. The decline in FY20 was due to the turmoil caused by the SEBI enquiry
on its officers and penalty, which was exacerbated by weak debt and credit market conditions. This led to a decline in business
volumes, mainly led by a reduction in the volume of new bank loans and lower debt issuances.
Exhibit 91: Operating cash flows of Rs10bn over the last 10 years

2,250 1,600

1,750 1,200

1,250 800

750 400

250 0

(250) (400)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before Wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital reverts to negative: Despite no creditors, net working capital was largely negative in the early part of the decade
due to high provisions for salaries, unearned revenue, and advance from customers. The ratings business is generally
characterized by negative working capital because of the upfront payment for services rendered. There was a steady decline
in negative working capital levels in line with increasing receivables over FY14-19, which dropped sharply after FY18 due to
revenue decline for CARE led by the NBFC crises.
Exhibit 92: Working capital levels negative, in line with the nature of ratings business
60 60

40 40

20 20

0 0

(20) (20)

(40) (40)

(60) (60)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Trade receivables (days) Trade payables (days) NWC (ex cash)


Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
CARE Ratings (CARE) 16 September 2021

Exhibit 93: EBITDA to OCF conversion of 59% over 10 years Exhibit 94: PAT to OCF conversion of 84% over 10 years

70% 100%
90%
60%
80%
50% 70%
40% 60%
50%
30%
40%
20% 30%
10% 20%
10%
0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Cash conversion ratios volatile: Though operating profits increased gradually over FY12-18, both EBITDA to OCF and PAT to OCF
conversion ratios were volatile due to the positive and negative working capital changes. The ratios improved in FY21 because
of a fall in EBITDA driven by lower revenue, and simultaneous positive working capital change.
FCF generation weakened recently: CARE generated operating cash flow of Rs10bn over FY12-21, mainly driven by improving
EBITDA. The OCF was sufficient to oversee any capital investments without affecting the free cash flow generation. However,
the free cash flow dipped in tandem with OCF over FY18-20, led by the significant impact on revenues as a fallout of the SEBI
enquiry due to the ILFS debacle.
Exhibit 95: Good OCF and low capex needs have led to healthy FCF generation
1,500 1,600

1,000 1,100

500 600

0 100

(500) (400)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO (Rs mn) Capex FCF (Rs mn)
Source: Company, Centrum Broking

Exhibit 96: Revenue from publications and info services rising fast
Revenue Mix (Rsmn) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Rating income 1,768 1,973 2,269 2,549 2,622 2,779 3,183 2,948 2,260 2,282
Sale of Publications/Info services 12 15 26 23 27 26 34 26 188 215
Fee for Technical know-how services 2 - - - - - - - - -
Source: Company, Centrum Broking

Exhibit 97: Rated volume per instrument growing


Volume/Instrument (Rsmn) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Long term debentures/bonds 6,384 8,792 10,311 11,987 13,015 16,446 17,918 24,053 21,828 -
Bank Facilities 1,391 794 911 1,276 903 1,018 789 1051 1028 -
Source: Company, Centrum broking

Exhibit 98: Return ratios consistent, but affected by Covid


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
ROE 29% 28% 28% 33% 31% 33% 29% 23% 15% 15%
ROCE 32% 28% 28% 33% 31% 33% 29% 23% 15% 15%
ROIC 24% 19% 20% 23% 25% 25% 25% 19% 10% 14%
Source: Company, Centrum Broking

Centrum Institutional Research 44


CARE Ratings (CARE) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 2,974 2,191 2,197 2,416 2,803 Equity share capital 295 295 295 295 295
Operating Expense 189 226 139 146 156 Reserves & surplus 5,202 5,021 5,538 6,076 6,712
Employee cost 935 967 1,032 1,084 1,160 Shareholders fund 5,497 5,316 5,833 6,371 7,007
Others 136 233 143 150 161 Minority Interest 0 0 0 0 0
EBITDA 1,713 766 883 1,037 1,327 Total debt 0 0 0 0 0
Depreciation & Amortisation 31 69 71 74 78 Non Current Liabilities 0 65 40 40 40
EBIT 1,682 696 812 962 1,249 Def tax liab. (net) 0 0 0 0 0
Interest expenses 0 7 6 6 6 Total liabilities 5,969 5,970 6,408 6,935 7,590
Other income 298 313 321 353 396 Gross block 732 728 697 731 768
PBT 1,980 1,002 1,127 1,310 1,639 Less: acc. Depreciation 0 0 0 0 0
Taxes 631 197 269 330 413 Net block 732 728 697 731 768
Effective tax rate (%) 31.8 19.7 23.9 25.2 25.2 Capital WIP 0 0 0 0 0
PAT 1,350 805 858 980 1,226 Net fixed assets 748 830 801 836 872
Minority/Associates 0 0 0 0 0 Non Current Assets 7 3 1 1 1
Recurring PAT 1,350 805 858 980 1,226 Investments 4,582 3,594 2,649 2,811 2,553
Extraordinary items 0 0 0 0 0 Inventories 0 0 0 0 0
Reported PAT 1,350 805 858 980 1,226 Sundry debtors 435 360 167 167 167
Cash & Cash Equivalents 205 1,012 2,619 2,950 3,825
Ratios Loans & advances 33 62 60 60 60
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 32 171 216 216 216
Growth (%)
Trade payables 0 0 0 0 0
Revenue (7.5) (26.3) 0.3 10.0 16.0
Other current liab. 372 469 399 384 402
EBITDA (18.2) (55.3) 15.3 17.4 28.0 Provisions 101 120 135 140 140
Adj. EPS (16.2) (40.4) 6.6 14.2 25.1 Net current assets 233 1,015 2,528 2,869 3,727
Margins (%) Total assets 5,969 5,970 6,408 6,935 7,590
Gross 93.6 89.7 93.7 94.0 94.4
EBITDA 57.6 34.9 40.2 42.9 47.3 Cashflow
EBIT 56.6 31.8 37.0 39.8 44.5 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 45.4 36.7 39.1 40.5 43.7 Profit Before Tax 1,980 1,002 1,127 1,310 1,639
Returns (%) Depreciation & Amortisation 31 69 71 74 78
ROE 23.5 14.9 15.4 16.1 18.3 Net Interest 0 0 0 0 0
ROCE 23.5 15.0 15.5 16.1 18.4 Net Change – WC (99) 46 117 (10) 18
ROIC 210.2 78.8 96.9 122.5 150.7 Direct taxes (631) 334 (269) (330) (413)
Turnover (days) Net cash from operations (143) 650 880 1,044 1,322
Gross block turnover ratio (x) 4.1 3.0 3.2 3.3 3.6 Capital expenditure (255) (36) (42) (109) (115)
Debtors 50 66 44 25 22 Acquisitions, net 0 0 0 0 0
Inventory 0 0 0 0 0 Investments 789 1,246 945 (162) 258
Creditors 0 0 0 0 0 Others 0 0 0 0 0
Net working capital 29 169 420 433 485 Net cash from investing 534 1,210 903 (271) 143
Solvency (x) FCF 391 1,860 1,783 772 1,465
Net debt-equity 0.0 (0.2) (0.4) (0.5) (0.5) Issue of share capital 0 0 0 0 0
Interest coverage ratio 0.0 103.6 155.7 182.9 234.1 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (0.1) (1.3) (3.0) (2.8) (2.9) Dividend paid (426) (1,060) (177) (442) (589)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 45.8 27.3 29.1 33.3 41.6 Others 0 0 0 0 0
BVPS 186.6 180.4 198.0 216.2 237.8 Net cash from financing (426) (1,060) (177) (442) (589)
CEPS 9.4 1.9 42.5 49.5 36.7 Net change in Cash (35) 685 1,607 330 876
DPS 30.0 19.5 6.0 15.0 20.0 Source: Company, Centrum Broking
Dividend payout (%) 65.5 71.4 20.6 45.1 48.1
Valuation (x)
P/E 41.5 22.7 12.8 21.9 17.5
P/BV 6.3 3.3 2.0 3.4 3.1
EV/EBITDA 19.4 24.1 11.3 17.8 13.3
Dividend yield (%) 2.6 2.9 1.4 2.1 2.8
Source: Company, Centrum Broking

Centrum Institutional Research 45


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

CRISIL
CRISIL is currently the market leader in the ratings business in India. Operating profits Market data
and OCF have seen a steady rise in the last decade, with the latter growing faster since Current price: Rs2,790
CY17. Due to the fee-based nature of business, OCF generation is high, also Bloomberg: CRISIL IN
contributed by negative working capital driven by unearned revenues. The company 52-week H/L: Rs3,330/1,680
has generated cumulative OCF of Rs30.4bn in the last decade, and given its low capex,
Market cap: Rs202.9bn
it has been able to generate FCF totalling to Rs27.8bn. Another strong suit has been
its healthy conversion of PAT to OCF, averaging at more than 100%, led by higher Free float: 17.1%
EBITDA to OCF conversion. The company has shown strong return ratios, suggesting Avg. daily vol. 3mth: 125,334
a clear competitive advantage. Source: Bloomberg

Cash generation consistent and growing: Cash flow from operations has steadily gone up since FY12 due to increasing revenues,
mainly driven by the growth in the European and North American markets. Given human capital as the major expense, CRISIL
has steadily improved revenue generated per employee. Further, its working capital changes have been positive for CY19 and
CY20, leading to increased OCF. The company has generated total OCF of over Rs30bn in the last decade, mainly driven by
higher-margin Ratings and Research Services segments.
Exhibit 99: Operating cash flows of Rs30bn over the last 10 years
6,000 6,000
5,000 5,000
4,000 4,000
3,000 3,000
2,000 2,000
1,000 1,000
0 0
(1,000) (1,000)
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

Operating profit before Wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital remains negative: Working capital has been negative, led by current liabilities (mainly unearned revenue and
employee-related payables) exceeding trade receivables. CRISIL has been able to largely maintain consistent receivable and
payable days. Quantum of negative working capital declined over CY11-16 due to substantial increase in receivables from
related parties. However, CY17-20 saw a reversal to the previous trend, led by higher payables and unearned revenue.
Exhibit 100: Working capital levels negative in line with the nature of Ratings business
100 20

0
50
(20)

0 (40)

(60)
(50)
(80)

(100) (100)
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

Trade receivables (days) Trade payables (days) NWC (ex cash)


Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
CRISIL 16 September 2021

Exhibit 101: EBITDA to OCF conversion of 67% over 10 years Exhibit 102: PAT to OCF conversion of 104% over 10 years

90% 140%
80% 120%
70%
100%
60%
50% 80%
40% 60%
30%
40%
20%
10% 20%
0% 0%
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

Source: Company, Centrum Broking Source: Company, Centrum Broking

Cash conversion ratios have improved in the last two years: EBITDA to OCF conversion dropped sharply in CY12 due to a large
increase in EBITDA, led by strong increase in operating income and negative working capital changes. The conversion increased
in CY19 and CY20 due to positive working capital changes. Similar trend was also observed in the PAT to OCF conversion ratio,
as higher operating income led to a higher PAT in CY12, leading to a sharp decline in the ratio, which increased again in CY19
due to positive working capital changes.
FCF generation has been strong: Despite the Covid impact, the company generated strong cash flows. FCF being a function of
OCF was in line with the OCF growth. With minimal capex, given the nature of the business, the company generated FCF of
nearly Rs28bn over the decade.
Exhibit 103: Consistent OCF, low capex needs have led to strong FCF generation
5,000 5,000

4,000 4,000

3,000 3,000

2,000 2,000

1,000 1,000

0 0

(1,000) (1,000)
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

CFO (Rs mn) Capex FCF (Rs mn)


Source: Company, Centrum Broking

Exhibit 104: Revenue mix highlights focus on Ratings and Research and the US as the biggest market
Revenue mix (Rsmn) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Ratings services 3,260 3,964 4,103 4,450 4,341 4,676 4,803 5,073 5,448 5,650
Research services 4,237 5,260 6,446 7,449 8,797 10,038 10,804 11,060 10,444 12,827
Advisory services 573 553 557 635 661 761 978 1,352 1,425 1,341
Revenue by Geography (Rsmn)
India 3,314 3,626 3,903 4,321 4,398 4,624 5,276 5,147 5,749 5,596
Europe 1,842 2,968 3,372 3,853 4,089 4,637 4,184 4,514 4,473 4,551
North America 2,132 2,617 3,149 3,557 4,495 5,085 5,784 6,202 5,446 8,176
ROW 781 566 682 803 817 1,129 1,340 1,622 1,650 1,495
Source: Company, Centrum Broking

Exhibit 105: Return ratios


Return Ratios (%) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
ROE 49% 47% 49% 35% 32% 32% 31% 34% 30% 29%
ROCE 58% 46% 38% 34% 31% 32% 31% 33% 29% 27%
ROIC 45% 89% 55% 46% 38% 39% 37% 42% 41% 36%
Source: Company, Centrum Broking

Centrum Institutional Research 47


CRISIL 16 September 2021

P&L Balance sheet


YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Revenues 17,485 17,317 19,818 21,443 23,432 Equity share capital 72 72 73 73 73
Operating Expense 1,865 1,947 2,024 2,178 2,330 Reserves & surplus 11,290 11,647 13,046 13,940 15,381
Employee cost 8,874 8,776 10,684 11,646 12,546 Shareholders fund 11,363 11,719 13,118 14,013 15,454
Others 2,034 2,037 2,117 2,308 2,486 Minority Interest 0 0 0 0 0
EBITDA 4,712 4,558 4,993 5,311 6,069 Total debt 25 26 0 0 0
Depreciation & Amortisation 361 361 1,211 1,235 1,260 Non Current Liabilities 77 78 1,846 1,846 1,846
EBIT 4,351 4,197 3,782 4,076 4,809 Def tax liab. (net) 118 153 162 162 162
Interest expenses 22 2 144 142 142 Total liabilities 16,338 16,887 22,067 23,311 25,132
Other income 734 728 945 992 1,042 Gross block 1,883 2,132 3,402 4,514 5,688
PBT 5,063 4,923 4,583 4,926 5,709 Less: acc. Depreciation (1,472) (1,781) (2,992) (4,227) (5,487)
Taxes 1,365 1,476 1,036 1,234 1,427 Net block 410 351 410 287 201
Effective tax rate (%) 27.0 30.0 22.6 25.1 25.0 Capital WIP 0 0 0 0 0
PAT 3,698 3,447 3,547 3,692 4,282 Net fixed assets 3,574 3,607 7,761 7,911 8,153
Minority/Associates 0 0 0 0 0 Non Current Assets 79 107 65 78 94
Recurring PAT 3,698 3,447 3,547 3,692 4,282 Investments 4,766 4,531 4,760 5,372 6,105
Extraordinary items 0 0 0 0 0 Inventories 0 0 0 0 0
Reported PAT 3,698 3,447 3,547 3,692 4,282 Sundry debtors 2,848 1,994 3,074 3,227 3,389
Cash & Cash Equivalents 2,071 3,456 2,787 2,721 2,939
Ratios Loans & advances 452 414 458 479 502
YE Dec CY18A CY19A CY20A CY21E CY22E
Other current assets 1,980 2,354 2,521 2,882 3,310
Growth (%)
Trade payables 648 755 1,053 1,210 1,392
Revenue 5.4 (1.0) 14.4 8.2 9.3
Other current liab. 3,336 3,343 4,835 4,980 5,129
EBITDA 3.5 (3.3) 9.5 6.4 14.3 Provisions 771 813 1,053 1,099 1,149
Adj. EPS 16.8 (7.0) 2.5 4.1 16.0 Net current assets 2,596 3,307 1,899 2,019 2,469
Margins (%) Total assets 16,338 16,887 22,067 23,311 25,132
Gross 89.3 88.8 89.8 89.8 90.1
EBITDA 27.0 26.3 25.2 24.8 25.9 Cashflow
EBIT 24.9 24.2 19.1 19.0 20.5 YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Adjusted PAT 21.1 19.9 17.9 17.2 18.3 Profit Before Tax 5,063 4,923 4,583 4,926 5,709
Returns (%) Depreciation & Amortisation 361 361 1,211 1,235 1,260
ROE 33.9 29.9 28.6 27.2 29.1 Net Interest 0 0 0 0 0
ROCE 34.0 29.8 29.4 28.0 29.8 Net Change – WC (234) 827 2,342 (199) (248)
ROIC 75.1 70.7 62.7 53.2 58.5 Direct taxes (1,688) (1,476) (1,036) (1,234) (1,427)
Turnover (days) Net cash from operations 3,504 4,330 7,680 4,728 5,294
Gross block turnover ratio (x) 9.3 8.1 5.8 4.7 4.1 Capital expenditure (318) (403) (5,365) (1,385) (1,502)
Debtors 57 51 47 54 52 Acquisitions, net 0 0 0 0 0
Inventory 0 0 0 0 0 Investments (413) 236 (230) (611) (734)
Creditors 119 131 163 190 204 Others 0 0 0 0 0
Net working capital 54 70 35 34 38 Net cash from investing (731) (167) (5,595) (1,997) (2,235)
Solvency (x) FCF 2,773 4,163 2,085 2,731 3,058
Net debt-equity (0.2) (0.3) (0.2) (0.2) (0.2) Issue of share capital 0 0 0 0 0
Interest coverage ratio 211.3 1,981.9 34.7 37.4 42.7 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (0.4) (0.8) (0.6) (0.5) (0.5) Dividend paid (2,020) (2,779) (2,753) (2,797) (2,841)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 51.3 47.7 48.9 50.9 59.0 Others 0 0 0 0 0
BVPS 157.6 162.1 180.7 193.0 212.9 Net cash from financing (2,020) (2,779) (2,753) (2,797) (2,841)
CEPS 44.7 38.9 66.3 68.4 71.4 Net change in Cash 753 1,385 (669) (66) 218
DPS 30.0 32.0 31.5 32.0 32.5 Source: Company, Centrum Broking
Dividend payout (%) 58.5 67.1 64.5 62.9 55.1
Valuation (x)
P/E 37.0 30.1 33.2 55.4 47.8
P/BV 10.9 8.1 8.7 14.6 13.2
EV/EBITDA 26.6 22.5 24.0 38.0 33.2
Dividend yield (%) 1.7 2.2 1.9 1.1 1.2
Source: Company, Centrum Broking

Centrum Institutional Research 48


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

City Union Bank (CUBK)


Over the last 10 years, CUBK has generated consistent and healthy returns – RoA of Market data
1.4%+ and RoE of 15%+, barring the Covid-impacted FY20/FY21. Material Current price: Rs158
improvement in CASA share and ability to attractively price products in the face of Bloomberg: CUBK IN
competition owing to its sole banking relationships enabled NIM enhancement from 52-week H/L: Rs200/132
3.1% to 3.8% over FY14-19. Even though credit costs have risen, granularity of the
Market cap: Rs116.5bn
portfolio due to SME/retail focus has led to better risk-adjusted returns. Recoveries
from delinquencies would be the key monitorable, since balance sheet stress saw a Free float: 90%
sharp spike in FY21. Positive ALM gap in the <1-year bucket bodes well, as the Avg. daily vol. 3mth: 2,097,543
likelihood of a rising interest scenario is higher. Source: Bloomberg

CASA share improving; retail loans gaining share: CASA share has consistently improved from 18% in FY14 to 29% in FY21,
which has been possible due to CUBK’s sole banking relationships. Along with a falling interest rate scenario, growth in CASA
also helped to bring down cost of deposits from 8.2% to 5.2%. On advances mix, CUBK maintained over 55% share in the higher
yielding SME loans for the period under discussion, which has also contributed to the higher NIM profile. Retail share was
constant in the 13-14% range over FY15-20, but rose sharply to 19% in FY21, led by strong growth in gold loans. Share of
corporate loans has declined over FY12-21, with the book becoming more granular.

Exhibit 106: CASA growing gradually, mainly led by savings Exhibit 107: Retail gaining share; SME remains 55%+
Deposit mix Advances mix
100% 100%

80% 80%

60% 60%
40% 40%
57% 58% 58% 59% 58% 55% 58%
20% 47% 44% 51%
20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Term Savings Current SME Retail Agri Corporate
Source: Company, Centrum Broking Source: Company, Centrum Broking

Stress within controllable levels till FY19; FY21 was challenging: CUBK managed to keep stress under check over FY13-19
(stress to average assets below 3%). The pandemic-hit FY20 and FY21 were tough for SME businesses. During the first lockdown,
as the SME segment was the hardest hit, stress to average assets spiked in FY21 to 7.1%, mainly led by MSME restructuring.
Industry segment saw high GNPA levels at 7.7%/6.7% in FY20/FY21, which remains a concern. Personal segment is doing well
– after a spike in FY17 to 8.8%, GNPA declined to 1.7% in FY21. Services also saw spike in GNPA numbers from 2.2% in FY19 to
6.3% in FY21. Overall GNPA has risen to 5.1% in FY21 from a stable ~3% over FY17-19, while stress to equity is ~62% in FY21,
which is worrisome. Recoveries would be the key monitorable.

Exhibit 108: Stress spiked in FY21 on account of restructuring Exhibit 109: Industry segment concerning; personal improved
Balance sheet stress Segment-wise GNPA
7.1% 63% 9.0%
6.1% 54% 8.0%
7.0%
5.1% 45% 6.0%
4.1% 36% 5.0%
3.1% 27% 4.0%
3.0%
2.1% 18%
2.0%
1.1% 9% 1.0%
0.1% 0% 0.0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Agri Industry Services Personal Others Overall
Stress to avg. assets Stress to equity (RHS) FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
City Union Bank (CUBK) 16 September 2021

Exhibit 110: Better risk-adjusted returns over FY15-19 Exhibit 111: Consistent RoA/RoE over FY15-19 led to re-rating
Du pont % (to avg. assets) Return ratios (%)
4.0 1.8 1.8 25.0
3.5 1.5 1.5 21.0
3.0 1.2 1.2 17.0
2.5 0.9 0.9 13.0
2.0 0.6 0.6 9.0
1.5 0.3 0.3 5.0
1.0 0.0 0.0 1.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM Opex PPoP Fees (RHS) Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Consistent attractive return profile over FY15-19 led to re-rating; recoveries a key to stress: CUBK has created a niche in SME
lending by developing entrenched sole banking relationships. This enabled it to price its products better, garner higher CASA
share, and charge adequate fees (~70bp over FY14-19). The strategy worked well, especially over FY15-19, resulting in better
risk-adjusted returns and strong RoA/RoE of 15%/1.5%. This drove its subsequent re-rating. Owing to stress in SME that led to
a provisioning spike over FY20-21, RoA/RoE were hit in FY20/21. Opex largely remained in the ~2% range over FY14-18, post
which it saw a slight blip in FY19 and FY20 due to wage revision that led to higher employee cost.
Exhibit 113: Liquidity has reduced leading to higher loan
Exhibit 112: Funding has slightly tilted in favour of capital
share
Liability mix Asset mix
100% 100%

80% 80%

60% 60%
40% 40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Deposits Capital Borrowings Other Liabilities Advances Investments Cash Other assets Fixed assets
Source: Company, Centrum Broking Source: Company, Centrum Broking

CUBK largely deposit-funded, though share of capital has risen: CUBK largely remains a deposit-funded franchise, with
deposits forming 83.5% of liabilities (share of deposits was 89% in FY12). It has minimal reliance on external borrowings, which
constitute 1-4% of liabilities. Equity capital share has risen consistently from 6.8% in FY12 to 11% in FY21, which is a positive.
In the last 10 years, CUBK has raised money thrice – in FY13, FY14 and FY15. On asset mix, advances’ share has ranged from
65% to 72% over FY12-21, with a lower share over FY12-15 since balance sheet liquidity was higher with investments
contributing 23-24% to total assets. Share of investments gradually declined from 25% in FY12 to 17.7% in FY21.
Exhibit 114: ALM profile stable; could have been better Exhibit 115: Positive gap in mismatch increasing from FY16
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 25

80% 20
60%
15
40%
20% 10

0% 5
A L A L A L A L A L A L A L A L A L A L
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0
<1yr 1-3yr 3-5yr >5yr FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile indicates a positive gap in the <1-year bucket for CUBK: A 10-year cycle indicates that CUBK has a positive ALM
profile in the <1-year bucket, suggesting that maturity of assets is shorter than liabilities. This has transpired since the bank has
a higher share of working capital loans (~60% share), which are relatively short-term in nature. A positive ALM gap exposes the
bank to interest rate risk in a falling rate scenario, but could be advantageous in a rising rate scenario, as assets would be
repriced higher at a faster rate than liabilities. In terms of maturity profile, assets are equally distributed in the <1-year and 1-
3 year buckets, while liabilities are largely concentrated (~60% share) in the 1-3year bucket.

Centrum Institutional Research 50


City Union Bank (CUBK) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest earned 37,672 41,686 41,347 41,790 47,204 Share capital 735 737 739 739 739
Interest expended 21,557 24,934 23,050 22,451 25,622 Reserves & surplus 47,673 52,223 57,686 64,543 73,265
Net Interest Income 16,114 16,752 18,297 19,340 21,582 Deposits 384,480 408,325 445,374 465,007 511,052
Other income 5,144 6,799 7,048 6,700 7,244 Borrowings 4,809 20,324 13,457 13,950 15,332
Total Income 21,259 23,551 25,344 26,040 28,826 Other Liabilities 14,893 15,726 15,861 15,806 16,160
Operating Expenses 8,859 10,137 10,506 11,068 12,270 Total liabilities 452,589 497,335 533,117 560,045 616,548
Employees 3,644 4,207 4,637 5,005 5,395 Cash balances with RBI 19,931 20,303 27,927 25,864 25,266
Others 5,214 5,931 5,869 6,063 6,875 Balances with banks 9,702 26,913 28,223 24,906 24,214
Operating profit 12,400 13,414 14,838 14,971 16,556 Investments 77,122 91,168 94,359 97,652 104,766
Provisions 3,151 7,551 7,910 6,463 5,127 Advances 326,733 339,275 361,578 388,762 437,986
Profit before tax 9,249 5,863 6,928 8,509 11,430 Fixed Assets 2,500 2,452 2,327 2,432 2,605
Taxes 2,420 1,100 1,000 1,702 2,400 Other Assets 16,600 17,225 18,702 20,429 21,710
Net Profit 6,829 4,763 5,928 6,807 9,029 Total assets 452,589 497,335 533,117 560,045 616,548

Ratios Ratios
YE Mar FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Growth (%) Balance Sheet (%)
Loans 17.3 3.8 6.6 7.5 12.7 Loans / Deposits 85.0 83.1 81.2 83.6 85.7
Deposits 17.0 6.2 9.1 4.4 9.9 Investments / Deposits 20.1 22.3 21.2 21.0 20.5
RWA growth 20.6 3.7 (2.8) 10.4 14.7 CASA 25.2 25.0 29.1 27.0 27.0
NII 12.7 4.0 9.2 5.7 11.6 Assets/equity (x) 9.3 9.4 9.1 8.6 8.3
Other income (3.3) 32.2 3.7 (4.9) 8.1 RWA / Total assets 69.5 65.6 59.5 62.5 65.2
Opex 17.4 14.4 3.6 5.4 10.9 Capital ratios (%)
PPoP 2.7 8.2 10.6 0.9 10.6 CET-1 15.0 15.8 18.5 18.4 18.1
Provisions (24.6) 139.7 4.8 (18.3) (20.7) Tier-1 15.0 15.8 18.5 18.4 18.1
Net profit 15.4 (30.3) 24.5 14.8 32.6 Tier-2 0.5 1.0 1.1 1.0 1.0
Profitability (%) CRAR 15.6 16.8 19.6 19.4 19.0
Yield on assets 9.7 9.6 8.8 8.4 8.7 Asset quality ratios (%)
Cost of funds 5.9 6.1 5.2 4.8 5.1 GNPA (Rs mn) 9,771 14,134 18,932 17,629 16,491
NIM 4.1 3.8 3.9 3.9 4.0 NNPA (Rs mn) 5,915 7,785 10,752 10,577 10,061
Other income / Total inc. 24.2 28.9 27.8 25.7 25.1 GNPA 3.0 4.1 5.1 4.5 3.7
Other inc. / avg assets 1.2 1.4 1.4 1.2 1.2 NNPA 1.8 2.3 3.0 2.7 2.3
Cost/Income 41.7 43.0 41.5 42.5 42.6 PCR 39.5 44.9 43.2 40.0 39.0
Employee 17.1 17.9 18.3 19.2 18.7 Slippage 2.3 3.4 3.3 3.2 2.8
Other 24.5 25.2 23.2 23.3 23.8 NNPA / Equity 12.2 14.7 18.4 16.2 13.6
Opex/ Avg assets 2.1 2.1 2.0 2.0 2.1 Per share
Provisioning cost 1.0 2.3 2.3 1.7 1.2 EPS 9.3 6.5 8.0 9.2 12.2
Tax rate 26.2 18.8 14.4 20.0 21.0 BVPS 65.9 71.8 79.1 88.4 100.2
RoE 15.2 9.4 10.6 11.0 13.0 ABVPS 57.9 61.3 64.5 74.0 86.5
RoA 1.6 1.0 1.2 1.2 1.5 Valuation (x)
RoRWA 2.4 1.5 1.8 2.0 2.4 P/E 27.4 26.2 18.7 17.1 12.9
Du-pont (%) P/BV 2.5 2.7 1.7 1.8 1.6
Interest income 8.8 8.8 8.0 7.6 8.0 P/ABV 2.9 3.3 2.0 2.1 1.8
Interest expenses 5.1 5.2 4.5 4.1 4.4 Source: Company, Centrum Broking
NII 3.8 3.5 3.6 3.5 3.7
Other income 1.2 1.4 1.4 1.2 1.2
Total income 5.0 5.0 4.9 4.8 4.9
Operating expenses 2.1 2.1 2.0 2.0 2.1
Employee 0.9 0.9 0.9 0.9 0.9
Other 1.2 1.2 1.1 1.1 1.2
PPOP 2.9 2.8 2.9 2.7 2.8
Provisions 0.7 1.6 1.5 1.2 0.9
PBT 2.2 1.2 1.3 1.6 1.9
Tax 0.6 0.2 0.2 0.3 0.4
RoA 1.6 1.0 1.2 1.2 1.5
Source: Company, Centrum Broking

Centrum Institutional Research 51


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

DCB Bank (DCB)


DCB’s performance over the last 10 years was a mixed bag. Retail liability build-up Market data
over FY12-18 fluctuated, though FY18-21 saw good traction on RTD while CASA Current price: Rs94
accretion was weak. On the asset side, retail exposure increased while corporate Bloomberg: DCBB IN
exposure declined. DCB saw higher opex over FY12-18 (average 280bp) owing to 52-week H/L: Rs127/74
aggressive growth focus, which translated to investments in branches and collection
Market cap: Rs29.2bn
architecture owing to its major SME focus. Over FY18-21, focus shifted to conservative
growth and operating leverage (opex to assets improved); however, as a fallout of the Free float: 99.1%
pandemic hitting the SME segment hard, credit costs spiked. Negative ALM profile in Avg. daily vol. 3mth: 1,425,277
a likely rising rate environment exposes DCB to risk of an NIM blip. Source: Bloomberg

Deposits more granular since FY18; loan mix tilted towards retail/agri: CASA performance has been a bit lackluster over FY12-
21. CASA ratio declined from 32% to 24% over FY12-18. Post FY18, deposit performance was rather mixed, as DCB started
focusing on garnering RTD and reducing wholesale deposits. Over FY18-21, RTD ratio improved from 49% to 61%, while
wholesale deposit share declined from 27% to 17%, which is a positive, but CASA ratio declined slightly from 24% to 23%, which
is a negative. On the loan mix side, DCB saw two sub-cycles. Over FY12-16, retail mix increased from 35% to 56%, while the
share of corporate/SME decreased from 23%/27% to 15%/12%. Over FY16-21, corporate share decreased from 15% to 11%,
while agri share increased from 17% to 22%.

Exhibit 116: RTD accretion improved over FY18-21 Exhibit 117: Corporate share rose over FY14-19
Deposit mix Advances mix
100% 100%
14% 16% 17% 15% 16% 17% 13% 12% 11%
20% 21% 22% 24% 27% 21% 22% 23% 24% 26% 23%
80% 80%
17% 20% 21% 22%
60% 60% 18% 18%
15%
12% 14%
40% 40% 15%
54% 52% 54% 60% 55% 52% 55% 57% 61% 56% 54% 53% 55% 56% 57%
49% 44% 49%
20% 20% 35% 41%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Retail term Savings Current Wholesale Retail Agri SME Corporate
Source: Company, Centrum Broking Source: Company, Centrum Broking

Stress largely controlled over FY13-19; pandemic impact after FY19: Total stress as defined by NNPA + restructuring + net SR
was largely controlled over FY13-19 and was in the 0.8-1.2% range, as corporate share also declined over the same time frame.
DCB was largely insulated from the stressed asset cycle that large banks saw over FY14-19, as the bank has a granular portfolio,
being mainly focused on retail/SME/agri. Provisions rose from 30bp in FY14 to ~50bp over FY15-17, led by corporate stress.
Covid appears to have done more financial damage to DCB customers – its agri/industries/services GNPA spiked sharply while
peers did not witness as much pain. Delinquent pool rose over FY18-21 from 0.6% to 6.9%.
Exhibit 118: Stress reduced over FY14-20 from 4.9% to 1.3% Exhibit 119: FY21 saw a spike in personal loan GNPA
Balance sheet stress Segment-wise GNPA
7.0% 75% 5.0%
6.0% 65% 4.0%
5.0% 55%
3.0%
4.0% 45%
3.0% 35% 2.0%
2.0% 25%
1.0%
1.0% 15%
0.0% 5% 0.0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Agri Industry Services Personal Overall
Stress to avg. assets Stress to equity (RHS) FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
DCB Bank (DCB) 16 September 2021

Exhibit 120: NIM, opex have led to better PPoP to assets Exhibit 121: Multiple levers have resulted in RoE build-up

Du pont % (to avg. assets) Return ratios (%)


4.0 1.2 1.4 16
3.5 1.0 1.2 14
3.0 0.8 1.0 12
0.8 10
2.5 0.6
0.6 8
2.0 0.4
0.4 6
1.5 0.2
0.2 4
1.0 0.0 0.0 2
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM Opex PPoP RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Operating metrics see an improving trend: NIM improved over FY12-18, largely led by increase in retail / decline in corporate
mix, coupled with supportive ALM mix. NIM declined in FY19, led by lower growth and excess liquidity. FY20/21 saw a sharp
decline in NIM due to lower growth and interest reversals. Fees to average assets has gradually declined over FY12-20 from
100bp to 83bp in tandem with a decline in corporate share. FY21 saw a much sharper contraction in fees to assets, led by the
pandemic impact. Opex remained elevated over 260bp over FY12-18, as the bank was in expansion mode. Opex leverage
started playing out after FY18 that saw opex to asset ratio decline over FY18-20 from 288bp to 243bp.
Exhibit 122: Borrowing rising; bulk deposit share falling Exhibit 123: Advances share has been stable over FY19-21
Liability mix Asset mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Deposits Capital Borrowings Other Liabilities Advances Investments Cash Other assets Fixed assets
Source: Company, Centrum Broking Source: Company, Centrum Broking

Bank has largely been deposit-funded; loan share stable after FY16: Share of deposits in total liabilities improved over FY12-
17 from 73% to 80%, while the share of borrowings declined from 13% to 5%. However, borrowing share rose over FY17-21
from 5.3% to 11.3% at the cost of deposits though bulk deposit contribution has fallen. Hence deposit share fell slightly over
FY17-20 from 80% to 75% though due to the bank’s focus on retail deposits, RTD share enhanced. In the last 10 years, DCB has
raised equity twice – in FY15 and in FY18. On assets, share of loans also improved over FY12-16 from 61% to 68%, as the bank
was in a high growth phase. Loan share declined after FY18, as DCB concentrated on risk-adjusted return, which resulted in
lower loan growth and more efficiency.

Exhibit 124: Balance sheet maturity has become more stable Exhibit 125: Mismatch in the <1-year bucket has reduced
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 6

80% 0
-6
60%
-12
40%
-18
20%
-24
0%
A L A L A L A L A L A L A L A L A L A L -30
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -36
<1yr 1-3yr 3-5yr >5yr FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile largely imbalanced with a negative tilt: DCB has generally witnessed a negative ALM in the 1-year bucket,
suggesting that the bank usually borrows short-term and lends long-term. This has also been led by an increasing share of
retail, particularly longer-term home loans and LAP. While this strategy has largely supported NIM improvement over FY12-17,
since systemic rates were declining, a negative ALM also exposes DCB to interest rate risk in case domestic rates rise. The <1-
year ALM gap has been negative at ~30% over FY12-20 that improved in FY21. Asset tenure is more concentrated in the 1-3
year and 3-5 year buckets, while liabilities’ maturity is weighted more in the 1-3 year bucket.

Centrum Institutional Research 53


DCB Bank (DCB) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest earned 30,415 35,366 34,582 35,692 41,025 Share capital 3,107 3,114 3,115 3,115 3,115
Interest expended 18,922 22,717 21,716 22,505 26,077 Reserves & surplus 28,049 31,108 34,471 36,190 39,818
Net Interest Income 11,493 12,649 12,866 13,188 14,948 Deposits 284,351 303,699 297,039 331,263 381,402
Other income 3,502 3,911 4,585 4,133 4,290 Borrowings 27,232 34,080 44,823 36,439 45,768
Total Income 14,995 16,560 17,451 17,321 19,237 Other Liabilities 15,179 13,051 16,574 16,679 17,346
Operating Expenses 8,529 9,029 8,466 9,380 9,951 Total liabilities 357,918 385,052 396,021 423,686 487,449
Employees 4,340 4,588 4,335 4,719 5,007 Cash balances with RBI 13,172 10,298 11,829 13,237 17,087
Others 4,189 4,441 4,131 4,661 4,945 Balances with banks 14,762 25,161 18,565 18,385 21,359
Operating profit 6,466 7,531 8,985 7,941 9,286 Investments 78,441 77,415 84,137 82,816 95,351
Provisions 1,401 2,611 4,457 3,602 3,045 Advances 235,680 253,453 259,592 288,127 331,251
Profit before tax 5,065 4,919 4,528 4,338 6,242 Fixed Assets 5,260 5,459 5,685 5,913 6,149
Taxes 1,812 1,540 1,170 1,132 1,629 Other Assets 10,604 13,266 16,214 15,210 16,254
Net Profit 3,254 3,379 3,358 3,206 4,613 Total assets 357,918 385,052 396,021 423,686 487,449

Ratios Ratios
YE Mar FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Growth (%) Balance Sheet (%)
Loans 15.9 7.5 2.4 11.0 15.0 Loans / Deposits 82.9 83.5 87.4 87.0 86.9
Deposits 18.4 6.8 (2.2) 11.5 15.1 Investments / Deposits 27.6 25.5 28.3 25.0 25.0
RWA growth 6.8 5.5 (0.9) 11.0 13.0 CASA 23.9 21.5 22.8 23.0 23.0
NII 15.5 10.1 1.7 2.5 13.3 Assets/equity (x) 11.5 11.3 10.5 10.8 11.4
Other income 12.9 11.7 17.2 (9.9) 3.8 RWA / Total assets 62.0 60.8 58.5 60.7 59.7
Opex 9.2 5.9 (6.2) 10.8 6.1 Capital ratios (%)
PPoP 23.2 16.5 19.3 (11.6) 16.9 CET-1 13.1 13.9 15.5 14.5 14.0
Provisions 0.9 86.4 70.7 (19.2) (15.5) Tier-1 13.1 13.9 15.5 14.5 14.0
Net profit 32.6 3.9 (0.6) (4.5) 43.9 Tier-2 3.7 3.8 4.2 4.0 4.0
Profitability (%) CRAR 16.8 17.7 19.7 18.5 18.0
Yield on assets 10.0 10.3 9.6 9.4 9.7 Asset quality ratios (%)
Cost of funds 6.6 7.0 6.4 6.3 6.6 GNPA (Rs mn) 4,395 6,315 10,834 11,207 8,276
NIM 3.8 3.7 3.6 3.5 3.6 NNPA (Rs mn) 1,538 2,935 5,942 6,497 4,243
Other income / Total inc. 23.4 23.6 26.3 23.9 22.3 GNPA 1.8 2.5 4.1 3.8 2.5
Other inc. / avg assets 1.1 1.1 1.2 1.0 0.9 NNPA 0.7 1.2 2.3 2.3 1.3
Cost/Income 56.9 54.5 48.5 54.2 51.7 PCR 65.0 53.5 45.2 42.0 48.7
Employee 28.9 27.7 24.8 27.2 26.0 Slippage 2.1 2.8 2.7 3.9 2.6
Other 27.9 26.8 23.7 26.9 25.7 NNPA / Equity 4.9 8.6 15.8 16.5 9.9
Opex/ Avg assets 2.6 2.4 2.2 2.3 2.2 Per share
Provisioning cost 0.6 1.1 1.7 1.3 1.0 EPS 10.5 10.9 10.8 10.3 14.8
Tax rate 35.8 31.3 25.8 26.1 26.1 BVPS 92.4 102.3 113.0 118.6 130.2
RoE 11.0 10.3 9.4 8.3 11.2 ABVPS 87.5 92.8 94.0 97.7 116.6
RoA 1.0 0.9 0.9 0.8 1.0 Valuation (x)
RoRWA 1.5 1.5 1.4 1.3 1.7 P/E 16.8 17.7 8.6 9.1 6.3
Du-pont (%) P/BV 1.8 1.7 0.8 0.8 0.7
Interest income 9.2 9.5 8.9 8.7 9.0 P/ABV 2.0 2.0 0.9 1.0 0.8
Interest expenses 5.7 6.1 5.6 5.5 5.7 Source: Company, Centrum Broking
NII 3.5 3.4 3.3 3.2 3.3
Other income 1.1 1.1 1.2 1.0 0.9
Total income 4.5 4.5 4.5 4.2 4.2
Operating expenses 2.6 2.4 2.2 2.3 2.2
Employee 1.3 1.2 1.1 1.2 1.1
Other 1.3 1.2 1.1 1.1 1.1
PPOP 2.0 2.0 2.3 1.9 2.0
Provisions 0.4 0.7 1.1 0.9 0.7
PBT 1.5 1.3 1.2 1.1 1.4
Tax 0.5 0.4 0.3 0.3 0.4
RoA 1.0 0.9 0.9 0.8 1.0
Source: Company, Centrum Broking

Centrum Institutional Research 54


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

Federal Bank (FB)


Over the last 10 years, FB has performed well on stress, fee income and balance sheet Market data
profile. NIM/CASA could have done better. A chunk of the employee base being IBA- Current price: Rs86
related poses an opex risk, which is offset by higher treasury income. RTD+CASA make Bloomberg: FB IN
up 90% of deposits, also led by a strong NRI business franchise. Loan mix, which saw 52-week H/L: Rs93/45
corporate share rising over FY14-19, resulting in NIM decline, reverted to
Market cap: Rs180.5bn
retail/SME/agri over FY19-21, leading to an NIM uptick. ALM mismatch declined,
indicating a reduction in interest rate risk. Overall stress declined over FY14-20 from Free float: 90.3%
4.9% to 1.3%, also driven by a significant improvement in corporate underwriting. Avg. daily vol. 3mth: 16,666,350
FY21 delinquency rose, driven by personal loans. Source: Bloomberg

Strong retail deposit franchise; loan mix back towards non-corporate: RTD+CASA make up 90% of total deposits, which is
better than some peers. This is also a function of its strong NRI business franchise. However, CASA performance has been
muted. While its share had improved from 27% to 33% over FY12-16, which was a positive, post FY16, it has stagnated in the
31-34% range. On the loan mix side, FB saw three sub-cycles. Over FY12-14, that saw muted loan growth, corporate share
declined from 46% to 31% while retail/SME share increased from 27%/16% to 32%/25%. Over FY14-19, credit flow reverted to
corporate, with its share rising from 31% to 42.5%. Over FY19-21, corporate share declined from 42.5% to 36%, while retail/SME
share rose from 47% to 52%. Agri also saw its share increase over FY19-21 from 10% to 12%.

Exhibit 126: RTD accretion healthy; CASA stagnated Exhibit 127: Corporate share rose over FY14-19
Deposit mix Advances mix
100% 5% 5% 2% 7% 7%
100%
15% 15% 9% 10% 10%
80% 80%

60% 60%
40% 40%
20% 20% 46% 42% 38% 42% 43% 41%
31% 32% 35% 36%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Retail term Savings Current Wholesale Corporate Retail SME Agri
Source: Company, Centrum Broking Source: Company, Centrum Broking

FB has done well to control overall stress over FY14-20: Total stress as defined by NNPA + restructuring + net SR declined over
FY14-20 from 4.9% to 1.3%. Corporate underwriting has improved, with the share of ‘A & above’ rising from 23% to 78%.
Overall provisions reduced from ~80bp to 60bp in the years following stress recognition. Led by the pandemic-related
lockdown, overall stress escalated from 1.3% in FY20 to 2% in FY21. Overall GNPA rose from 2.8% in FY20 to 3.4% in FY21.
Contrary to the previous two stress testing cycles in FY16 and FY18 that saw corporate stress rising, FY21 saw stress
deterioration largely led by personal loans. Personal loan GNPA rose from 2.2% to 4.9%.

Exhibit 128: Stress reduced over FY14-20 from 4.9% to 1.3% Exhibit 129: FY21 saw a spike in personal loan GNPA
Balance sheet stress Segment-wise GNPA
5% 52% 7.0%
6.0%
4% 42%
5.0%
3% 32% 4.0%
2% 22% 3.0%
2.0%
1% 12%
1.0%
0% 2% 0.0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Agri Industry Services Personal Others Overall
Stress to avg. assets Stress to equity (RHS) FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Federal Bank (FB) 16 September 2021

Exhibit 130: NIM, fees, opex have led to rise in PPoP to assets Exhibit 131: Multiple levers have resulted in RoE build-up
Du pont % (to avg. assets) Return ratios (%)
3.5 1.0 1.4 14
3.0 0.8 1.2 12
1.0 10
2.5 0.6 0.8 8
2.0 0.4 0.6 6
0.4 4
1.5 0.2
0.2 2
1.0 0.0 0.0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM Opex PPoP Fees (RHS) Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Operating metrics see an improving trend: NIM declined over FY14-20, largely led by increase in corporate share from 31% to
41%. However, NIM improved from 3% in FY20 to 3.2% in FY21 since combined share of retail/SME/agri increased from 59%
to 64%. Fees to average assets has risen from 45-47bp over FY12-16 to ~54bp over FY17-21 since the bank focused more on
cross-sell and improving the self-funding ratio across customers. Opex to assets spiked over FY12-14 from 175bp to 198bp, as
branch/employee addition was aggressive. During FY14-20, this ratio was stable to declining. In FY20, opex to assets escalated,
led by decline in discount rate from 7.8% to 6.85%, resulting in an increase in pension liability.
Exhibit 132: Deposit share in liabilities relatively higher Exhibit 133: LDR improved though NIM execution was mixed
Liability mix Asset mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Deposits Capital Borrowings Other Liabilities Advances Investments Cash Other assets Fixed assets
Source: Company, Centrum Broking Source: Company, Centrum Broking

Deposits share relatively higher; loan share saw three cycles: FB has largely been deposit-funded; the share of deposits rose
to ~85% of total assets over FY15-21 from ~80% over FY12-14. In the last 10 years, FB has raised equity only once in FY18 that
resulted in CET-1 ratio improving from 11.8% to 14.2%. On assets, FB has seen three sub-cycles – FY12-14 saw controlled credit
growth (loan CAGR was 7.3%) that resulted in loan share declining from 62% to 58%; FY14-19 witnessed a strong 20.5% loan
CAGR; FY19-21 again saw the bank slowing its growth. Share of other assets jumped in FY15 from 2.8% to 6.9%, as priority
sector shortfall deposits (PSSD) were reclassified from investments to other assets.

Exhibit 134: Balance sheet maturity has become more stable Exhibit 135: Mismatch in the <1-year bucket has reduced
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 5

80% 0
60% -5
40% -10
20% -15
0% -20
A L A L A L A L A L A L A L A L A L A L
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -25
<1yr 1-3yr 3-5yr >5yr FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile has become more balanced from FY14 to FY21: Advances’ tenure has remained largely stable over FY12-21, with
the 1-3 year bucket seeing the maximum share of 40-50%. Share of >5-year deposits saw a jump from 2% to 20% in FY15, while
investments declined in its >5-year bucket from 74% to 42%, implying an increase in borrowing tenor and a decline in
investment tenor. This suggests FB shifted to borrowing long-term and investing in shorter tenor securities, which largely
reduces interest rate risk and NIM outcomes would more be a function of asset-liability mix rather than systemic interest rates.
This is also indicated by a reduction in its negative <1-year ALM gap from -21% in FY14 to -5% in FY21.

Centrum Institutional Research 56


Federal Bank (FB) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest earned 114,190 132,108 137,579 147,674 168,242 Share capital 3,970 3,985 3,992 4,202 4,212
Interest expended 72,427 85,618 82,242 86,878 100,589 Reserves & surplus 128,760 141,191 157,244 178,943 193,540
Net Interest Income 41,763 46,489 55,337 60,796 67,653 Deposits 1,349,544 1,522,901 1,726,445 1,895,104 2,126,899
Other income 13,510 19,314 19,449 19,066 20,059 Borrowings 77,813 103,724 90,685 104,231 116,979
Total Income 55,274 65,803 74,786 79,861 87,712 Other Liabilities 33,313 34,579 35,308 36,676 37,836
Operating Expenses 27,643 33,756 36,917 40,319 44,835 Total liabilities 1,593,400 1,806,381 2,013,674 2,219,154 2,479,467
Employees 13,778 17,724 20,342 22,196 24,667 Cash balances with RBI 64,192 61,749 76,470 81,973 91,999
Others 13,865 16,033 16,575 18,123 20,169 Balances with banks 36,476 63,997 119,444 103,965 100,975
Operating profit 27,631 32,047 37,869 39,542 42,877 Investments 318,245 358,927 371,862 418,818 457,283
Provisions 8,559 11,722 16,496 15,782 14,382 Advances 1,102,230 1,222,679 1,318,786 1,476,601 1,682,626
Profit before tax 19,073 20,325 21,373 23,761 28,495 Fixed Assets 4,720 4,800 4,911 5,118 5,350
Taxes 6,634 4,898 5,470 5,988 7,181 Other Assets 67,537 94,229 122,201 132,679 141,234
Net Profit 12,439 15,428 15,903 17,773 21,314 Total assets 1,593,400 1,806,381 2,013,674 2,219,154 2,479,467

Ratios Ratios
YE Mar FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Growth (%) Balance Sheet (%)
Loans 19.9 10.9 7.9 12.0 14.0 Loans / Deposits 81.7 80.3 76.4 77.9 79.1
Deposits 20.5 12.8 13.4 9.8 12.2 Investments / Deposits 23.6 23.6 21.5 22.1 21.5
RWA growth 12.9 12.8 5.5 7.7 10.0 CASA 32.4 30.7 34.0 32.7 33.0
NII 16.6 11.3 19.0 9.9 11.3 Assets/equity (x) 12.0 12.4 12.5 12.1 12.5
Other income 16.6 43.0 0.7 (2.0) 5.2 RWA / Total assets 58.8 58.6 55.4 54.2 53.3
Opex 12.8 22.1 9.4 9.2 11.2 Capital ratios (%)
PPoP 20.6 16.0 18.2 4.4 8.4 CET-1 13.4 13.3 13.8 14.6 14.4
Provisions (9.6) 37.0 40.7 (4.3) (8.9) Tier-1 13.4 13.3 13.8 14.6 14.4
Net profit 41.5 24.0 3.1 11.8 19.9 Tier-2 0.8 1.1 0.8 1.0 1.0
Profitability (%) CRAR 14.1 14.3 14.6 15.6 15.4
Yield on assets 8.4 8.5 7.8 7.6 7.8 Asset quality ratios (%)
Cost of funds 5.4 5.6 4.8 4.6 4.7 GNPA (Rs mn) 32,607 35,308 46,024 51,757 53,642
NIM 3.1 3.0 3.2 3.2 3.2 NNPA (Rs mn) 16,262 16,072 15,693 19,124 21,414
Other income / Total inc. 24.4 29.4 26.0 23.9 22.9 GNPA 2.9 2.8 3.4 3.4 3.1
Other inc. / avg assets 0.9 1.1 1.0 0.9 0.9 NNPA 1.5 1.3 1.2 1.3 1.3
Cost/Income 50.0 51.3 49.4 50.5 51.1 PCR 50.1 54.5 65.9 63.0 60.1
Employee 24.9 26.9 27.2 27.8 28.1 Slippage 1.8 1.7 1.6 1.5 1.4
Other 25.1 24.4 22.2 22.7 23.0 NNPA / Equity 12.3 11.1 9.7 10.4 10.8
Opex/ Avg assets 1.9 2.0 1.9 1.9 1.9 Per share
Provisioning cost 0.8 1.0 1.3 1.1 0.9 EPS 6.3 7.7 8.0 8.5 10.1
Tax rate 34.8 24.1 25.6 25.2 25.2 BVPS 66.8 72.8 80.7 87.1 93.9
RoE 9.8 11.1 10.4 10.3 11.2 ABVPS 58.7 64.8 72.9 78.1 83.7
RoA 0.8 0.9 0.8 0.8 0.9 Valuation (x)
RoRWA 1.4 1.5 1.5 1.5 1.7 P/E 11.1 11.2 7.4 10.2 8.5
Du-pont (%) P/BV 1.2 1.1 0.7 1.0 0.9
Interest income 7.7 7.8 7.2 7.0 7.2 P/ABV 1.3 1.2 0.8 1.1 1.0
Interest expenses 4.9 5.0 4.3 4.1 4.3 Source: Company, Centrum Broking
NII 2.8 2.7 2.9 2.9 2.9
Other income 0.9 1.1 1.0 0.9 0.9
Total income 3.7 3.9 3.9 3.8 3.7
Operating expenses 1.9 2.0 1.9 1.9 1.9
Employee 0.9 1.0 1.1 1.0 1.0
Other 0.9 0.9 0.9 0.9 0.9
PPOP 1.9 1.9 2.0 1.9 1.8
Provisions 0.6 0.7 0.9 0.7 0.6
PBT 1.3 1.2 1.1 1.1 1.2
Tax 0.4 0.3 0.3 0.3 0.3
RoA 0.8 0.9 0.8 0.8 0.9
Source: Company, Centrum Broking

Centrum Institutional Research 57


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

HDFC AMC
HDFC AMC delivered robust performance over FY12-20, maintaining overall market Market data
share and operating yields, driven by strong parentage and distribution network. This Current price: Rs3,288
led to best return ratios in the industry, enabling HDFC AMC to command a premium Bloomberg: HDFCAMC IN
to peers. However, its equity market share declined over the last decade, led by lower 52-week H/L: Rs3,365/2070
flows due to heightened competition, and FY21 was a bit challenging. Debt share in
Market cap: Rs700.8bn
AUM shifted to liquid over FY12-20, also partly contributing to lower blended yields,
though ETF share remains low, cushioning margins. Operating yields saw a V-shaped Free float: 20.5%
trend over FY14-20 with yield compression being higher in the initial phase; in the Avg. daily vol. 3mth: 363,816
following period, opex control led to better profitability. Source: Bloomberg

Equity share one of the highest; equity and debt share reduced from FY19: HDFC AMC saw equity proportion being
consistently better than the industry over FY16-19 (equity CAGR of 23.3% over FY12-19). This coupled with healthy payout
ratios led to best return ratios in the industry. However, share of equity and debt reduced after FY19, mainly on account of
three reasons. Firstly, liquid funds picked up pace since FY19, putting pressure on equity and debt share. Secondly, debt AUM
saw muted growth compared to others (10-year CAGR 12.9%). Lastly, equity share declined, driven by the pandemic impact
and drop in market share of flows. Equities bounced back partially in FY21, as the equity markets were buoyant.

Exhibit 136: Strong AUM growth; liquid jumped in FY19 Exhibit 137: Debt share contracted; liquid AUM grew
Closing AUM Closing AUM Mix
1750
100%
1500
1250 80%
1000 60%
750 40%
500
20%
250
0 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Equity Debt Liquid Others Equity Debt Liquid Others
Source: Company, Centrum Broking Source: Company, Centrum Broking

Overall market share sustained despite lost equity share; SIP share disappointing: Being an early entrant in the AMC business,
HDFC AMC had a solid 20.7% equity market share in FY13, which declined over FY13-21 to 12.8% with the entry of new mutual
funds and flows diverging to other funds. Despite losing market share in equity, the company has maintained overall AUM
share at 13-15% over FY12-20, as strong growth in liquid made up for the lost share in equities. Overall share dipped by 1.7%
to 12.6% in FY21. On the SIP flows side, HDFC AMC saw improving flows and share from FY18-20; however, it lost market share
in FY21. Annualized SIP flows were strong in FY19 and FY20 at Rs140-147bn, though they dropped in FY21 to Rs113bn.

Exhibit 138: Equity share contracted; overall share even Exhibit 139: SIP market share declined over FY18-21
Market share SIP Flows
22.5% 150 21%
20.0% 125 18%
17.5%
15.0% 100 15%
12.5% 75 12%
10.0% 50 9%
7.5%
5.0% 25 6%
2.5% 0 3%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21
Overall Equity SIP Flows (bn) SIP Flows Share
Source: Company, Centrum Broking Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
HDFC AMC 16 September 2021

Exhibit 140: Yields suffered due to higher liquid share in AUM Exhibit 141: Operating leverage played out well
Operating metrics (bps) Opex
100 60 12
10
80 50
8
60 40
6
40 30 4
20 20 2

0 10 0
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Revenue yields Opex/AUM Operating yields (RHS) EBE/AUM (bps) Other exp/AUM (bps)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Revenue yields drop though operating yields improve on lower opex: Revenue to AAUM dropped over FY14-17 from 85bp to
75bp, while the contraction in operating yields was not as sharp. Operating yields dropped due to higher distributor
commissions paid over the same time frame, as the industry followed the upfront plus trail mode. Despite the industry shifting
from the upfront to trail model, operating yields increased for HDFC AMC over FY17-21 due to strong control on opex. Employee
expense to AUM ratio fell from 8bp to 6bp over the same time frame while other expenses dropped from 10bp to 5bp, led by
a sharp fall in scheme expenses. The steep revenue yield contraction over FY16-19 was also driven by the rise in the lower-
yielding liquid share in overall AUM.

Exhibit 142: RoE slips on lower payout ratio Exhibit 143: Core RoAUM intact due to lower opex
Core RoE and Payout Ratio RoAAuM
50% 70% 40
35
40% 56%
30
30% 42% 25
20
20% 28% 15
10
10% 14%
5
0% 0% 0
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Core ROE ROE Payout Ratio (RHS) Core ROAUM ROAUM
Source: Company, Centrum Broking Source: Company, Centrum Broking

RoE suffers partly due to payout ratio; core RoAUM largely flat: Led by its market dominance, higher equity AUM share and
an attractive payout ratio, HDFC AMC has one of the best return profiles in the AMC space. Core RoE/RoAUM were at 35-40%
and 25-35bp, respectively from FY17-20. Core RoE has consistently declined over FY13-21, despite an increasing payout ratio.
HDFC AMC’s payout is lower than NAM. In contrast, core RoAUM increased over FY17-20 due to the positive impact of lower
operating cost ratios. In line with lower operating yields, core RoAUM declined in FY21.

Exhibit 144: Contribution of Top 5 increased in FY20 Exhibit 145: Direct channels grew due to digital push
Geographic mix Distribution mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Overall Equity
Top 5 Next 10 Next 20 Next 75 Others IFAs BND Direct
Source: Company, Centrum Broking Source: Company, Centrum Broking

Share from Top 5 cities rises; investments from direct channels continue to grow: Share from Top 5 geographies continues to
grow, putting additional pressure on yields. FY20 saw Top 5 gaining 600bp share to 69%, while the Next 20, Next 75, and others
lost share during the year. Distribution mix saw robust shift to direct channels, which now have 47% share (compared to 34%
in FY18), mainly driven by digital initiatives and awareness among customers about commission costs associated with
distributors. A similar trend is also visible on the equity side that saw share of direct channel increase. However, equity
distribution saw a shift from BND to IFA and direct over FY18-21.

Centrum Institutional Research 59


HDFC AMC 16 September 2021
P&L Balance sheet
YE March (Rs mn) FY19 FY20 FY21 FY22E FY23E YE March (Rs mn) FY19 FY20 FY21 FY22E FY23E
Revenue from Operations 19,152 20,033 18,525 21,359 22,380 Share Capital 1,063 1,064 1,065 1,065 1,065
Investment Management Fees 18,954 19,653 18,174 20,954 21,956 Reserves and Surplus 29,644 39,229 46,697 52,274 57,552
PMS and Advisory Fees 198 380 351 405 424 Net Worth 30,707 40,293 47,762 53,339 58,617
Expenses 6,821 4,904 4,528 5,482 5,187 Trade Payables 474 467 421 360 400
Employees 2,063 2,147 2,268 3,002 2,437 Employee Benefit 649 601 552 1,480 1,202
Others 2,227 2,044 1,649 1,815 2,020 Others 390 1,685 2,168 2,172 2,176
Depreciation 129 504 554 603 662 Total Liabilities and Equity 32,220 43,046 50,904 57,352 62,396
Fees 2,403 209 57 62 67 Cash and Bank 320 271 24 24 24
Core Operating Income 12,331 15,129 13,997 15,877 17,193 Investment 29,350 39,445 47,533 52,841 56,919
Other Income 1,816 1,401 3,492 2,763 2,965 Fixed Asset 429 1,613 1,544 2,280 3,384
Exceptional Item: Impairment of FI 400 0 0 0 0 Receivables 1,029 646 838 1,229 1,288
PBT 13,747 16,530 17,490 18,640 20,158 Others 1,093 1,072 966 1,172 1,195
Tax 4,441 3,906 4,232 4,697 5,080 Total Assets 32,220 43,046 50,904 57,545 62,809
PAT 9,306 12,624 13,258 13,942 15,078
Dividend 6,150 11,300 7,241 8,366 9,801 Closing AuM (Rs bn)
Retained Earnings 3,156 1,323 6,017 5,576 5,277 YE March FY19 FY20 FY21 FY22E FY23E
Closing AuM 3,437 3,191 3,955 4,198 4,511
Growth ratios (%) Equity 1,688 1,269 1,738 1,859 2,045
YE March FY19 FY20 FY21 FY22E FY23E Debt 998 855 1,216 1,301 1,391
Closing AuM 17.8 (7.2) 23.9 6.1 7.5 Liquid 745 1,033 921 948 977
Revenue 9.0 4.6 (7.5) 15.3 4.8 Others 6 34 81 89 98
EBE 10.8 4.1 5.6 32.4 (18.8) Closing AUM Breakup (%)
PAT 30.8 35.7 5.0 5.2 8.1 Overall AuM 100.0 100.0 100.0 100.0 100.0
Profitability Ratios (%) Equity 49.1 39.8 43.9 44.3 45.3
Yield on AUM 0.60 0.60 0.52 0.52 0.51 Debt 29.0 26.8 30.7 31.0 30.8
Yield on Investments 6.35 3.48 7.83 5.30 5.20 Liquid 21.7 32.4 23.3 22.6 21.7
EBE / Core Revenue 10.8 10.7 12.2 14.1 10.9 Others 0.2 1.1 2.0 2.1 2.2
Operating Income/ Core Revenue 62.3 75.5 75.6 74.3 76.8
Other Income / Core Revenue 9.5 7.0 18.9 12.9 13.2 AuM Growth (%)
Effective tax rate 32.3 23.6 24.2 25.2 25.2 YE March FY19 FY20 FY21 FY22E FY23E
PAT Margin 48.6 63.0 71.6 65.3 67.4 Overall 17.8 (7.2) 23.9 6.1 7.5
ROE 35.0 35.6 30.1 27.6 26.9 Equity 12.8 (24.8) 36.9 7.0 10.0
Core ROE 35.9 38.2 28.8 28.9 29.0 Debt (5.4) (14.4) 42.2 7.0 6.9
ROAAUM 0.29 0.38 0.37 0.34 0.35 Liquid 107.0 38.8 (10.9) 3.0 3.0
DuPont analysis (%) Others 15.4 427.2 138.1 10.0 10.0
Revenue from Operations 0.60 0.60 0.52 0.52 0.51
Investment Mgmt. Fees 0.60 0.59 0.51 0.51 0.50 Valuations (per share)
PMS and Advisory Fees 0.01 0.01 0.01 0.01 0.01 YE March FY19 FY20 FY21 FY22E FY23E
Expenses 0.23 0.15 0.13 0.13 0.12 EPS 43.8 59.3 62.3 65.5 70.8
Employee 0.06 0.06 0.06 0.07 0.06 DPS 24.0 44.0 34.0 39.3 46.0
Others 0.07 0.06 0.05 0.04 0.05 BVPS 144 189 224 250 275
Depreciation 0.00 0.02 0.02 0.01 0.02 Dividend Yield 0.8 1.4 1.3 1.2 1.4
Fees 0.08 0.01 0.00 0.00 0.00 P/E 53.6 40.9 39.9 50.2 46.5
Core Operating Income 0.38 0.46 0.39 0.39 0.39 P/B 16.8 11.4 10.4 13.1 11.9
Other Income 0.06 0.04 0.10 0.07 0.07 Source: Company, Centrum Broking
PBT 0.43 0.50 0.49 0.46 0.46
Tax 0.14 0.12 0.12 0.12 0.12
PAT 0.29 0.38 0.37 0.34 0.35
Source: Company, Centrum Broking

Centrum Institutional Research 60


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

ICICI Bank
ICICI Bank (ICICI) is on a transformation path. Due to its scale and presence, CASA has Market data
remained over 45%, while loan mix materially changed for the better, with the share Current price: Rs727
of higher-yielding retail increasing and the margin-dilutive overseas pool declining. Bloomberg: ICICIBC IN
Although NIM was depressed over FY15-18, led by delinquencies, it improved 52-week H/L: Rs735/334
significantly over FY18-21, driven by better retail share. Fee income declined slightly
Market cap: Rs5,040.1bn
over FY12-21 while opex to assets rose, since retail entails higher operating costs. Post
FY19, as credit costs and slippages moderated, NIM started positively impacting the Free float: 89.4%
return ratios. The bank is moving towards RoE profile of 15%. ALM profile was largely Avg. daily vol. 3mth: 11,932,080
balanced, which largely reduces the interest rate risk. Source: Bloomberg

CASA has been 45%+ after FY14; retail share in loans has surged: CASA contributes 46% to total deposits, which is largely in-
line with peers. CASA rose from 46% to 52% over FY15-18, as reliance on term deposits reduced. However, after FY18, the bank
focused on garnering retail term deposits, whose share increased from 47% in FY18 to 54% in FY20. On loan mix, the bank has
consistently increased its retail contribution over the last 10 years from 38% in FY12 to 67% in FY21. This has been largely
contributed by housing growth (CAGR of 20% over FY12-21) since it makes up ~50% of retail loans. The other positive has been
the reduction of overseas loan contribution, which declined from 27% to 5% over FY12-21. This has also partly contributed to
NIM improvement over the same time frame.

Exhibit 146: CASA has been 42%+; more recent reliance on TD Exhibit 147: Retail share improved; overseas share declined
Deposit mix Advances Mix
100% 100%
14% 13% 14% 14% 15% 16% 15% 13% 15%
13%
80% 80%
30% 29% 30% 32% 32% 35% 35% 32% 32%
36%
60% 60%

40% 40%
60% 63% 67%
52% 57%
20% 20% 38% 39% 42% 47%
37%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Term Savings Current Overseas Retail Corporate SME Overseas
Source: Company, Centrum Broking Source: Company, Centrum Broking

Most of the stress recognized over FY14-18: Total stress as defined by NNPA + restructuring + net SR rose over FY13-17 from
1.5% to 5.3%, led by delinquencies in long-term infrastructure loans. This was also reflected by a rise industry GNPA from 4.7%
in FY15 to 22.5% in FY18. Overall stress for ICICI declined over FY18-19 from 4.1% to 1.8%. Underwriting has dramatically improved
over FY17-21, with the share of ‘A & above’ rising from 56% to 75%. Overall provisions reduced from ~2% in FY18 to 1.4% in FY21.
Led by the pandemic-related lockdown, overall stress rose slightly from 1.1% in FY20 to 1.2% in FY21, while overall slippage
ratio increased from 2.3% to 2.5%. FY21 saw personal loan GNPA rise from 1.5% to 2.8%.

Exhibit 148: Stress reduced over FY14-20 from 4.9% to 1.3% Exhibit 149: FY21 saw a spike in personal loan GNPA
Balance sheet stress Segment-wise GNPA
5% 52% 24%
21%
4% 42% 18%
3% 32% 15%
12%
2% 22% 9%
1% 12% 6%
3%
0% 2% 0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Agri Industry Services Personal Overall
Stress to avg. assets Stress to equity (RHS) FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
ICICI Bank 16 September 2021

Exhibit 150: NIM boost over FY12-21; PPoP rising since FY19 Exhibit 151: Elevated credit cost cycle depressed RoE
Du pont % (to avg. assets) Return ratios (%)
3.5 2.2 1.8 17
3.0 1.9 1.6 15
2.5 1.6 1.4 13
2.0 1.3 1.2 11
1.0 9
1.5 1.0
0.8 7
1.0 0.7
0.6 5
0.5 0.4 0.4 3
0.0 0.1 0.2 1
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM Opex PPoP Fees (RHS) Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Strong NIM performance over FY12-21 led by increase/decrease in retail/overseas loans: NIM improved over FY12-20 from
2.91% to 3.35%, largely led by increase/decrease in retail/overseas loans. NIM dipped over FY15-18, driven by interest reversals
led by the stressed asset cycle. Fees to average assets has been strong at 1.3% (FY17-20) after declining from ~1.5% (FY12-16),
since corporate share shifted in favor of retail. Opex to assets rose over FY12-20 from 175bp to 210bp since a retail strategy
entails greater utilization of resources. Provisions costs spiked from 35bp in FY12 to 210bp in FY19, which coupled with lower
stake sale gains in FY19 led to RoE decline (peak 14.6% in FY15; bottom 3.2% in FY19).
Exhibit 152: Bank has largely shifted to being deposit-funded Exhibit 153: Balance sheet liquidity declined, supporting NIM
Liability mix Asset mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Deposits Capital Borrowings Other Liabilities Advances Investments Cash Other assets Fixed assets
Source: Company, Centrum Broking Source: Company, Centrum Broking

The bank has become increasingly deposit funded; lower liquidity supported NIM: ICICI has largely become deposit-funded,
with deposits to total assets rising from 52% in FY12 to 76% in FY21. This was in sync with its retail-focused strategy, as the
proportion of domestic retail assets/deposits has risen over the same time frame. In the last 10 years, the bank raised equity
only once in FY21 that resulted in CET-1 ratio improving from 13.4% to 16.8%. On assets, loans share improved over FY12-15,
post which it remained stable. Balance sheet liquidity declined over FY12-15, which also supported NIM. However, with the
pandemic driving lenders to maintain liquidity buffers, ICICI raised its liquidity share from 30% in FY19 to 34% in FY20.
Exhibit 154: Balance sheet maturity has become more stable Exhibit 155: Mismatch in the <1-year bucket has reduced

Asset (A) Liability (L) Maturity Pattern 25 ALM mismatch (%)

100%
15
80%
60% 5
%

40%
-5
20%
0% -15
A L A L A L A L A L A L A L A L A L A L
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -25
<1yr 1-3yr 3-5yr >5yr FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile became more balanced from FY14 to FY21: Advances’ tenure has remained largely stable over FY12-21, with the
<1-year bucket seeing the maximum share of 26-33%. Overall loan maturity has increased, as the share of 1-3 year bucket
declined from 40% in FY15 to 28% in FY21, reflecting a shift from corporate lending to longer-tenure housing loans. In tandem
with assets, liabilities have also seen their tenures rise, led by a focus on retail term deposits. Share of >5-year deposits rose
from 16% in FY12 to 28% in FY20. Overall balance sheet maturity pattern indicates a stable ALM profile with <1-year ALM gap
not being material, suggesting that NIM would be more a function of asset-liability mix rather than systemic interest rates.

Centrum Institutional Research 62


ICICI Bank 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest earned 634,012 747,983 791,183 848,592 1,006,499 Share capital 12,941 12,983 13,865 13,865 13,865
Interest expended 363,864 415,313 401,288 410,432 507,978 Reserves & surplus 1,070,739 1,152,062 1,461,227 1,625,686 1,828,855
Net Interest Income 270,148 332,671 389,894 438,160 498,520 Deposits 6,529,197 7,709,690 9,325,222 10,499,400 12,003,803
Other income 145,122 164,486 189,685 202,475 230,421 Borrowings 1,653,200 1,628,968 916,310 944,946 1,013,121
Total Income 415,270 497,157 579,580 640,635 728,941 Other Liabilities 378,515 479,950 587,704 675,216 781,015
Operating Expenses 180,891 216,144 215,608 250,471 277,087 Total liabilities 9,644,591 10,983,651 12,304,327 13,759,113 15,640,659
Employees 68,082 82,712 80,918 91,263 101,933 Cash balances with RBI 378,580 352,840 460,312 469,218 533,694
Others 112,808 133,432 134,691 159,208 175,154 Balances with banks 424,383 838,718 870,971 926,992 1,002,303
Operating profit 234,379 281,013 363,971 390,164 451,854 Investments 2,077,327 2,495,315 2,812,866 3,089,973 3,514,570
Provisions 196,611 140,532 162,144 105,385 100,048 Advances 5,866,466 6,452,900 7,337,291 8,378,397 9,636,631
Profit before tax 37,768 140,480 201,827 284,778 351,807 Fixed Assets 79,314 84,103 88,776 91,747 98,634
Taxes 4,135 61,172 39,900 71,195 87,952 Other Assets 818,522 759,777 734,112 802,786 854,828
Net Profit 33,633 79,308 161,927 213,584 263,855 Total assets 9,644,591 10,983,651 12,304,327 13,759,113 15,640,659

Ratios Ratios
YE Mar FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Growth (%) Balance Sheet (%)
Loans 14.5 10.0 13.7 14.2 15.0 Loans / Deposits 89.8 83.7 78.7 79.8 80.3
Deposits 16.4 18.1 21.0 12.6 14.3 Investments / Deposits 18.3 20.5 22.3 20.7 20.5
RWA growth 8.3 10.5 3.4 9.0 12.0 CASA 49.6 45.1 46.3 46.1 45.2
NII 17.3 23.1 17.2 12.4 13.8 Assets/equity (x) 890.0 942.8 834.1 839.2 848.8
Other income (16.7) 13.3 15.3 6.7 13.8 RWA / Total assets (%) 71.3 69.1 63.8 62.2 61.3
Opex 15.2 19.5 (0.2) 16.2 10.6 Capital ratios (%)
PPoP (5.3) 19.9 29.5 7.2 15.8 CET-1 13.6 13.4 16.8 16.9 16.6
Provisions 13.6 (28.5) 15.4 (35.0) (5.1) Tier-1 15.1 14.7 18.1 18.1 17.8
Net profit (50.4) 135.8 104.2 31.9 23.5 Tier-2 1.8 1.4 1.1 0.8 0.7
Profitability (%) CRAR 16.9 16.1 19.1 18.9 18.6
Yield on assets 7.9 8.2 7.6 7.2 7.6 Asset quality ratios (%)
Cost of funds 4.7 4.7 4.1 3.8 4.2 GNPA (Rs mn) 502,981 459,652 408,414 440,733 484,023
NIM 3.4 3.7 3.7 3.7 3.8 NNPA (Rs mn) 141,187 103,579 95,015 100,430 115,376
Other income / Total inc. 34.9 33.1 32.7 31.6 31.6 GNPA 7.5 6.3 5.6 5.3 5.0
Other inc. / avg assets 1.6 1.6 1.6 1.6 1.6 NNPA 2.2 1.5 1.2 1.1 1.1
Cost/Income 43.6 43.5 37.2 39.1 38.0 PCR 3.1 2.0 2.1 1.2 1.0
Employee 16.4 16.6 14.0 14.2 14.0 Slippage 2.1 2.4 2.4 2.5 2.3
Other 27.2 26.8 23.2 24.9 24.0 NNPA / Equity 13.0 8.9 6.4 6.1 6.3
Opex/ Avg assets 2.0 2.1 1.9 1.9 1.9 Per share
Provisioning cost 3.1 2.0 2.1 1.2 1.0 EPS 5.2 12.2 23.4 30.8 38.1
Tax rate 10.9 43.5 19.8 25.0 25.0 BVPS 167.5 179.5 212.8 236.5 265.8
RoE 3.2 7.1 12.3 13.7 15.2 ABVPS 145.7 163.5 199.1 222.0 249.2
RoA 0.4 0.8 1.4 1.6 1.8 Valuation (x)
RoRWA 0.5 1.1 2.1 2.6 2.9 P/E 26.7 19.3 14.2 23.6 19.1
Du-pont (%) P/BV 1.8 2.1 1.9 3.1 2.7
Interest income 6.9 7.3 6.8 6.5 6.8 P/ABV 2.0 2.3 2.0 3.3 2.9
Interest expenses 3.9 4.0 3.4 3.1 3.5 Source: Company, Centrum Broking
NII 2.9 3.2 3.3 3.4 3.4
Other income 1.6 1.6 1.6 1.6 1.6
Total income 4.5 4.8 5.0 4.9 5.0
Operating expenses 1.2 1.3 1.2 1.2 1.2
Employee 2.0 2.1 1.9 1.9 1.9
Other 0.7 0.8 0.7 0.7 0.7
PPOP 2.5 2.7 3.1 3.0 3.1
Provisions 2.1 1.4 1.4 0.8 0.7
PBT 0.4 1.4 1.7 2.2 2.4
Tax 0.0 0.6 0.3 0.5 0.6
RoA 0.4 0.8 1.4 1.6 1.8
Source: Company, Centrum Broking

Centrum Institutional Research 63


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

LIC Housing Finance (LICHF)


LICHF saw mixed performance over the last 10 years. Ability to source lower cost Market data
funds due to its sovereign franchise and salaried housing being a major contributor to Current price: Rs417
loans have been its key strengths. Funding mix changed over FY18-21, with greater Bloomberg: LICHF IN
reliance on bank loans due to a favourable interest rate regime. On the loans side, the 52-week H/L: Rs542/260
share of higher-risk LAP/LRD/project increased over FY15-21 to counter the pricing
Market cap: Rs210.4bn
pressure in housing, which also led to a spike in non-housing stress over FY17-21.
Opex did well over FY12-21, barring FY17 that saw staff cost rise owing to wage Free float: 53.4%
revision. A single product dominating the loan mix exposes LICHF to interest rate risk Avg. daily vol. 3mth: 3,901,891
since ALM profile suggests a negative mismatch in the <1-year bucket. Source: Bloomberg

Borrowing mix in FY21 similar to FY12 levels; LAP/Builder portfolio share rose: Borrowing mix broadly saw two cycles. Over
FY12-17, the share of banks declined from 32% to 9.5%, while the share of NCDs rose from 63% to 81%. As systemic rates eased
post FY17, funding mix shifted back towards banks and CPs. The share of banks increased back to 25% in FY17. This was also
indicated by the cost of funds trajectory, which saw a tighter range of 9-9.5% over FY12-16, after which it materially reduced
to 7.2%. On the loan mix side, the share of individual housing declined over FY15-17 from 93% to 78%, while that of
LAP/LRD/developer loans increased, leading to subsequent asset quality pressures. However, in the recent past, LICHF has
slightly de-risked the portfolio with the share of LAP/LRD/Project declining from 24% to 22% over FY19-21.

Exhibit 156: Lower systemic rates led to rise in bank funding Exhibit 157: Share of LAP/LRD/Project rose over FY15-21
Borrowings mix Advances mix
100% 100%

80% 80%

60% 60%
40% 40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NCD Banks Deposits CP Others Retail home Retail LAP / LRD Developer
Source: Company, Centrum Broking Source: Company, Centrum Broking

Project loans and LAP a problem area for LICHF: Asset quality was largely controlled over FY12-17, with GNPA below 0.7%
levels. Although non-housing GNPA looks higher over FY13-16, non-housing loan contribution was not material (~5% share);
therefore, overall GNPA was controlled. However, increasing share of LAP/LRD/project loans started affecting asset quality
since FY18, and over FY17-21, GNPA rose from 0.43% to 4.1%. As at Q4FY21, the GNPA split is as follows: individual housing -
1.9%, LAP - 5.8%, and developer loans - 18%. The overall proportion of stage-2 assets also increased over FY17-21 from 3.7%
to 6.2%. Stage 1&2 provisions, indicating a buffer, declined and is lower compared to peers.

Exhibit 158: Non-housing NPA a concern Exhibit 159: Stage 1+2 provision cover lower than peers
Segment-wise GNPA
5.0% Stress
7% 42
4.0% 6% 35
5% 28
3.0%
4% 21
2.0%
3% 14
1.0% 2% 7

0.0% 1% 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21
Stage 2 assets Stage 1+2 provisions (bps)
Housing Non-Housing Overall
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
LIC Housing Finance (LICHF) 16 September 2021

Exhibit 160: Rise in balance sheet stress over FY18-21 Exhibit 161: Leverage near 10x from FY17 to FY21
Balance sheet stress Debt/Equity
4% 40% 12
10
3% 30%
8
2% 20%
6
1% 10% 4

0% 0% 2
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
0
Stress to AuM Stress to Equity FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Overall stress saw a significant rise over FY18-21: As the share of LAP/developer loans increased, stress to assets increased to
3.3% of AUM in FY21 from 0.1% in FY17. Stress to equity also rose from 1.7% in FY17 to 37% in FY21. FY17-19 saw rise in stress,
led by developer loans. Over FY19-21, delinquencies rose in housing and LAP. LICHF has consistently maintained a leverage of
10-10.5x over FY17-21. Leverage rose in FY15, but declined in FY17 due to deferred tax adjustment.

Exhibit 162: Lower NIM coupled with higher provisions Exhibit 163: Credit costs led to lower RoEs
Du pont % (to avg. assets) Return ratios (%)
2.8 1.0 1.6 20

2.3 0.8 1.3 16


0.6
1.8 1.0 12
0.4
1.3 0.6 8
0.2
0.8 0.0 0.3 4
0.3 -0.2 0.0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM PPoP Opex Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Credit quality led to decreasing return ratios: NIM grew over FY13-17 from 2.2% to 2.7% due to a favourable ALM profile that
led to a faster reduction in funding cost compared to yields. However, FY18 saw sharp reduction in NIM to 2.2%, led by
competitive pressures and rate hardening. As the share of the non-housing portfolio rose, coupled with a favourable soft
interest rate environment, NIM improved to 2.3% in FY21. From FY16 to FY21, as credit costs rose from 12bp to 58bp, RoE
dipped from 20% to 14%. Opex declined from 40bp to 30bp over FY12-21, which provided tailwinds to the PPoP, though FY17
saw a spike in employee cost due to wage revision.

Exhibit 164: Housing loans have led to longer asset duration Exhibit 165: ALM mismatch has largely been negative
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 0

80%
-5
60%
40% -10
20%
-15
0%
A L A L A L A L A L A L A L A L A L A L
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -20
<1yr 1-3yr 3-5yr >5yr FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile unbalanced, as most of the portfolio is longer duration: Over FY12-21, 70-80% of assets had a maturity of three
years and above, since housing loans are generally longer term. Hence, the ALM profile for an HFC is generally negative in the
less than 1-year bucket. This also exposes HFCs to interest rate risk in case of a rising rate environment, as liabilities would
mature faster than assets. Currently, as systemic rates are at historic lows, HFCs are exposed to interest rate risk, which coupled
with competition from banks may result in NIM pressure.

Centrum Institutional Research 65


LIC Housing Finance (LICHF) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest income 172,668 196,112 197,066 206,742 238,556 Financial assets 1,996,422 2,155,652 2,342,082 2,627,913 2,938,462
Interest expense 131,593 148,314 144,800 150,973 176,620 Cash 28,018 13,657 13,292 12,907 14,460
NII 41,075 47,799 52,266 55,769 61,936 Bank balance 2,117 6,132 176 2,581 2,892
Other income 978 586 1,411 1,025 1,064 Loans 1,929,927 2,079,880 2,281,143 2,559,560 2,867,677
Total income 42,053 48,384 53,677 56,794 63,000 Investment 35,951 54,964 46,356 51,652 52,073
Operating expenses 4,754 6,167 7,015 9,462 8,645 Other financial assets 409 1,019 1,116 1,213 1,359
Employee 2,479 2,991 2,932 5,015 3,771 Non-financial assets 9,413 12,404 14,174 15,488 16,195
Others 2,275 3,176 4,083 4,447 4,874 Current tax assets 1,781 3,541 (78) (85) (89)
PPOP 37,299 42,217 46,662 47,332 54,355 Deferred tax assets 5,534 5,200 9,129 9,976 10,431
Provisions 3,504 9,527 13,176 17,055 12,033 Fixed Assets 1,359 2,544 2,470 2,699 2,822
PBT 33,796 32,690 33,486 30,277 42,322 Other Non-fin. assets 740 1,119 2,652 2,898 3,030
Tax 9,486 8,672 6,142 7,630 10,665 Total Assets 2,005,835 2,168,056 2,356,256 2,643,401 2,954,657
PAT 24,310 24,018 27,343 22,647 31,657 Financial liabilities 1,840,622 1,982,435 2,146,767 2,391,609 2,676,013
Debt securities 1,346,157 1,320,823 1,255,980 1,381,938 1,455,562
Ratios Borrowings 340,513 577,494 804,684 915,025 1,113,526
YE Mar FY19A FY20A FY21A FY22E FY23E
Subordinated Debt 20,000 15,000 17,951 19,556 20,507
Growth (%) Other financial liabilities 133,952 69,118 68,152 75,090 86,418
AUM 16.2 8.2 10.2 11.3 12.0 Non-financial liabilities 2,620 3,690 4,276 4,401 4,661
Borrowings 17.5 12.1 8.6 11.4 11.8 Provisions 1,134 1,453 1,425 1,467 1,553
NII 14.6 16.4 9.3 6.7 11.1
Other Non-fin liabilities 1,487 2,237 2,851 2,935 3,108
Other income 8.6 (40.1) 141.0 (27.4) 3.8
Total equity 162,593 181,931 205,213 247,391 273,983
Opex 8.2 29.7 13.8 34.9 (8.6)
Share capital 1,010 1,010 1,010 1,101 1,101
PPoP 15.3 13.2 10.5 1.4 14.8 Other equity 161,583 180,921 204,203 246,290 272,882
Provisions (25.2) 171.9 38.3 29.4 (29.4) Total Liabilities 2,005,835 2,168,056 2,356,256 2,643,401 2,954,657
PAT 21.4 (1.2) 13.8 (17.2) 39.8 Balance Sheet ratios (%)
Profitability (%) Debt / Equity 10.5 10.5 10.1 9.4 9.5
Yield on advances 9.5 9.6 8.8 8.4 8.7 Assets / Equity 12.3 11.9 11.5 10.7 10.8
Cost of funds 8.3 8.2 7.3 6.9 7.2
Cash / Borrowings 1.8 1.0 0.6 0.7 0.7
NIM (on AuM) 2.3 2.3 2.3 2.3 2.2
Capital Adequacy (%)
Other Income/ Total Income 2.3 1.2 2.6 1.8 1.7
CRAR 14.4 13.9 14.1 15.3 15.3
Other Income / Total Assets 0.1 0.0 0.1 0.0 0.0 Tier-1 12.3 12.2 13.9 14.1 14.1
Cost/Income 11.3 12.7 13.1 16.7 13.7 Tier-2 2.1 1.7 1.4 1.2 1.2
Employee 5.9 6.2 5.5 8.8 6.0 Asset quality (%)
Others 5.4 6.6 7.6 7.8 7.7 GNPA (Rs mn) 29,717 59,679 95,585 129,916 121,808
Opex/ Avg AuM 0.3 0.3 0.3 0.4 0.3 NNPA (Rs mn) 20,812 41,201 64,788 89,508 82,812
Provisions 0.2 0.5 0.6 0.7 0.4
GNPA 1.5 2.8 4.1 5.0 4.2
Tax Rate 28.1 26.5 18.3 25.2 25.2
NNPA 1.1 2.0 2.8 3.5 2.9
RoA 1.3 1.2 1.2 0.9 1.1
PCR 30.0 31.0 32.2 31.1 32.0
RoE 15.9 13.9 14.1 10.0 12.1 NNPA / Equity 12.8 22.6 31.6 36.2 30.2
Per share (Rs)
DuPont (% avg assets)
EPS 48.1 47.6 54.2 41.2 57.5
YE Mar FY19A FY20A FY21A FY22E FY23E
BVPS 322.0 360.3 406.4 449.5 497.8
Interest income 9.3 9.4 8.7 8.3 8.5
ABVPS 280.8 278.7 278.1 286.9 347.4
Interest expense 7.1 7.1 6.4 6.0 6.3 Valuation (x)
NII 2.2 2.3 2.3 2.2 2.2 P/E 10.2 8.2 7.8 10.1 7.2
Other income 0.1 0.0 0.1 0.0 0.0 P/BV 1.3 1.1 0.7 0.9 0.8
Total income 2.3 2.3 2.4 2.3 2.3 P/ABV 1.7 1.6 1.1 1.5 1.2
Operating expenses 0.3 0.3 0.3 0.4 0.3 Source: Company, Centrum Broking
Employee 0.1 0.1 0.1 0.2 0.1
Others 0.1 0.2 0.2 0.2 0.2
PPOP 2.0 2.0 2.1 1.9 1.9
Provisions 0.2 0.5 0.6 0.7 0.4
PBT 1.8 1.6 1.5 1.2 1.5
Tax 0.5 0.4 0.3 0.3 0.4
PAT 1.3 1.2 1.2 0.9 1.1
Source: Company, Centrum Broking

Centrum Institutional Research 66


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

M&M Financial Services (MMFS)


The last 10-year cycle for MMFS has been tough on asset quality, leading to declining Market data
return ratios. GNPA rose from 2.7% in FY12 to 9% in FY21, while PCR dropped from Current price: Rs174
78% in FY12 to 31% in FY20. Focus on earn-and-pay customers, whose cash flows are Bloomberg: MMFS IN
usually stretched and volatile, impacted asset quality. Ability to source funds was 52-week H/L: Rs224/113
never a challenge owing to its strong parentage. Funding mix shifted from banks to
Market cap: Rs214.5bn
NCDs over FY12-21 while AUM mix was stable. Opex performance has been variable,
although the recent past (FY19-21) saw controlled employee and overhead costs, Free float: 40.4%
leading to a decline in cost to average assets from 3.1% to 2.2%. A slight positive ALM Avg. daily vol. 3mth: 8,071,719
bodes well from an NIM standpoint since interest rates may have hit a trough. Source: Bloomberg

Share of NCD has gone up in borrowings; AUM mix largely stable: Borrowing mix for MMFS was largely dominated by NCDs
and banks, though share of banks tilted in favor on NCDs over FY12-21, as asset quality pressures rose. Reliance on CPs was
not material at ~10% over FY15-18, which declined to negligible levels after the credit crises in FY19. Over FY18-21, share of
NCDs and CPs reduced in favor of deposits and ECB. The AUM mix has broadly been stable, with the auto segment contributing
72%. Share of CV/CE was relatively volatile, since it would have been more dependent on new auto volumes.

Exhibit 166: NCD share rose while bank funding reduced Exhibit 167: AUM mix largely stable, dominated by auto
Borrowings mix Advances Mix
100% 100%

80% 80%
60% 60%
40% 40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NCD Banks Deposits CP ECB Auto / UV Tractors Cars CV / CE Pre-owned Others
Source: Company, Centrum Broking. *Incl. Securitisation Source: Company, Centrum Broking

Asset quality a problem area for MMFS: Asset quality pressure has remained a challenge for MMFS. Over FY12-18, GNPA
spiked from 2.7% to 9.8% and remained elevated thereafter (though FY19 was a slight improvement). The MSME segment was
relatively better-performing, followed by auto; agriculture remains a pain point. As with other lenders, personal loans
(unsecured) saw a sharp spike in FY21 owing to the pandemic impact. Owing to greater reliance on earn-and-pay customers,
stage-2 assets have remained elevated at 9-12% over the last five years, indicating that customers generate cash flows with a
lag. Stage 1+2 provisions as a percentage of assets have remained a bit lower at 2%.

Exhibit 168: GNPA has remained elevated Exhibit 169: Stage 1+2 provision cover not adequate
Segment-wise GNPA Stress
14.0% 14% 4.0%
12.0% 12% 3.5%
10.0% 10% 3.0%
8.0% 2.5%
8%
2.0%
6.0% 6%
1.5%
4.0% 4% 1.0%
2.0% 2% 0.5%
0.0% 0% 0.0%
Agri Auto MSME Corporate PL Overall FY17 FY18 FY19 FY20 FY21
FY17 FY18 FY19 FY20 FY21 Stage 2 Assets Stage 1+2 provisions (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxx

Please see Appendix for analyst certifications and all other important disclosures.
M&M Financial Services (MMFS) 16 September 2021

Exhibit 170: Stress rose; fall in FY21 due to higher PCR Exhibit 171: Leverage is at comfortable levels
Balance sheet stress Debt/Equity (x)
8% 40% 5.4

6% 30% 4.4

3.4
4% 20%
2.4
2% 10%
1.4
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0.4
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Stress to AuM Stress to Equity
Source: Company, Centrum Broking Source: Company, Centrum Broking

Balance sheet stress rose over the last decade: Owing to its ‘earn and pay’ customer profile, stress (defined as NNPA +
restructuring to AUM) consistently rose for MMFS. In FY18 and FY20, stress to overall equity reached as high as 35%. Stress in
FY21 seems optically lower since the management raised provisions in Q4FY21 to provide for stress that could emanate from
the effects of the second wave. This led to a significant improvement in PCR in FY21 over FY20. Stress to equity in Q1FY22
spiked to 51%. On leverage, debt to equity has stayed near 5x, barring FY18 and FY21, when MMFS raised capital.

Exhibit 172: Lower NIM coupled with higher provisions Exhibit 173: Credit costs led to lower RoEs
Du pont (to avg. assets) Return ratios (%)
12.0 6.0 4.0 25
10.0 5.0
3.2 20
8.0 4.0
2.4 15
6.0 3.0
1.6 10
4.0 2.0
2.0 1.0 0.8 5

0.0 0.0 0.0 0


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM PPoP Opex Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Rise in credit costs impacted returns; cost control was good recently: NIM has consistently declined over the last 10 years,
mainly led by interest reversals and to some extent due to a positive ALM mix. Performance on opex was unstable, with some
periods seeing improvements with spikes in between. However, over FY19-21, the company has done well to control its
operating expenses, led by both lower employee cost and reduced overheads cost. Provisions have risen, impacting
profitability. Provision costs declined in FY18 and FY19, which only seems optically lower, since PCR also dropped sharply in
both these years, implying underprovided stress. Hence, RoA/RoE has consistently weakened.

Exhibit 174: Asset liability profile largely balanced Exhibit 175: ALM mismatch has largely been positive
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 10

80% 8
60%
6
40%
20% 4

0% 2
A L A L A L A L A L A L A L
FY15 FY16 FY17 FY18 FY19 FY20 FY21 0
<1yr 1-3yr 3-5yr >5yr FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM mismatch with a positive tilt, as vehicle loans have a 1-3 year tenure: Over FY12-21, 80-90% of assets had a maturity of
less than three years, as vehicle loans generally have a maturity of 1-3 years. Hence, MMFS’ ALM profile was positive in the
less than 1-year bucket. The positive mismatch reduced materially in FY18, as the share of deposits, which have a longer
maturity, dropped by 5% over FY17-18. MMFS has a slight advantage in a rising interest rate environment, as assets would
mature faster than liabilities. Currently, as systemic rates are at historic lows, there is a higher likelihood of rates rising.

Centrum Institutional Research 68


M&M Financial Services (MMFS) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest income 86,214 99,679 103,073 92,167 98,118 Financial assets 661,840 729,084 753,725 727,859 782,285
Interest expense 39,446 48,287 47,332 41,534 47,094 Cash 5,017 6,768 5,706 6,329 6,985
NII 46,768 51,391 55,742 50,634 51,024 Bank balance 4,568 7,490 26,991 18,988 13,969
Other income 1,884 2,773 2,095 2,263 2,297 Loans 612,496 649,935 599,474 624,566 689,249
Total income 48,653 54,164 57,836 52,896 53,321 Investment 37,917 59,110 116,072 75,950 69,847
Operating expenses 18,476 20,182 16,325 17,868 19,423 Other financial assets 1,842 5,782 5,482 2,025 2,235
Employee 10,901 11,484 10,152 11,193 11,988 Non-financial assets 8,940 11,628 16,640 10,127 11,175
Others 7,575 8,697 6,172 6,675 7,436 Current tax assets 3,021 2,400 4,017 2,444 2,698
PPOP 30,177 33,982 41,512 35,028 33,898 Deferred tax assets 3,717 4,896 8,624 5,248 5,792
Provisions 6,352 20,545 37,348 33,317 17,584 Fixed Assets 1,631 3,635 3,405 2,072 2,287
PBT 23,824 13,438 4,163 1,711 16,314 Other Non-fin. assets 571 697 595 362 400
Tax 8,254 4,374 873 431 4,111 Total Assets 670,780 740,712 770,365 737,986 793,460
PAT 15,571 9,064 3,291 1,280 12,203 Financial liabilities 558,642 624,522 619,972 586,459 631,295
Debt securities 223,194 177,449 168,346 152,083 158,730
Ratios Borrowings 269,687 382,995 385,927 372,840 407,305
YE Mar FY19A FY20A FY21A FY22E FY23E
Subordinated Debt 35,588 34,179 31,494 28,863 30,089
Growth (%) Other financial liabilities 30,173 29,899 34,205 32,673 35,171
AUM 22.5 7.9 (5.1) (2.0) 10.4 Non-financial liabilities 3,057 2,552 3,277 3,323 3,577
Borrowings 31.8 12.5 (1.5) (5.5) 7.6 Provisions 2,065 1,432 2,149 2,179 2,345
NII 33.5 9.9 8.5 (9.2) 0.8
Other Non-fin liabilities 853 980 989 1,144 1,231
Other income 86.8 47.2 (24.5) 8.0 1.5
Total equity 109,080 113,639 147,115 148,204 158,588
Opex 28.9 9.2 (19.1) 9.5 8.7
Share capital 1,230 1,231 2,464 2,464 2,464
PPoP 39.1 12.6 22.2 (15.6) (3.2) Other equity 107,850 112,408 144,651 145,740 156,124
Provisions 11.8 223.4 81.8 (10.8) (47.2) Total Liabilities 670,780 740,712 770,365 737,986 793,460
PAT 54.0 (41.8) (63.7) (61.1) NM Balance Sheet ratios (%)
Profitability (%) Debt / Equity 4.8 5.2 4.0 3.7 3.8
Yield on advances 14.5 14.7 15.0 13.8 14.3 Assets / Equity 6.1 6.5 5.2 5.0 5.0
Cost of funds 8.5 8.6 8.0 7.5 7.9
Cash / Borrowings 1.8 2.4 5.6 4.6 3.5
NIM (on AuM) 7.9 7.6 8.1 7.6 7.4
Capital Adequacy (%)
Other Income/ Total Income 3.9 4.5 3.6 4.3 4.3
CRAR 20.3 19.6 26.0 26.2 24.3
Other Income / Total Assets 0.3 0.4 0.3 0.3 0.3 Tier-1 15.5 15.4 22.2 21.8 20.1
Cost/Income 38.0 37.3 28.2 33.8 36.4 Tier-2 4.8 4.2 3.8 4.4 4.3
Employee 22.4 21.2 17.6 21.2 22.5 Asset quality (%)
Others 15.6 16.1 10.7 12.6 13.9 GNPA (Rs mn) 40,706 57,467 57,859 69,606 66,198
Opex/ Avg AuM 3.1 2.9 2.2 2.4 2.5 NNPA (Rs mn) 32,907 39,665 24,339 34,792 36,430
Provisions 1.1 3.1 5.6 5.2 2.6
GNPA 6.4 8.4 9.0 11.0 9.5
Tax Rate 34.6 32.5 21.0 25.2 25.2
NNPA 5.2 5.8 3.8 5.5 5.2
RoA 2.3 1.2 0.4 0.2 1.5
PCR 19.2 31.0 57.9 50.0 45.0
RoE 15.2 8.1 2.5 0.9 8.0 NNPA / Equity 30.2 34.9 16.5 23.5 23.0
Per share (Rs)
DuPont (% avg assets)
EPS 12.7 7.4 2.7 1.0 9.9
YE Mar FY19A FY20A FY21A FY22E FY23E
BVPS 88.7 92.3 119.4 120.3 128.7
Interest income 14.4 14.1 13.6 12.2 12.8
ABVPS 61.9 60.1 99.7 92.1 99.2
Interest expense 6.6 6.8 6.3 5.5 6.2 Valuation (x)
NII 7.8 7.3 7.4 6.7 6.7 P/E 34.0 79.6 137.9 167.1 17.5
Other income 0.3 0.4 0.3 0.3 0.3 P/BV 2.7 1.8 1.2 1.2 1.1
Total income 8.1 7.7 7.7 7.0 7.0 P/ABV 4.2 2.1 1.6 1.6 1.5
Operating expenses 3.1 2.9 2.2 2.4 2.5 Source: Company, Centrum Broking
Employee 1.8 1.6 1.3 1.5 1.6
Others 1.3 1.2 0.8 0.9 1.0
PPOP 5.0 4.8 5.5 4.6 4.4
Provisions 1.1 2.9 4.9 4.4 2.3
PBT 4.0 1.9 0.6 0.2 2.1
Tax 1.4 0.6 0.1 0.1 0.5
PAT 2.6 1.3 0.4 0.2 1.6
Source: Company, Centrum Broking

Centrum Institutional Research 69


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

Nippon Life AMC (NAM)


After a challenging phase, NAM improved its operating metrics over FY19-21. AUM Market data
performance was mixed over FY12-21, as equity saw a steady CAGR over FY12-19 and Current price: Rs441
debt too grew strongly over FY12-17. However, debt saw significant outflows over Bloomberg: NAM IN
FY17-20 as a fallout of the problems faced by its then promoter. Hence, market share 52-week H/L: Rs451/249
that was stable till FY17, declined thereafter. Moreover, declining debt share was
Market cap: Rs273.6bn
replaced by lower-yielding ETF, which led to softer operating yields over FY14-19.
However, after Nippon Life gained controlling stake, debt outflows have been Free float: 22.1%
arrested and market share has stabilized. NAM also focused on opex control, which Avg. daily vol. 3mth: 1,785,405
propelled core RoE over FY19-21. Source: Bloomberg

Debt declined post FY17; equity and ETFs saw steady growth: Debt AUM saw strong growth over FY12-17 (CAGR of 28%) and
reached an all-time high of ~Rs1trn. However, post FY17, debt AUM dropped to Rs383bn in FY20 owing to the credit crises
coinciding with leverage challenges at Reliance Capital on a consolidated level. Contrary to this, equity saw steady growth over
FY12-19 also supported by NAM’s distribution network. FY20 saw a sharp decline in equity, led by the pandemic, but rebounded
in FY21. ETFs also saw a healthy 41% CAGR over FY12-19 with a decline in FY20. AUM mix changed drastically after FY16. Debt
mix contracted from 52% in FY16 to 19% in FY21 in favour of equity (from 33% in FY16 to 42% FY21) and ETF (1% in FY16 to
17% in FY21). Liquid contribution also increased from 14% to 22% over the same time frame.

Exhibit 176: Debt declined from FY17; ETFs growth strong Exhibit 177: Debt share lost to ETFs; equity mix increasing
Closing AUM Closing AUM Mix
1000 100%

800 80%

600 60%

400 40%

200 20%

0 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Equity Debt Liquid ETF Equity Debt Liquid Others
Source: Company, Centrum Broking Source: Company, Centrum Broking

Market share drop in overall and equity AUM, as well as in SIP: NAM was able to maintain overall market share over FY13-17
despite equity share falling from 14.3% to 9.7%. This was because lost equity share was offset by a strong uptick in debt AUM
over FY12-17. Post FY17, NAM lost overall and equity market share, as debt AUM contracted while equity market share was
also lost due to diverging flows resulting from increasing competition with the onset of new mutual funds. SIP flows dropped
in FY21 to ~Rs78bn from Rs101bn in FY20, and NAM lost market share from 11% to 8% over the period.

Exhibit 178: Overall share tumbling down from FY17 Exhibit 179: SIP share saw sharp drop over FY19-21
Market share SIP Flows and market share
15.0% 102 12%

12.0% 82 10%

9.0% 62 8%

6.0% 42 6%

3.0% 22 4%
0.0% 2 2%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21
Overall share Equity share SIP flows (Rs bn) SIP market share
Source: Company, Centrum Broking Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Nippon Life AMC (NAM) 16 September 2021

Exhibit 180: Softer yield contraction; stable operating yields Exhibit 181: EBE marginally lower; other opex in check
Operating metrics (bps) Opex
100 36 25

80 30 20
24 15
60
18
40 10
12
20 5
6
0 0 0
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Revenue yields Opex/AUM (RHS) Operating yields EBE/AUM (bps) Other exp/AUM (bps)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Operating yields dipped over FY14-18 due to lower yields and improved again due to opex control: Revenue yield to AAUM
dropped over FY13-15 from 78bp to 73bp due to share of equity being replaced by debt over FY12-14. Despite yields dropping
over FY13-14, operating yields improved due to lower fee expenses led by the full upfront model for AMCs. Yields increased in
FY16, led by rise in equity share in FY15, though operating yields dropped as distributor commissions rose. Yields dropped over
FY16-18, translating to lower operating yields, as share of equity was replaced by lower-yielding ETF. As AMCs transitioned to
the full trail model since FY19, yields and opex to AUM shrank. However, NAM controlled opex to AUM, which declined over
FY19-21, leading to better operating yields.

Exhibit 182: Core RoE was volatile Exhibit 183: Movement in core RoAuM in-line with core RoE
ROE and Payout RoAAuM
25% 113% 40
20% 93%
30
15% 73%
20
10% 53%

5% 33% 10

0% 13% 0
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Core ROE ROE Payout Ratio (RHS) Core ROAUM (bps) ROAUM (bps)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Strong payout ratio helped to sustain core RoE; core RoAUM improved over FY19-21: Core RoE saw a strong surge over FY13-
15 in tandem with a sharp decline in opex to assets and increase in payout ratio. FY15-19 saw a decline in core RoE from 24%
to 21% since the share of debt was replaced by lower-yielding ETF. Payout ratio consistently remained high in line with its
dividend policy of paying 60-90% of PAT. Due to transition to Ind-AS, variation between core RoE and RoE increased since FY19,
as unrealized gains are also included in other income under Ind-AS. NAM did well to control opex over FY19-21 which saw its
core RoE/core RoAUM improve over the same time frame.

Exhibit 184: Share of Next 10 reduced over time Exhibit 185: High share from IFA/MFDs
Geographic mix Distribution mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY20 FY21
Top 5 Next 10 Next 20 Next 75 Others IFA/MFD Banks NDs
Source: Company, Centrum Broking Source: Company, Centrum Broking

Incremental focus on locations other than top-15; distribution skewed towards IFA/MFDs: Share of the Top 15 geographical
locations increased over FY12-16 from 80% to 85%; FY17 onwards, the company started focusing on smaller cities, which would
explain the rise in its retail flows. Share of Top 15 declined from 81% in FY17 to 77% in FY21. On distribution mix, the share of
banks fell from 28% to 22%, while that of MFD/NDs increased from 54/18% in FY20 to 57/21% in FY21. NAM is clearly increasing
reliance on IFA/MFDs.

Centrum Institutional Research 71


Nippon Life AMC (NAM) 16 September 2021
P&L Balance sheet
YE March (Rs mn) FY19 FY20 FY21 FY22E FY23E YE March (Rs mn) FY19 FY20 FY21 FY22E FY23E
Revenue from Operations 14,786 12,030 10,621 11,906 12,855 Share Capital 6,120 6,121 6,165 6,165 6,165
Investment Management Fees 14,464 11,636 10,274 11,668 12,598 Reserves and Surplus 19,580 19,809 24,844 26,322 27,824
PMS and Advisory Fees 322 394 348 238 257 Net Worth 25,700 25,931 31,009 32,487 33,989
Expenses 9,497 6,332 5,423 5,801 6,261 Trade Payables 474 677 629 358 388
Employees 2,935 3,024 2,713 2,875 3,049 Employee Benefit 435 393 234 299 317
Others 3,878 2,271 1,945 2,127 2,319 Others 1,150 1,808 1,655 1,490 1,341
Depreciation 101 333 333 314 381 Total Liabilities and Equity 27,758 28,808 33,527 34,634 36,035
Fees 2,583 705 432 485 513 Cash and Bank 5,428 4,633 3,606 3,640 3,675
Core Operating Income 5,290 5,698 5,198 6,104 6,594 Investment 12,900 18,846 25,500 26,363 27,434
Other Income 1,713 (98) 3,572 1,801 2,137 Fixed Asset 2,568 3,256 3,021 3,172 3,330
Exceptional Item 0 0 0 0 0 Loans 3,696 9 7 7 7
PBT 7,002 5,600 8,770 7,905 8,731 Receivables 1,026 593 459 424 458
Tax 2,132 1,441 1,976 1,992 2,200 Others 2,141 1,472 934 1,457 1,596
PAT 4,871 4,160 6,794 5,913 6,531 Total Assets 27,758 28,808 33,527 34,634 36,035
Dividend 5,165 3,690 4,932 4,435 5,029
Retained Earnings (294) 470 1,862 1,478 1,502 Closing AuM (Rs bn)
YE March FY19 FY20 FY21 FY22E FY23E
Growth ratios (%) Closing AuM 2,278 1,635 2,118 2,405 2,636
YE March FY19 FY20 FY21 FY22E FY23E
Equity 945 625 933 1,017 1,139
AAUM 5.6 (13.8) (1.5) 20.0 9.0
Debt 752 383 423 473 529
Revenue (7.1) (18.6) (11.7) 12.1 8.0
Liquid 280 384 479 493 503
EBE 14.1 3.0 (10.3) 6.0 6.1
Others 301 244 384 422 464
PAT 6.5 (14.6) 63.3 (13.0) 10.4
Profitability Ratios (%) Closing AUM Breakup (%)
Yield on AUM 0.65 0.61 0.55 0.52 0.51 YE March FY19 FY20 FY21 FY22E FY23E
Yield on Investments 8.15 (0.49) 14.47 6.10 7.00 Overall AuM 100.0 100.0 100.0 100.0 100.0
EBE / Core Revenue 19.8 25.1 25.5 24.1 23.7 Equity 41.5 38.2 42.1 42.3 43.2
Operating Income/ Core Revenue 35.8 47.4 48.9 51.3 51.3 Debt 33.0 23.4 19.0 19.7 20.1
Other Income / Core Revenue 11.6 (0.8) 33.6 15.1 16.6 Liquid 12.3 23.5 21.6 20.5 19.1
Effective tax rate 30.4 25.7 22.5 25.2 25.2 Others 13.2 14.9 17.3 17.5 17.6
PAT Margin 32.9 34.6 64.0 49.7 50.8
ROE 19.5 16.1 23.9 18.6 19.6 AUM Growth (%)
Core RoE 21.1 23.9 21.2 22.6 24.3 YE March FY19 FY20 FY21 FY22E FY23E
ROAAUM 0.21 0.21 0.35 0.26 0.26 Overall 0.8 (28.2) 35.6 8.4 9.6
DuPont analysis (%) Equity 12.3 (33.9) 49.2 9.0 12.0
Revenue from Operations 0.65 0.61 0.55 0.52 0.51 Debt (21.8) (49.1) 10.5 11.9 11.9
Investment Mgmt. Fees 0.64 0.59 0.53 0.50 0.50 Liquid (15.3) 37.3 24.7 3.0 2.0
PMS and Advisory Fees 0.01 0.02 0.02 0.01 0.01 Others 135.9 (19.0) 57.4 10.0 10.0
Expenses 0.42 0.32 0.28 0.25 0.25
Employee 0.13 0.15 0.14 0.12 0.12
Valuations (per share)
Others 0.17 0.12 0.10 0.09 0.09
YE March FY19 FY20 FY21 FY22E FY23E
Depreciation 0.00 0.02 0.02 0.01 0.02
EPS 8.0 6.8 11.0 9.6 10.6
Fees 0.11 0.04 0.02 0.02 0.02
DPS 8.4 6.0 8.0 7.2 8.2
Core Operating Income 0.23 0.29 0.27 0.26 0.26
BVPS 42.0 42.4 50.3 52.7 55.1
Other Income 0.08 0.00 0.19 0.08 0.08
Dividend Yield 4.2 2.1 2.8 1.6 1.8
PBT 0.31 0.29 0.46 0.34 0.35
P/E 29.3 25.6 30.2 46.0 41.6
Tax 0.09 0.07 0.10 0.09 0.09
P/B 4.7 5.6 5.5 8.4 8.0
PAT 0.21 0.21 0.35 0.26 0.26
Source: Company, Centrum Research estimates
Source: Company, Centrum Research

Centrum Institutional Research 72


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

State Bank of India (SBIN)


After weakening overall performance over FY12-18, SBIN entered a new chapter post Market data
FY18. Liability mix was fairly stable over FY12-21, though the share of retail increased Current price: Rs464
and that of corporate/overseas declined. NIM compressed over FY12-18, largely led by Bloomberg: SBIN IN
rise in corporate stress, despite a favorable ALM profile. Stress was exacerbated by the 52-week H/L: Rs467/176
consolidation of regional subsidiaries in FY17. Spike in credit costs led to a significant
Market cap: Rs4138.3bn
decline in RoE over FY12-18. However, the bank has transformed since, as stress peaked
in FY18, leading to a significant improvement in credit costs and return ratios over Free float: 33.4%
FY18-21. Being a government entity, fee income franchise remains weak. Negative Avg. daily vol. 3mth: 23,733,650
ALM profile poses a risk in a rising interest rate environment. Source: Bloomberg

Stable deposit mix; retail advances gaining share: Deposit mix has largely remained stable over the last 10 years. CASA share
has remained in a healthy range of 43-45%, while term deposits have remained near 52% over the last four years. Strong
outreach with a dominant presence pan India has led to a robust deposit franchise. Corporate/SME share in advances clearly
decreased from FY17/FY18, as industrial GNPA spiked. Corporate/SME loans dropped to 32.2/11% in FY21 from 36.2/13.3% in
FY17. As SBIN focused more on retail loans after FY17, retail share increased from 24.5% in FY17 to 34.3% in FY21. Overseas
portfolio saw a slight drop in share from 18% in FY15 to 14.1% in FY21.

Exhibit 186: Stable deposit mix; CASA healthy Exhibit 187: Clear shift to retail after high industrial stress
Deposit mix Advances mix
100% 100%

80% 80%

60% 60%
20% 21% 22% 25% 27% 28% 31% 34%
21% 20%
40% 40%

20% 20% 34% 34% 38% 38% 38% 36% 37% 37% 35% 32%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Term Savings Current Overseas Corporate Retail SME Agri Overseas
Source: Company, Centrum Broking Source: Company, Centrum Broking

Significant reduction in stress after FY17: FY17 and FY18 were a double whammy for SBIN, as it faced asset quality issues on
its standalone balance sheet and was also grappling with its subsidiaries’ delinquent pool since its regional subsidiaries were
merged into it. Consequently, stressed pool to average assets rose from ~6% over FY13-16 to a peak of ~7.8% in FY21. However,
after FY17, SBIN saw a consistent decrease in stress levels to 3.3% in FY21, with bulk of the delinquent pool already provided
for. Stress to equity also reduced from 109% in FY18 to 54% in FY21. High GNPA levels (17.8%) in industries as at FY17 triggered
a shift in portfolio mix towards retail loans. Personal loans for SBIN have performed better than peers (GNPA consistently below
1%). Agri loans also remain a pain point, with GNPA rising from 8.8% in FY15 to 15.2% in FY21.

Exhibit 188: Stress peaked in FY17; fared better thereafter Exhibit 189: Agri stress around 15%; personal has been low
Balance sheet stress Segment-wise GNPA
8% 110% 18%
15%
6% 90%
12%
4% 70% 9%
6%
2% 50%
3%
0% 30%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0%
Agri Industry Services Personal Overall
Stress to avg. assets Stress to equity (RHS) FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
State Bank of India (SBIN) 16 September 2021

Exhibit 190: NIM and provision trend improving since FY18 Exhibit 191: Strong rebound in returns as provisions reduce
Du pont % (to avg. assets) Return ratios (%)
3.5 2.4 1.0 21
0.8 17
3.0 2.0
0.6 13
2.5 1.6
0.4 9
2.0 1.2
0.2 5
1.5 0.8 0.0 1
1.0 0.4 -0.2 -4
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM Opex PPoP Fees (RHS) Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Strong rebound after negative returns; provisions back to normal: In tandem with asset quality pressures the bank faced over
FY12-18 that led to higher slippages and interest reversals, NIM consistently shrank from 3.4% to 2.2%. Provisions rose from
1% to 2.2% over the same time frame. This had a direct bearing on RoE that declined from 15.7% to -3.5%. However, over FY18-
21, NIM and credit costs saw an improving trajectory, as slippage ratio was controlled with most of the stress provided for.
NIM improved from 2.2% to 2.6% while provisions declined from 2.2% to 1%. Hence, RoE improved from -3.5% to 8.4%. Opex
and fee income were largely stable, with opex to assets being near 2% and fees being near 70bp.

Exhibit 192: Deposit share in liabilities increasing Exhibit 193: Advances share lost to investments over time
Liability Mix Asset Mix
100% 100%
80% 80%
60% 60%
40% 40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Deposits Capital Borrowings Other Liabilities Advances Investments Cash Other assets Fixed assets
Source: Company, Centrum Broking Source: Company, Centrum Broking

Deposits share improving; loan share decreased after FY14: Deposits share declined over FY12-16 in favor of borrowings.
While the share of deposits declined from 78% to 73%, that of borrowings increased from 9.5% to 13.7%. As its subsidiaries
were largely deposit-funded, overall deposit share post consolidation rose to 78% in FY17 and gradually to 81.2% in FY21.
Borrowing share over FY18-21 declined from 11% to 9%. Capital contribution to liabilities has broadly remained in the 6%
range. On asset mix, contrary to private banks that saw liquidity decline over a 10-year cycle, SBIN saw its share of investments
rise from 23% in FY12 to 30% FY21. Share of advances decreased to 54% in FY21 after peak of 67.6% in FY14.

Exhibit 194: Steady ALM profile; higher short-term liabilities Exhibit 195: Mismatch in <1-year bucket in 15-25% range
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 0
80% -5
60%
-10
40%
-15
20%
-20
0%
A L A L A L A L A L A L A L A L A L A L -25
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
<1yr 1-3yr 3-5yr >5yr
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile suggests longer-term lending and short-term borrowing: SBIN’s ALM profile has mainly remained negative in the
<1-year bucket, with higher share of short-term liabilities compared to assets. Liabilities in the <1-year bucket remain at 40-
45% levels compared to assets at 17-28%, creating negative ALM gap. The <1-year gap has been in the 20-30% range over FY16-
21. This gap poses interest rate risk to SBIN, if systemic rates are on a rising trend, as liabilities would get repriced faster than
assets. Bulk of the liabilities are concentrated in the <1-year bucket, while bulk of the assets are in the >5-year bucket, also
driven by a higher share of investments in the form of government securities.

Centrum Institutional Research 74


State Bank of India (SBIN) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest earned 2,428,687 2,573,236 2,651,506 2,744,291 3,116,947 Share capital 8,925 8,925 8,925 8,925 8,925
Interest expended 1,545,198 1,592,388 1,544,406 1,584,959 1,894,694 Reserves & surplus 2,200,214 2,311,150 2,529,827 2,732,377 2,972,159
Net Interest Income 883,489 980,848 1,107,100 1,159,332 1,222,253 Deposits 29,113,860 32,416,208 36,812,772 39,872,096 43,237,184
Other income 367,749 452,214 434,964 461,342 495,136 Borrowings 4,030,171 3,146,557 4,172,977 3,873,945 4,201,661
Total Income 1,251,238 1,433,063 1,542,064 1,620,674 1,717,389 Other Liabilities 1,455,973 1,631,101 1,819,797 1,936,973 2,100,830
Operating Expenses 696,877 751,737 826,522 892,644 955,129 Total liabilities 36,809,144 39,513,940 45,344,296 48,424,312 52,520,760
Employees 410,547 457,150 509,360 550,109 588,616 Cash balances with RBI 1,769,325 1,667,358 2,132,016 2,437,495 2,639,729
Others 286,330 294,587 317,162 342,535 366,513 Balances with banks 455,576 843,612 1,298,372 1,117,185 1,099,887
Operating profit 554,360 681,326 715,542 728,030 762,260 Investments 9,670,220 10,469,545 13,517,052 14,415,294 15,426,986
Provisions 538,286 430,699 440,130 405,637 383,447 Advances 21,858,770 23,252,896 24,494,978 26,209,626 28,568,492
Profit before tax 16,074 250,627 275,411 322,393 378,813 Fixed Assets 391,976 384,393 384,192 385,345 386,116
Taxes 7,452 105,747 71,307 84,144 98,870 Other Assets 2,663,277 2,896,136 3,517,687 3,859,368 4,399,548
Net Profit 8,622 144,881 204,105 238,248 279,943 Total assets 36,809,144 39,513,940 45,344,296 48,424,312 52,520,760

Ratios Ratios
YE Mar FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Growth (%) Balance Sheet (%)
Loans 13.0 6.4 5.3 7.0 9.0 Loans / Deposits 75.1 71.7 66.5 65.7 66.1
Deposits 7.6 11.3 13.6 8.3 8.4 Investments / Deposits 44.2 45.0 55.2 55.0 54.0
RWA growth 2.0 8.9 7.2 12.2 9.4 CASA 0.0 0.0 0.0 0.0 0.0
NII 18.0 11.0 12.9 4.7 5.4 Assets/equity (x) 16.7 17.0 17.9 17.7 17.6
Other income (17.5) 23.0 (3.8) 6.1 7.3 RWA / Total assets 52.4 53.1 49.6 52.1 52.6
Opex 16.3 7.9 9.9 8.0 7.0 Capital ratios (%)
PPoP (6.8) 22.9 5.0 1.7 4.7 CET-1 9.6 9.8 10.0 9.8 9.8
Provisions (28.3) (20.0) 2.2 (7.8) (5.5) Tier-1 10.6 11.0 11.4 11.2 11.2
Net profit nm nm 40.9 16.7 17.5 Tier-2 2.1 2.1 2.3 2.2 2.1
Profitability (%) CRAR 12.7 13.1 13.7 13.4 13.3
Yield on assets 7.8 7.7 7.2 6.8 7.2 Asset quality ratios (%)
Cost of funds 4.8 4.6 4.0 3.7 4.2 GNPA (Rs mn) 1,727,505 1,490,925 1,263,890 1,315,786 1,359,275
NIM 2.8 2.9 3.0 2.9 2.8 NNPA (Rs mn) 658,947 518,713 368,097 421,052 462,154
Other income / Total inc. 29.4 31.6 28.2 28.5 28.8 GNPA 7.5 6.2 5.0 4.9 4.6
Other inc. / avg assets 1.0 1.2 1.0 1.0 1.0 NNPA 3.0 2.2 1.5 1.6 1.6
Cost/Income 55.7 52.5 53.6 55.1 55.6 PCR 61.9 65.2 70.9 68.0 66.0
Employee 32.8 31.9 33.0 33.9 34.3 Slippage 1.9 2.4 1.2 1.8 1.6
Other 22.9 20.6 20.6 21.1 21.3 NNPA / Equity 29.8 22.4 14.5 15.4 15.5
Opex/ Avg assets 2.0 2.0 1.9 1.9 1.9 Per share
Provisioning cost 2.6 1.9 1.8 1.6 1.4 EPS 1.0 16.2 22.9 26.7 31.4
Tax rate 46.4 42.2 25.9 26.1 26.1 BVPS 247.5 260.0 284.5 307.2 334.0
RoE 0.4 6.4 8.4 9.0 9.8 ABVPS 0.0 0.0 0.0 0.0 0.0
RoA 0.0 0.4 0.5 0.5 0.6 Valuation (x)
RoRWA 0.0 0.7 0.9 1.0 1.1 P/E 286.7 19.1 10.4 17.4 14.8
Du-pont (%) P/BV 1.1 1.2 0.8 1.5 1.4
Interest income 6.8 6.7 6.2 5.9 6.2 P/ABV 1.4 1.3 1.0 1.8 1.6
Interest expenses 4.3 4.2 3.6 3.4 3.8 Source: Company, Centrum Broking
NII 2.5 2.6 2.6 2.5 2.4
Other income 1.0 1.2 1.0 1.0 1.0
Total income 3.5 3.8 3.6 3.5 3.4
Operating expenses 2.0 2.0 1.9 1.9 1.9
Employee 1.2 1.2 1.2 1.2 1.2
Other 0.8 0.8 0.7 0.7 0.7
PPOP 1.6 1.8 1.7 1.6 1.5
Provisions 1.5 1.1 1.0 0.9 0.8
PBT 0.0 0.7 0.6 0.7 0.8
Tax 0.0 0.3 0.2 0.2 0.2
RoA 0.0 0.4 0.5 0.5 0.6
Source: Company, Centrum Broking

Centrum Institutional Research 75


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

Sundaram Finance (SUF)


SUF has been a conservative vehicle financier as suggested by its controlled asset Market data
quality and consistency in delivering returns. The funding mix has been dominated by Current price: Rs2,554
NCDs, while on the lending side, CV has been the mainstay. As the share of CP has Bloomberg: SUF IN
reduced, ALM profile has become more balanced, reducing interest rate risk. Focus 52-week H/L: Rs2,884/1,270
on asset quality control, leading to tighter credit costs, was the key highlight for SUF Market cap: Rs283.8bn
over FY12-19, although the Covid-impacted FY20 and FY21 witnessed a surge in stress.
Free float: 60.4%
Over FY15-19, as growth was a priority, NIM compressed, leading to RoE declining
Avg. daily vol. 3mth: 38,174
from 17% to 13%. Despite higher NIM in FY20/21, RoE could not improve due to
Source: Bloomberg
elevated credit costs. Opex to assets improved over FY12-21.

Share of NCD has gone up over FY17-21; share of CV declined in FY21: SUF’s funding mix was evenly divided between banks
and NCDs in FY12 at ~40%. However, FY13 saw the mix materially shifting from banks to NCDs and CPs. Bank funding was
volatile over the last 10 years. Contribution of CP reduced over FY17-21 from 26% to 3% while that of NCDs increased from
47.5% to 59%. On the lending side, CV has the maximum share, which was 52-53% over FY16-20. However, FY21 saw a sharp
decline in CV share owing to the CV slowdown over FY19-20. Contribution of cars consistently declined over FY15-21 from 37%
to 25% while that of CE improved from 6.6% to 11.2% and that of tractors enhanced over FY18-21 from 5% to 7.5%.

Exhibit 196: NCD the main funding source; bank share rises Exhibit 197: CV share at 52%; saw a decline in FY21
Borrowings mix Advances mix
100% 100%

80% 80%

60% 60%
40% 40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NCD Banks Deposits CP CV Cars CE Tractor Others
Source: Company, Centrum Broking. *Incl. Securitisation Source: Company, Centrum Broking

Best-in-class asset quality, led by solid underwriting practices: SUF’s asset quality has remained the best-in-class owing to its
conservative underwriting practices. Overall GNPA was controlled at 1.3-2% over FY15-19. FY20 saw a surge to 2.8% owing to
the sudden lockdown in March 2020, severely affecting vehicle movement. The trucking and CE segments were most impacted,
with GNPA surging ~3x. FY21 saw a reduction in GNPA to 1.8% as part of the stress was recovered while part was restructured.
Stage-2 assets rose over FY17-19 while GNPA were largely under control, indicating higher recoveries. The stage-2 pool spiked
in FY20 to 5.3% in line with GNPA. However, SUF also increased its provisions on stage 1+2 assets.

Exhibit 198: GNPA controlled, barring FY20 Exhibit 199: Stage 2 assets rose more in FY20 due to Covid
Segment-wise GNPA Stress
9.0% 6% 90
7.5% 5% 75
6.0% 4% 60
4.5% 3% 45
3.0% 2% 30
1.5% 1% 15
0.0% 0% 0
Truck Auto Infra Agri Others Overall FY17 FY18 FY19 FY20 FY21
FY15 FY16 FY17 FY18 FY19 FY20 FY21 Stage 2 Stage 1+2 provisions bps (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Sundaram Finance (SUF) 16 September 2021

Exhibit 200: Stress spiked in FY21 due to restructuring Exhibit 201: Debt/Equity at comfortable levels
Balance sheet stress Debt to Equity (x)
6% 30% 6.0
5% 25% 5.0
4% 20% 4.0
3% 15% 3.0
2% 10% 2.0
1% 5%
1.0
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Stress to AuM Stress to Equity
Source: Company, Centrum Broking Source: Company, Centrum Broking

Balance sheet stress surged in FY21; leverage reduced over FY12-16: Overall balance sheet stress as defined by NNPA +
restructuring was consistently under control for SUF over FY12-19 below 1%. It surged to 1.9% in FY20 owing to GNPA rise and
further to 5.2% in FY21 due to increase in restructuring to 4.4%. The dispensation was targeted towards segments severely
impacted by the Covid-19 pandemic: education (school bus operators), transportation (staff and route bus operators),
travel/tourism (tour operators, taxi operators) and market-load operators hit by lack of demand for their services as well as
rising fuel prices. Debt to equity consistently declined over FY12-16 from 6x to 4x, and has remained near 4x since.

Exhibit 202: NIM contracted over FY15-19 led by CV share Exhibit 203: Though NIM dropped, consistency was the key
Du pont % (to avg. assets) Return ratios (%)
6.0 3.0 2.5 25
5.0 2.5 2.0 20
4.0 2.0
1.5 15
3.0 1.5
2.0 1.0 1.0 10

1.0 0.5 0.5 5


0.0 0.0 0.0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM PPoP Opex (RHS) Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Rise in credit costs impacted returns; cost control was good recently: NIM consistently declined over FY15-19, as the share of
CV rose and focus was more on growth than pricing. This also led to a dip in RoE from 17% to 13% over the same time frame.
Being a conservative auto financier, credit cost was well under control at 20-60bp over FY12-19. NIM uptick in FY20 and FY21,
led by incremental credit flow to the higher-yielding segments, could not translate to better RoE, as credit cost rose from 40bp
in FY19 to 100bp in FY20 and remained elevated in FY21. SUF did well on opex to assets, which improved from 2.5% in FY16 to
1.7% in FY21, led by slower branch/employee accretion while cost per employee also reduced.

Exhibit 204: ~85% of assets in <3-year bucket Exhibit 205: ALM profile has turned more balanced
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 8

80% 4
0
60%
-4
40%
-8
20%
-12
0%
A L A L A L A L A L A L A L -16
FY15 FY16 FY17 FY18 FY19 FY20 FY21 -20
<1yr 1-3yr 3-5yr >5yr FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM mismatch became more balanced over FY16-20: The <1-year bucket saw a surge over FY15-16 owing to rise in shorter
term bank funding. However, over FY16-19, as shorter maturity CP funding reduced, ALM became more balanced. Shift to a
more balanced ALM profile reduces the interest rate risk on the balance sheet and NIM would depend more on product mix.
80-90% of assets had a maturity of less than three years, as vehicle loans generally have a tenure of 1-3 years.

Centrum Institutional Research 77


Sundaram Finance (SUF) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest income 30,705 35,745 37,009 37,754 41,726 Financial assets 300,814 327,258 341,825 361,998 407,951
Interest expense 17,665 20,720 20,307 20,238 22,705 Cash 1,298 190 1,024 1,011 1,153
NII 13,040 15,025 16,702 17,515 19,021 Bank balance 7,088 6,108 5,908 6,740 7,684
Other income 2,716 2,924 3,133 3,760 4,112 Loans 272,715 280,447 294,039 316,343 360,681
Total income 15,756 17,949 19,835 21,275 23,133 Investment 18,663 39,377 40,524 36,818 37,283
Operating expenses 5,730 6,234 6,111 6,672 7,432 Other financial assets 1,050 1,135 331 1,085 1,151
Employee 3,224 3,586 3,822 4,173 4,678 Non-financial assets 5,677 6,937 7,699 8,088 8,836
Others 2,506 2,648 2,289 2,499 2,754 Current tax assets 1,183 1,598 2,230 2,343 2,560
PPOP 10,026 11,715 13,724 14,603 15,701 Deferred tax assets 801 1,231 1,589 1,669 1,824
Provisions 1,073 2,864 3,161 3,212 2,010 Fixed Assets 3,051 3,596 3,309 3,476 3,798
PBT 8,953 8,851 10,563 11,392 13,691 Other Non-fin. assets 643 512 571 600 655
Tax 2,912 2,071 2,473 2,871 3,450 Total Assets 306,492 334,195 349,525 370,086 416,788
PAT 6,041 6,779 8,090 8,521 10,241 Financial liabilities 255,309 278,246 287,087 301,535 340,707
Debt securities 104,795 147,395 146,929 163,176 185,215
Ratios Borrowings 128,011 104,572 110,146 106,598 120,119
YE Mar FY19A FY20A FY21A FY22E FY23E
Subordinated Debt 17,252 21,400 25,059 26,332 29,258
Growth (%) Other financial liabilities 5,251 4,879 5,108 5,429 6,114
AUM 16.1 3.3 3.2 9.1 14.0 Non-financial liabilities 745 475 488 536 590
Borrowings 18.5 9.3 3.2 5.0 13.0 Provisions 514 307 241 265 292
NII 5.2 15.2 11.2 4.9 8.6
Other Non-fin liabilities 231 168 247 271 298
Other income 0.5 7.6 7.2 20.0 9.4
Total equity 50,438 55,474 61,795 68,015 75,491
Opex (0.2) 8.8 (2.0) 9.2 11.4
Share capital 1,111 1,111 1,111 1,111 1,111
PPoP 7.2 16.8 17.1 6.4 7.5 Other equity 49,327 54,363 60,683 66,904 74,380
Provisions 25.5 166.8 10.4 1.6 (37.4) Total Liabilities 306,492 334,195 349,525 370,086 416,788
PAT 7.2 12.2 19.3 5.3 20.2 Balance Sheet ratios (%)
Profitability (%) Debt / Equity 5.0 4.9 4.6 4.4 4.4
Yield on advances 10.8 11.6 11.7 11.3 11.2 Assets / Equity 6.1 6.0 5.7 5.4 5.5
Cost of funds 7.7 7.9 7.3 7.0 7.2
Cash / Borrowings 3.4 2.3 2.5 2.6 2.6
NIM (on AuM) 4.6 4.9 5.3 5.2 5.1
Capital Adequacy (%)
Other Income/ Total Income 17.2 16.3 15.8 17.7 17.8
CRAR 19.4 18.4 22.1 19.3 18.9
Other Income / Total Assets 1.0 0.9 0.9 1.0 1.0 Tier-1 14.6 13.2 15.2 13.9 13.6
Cost/Income 36.4 34.7 30.8 31.4 32.1 Tier-2 4.8 5.2 6.9 5.4 5.3
Employee 20.5 20.0 19.3 19.6 20.2 Asset quality (%)
Others 15.9 14.8 11.5 11.7 11.9 GNPA (Rs mn) 3,670 7,881 6,831 8,908 7,402
Opex/ Avg AuM 1.9 1.9 1.7 1.8 1.8 NNPA (Rs mn) 2,286 5,414 4,009 5,949 4,903
Provisions 0.4 1.0 1.0 1.0 0.6
GNPA 1.3 2.8 2.3 2.8 2.0
Tax Rate 32.5 23.4 23.4 25.2 25.2
NNPA 0.8 1.9 1.3 1.9 1.3
RoA 2.0 2.1 2.3 2.3 2.5
PCR 37.7 31.3 41.3 33.2 33.8
RoE 13.2 12.8 13.8 13.1 14.3 NNPA / Equity 4.5 9.8 6.5 8.7 6.5
Per share (Rs)
DuPont (% avg assets)
EPS 54.4 61.0 72.8 76.7 92.2
YE Mar FY19A FY20A FY21A FY22E FY23E
BVPS 454.0 499.3 556.2 612.2 679.5
Interest income 10.1 10.6 10.4 10.1 10.1
ABVPS 433.4 450.6 520.1 558.6 635.3
Interest expense 5.8 6.2 5.7 5.4 5.5 Valuation (x)
NII 4.3 4.5 4.7 4.7 4.6 P/E 25.3 26.1 22.0 33.2 27.6
Other income 0.9 0.9 0.9 1.0 1.0 P/BV 3.1 3.4 2.9 4.2 3.7
Total income 5.2 5.3 5.6 5.7 5.6 P/ABV 3.4 3.7 3.1 4.6 4.0
Operating expenses 1.9 1.9 1.7 1.8 1.8 Source: Company, Centrum Broking
Employee 1.1 1.1 1.1 1.1 1.1
Others 0.8 0.8 0.6 0.7 0.7
PPOP 3.3 3.5 3.9 3.9 3.8
Provisions 0.4 0.9 0.9 0.9 0.5
PBT 2.9 2.6 3.0 3.0 3.3
Tax 1.0 0.6 0.7 0.8 0.8
PAT 2.0 2.0 2.3 2.3 2.5
Source: Company, Centrum Broking

Centrum Institutional Research 78


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

Ujjivan Small Finance Bank (USFB)


USFB, originally an NBFC-MFI, faced three challenges–deposit accretion after Market data
conversion to an SFB, reduction of unsecured loan share, operating cost control, and Current price: Rs21
stress largely emanating from MFI. FY20 and FY21 saw a substantial improvement in Bloomberg: UJJIVANS IN
performance parameters barring asset quality. Build-up of RTD+CASA (41% of total 52-week H/L: 45/18
funding) was slow initially but gathered steam in the last two years. Operating
Market cap: Rs35.6bn
leverage and cost control started after FY19. The non-MFI portfolio increased from
2.4% in FY17 to 30% in FY21. However, since unsecured loans account for a large share Free float: 16.7%
of GLP, the bank saw a steep rise in delinquent pool in FY18 and FY21 as a fallout of Avg. daily vol. 3mth: 7,631,983
demonetization and Covid-19, respectively, leading to a surge in provisions. Source: Bloomberg

Deposits gaining traction albeit with a slow start; secured loan share rising: Originally an NBFC-MFI, USFB relied
predominantly on term loans (mainly bank loans) prior to FY18. After conversion to a bank, it began to focus on deposit
accretion and building a secured loan book. Deposit build-up in terms of RTD and CASA was slow initially, contributing 11% to
total deposits in FY18. FY19 saw good traction on CASA+RTD, which contributed 37% to total deposits. Over Q3FY20-Q4FY21,
CASA consistently increased from 11.6% to 20.5%, while RTD stagnated at ~33%. On the loan mix side, USFB had a 100%
unsecured portfolio over FY12-16, being MFI loans. Although the secured portfolio originated in FY15, it started meaningfully
contributing since FY18 (7.3%). This share has risen to 30% in FY21 with Housing & MSE making up for 22%.

Exhibit 206: Deposit build-up while slow picked up in FY20/21 Exhibit 207: Over FY17-21 secured pool rose from 2.4% to 30
Funding mix Advances mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inst TD RTD CASA CD Refinance TL Others GL IL Hsg MSE FIG Rural Others
Source: Company, Centrum Broking Source: Company, Centrum Broking

FY18 and FY21 were challenging for the MFI space: As with other MFI players, USFB is exposed to systemic event risks which
may affect marginal borrowers. The bank witnessed major stress in FY18 due to demonetization, with GNPA spiking from 0.3%
in FY17 to 3.7% in FY18. Rise in net stress (NNPA+restructuring) to average assets is not visible in FY18, since adequate
provisions were created (PCR at 81%), while there was no restructuring. The Covid-related asset quality pain was much greater
in FY21 that saw GNPA rise to 7%, while net stress also spiked to 7% of average assets. The strain was more for USFB compared
to peers due to higher MFI exposure, that too in urban areas.

Exhibit 208: Demonetization and Covid the pain points Exhibit 209: GNPA spiked to 3.7%/7% in FY18/21
Balance sheet stress GNPA
7.5% 50% 10.5%
9.0%
6.0% 40%
7.5%
4.5% 30%
6.0%
3.0% 20% 4.5%
1.5% 10% 3.0%
1.5%
0.0% 0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0.0%
Agri Industry Services Personal Overall
Stress to avg. assets Stress to equity (RHS) FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Ujjivan Small Finance Bank (USFB) 16 September 2021

Exhibit 210: Bank conversion led to opex rise Exhibit 211: Return ratios marred in demon and Covid years
Du pont (to avg. assets) Return ratios (%)
12.0 4.8 4.0 20

10.0 4.0 3.2 16


8.0 3.2 2.4 12
6.0 2.4
1.6 8
4.0 1.6
0.8 4
2.0 0.8
0.0 0.0 0.0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
NIM Opex PPoP Fees (RHS) Provisions (RHS) RoA RoE (RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Operating metrics saw an improving trend in FY20: Opex is a key monitorable, especially in case of NBFC-MFIs, which require
a higher customer interface. Operating leverage and asset sweating over FY12-16 led to improvement in opex to assets ratio
from 11.2% to 6.3%. However, after conversion to a bank, opex surged to 8.6% in FY19 due to branch conversion and IT spends.
Over FY19-21, opex has been well controlled from 8.6% to 6.3%. NIM was 10%+ over FY12-17; however, due to SLR
requirements post conversion to a bank and lower loan growth led by demonetization, NIM declined in FY18 and FY19. Elevated
opex levels in FY12 and provision surge in FY18 and FY21 wiped out the return ratios for those years.

Exhibit 212: Deposit share increasing since FY19 Exhibit 213: SLR needs led to lower loan share post FY16
Liability mix Asset mix
100% 100%
80% 80%
60% 60%
40% 40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Deposits Capital Borrowings Other Liabilities Advances Investments Cash Other assets Fixed assets
Source: Company, Centrum Broking Source: Company, Centrum Broking

Deposits gaining traction; loan share reduced due to bank conversion: Initially an NBFC, USFB mainly relied on external
borrowings as a source of funding; its share in total liabilities was 75-80% over FY12-17. Post SFB conversion, deposits started
gaining traction in FY18 that saw deposit share increase to 40% from 2.4%. Over FY18-21, the share of deposits rose from 40%
to 64.5% while that of borrowings declined from 41% to 16%. Within deposits, the share of RTD+CASA improved over the same
time frame. On assets, the share of loans has largely been 77-90% over FY12-21, barring FY17 and FY21 that were characterized
by systemic shocks. Due to SLR requirements, investment share rose post FY16.

Exhibit 214: As secured share rose, asset tenure increased Exhibit 215: Higher secured+RTD share led to balanced ALM
Asset (A) Liability (L) Maturity Pattern ALM mismatch (%)
100% 40

80% 30
60% 20
40% 10
20% 0
0% -10
A L A L A L A L A L A L A L A L A L A L
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -20
<1yr 1-3yr 3-5yr >5yr FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

ALM profile more balanced post SFB conversion: Over FY12-17, USFB’s ALM profile suggested a positive difference in the >1-
year bucket, since MFI loans are generally shorter term. After bank conversion, share of longer maturity assets and liabilities
increased, since share of secured assets/G-Secs on the asset side and share of RTD in deposits increased. This translated to a
more balanced ALM profile after FY17, which decreases the interest rate risk for USFB. In terms of maturity profile, bulk of the
assets and liabilities are concentrated in the less than 1-year bucket.

Centrum Institutional Research 80


Ujjivan Small Finance Bank (USFB) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Interest earned 18,316 27,036 28,061 28,382 35,202 Share capital 16,400 19,496 19,720 19,720 19,720
Interest expended 7,252 10,700 10,775 11,350 14,751 Reserves & surplus 1,796 12,381 12,467 13,124 18,019
Net Interest Income 11,064 16,336 17,286 17,032 20,451 Deposits 73,794 107,805 131,358 161,053 199,110
Other income 2,060 3,222 3,108 3,601 4,502 Borrowings 41,661 39,534 32,473 28,989 29,866
Total Income 13,124 19,558 20,394 20,632 24,953 Other Liabilities 3,771 4,898 7,786 7,602 9,388
Operating Expenses 10,034 13,186 12,301 12,356 13,993 Total liabilities 137,422 184,113 203,805 230,488 276,103
Employees 5,188 7,185 7,488 7,284 8,339 Cash balances with RBI 4,465 12,249 17,115 14,253 11,449
Others 4,846 6,001 4,813 5,072 5,654 Balances with banks 6,480 1,180 8,660 7,792 7,327
Operating profit 3,090 6,372 8,093 8,276 10,960 Investments 15,266 23,961 25,165 32,211 37,831
Provisions 406 1,710 7,991 7,103 4,127 Advances 105,525 140,436 144,940 166,686 208,415
Profit before tax 2,684 4,662 102 1,173 6,833 Fixed Assets 2,844 3,005 2,807 3,182 3,940
Taxes 692 1,163 19 296 1,722 Other Assets 2,842 3,282 5,118 6,365 7,141
Net Profit 1,992 3,499 83 877 5,111 Total assets 137,422 184,113 203,805 230,488 276,103

Ratios Ratios
YE Mar FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Growth (%) Balance Sheet (%)
Loans 46.2 28.1 7.0 15.0 25.0 Loans / Deposits 143.0 130.3 110.3 103.5 104.7
Deposits 95.6 46.1 21.8 22.6 23.6 Investments / Deposits 20.7 22.2 19.2 20.0 19.0
RWA growth 35.3 19.9 6.0 14.0 24.0 CASA 10.6 13.5 20.5 23.0 26.1
NII 28.5 47.6 5.8 (1.5) 20.1 Assets/equity (x) 7.6 5.8 6.3 7.0 7.3
Other income 84.8 56.4 (3.5) 15.8 25.0 RWA / Total assets 65.4 58.5 56.0 56.5 58.5
Opex 53.7 31.4 (6.7) 0.4 13.2 Capital ratios (%)
PPoP (3.3) 106.2 27.0 2.3 32.4 Tier-1 18.4 28.0 25.1 22.2 20.6
Provisions (86.9) 321.2 367.3 (11.1) (41.9) Tier-2 0.6 0.8 1.4 1.0 1.0
Net profit 2,802.9 75.6 (97.6) 957.1 482.5 CRAR 18.9 28.8 26.4 23.2 21.6
Profitability (%) Asset quality ratios (%)
Yield on assets 16.5 18.1 15.9 14.5 15.3 GNPA (Rs mn) 979 1,371 10,706 15,990 13,238
Cost of funds 7.6 8.1 6.9 6.4 7.0 NNPA (Rs mn) 275 275 4,246 6,398 4,888
NIM 9.9 10.9 9.8 8.7 8.9 GNPA 0.9 1.0 7.1 9.1 6.1
Other income / Total inc. 15.7 16.5 15.2 17.5 18.0 NNPA 0.3 0.2 2.9 3.8 2.3
Other inc. / avg assets 1.8 2.0 1.6 1.7 1.8 PCR 71.8 80.0 60.3 60.0 63.1
Cost/Income 76.5 67.4 60.3 59.9 56.1 Slippage 1.1 1.4 7.4 11.0 4.1
Employee 39.5 36.7 36.7 35.3 33.4 NNPA / Equity 1.5 0.9 13.2 19.5 13.0
Other 36.9 30.7 23.6 24.6 22.7 Per share
Opex/ Avg assets 8.6 8.2 6.3 5.7 5.5 EPS 1.4 2.0 0.0 0.5 3.0
Provisioning cost 0.5 1.4 5.6 4.6 2.2 BVPS 11.2 17.2 17.2 17.6 20.4
Tax rate 25.8 24.9 18.6 25.2 25.2 ABVPS 11.1 17.0 14.8 13.9 17.6
RoE 11.5 14.0 0.3 2.7 14.5 Valuation (x)
RoA 1.7 2.2 0.0 0.4 2.0 P/E 18.3 NM NM 40.6 7.0
RoRWA 2.5 3.5 0.1 0.7 3.5 P/BV 2.2 2.8 2.0 1.2 1.0
Du-pont (%) P/ABV 2.2 3.3 2.4 1.5 1.2
Interest income 15.8 16.8 14.5 13.1 13.9 Source: Company, Centrum Broking
Interest expenses 6.2 6.7 5.6 5.2 5.8
NII 9.5 10.2 8.9 7.8 8.1
Other income 1.8 2.0 1.6 1.7 1.8
Total income 11.3 12.2 10.5 9.5 9.9
Operating expenses 8.6 8.2 6.3 5.7 5.5
Employee 4.5 4.5 3.9 3.4 3.3
Other 4.2 3.7 2.5 2.3 2.2
PPOP 2.7 4.0 4.2 3.8 4.3
Provisions 0.3 1.1 4.1 3.3 1.6
PBT 2.3 2.9 0.1 0.5 2.7
Tax 0.6 0.7 0.0 0.1 0.7
RoA 1.7 2.2 0.0 0.4 2.0
Source: Company, Centrum Broking

Centrum Institutional Research 81


16 September 2021

Institutional Research
Gaurav Jani
Research Analyst, BFSI
+91 22 4215 9110
SECTOR: BFSI [email protected]

UTI AMC
The past decade was a tad challenging for UTI AMC. It witnessed a fall in market share, Market data
with equity flows being impacted over FY15-19 resulting from vacuum created after Current price: Rs1,175
senior management changes in FY15. Debt also saw sharp contraction after FY18, as Bloomberg: UTIAM IN
a fallout of the NBFC credit crisis. Consequently, equity and debt share was affected, 52-week H/L: Rs1,217/471
translating to higher share of ETFs/liquid. Revenue yields contracted sharply over
Market cap: Rs148.9bn
FY14-20. Core returns were further impacted, as opex to AUM could not reduce, as
seen with other peers, due to elevated employee expense while payout ratio was sub- Free float: 54.8%
optimal. However, UTI is on the mend, with market share improving in FY21 due to Avg. daily vol. 3mth: 505,264
better performance. Payout ratio would be better henceforth. Source: Bloomberg

Equity and ETFs saw strong growth; debt contracted: Debt AUM grew consistently from FY13 at a CAGR of 14.6% to reach a
peak of Rs609bn in FY18, but contracted thereafter to Rs350bn in FY21 due to the credit crises that spooked the NBFC space.
Equity grew steadily at a CAGR of 15.7%, except for FY20 on account of the pandemic. ETFs registered strong growth from FY17
at 84.3% CAGR to Rs425bn, surpassing debt and liquid AUM in FY21. Closing AUM mix changed dramatically from FY19, as debt
AUM started contracting and lost share to growing ETFs and equities. Debt mix contracted from 53% in FY13 to 20% in FY21
while Equity/Liquid/ETFs grew from 36%/10%/1% in FY13 to 38%/18%/24% in FY21.

Exhibit 216: Debt AUM down; upswing in equity and ETFs Exhibit 217: ETFs capture debt’s share in the mix from FY18
Closing AUM Closing AUM Mix
700 100%
600
80%
500
400 60%
300 40%
200
20%
100
0 0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Equity Debt Liquid ETF Equity Debt Liquid ETF
Source: Company, Centrum Broking Source: Company, Centrum Broking

Market share reduced over FY13-19, though improved marginally in FY21 due to better performance: Overall market share
stabilized at sub-6% levels from FY18 after a drop in share from 8.3% in FY13. UTI was able to sustain market share after FY18
despite lost debt AUM on account of strong uptick in ETFs and equities for the same period. Equity market share dropped from
11% in FY13 to 4.9% in FY18 and stabilized thereafter at similar levels on account of better equity fund performance in recent
years when compared to the peers. Share in SIP flows dropped to 1.3% in FY21 from 3.4% in FY20 despite increase in flows
from Rs29.5bn in FY20 to ~Rs32bn in FY21.

Exhibit 218: Market share stabilized from FY18 Exhibit 219: FY21 saw a reversal in SIP flow trends
Market Share SIP flows and market share
12% 35.0 4.0%
10% 30.0 3.5%
8% 25.0 3.0%
20.0 2.5%
6%
15.0 2.0%
4% 10.0 1.5%
2% 5.0 1.0%
0% 0.0 0.5%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21
Overall share Equity share SIP flows (Rs bn) SIP market share
Source: Company, Centrum Broking Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
UTI AMC 16 September 2021

Exhibit 220: Operating margins declining Exhibit 221: Overall opex drops but remains higher than peers
Revenue and opex yields (bps) Opex
91 40 35
81 36 30
71 32
25
61 28
51 24 20
41 20 15
31 16 10
21 12
5
11 8
1 4 0
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Revenue yields Opex/AUM (RHS) Operating yields EBE/AUM (bps) Other exp/AUM (bps)
Source: Company, Centrum Broking Source: Company, Centrum Broking

Revenue yields saw a sharper decline than opex, affecting operating margins: Operating yields increased over FY14-16 since
the share of higher yielding equity rose over FY13-15 from 36% to 41%. As the industry shifted to a combination of upfront and
trail commissions after FY15, yields also contracted, though for UTI, the share of equity declined over FY15-18 led by top
management changes in FY15, which also contributed to contraction in revenue yields. Over FY18-21, operating yields fell
further due to shift to full trail model, drastic decline in debt share in favour of ETF and liquid, and a less sharp reduction in
opex to AUM compared to peers led by higher employee cost.

Exhibit 222: Core RoE depressed also led by lower payout Exhibit 223: Core RoAUM contracting, led by operating yields
RoE and pay-out ROAUM (bps)
20% 50% 35
16% 40% 30
25
12% 30% 20
8% 20% 15
10
4% 10%
5
0% 0% 0
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Core ROE ROE Payout Ratio (RHS) ROAUM Core ROAUM
Source: Company, Centrum Broking Source: Company, Centrum Broking

Operating yield contraction with lower payout ratio impacted core RoE: Core RoE moved in tandem with a decline in revenue
yields that could not be offset by a sharp decline in opex to AUM as seen with other AMCs. However, core RoE was also affected
by a lower payout ratio compared to peers over FY14-20 averaging 20%. The company has partly rectified this by introducing
a dividend policy at the time of its listing, which states that the company would declare dividend equivalent to 50% or more of
the standalone PAT. Hence, this ratio improved considerably in FY21. There is a significant difference between core and overall
returns, especially in FY21 due to the unrealized gains included in other income.

Exhibit 224: Market-leading share from low-tier cities Exhibit 225: Direct channels dominate in equity
Geographic mix Distribution mix
100% 100%

80% 80%

60% 60%

40% 40%

20% 20%

0% 0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Overall Equity
Top 5 Next 10 Next 20 Next 75 Others IFAs Direct BND
Source: Company, Centrum Broking Source: Company, Centrum Broking

UTI continues to see high share from low tier-cities; direct channels have clear preference: Share from Top 5 cities bottomed
out in FY15 at 44% and increased thereafter to 60% in FY21. However, it remains low when compared to peers, which is positive
for UTI, as expense ratios and fees that can be charged are higher in lower-tier cities. Share of Next 10 also reduced from 15%
in FY13 to 10% in FY21. Other cities’ share averaged at about 13%, which is higher than peers. Share of Next 75 remained
relatively flat. Direct channels clearly dominate the distribution mix, with 59/62% share in FY20/21. Banks/MFD share in
distribution mix continues to be low compared to its peers.

Centrum Institutional Research 83


UTI AMC 16 September 2021
P&L Balance sheet
YE March (Rs bn) FY19A FY20A FY21A FY22E FY23E YE March (Rs bn) FY19A FY20A FY21A FY22E FY23E
Revenue from Operations 8,906 7,879 8,066 10,663 11,675 Share Capital 1,268 1,268 1,268 1,268 1,268
Investment Management Fees 8,814 7,865 8,060 10,647 11,657 Reserves and Surplus 25,263 26,563 31,102 33,934 36,981
PMS and Advisory Fees 92 14 6 16 18 Net Worth 26,530 27,831 32,370 35,202 38,249
Expenses 5,845 5,487 5,956 6,255 6,183 Trade Payables 713 662 933 850 905
Employee benefit 3,067 3,399 3,795 3,867 3,645 Employee Benefit 590 1,726 1,715 1,324 1,248
Other Expenses 2,596 1,723 1,774 2,031 2,163 Others 1,470 1,433 1,631 1,655 1,680
Depreciation 162 336 358 319 335 Total Liabilities and Equity 29,304 31,654 36,649 39,031 42,083
Fees and Commission 21 29 30 37 40 Cash and Bank 1,242 1,193 2,060 2,060 2,060
Operating Income 3,061 2,392 2,110 4,408 5,493 Investment 22,614 23,558 27,469 29,005 31,609
Other Income 1,905 1,021 3,921 2,109 1,784 Fixed Asset 2,687 3,737 3,647 3,824 4,010
PBT 4,966 3,413 6,030 6,518 7,281 Receivables 929 933 748 1,169 1,279
Tax 1,447 664 1,087 1,369 1,528 Others 1,833 2,233 2,725 2,974 3,124
PAT 3,519 2,749 4,943 5,148 5,749 Total Assets 29,304 31,654 36,649 39,031 42,083
Dividend 764 692 2,155 2,317 2,702 Closing AUM (Rs bn)
Retained Earnings 2,755 2,057 2,788 2,832 3,047 Overall 1,423 1,178 1768 1,915 2,090
Growth ratios (%) Equity 499 413 667 667 739
AAuM 5.4 (6.5) 13.3 25.0 8.7 Debt 486 308 350 350 364
Revenue from Operations (7.9) (11.5) 2.4 32.2 9.5 Liquid 265 240 326 326 333
EBE (4.6) 10.8 11.7 1.9 (5.8) Others 174 217 425 425 479
PAT (11.3) (21.9) 79.8 4.2 11.7 Closing AUM Breakup (%)
Profitability Ratios (%) Overall 100.0 100.0 100.0 100.0 100.0
Yield on AUM 0.64 0.61 0.55 0.58 0.58 Equity 35.0 35.1 37.7 38.6 39.6
Yield on Investments 6.9 2.48 13.8 6.0 4.5 Debt 34.2 26.1 19.8 19.0 18.8
EBE / Core Revenue 34.4 43.1 47.0 36.3 31.2 Liquid 18.6 20.4 18.5 17.4 16.1
Operating Income/ Core Revenue 34.4 30.4 26.2 41.3 47.0 Others 12.2 18.4 24.0 25.0 25.5
Other Income / Core Revenue 21.4 13.0 48.6 19.8 15.3 Closing AUM Growth (%)
Effective tax rate 29.1 19.5 18.0 21.0 21.0 AuM 4.7 (17.2) 50.1 8.3 9.1
PAT Margin 39.5 34.9 61.3 48.3 49.3 Equity 11.2 (17.1) 61.4 10.8 12.0
ROE 13.9 10.1 16.4 15.2 15.7 Debt (20.2) (36.7) 13.6 4.1 8.1
Core RoE 8.6 7.1 7.8 14.9 17.5 Liquid 28.7 (9.4) 36.2 2.0 1.0
ROAAAUM 0.25 0.21 0.34 0.28 0.29 Others 80.5 24.8 95.5 12.9 11.1
Core RoAAuM 0.16 0.15 0.12 0.19 0.22 Valuations
DuPont analysis (%) EPS 27.8 21.7 39.0 40.6 45.3
Revenue from Operations 0.64 0.61 0.55 0.58 0.58 DPS 6.0 5.5 17.0 18.3 21.3
Investment Management Fees 0.63 0.60 0.55 0.58 0.58 BVPS 209 220 255 278 302
PMS and Advisory Fees 0.01 0.00 0.00 0.00 0.00 Dividend Yield - 1.0 3.1 2.1 2.5
Expenses 0.42 0.42 0.40 0.34 0.31 P/E 0.0 14.0 13.5 28.9 25.9
Fees and Commission 0.00 0.00 0.00 0.00 0.00 P/B 0.0 2.1 2.0 4.2 3.9
Employees 0.22 0.26 0.26 0.21 0.18 Source: Company, Centrum Broking
Depreciation 0.01 0.03 0.02 0.02 0.02
Other Expenses 0.19 0.13 0.12 0.11 0.11
Operating Income 0.22 0.18 0.14 0.24 0.27
Other Income 0.14 0.08 0.27 0.11 0.09
PBT 0.36 0.26 0.41 0.35 0.36
Tax 0.10 0.05 0.07 0.07 0.08
PAT 0.25 0.21 0.34 0.28 0.29
Core PAT 0.16 0.15 0.12 0.19 0.22
Source: Company, Centrum Broking

Centrum Institutional Research 84


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

ACC
ACC’s operating profits have remained steady over the decade. Of the cumulative Market data
OCF of Rs143bn, ACC incurred Rs66bn on capex, largely on improving operating Current price: Rs2,430
efficiencies. New capacity addition was limited. With stable working capital, Bloomberg: ACC IN
operating cash flows followed a trend similar to operating profits. Additionally, 52-week H/L: Rs2,509/1,294
limited capex funded through internal accruals helped the company to maintain
Market cap: Rs456.3bn
negative debt. With less focus on adding capacities (organic or inorganic), balance
sheet strengthened consistently, but reflected in limited momentum in return ratios Free float: 43.3%
over the decade. Avg. daily vol. 3mth: 632,645
Source: Bloomberg

Volatile cash flows from operations: Operating profit began and ended the decade almost at the same level after being
subdued over CY13-17 due to macroeconomic conditions. OCF followed an almost similar path, but with higher volatility.
Working capital remained stable and range-bound, with negligible volatility.
Exhibit 226: Cash flows from operations have followed the trend in operating profit, but with higher volatility
30
25
20
15
Rs bn

10
5
-
-5
-10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Operating profit Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: With capacity maintained over the decade, ACC has managed its working capital
efficiently, as evidenced by its consistently negative NWC. Gradual increase in payable days coupled with marginal fall in
inventory and debtor days has led to a further fall in NWC in the recent years. Inventory management has been prudent,
driven by reliance on a judicious mix of fuels procured from domestic and overseas sources.
Exhibit 227: No working capital stress
150

100
In days of revenue

50

0
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
-50

-100
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
ACC 16 September 2021

Exhibit 228: OCF/PAT Exhibit 229: OCF/EBITDA

300% 140%

250% 120%
100%
200%
80%
150%
60%
100%
40%
50% 20%
0% 0%

CY17
CY11

CY12

CY13

CY14

CY15

CY16

CY18

CY19

CY20

CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20
Source: Company, Centrum Broking Source: Company, Centrum Broking

Minimal capacity expansions and negligible acquisitions led to free cash proportionate with operating cash: Apart from
expansions of 1.1mtpa at Jamul and 1.4mtpa at Sindri (both commissioned in CY16), ACC has incurred marginal capex,
especially towards waste heat recovery system (WHRS), with focus on cost reduction. Net FCF (excluding marketable
securities) has remained in proportion to operating cash flows. Positive cash flows helped to fund capex internally, with no
requirement of leverage. Against the cumulative OCF of Rs143bn, capex of Rs66bn was incurred.
Exhibit 230: Low capex intensity aids free cash flows
30 Expansion at Jamul (Chhattisgarh) and
Sindri (Jharkhand)
20

10
Rs bn

-10

-20
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 231: Asset turn


CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Asset turn (x) 0.8 0.9 0.9 0.9 0.9 0.8 0.9 1.0 1.0 0.8
Source: Company, Centrum Broking

Negative net debt; no equity raised in 10 years: Cash accruals funded capex, leading to no debt requirement over the
decade. In fact, there was marginal repayment of debt, leading to negative net debt.
Exhibit 232: Balance sheet concerns minimal due to strong cash balances
Leverage ratios (x) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Net Debt/Equity -0.3 -0.4 -0.3 -0.2 -0.2 -0.3 -0.3 -0.3 -0.4 -0.5
Net Debt/EBITDA -1.3 -1.4 -1.7 -1.1 -1.3 -1.7 -1.4 -1.5 -1.9 -2.5
Source: Company, Centrum Broking

Profitability has declined over the last decade: Return ratios have deteriorated over the decade, with some signs of
improvement in the last two years. With increased focus on cost rationalization in the recent years, especially considering its
Par vat project, we might see some improvement in return ratios in the coming years.
Exhibit 233: Profitability impacted after starting the decade well
Return Ratios (%) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
RoE 16.1 17.7 10.9 14.0 8.9 7.6 9.3 15.2 11.1 14.2
RoCE 21.0 23.4 15.0 10.1 9.3 7.7 9.6 10.4 11.3 12.2
Source: Company, Centrum Broking

Exhibit 234: Net FCF has stayed strong as capacity expansion was limited
Rsbn CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Net FCF 11.7 9.6 0.1 -3.6 7.5 10.1 7.1 1.9 19.0 13.5
Equity raised 0.0 0.0 0.0 0.0 0.0 0.0 -0.1 0.0 0.0 0.0
Increase / (decrease) in debt -0.1 -3.5 -1.3 -0.4 0.4 0.1 0.1 -0.6 0.0 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 86


ACC 16 September 2021

P&L Balance sheet


YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Revenues 1,44,775 1,53,431 1,34,868 1,68,028 1,91,863 Equity share capital 1,880 1,880 1,880 1,880 1,880
Operating Expense 99,952 1,05,807 89,913 1,10,197 1,26,053 Reserves & surplus 1,03,397 1,13,333 1,24,735 1,39,455 1,56,923
Employee cost 8,811 8,640 8,391 8,632 8,891 Shareholders fund 1,05,277 1,15,213 1,26,614 1,41,335 1,58,803
Others 18,805 18,025 14,732 20,870 23,813 Minority Interest 0 0 0 0 0
EBITDA 20,446 24,095 24,811 31,745 36,813 Total debt 0 0 0 1,300 1,950
Depreciation & Amortisation 5,996 6,030 6,353 6,456 6,780 Non Current Liabilities 0 0 0 0 0
EBIT 14,450 18,065 18,458 25,290 30,033 Def tax liab. (net) 6,631 6,422 3,762 3,762 3,762
Interest expenses 892 862 570 544 545 Total liabilities 1,11,908 1,21,635 1,30,376 1,46,397 1,64,515
Other income 1,021 1,276 1,824 0 0 Gross block 88,292 93,484 95,891 1,01,961 1,23,671
PBT 14,943 18,940 19,927 27,787 31,828 Less: acc. Depreciation (18,280) (24,059) (31,507) (37,122) (43,937)
Taxes 4,883 6,726 5,422 8,892 10,185 Net block 70,013 69,426 64,384 64,839 79,734
Effective tax rate (%) 32.7 35.5 27.2 32.0 32.0 Capital WIP 3,922 4,353 7,011 16,000 4,535
PAT 10,060 12,214 14,505 18,895 21,643 Net fixed assets 74,416 74,267 72,039 80,976 84,506
Minority/Associates 5,006 0 2,694 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 15,066 12,214 17,199 18,895 21,643 Investments 2,302 2,302 2,206 2,206 2,206
Extraordinary items 0 1,375 0 0 0 Inventories 16,786 11,410 9,005 11,679 12,810
Reported PAT 15,066 13,589 17,199 18,895 21,643 Sundry debtors 8,683 6,284 4,515 6,086 7,475
Cash & Cash Equivalents 30,003 45,381 58,911 77,819 95,572
Ratios Loans & advances 28,062 31,178 34,583 27,825 28,401
YE Dec CY18A CY19A CY20A CY21E CY22E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 34,849 32,279 33,640 41,575 47,247
Revenue 12.0 6.0 (12.1) 24.6 14.2 Other current liab. 11,826 14,331 14,949 17,003 17,538
EBITDA 12.0 17.8 3.0 28.0 16.0 Provisions 1,668 2,575 2,294 1,616 1,670
Adj. EPS 81.3 (18.9) 40.8 9.9 14.5 Net current assets 35,190 45,067 56,131 63,214 77,802
Margins (%) Total assets 1,11,908 1,21,635 1,30,376 1,46,397 1,64,515
Gross 86.1 84.3 83.6 85.0 84.7
EBITDA 13.8 15.4 18.0 18.5 18.8 Cashflow
EBIT 9.8 11.5 13.4 14.8 15.4 YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Adjusted PAT 10.2 7.8 12.5 11.0 11.1 Profit Before Tax 14,943 20,315 16,878 27,787 31,828
Returns (%) Depreciation & Amortisation 5,891 5,779 7,448 5,615 6,815
ROE 15.2 11.1 14.2 14.1 14.4 Net Interest 0 0 0 0 0
ROCE 10.4 11.3 12.2 12.8 13.5 Net Change – WC (7,085) 3,898 2,493 10,117 2,986
ROIC 13.0 15.2 18.8 25.4 30.7 Direct taxes (6,522) (5,331) (8,110) (8,722) (10,007)
Turnover (days) Net cash from operations 7,227 24,661 18,709 34,798 31,623
Gross block turnover ratio (x) 1.6 1.6 1.4 1.6 1.6 Capital expenditure (5,279) (5,630) (5,220) (14,553) (10,345)
Debtors 18 15 12 11 13 Acquisitions, net 0 0 0 0 0
Inventory 42 27 24 22 23 Investments 0 0 0 0 0
Creditors 100 89 107 110 115 Others 0 0 0 0 0
Net working capital (36) (47) (71) (77) (79) Net cash from investing (5,279) (5,630) (5,220) (14,553) (10,345)
Solvency (x) FCF 1,948 19,031 13,489 20,245 21,278
Net debt-equity (0.3) (0.4) (0.5) (0.5) (0.6) Issue of share capital 0 0 0 0 0
Interest coverage ratio 22.9 27.9 43.5 58.4 67.5 Increase/(decrease) in debt (592) 0 0 1,300 650
Net debt/EBITDA (1.5) (1.9) (2.4) (2.4) (2.5) Dividend paid (3,396) (3,169) (2,629) (2,637) (4,175)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 80.2 65.0 91.5 100.6 115.2 Others 5,089 (483) 2,670 0 0
BVPS 560.3 613.2 673.8 752.2 845.1 Net cash from financing 1,102 (3,652) 41 (1,337) (3,525)
CEPS 112.0 97.0 125.3 134.9 151.2 Net change in Cash 3,049 15,378 13,530 18,908 17,753
DPS 15.0 14.0 14.0 19.0 19.0 Source: Company, Centrum Broking
Dividend payout (%) 18.7 19.3 15.3 18.9 16.5
Valuation (x)
P/E 30.3 37.4 26.5 24.2 21.1
P/BV 4.3 4.0 3.6 3.2 2.9
EV/EBITDA 20.8 17.1 16.0 12.0 9.9
Dividend yield (%) 0.6 0.6 0.6 0.8 0.8
Source: Company, Centrum Broking

Centrum Institutional Research 87


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Ambuja Cement (ACEM)


ACEM funded the acquisition of majority stake (50.05%) in ACC in 2016 through Market data
internal cash accruals (~Rs35bn). It did not weaken the balance sheet by adding Current price: Rs430
debt. Over CY11-20, ACEM generated cumulative OCF of Rs196bn and its capex was Bloomberg: ACEM IN
Rs63bn, including the ~Rs35bn for ACC’s acquisition. Post-acquisition synergies are 52-week H/L: Rs443/197
not yet fully evident – ACEM’s performance has been impacted. Additionally, while
Market cap: Rs854.2bn
equity-backed acquisition has expanded the base, it has not supported earnings,
impacting ACEM’s return ratios post 2016 (following the acquisition). Free float: 29.3%
Avg. daily vol. 3mth: 4,204,744
Source: Bloomberg

Stable cash flows from operations: Operating profits, which lost strength post CY12 due to adverse macroeconomic
conditions, have begun to show some improvement at the end of the decade in CY19 and CY20, and have once again reached
CY12 levels. Operating cash flows have been consistent, except for CY18, impacted by working capital. Working capital turned
volatile from CY16, following the investment in ACC.
Exhibit 235: Steady and healthy cash flows from operations

40

30

20
Rs bn

10

-10 CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20

-20
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital (NWC) days remained stable in the middle years after worsening
at start of the decade in CY12 due to fall in creditor days. NWC days have improved towards the end of the decade, once
again entering the negative zone with the help of simultaneous fall in inventory and receivable days in CY20. Well controlled
receivable days due to higher exposure to the trade segment (80-85%) and pan-India presence enabling better inventory
management (synergies post ACC acquisition) have aided working capital improvement in the second half of the decade.
Exhibit 236: Working capital cycle has improved towards the end of the decade
80

60
In days of revenue

40

20

0
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
-20

-40 Receivable Inventory Payable NWC

Source: Company, Centrum Broking


xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Ambuja Cement (ACEM) 16 September 2021

Exhibit 237: OCF/PAT Exhibit 238: OCF/EBITDA

250% 160%
140%
200%
120%
150% 100%
80%
100% 60%
40%
50%
20%
0% 0%
CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20

CY11

CY12

CY13

CY14

CY15

CY16

CY17

CY18

CY19

CY20
Source: Company, Centrum Broking Source: Company, Centrum Broking

Limited capacity expansions, one major acquisition funded by accumulated free cash: The major highlight of the decade on
the expansion front was the acquisition of 50.05% stake in ACC (indirectly via Holcim India), along with some minor
expansions of 2.6mtpa at Pali and 0.75mtpa at Sankrail. Operating and free cash flows showed good stability, with FCF
following the direction of OCF, with limited capex. Effectively, against OCF of Rs196bn, ACEM incurred capex of Rs63bn.
Exhibit 239: Capex intensity and free cash flows
50 50.05% stake acquired in ACC

-
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Rs bn

-50

-100

-150
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 240: Asset turn impacted following ACC’s acquisition


CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Asset turn (x) 0.8 0.8 0.7 0.7 0.7 0.5 0.5 0.5 0.5 0.5
Source: Company, Centrum Broking

No leverage requirement; negative net debt: Internal cash flows funded ACEM’s limited capex requirements and the ACC
deal involving a Rs35bn outflow. ACEM is a net cash company. Net Debt/Equity has decreased since CY16 post the increase in
equity as a consequence of the ACC acquisition.
Exhibit 241: Leverage ratios stay in comfort zone
Leverage ratios (x) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Net Debt/Equity -0.3 -0.4 -0.4 -0.4 -0.5 -0.1 -0.2 -0.2 -0.2 -0.1
Net Debt/EBITDA -1.4 -1.5 -2.4 -2.3 -3.2 -1.4 -1.8 -1.7 -2.2 -1.1
Source: Company, Centrum Broking

Exhibit 242: No major concerns on FCF except in the year of ACC’s acquisition
Rs bn CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Net FCF 9.6 12.1 8.9 12.7 12.2 -100.5 17.0 2.4 17.3 23.0
Equity raised 0.8 0.8 0.2 0.5 0.3 110.5 -0.5 0.4 0.1 0.0
Increase / (decrease) in debt -0.2 0.0 0.0 -0.2 0.0 0.0 -0.1 0.1 0.0 0.1
Source: Company, Centrum Broking

Profitability has been impacted, with return ratios declining after a good start to the decade: Synergies from the ACC
acquisition are still not fully evident. With a higher value of equity (denominator) post the acquisition and stable profits
(numerator), return ratios have been impacted after a good start to the decade. In the recent years of CY19/CY20, there is
some improvement, but return ratios are still far from the levels seen at the start of the decade.
Exhibit 243: Profitability on a downtrend after stellar start to the decade
Return Ratios (%) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
RoE 15.4% 18.7% 11.3% 12.7% 8.5% 6.7% 6.3% 6.8% 9.0% 10.9%
RoCE 21.3% 24.8% 15.9% 12.6% 8.2% 8.2% 8.1% 8.7% 9.9% 11.3%
Source: Company, Centrum Broking

Centrum Institutional Research 89


Ambuja Cement (ACEM) 16 September 2021

P&L Balance sheet


YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Revenues 2,54,226 2,65,471 2,41,160 3,05,659 3,46,990 Equity share capital 3,971 3,971 3,971 3,971 3,971
Operating Expense 1,68,312 1,73,705 1,47,156 1,90,108 2,15,953 Reserves & surplus 2,19,734 2,36,808 2,23,605 2,32,091 2,62,199
Employee cost 15,244 15,708 15,404 15,521 16,055 Shareholders fund 2,23,617 2,40,780 2,27,576 2,36,062 2,66,171
Others 36,782 35,738 32,767 38,019 42,050 Minority Interest 52,312 57,368 63,409 72,857 83,678
EBITDA 40,108 45,970 50,056 66,811 77,929 Total debt 480 775 4,644 4,689 4,735
Depreciation & Amortisation 11,539 11,525 11,618 11,847 12,342 Non Current Liabilities 0 0 0 0 0
EBIT 28,569 34,445 38,438 54,964 65,588 Def tax liab. (net) 11,153 9,367 6,260 6,385 6,513
Interest expenses 1,705 1,699 1,402 1,291 1,330 Total liabilities 2,87,562 3,08,290 3,01,889 3,19,993 3,61,097
Other income 2,899 5,281 4,096 3,574 3,591 Gross block 1,61,559 1,72,448 1,77,061 1,95,869 1,98,683
PBT 30,578 38,553 41,532 57,491 68,070 Less: acc. Depreciation (37,906) (48,967) (61,496) (73,343) (85,684)
Taxes 8,185 10,922 8,848 16,581 20,852 Net block 1,23,653 1,23,481 1,15,565 1,22,527 1,12,999
Effective tax rate (%) 26.8 28.3 21.3 28.8 30.6 Capital WIP 91,253 96,716 1,10,996 91,438 98,060
PAT 22,393 27,632 32,684 40,909 47,218 Net fixed assets 2,16,441 2,22,558 2,29,078 2,16,481 2,13,574
Minority/Associates (7,828) (6,682) (7,270) (9,232) (10,597) Non Current Assets 0 0 0 0 0
Recurring PAT 14,566 20,950 25,415 31,678 36,621 Investments 2,218 2,156 2,629 1,242 1,242
Extraordinary items (1,518) 0 (1,760) 0 0 Inventories 29,579 20,965 16,486 21,354 24,717
Reported PAT 13,048 20,950 23,654 31,678 36,621 Sundry debtors 13,045 10,686 5,611 8,374 9,982
Cash & Cash Equivalents 64,393 93,546 89,356 1,28,110 1,83,990
Ratios Loans & advances 47,644 51,914 54,047 42,668 39,071
YE Dec CY18A CY19A CY20A CY21E CY22E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 57,824 57,557 58,452 60,205 72,246
Revenue 10.1 4.4 (9.2) 26.7 13.5 Other current liab. 24,927 31,990 33,941 34,959 36,008
EBITDA 4.0 14.6 8.9 33.5 16.6 Provisions 3,007 3,987 2,926 3,072 3,225
Adj. EPS (3.9) 43.8 21.3 24.6 15.6 Net current assets 68,904 83,576 70,182 1,02,270 1,46,281
Margins (%) Total assets 2,87,562 3,08,290 3,01,889 3,19,993 3,61,097
Gross 86.1 85.1 85.8 86.3 85.5
EBITDA 15.4 17.0 20.4 21.5 22.1 Cashflow
EBIT 11.0 12.7 15.7 17.7 18.6 YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Adjusted PAT 5.6 7.7 10.4 10.2 10.4 Profit Before Tax 29,061 38,553 39,772 57,491 68,070
Returns (%) Depreciation & Amortisation 11,219 11,061 12,529 11,847 12,342
ROE 6.8 9.0 10.9 13.7 14.6 Net Interest 0 0 0 0 0
ROCE 8.7 9.9 11.3 13.7 14.4 Net Change – WC (20,686) 14,480 9,205 6,666 11,869
ROIC 10.0 11.4 14.3 19.5 24.8 Direct taxes (8,425) (12,707) (11,955) (16,456) (20,724)
Turnover (days) Net cash from operations 11,169 51,387 49,551 59,547 71,557
Gross block turnover ratio (x) 1.6 1.5 1.4 1.6 1.7 Capital expenditure (12,006) (17,177) (19,050) 750 (9,434)
Debtors 16 16 6 8 10 Acquisitions, net 0 0 0 0 0
Inventory 42 31 24 22 24 Investments (227) 62 (473) 1,387 (1)
Creditors 43 36 37 41 43 Others 0 0 0 0 0
Net working capital 15 11 (6) (11) (9) Net cash from investing (12,233) (17,116) (19,522) 2,137 (9,435)
Solvency (x) FCF (1,064) 34,272 30,029 61,685 62,122
Net debt-equity (0.2) (0.3) (0.3) (0.4) (0.5) Issue of share capital 650 88 0 0 0
Interest coverage ratio 23.5 27.1 35.7 51.8 58.6 Increase/(decrease) in debt (1,446) (1,331) 2,641 261 271
Net debt/EBITDA (1.6) (2.0) (1.7) (1.8) (2.3) Dividend paid (6,513) (6,513) (41,669) (6,513) (6,513)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 7.3 10.6 12.8 16.0 18.4 Others 10,449 2,637 4,811 (16,679) 0
BVPS 112.6 121.3 114.6 118.9 134.0 Net cash from financing 3,141 (5,119) (34,217) (22,931) (6,242)
CEPS 13.1 16.4 18.6 21.9 24.7 Net change in Cash 2,077 29,152 (4,189) 38,754 55,880
DPS 2.8 2.8 18.0 2.8 2.8 Source: Company, Centrum Broking
Dividend payout (%) 42.6 26.5 151.1 17.6 15.2
Valuation (x)
P/E 58.9 40.8 33.6 27.0 23.3
P/BV 3.8 3.5 3.8 3.6 3.2
EV/EBITDA 19.7 16.6 15.4 10.9 8.7
Dividend yield (%) 0.7 0.7 4.2 0.7 0.7
Source: Company, Centrum Broking

Centrum Institutional Research 90


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Cera Sanitaryware (CRS)


CRS has tread a balanced path over the decade – expansion has aided growth without Market data
impacting its balance sheet strength. Working capital stress has been higher due to the Current price: Rs4,394
unorganized segment’s extended credit period. A level playing field was created only Bloomberg: CRS IN
towards the fag end of the decade with the introduction of GST and ban of coal usage. 52-week H/L: Rs4,895/2,214
Working capital stress has been moderating in the last couple of years, though this has
Market cap: Rs57.1bn
been negated by slow growth (demonetization + GST impact). CRS has maintained
balance sheet health; however, the challenging business environment, diversification Free float: 41.9%
into tiles, and fierce competition have impacted its growth. Avg. daily vol. 3mth: 25,592
Source: Bloomberg

Improved cash flows from operations: CRS has shown consistent growth in its operating profits over the decade, multiplying
nearly four times with the help of expansions. However, the Covid pandemic led to a decline in FY20 operating profits. CRS
has faced working capital challenges throughout the decade with increased capex intensity. This also led to a proportionate
lowering of operating cash conversion, though cash flows remained positive and improved over the decade.
Exhibit 244: Cash flows from operations have improved over the decade

3,000
2,500
2,000
1,500
1,000
Rs mn

500
-
-500
-1,000
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1,500
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: The overall working capital strength had been poor, contributed by rising debtors
and lower payable days. Facing some impact of a growth company, debtors have been rising whereas creditors have
remained stable but lower (after falling from an unstainable high level at decade initiation), not allowing any improvement in
the high NWC line. Inventory days have also remained stable but high comparatively (to fuel growth and retain market share)
after some improvement at the start of the decade, all of which are impacting NWC days.
Exhibit 245: Extended receivable days/higher inventory have led to higher working capital days
140
120
In days of revenue

100
80
60
40
20
0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Cera Sanitaryware (CRS) 16 September 2021
Exhibit 246: OCF/PAT Exhibit 247: OCF/EBITDA
300% 180%
160%
250%
140%
200% 120%
100%
150%
80%
100% 60%
50% 40%
20%
0% 0%
FY16
FY11

FY12

FY13

FY14

FY15

FY17

FY18

FY19

FY20

FY21

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Expansions aided growth without too much impact on FCF conversion: CRS expanded its sanitaryware capacity to 3.2mn
pieces per year (2mn pieces in FY11) and doubled its faucet ware capacity to 2.34mn pieces per year. As capex was incurred
in the mid-decade period, when profits were stronger, FCF remained positive. Being a growth company, CRS has had to rely
marginally on debt and equity to fund its expansions, though improved cash flows helped it to repay debt during periods of
lower capex. Effectively, against cumulative OCF of Rs7.4bn, gross debt raising of Rs843mn, and equity raising of Rs717mn
during the decade, CRS incurred cumulative capex of Rs5.2bn.
Exhibit 248: Capex intensity and free cash flows
3,000
2,500
2,000
1,500
Rs mn

1,000
500
-
-500
-1,000
-1,500
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Acquisitions and Investments Net FCF


Source: Company, Centrum Broking

Exhibit 249: Healthy asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 1.1 1.2 1.4 1.6 1.5 1.3 1.1 1.2 1.2 1.0 1.0
Source: Company, Centrum Broking

Exhibit 250: Conservative balance sheet approach helps maintain decent free cash; could be detrimental to growth
Rs mn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF 50 -168 31 238 -433 507 185 191 91 204 187
Equity raised 5 0 0 0 706 0 0 0 0 6 -3
Increase / (decrease) in debt 107 97 135 -128 199 -15 171 -83 -56 135 -149
Source: Company, Centrum Broking

Negligible leverage requirement helps keep leverage ratios stable and lower: Healthy profits and cash flows implied lower
debt requirement. Net Debt/Equity hovered around 0.1x, helping to maintain a healthy balance sheet.
Exhibit 251: Consistently maintained healthy leverage ratios, with capex backed by internal accruals
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity -0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1
Net Debt/EBITDA -0.1 0.3 0.3 0.1 -0.1 0.0 0.2 0.3 0.3 0.5 0.4
Source: Company, Centrum Broking

Profitability and balance sheet consistently strong, supporting growth: Return ratios have remained strong. With profits
and balance sheet moving in tandem, there has been negligible impact on return ratios (FY20 being an outlier). Timely
expansions have supported growth.
Exhibit 252: Healthy return ratios sustained throughout the decade
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 26.5 25.6 29.0 25.7 23.5 21.6 21.1 18.3 17.6 15.4 12.3
RoCE 30.3 28.9 32.8 21.8 21.1 18.8 18.1 16.8 15.6 13.3 10.5
Source: Company, Centrum Broking

Centrum Institutional Research 92


Cera Sanitaryware (CRS) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 13,444 12,119 12,181 13,530 16,354 Equity share capital 65 65 65 65 65
Operating Expense 8,992 7,957 8,326 9,225 11,124 Reserves & surplus 6,944 7,642 8,652 9,710 11,064
Employee cost 1,655 1,707 1,537 1,691 2,044 Shareholders fund 7,009 7,713 8,717 9,775 11,129
Others 887 918 800 910 1,046 Minority Interest 103 77 117 109 140
EBITDA 1,983 1,655 1,581 1,802 2,252 Total debt 698 833 684 685 610
Depreciation & Amortisation 280 388 396 353 347 Non Current Liabilities 401 127 214 127 127
EBIT 1,703 1,267 1,185 1,448 1,905 Def tax liab. (net) 436 299 303 306 309
Interest expenses 85 101 97 75 73 Total liabilities 8,648 9,050 10,036 11,002 12,315
Other income 94 69 87 93 99 Gross block 5,336 5,999 6,124 6,316 6,408
PBT 1,803 1,349 1,339 1,648 2,127 Less: acc. Depreciation (1,534) (1,852) (2,172) (2,427) (2,686)
Taxes 652 243 340 404 542 Net block 3,801 4,147 3,952 3,889 3,722
Effective tax rate (%) 36.2 18.0 25.4 24.5 25.5 Capital WIP 190 181 151 310 243
PAT 1,151 1,105 999 1,244 1,584 Net fixed assets 4,049 4,391 4,168 4,272 4,039
Minority/Associates 0 27 8 (30) (30) Non Current Assets 0 0 0 0 0
Recurring PAT 1,151 1,132 1,007 1,215 1,555 Investments 127 306 320 157 157
Extraordinary items 0 0 0 0 0 Inventories 2,158 2,430 1,997 2,187 2,621
Reported PAT 1,151 1,132 1,007 1,215 1,555 Sundry debtors 2,984 2,228 2,095 2,224 2,643
Cash & Cash Equivalents 110 21 104 252 906
Ratios Loans & advances 829 840 670 738 811
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,570 1,895 4,340 4,471 4,918
Growth (%) Trade payables 1,109 953 1,554 1,264 1,519
Revenue 14.2 (9.9) 0.5 11.1 20.9 Other current liab. 2,112 1,980 2,022 2,073 2,125
EBITDA 11.8 (16.5) (4.5) 14.0 25.0 Provisions 95 132 127 102 141
Adj. EPS 11.5 (1.6) (11.0) 20.6 28.0 Net current assets 4,335 4,350 5,503 6,433 8,115
Margins (%) Total assets 8,648 9,050 10,036 11,002 12,315
Gross 55.4 55.6 49.1 54.5 54.2
EBITDA 14.7 13.5 12.9 13.2 13.7 Cashflow
EBIT 12.6 10.4 9.7 10.6 11.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 8.5 9.2 8.2 8.9 9.4 Profit Before Tax 1,803 1,349 1,339 1,648 2,127
Returns (%) Depreciation & Amortisation 222 317 320 255 259
ROE 17.6 15.4 12.3 13.1 14.9 Net Interest 0 0 0 0 0
ROCE 15.6 13.3 10.5 11.6 13.3 Net Change – WC (53) (53) 1,462 (739) (581)
ROIC 13.7 12.1 9.6 10.8 13.0 Direct taxes (649) (246) (378) (497) (403)
Turnover (days) Net cash from operations 1,323 1,367 2,744 668 1,402
Gross block turnover ratio (x) 2.5 2.0 2.0 2.1 2.6 Capital expenditure (621) (659) (97) (359) (26)
Debtors 76 78 64 58 54 Acquisitions, net 0 0 0 0 0
Inventory 55 68 66 56 53 Investments (612) (504) (2,459) 33 (447)
Creditors 42 47 55 56 46 Others 0 0 0 0 0
Net working capital 89 99 75 58 61 Net cash from investing (1,232) (1,163) (2,557) (326) (473)
Solvency (x) FCF 91 204 187 341 929
Net debt-equity 0.1 0.1 0.1 0.0 0.0 Issue of share capital 0 6 (6) 0 0
Interest coverage ratio 23.2 16.5 16.2 23.9 30.8 Increase/(decrease) in debt (56) 135 (149) 1 (75)
Net debt/EBITDA 0.3 0.5 0.4 0.2 (0.1) Dividend paid (188) (408) 0 (201) (201)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 88.5 87.0 77.4 93.4 119.5 Others 26 (26) 51 7 1
BVPS 538.9 593.1 670.3 751.6 855.7 Net cash from financing (218) (293) (104) (194) (275)
CEPS 110.0 116.8 107.9 120.6 146.2 Net change in Cash (127) (89) 82 147 654
DPS 12.0 26.0 0.0 13.0 13.0 Source: Company, Centrum Broking
Dividend payout (%) 13.6 29.9 0.0 13.9 10.9
Valuation (x)
P/E 49.7 50.6 56.8 47.1 36.8
P/BV 8.2 7.4 6.6 5.9 5.1
EV/EBITDA 29.2 35.1 36.6 32.0 25.3
Dividend yield (%) 29.2 35.1 36.6 32.0 25.3
Source: Company, Centrum Broking

Centrum Institutional Research 93


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Heidelberg Cement India (HEIM)


HEIM’s capacity expansion in the initial years helped improve working capital due to Market data
better economies of scale. This aided prudent use of inventory after the initial Current price: Rs276
challenging years due to capex. As HEIM gets over 80% of its revenue from the trade Bloomberg: HEIM IN
segment, receivables have been under control. Capacity expansion took a back seat 52-week H/L: Rs285/174
in the latter part of the decade, and in the absence of major capex, the company
Market cap: Rs62.5bn
generated free cash flows equivalent to operating cash flows. However, this has
capped growth, and increasing competition and minimal cost levers will add to Free float: 27.5%
HEIM’s challenges. Avg. daily vol. 3mth: 405,254
Source: Bloomberg

Cash flows from operations improved after capacity expansion in CY13: Operating profits have improved over the last 5-6
years post capacity expansion of ~3mtpa in CY13. However, the halt in capex has limited further growth. Working capital has
stabilized in recent years along with operating profits. Effectively, HEIM has been able to maintain its operating cash flow.
The company faced constraints in the initial phase of the decade largely due to lower economies of scale, but capacity
addition helped stabilize OCF in the years following the capex.
Exhibit 253: Cash flows from operations

10
8
6
4
Rs bn

2
-
-2
-4 CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: NWC, which was stable in the first half of the decade, strengthened in the second
half, post capacity expansion. As operating capacity nearly doubled and economies of scale improved, NWC showed a
declining trend, aided by a decline in inventory days. Additionally, focus on the trade segment has kept receivable days well
under check. Collectively, this led to an improvement in HEIM’s working capital in the second half of the decade.
Exhibit 254: Net working capital turned negative after new capacity addition in CY13
80

60
In days of revenue

40

20

0
CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20

-40
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Heidelberg Cement India (HEIM) 16 September 2021
Exhibit 255: OCF/PAT Exhibit 256: OCF/EBITDA

1000% 300%
Growth distorted
due to change in 200%
750%
reporting from
CY to FY 100%
500%
0%
250%
-100%
0%
CY11

CY12

CY13

FY15

FY16

FY17

FY18

FY19

FY20

FY21
-200%
-250%
-300%

CY11

CY12

CY13

FY15

FY16

FY17

FY18

FY19

FY20

FY21
-500%

Source: Company, Centrum Broking*FY15 includes first three months of CY14, (15 months) Source: Company, Centrum Broking

Limited capacity expansions, no acquisitions – FCF a function of OCF: Its sole capacity expansion of 3mtpa in Central India in
the early part of the decade has enabled HEIM to earn range-bound operating/free cash flows in the later part of the decade.
Effectively, of the Rs18bn OCF generated during the decade, Rs8.2bn was incurred on capex and residual was used for debt
repayment (Rs9.6bn repayment since FY15).
Exhibit 257: Capex intensity and free cash flows
20
15 Sold 0.6mtpa
3mtpa
grinding unit
10 expansion in
to JSW Steel
Central India
5
Rs bn

-
-5
-10
CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Acquisitions and Investments Net FCF


Source: Company, Centrum Broking *FY15 includes first three months of CY14, (15 months)

Exhibit 258: Asset turn steady


CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.6 0.5 0.5 0.7 0.9 0.8 0.8 0.8 0.8 0.8
Source: Company, Centrum Broking

Exhibit 259: Improvement in FCF as capex takes a back seat towards the end of the decade
Rs bn CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF -6.8 -4.8 -3.1 15.7 1.0 -1.0 3.3 1.6 3.9 3.2
Equity raised 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Increase / (decrease) in debt 7.8 2.5 3.3 -4.3 -2.4 -0.8 -0.8 0.7 -1.3 -0.4
Source: Company, Centrum Broking *FY15 includes first three months of CY14,(15 months)

Leverage has declined to nil due to improved operating performance and no capex: With no capex post CY13, cash flows
helped reduce leverage. HEIM’s Net Debt/Equity and Net Debt/EBITDA stands at nil as at FY20. However, with no further
capacity expansion, further growth could be restrained for HEIM.
Exhibit 260: Strong balance sheet aids healthy leverage ratios
Leverage ratios (x) CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.6 1.1 1.5 0.9 0.8 0.6 0.3 0.2 0.0 -0.1
Net Debt/EBITDA 6.9 12.3 13.8 2.5 2.9 2.1 0.9 0.5 0.0 -0.2
Source: Company, Centrum Broking

Improved profitability reflected in return ratios, though muted growth concerns remain: HEIM is utilizing its limited
capacity effectively, leading to above par improvement in overall performance, reflecting in increasing EBITDA and return
ratios. HEIM is also benefiting from higher realizations prevalent in its region. However, growth concerns coupled with entry
of new big players (Ultratech, JK Cement, Birla Corporation) may lead to loss in market share and affect future profitability.
Exhibit 261: Profitability has improved, resulting in strong return ratios
Return Ratios (%) CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 3.6 3.7 -5.4 -0.1 4.0 8.2 12.1 19.9 21.6 17.7
RoCE 3.9 3.2 0.0 0.0 7.1 8.4 10.6 16.1 17.9 17.2
Source: Company, Centrum Broking

Centrum Institutional Research 95


Heidelberg Cement India (HEIM) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 21,049 21,532 21,167 22,796 26,631 Equity share capital 2,266 2,266 2,266 2,266 2,266
Operating Expense 13,919 13,510 13,452 14,709 17,090 Reserves & surplus 9,446 10,880 12,025 13,529 15,685
Employee cost 1,239 1,312 1,273 1,406 1,694 Shareholders fund 11,712 13,146 14,923 15,795 17,951
Others 1,342 1,596 1,482 1,731 1,912 Minority Interest 0 0 0 0 0
EBITDA 4,833 5,278 5,140 5,150 6,154 Total debt 5,964 4,701 1,866 2,050 2,375
Depreciation & Amortisation 1,018 1,086 1,110 1,026 1,046 Non Current Liabilities 0 0 0 0 0
EBIT 3,816 4,192 4,030 4,124 5,108 Def tax liab. (net) 0 0 0 0 0
Interest expenses 748 739 509 370 393 Total liabilities 17,675 17,847 16,789 17,845 20,326
Other income 344 527 509 520 533 Gross block 21,344 21,765 22,502 22,799 23,242
PBT 3,412 3,981 3,805 4,274 5,248 Less: acc. Depreciation (3,976) (4,954) (6,064) (7,090) (8,136)
Taxes 1,210 1,300 1,304 1,411 1,732 Net block 17,368 16,811 16,438 15,710 15,106
Effective tax rate (%) 35.4 32.7 34.3 33.0 33.0 Capital WIP 172 279 266 4,000 3,250
PAT 2,203 2,681 2,501 2,864 3,516 Net fixed assets 17,540 17,090 16,704 19,710 18,356
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 2,203 2,681 2,501 2,864 3,516 Investments 0 0 0 0 0
Extraordinary items 0 0 647 0 0 Inventories 1,674 1,458 1,607 1,749 2,043
Reported PAT 2,203 2,681 3,148 2,864 3,516 Sundry debtors 253 257 333 375 474
Cash & Cash Equivalents 3,377 4,706 4,317 3,765 7,372
Ratios Loans & advances 4,110 4,418 5,492 4,909 5,640
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 1,076 907 2,763 2,640 3,062
Revenue 13.4 2.3 (1.7) 7.7 16.8 Other current liab. 4,362 4,433 4,591 4,757 4,929
EBITDA 37.3 9.2 (2.6) 0.2 19.5 Provisions 2,540 2,839 2,372 3,133 3,224
Adj. EPS 81.0 21.7 (6.7) 14.5 22.8 Net current assets 1,438 2,659 2,022 267 4,315
Margins (%) Total assets 17,675 17,847 16,789 17,845 20,326
Gross 83.0 82.7 83.3 81.8 82.7
EBITDA 22.7 24.3 24.1 22.4 22.9 Cashflow
EBIT 17.9 19.3 18.9 17.9 19.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 10.3 12.4 11.7 12.5 13.1 Profit Before Tax 3,416 3,981 3,911 4,274 5,248
Returns (%) Depreciation & Amortisation 999 977 1,110 1,026 1,046
ROE 19.9 21.6 17.8 18.6 20.8 Net Interest 0 0 0 0 0
ROCE 16.1 17.9 17.2 18.0 19.8 Net Change – WC (1,720) 108 248 1,204 (441)
ROIC 17.6 20.6 20.7 20.8 25.3 Direct taxes (741) (701) (1,269) (1,217) (1,519)
Turnover (days) Net cash from operations 1,954 4,365 4,001 5,287 4,334
Gross block turnover ratio (x) 1.0 1.0 0.9 1.0 1.1 Capital expenditure (399) (527) (725) (4,031) 308
Debtors 4 4 5 6 6 Acquisitions, net 0 0 0 0 0
Inventory 29 25 27 27 26 Investments 0 0 0 0 0
Creditors 62 58 53 67 61 Others 0 0 0 0 0
Net working capital (29) (29) (22) (34) (29) Net cash from investing (399) (527) (725) (4,031) 308
Solvency (x) FCF 1,554 3,838 3,276 1,256 4,642
Net debt-equity 0.2 0.0 (0.2) (0.1) (0.3) Issue of share capital 0 0 632 (632) 0
Interest coverage ratio 6.5 7.1 10.1 13.9 15.7 Increase/(decrease) in debt 657 (1,263) (2,834) 184 325
Net debt/EBITDA 0.5 0.0 (0.5) (0.3) (0.8) Dividend paid (793) (1,020) (1,813) (1,360) (1,360)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 9.7 11.8 11.0 12.6 15.5 Others (165) (226) 350 0 0
BVPS 51.7 58.0 65.9 69.7 79.2 Net cash from financing (302) (2,509) (3,665) (1,808) (1,035)
CEPS 14.2 16.6 15.9 17.2 20.1 Net change in Cash 1,253 1,330 (389) (552) 3,607
DPS 3.5 4.5 8.0 6.0 6.0 Source: Company, Centrum Broking
Dividend payout (%) 36.0 38.0 57.6 47.5 38.7
Valuation (x)
P/E 28.4 23.3 25.0 21.8 17.8
P/BV 5.3 4.8 4.2 4.0 3.5
EV/EBITDA 12.2 10.9 11.7 11.8 9.3
Dividend yield (%) 1.3 1.6 2.9 2.2 2.2
Source: Company, Centrum Broking

Centrum Institutional Research 96


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

JK Cement (JKCE)
JKCE’s free cash flow conversion from operating cash flow has been impacted, but Market data
this is typical of capex-heavy industries. Higher capex intensity impacted OCF Current price: Rs710
conversion to FCF in the mid-decade years and towards the end of the decade post Bloomberg: JKLC IN
the capacity expansion in the northern region. However, capacity expansion has 52-week H/L: Rs816/244
helped improve profitability and return ratios. With strong operating performance
Market cap: Rs83.5bn
and prudent working capital management, JKCE has been able to restrict the impact
on operating cash flows. Its cash flow management has also improved following the Free float: 51.7%
stability of newly-added capacities. Avg. daily vol. 3mth: 736,859
Source: Bloomberg

Consistent cash flows from operations: JKCE’s operating profits have been following the growth trend consistently over the
decade except for a hit in FY14. Cash flows have also been consistent and profits have strengthened. Working capital has
been range-bound with minimal volatility.
Exhibit 262: Consistent growth in cash flows from operations
15

10
Rs bn

FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-5
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Along with operating profits, net working capital (NWC) has shown strong
improvement in the later part of the decade. This is evident from the sustained fall in NWC since FY15 and its entry into
negative territory by FY20, aided by lower inventory days, higher payable days and flat debt or days. The more cautious
receivables approach has kept debtor days under check while a judicious mix of multiple fuels helped to improve inventory
days. Collectively, this has helped to improve WC management.
Exhibit 263: Working capital cycle has improved over the decade
100
80
In days of revenue

60
40
20
0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20
-40
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
JK Cement (JKCE) 16 September 2021

Exhibit 264: OCF/PAT Exhibit 265: OCF/EBITDA


350% 90%
300% 80%
70%
250%
60%
200% 50%
150% 40%
100% 30%
20%
50%
10%
0% 0%
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY17

FY18

FY19
FY11

FY12

FY13

FY14

FY15

FY16

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Doubling of capacity impacted OCF to FCF conversion: Expansions at Mangrol (2.5mtpa), Jhajjar (1.5mtpa), Aligarh (1.5mtpa)
and Nimbahera (1mtpa) in the gray cement segment doubled JKCE’s capacity to 14mtpa by the end of the decade. JKCE also
doubled its white cement capacity and expanded its product portfolio by adding wall putty (both having capacity of 1.2mtpa
by FY20). These expansions impacted FCF in the capex-intensive years. The expansions were funded by debt, marginal equity
raise, and internal accruals. There was no major acquisition during the decade. Against cumulative OCF of Rs38bn, net debt
of Rs17bn, and additional equity of Rs5bn, JKCE incurred capex of Rs40bn.
Exhibit 266: Capex intensity and free cash flows
15 Mangrol and Jhajjar Aligarh, Nimbahera and
expansion, wall putty entry, Mangrol expansion
10 white cement expansion

5
Rs bn

-5

-10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-15
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 267: Asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.7 0.7 0.8 0.6 0.6 0.7 0.7 0.8 0.8 0.7 0.7
Source: Company, Centrum Broking

Exhibit 268: Capex mode kept net FCF subdued


Rs bn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF -0.9 3.4 -1.0 -9.5 0.8 -0.6 0.8 4.6 (4.2) 0.1 2.2
Equity raised 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.5
Increase / (decrease) in debt 3.2 -2.1 0.7 10.7 2.5 1.1 0.2 -2.2 -0.4 3.3 4.0
Source: Company, Centrum Broking

Moderate leverage: Rapid expansions necessitated leverage (partial capex funded by debt), as indicated by the rise in
leverage ratios during the capex period. However, with consistent improvement in operating performance, leverage ratios
declined towards the end of the decade.
Exhibit 269: Leverage declined in the second half of the last decade
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.7 0.4 0.5 1.1 1.3 1.3 1.1 0.8 0.6 0.7 0.5
Net Debt/EBITDA 3.7 1.3 1.5 5.3 4.7 4.6 3.4 2.6 2.5 1.8 1.4
Source: Company, Centrum Broking

Exhibit 270: Profitability has improved, resulting in strong return ratios


Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 4.7 12.7 14.5 5.6 9.4 6.2 15.4 17.4 12.7 19.1 22.3
RoCE 6.7 13.8 14.5 5.2 8.3 7.2 11.2 12.0 9.6 13.2 14.4
Source: Company, Centrum Broking

Centrum Institutional Research 98


JK Cement (JKCE) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22A FY23A YE Mar (Rs mn) FY19A FY20A FY21A FY22A FY23A
Revenues 49,192 53,971 62,334 69,937 84,171 Equity share capital 773 773 773 773 773
Operating Expense 35,841 35,709 40,803 45,440 55,034 Reserves & surplus 28,464 30,516 36,558 44,561 55,389
Employee cost 3,535 3,909 4,121 4,324 4,712 Shareholders fund 29,237 31,289 38,060 45,405 56,241
Others 2,335 3,204 3,220 3,432 3,585 Minority Interest 0 0 0 0 0
EBITDA 7,481 11,149 14,190 16,740 20,841 Total debt 23,589 26,913 30,959 35,886 40,461
Depreciation & Amortisation 1,944 2,144 2,447 2,597 2,774 Non Current Liabilities 519 833 165 600 500
EBIT 5,537 9,005 11,743 14,143 18,067 Def tax liab. (net) 3,125 4,181 5,939 3,880 3,492
Interest expenses 2,221 2,229 2,232 2,615 2,874 Total liabilities 56,470 63,216 75,124 85,771 1,00,694
Other income 1,382 1,525 2,024 1,925 2,050 Gross block 51,673 59,694 64,999 66,203 86,375
PBT 4,737 8,302 11,593 13,453 17,243 Less: acc. Depreciation (15,413) (16,638) (18,530) (20,218) (21,803)
Taxes 1,487 2,516 3,897 4,372 5,518 Net block 36,260 43,056 46,469 45,985 64,573
Effective tax rate (%) 31.4 30.3 33.6 32.5 32.0 Capital WIP 5,438 6,615 6,384 18,000 12,000
PAT 3,250 5,785 7,696 9,081 11,725 Net fixed assets 41,791 49,773 52,974 64,110 76,700
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 3,250 5,785 7,696 9,081 11,725 Investments 10,047 5,662 8,070 8,798 9,064
Extraordinary items 0 (1,782) 0 0 0 Inventories 5,705 6,272 6,867 8,048 10,377
Reported PAT 3,250 4,004 7,696 9,081 11,725 Sundry debtors 2,056 2,234 3,161 3,641 4,612
Cash & Cash Equivalents 4,857 6,311 11,618 12,816 11,793
Ratios Loans & advances 5,066 8,298 9,000 6,334 7,801
YE Mar FY19A FY20A FY21A FY22A FY23A
Other current assets 0 0 0 0 0
Growth (%) Trade payables 9,406 7,900 7,433 10,056 11,625
Revenue 8.3 9.7 15.5 12.2 20.4 Other current liab. 3,197 5,924 7,866 6,572 6,638
EBITDA 5.1 49.0 27.3 18.0 24.5 Provisions 449 1,511 1,266 1,346 1,391
Adj. EPS (18.0) 78.0 33.0 18.0 29.1 Net current assets 4,632 7,781 14,079 12,863 14,929
Margins (%) Total assets 56,470 63,216 75,124 85,771 1,00,694
Gross 83.0 84.1 83.1 83.0 82.1
EBITDA 15.2 20.7 22.8 23.9 24.8 Cashflow
EBIT 11.3 16.7 18.8 20.2 21.5 YE Mar (Rs mn) FY19A FY20A FY21A FY22A FY23A
Adjusted PAT 6.6 10.7 12.3 13.0 13.9 Profit Before Tax 4,737 6,520 11,593 13,453 17,243
Returns (%) Depreciation & Amortisation 1,866 1,225 1,892 1,688 1,585
ROE 12.7 19.1 22.2 21.8 23.1 Net Interest 0 0 0 0 0
ROCE 9.6 13.2 14.4 14.4 15.4 Net Change – WC 765 (1,379) (1,660) 2,848 (3,189)
ROIC 7.7 12.1 12.7 13.9 15.2 Direct taxes (1,034) (1,460) (2,139) (6,432) (5,906)
Turnover (days) Net cash from operations 6,334 4,906 9,687 11,557 9,734
Gross block turnover ratio (x) 1.0 0.9 1.0 1.1 1.0 Capital expenditure (6,812) (9,207) (5,094) (12,823) (14,176)
Debtors 15 15 19 18 18 Acquisitions, net 0 0 0 0 0
Inventory 42 42 40 39 40 Investments (3,702) 4,385 (2,408) (728) (266)
Creditors 82 67 56 61 59 Others 0 0 0 0 0
Net working capital -25 -10 2 (3) (1) Net cash from investing (10,514) (4,823) (7,501) (13,550) (14,442)
Solvency (x) FCF (4,180) 83 2,186 (1,993) (4,708)
Net debt-equity 0.6 0.7 0.5 0.5 0.5 Issue of share capital 4,520 0 729 (657) 7
Interest coverage ratio 3.4 5.0 6.4 6.4 7.3 Increase/(decrease) in debt (388) 3,324 4,046 4,927 4,575
Net debt/EBITDA 2.5 1.8 1.4 1.4 1.4 Dividend paid (407) (1,630) 0 (1,085) (904)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 42.1 74.9 99.6 117.5 151.7 Others (123) (322) (1,654) 7 7
BVPS 378.4 404.9 492.6 587.6 727.9 Net cash from financing 3,601 1,372 3,121 3,192 3,685
CEPS 70.6 102.6 131.3 151.1 187.7 Net change in Cash (579) 1,455 5,307 1,198 (1,023)
DPS 4.7 17.5 0.0 12.0 10.0 Source: Company, Centrum Broking
Dividend payout (%) 10.7 33.8 0.0 10.2 6.6
Valuation (x)
P/E 81.8 46.0 34.5 29.3 22.7
P/BV 9.1 8.5 7.0 5.9 4.7
EV/EBITDA 38.0 25.7 20.1 17.3 14.1
Dividend yield (%) 0.1 0.5 0.0 0.3 0.3
Source: Company, Centrum Broking

Centrum Institutional Research 99


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

JK Lakshmi Cement (JKLC)


Market data
JK Lakshmi Cement (JKLC) stayed in the expansionary phase in the initial part of the
Current price: Rs3,441
decade, when it added grinding/integrated units with a focus on spreading across
regions. This put stress on its cash flows. JKLC relied more on pet-coke (proportion Bloomberg: JKCE IN
was dominant/fully-reliant, 100%); hence, inventory holding period was longer and 52-week H/L: Rs3,863/1,460
that kept working capital on a positive trajectory. Despite better fuel mix, JKLC’s Market cap: Rs265.9bn
realization continued to be weak, impacting overall financial performance. This also Free float: 40.5%
impacted D/E in the mid-decade years. This should be corrected in the near future, Avg. daily vol. 3mth: 93,108
with incremental cash flows generated in FY20/FY21. Source: Bloomberg

Steady cash flows from operations: Operating profits have been improving since FY17, post capacity enhancement and with
supportive macroeconomic factors. Working capital has remained healthy for most part of the decade and the temporary
surge in FY17 and FY19 was caused by sudden hike in other current liabilities. Operating cash flows have remained a function
of operating profits and working capital.
Exhibit 271: Operating profit consistently improving since FY17

12
10
8
6
Rs bn

4
2
-
-2
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Except in the last three years, net working capital (NWC) days were in the positive
range due to higher inventory holding period. JKLC was ~100% reliant on pet coke as fuel, resulting in higher inventory days.
Exhibit 272: Contrary to industry trend, JKLC’s NWC days have been positive for most of the decade
80

60
In days of revenue

40

20

0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20

-40
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
JK Lakshmi Cement (JKLC) 16 September 2021

Exhibit 273: OCF/PAT Exhibit 274: OCF/EBITDA

1000% 160%
140%
800% 120%
100%
600%
80%
400% 60%
40%
200%
20%
0% 0%

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY21
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20
Source: Company, Centrum Broking Source: Company, Centrum Broking

Capacity trebled during last decade, temporarily impacting FCF conversion: Multiple expansions were commissioned during
the decade, including Durg (2.7mtpa), Jharli (1.3mtpa) and Surat (1.4mtpa), which trebled JKLC’s capacity to 13.3mtpa. FCF
was impacted during the periods when capex was being incurred. For most of the period, the company struggled to generate
positive free cash flows. The marginal movement in investments can be majorly attributed to commissioning of 1.6mtpa
capacity by its subsidiary, Udaipur Cement Works Ltd (UCWL), with no acquisition executed during the decade. Effectively,
against Rs31bn OCF generation and Rs12bn debt raised, capex incurred was Rs33bn and debt repaid was Rs5bn.
Exhibit 275: Capex intensity and free cash flows
15
Commissioned
expansions at Jharli,
10
Durg, Sirohi, Kalol

5
Rs bn

-5
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-10
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 276: Asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.5 0.6 0.7 0.6 0.6 0.6 0.7 0.8 0.9 0.9 0.9
Source: Company, Centrum Broking

Exhibit 277: FCF a mixed bag


Rs bn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF -1.6 -2.3 -3.0 -2.4 -3.7 -1.3 1.5 1.1 3.5 2.8 8.4
Equity raised 0.0 0.0 -0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Increase/(decrease) in debt 1.0 0.8 2.7 3.0 2.9 1.1 0.9 -1.5 -4.1 -1.5 0.2
Source: Company, Centrum Broking

Capex payoff helps to bring down leverage in the latter half of the decade: Partial funding for expansions via debt led
leverage ratios to increase in the middle of the decade. Net Debt to EBITDA also soured to ~6x. However, leverage ratios
improved during the latter half of the decade, as new capacities (particularly in the eastern region) helped generate higher
profits and cash flows, which in turn helped repay debt partially.
Exhibit 278: Leverage ratios improved in the second half of the last decade
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.4 0.5 0.8 1.0 1.3 1.4 1.2 1.1 0.8 0.6 0.1
Net Debt/EBITDA 2.2 1.7 2.3 4.3 5.6 6.8 4.5 3.8 3.0 1.5 0.2
Source: Company, Centrum Broking

Exhibit 279: Profitability impacted for several years, though improvement has begun
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 5.7 13.3 15.8 8.7 8.3 1.3 6.0 5.9 5.2 16.4 20.8
RoCE 6.2 11.5 13.0 7.2 6.6 4.8 7.5 8.5 8.8 16.9 19.6
Source: Company, Centrum Broking

Centrum Institutional Research 101


JK Lakshmi Cement (JKLC) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 38,823 40,435 43,847 47,368 51,175 Equity share capital 589 589 589 589 589
Operating Expense 30,731 27,666 30,629 33,652 36,387 Reserves & surplus 14,638 16,538 20,201 23,246 26,762
Employee cost 2,599 3,120 3,270 3,433 3,605 Shareholders fund 15,227 17,127 20,789 23,835 27,351
Others 1,344 2,926 2,051 2,562 2,818 Minority Interest 0 0 0 0 0
EBITDA 4,150 6,724 7,898 7,721 8,365 Total debt 16,129 14,667 14,892 15,595 16,500
Depreciation & Amortisation 1,794 1,884 1,942 1,896 1,930 Non Current Liabilities 0 0 0 0 0
EBIT 2,356 4,840 5,956 5,825 6,435 Def tax liab. (net) 0 205 641 150 150
Interest expenses 1,874 1,644 1,425 1,730 1,821 Total liabilities 31,355 31,999 36,323 39,580 44,001
Other income 563 501 744 637 737 Gross block 33,225 36,479 37,959 39,557 41,432
PBT 1,044 3,697 5,274 4,732 5,351 Less: acc. Depreciation (6,907) (8,634) (10,562) (12,457) (14,387)
Taxes 272 1,042 1,328 1,136 1,284 Net block 26,318 27,845 27,397 27,099 27,045
Effective tax rate (%) 26.1 28.2 25.2 24.0 24.0 Capital WIP 4,111 1,639 1,425 1,000 6,000
PAT 772 2,655 3,946 3,596 4,066 Net fixed assets 30,501 29,556 28,895 28,171 33,117
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 772 2,655 3,946 3,596 4,066 Investments 3,573 3,673 3,673 3,673 3,673
Extraordinary items 0 (302) (309) 0 0 Inventories 3,117 4,128 3,155 4,932 5,538
Reported PAT 772 2,352 3,637 3,596 4,066 Sundry debtors 1,066 882 537 1,557 1,963
Cash & Cash Equivalents 3,813 4,512 13,188 13,308 10,694
Ratios Loans & advances 2,485 2,729 2,931 5,328 7,071
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 5,114 4,685 6,303 7,604 7,976
Revenue 13.8 4.2 8.4 8.0 8.0 Other current liab. 7,799 8,646 9,565 9,111 9,383
EBITDA 0.9 62.0 17.5 (2.2) 8.3 Provisions 286 151 186 675 696
Adj. EPS (8.0) 243.7 48.7 (8.9) 13.1 Net current assets (2,718) (1,231) 3,755 7,736 7,211
Margins (%) Total assets 31,355 31,998 36,323 39,580 44,001
Gross 75.0 78.9 75.3 75.4 75.3
EBITDA 10.7 16.6 18.0 16.3 16.3 Cashflow
EBIT 6.1 12.0 13.6 12.3 12.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 2.0 6.6 9.0 7.6 7.9 Profit Before Tax 1,044 3,395 4,965 4,732 5,351
Returns (%) Depreciation & Amortisation 1,794 1,884 1,928 1,896 1,930
ROE 5.2 16.4 20.8 16.1 15.9 Net Interest 0 0 0 0 0
ROCE 6.5 12.1 14.9 13.1 13.1 Net Change – WC 2,994 (789) 3,690 (3,860) (2,090)
ROIC 6.9 14.5 20.6 21.0 18.7 Direct taxes (272) (838) (891) (1,627) (1,284)
Turnover (days) Net cash from operations 5,561 3,652 9,692 1,140 3,906
Gross block turnover ratio (x) 1.2 1.1 1.2 1.2 1.2 Capital expenditure (2,065) (782) (1,266) (1,173) (6,875)
Debtors 10 9 6 8 13 Acquisitions, net 0 0 0 0 0
Inventory 30 33 30 31 37 Investments 0 0 0 0 0
Creditors 49 65 65 75 78 Others 0 0 0 0 0
Net working capital (9) (23) (29) (36) (28) Net cash from investing (2,065) (782) (1,266) (1,173) (6,875)
Solvency (x) FCF 3,496 2,870 8,425 (32) (2,969)
Net debt-equity 0.8 0.6 0.1 0.1 0.2 Issue of share capital 0 0 0 0 0
Interest coverage ratio 2.2 4.1 5.5 4.5 4.6 Increase/(decrease) in debt (4,076) (1,462) 225 703 905
Net debt/EBITDA 3.0 1.5 0.2 0.3 0.7 Dividend paid (106) (461) (441) (471) (471)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 6.6 22.6 33.5 30.6 34.5 Others (19) (249) 467 (79) (79)
BVPS 129.4 145.5 176.6 202.5 232.4 Net cash from financing (4,201) (2,171) 250 153 355
CEPS 21.8 38.6 50.0 46.7 50.9 Net change in Cash (705) 699 8,676 120 (2,614)
DPS 0.9 3.9 3.8 4.0 4.0 Source: Company, Centrum Broking
Dividend payout (%) 13.8 19.6 12.1 13.1 11.6
Valuation (x)
P/E 108.2 31.5 21.2 23.2 20.5
P/BV 5.5 4.9 4.0 3.5 3.1
EV/EBITDA 23.1 13.9 10.8 11.1 10.7
Dividend yield (%) 0.1 0.6 0.5 0.6 0.6
Source: Company, Centrum Broking

Centrum Institutional Research 102


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Kajaria Ceramics (KJC)


KJC has been above par, with strong operating cash flows, healthy capacity expansion, Market data
and well-maintained balance sheet health. Extended credit periods by the unorganized Current price: Rs1,180
segment (Morbi manufacturers) had stretched the receivable days of organized players Bloomberg: KJC IN
like KJC. Also, demonetization and the introduction GST towards the end of the decade 52-week H/L: Rs1,229/485
impacted industry growth. KJC’s capex intensity has stayed higher, affecting its free
Market cap: Rs187.7bn
cash flows, but aiding growth. Increasing operating cash flows together with some
equity raising have enabled KJC to repay outstanding debt and become debt-free. Free float: 94.3%
Avg. daily vol. 3mth: 319,430
Source: Bloomberg

Moderate conversion of operating profits to OCF: In the initial part of the decade, KJC’s operating profits saw consistent
growth, trebling over FY11-17. However, growth has taken a pause since then, hit by demonetization, GST, and capacity
expansion. Being in the growth phase, KJC’s working capital has been unfavorable for most part of the decade (FY11 being an
outlier due to temporary surge in current liabilities). Consequently, operating cash flow conversion has been slow.
Exhibit 280: Healthy cash flows from operations

6
5
4
3
Rs bn

2
1
-
-1
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-2
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital (NWC) days have been rising, led by increasing debtors, as KJC
has been focusing on establishing its position in the industry. Elevated inventory days have also contributed to the high NWC
level. A temporary surge in payable days in the initial phase had helped to lower NWC days, but this did not sustain, as the
industry structure kept receivable days higher and elevated inventory added further stress.
Exhibit 281: Higher working capital days can largely be attributed to increasing receivable days
100

80
In days of revenue

60

40

20

0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Receivable Inventory Payable NWC


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Kajaria Ceramics (KJC) 16 September 2021

Exhibit 282: OCF/PAT Exhibit 283: OCF/EBITDA


350% 140%
300% 120%
250% 100%
200% 80%
150% 60%
100% 40%
50% 20%
0% 0%

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Rapid expansions have aided growth with minimal impact on FCF conversion: KJC’s capacity tripled to 73msm (of which
18.8msm is through JV) over FY11-21, paving its growth path. It focused on expanding its vitrified tiles capacity, which
increased from 11msm to 45msm. KJC also expanded into the bathware segment (1mn pieces for faucets and 0.75mn pieces
for sanitaryware by FY20). Increasing profits and cash flows during the capex period minimized the impact on FCF and led to
lower debt requirement. KJC was also able to repay outstanding debt, though marginal equity was raised. Effectively, against
Rs20bn of OCF generation and Rs2bn of equity raising, KJC incurred a capex of Rs14bn and became debt-free.
Exhibit 284: Capex intensity and free cash flows
6 Commissioned
expansions at Jharli, Durg,
4 Sirohi, Kalol

2
Rs bn

-2
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-4
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 285: Asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 1.3 1.5 1.7 1.6 1.6 1.4 1.3 1.3 1.3 1.2 1.1
Source: Company, Centrum Broking

Exhibit 286: Free cash flows on an improving trend in the latter part of the decade
Rs bn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF 0.0 0.3 -0.3 0.5 -0.5 -0.1 1.8 1.6 2.7 0.7 4.1
Equity raised 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0
Increase / (decrease) in debt 0.3 -0.1 0.4 -0.8 0.1 0.5 -0.8 -0.4 -0.5 0.5 -0.4
Source: Company, Centrum Broking

Negligible leverage requirement; capex payoff helps repay debt: KJC’s capex aided healthy growth in profits and cash flows,
helping to bring leverage ratios down and eventually turning the company debt-free.
Exhibit 287: Healthy leverage ratios despite near tripling of tiles capacity
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 1.3 0.9 0.8 0.4 0.3 0.3 0.1 0.1 -0.1 0.0 -0.2
Net Debt/EBITDA 1.9 1.3 1.3 0.8 0.7 0.6 0.3 0.2 -0.3 -0.1 -0.6
Source: Company, Centrum Broking

Healthy profitability growth; muted towards the end: KJC has witnessed marginal decline in return ratios since FY18 due to
increased equity. However, return ratios should improve in the medium term, as business normalizes.
Exhibit 288: Strong ratios, reflecting profitability growth
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 29.3 31.5 30.8 27.9 28.5 27.1 23.6 18.6 15.9 15.6 17.2
RoCE 22.1 28.0 28.9 21.0 22.4 21.7 19.6 16.0 14.6 14.5 15.8
Source: Company, Centrum Broking

Centrum Institutional Research 104


Kajaria Ceramics (KJC) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 29,508 28,004 27,724 31,495 38,866 Equity share capital 159 159 159 159 159
Operating Expense 19,572 18,378 18,037 20,096 24,811 Reserves & surplus 15,590 16,984 18,530 21,020 25,078
Employee cost 3,455 3,569 3,247 3,571 3,660 Shareholders fund 15,749 17,143 18,689 21,179 25,237
Others 2,040 1,974 1,438 1,797 2,416 Minority Interest 659 637 646 656 671
EBITDA 4,495 4,159 5,088 6,121 8,076 Total debt 1,203 1,660 1,243 1,287 964
Depreciation & Amortisation 884 1,074 1,067 1,117 1,134 Non Current Liabilities 0 0 0 0 0
EBIT 3,611 3,085 4,022 5,005 6,942 Def tax liab. (net) 1,073 731 687 687 687
Interest expenses 156 195 107 161 121 Total liabilities 18,684 20,171 21,264 23,810 27,560
Other income 175 233 200 316 345 Gross block 16,605 18,183 18,549 20,204 21,503
PBT 3,636 3,131 4,127 5,176 7,185 Less: acc. Depreciation (5,980) (6,828) (7,854) (8,971) (10,105)
Taxes 1,293 589 1,038 1,279 1,708 Net block 10,624 11,355 10,695 11,233 11,398
Effective tax rate (%) 35.6 18.8 25.2 24.7 23.8 Capital WIP 934 677 1,196 2,500 2,000
PAT 2,343 2,542 3,089 3,897 5,477 Net fixed assets 11,728 12,214 12,073 13,918 13,584
Minority/Associates (22) 18 (9) (11) (15) Non Current Assets 0 0 0 0 0
Recurring PAT 2,321 2,560 3,081 3,886 5,462 Investments 3 101 50 0 0
Extraordinary items (48) 0 0 0 0 Inventories 4,058 5,127 3,731 4,401 5,537
Reported PAT 2,273 2,560 3,081 3,886 5,462 Sundry debtors 4,751 3,967 4,317 4,573 5,537
Cash & Cash Equivalents 2,524 2,252 4,427 4,793 7,403
Ratios Loans & advances 671 710 655 800 851
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 3,091 2,393 2,201 2,930 3,554
Revenue 9.0 (5.1) (1.0) 13.6 23.4 Other current liab. 1,757 1,534 1,572 1,611 1,651
EBITDA (1.5) (7.5) 22.3 20.3 31.9 Provisions 200 288 228 148 163
Adj. EPS (1.2) 10.3 20.3 26.2 40.5 Net current assets 6,955 7,841 9,128 9,878 13,961
Margins (%) Total assets 18,684 20,170 21,264 23,810 27,560
Gross 61.3 61.0 55.3 60.4 61.5
EBITDA 15.2 14.8 18.3 19.4 20.7 Cashflow
EBIT 12.2 11.0 14.5 15.8 17.8 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 7.9 9.1 11.1 12.3 14.0 Profit Before Tax 3,580 3,125 4,127 5,116 7,117
Returns (%) Depreciation & Amortisation 483 848 1,026 1,117 1,134
ROE 15.9 15.6 17.2 19.5 23.5 Net Interest 0 0 0 0 0
ROCE 14.6 14.5 15.8 18.3 22.2 Net Change – WC 86 (1,158) 888 (384) (1,472)
ROIC 14.4 14.7 17.4 21.0 27.0 Direct taxes (1,331) (949) (1,080) (1,280) (1,709)
Turnover (days) Net cash from operations 2,818 1,866 4,961 4,568 5,069
Gross block turnover ratio (x) 1.8 1.5 1.5 1.6 1.8 Capital expenditure (569) (1,333) (885) (2,961) (800)
Debtors 59 52 57 55 53 Acquisitions, net 0 0 0 0 0
Inventory 50 67 49 47 47 Investments 0 (98) 52 50 0
Creditors 45 37 35 37 39 Others 0 0 0 0 0
Net working capital 64 82 71 65 69 Net cash from investing (569) (1,431) (834) (2,912) (800)
Solvency (x) FCF 2,250 435 4,128 1,657 4,269
Net debt-equity (0.1) 0.0 (0.2) (0.2) (0.2) Issue of share capital 0 4 0 0 0
Interest coverage ratio 28.8 21.3 47.5 37.9 66.7 Increase/(decrease) in debt (500) 457 (418) 44 (323)
Net debt/EBITDA (0.3) (0.1) (0.6) (0.6) (0.8) Dividend paid (575) (1,150) (1,908) (1,336) (1,336)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 14.6 16.1 19.4 24.4 34.4 Others 524 (18) 374 0 0
BVPS 99.1 107.8 117.5 133.2 158.7 Net cash from financing (551) (707) (1,952) (1,291) (1,659)
CEPS 20.2 22.9 26.1 31.5 41.5 Net change in Cash 1,699 (272) 2,176 366 2,610
DPS 3.0 6.0 10.0 7.0 7.0 Source: Company, Centrum Broking
Dividend payout (%) 21.0 37.3 51.6 28.6 20.4
Valuation (x)
P/E 80.8 73.3 60.9 48.3 34.4
P/BV 11.9 10.9 10.0 8.9 7.4
EV/EBITDA 41.5 45.0 36.3 30.1 22.4
Dividend yield (%) 0.3 0.5 0.8 0.6 0.6
Source: Company, Centrum Broking

Centrum Institutional Research 105


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Orient Cement (ORCMNT)


For ORCMNT, the initial years post demerger were challenging, as cash flows stayed Market data
volatile. Following the 3mtpa capacity addition in Karnataka, free cash flows were Current price: Rs161
impacted briefly, but improved in the second half of the decade. Inventory days Bloomberg: ORCMNT IN
increased due to the Karnataka capacity addition, as fuel is sourced from multiple 52-week H/L: Rs174/56
sources including imports (its Devapur, Telangana facility enjoys the advantage of
Market cap: Rs33.1bn
locational proximity to fuel sources). Also, shift towards the non-trade segment
(focus on infrastructure segment in Maharashtra) impacted receivable days. As a Free float: 57.2%
result, the working capital cycle has weakened. Lower capex and better profitability Avg. daily vol. 3mth: 1,150,738
have helped improve free cash flows in the recent past. Source: Bloomberg

Volatile cash flows from operations: Being a relatively new company formed from demerger, there have been disturbances
in operations, though operating profits have started to stabilize, with growth since FY16. However, operating cash flows
remain volatile, as operational efficiencies are still developing. Working capital volatility has reduced since FY18.
Exhibit 289: Cash flows from operations remain volatile

6
5
4
3
Rs bn

2
1
-
-1
-2 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital (NWC) days started off moderately. An unsustainable surge in
creditors during FY16-18 led to a temporary improvement, post which NWC days have increased until FY20. Higher inventory
(maintaining fuel stocks at Karnataka) and debtors (more non-trade sales to boost volumes) continue to impact NWC. Except
for the surge in the mid period, payable days have remained consistent.
Exhibit 290: Demerger and Karnataka expansion increased working capital requirement
60
50
In days of revenue

40
30
20
10
0
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-10
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Orient Cement (ORCMNT) 16 September 2021

Exhibit 291: OCF/PAT Exhibit 292: OCF/EBITDA

1000% 180%
160%
800% 140%
120%
600%
100%
80%
400%
60%
200% 40%
20%
0% 0%
FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Initial capex impacted FCF: Post demerger, ORCMNT implemented a 3mtpa expansion at Gulbarga (Karnataka). However,
since FY17, capacity has been capped at 8mtpa and expansions have been slow. ORCMNT has a presence mainly in the South
and in Maharashtra. Its initial capex towards the 3mtpa expansion in Karnataka impacted FCF, and lacking accumulated cash
to fund the expansion, ORCMNT had to take debt. Effectively, against cumulative OCF of Rs178bn, net debt raising of Rs18bn,
and additional equity of Rs24bn over FY13-21, ORCMNT incurred a capex of Rs131bn.
Exhibit 293: Capex intensity and free cash flows
10

-
Rs bn

-5

-10 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
3mtpa expansion at
-15 Gulbarga, Karnataka
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 294: Asset turn improving in the recent past


FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.9 1.0 0.8 0.6 0.7 0.8 0.9 0.9 0.8
Source: Company, Centrum Broking

Exhibit 295: Free cash flow shows mixed trend


Rs bn FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF 2.9 -2.7 -7.4 -1.5 1.6 0.0 0.5 1.3 4.1
Equity raised 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Increase / (decrease) in debt 0.0 3.0 7.8 2.0 -0.6 -0.3 -0.3 -0.9 -3.2
Source: Company, Centrum Broking

Debt-funded capex results in higher leverage: Post demerger, accumulated cash was limited. Hence, ORCMT took debt to
fund the capex, which led its Net Debt/Equity to above 1x and Net Debt/EBITDA to over 3x, on an average.
Exhibit 296: Capex was debt-funded, leading to higher leverage
Leverage ratios (x) FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.0 0.4 1.1 1.3 1.2 1.2 1.1 1.0 0.7
Net Debt/EBITDA 0.0 1.4 3.6 7.2 6.8 4.0 3.9 2.9 1.7
Source: Company, Centrum Broking

Debt-aided capex impacts profitability: ORCMNT began the decade with strong return ratios, which were impacted by the
debt-funded capacity expansion. The fall in its return ratios indicates that ORCMNT has not utilized its additional capacity
efficiently. Marginal improvement is seen towards the end of the decade, indicating positive signs for the medium term.
Exhibit 297: Profitability lost its way in mid-decade as new capacity kicked in; has reversed in the recent past
Return Ratios (%) FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 19.8 12.7 21.6 6.3 -3.2 4.4 4.6 8.0 13.2
RoCE 21.4 10.8 12.9 4.9 1.4 5.4 5.4 7.2 12.6
Source: Company, Centrum Broking

Centrum Institutional Research 107


Orient Cement (ORCMNT) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 26,680 25,925 25,652 28,131 31,278 Equity share capital 205 205 205 205 205
Operating Expense 20,642 18,956 17,264 19,149 21,388 Reserves & surplus 10,330 10,979 12,854 15,106 17,681
Employee cost 1,548 1,549 1,525 1,641 1,709 Shareholders fund 10,535 11,184 13,059 15,311 17,886
Others 1,419 1,617 1,373 1,414 1,520 Minority Interest 0 0 0 0 0
EBITDA 3,120 3,829 5,507 5,997 6,734 Total debt 12,308 11,370 7,838 6,038 8,118
Depreciation & Amortisation 1,327 1,409 1,419 1,423 1,558 Non Current Liabilities 0 0 0 0 0
EBIT 1,793 2,420 4,088 4,574 5,176 Def tax liab. (net) 961 1,219 1,811 1,838 1,866
Interest expenses 1,185 1,223 936 649 759 Total liabilities 23,804 23,773 22,708 23,188 27,870
Other income 140 177 183 105 109 Gross block 27,319 27,825 28,503 29,542 30,864
PBT 748 1,374 3,336 4,030 4,526 Less: acc. Depreciation (4,546) (5,932) (7,345) (8,768) (10,326)
Taxes 272 508 1,194 1,470 1,644 Net block 22,773 21,893 21,157 20,774 20,538
Effective tax rate (%) 36.4 37.0 35.8 36.5 36.3 Capital WIP 478 668 413 1,000 4,500
PAT 476 866 2,142 2,559 2,882 Net fixed assets 24,023 23,383 22,486 22,718 26,020
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 476 866 2,142 2,559 2,882 Investments 0 0 0 0 0
Extraordinary items 0 0 0 0 0 Inventories 1,860 2,366 1,705 2,929 3,171
Reported PAT 476 866 2,142 2,559 2,882 Sundry debtors 1,795 1,618 1,102 1,927 2,142
Cash & Cash Equivalents 288 360 1,512 550 1,844
Ratios Loans & advances 1,303 1,271 1,315 1,422 1,537
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 1,869 1,764 1,844 2,738 3,170
Revenue 12.7 (2.8) (1.1) 9.7 11.2 Other current liab. 2,825 2,644 2,665 2,704 2,743
EBITDA 2.2 22.7 43.8 8.9 12.3 Provisions 771 818 903 917 931
Adj. EPS 7.5 82.1 147.3 19.5 12.6 Net current assets (220) 390 223 470 1,850
Margins (%) Total assets 23,804 23,773 22,708 23,188 27,870
Gross 88.9 92.3 87.4 86.5 85.9
EBITDA 11.7 14.8 21.5 21.3 21.5 Cashflow
EBIT 6.7 9.3 15.9 16.2 16.5 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 1.8 3.3 8.3 9.1 9.2 Profit Before Tax 748 1,374 3,336 4,030 4,526
Returns (%) Depreciation & Amortisation 1,311 1,386 1,414 1,423 1,558
ROE 4.6 8.0 17.7 18.0 17.4 Net Interest 0 0 0 0 0
ROCE 5.4 7.2 12.6 14.1 14.2 Net Change – WC (147) (537) 1,319 (1,209) (87)
ROIC 4.9 6.5 11.8 13.3 13.5 Direct taxes (166) (250) (602) (1,443) (1,617)
Turnover (days) Net cash from operations 1,745 1,973 5,467 2,800 4,381
Gross block turnover ratio (x) 1.0 0.9 0.9 1.0 1.0 Capital expenditure (1,245) (745) (517) (1,655) (4,860)
Debtors 25 23 17 20 24 Acquisitions, net 0 0 0 0 0
Inventory 25 33 27 30 36 Investments 0 0 0 0 0
Creditors 29 29 47 44 50 Others 0 0 0 0 0
Net working capital 21 27 -3 6 10 Net cash from investing (1,245) (745) (517) (1,655) (4,860)
Solvency (x) FCF 501 1,228 4,950 1,145 (479)
Net debt-equity 1.1 1.0 0.5 0.4 0.4 Issue of share capital 0 0 0 0 0
Interest coverage ratio 2.6 3.1 5.9 9.2 8.9 Increase/(decrease) in debt (321) (938) (3,532) (1,800) 2,080
Net debt/EBITDA 3.9 2.9 1.1 0.9 0.9 Dividend paid (185) (154) (256) (307) (307)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 2.3 4.2 10.5 12.5 14.1 Others (38) (64) (10) 0 0
BVPS 51.4 54.6 63.7 74.7 87.3 Net cash from financing (544) (1,155) (3,798) (2,107) 1,773
CEPS 8.8 11.1 17.4 19.4 21.7 Net change in Cash (43) 72 1,152 (962) 1,293
DPS 0.9 0.8 1.3 1.5 1.5 Source: Company, Centrum Broking
Dividend payout (%) 39.0 17.7 12.0 12.0 10.7
Valuation (x)
P/E 69.5 38.1 15.4 12.9 11.5
P/BV 3.1 3.0 2.5 2.2 1.8
EV/EBITDA 14.4 11.5 7.2 6.4 5.8
Dividend yield (%) 0.6 0.5 0.8 0.9 0.9
Source: Company, Centrum Broking

Centrum Institutional Research 108


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

The Ramco Cements (TRCL)


TRCL’s operating profits have been healthy due to better operating regions and cost Market data
control. However, working capital has been stressed due to conservative inventory Current price: Rs1,033
management, as fuel (coal and pet-coke) is from imported sources. With diversification Bloomberg: TRCL IN
in the eastern region, receivable days were higher, particularly in the latter part (post- 52-week H/L: Rs1,133/688
FY15) of the decade. Healthy operating efficiencies (aided by prudent fuel mix) and
Market cap: Rs243.7bn
presence in relatively better regions helped TRCL’s profitability, leading to better
return ratios and healthy balance sheet. Debt increased towards the end of the decade Free float: 45.7%
to finance the clinkerization expansion at Kurnool and Jayantipuram. Avg. daily vol. 3mth: 505,287
Source: Bloomberg

Stable cash flows from operations: Except for the rough patch of FY14 and FY15 (macroeconomic factors and higher costs a
contributor), operating profits have remained stable throughout the decade, with marginal growth in the second half of
decade, as expanded capacity stabilized and macroeconomic conditions improved. With low volatility in working capital for
most of the decade (except for sudden surge in FY15 due to rise in current liabilities), operating cash flows also moved in
tandem with operating profits.
Exhibit 298: Cash flows from operations have been healthy

20

16

12
Rs bn

-4 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital (NWC) days have remained high throughout the decade, with
high inventory days the key contributor. TRCL has been conservative on inventory management due to reliance on imported
sources. There was some improvement in inventory days towards the end of the decade, leading to marginally lower NWC.
With its entry into the newer eastern region, TRCL’s debtors surged in the mid-decade years and gradually declined towards
the end, supporting the improvement in NWC. Payable days stayed low and range-bound.
Exhibit 299: Higher fuel inventory to maintain production continuity leads to high working capital days
80
70
In days of revenue

60
50
40
30
20
10
0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
The Ramco Cements (TRCL) 16 September 2021
Exhibit 300: OCF/PAT Exhibit 301: OCF/EBITDA
400% 140%
350% 120%
300% 100%
250%
80%
200%
60%
150%
100% 40%
50% 20%
0% 0%
FY13

FY20
FY11

FY12

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Expanded capacity by 7mpta; made no acquisitions during the decade: TRCL expanded its capacity by 7mtpa to 19.1mtpa by
FY20. While it raised debt for its recent capex, it partially repaid outstanding debt during FY15-18, when capex requirement
was lower. TRCL has not made any acquisitions during the decade. Against cumulative OCF of Rs72bn and gross debt raising
of Rs21bn, TRCL has incurred capex of Rs63bn. Debt was added towards the end of the decade for the clinkerization
expansion at Kurnool and Jayantipuram.
Exhibit 302: Capex intensity and free cash flows
Expansions at Expansions at Vishakapatnam and Kolaghat
20 Ariyalur and Salem

10

-
Rs bn

-10

-20 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-30 CFO Capex Acquisitions and Investments Net FCF


Source: Company, Centrum Broking

Exhibit 303: Asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.5 0.6 0.6 0.5 0.5 0.5 0.6 0.6 0.7 0.6 0.5
Source: Company, Centrum Broking

Exhibit 304: FCF impacted in the capex period


Rs bn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF -1.8 1.7 1.2 -1.3 3.7 6.6 6.7 3.3 -2.8 -9.9 -3.6
Equity raised -0.1 0.3 0.0 0.0 0.0 0.0 0.0 -0.1 0.1 0.0 0.0
Increase / (decrease) in debt 2.2 -0.8 -0.4 2.6 -7.2 -5.2 -5.4 -1.4 4.2 12.2 4.7
Source: Company, Centrum Broking

Leverage ratios under control with minimal debt requirement: Asset turnover has been limited due to weak utilization
rates, as focus has been on profitability (supply > demand). Leverage ratios have been under control due to healthy internal
accruals, leading to minimal debt requirement and ability to repay debt during periods of low capex.
Exhibit 305: Leverage ratios improving
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 1.6 1.3 1.1 1.2 0.8 0.5 0.3 0.2 0.3 0.5 0.5
Net Debt/EBITDA 4.5 2.9 2.7 5.6 3.2 1.5 0.9 0.8 1.3 2.3 1.9
Source: Company, Centrum Broking

Stable and strong return ratios: Return ratios have been stable and strong except in FY14 and FY15. One factor that has
contributed to the stable return ratios is staggered capex. When there was a surge in capex in FY19, return ratios were
impacted. Low capacity utilization could be a cause for concern.
Exhibit 306: Return ratios a mixed bag
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 13.0 20.5 18.3 5.7 9.4 18.8 19.2 14.4 11.9 12.8 14.4
RoCE 8.9 13.6 13.7 5.8 7.3 14.2 15.2 12.1 9.9 9.7 10.1
Source: Company, Centrum Broking

Centrum Institutional Research 110


The Ramco Cements (TRCL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 51,220 53,435 52,451 60,426 75,748 Equity share capital 236 236 236 236 236
Operating Expense 36,375 37,003 31,394 37,887 48,045 Reserves & surplus 44,365 48,950 56,032 63,562 73,768
Employee cost 3,295 3,682 4,021 4,222 4,518 Shareholders fund 44,600 49,186 56,268 63,798 74,004
Others 1,428 1,633 1,789 1,955 2,131 Minority Interest 0 0 0 0 0
EBITDA 10,123 11,117 15,246 16,362 21,054 Total debt 14,278 26,452 31,132 33,118 32,788
Depreciation & Amortisation 2,985 3,153 3,553 3,831 4,081 Non Current Liabilities 0 (54) (54) 0 0
EBIT 7,137 7,964 11,693 12,531 16,973 Def tax liab. (net) 8,704 9,172 10,877 11,027 11,177
Interest expenses 509 714 876 1,272 1,579 Total liabilities 67,583 84,756 98,222 1,07,943 1,17,969
Other income 527 622 580 474 496 Gross block 86,874 95,490 1,07,676 1,35,758 1,46,911
PBT 7,156 7,872 11,397 11,733 15,891 Less: acc. Depreciation (33,707) (35,979) (38,968) (44,441) (50,271)
Taxes 2,097 1,861 3,786 3,367 4,849 Net block 53,168 59,510 68,708 91,317 96,640
Effective tax rate (%) 29.3 23.6 33.2 28.7 30.5 Capital WIP 8,526 18,553 23,701 8,000 8,500
PAT 5,059 6,011 7,611 8,366 11,041 Net fixed assets 62,284 78,674 93,118 1,00,065 1,05,901
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 5,059 6,011 7,611 8,366 11,041 Investments 1,747 1,834 1,956 1,943 1,993
Extraordinary items 0 0 0 0 0 Inventories 5,597 6,453 5,979 7,450 9,339
Reported PAT 5,059 6,011 7,611 8,366 11,041 Sundry debtors 4,900 5,269 3,752 4,966 6,641
Cash & Cash Equivalents 928 914 1,419 750 873
Ratios Loans & advances 5,625 7,273 7,181 8,716 10,455
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 2,572 3,414 3,634 3,742 4,945
Revenue 16.8 4.3 (1.8) 15.2 25.4 Other current liab. 10,769 12,005 11,227 11,825 11,908
EBITDA (5.8) 9.8 37.1 7.3 28.7 Provisions 157 240 321 380 380
Adj. EPS (7.9) 18.8 26.5 9.8 32.0 Net current assets 3,551 4,249 3,149 5,935 10,075
Margins (%) Total assets 67,583 84,756 98,222 1,07,943 1,17,969
Gross 83.5 83.6 83.5 84.1 83.1
EBITDA 19.8 20.8 29.1 27.1 27.8 Cashflow
EBIT 13.9 14.9 22.3 20.7 22.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 9.9 11.2 14.5 13.8 14.6 Profit Before Tax 7,156 7,872 11,397 11,733 15,891
Returns (%) Depreciation & Amortisation 2,408 2,273 2,989 5,473 5,830
ROE 11.9 12.8 14.4 13.9 16.0 Net Interest 0 0 0 0 0
ROCE 9.9 9.7 10.1 10.1 11.9 Net Change – WC (1,788) (802) 1,574 (3,916) (4,017)
ROIC 8.4 8.3 8.8 8.9 10.7 Direct taxes (989) (1,393) (2,082) (3,217) (4,699)
Turnover (days) Net cash from operations 6,786 7,949 13,878 10,072 13,005
Gross block turnover ratio (x) 0.6 0.6 0.5 0.4 0.5 Capital expenditure (9,962) (18,663) (17,432) (12,420) (11,667)
Debtors 33 35 31 26 28 Acquisitions, net 0 0 0 0 0
Inventory 40 41 43 41 40 Investments (209) (86) (122) 13 (50)
Creditors 26 30 41 36 33 Others 0 0 0 0 0
Net working capital 47 46 33 41 45 Net cash from investing (10,171) (18,749) (17,554) (12,407) (11,717)
Solvency (x) FCF (3,384) (10,800) (3,676) (2,335) 1,289
Net debt-equity 0.3 0.5 0.5 0.5 0.4 Issue of share capital 53 0 0 0 0
Interest coverage ratio 19.9 15.6 17.4 12.9 13.3 Increase/(decrease) in debt 4,162 12,174 4,679 1,986 (330)
Net debt/EBITDA 1.3 2.3 1.9 2.0 1.5 Dividend paid (1,084) (1,526) (679) (320) (835)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 21.5 25.5 32.3 35.5 46.8 Others (12) 138 180 0 0
BVPS 189.3 208.8 238.7 270.4 313.7 Net cash from financing 3,118 10,786 4,181 1,666 (1,165)
CEPS 34.1 38.9 47.4 51.7 64.1 Net change in Cash (266) (14) 505 (668) 123
DPS 3.1 6.6 3.0 3.0 3.0 Source: Company, Centrum Broking
Dividend payout (%) 14.4 26.0 9.3 8.5 6.5
Valuation (x)
P/E 48.1 40.5 32.0 29.1 22.1
P/BV 5.5 4.9 4.3 3.8 3.3
EV/EBITDA 24.0 21.8 17.9 16.9 13.1
Dividend yield (%) 0.3 0.6 0.3 0.3 0.3
Source: Company, Centrum Broking

Centrum Institutional Research 111


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Shree Cement (SRCM)


Over the last decade, SRCM has funded its capacity additions by strong operating Market data
profits and a judicious mix of debt and equity. Against cumulative OCF of Rs178bn, Current price: Rs30,661
net debt raising of Rs18bn, and additional equity of Rs24bn, SRCM has incurred Bloomberg: SRCM IN
capex of Rs131bn. While maintaining high cost pet coke inventory has adversely 52-week H/L: Rs32,050/18,184
affected working capital, this has been compensated by better operating efficiencies.
Market cap: Rs1,106.3bn
SRCM’s debt requirements have been limited, keeping leverage ratios under check.
SRCM started the decade with high return ratios, which declined in the following Free float: 76.7%
years. While return ratios have improved towards the end of the decade, unused Avg. daily vol. 3mth: 52,723
funds raised through equity (QIP) are a dampener. Source: Bloomberg

Strong cash flows from operations: After a stable start in the first half of the decade, operating profits gained good
momentum in the second half, supported by improving macroeconomic conditions. Cash flows followed profits, showing
good strength and consistency throughout the decade. Working capital stayed range-bound, with minimal volatility.
Exhibit 307: Strong cash flows from operations

50
40
30
20
Rs bn

10
-
-10
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital (NWC) days have remained high throughout the decade, except
for FY12, when NWC days turned negative due to sudden hike in payable days. In FY13, payable days declined sharply and
have remained range-bound since. The major contributor to the higher NWC days is high inventory days, as SRCM uses high
cost petcoke as its dominant fuel (~100%), though this is compensated by better operating efficiencies. Debtor days have
remained stable, with minimal contribution to NWC movement.
Exhibit 308: Fuel inventory leads to stress on working capital
80

60
In days of revenue

40

20

0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Shree Cement (SRCM) 16 September 2021
Exhibit 309: OCF/PAT Exhibit 310: OCF/EBITDA
500% 160%
140%
400%
120%
300% 100%
80%
200% 60%
40%
100%
20%
0% 0%
FY13

FY20
FY11

FY12

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Expansions multiply capacity by 4x, impact OCF to FCF conversion: SRCM has expanded its capacity from 10mtpa to 40mtpa
over the decade and has benefited from multi-regional presence. Strong operating cash flows have helped partially fund
these expansions, with the balance funding coming from debt and equity. SRCM’s expansions include the acquisition of a
grinding unit from JP Associates and the acquisition of UAE-based Union Cement. Against cumulative OCF of Rs178bn, net
debt raising of Rs18bn, and additional equity of Rs24bn, SRCM incurred capex of Rs131bn over FY11-21.
Exhibit 311: Capex intensity and free cash flows
60
Acquisition of UAE-
40 based Union Cement

20
Rs bn

-20

-40 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 312: Asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.7 0.9 0.9 0.9 0.8 0.9 0.9 0.8 0.8 0.7 0.7
Source: Company, Centrum Broking

Healthy operational performance leads to minimal debt requirement, negative leverage ratios: Healthy operational
performance has limited the need for debt. Net leverage ratios have remained in the negative range for most of the decade.
Exhibit 313: FCF stays healthy for better part of the decade
Rs bn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF -2.0 11.5 -0.1 -0.7 4.6 8.5 8.0 -6.0 -4.3 27.5 33.5
Equity raised 0.0 0.0 0.2 -0.2 0.0 0.0 0.0 0.1 0.0 23.8 -0.1
Increase / (decrease) in debt -1.0 0.7 -3.5 0.0 -1.8 -0.4 7.4 22.3 -4.0 -1.9 -11.1
Source: Company, Centrum Broking

Exhibit 314: Healthy balance sheet helps maintain strong leverage ratios
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.2 -0.3 -0.2 -0.1 -0.2 -0.3 -0.3 -0.1 -0.1 -0.4 -0.6
Net Debt/EBITDA 0.4 -0.6 -0.5 -0.5 -0.7 -1.4 -0.9 -0.6 -0.3 -1.5 -2.1
Source: Company, Centrum Broking

Volatile profitability despite stable operational performance: SRCM started the decade with high return ratios, which
declined in the following years, led by higher depreciation provisions. Return ratios have recovered towards the end of the
decade on the back of better efficiencies and new regional capacities. With improving capacity utilization, return ratios
should remain healthy.
Exhibit 315: After a stellar start, profitability lost its momentum, but has begun improving again
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 11.0 21.0 30.4 18.4 8.1 9.5 18.4 16.7 12.2 13.9 16.4
RoCE 7.2 17.1 25.7 15.2 7.0 6.7 15.9 12.7 10.0 11.8 14.4
Source: Company, Centrum Broking

Centrum Institutional Research 113


Shree Cement (SRCM) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 1,14,680 1,16,652 1,23,160 1,45,563 1,70,840 Equity share capital 348 361 361 361 361
Operating Expense 79,470 72,007 75,082 88,639 1,06,045 Reserves & surplus 95,626 1,29,003 1,52,140 1,74,397 2,00,573
Employee cost 6,778 7,310 7,597 8,798 9,184 Shareholders fund 96,046 1,29,441 1,52,583 1,74,758 2,00,935
Others 4,479 3,001 3,538 3,788 4,017 Minority Interest 0 0 0 0 0
EBITDA 23,952 34,334 36,943 44,337 51,594 Total debt 40,689 38,790 27,562 39,878 41,464
Depreciation & Amortisation 13,917 16,994 11,399 11,969 13,455 Non Current Liabilities 0 0 0 0 0
EBIT 10,035 17,340 25,544 32,368 38,138 Def tax liab. (net) (6,126) (7,438) (7,855) (8,702) (9,445)
Interest expenses 2,470 2,865 2,471 2,950 3,524 Total liabilities 1,30,609 1,60,794 1,72,290 2,05,934 2,32,953
Other income 5,030 5,127 7,184 4,656 4,491 Gross block 88,132 99,462 1,08,857 1,22,512 1,32,812
PBT 12,596 19,602 30,257 34,073 39,105 Less: acc. Depreciation (43,608) (60,042) (71,155) (83,124) (96,579)
Taxes 1,304 3,900 7,138 8,759 9,872 Net block 44,523 39,420 37,702 39,388 36,233
Effective tax rate (%) 10.4 19.9 23.6 25.7 25.2 Capital WIP 11,211 13,024 13,448 29,948 46,448
PAT 11,292 15,702 23,119 25,314 29,233 Net fixed assets 55,968 52,810 51,625 69,811 83,172
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 11,292 15,702 23,119 25,314 29,233 Investments 0 0 0 0 0
Extraordinary items (1,581) 0 0 0 0 Inventories 15,891 14,279 14,772 17,581 21,018
Reported PAT 9,711 15,702 23,119 25,314 29,233 Sundry debtors 7,324 8,285 4,859 6,243 7,679
Cash & Cash Equivalents 47,517 90,236 1,12,604 1,15,767 1,24,411
Ratios Loans & advances 19,107 20,332 18,673 20,541 22,595
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 4,508 5,280 7,858 7,460 8,761
Revenue 19.4 1.7 5.6 18.2 17.4 Other current liab. 10,669 19,841 22,343 25,048 26,161
EBITDA 8.7 43.3 7.6 20.0 16.4 Provisions 20 26 43 (8,500) (9,000)
Adj. EPS (18.4) 34.1 47.2 9.5 15.5 Net current assets 74,641 1,07,984 1,20,664 1,36,123 1,49,781
Margins (%) Total assets 1,30,609 1,60,794 1,72,290 2,05,934 2,32,953
Gross 92.5 93.4 92.9 90.6 90.5
EBITDA 20.9 29.4 30.0 30.5 30.2 Cashflow
EBIT 8.8 14.9 20.7 22.2 22.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 9.8 13.5 18.8 17.4 17.1 Profit Before Tax 11,015 19,602 30,257 34,073 39,105
Returns (%) Depreciation & Amortisation 14,251 16,434 11,113 11,969 13,455
ROE 12.2 13.9 16.4 15.5 15.6 Net Interest 0 0 0 0 0
ROCE 10.0 11.8 14.4 13.9 13.9 Net Change – WC (6,663) 9,377 9,687 (21,854) (6,127)
ROIC 11.7 18.1 30.0 32.1 28.7 Direct taxes (2,300) (5,212) (7,555) (456) (9,502)
Turnover (days) Net cash from operations 16,111 40,201 43,502 23,733 36,932
Gross block turnover ratio (x) 1.3 1.2 1.1 1.2 1.3 Capital expenditure (20,055) (13,277) (9,928) (30,155) (26,816)
Debtors 23 26 14 14 15 Acquisitions, net 0 0 0 0 0
Inventory 51 45 42 41 41 Investments 0 0 0 0 0
Creditors 18 23 26 32 28 Others 0 0 0 0 0
Net working capital 56 47 30 23 28 Net cash from investing (20,055) (13,277) (9,928) (30,155) (26,816)
Solvency (x) FCF (3,944) 26,925 33,574 (6,422) 10,116
Net debt-equity (0.1) (0.4) (0.6) (0.4) (0.4) Issue of share capital 5 23,839 5 (82) 0
Interest coverage ratio 9.7 12.0 15.0 15.0 14.6 Increase/(decrease) in debt (4,042) (1,899) (11,228) 12,317 1,585
Net debt/EBITDA (0.3) (1.5) (2.3) (1.7) (1.6) Dividend paid (2,310) (6,255) 0 (2,649) (3,057)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 324.1 434.7 640.1 700.9 809.4 Others (200) 110 17 0 0
BVPS 2,757.0 3,583.9 4,224.7 4,838.6 5,563.4 Net cash from financing (6,547) 15,795 (11,206) 9,585 (1,472)
CEPS 723.6 905.3 955.7 1,032.3 1,181.9 Net change in Cash (10,491) 42,720 22,368 3,163 8,644
DPS 55.0 143.6 0.0 72.3 72.3 Source: Company, Centrum Broking
Dividend payout (%) 19.7 33.0 0.0 10.3 8.9
Valuation (x)
P/E 94.6 70.5 47.9 43.7 37.9
P/BV 11.1 8.6 7.3 6.3 5.5
EV/EBITDA 45.9 30.7 27.6 23.2 19.8
Dividend yield (%) 0.2 0.5 0.0 0.2 0.2
Source: Company, Centrum Broking

Centrum Institutional Research 114


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Star Cement (STRCEM)


At the beginning of the decade, STRCEM’s higher receivables (share of incentives Market data
from central and state governments) burdened its working capital. This changed with Current price: Rs108
the commissioning of its grinding unit in FY14, steady pick-up in economic activity, Bloomberg: STRCEM IN
and the government settling its dues. STRCEM’s financial performance turned 52-week H/L: Rs120/75
around, with improvement in return ratios and leverage ratios. Its diversification
Market cap: Rs44.5bn
into East India and energy requirements (coal in particular) put some stress on
financials towards the later years. This should improve, however, as coal availability Free float: 26.4%
normalizes and STRCEM receives greater acceptance in the eastern region. Avg. daily vol. 3mth: 899,044
Source: Bloomberg

Improved cash flows from operations: After a weak start to the decade, STRCEM’s operating profits showed healthy growth
in FY14 and FY15, aided by capacity addition, and remained around those levels for the rest of the decade. With working
capital being weak in first half of the decade, operating cash flows too were impacted. With improvement in working capital
from FY17, operating cash flows have improved and stabilized.
Exhibit 316: Cash flows from operations have improved over the decade

4
Rs bn

-2
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-4
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Having begun the decade at very high levels, net working capital (NWC) days have
shown substantial improvement, declining by more than 50% to 51 days by end of the decade. The major contributor to this
improvement has been lower debtor days, while inventory days stayed high and range-bound with temporary improvement
in the mid-period. Payable days contributed the least and stayed low.
Exhibit 317: Working capital requirement eased after incentive clearances by the government
120

100
In days of revenue

80

60

40

20

0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Receivable Inventory Payable NWC


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Star Cement (STRCEM) 16 September 2021

Exhibit 318: OCF/PAT Exhibit 319: OCF/EBITDA


3000% 200%
2500% 150%
100%
2000%
50%
1500%
0%
1000% -50%
500% -100%
0% -150%

FY16

FY20
FY11

FY12

FY13

FY14

FY15

FY17

FY18

FY19

FY21
FY21
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20
-500%

Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady FCF except for the capex years at the beginning of the decade: The 1.8mtpa capacity addition at Guwahati
commissioned in FY14 was the only expansion carried out in the decade. Though FCF was temporarily impacted at start of
decade owing to capex, it improved later along with operating profits. STRCEM had to resort to debt, which it repaid, as the
capacity addition and its strength in the NE region boosted profits and cash flows. Against cumulative OCF of Rs23bn and
gross debt raising of Rs9bn over the decade, STRCEM incurred capex of Rs18bn and repaid its entire debt.
Exhibit 320: Capex intensity and free cash flows
10 1.8mtpa expansion at
Guwahati (Assam)
5
Rs bn

-5

-10
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 321: Asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.6 0.5 0.3 0.5 0.7 0.7 0.6 0.6 0.8 0.8 0.7
Source: Company, Centrum Broking

Temporary leverage requirement: Elevated leverage ratios at the beginning of decade were due to debt-funded capex. As
the capex began paying off and STRCEM repaid its debt, leverage ratios began improving and turned negative.
Exhibit 322: FCF healthy over the latter half of the decade
Rs bn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF -2.4 -3.2 -4.3 -0.6 1.3 -0.5 2.2 3.6 6.0 2.8 0.0
Equity raised 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7
Increase / (decrease) in debt 2.0 3.2 2.1 0.6 -0.8 0.6 -1.4 -3.7 -3.6 -0.6 0.0
Source: Company, Centrum Broking

Exhibit 323: Debt-free status boosts leverage ratios


Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.6 1.0 1.0 1.1 0.9 0.8 0.6 0.3 -0.1 -0.1 -0.2
Net Debt/EBITDA 2.4 4.6 7.4 4.1 2.0 2.3 1.9 0.8 -0.3 -0.7 -1.4
Source: Company, Centrum Broking

Healthy profitability maintained with limited capacity: STRCEM’s profitability was temporarily impacted during the capex
period. As the capex began paying off, and improved efficiencies and its regional strengths began reflecting in profits, return
ratios improved.
Exhibit 324: After being impacted by capex at the beginning of the decade, profitability has improved
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 25.0 16.1 5.5 -0.4 12.8 13.0 16.9 24.1 18.7 15.9 12.8
RoCE 16.8 10.3 4.8 4.3 11.5 11.7 14.4 20.4 16.6 15.5 12.8
Source: Company, Centrum Broking

Centrum Institutional Research 116


Star Cement (STRCEM) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 18,256 18,407 17,199 20,781 24,991 Equity share capital 419 412 412 404 404
Operating Expense 12,376 12,960 12,293 14,395 17,291 Reserves & surplus 16,817 18,159 20,329 22,051 26,027
Employee cost 1,164 1,266 1,313 1,532 1,586 Shareholders fund 17,237 18,571 20,742 22,455 26,432
Others 278 262 267 279 297 Minority Interest 683 701 0 0 0
EBITDA 4,492 3,951 3,326 4,575 5,818 Total debt 738 134 148 177 195
Depreciation & Amortisation 1,056 930 900 928 999 Non Current Liabilities 0 0 0 0 0
EBIT 3,435 3,021 2,426 3,647 4,819 Def tax liab. (net) 0 0 0 0 0
Interest expenses 144 93 70 48 57 Total liabilities 18,658 19,405 20,889 22,632 26,626
Other income 55 287 282 345 205 Gross block 10,955 11,619 15,289 15,580 16,771
PBT 3,346 3,215 2,638 3,944 4,967 Less: acc. Depreciation (3,738) (4,694) (5,594) (6,522) (7,520)
Taxes 296 342 121 454 571 Net block 7,217 6,925 9,695 9,058 9,250
Effective tax rate (%) 8.9 10.6 4.6 11.5 11.5 Capital WIP 743 2,404 420 1,504 4,504
PAT 3,050 2,873 2,517 3,491 4,396 Net fixed assets 7,966 9,337 10,124 10,574 13,768
Minority/Associates (62) (18) 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 2,988 2,855 2,517 3,491 4,396 Investments 17 16 16 16 16
Extraordinary items 0 0 (646) 0 0 Inventories 2,772 2,569 2,347 2,647 3,184
Reported PAT 2,988 2,855 1,871 3,491 4,396 Sundry debtors 1,438 1,222 1,317 1,651 1,986
Cash & Cash Equivalents 2,113 2,820 4,888 3,715 3,504
Ratios Loans & advances 5,952 4,725 3,818 5,579 5,766
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 1,254 958 1,415 1,554 1,839
Revenue 13.6 0.8 (6.6) 20.8 20.3 Other current liab. 2,992 3,131 3,218 3,310 3,404
EBITDA (13.8) (12.0) (15.8) 37.5 27.2 Provisions 65 88 99 109 120
Adj. EPS (9.6) (4.4) (11.9) 38.7 25.9 Net current assets 7,964 7,159 7,637 8,619 9,077
Margins (%) Total assets 18,658 19,405 20,889 22,632 26,626
Gross 76.4 78.3 76.6 79.7 80.3
EBITDA 24.5 21.4 19.3 22.0 23.3 Cashflow
EBIT 18.8 16.4 14.1 17.5 19.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 16.3 15.5 14.6 16.8 17.6 Profit Before Tax 3,346 3,215 1,993 3,944 4,967
Returns (%) Depreciation & Amortisation 1,029 956 900 928 999
ROE 18.7 15.9 12.8 16.2 18.0 Net Interest 0 0 0 0 0
ROCE 16.6 15.5 12.8 16.2 18.1 Net Change – WC 3,112 1,511 1,590 (2,155) (668)
ROIC 17.4 16.3 14.2 18.5 20.3 Direct taxes (678) (525) (340) (765) (914)
Turnover (days) Net cash from operations 6,809 5,157 4,142 1,952 4,384
Gross block turnover ratio (x) 1.7 1.6 1.1 1.3 1.5 Capital expenditure (790) (2,327) (1,687) (1,378) (4,193)
Debtors 29 26 27 26 27 Acquisitions, net 0 0 0 0 0
Inventory 57 53 52 44 43 Investments (3) 1 0 0 0
Creditors 46 31 35 38 36 Others 0 0 0 0 0
Net working capital 40 48 43 32 34 Net cash from investing (793) (2,325) (1,687) (1,378) (4,193)
Solvency (x) FCF 6,016 2,832 2,456 575 191
Net debt-equity (0.1) (0.1) (0.2) (0.2) (0.1) Issue of share capital 2 (4) 718 (8) 0
Interest coverage ratio 31.2 42.3 47.6 95.0 102.8 Increase/(decrease) in debt (3,586) (605) 14 30 18
Net debt/EBITDA (0.3) (0.7) (1.4) (0.8) (0.6) Dividend paid (516) (497) (419) (419) (419)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 7.1 6.8 6.0 8.3 10.5 Others 0 (1,020) (701) (1,350) 0
BVPS 41.1 44.3 49.5 53.6 63.0 Net cash from financing (4,100) (2,125) (388) (1,748) (402)
CEPS 9.6 9.0 8.2 10.5 12.9 Net change in Cash 1,916 707 2,068 (1,173) (211)
DPS 1.0 1.0 1.0 1.0 1.0 Source: Company, Centrum Broking
Dividend payout (%) 14.0 14.4 22.4 12.0 9.5
Valuation (x)
P/E 15.1 15.8 18.0 12.9 10.3
P/BV 2.6 2.4 2.2 2.0 1.7
EV/EBITDA 9.6 10.6 11.9 8.9 7.1
Dividend yield (%) 0.9 0.9 0.9 0.9 0.9
Source: Company, Centrum Broking

Centrum Institutional Research 117


16 September 2021

Institutional Research
Milind Raginwar
Research Analyst, Cement
+91 22 4215 9201
[email protected]
SECTOR: CEMENT & BUILDING MATERIALS

Ultratech Cement (UTCEM)


Despite UTCEM’s aggressive expansions (both organic and inorganic), the impact on Market data
its cash flows has been manageable. In the initial years of the decade, investments Current price: Rs7,765
were more towards organic growth. In the second half of the decade, it acquired Bloomberg: UTCEM IN
cement assets from Binani and Century, leading to stress on FCF. As the acquired 52-week H/L: Rs8,073/3,754
assets began to contribute to earnings, cash flows improved. There has been no
Market cap: Rs2,241.5bn
major impact on the balance sheet – there has been no equity infusion and
Debt/EBITDA did not cross 3x during the expansion period. Though return ratios Free float: 37.6%
were impacted, the recent years indicate an improvement. Avg. daily vol. 3mth: 350,215
Source: Bloomberg

Acquisitions impacted cash flows in the second half of the decade: Operating profits and cash flows have grown steadily
over the last 10 years (except for FY14 and FY15), in tandem with ongoing capacity expansions. However, the acquisition of
cement assets from Binani and Century impacted cash flows in FY18 and FY19.
Exhibit 325: Cash flows from operations have improved over the decade

200

150

100
Rs bn

50

-
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50
Operating profit Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Conservative inventory management approach impacted UTCEM’s net working
capital (NWC) cycle, which doubled in the second half of the decade, as expansions gained pace and acquisitions kicked off.
While receivable days have been stable through the decade, payable days have been lower in the second half of the decade.
In the last two years, there has been an improvement in the NWC cycle.
Exhibit 326: Working capital stress easing towards the end of the decade
70
60
In days of revenue

50
40
30
20
10
0
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Receivable Inventory Payable NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Ultratech Cement (UTCEM) 16 September 2021

Exhibit 327: OCF/PAT Exhibit 328: OCF/EBITDA


300%
140%
250% 120%
200% 100%
80%
150%
60%
100%
40%
50% 20%
0% 0%

FY16
FY11

FY12

FY13

FY14

FY15

FY17

FY18

FY19

FY20

FY21
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Ongoing capacity expansions, three acquisitions result in negative free cash: Continuous expansions along with three
acquisitions (Jaypee, Binani and Century) during FY17-19 led UTCEM’s capacity to more than double from 52mtpa at the start
of FY11 to 116.75mtpa in FY20. UTCEM has announced further expansion plans in FY21 to reach 136.25mtpa (by FY23/24).
Ongoing capex impacted FCF (negative on average during the decade). Effectively, against OCF of Rs386bn and borrowings of
Rs167bn during the decade, UTCEM incurred Rs570bn on capex and Rs41bn on acquisitions.
Exhibit 329: Capex intensity and free cash flows
200 Acquisition of Acquisition of
Binani Assets Century Assets
100
Rs bn

-100

-200
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisitions and Investments Net FCF
Source: Company, Centrum Broking

Exhibit 330: Asset turn


FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.9 0.8 0.8 0.7 0.7 0.7 0.6 0.6 0.6 0.6 0.6
Source: Company, Centrum Broking

Exhibit 331: Capex intense years impact FCF


Rs bn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net FCF -80.1 3.3 1.8 8.9 -31.1 22.9 53.5 -132.8 -110.6 38.5 69.6
Equity raised 1.5 0.0 0.0 0.0 0.0 -0.1 0.0 0.0 0.0 0.1 0.0
Increase / (decrease) in debt 25.4 0.1 12.6 -2.1 22.1 2.5 -24.1 113.2 40.7 -23.6 -21.3
Source: Company, Centrum Broking

Leverage in control as cash flows take care of major capex requirement (no equity raised): UTCEM maintained its net debt
free status initially. However, Net Debt/Equity reached 0.5x. Debt raising peaked in FY18. In the last two years, UTCEM repaid
some debt with the help of internal cash flows.
Exhibit 332: Well-managed leverage ratios despite continuing on expansionary path
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.0 0.0 0.0 0.0 0.1 0.1 -0.1 0.5 0.5 0.3 0.1
Net Debt/EBITDA 0.2 0.1 0.1 0.0 0.7 0.3 -0.6 2.0 2.5 1.5 0.5
Source: Company, Centrum Broking

Return ratios under pressure due to rapid expansions/acquisitions: Return ratios were healthy initially. However, with
expansions/acquisitions, return ratios were impacted. As new capacities stabilize and are utilized efficiently, UTCEM should
be able to improve its return ratios.
Exhibit 333: Fresh expansions and acquisitions impact profitability
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 18.4 20.8 18.9 12.7 10.5 12.0 11.2 9.9 8.6 10.2 13.5
RoCE 17.5 20.5 19.5 9.6 8.3 8.9 9.0 8.4 7.4 8.6 11.2
Source: Company, Centrum Broking

Centrum Institutional Research 119


Ultratech Cement (UTCEM) 16 September 2021
P&L Balance sheet
YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 3,92,339 4,00,333 4,31,883 5,16,008 5,91,841 Equity share capital 2,746 2,886 2,886 2,886 2,886
Operating Expense 2,70,330 2,56,612 2,77,369 3,19,822 3,64,527 Reserves & surplus 3,30,227 3,80,077 4,30,640 4,87,141 5,57,638
Employee cost 21,583 23,362 21,820 27,497 31,560 Shareholders fund 3,32,974 3,82,963 4,33,526 4,90,028 5,60,525
Others 37,282 39,995 23,046 42,723 46,985 Minority Interest 0 0 0 0 0
EBITDA 70,790 86,523 1,15,515 1,31,894 1,54,786 Total debt 2,06,431 1,82,874 1,61,577 1,57,353 1,36,584
Depreciation & Amortisation 23,212 24,549 24,344 27,950 28,436 Non Current Liabilities 0 0 0 0 0
EBIT 47,578 61,974 91,172 1,03,944 1,26,350 Def tax liab. (net) 52,465 40,769 52,191 55,341 58,491
Interest expenses 16,484 17,042 12,591 10,716 9,856 Total liabilities 5,91,869 6,06,606 6,47,294 7,02,722 7,55,600
Other income 3,213 5,873 4,097 4,026 3,959 Gross block 5,05,836 5,29,586 5,50,731 5,85,216 6,63,736
PBT 36,063 52,197 80,601 98,285 1,21,516 Less: acc. Depreciation (63,756) (86,327) (1,10,670) (1,38,620) (1,67,056)
Taxes 10,799 15,675 25,540 31,653 40,212 Net block 4,42,080 4,43,260 4,40,061 4,46,596 4,96,681
Effective tax rate (%) 29.9 30.0 31.7 32.2 33.1 Capital WIP 11,062 8,600 5,084 40,500 13,000
PAT 25,263 36,522 55,061 66,632 81,303 Net fixed assets 4,77,476 4,76,454 4,69,939 5,12,390 5,35,724
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 25,263 36,522 55,061 66,632 81,303 Investments 50,788 51,297 1,07,794 51,235 51,235
Extraordinary items 0 0 0 0 0 Inventories 37,875 38,339 37,221 45,884 54,249
Reported PAT 25,263 36,522 55,061 66,632 81,303 Sundry debtors 23,532 18,483 22,860 28,726 34,570
Cash & Cash Equivalents 26,974 53,009 80,371 87,210 98,324
Ratios Loans & advances 76,065 80,589 79,679 98,774 1,08,499
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 63,799 62,399 61,828 71,627 77,719
Revenue 33.6 2.0 7.9 19.5 14.7
Other current liab. 29,794 41,687 80,969 41,789 40,869
EBITDA 20.3 22.2 33.5 14.2 17.4 Provisions 7,247 7,476 7,771 8,083 8,412
Adj. EPS 2.7 37.6 50.8 21.0 22.0 Net current assets 63,606 78,856 69,562 1,39,097 1,68,641
Margins (%) Total assets 5,91,869 6,06,606 6,47,294 7,02,722 7,55,600
Gross 84.9 84.4 83.9 85.5 85.7
EBITDA 17.7 21.3 26.4 25.3 25.9 Cashflow
EBIT 11.9 15.2 20.8 19.9 21.1 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 6.3 9.0 12.6 12.8 13.6 Profit Before Tax 34,924 52,197 78,961 98,285 1,21,516
Returns (%) Depreciation & Amortisation 22,311 22,571 24,344 27,950 28,436
ROE 8.6 10.2 13.5 14.4 15.5 Net Interest 0 0 0 0 0
ROCE 7.4 8.6 11.2 11.8 13.0 Net Change – WC (31,392) 10,784 36,070 (62,109) (18,430)
ROIC 7.4 8.5 13.0 13.8 14.4 Direct taxes 9,925 (27,372) (13,530) (29,090) (37,062)
Turnover (days) Net cash from operations 35,768 58,180 1,25,844 35,036 94,459
Gross block turnover ratio (x) 0.8 0.8 0.8 0.9 0.9 Capital expenditure (1,12,940) (21,548) (17,829) (70,401) (51,770)
Debtors 22 17 19 18 17 Acquisitions, net 0 0 0 0 0
Inventory 35 35 33 31 30 Investments (34,387) (508) (56,497) 56,559 0
Creditors 32 40 40 41 42 Others 0 0 0 0 0
Net working capital 26 12 12 8 5 Net cash from investing (1,47,327) (22,056) (74,326) (13,842) (51,770)
Solvency (x) FCF (1,11,559) 36,124 51,518 21,194 42,689
Net debt-equity 0.5 0.3 0.2 0.1 0.1 Issue of share capital 0 0 0 0 0
Interest coverage ratio 4.3 5.1 9.2 12.3 15.7 Increase/(decrease) in debt 40,703 (23,556) (21,297) (4,224) (20,768)
Net debt/EBITDA 2.5 1.5 0.7 0.5 0.2 Dividend paid (6,513) (3,806) (12,495) (10,131) (10,806)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 92.0 126.5 190.8 230.9 281.7 Others 57,122 17,273 9,637 0 0
BVPS 1,212.4 1,326.8 1,502.0 1,697.8 1,942.0 Net cash from financing 91,312 (10,089) (24,155) (14,355) (31,574)
CEPS 176.5 211.6 275.1 327.7 380.2 Net change in Cash (20,248) 26,035 27,363 6,839 11,114
DPS 12.7 10.9 37.0 30.0 32.0 Source: Company, Centrum Broking
Dividend payout (%) 13.8 8.6 19.4 13.0 11.4
Valuation (x)
P/E 84.4 61.4 40.7 33.6 27.6
P/BV 6.4 5.9 5.2 4.6 4.0
EV/EBITDA 34.2 27.4 20.1 17.5 14.7
Dividend yield (%) 0.2 0.1 0.5 0.4 0.2
Source: Company, Centrum Broking

Centrum Institutional Research 120


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Chemicals
+91 22 4215 9001
[email protected]
SECTOR: CHEMICALS

Dhanuka Agritech (DAGRI)


DAGRI’s cash flows have grown steadily over the last decade, despite some years of Market data
cyclicality, driven by vagaries of profitability owing to Indian monsoons. Working Current price: Rs851
capital tends to be a drag on OCF owing to higher inventories and receivables in the Bloomberg: DAGRI IN
system due to the nature of consumers (Indian farming community). Cumulative 52-week H/L: Rs10,54/658
OCFof Rs13.4bn over FY12-21 has been utilized in capex of Rs1.7bn and NIL
Market cap: Rs39.6bn
investments/acquisitions, leaving FCF of Rs9.3bn over the period. Steadily improving
profitability, reflecting in higher cash flows, has reflected in lower leverage (net DER Free float: 26.6%
down to negative 0.3x in FY21 from 0.1x in FY12). Return ratios have also improved Avg. daily vol. 3mth: 112,444
somewhat, owing to gradually rising earnings over FY12-21. Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have been robust and have consistently
expanded over the last 10 years. Working capital intensity in the business has been high. However, the impact of WC on
overall cash flows has reduced marginally in the last two years due to better pricing power, with farmers’ income and hence
paying capabilities improving sharply, reducing payables days for DAGRI.
Exhibit 334: Size and scale of operating cash flows have improved over the last 5-6 years
4,000 Given the nature of final customers (Indian farming community), working capital has been volatile
3,000

2,000
Rsmn

1,000

-1,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-2,000
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally been a drag on the business cash flows, with net
working capital (NWC) significantly influencing cash flows due to the relatively unorganized nature of the end consumer
segment and the need to keep significantly high inventory. This trend has remained consistent, despite a marked change in
the scale of operations.
Exhibit 335: NWC settled at ~150 days after hitting a high of 200 days in FY17
250 250

200 200
# of days

# of days

150 150

100 100

50 50

0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Dhanuka Agritech (DAGRI) 16 September 2021

Exhibit 336: OCF/PAT has been volatile… Exhibit 337: …So has OCF/EBITDA

180% 140%
160% 120%
140%
100%
120%
100% 80%
%

80%

%
60%
60%
40%
40%
20% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of OCF to FCF has been volatile: Conversion of OCF to FCF has been >80% in most years, with limited inorganic
expansion by the company over FY12-21. Since FY16, there has not been any meaningful acquisition or investment in any
subsidiary. Hence, FCF is a direct function of OCF less capex for the period.
Exhibit 338: Capex intensity, acquisitions and free cash flows – FCF mirrors OCF (net of capex) for the most part
3,500 3,000
3,000
2,500
2,500
2,000
2,000
Rsmn

Rsmn
1,500 1,500
1,000
1,000
500
500
0
-500 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0
CFO Capex Acquisition/Investments FCF
Source: Company, Centrum Broking

Return ratios have improved somewhat; leverage remains a non-issue: Sustained improvement in profitability and no
material impact of working capital-related issues has meant that balance sheet has consistently remained free of leverage
over the last decade. RoE/RoCE have also improved by 140bp/370bp over FY12-21.
Exhibit 339: Return ratios and leverage trends
0.4 35.0%

0.2 30.0%
25.0%
0.0
20.0%
-0.2
15.0%
X

-0.4
10.0%
-0.6 5.0%
-0.8 0.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 122


Dhanuka Agritech (DAGRI) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 10,058 11,201 13,875 15,351 17,387 Equity share capital 95 95 93 93 93
Operating Expense 7,033 7,905 9,460 10,523 11,911 Reserves & surplus 6,327 6,982 7,870 10,038 12,487
Employee cost 1,047 1,052 1,183 1,325 1,484 Shareholders fund 6,422 7,077 7,963 10,131 12,580
Others 518 509 541 578 619 Minority Interest 0 0 0 0 0
EBITDA 1,460 1,735 2,691 2,925 3,374 Total debt 222 80 84 450 750
Depreciation & Amortisation 123 164 152 195 251 Non Current Liabilities 153 160 497 497 497
EBIT 1,336 1,571 2,539 2,731 3,123 Def tax liab. (net) 122 53 83 83 83
Interest expenses 9 16 27 21 48 Total liabilities 6,919 7,370 8,626 11,161 13,910
Other income 212 251 337 377 392 Gross block 1,554 1,709 2,355 2,510 3,760
PBT 1,540 1,806 2,849 3,086 3,466 Less: acc. Depreciation (385) (534) (686) (881) (1,131)
Taxes 414 392 744 806 905 Net block 1,169 1,175 1,669 1,630 2,629
Effective tax rate (%) 26.9 21.7 26.1 26.1 26.1 Capital WIP 10 37 76 1,053 1,978
PAT 1,126 1,415 2,106 2,281 2,562 Net fixed assets 1,179 1,211 1,745 2,683 4,607
Minority/Associates 0 0 0 0 0 Non Current Assets 298 418 39 39 39
Recurring PAT 1,126 1,415 2,106 2,281 2,562 Investments 898 991 903 948 996
Extraordinary items 0 0 0 0 0 Inventories 2,068 2,499 2,955 3,365 3,811
Reported PAT 1,126 1,415 2,106 2,281 2,562 Sundry debtors 2,187 2,424 2,427 3,365 3,811
Cash & Cash Equivalents 318 860 1,892 2,540 2,635
Ratios Loans & advances 364 353 443 443 443
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,041 566 907 907 907
Growth (%) Trade payables 775 1,132 1,086 1,531 1,741
Revenue 4.5 11.4 23.9 10.6 13.3 Other current liab. 631 761 1,586 1,586 1,586
EBITDA (12.1) 18.8 55.1 8.7 15.3 Provisions 27 59 12 12 12
Adj. EPS (10.8) 25.7 48.8 8.3 12.3 Net current assets 4,545 4,750 5,939 7,491 8,268
Margins (%) Total assets 6,919 7,370 8,626 11,161 13,910
Gross 38.7 36.5 37.8 37.3 37.0
EBITDA 14.5 15.5 19.4 19.1 19.4 Cashflow
EBIT 13.3 14.0 18.3 17.8 18.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 11.2 12.6 15.2 14.9 14.7 Profit Before Tax 1,540 1,806 2,849 3,086 3,466
Returns (%) Depreciation & Amortisation 123 164 152 195 251
ROE 17.7 21.0 28.0 25.2 22.6 Net Interest (63) (97) (130) (356) (344)
ROCE 17.4 20.7 28.0 24.7 21.7 Net Change – WC (877) 157 169 (903) (683)
ROIC 19.8 22.9 35.5 32.7 27.5 Direct taxes (542) (363) (610) (806) (905)
Turnover (days) Net cash from operations 133 1,621 2,311 1,217 1,786
Gross block turnover ratio (x) 6.5 6.6 5.9 6.1 4.6 Capital expenditure (47) (104) (123) (1,132) (2,175)
Debtors 77 75 64 69 75 Acquisitions, net 0 0 0 0 0
Inventory 122 117 115 120 120 Investments 596 (488) (1,160) (327) (371)
Creditors 48 49 47 50 55 Others 84 149 16 377 392
Net working capital 165 155 156 178 174 Net cash from investing 632 (443) (1,266) (1,082) (2,155)
Solvency (x) FCF 86 1,517 2,188 84 (389)
Net debt-equity 0.0 (0.1) (0.2) (0.2) (0.1) Issue of share capital (825) 0 (1,232) 0 0
Interest coverage ratio 163.5 111.4 99.9 137.1 70.3 Increase/(decrease) in debt 175 (192) (31) 366 300
Net debt/EBITDA (0.1) (0.4) (0.7) (0.7) (0.6) Dividend paid (207) (723) 0 (113) (113)
Per share (Rs) Interest paid (9) (16) (27) (21) (48)
Adjusted EPS 24.2 30.4 45.2 49.0 55.0 Others 0 0 0 0 0
BVPS 137.9 151.9 171.0 217.5 270.1 Net cash from financing (866) (930) (1,291) 232 139
CEPS 26.8 33.9 48.5 53.1 60.4 Net change in Cash (101) 248 (246) 367 (229)
DPS 0.6 12.3 2.0 2.0 2.0 Source: Company, Centrum Broking
Dividend payout (%) 2.5 40.4 4.4 4.1 3.6
Valuation (x)
P/E 35.2 28.0 18.8 17.4 15.5
P/BV 6.2 5.6 5.0 3.9 3.1
EV/EBITDA 27.1 22.4 14.0 12.8 11.2
Dividend yield (%) 0.1 1.4 0.2 0.2 0.2
Source: Company, Centrum Broking

Centrum Institutional Research 123


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Chemicals
+91 22 4215 9001
[email protected]
SECTOR: CHEMICALS

PI Industries (PII)
PII’s cash flows have grown steadily over the last decade, despite relatively lower Market data
profitability in FY17-18 driven by seasonal factors globally and weak agricultural Current price: Rs3,454
environment in India. Working capital impact has been moderate except over FY17- Bloomberg: PI IN
19, when inventory/payables increased due to difficult economic conditions across 52-week H/L: Rs3535/1850
target markets. Cumulative OCF of Rs44bn has been utilized in capex of Rs30bn and
Market cap: Rs524bn
investments/acquisitions of Rs4.5bn, leaving FCF of Rs13.3bn. Steadily improving
profitability, reflecting in higher cash flows, has reflected in lower leverage (Net DER Free float: 50.2%
down to negative 0.4x in FY21 from 0.7x in FY12), but return ratios have moderated Avg. daily vol. 3mth: 408,081
owing to higher investment in the business. Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have been robust and have consistently
expanded over the last 10 years. Working capital intensity in the business has been high, but the impact of WC on overall
cash flows has reduced marginally in the last two years due to better pricing power and inorganic growth.
Exhibit 340: Consistent growth in OCF over the last 10 years
12000
Rapid scale-up of CSM business has improved cash flows; working capital impact far less than
10000 domestic market dependent agriculture companies
8000
6000
Rsmn

4000
2000
0
-2000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-4000 Operating Cash flow before WCAP changes WCAP changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally been a drag on the business cash flows with net
working capital (NWC) being a significant influence on cash flows due to the relatively diversified and widespread nature of
PII’s business, and >25% of business having the Indian farmer as the end consumer.
Exhibit 341: NWC steady at 70-80 days for most years in the last decade
200 140
120
150 100
# of days

80
# days

100
60

50 40
20
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
PI Industries (PII) 16 September 2021

Exhibit 342: OCF/PAT Exhibit 343: OCF/EBITDA

200% 120%

160% 100%

80%
120%
60%
%

%
80%
40%
40% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of OCF to FCF has been volatile: Conversion of OCF to FCF has been uneven, with the ISAGRO acquisition in FY20
being the company’s biggest acquisition during the decade. Barring that year, FCF has steadily improved, with rising
profitability, and hence, higher OCF.
Exhibit 344: Capex intensity, acquisitions and free cash flows
10,000 6,000

4,000
5,000
2,000
Rsmn

Rsmn
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0
-5,000
-2,000
Except in FY20, the year of ISAGRO acquisition, FCF has steadily
grown over the last decade
-10,000 -4,000

CFO Capex Acquisition/Investments FCF

Source: Company, Centrum Broking

Return ratios have improved somewhat; leverage remains a non-issue: The sustained improvement in profitability and no
material impact of working capital-related issues has meant that balance sheet has consistently remained free of leverage
over the last decade. Return ratios have, however, reverted to lower levels owing to higher capex and investments over
FY17-21.
Exhibit 345: Return ratios and leverage trends
2.0 35.0%

30.0%
1.0
25.0%
0.0 20.0%
x

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1.0 15.0%

Leverage has been negligible over the period, but return ratios have taken a hit due to QIP proceeds of 10.0%
-2.0 Rs20bn, which did not get deployed till Q1FY22
5.0%

-3.0 Net Debt/Equity Net Debt/EBITDA ROE ROCE 0.0%

Source: Company, Centrum Broking

Centrum Institutional Research 125


PI Industries (PII) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 28,409 33,665 45,770 52,388 59,477 Equity share capital 138 138 152 152 152
Operating Expense 18,077 21,199 28,788 33,334 37,827 Reserves & surplus 22,716 26,053 53,272 61,064 70,040
Employee cost 2,647 3,209 4,169 4,919 5,657 Shareholders fund 22,854 26,191 53,424 61,216 70,192
Others 1,921 2,079 2,691 3,122 3,496 Minority Interest 0 0 0 0 0
EBITDA 5,764 7,178 10,122 11,013 12,496 Total debt 492 5,174 2,574 2,574 2,574
Depreciation & Amortisation 930 1,367 1,748 1,998 2,313 Non Current Liabilities 190 832 559 621 682
EBIT 4,834 5,811 8,374 9,015 10,184 Def tax liab. (net) 0 102 796 796 796
Interest expenses 50 170 282 164 164 Total liabilities 23,536 32,299 57,353 65,206 74,244
Other income 595 489 1,249 2,275 2,655 Gross block 15,148 22,424 26,286 30,786 35,286
PBT 5,379 6,138 9,385 11,252 12,801 Less: acc. Depreciation (3,007) (4,341) (6,089) (8,087) (10,399)
Taxes 1,277 1,572 2,002 2,651 3,016 Net block 12,141 18,083 20,197 22,699 24,887
Effective tax rate (%) 23.7 25.6 21.3 23.6 23.6 Capital WIP 1,544 2,371 2,495 3,079 3,529
PAT 4,102 4,566 7,383 8,601 9,785 Net fixed assets 13,685 21,282 24,257 27,343 29,981
Minority/Associates 0 0 0 0 0 Non Current Assets 600 493 411 432 453
Recurring PAT 4,102 4,566 7,383 8,601 9,785 Investments 172 179 207 248 298
Extraordinary items 0 0 0 0 0 Inventories 5,357 7,989 10,528 10,047 11,407
Reported PAT 4,102 4,566 7,383 8,601 9,785 Sundry debtors 6,618 6,465 7,035 10,047 11,407
Cash & Cash Equivalents 2,011 2,667 23,274 26,833 31,630
Ratios Loans & advances 104 144 170 177 184
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 2,860 3,029 3,991 3,991 3,991
Growth (%) Trade payables 5,130 5,909 7,960 9,326 10,494
Revenue 24.8 18.5 36.0 14.5 13.5 Other current liab. 2,466 3,492 4,154 4,154 4,154
EBITDA 16.8 24.5 41.0 8.8 13.5 Provisions 416 548 552 578 604
Adj. EPS 11.6 11.3 61.7 16.5 13.8 Net current assets 8,938 10,345 32,332 37,037 43,367
Margins (%) Total assets 23,536 32,299 57,353 65,206 74,244
Gross 45.4 45.1 43.8 43.5 44.0
EBITDA 20.3 21.3 22.1 21.0 21.0 Cashflow
EBIT 17.0 17.3 18.3 17.2 17.1 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 14.4 13.6 16.1 16.4 16.5 Profit Before Tax 5,379 6,138 9,385 11,252 12,801
Returns (%) Depreciation & Amortisation 930 1,367 1,748 1,998 2,313
ROE 19.5 18.6 18.5 15.0 14.9 Net Interest 50 170 282 164 164
ROCE 19.1 17.1 17.3 14.4 14.4 Net Change – WC (1,503) 255 (1,303) (1,105) (1,492)
ROIC 19.2 17.4 21.6 19.9 20.1 Direct taxes (1,183) (1,048) (1,647) (2,651) (3,016)
Turnover (days) Net cash from operations 3,908 6,981 7,249 7,382 8,113
Gross block turnover ratio (x) 1.9 1.5 1.7 1.7 1.7 Capital expenditure (3,677) (11,040) (4,375) (5,084) (4,950)
Debtors 76 71 54 60 66 Acquisitions, net (160) 0 15 (41) (50)
Inventory 116 132 131 127 118 Investments 427 1,014 (20,173) (354) (372)
Creditors 104 109 98 107 109 Others 194 175 230 2,275 2,655
Net working capital 115 112 258 258 266 Net cash from investing (3,216) (9,851) (24,303) (3,204) (2,716)
Solvency (x) FCF 231 (4,059) 2,874 2,298 3,163
Net debt-equity (0.1) 0.1 (0.4) (0.4) (0.4) Issue of share capital 29 80 19,789 0 0
Interest coverage ratio 115.3 42.2 35.9 67.2 76.3 Increase/(decrease) in debt (399) 4,562 (1,786) 0 0
Net debt/EBITDA (0.3) 0.3 (2.0) (2.2) (2.3) Dividend paid (831) (748) (607) (809) (809)
Per share (Rs) Interest paid (50) (179) (244) (164) (164)
Adjusted EPS 27.0 30.0 48.6 56.6 64.4 Others 0 (215) (248) 0 0
BVPS 150.4 172.3 351.5 402.7 461.8 Net cash from financing (1,251) 3,500 16,904 (973) (972)
CEPS 33.1 39.0 60.1 69.7 79.6 Net change in Cash (559) 630 (150) 3,205 4,425
DPS 3.6 3.6 5.0 4.0 4.0 Source: Company, Centrum Broking
Dividend payout (%) 13.5 12.1 10.3 7.1 6.2
Valuation (x)
P/E 128.0 115.0 71.1 61.0 53.7
P/BV 23.0 20.0 9.8 8.6 7.5
EV/EBITDA 90.7 73.4 49.7 45.4 39.6
Dividend yield (%) 0.1 0.1 0.1 0.1 0.1
Source: Company, Centrum Broking

Centrum Institutional Research 126


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Chemicals
+91 22 4215 9001
[email protected]
SECTOR: CHEMICALS

UPL
UPL’s cash flows have grown steadily over the last ten years, helped by its penchant Market data
to keep bolstering profitability via acquisitions (Advanta in 2011 and Arysta in 2019 Current price: Rs754
being the key large buys). Overall, net OCF has steadily grown over FY12-21 (CAGR of Bloomberg: UPLL IN
44%), with cumulative working capital impact negligible. Cumulative OCF of Rs348bn 52-week H/L: Rs865/399
has been utilized for capex of Rs115.3bn and investments/acquisitions of Rs306bn, Market cap: Rs575.9bn
leading to negative FCF of Rs73bn over the period. Despite the lower FCF, improving
Free float: 63%
profitability has ensured that Net DER, which touched a high of 1.5x in FY19 (Arysta
Avg. daily vol. 3mth: 3,311,686
acquisition), dipped back to <1x over FY20-21.
Source: Bloomberg

History of steady improvement in cash flows: Operating profits have been robust and have mostly expanded over the last 10
years. Working capital intensity in the business has been low, except for FY12 and FY20, the years following large acquisitions
(Arysta in FY19). The company has generated strong operating cash flows, though the trend has been a bit inconsistent.
Exhibit 346: Consistent improvement in cash flow from operations
120,000 A history of steady improvement in scale and scope of OCF, topped by a sudden jump aided by
100,000 Arysta acquisition in FY19

80,000

60,000
Rsmn

40,000

20,000

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20,000
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on business cash flows, with net
working capital (NWC) sustaining at an average of 100 days over most of last decade. However, the years following major
acquisitions (FY20; Arysta acquired in FY19) have seen unusual WC movements, which have impacted net OCF.
Exhibit 347: Net working capital has sustained at an average of 100 days over most of the decade
350 200
Impact of Arysta acquistion – NWC has normalized
300 thereafter
250 150
# of days

# of days

200
100
150
100 50
50
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Inventory Trade receivables Trade payables NWC

Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
UPL 16 September 2021

Exhibit 348: OCF/PAT Exhibit 349: OCF/EBITDA


500% 160%
450%
140%
400%
350% 120%
300% 100%
250% 80%
200%
60%
150%
40%
100%
50% 20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been volatile: UPL has followed a mix of organic and inorganic expansion to
augment earnings and increase scale. Its biggest acquisition by far happened only recently in FY19, when UPL acquired Arysta
for USD4.2bn (Rs295bn). Other than that, multiple small acquisitions have kept impacting FCF in limited ways over FY12-21.
Exhibit 350: Capex intensity, acquisitions and free cash flows
200,000 200,000

100,000 100,000
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0
Rsmn

Rsmn
-100,000
-100,000
-200,000
The Arysta acquisition makes the other
-300,000 -200,000
smaller transactions relatively irrelevant!

-400,000 -300,000

CFO Capex Acquisition/Investments FCF


Source: Company, Centrum Broking

Return ratios have moderated somewhat; leverage improving after a spike over FY19-20: The sustained improvement in
profitability and low working capital impact has meant that leverage remained moderate till FY18. The USD4bn Arysta
acquisition, however, caused Net DER to jump to 1.5x in FY19 (0.4x in FY18). While Net DER has dipped to <1x by FY21, return
ratios remain below historical average over the last three years.
Exhibit 351: Return ratios and leverage trends
8.0 Some way to go to make the Arysta acquisition return ratio 30.0%
7.0 accretive – as of now, sharply lower trajectory seen over FY19-21 25.0%
6.0
20.0%
5.0
4.0 15.0%
x

3.0
10.0%
2.0
5.0%
1.0
0.0 0.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Net Debt/Equity Net Debt/EBITDA ROE ROCE


Source: Company, Centrum Broking

Centrum Institutional Research 128


UPL 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 218,370 357,560 386,940 416,242 448,099 Equity share capital 1,020 1,530 1,530 1,530 1,530
Operating Expense 128,900 212,560 218,672 231,995 249,642 Reserves & surplus 146,130 191,290 207,340 240,555 275,303
Employee cost 20,950 33,910 37,120 41,574 46,979 Shareholders fund 147,150 192,820 208,870 242,085 276,833
Others 30,390 43,360 47,628 47,365 51,391 Minority Interest 34,540 33,120 36,930 41,430 45,930
EBITDA 38,130 67,730 83,520 95,308 100,087 Total debt 291,360 287,020 237,740 259,990 224,990
Depreciation & Amortisation 8,800 20,120 21,730 24,097 25,586 Non Current Liabilities 1,360 6,310 11,640 11,640 11,640
EBIT 29,330 47,610 61,790 71,211 74,501 Def tax liab. (net) 21,970 27,770 26,620 26,620 26,620
Interest expenses 9,630 14,810 20,600 17,421 16,974 Total liabilities 496,380 547,040 521,800 581,765 586,013
Other income 2,400 1,040 2,580 2,330 2,392 Gross block 251,850 287,710 311,440 331,140 351,140
PBT 17,730 27,640 41,810 56,121 59,919 Less: acc. Depreciation (89,740) (106,770) (128,500) (152,597) (178,182)
Taxes 1,980 5,860 6,860 10,102 11,984 Net block 162,110 180,940 182,940 178,543 172,958
Effective tax rate (%) 11.2 21.2 16.4 18.0 20.0 Capital WIP 11,660 10,590 8,990 8,990 8,990
PAT 15,750 21,780 34,950 46,019 47,935 Net fixed assets 340,040 373,940 368,820 364,423 358,838
Minority/Associates (840) (4,020) (6,240) (4,500) (4,500) Non Current Assets 8,430 8,880 6,160 6,160 6,160
Recurring PAT 18,916 22,669 30,700 41,519 43,435 Investments 7,060 5,580 5,810 6,391 7,030
Extraordinary items (4,006) (4,909) (1,990) 0 0 Inventories 91,330 78,500 94,220 96,933 104,352
Reported PAT 14,910 17,760 28,710 41,519 43,435 Sundry debtors 116,830 120,570 130,260 136,847 147,320
Cash & Cash Equivalents 28,530 67,520 48,900 89,004 88,756
Ratios Loans & advances 2,070 1,970 2,360 2,360 2,360
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 30,060 27,320 31,120 32,676 34,310
Growth (%) Trade payables 98,470 102,330 125,250 110,279 118,105
Revenue 25.7 63.7 8.2 7.6 7.7 Other current liab. 21,530 36,270 43,000 45,150 47,408
EBITDA 8.8 77.6 23.3 14.1 5.0 Provisions 15,280 15,190 14,260 14,260 14,260
Adj. EPS (8.9) 19.8 35.4 35.2 4.6 Net current assets 133,540 142,090 124,350 188,131 197,325
Margins (%) Total assets 496,380 547,040 521,800 581,765 586,013
Gross 50.1 47.6 50.6 51.6 51.9
EBITDA 17.5 18.9 21.6 22.9 22.3 Cashflow
EBIT 13.4 13.3 16.0 17.1 16.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 8.7 6.3 7.9 10.0 9.7 Profit Before Tax 21,210 33,840 41,810 56,121 59,919
Returns (%) Depreciation & Amortisation 9,690 20,120 21,730 24,097 25,586
ROE 15.8 13.3 15.3 18.4 16.7 Net Interest 8,260 13,950 18,670 15,361 14,853
ROCE 8.9 7.8 10.8 11.7 11.3 Net Change – WC (5,630) 30,500 (2,140) (23,677) (9,442)
ROIC 9.4 8.6 11.9 13.3 13.2 Direct taxes (3,540) (8,190) (7,250) (10,102) (11,984)
Turnover (days) Net cash from operations 23,560 87,390 72,120 61,799 78,931
Gross block turnover ratio (x) 0.9 1.2 1.2 1.3 1.3 Capital expenditure (15,530) (19,350) (20,650) (19,700) (20,000)
Debtors 148 121 118 117 116 Acquisitions, net (309,890) (7,610) (1,540) 0 0
Inventory 229 165 165 173 170 Investments 3,310 540 (280) (581) (639)
Creditors 260 196 217 214 193 Others 2,430 (10) 1,460 2,060 2,122
Net working capital 223 145 117 165 161 Net cash from investing (319,680) (26,430) (21,010) (18,221) (18,517)
Solvency (x) FCF 8,030 68,040 51,470 42,099 58,931
Net debt-equity 1.4 1.0 0.8 0.6 0.4 Issue of share capital 83,580 0 0 0 0
Interest coverage ratio 4.0 4.6 4.1 5.5 5.9 Increase/(decrease) in debt 219,660 (28,700) (42,190) 22,250 (35,000)
Net debt/EBITDA 6.9 3.2 2.3 1.8 1.4 Dividend paid (4,240) (4,570) (4,580) (8,304) (8,687)
Per share (Rs) Interest paid (10,070) (16,460) (16,550) (17,421) (16,974)
Adjusted EPS 24.7 29.6 40.1 54.3 56.8 Others 0 27,980 (3,810) 0 0
BVPS 192.4 252.1 273.0 316.5 361.9 Net cash from financing 288,930 (21,750) (67,130) (3,474) (60,661)
CEPS 36.2 55.9 68.5 85.8 90.2 Net change in Cash (10,810) 38,980 (19,270) 40,104 (248)
DPS 5.3 6.0 10.0 10.9 11.4 Source: Company, Centrum Broking
Dividend payout (%) 27.3 25.8 26.6 20.0 20.0
Valuation (x)
P/E 30.5 25.4 18.8 13.9 13.3
P/BV 3.9 3.0 2.8 2.4 2.1
EV/EBITDA 22.0 11.7 9.2 7.8 7.1
Dividend yield (%) 0.7 0.8 1.3 1.4 1.5
Source: Company, Centrum Broking

Centrum Institutional Research 129


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Asian Paints (APNT)


APNT’s revenue grew at a CAGR of 10.9% over FY12-21 and EBITDA grew faster at Market data
13.8%. Operating profits have been robust and consistently expanded over the Current price: Rs3,342
decade. Since the paint industry operates on direct dealer model, it has efficient Bloomberg: APNT IN
inventory management. Over FY12-21, cumulative profit before WC was Rs300.3bn 52-week H/L: Rs3,395/1,908
(tax paid: Rs78.6bn) and OCF was Rs195.5bn. OCF/PAT was at an average of 103% till
Market cap: Rs3205.7bn
FY21 (FY21: 117%) and OCF/EBITDA was at an average of 66% (FY21: 76%). Cumulative
capex was Rs65.2bn and FCF was Rs130.3bn. Average dividend payout has been Free float: 63.4%
46.9%. Every four years, APNT has invested in capacity expansion. Avg. daily vol. 3mth: 1,235,714
Source: Bloomberg

History of steady improvement in cash flow from operations: Operating profits have been strong and have expanded over
the last 10 years, primarily driven by 450bp expansion in gross margin. Due to unique direct dealer business model, working
capital intensity in the business has been low. APNT focused on cutting system inventory by expanding its tinting machine
network and has ensured sufficient liquidity at all times. The company has been consistently generating healthy operating cash
flows over the years. Over FY12-21, cumulative profit before WC has been Rs300.3bn (of which tax paid: Rs78.6bn) and cash
flow from operating activities has been Rs195.5bn.
Exhibit 352: Cash flows from operations have been strong and have consistently expanded
60

50

40
Rs bn

30

20

10

-10 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital movement: Being the market leader, APNT enjoys bargaining power with both buyers and
suppliers. Its OCF/PAT has improved from 71% in FY12 to 117% in FY21 and OCF/EBITDA has improved from 46% in FY12 to
76% in FY21. This has been driven by 450bp gross margin expansion, despite inventory being in the range of 95-100 days.
OCF/PAT has been at 103% on average till FY21 and OCF/EBITDA at 66% on average till FY21.
Exhibit 353: Cash conversion cycle by-and-large steady over the decade
120 70

100 60
50
80
Days

40
Days

60
30
40
20
20 10
0 -
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Debtor days Inventory days Payable days Cash conversion cycle


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures. 130
Asian Paints (APNT) 16 September 2021

Exhibit 354: OCF/PAT Exhibit 355: OCF/EBITDA


140 100
120
80
100
80 60
%

%
60 40
40
20
20
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Growing free cash flows: Over FY12-21, cumulative cash from operating activities was Rs195.5bn, capex was Rs65.2bn (~21.7%
of net sales) and FCF generated was Rs130.3bn. APNT doubled capacity in Rohtak in 2016 to 400k KL/annum. Further, it added
500k KL/annum at Vizag, investing Rs17.9bn, and 600k KL/annum in Mysuru for Rs23bn. This helped the company to expand
its profitability, as these plants were opened in high growth southern markets, adding to operating leverage.
Exhibit 356: Generated cumulative FCF of over Rs130bn in 10 years
40
FY16: Expansion at Rohtak plant; FY18 and FY19: Capacity addition at
30 modernization at Ankleshwar and Kasna Visakhapatnam and Mysuru

20
Rs bn

10
0
-10
-20 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 357: Return ratios (%)


50

40

30
%

20

10

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE RoCE
Source: Company, Centrum Broking

Healthy return ratios: Overall return ratios have been healthy, as the company has been investing in capacities ahead of market
demand. Major chunk of its cash outflows has been towards dividend payout and some portion has been towards working
capital needs. Over FY12-21, average dividend payout has been 46.9%.
Exhibit 358: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Payout (%) 38.7 41.5 44.9 49.8 43.8 48.8 59.7 48.6 77.0 15.9
Source: Company, Centrum Broking

Exhibit 359: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 6,996 11,868 14,020 11,877 22,430 15,273 21,134 24,695 30,382 36,834
Cash Flow from Investing Activities -3,856 -4,993 -6,052 -4,778 -8,663 -6,561 -15,993 -9,445 -5,214 -5,478
Cash from Financing Activities -3,266 -6,010 -6,259 -5,761 -8,490 -7,564 -13,791 -11,175 -28,715 -6,504
Net increase/ (decrease) in Cash and Cash Equivalents -126 864 1,709 1,338 5,277 1,148 -8,650 4,076 -3,547 24,852
Closing Cash & Cash Equivalent 6,137 7,362 9,264 10,669 15,777 16,675 8,457 12,800 9,287 34,212
Source: Company, Centrum Broking

Centrum Institutional Research 131


Asian Paints (APNT) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 193,415 202,113 217,128 262,330 300,050 Equity share capital 959 959 959 959 959
Operating Expense 113,423 113,835 120,972 145,295 164,722 Reserves & surplus 94,238 100,342 127,104 147,772 171,711
Employee cost 12,700 13,661 15,408 18,353 20,992 Shareholders fund 95,197 101,302 128,063 148,731 172,670
Others 32,046 32,999 32,192 39,579 44,100 Minority Interest 3,631 4,035 4,229 4,679 5,086
EBITDA 35,245 41,618 48,556 59,104 70,236 Total debt 6,160 11,039 10,848 10,202 9,702
Depreciation & Amortisation 4,307 7,805 7,913 8,704 8,948 Non Current Liabilities 1,625 1,883 2,231 2,696 3,083
EBIT 30,939 33,813 40,643 50,399 61,288 Def tax liab. (net) 5,397 4,270 4,013 4,013 4,013
Interest expenses 510 1,023 916 881 823 Total liabilities 112,010 122,529 149,384 170,322 194,555
Other income 2,271 3,043 3,031 4,704 4,671 Gross block 69,241 79,096 80,366 98,312 111,232
PBT 32,699 35,833 42,758 54,222 65,135 Less: acc. Depreciation (13,942) (19,573) (24,807) (33,511) (42,459)
Taxes 10,988 8,549 10,976 13,919 16,720 Net block 55,299 59,523 55,559 64,801 68,773
Effective tax rate (%) 33.6 23.9 25.7 25.7 25.7 Capital WIP 2,097 1,402 1,830 1,830 1,830
PAT 21,711 27,284 31,782 40,303 48,414 Net fixed assets 60,609 64,126 60,415 69,657 73,629
Minority/Associates (116) (262) (347) (451) (407) Non Current Assets 5,432 6,389 8,176 9,878 11,298
Recurring PAT 21,595 27,023 31,434 39,852 48,008 Investments 13,952 15,064 14,697 14,697 14,697
Extraordinary items 0 534 0 0 0 Inventories 31,499 33,898 37,986 45,535 51,671
Reported PAT 21,595 27,556 31,434 39,852 48,008 Sundry debtors 19,073 17,952 26,022 31,259 35,548
Cash & Cash Equivalents 16,194 12,953 38,779 43,984 59,236
Ratios Loans & advances 5,416 8,003 11,972 14,465 16,545
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 4,159 2,995 5,507 6,654 7,610
Growth (%) Trade payables 23,943 21,366 33,787 41,180 47,513
Revenue 15.0 4.5 7.4 20.8 14.4 Other current liab. 19,618 16,860 19,538 23,606 27,000
EBITDA 10.2 18.1 16.7 21.7 18.8 Provisions 762 625 844 1,020 1,167
Adj. EPS 9.7 25.1 16.3 26.8 20.5 Net current assets 32,017 36,951 66,096 76,091 94,932
Margins (%) Total assets 112,010 122,529 149,384 170,322 194,555
Gross 41.4 43.7 44.3 44.6 45.1
EBITDA 18.2 20.6 22.4 22.5 23.4 Cashflow
EBIT 16.0 16.7 18.7 19.2 20.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 11.2 13.4 14.5 15.2 16.0 Profit Before Tax 33,107 36,283 43,044 54,222 65,135
Returns (%) Depreciation & Amortisation 4,307 7,819 7,913 8,704 8,948
ROE 24.1 27.5 27.4 28.8 29.9 Net Interest (282) 96 165 (3,823) (3,847)
ROCE 22.3 25.4 25.0 26.7 27.9 Net Change – WC (4,274) (7,371) (2,065) (6,026) (4,622)
ROIC 28.9 31.6 33.9 38.5 41.7 Direct taxes (9,820) (10,108) (10,797) (13,919) (16,720)
Turnover (days) Net cash from operations 22,143 26,319 36,834 39,158 48,894
Gross block turnover ratio (x) 2.8 2.6 2.7 2.7 2.7 Capital expenditure (11,336) (3,669) (2,543) (17,946) (12,920)
Debtors 34 33 37 40 41 Acquisitions, net 0 0 0 0 0
Inventory 93 105 108 105 108 Investments 1,304 (2,368) (3,679) 0 0
Creditors 73 73 83 94 98 Others 795 823 743 4,704 4,671
Net working capital 60 67 111 106 115 Net cash from investing (9,237) (5,214) (5,478) (13,242) (8,250)
Solvency (x) FCF 12,906 21,105 31,356 25,916 40,644
Net debt-equity (0.1) 0.0 (0.2) (0.2) (0.3) Issue of share capital 0 0 0 0 0
Interest coverage ratio 69.1 40.7 53.0 67.1 85.3 Increase/(decrease) in debt 2,170 (582) 1,412 (645) (500)
Net debt/EBITDA (0.3) 0.0 (0.6) (0.6) (0.7) Dividend paid (10,487) (21,207) (4,994) (19,184) (24,069)
Per share (Rs) Interest paid (512) (2,800) (2,923) (881) (823)
Adjusted EPS 22.5 28.2 32.8 41.5 50.0 Others 0 (63) 0 0 0
BVPS 99.2 105.6 133.5 155.1 180.0 Net cash from financing (8,830) (24,652) (6,504) (20,711) (25,392)
CEPS 27.0 36.3 41.0 50.6 59.4 Net change in Cash 4,076 (3,547) 24,852 5,206 15,252
DPS 10.9 22.1 5.2 20.0 25.1 Source: Company, Centrum Broking
Dividend payout (%) 48.6 77.0 15.9 48.1 50.1
Valuation (x)
P/E 148.5 118.6 102.0 80.4 66.8
P/BV 33.7 31.6 25.0 21.6 18.6
EV/EBITDA 90.5 76.7 65.4 53.7 44.9
Dividend yield (%) 0.3 0.7 0.2 0.6 0.3
Source: Company, Centrum Broking

Centrum Institutional Research 132


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Bajaj Consumer Care


Bajaj Consumer’s revenue grew at a CAGR of 9.7% over the last decade while Market data
operating profits expanded at 11%. Despite the Nomarks acquisition in FY14 for Current price: Rs256
Rs1.5bn, over FY12-21, cumulative profit before WC has been Rs22.2bn (tax paid: Bloomberg: BAJAJCON IN
Rs4.8bn) and cash flow from operating activities has been Rs17.2bn, driven by gross 52-week H/L: Rs324/168
margin expansion of 730bp. OCF/PAT has been at 85% on an average till FY21 (FY21:
Market cap: Rs37.7bn
106%) and OCF/EBITDA at 81% till FY21 (FY21: 105%). Over the decade, the company
invested Rs2.7bn in capex and generated FCF of Rs14.5bn. Over FY12-21, average Free float: 60.8%
dividend payout has been 68.7%. Avg. daily vol. 3mth: 808,368
Source: Bloomberg

History of improved cash flows from operations: Operating profits have shown strong growth over the last 10 years. Despite
the dominance of a single brand (ADHO; 95% of revenue), working capital intensity has been moderate due to high gross
margins. The company has been ensuring sufficient liquidity at all times. It has been consistently generating healthy operating
cash flows over the years. Over FY12-21, cumulative profit before WC has been Rs22.2bn (of which tax paid: Rs4.8bn) and cash
flow from operating activities has been Rs17.2bn, driven by healthy expansion in margins.
Exhibit 360: Healthy cash flows from operations
3
2.5
2
1.5
Rs bn

1
0.5
0
-0.5 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: Bajaj Consumer has been able to increase its payable days (+13) over the last decade by
strengthening its network/better negotiations (FY21 being an exception), but there is scope for improvement in terms of debtor
days (up from 4 days to 10 days) and inventory days (~60 days). Cash conversion cycle has improved from -3 days in FY12 to -
15 days in FY21. OCF/PAT has improved from 75% in FY12 to 106% in FY21, and OCF/EBITDA has improved from 78% in FY12
to 105% in FY21. Notably, the company had to increase debtor days to meet operational challenges post GST and
demonetization for sales recovery. Inventory days have remained range-bound. On an average, OCF/PAT has been at 85% till
FY21 and OCF/EBITDA has been at 81%.
Exhibit 361: Working capital cycle – consistent improvement since FY17
120 FY17: Inventory days and 20
debtor days shot up, while 15
100
payable days were flat 10
80
5
Days
Days

60 -
-5
40
-10
20
-15
0 -20
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtor days Inventory days Payable days Cash conversion cycle
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Bajaj Consumer Care 16 September 2021

Exhibit 362: OCF/PAT Exhibit 363: OCF/EBITDA

120 120

100 100

80 80

60 60
%

%
40 40

20 20

0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady free cash flows: Over FY12-21, cumulative cash from operating activities was Rs17.2bn, while capex was Rs2.7bn and
FCF was Rs14.5bn. Gross margin expanded from 56.3% in FY11 to 63.6% in FY21, reflecting in improved profits.
Exhibit 364: FCF generation has been healthy at Rs14.5bn over the last decade
3000

2000 FY14: Nomarks deal at Rs1.5bn

1000
Rs bn

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1000

-2000 Cash From Operating Activities CAPEX FCFF OCF/EBITDA OCF/EBITDA


Source: Company, Centrum Broking

Healthy return ratios: Overall return ratios have been healthy, as the company has efficiently managed its operations by
controlling debtor days. It has paid back cash to investors through higher dividend except in FY20.
Exhibit 365: Return ratios (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE (%) 29.9 36.5 34.3 43.6 50.2 48.5 42.8 46.2 33.0 31.6
RoCE (%) 29.9 36.5 35.3 43.6 50.2 48.7 43.0 46.4 33.6 31.8
Source: Company, Centrum Broking

High dividend payout: In terms of cash flow from financing activities, major chunk of outflows has been towards dividend and
some portion has been towards export credit facilities availed. The company deploys money in debt funds and tax-free bonds
issued by government bodies, ensuring sufficient liquidity. Over FY12-21, average dividend payout has been 68.7%.
Exhibit 366: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Pay-out (%) 72.5 57.7 64.4 98.2 86.3 78.1 83.8 93.5 - 52.8
Source: Company, Centrum Broking

Exhibit 367: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 896 1,230 1,259 2,067 1,929 2,120 1,801 1,764 1,790 2,371
Cash Flow from Investing Activities -422 -99 35 -195 60 -152 368 686 -1,726 -1,063
Cash from Financing Activities -1,013 -1,114 -1,122 -2,035 -1,943 -2,000 -2,155 -2,384 -91 -1,342
Net increase/ (decrease) in Cash and Cash Equivalents -539 17 173 -164 46 -32 14 65 -26 -34
Closing Cash & Cash Equivalent 275 31 203 42 88 54 67 129 98 65
Source: Company, Centrum Broking

Centrum Institutional Research 134


Bajaj Consumer Care 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 8,901 8,258 9,052 10,133 11,265 Equity share capital 148 148 148 148 148
Operating Expense 5,075 5,160 5,477 6,101 6,765 Reserves & surplus 4,526 6,384 7,424 8,558 9,766
Employee cost 972 869 850 951 945 Shareholders fund 4,674 6,532 7,571 8,705 9,913
Others 394 441 457 449 495 Minority Interest 0 0 0 0 0
EBITDA 2,460 1,787 2,268 2,632 3,060 Total debt 0 0 0 0 0
Depreciation & Amortisation 71 58 63 51 55 Non Current Liabilities 0 0 0 0 0
EBIT 2,389 1,729 2,205 2,581 3,005 Def tax liab. (net) 2 0 0 0 0
Interest expenses 12 42 14 6 4 Total liabilities 4,675 6,532 7,571 8,705 9,913
Other income 454 564 512 596 662 Gross block 1,340 1,364 1,402 1,498 1,605
PBT 2,831 2,250 2,704 3,171 3,663 Less: acc. Depreciation (226) (284) (347) (398) (452)
Taxes 616 402 472 567 655 Net block 1,114 1,080 1,056 1,101 1,153
Effective tax rate (%) 21.7 17.9 17.5 17.9 17.9 Capital WIP 225 244 252 252 252
PAT 2,216 1,848 2,231 2,605 3,008 Net fixed assets 1,769 1,776 1,738 1,783 1,835
Minority/Associates 0 0 0 0 0 Non Current Assets 33 46 39 39 39
Recurring PAT 2,216 1,848 2,231 2,605 3,008 Investments 0 0 0 0 0
Extraordinary items (6) (3) 5 5 5 Inventories 609 630 432 595 659
Reported PAT 2,210 1,845 2,236 2,610 3,013 Sundry debtors 374 255 224 349 372
Cash & Cash Equivalents 2,652 4,589 5,944 6,924 8,080
Ratios Loans & advances 3 5 3 4 4
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 612 844 555 622 691
Growth (%) Trade payables 723 811 689 874 969
Revenue 10.2 (7.2) 9.6 11.9 11.2 Other current liab. 647 802 671 730 793
EBITDA 4.9 (27.4) 26.9 16.1 16.2 Provisions 6 1 5 6 6
Adj. EPS 5.0 (16.6) 20.8 16.7 15.5 Net current assets 2,873 4,710 5,793 6,883 8,039
Margins (%) Total assets 4,675 6,532 7,571 8,705 9,913
Gross 65.9 66.9 63.6 65.9 66.0
EBITDA 27.6 21.6 25.1 26.0 27.2 Cashflow
EBIT 26.8 20.9 24.4 25.5 26.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 24.9 22.4 24.7 25.8 26.7 Profit Before Tax 2,831 2,250 2,704 3,171 3,663
Returns (%) Depreciation & Amortisation 71 58 63 51 55
ROE 46.2 33.0 31.6 32.0 32.3 Net Interest (225) (247) (316) (405) (452)
ROCE 46.4 33.6 31.8 32.1 32.4 Net Change – WC (394) 206 411 (95) 16
ROIC 100.0 71.6 102.0 124.4 136.6 Direct taxes (614) (478) (456) (567) (655)
Turnover (days) Net cash from operations 1,764 1,790 2,371 2,161 2,631
Gross block turnover ratio (x) 6.6 6.1 6.5 6.8 7.0 Capital expenditure (98) (58) (24) (96) (107)
Debtors 14 14 10 10 12 Acquisitions, net 0 0 0 0 0
Inventory 65 83 59 54 60 Investments 548 (1,956) (1,367) 0 0
Creditors 84 102 83 83 88 Others 235 288 328 405 452
Net working capital 118 208 234 248 260 Net cash from investing 686 (1,726) (1,063) 309 345
Solvency (x) FCF 2,449 65 1,308 2,470 2,977
Net debt-equity (0.6) (0.7) (0.8) (0.8) (0.8) Issue of share capital 0 0 0 0 0
Interest coverage ratio 210.1 42.1 164.9 446.0 698.9 Increase/(decrease) in debt 115 (50) (150) (15) (15)
Net debt/EBITDA (1.1) (2.6) (2.6) (2.6) (2.6) Dividend paid (2,489) 0 (1,180) (1,475) (1,805)
Per share (Rs) Interest paid (10) (41) (12) 0 0
Adjusted EPS 15.0 12.5 15.1 17.7 20.4 Others 0 0 0 0 0
BVPS 31.7 44.3 51.3 59.0 67.2 Net cash from financing (2,384) (91) (1,342) (1,491) (1,820)
CEPS 15.5 12.9 15.5 18.0 20.8 Net change in Cash 65 (26) (34) 980 1,157
DPS 14.0 0.0 8.0 10.0 12.2 Source: Company, Centrum Broking
Dividend payout (%) 93.5 0.0 52.8 56.5 59.9
Valuation (x)
P/E 17.0 20.4 16.9 14.5 12.5
P/BV 8.1 5.8 5.0 4.3 3.8
EV/EBITDA 14.3 18.5 14.0 11.7 9.7
Dividend yield (%) 5.5 0.0 3.1 3.9 4.8
Source: Company, Centrum Broking

Centrum Institutional Research 135


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Britannia Industries
Britannia has delivered 10.9% revenue CAGR and 29.9% PAT CAGR over the last Market data
decade. Operating profits have expanded consistently, with gross margin increasing Current price: Rs4,073
from 34.8% in FY11 to 42.8% in FY21. Cumulative profit before WC has been Bloomberg: BRIT IN
Rs124.2bn (tax paid: Rs36.6bn) and cash flow from operating activities has been 52-week H/L: Rs4,153/3,305
Rs89.6bn. On an average, OCF/PAT has been at 110% till FY21 (FY21: 101%) and
Market cap: Rs981.1bn
OCF/EBITDA has been at 75% till FY21 (FY21: 74%). Cumulative capex has been
Rs24.2bn and FCF has been Rs65.5bn, as the company could expand in-house Free float: 16.8%
manufacturing for its premium portfolio. Over FY12-21, the company used bonus Avg. daily vol. 3mth: 472,082
debentures to reward shareholders; average dividend payout has been 46.1%. Source: Bloomberg

History of improved cash flows from operations: Operating profits have grown consistently, driven by 700bp gross margin
expansion over FY12-21. Working capital intensity is low, and the company has been generating healthy OCF. Cumulative profit
before WC has been Rs124.2bn (of which tax paid: Rs36.6bn) and cash flow from operating activities has been Rs89.6bn.
Exhibit 368: Healthy cash flows from operations
30
25
20 FY17: High inventory and
advances
15
Rs bn

10
5
0
-5
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-10
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: Significant improvement in payable days from 34 days in FY12 to 58 days in FY21 has led to
cash conversion cycle improving from 13 days in FY12 to -6 days in FY21. OCF/PAT has been ~110% till FY21 and OCF/EBITDA
~75%. In FY17, these ratios were abnormally low due to low OCF (following increase in inventory, and loans and advances).
Exhibit 369: Cash conversion cycle has improved from 13 days in FY12 to -6 days in FY21
70 15
60 10
50 5
40 -
Days
Days

30 -5
20 -10
10 -15
0 -20
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtor days Inventory days Payable days Cash conversion cycle
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Britannia Industries 16 September 2021

Exhibit 370: OCF/PAT Exhibit 371: OCF/EBITDA


200 120
100
150
80
100
%

60

%
40
50
20
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady free cash flows: Over FY12-21, cumulative OCF was Rs89.6bn, while capex was Rs24.2bn, translating into cumulative
FCF of Rs65.5bn. In line with its strategy to expand in-house production, over FY12-19, Britannia added a series of greenfield
capacities to expand its premium biscuits and value-added segment, including one in Nepal.
Exhibit 372: Britannia generated cumulative FCF of Rs65.5bn in the last 10 years
20 FY17: Banglore and FY19: Ranjangaon
FY16: Tamil Nadu Madurai greenfield and Nepal greenfield
15 FY13: Rudrapur and
Hyderabad greenfield
FY12: Bihar
10 greenfield
and Orissa
Rs bn

5 greenfield

-5
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-10
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 373: Return ratios (%)


80

60

40
%

20

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE RoCE
Source: Company, Centrum Broking

Healthy return ratios: Overall return ratios have been healthy. Over FY17-19, PAT growth was lower than in previous years,
resulting in lower return ratios. However, return ratios improved post FY20. Cash flows from financing activities majorly include
ICD issues, which have been at Rs700mn on an average. Over FY12-21, average dividend payout has been 46.1%.
Exhibit 374: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Payout (%) 45.1 45.4 30.1 24.4 28.0 32.6 31.6 30.8 31.1 162.2
Source: Company, Centrum Broking

Exhibit 375: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 2,461 3,198 6,715 5,845 9,592 4,413 12,488 11,558 14,845 18,511
Cash Flow from Investing Activities -648 282 -2,456 -4,503 -7,052 -1,499 -9,563 -8,555 -15,316 4,613
Cash from Financing Activities -1,684 -3,782 -3,573 -1,814 -2,462 -2,951 -2,318 -3,527 579 -22,437
Net increase/ (decrease) in Cash and Cash Equivalents 129 -302 685 -472 78 -37 608 -524 109 686
Closing Cash & Cash Equivalent 520 219 904 431 510 473 1,078 587 753 1,427
Source: Company, Centrum Broking

Centrum Institutional Research 137


Britannia Industries 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 109,735 114,440 128,830 142,464 159,581 Equity share capital 240 241 241 241 241
Operating Expense 78,967 82,781 90,820 100,874 112,819 Reserves & surplus 42,292 43,788 35,236 46,639 59,897
Employee cost 4,418 4,867 5,274 5,742 6,427 Shareholders fund 42,533 44,028 35,476 46,880 60,138
Others 9,827 9,915 11,128 12,221 13,552 Minority Interest 327 357 363 449 535
EBITDA 17,334 18,432 24,140 26,539 30,130 Total debt 1,380 15,299 21,030 20,880 20,730
Depreciation & Amortisation 1,619 1,848 1,979 1,984 2,213 Non Current Liabilities 387 439 383 423 474
EBIT 15,715 16,584 22,161 24,555 27,916 Def tax liab. (net) (99) (69) (10) (10) (10)
Interest expenses 91 769 1,109 1,270 1,672 Total liabilities 44,528 60,054 57,242 68,622 81,867
Other income 2,065 2,794 3,129 3,719 4,940 Gross block 20,457 24,593 25,752 26,921 28,991
PBT 17,689 18,609 24,181 27,005 31,183 Less: acc. Depreciation (5,025) (7,345) (9,324) (11,308) (13,521)
Taxes 6,125 4,507 6,630 7,084 8,203 Net block 15,432 17,247 16,428 15,614 15,469
Effective tax rate (%) 34.6 24.2 27.4 26.2 26.3 Capital WIP 1,012 396 1,165 1,165 1,165
PAT 11,564 14,102 17,551 19,921 22,980 Net fixed assets 17,748 19,033 18,953 18,138 17,994
Minority/Associates (46) (86) (125) (86) (86) Non Current Assets 1,858 3,455 2,825 3,048 3,328
Recurring PAT 11,518 14,016 17,426 19,835 22,894 Investments 7,411 18,989 14,017 14,017 14,017
Extraordinary items 0 (119) (21) 0 0 Inventories 7,814 7,410 10,915 7,832 12,845
Reported PAT 11,518 13,897 17,405 19,835 22,894 Sundry debtors 3,942 3,204 2,573 5,393 3,463
Cash & Cash Equivalents 8,597 11,316 16,046 28,881 40,432
Ratios Loans & advances 14,910 14,820 14,663 16,215 18,163
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 11,405 11,163 13,148 14,284 16,483
Revenue 11.6 4.3 12.6 10.6 12.0 Other current liab. 4,383 5,098 5,726 6,332 7,093
EBITDA 15.4 6.3 31.0 9.9 13.5 Provisions 1,965 1,913 3,875 4,285 4,800
Adj. EPS (42.7) 21.6 24.1 13.8 15.4 Net current assets 17,510 18,577 21,448 33,420 46,528
Margins (%) Total assets 44,528 60,054 57,242 68,622 81,867
Gross 40.9 40.8 42.8 42.0 42.2
EBITDA 15.7 15.9 18.4 18.3 18.5 Cashflow
EBIT 14.2 14.3 16.9 16.9 17.1 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 10.4 12.1 13.3 13.6 14.1 Profit Before Tax 17,689 18,439 25,128 27,005 31,183
Returns (%) Depreciation & Amortisation 1,619 1,848 1,979 1,984 2,213
ROE 30.1 32.4 43.8 48.2 42.8 Net Interest (1,277) (999) (1,238) (1,737) (2,532)
ROCE 29.0 28.3 31.5 33.4 32.4 Net Change – WC (25) 1,274 (562) 681 (1,786)
ROIC 33.4 29.7 35.8 44.8 50.7 Direct taxes (5,961) (5,033) (6,328) (7,084) (8,203)
Turnover (days) Net cash from operations 11,558 14,845 18,511 22,053 22,080
Gross block turnover ratio (x) 5.4 4.7 5.0 5.3 5.5 Capital expenditure (3,994) (2,434) (2,399) (1,169) (2,069)
Debtors 12 11 8 10 10 Acquisitions, net 0 0 0 0 0
Inventory 40 40 44 40 39 Investments (5,730) (14,158) 4,677 (9,000) 0
Creditors 59 59 58 59 59 Others 1,169 1,276 2,334 3,006 4,204
Net working capital 58 59 61 86 106 Net cash from investing (8,555) (15,316) 4,613 (7,163) 2,134
Solvency (x) FCF 3,003 (471) 23,123 14,890 24,215
Net debt-equity (0.2) 0.1 0.1 (0.2) (0.3) Issue of share capital 530 360 1,172 0 0
Interest coverage ratio 190.7 24.0 21.8 20.9 18.0 Increase/(decrease) in debt (419) 4,925 5,678 (150) (150)
Net debt/EBITDA (0.4) 0.2 0.2 (0.3) (0.7) Dividend paid (3,544) (4,325) (28,238) (9,636) (10,841)
Per share (Rs) Interest paid (94) (380) (1,049) (1,270) (1,672)
Adjusted EPS 47.9 58.3 72.3 82.3 95.0 Others 0 0 0 0 0
BVPS 177.0 183.1 147.3 194.6 249.6 Net cash from financing (3,527) 579 (22,437) (11,056) (12,663)
CEPS 54.7 66.0 80.5 90.6 104.2 Net change in Cash (524) 109 686 3,835 11,552
DPS 14.7 18.0 117.2 40.0 45.0 Source: Company, Centrum Broking
Dividend payout (%) 30.8 31.1 162.2 48.6 47.4
Valuation (x)
P/E 85.0 69.9 56.3 49.5 42.9
P/BV 23.0 22.2 27.7 20.9 16.3
EV/EBITDA 56.2 53.4 40.8 36.7 31.9
Dividend yield (%) 0.4 0.4 2.9 1.0 1.1
Source: Company, Centrum Broking

Centrum Institutional Research 138


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Colgate Palmolive India (CLGT)


Over the last 10 years, CLGT has recorded 9.3% revenue CAGR and 9.9% PAT CAGR. Market data
Operating profits have been robust and gross margin has expanded by 700bp. Over Current price: Rs1,716
FY12-21, cumulative profit before WC has been Rs97.7bn (of which tax paid: Bloomberg: CLGT IN
Rs26.6bn) and cash flow from operating activities has been Rs68.8bn. On an average, 52-week H/L: Rs1,823/1,322
OCF/PAT has been 111% till FY20 (FY21: 76%) and OCF/EBITDA has been 75% till FY20 Market cap: Rs466.8bn
(FY21: 52%). Against cumulative OCF of Rs68.8bn, capex has been Rs19bn, translating
Free float: 44.5%
into cumulative FCF generation of Rs50bn. Over FY12-21, average dividend payout has
Avg. daily vol. 3mth: 591,477
been 74.5%, resulting in healthy RoE/RoCE.
Source: Bloomberg

Strong cash flows from operations: Operating profits have been healthy and have consistently expanded over the last 10 years.
As CLGT is in a single category, working capital intensity in the business has been moderate. In FY21, there was an increase in
other financial assets, resulting in high cash outflows. The company has been ensuring sufficient liquidity at all times. CLGT has
been consistently generating strong operating cash flows. Over FY12-21 cumulative profit before WC has been Rs97.7bn (of
which tax paid: Rs26.6bn) and cash flow from operating activities has been Rs68.8bn.
Exhibit 376: Consistently generating strong cash flows from operations
20.00

15.00

10.00
Rs bn

5.00

0.00

-5.00
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: The FMCG sector has inherently enjoyed negative working capital cycle. FMCG companies
enjoy credit period but most sales are conducted on cash/NEFT terms, which is highly beneficial for them. CLGT has been able
to increase its payable days over the years by strengthening its network/better negotiations and has maintained tight control
over its inventory days as well. Its cash conversion cycle improved considerably from -44 days in FY12 to -78 days in FY21. While
OCF/PAT has improved from 90% in FY12 to 114% in FY20, OCF/EBITDA has improved from 70% in FY12 to 77% in FY20. On an
average, OCF/PAT has been 111% till FY20 (FY21: 76%) and OCF/EBITDA has been 75% till FY20 (FY21: 52%).
Exhibit 377: Significant improvement in cash conversion cycle over FY12-21
200.00

150.00

100.00
Days

50.00

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(50.00)

(100.00)
Debtor days Inventory days Payable days Cash conversion cycle
Source: Company, Centrum Broking

xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Colgate Palmolive India (CLGT) 16 September 2021

Exhibit 378: OCF/PAT Exhibit 379: OCF/EBITDA


140.00 100.00
120.00 90.00
80.00
100.00 70.00
80.00 60.00
50.00

%
%

60.00 40.00
40.00 30.00
20.00
20.00 10.00
- -

FY14
FY12

FY13

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY14
FY12

FY13

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking
Steady free cash flows: Over FY12-21, CLGT generated cumulative OCF of Rs68.8bn, while it incurred capex of Rs19bn.
Cumulative FCF was Rs50bn, mainly due to expansion of in-house manufacturing. CLGT invested in new capacities – a
toothpaste plant in 2014 at Sanand (~Rs6.3bn) and a toothbrush plant in 2016 at Sricity (~Rs3.4bn).
Exhibit 380: Generated cumulative FCF of Rs50bn over FY12-21, driven by expansion of in-house manufacturing
12.00
10.00 2014: Sanand toothpaste plant 2016: Sricity toothbrush plant
8.00
6.00
Rs bn

4.00
2.00
0.00
-2.00
-4.00
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 381: Return ratios (%)


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE (%) 109.0 107.4 87.3 81.6 68.0 50.1 49.0 50.1 53.7 75.0
RoCE (%) 105.3 100.2 82.6 76.7 65.7 50.0 48.9 48.9 51.4 71.2
Source: Company, Centrum Broking

Return ratios impacted by 1:1 bonus issue in FY16: Return ratios were impacted mainly on account of 1:1 bonus issue in FY16.
A net cash company, with limited capex requirement, CLGT has returned cash to shareholders. Over FY12-21, its average
dividend payout has been 74.5%.
Exhibit 382: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Payout (%) 76.1 76.7 68.0 58.4 46.8 47.1 96.9 80.7 95.1 99.5
Source: Company, Centrum Broking

Exhibit 383: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 4,028 6,149 4,574 6,382 6,887 6,880 6,939 9,830 9,296 7,839
Cash Flow from Investing Activities -102 -473 -1,804 -2,716 -2,366 -3,421 -2,073 -957 -187 714
Cash from Financing Activities -3,981 -4,276 -4,221 -3,848 -3,914 -3,406 -3,798 -8,147 -8,911 -9,565
Net increase/ (decrease) in Cash and Cash Equivalents -55 1,400 -1,451 -183 607 53 1,068 726 198 -1,012
Closing Cash & Cash Equivalent 1,557 2,957 1,506 1,324 1,932 1,986 3,054 3,780 3,978 2,966
Source: Company, Centrum Broking

Centrum Institutional Research 140


Colgate Palmolive India (CLGT) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 44,624 45,251 48,412 51,568 55,438 Equity share capital 272 272 272 272 272
Operating Expense 24,957 25,677 25,670 27,962 29,988 Reserves & surplus 14,196 15,670 11,387 11,947 12,569
Employee cost 2,959 3,323 3,656 3,895 4,187 Shareholders fund 14,468 15,942 11,659 12,219 12,841
Others 4,347 4,234 3,990 4,373 4,698 Minority Interest 0 0 0 0 0
EBITDA 12,361 12,017 15,096 15,338 16,564 Total debt 794 856 791 791 791
Depreciation & Amortisation 1,592 1,979 1,825 1,700 1,594 Non Current Liabilities 0 0 0 0 0
EBIT 10,769 10,037 13,271 13,638 14,970 Def tax liab. (net) 309 50 0 0 0
Interest expenses 25 96 73 0 0 Total liabilities 15,570 16,848 12,449 13,010 13,631
Other income 377 492 304 467 675 Gross block 17,476 18,624 19,831 21,629 23,284
PBT 11,120 10,434 13,502 14,105 15,645 Less: acc. Depreciation (5,567) (7,395) (9,184) (10,885) (12,478)
Taxes 3,670 2,269 3,148 3,281 3,639 Net block 11,909 11,229 10,647 10,744 10,805
Effective tax rate (%) 33.0 21.7 23.3 23.3 23.3 Capital WIP 1,987 1,900 1,448 1,448 1,448
PAT 7,451 8,165 10,354 10,824 12,006 Net fixed assets 13,896 13,129 12,096 12,192 12,254
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 7,451 8,165 10,354 10,824 12,006 Investments 0 0 0 0 0
Extraordinary items 305 (155) 32 0 0 Inventories 2,486 2,969 3,358 3,577 3,846
Reported PAT 7,756 8,009 10,386 10,824 12,006 Sundry debtors 2,098 1,326 1,171 1,122 1,086
Cash & Cash Equivalents 4,305 4,399 8,862 7,200 10,234
Ratios Loans & advances 3,481 4,217 3,453 3,553 3,653
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 6,132 6,125 7,604 8,181 8,883
Revenue 6.6 1.4 7.0 6.5 7.5 Other current liab. 3,740 1,973 7,765 5,260 7,273
EBITDA 11.1 (2.8) 25.6 1.6 8.0 Provisions 823 1,093 1,122 1,195 1,285
Adj. EPS 8.8 9.6 26.8 4.5 10.9 Net current assets 1,675 3,720 354 817 1,378
Margins (%) Total assets 15,570 16,848 12,449 13,010 13,631
Gross 65.1 65.2 68.0 67.0 67.0
EBITDA 27.7 26.6 31.2 29.7 29.9 Cashflow
EBIT 24.1 22.2 27.4 26.4 27.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 16.7 18.0 21.4 21.0 21.7 Profit Before Tax 8,336 8,934 11,664 12,524 13,600
Returns (%) Depreciation & Amortisation 0 0 0 0 0
ROE 50.1 53.7 75.0 90.7 95.8 Net Interest 0 0 0 0 0
ROCE 48.9 51.4 71.2 85.0 90.1 Net Change – WC 1,494 (35) (3,826) (2,126) 2,473
ROIC 67.6 67.3 127.3 222.8 249.5 Direct taxes 0 0 0 0 0
Turnover (days) Net cash from operations 9,830 8,899 7,839 10,398 16,072
Gross block turnover ratio (x) 2.6 2.4 2.4 2.4 2.4 Capital expenditure (1,388) (604) (578) (1,801) (1,659)
Debtors 17 14 9 8 7 Acquisitions, net 0 0 0 0 0
Inventory 56 63 75 74 74 Investments 85 417 1,287 0 0
Creditors 144 142 162 169 170 Others 346 0 4 4 4
Net working capital 14 30 3 6 9 Net cash from investing (957) (187) 714 (1,797) (1,655)
Solvency (x) FCF 8,873 8,712 8,552 8,601 14,417
Net debt-equity (0.2) (0.2) (0.7) (0.5) (0.7) Issue of share capital (111) (81) (103) 0 0
Interest coverage ratio 494.4 124.9 208.0 0.0 0.0 Increase/(decrease) in debt (121) 0 0 0 0
Net debt/EBITDA (0.3) (0.3) (0.5) (0.4) (0.6) Dividend paid (7,916) (8,433) (9,211) (10,263) (11,384)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 27.4 30.0 38.1 39.8 44.1 Others 0 0 0 0 0
BVPS 53.2 58.6 42.9 44.9 47.2 Net cash from financing (8,147) (8,514) (9,314) (10,263) (11,384)
CEPS 33.2 37.3 44.8 46.0 50.0 Net change in Cash 726 198 (762) (1,662) 3,033
DPS 23.0 28.0 38.0 37.7 41.9 Source: Company, Centrum Broking
Dividend payout (%) 80.7 95.1 99.5 94.8 94.8
Valuation (x)
P/E 62.7 57.2 45.1 43.1 38.9
P/BV 32.3 29.3 40.0 38.2 36.4
EV/EBITDA 37.5 38.6 30.4 30.0 27.6
Dividend yield (%) 1.3 1.6 2.2 2.2 2.4
Source: Company, Centrum Broking

Centrum Institutional Research 141


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Dabur India (DABUR)


DABUR reported 8.8% revenue CAGR and 10.9% PAT CAGR over FY12-21. Operating Market data
profits have been healthy and have consistently expanded. Gross margins have Current price: Rs640
remained at 48-49%, driven by healthcare segment, where margins are higher than Bloomberg: DABUR IN
company average. Cumulative profit before WC has been Rs149.8bn (tax paid: 52-week H/L: Rs651/479
Rs26.3bn) and cash flow from operating activities has been Rs123.4bn. On an average,
Market cap: Rs1,132.1bn
OCF/PAT has been 102% till FY21 (FY21: 125%) and OCF/EBITDA has been 87% (FY21:
112%). Cumulative capex has been Rs27.2bn and DABUR has generated cumulative Free float: 49.8%
FCF of Rs96.3bn over FY12-21. Average dividend payout has been 41.5%. Avg. daily vol. 3mth: 2,538,091
Source: Bloomberg

History of steady improvement in cash flows from operations: Operating profits have grown steadily over the last 10 years.
Working capital intensity in the business has been a bit higher due to focus on healthcare, a seasonal business. DABUR has
been ensuring sufficient liquidity at all times. Over FY12-21, cumulative profit before WC has been Rs149.7bn (of which tax
paid: Rs26.3bn) and cash flow from operating activities has been Rs123.4bn.
Exhibit 384: Consistent growth in cash flows from operations
25

20
Rs bn

15

10

-5 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: DABUR has increased its payable days from 25 to 35 days by strengthening its network and
better negotiations. It has also reduced debtor days, but there is scope to cut inventory days, which have shot up from 98 to
119 days. The higher inventory days could be because of higher contribution from the healthcare business. Cash conversion
cycle has improved from 55 days in FY12 to 16 days in FY21. OCF/PAT improved from 93% in FY12 to 125% in FY21, while
EBITDA/PAT improved from 69% in FY12 to 112% in FY21. On an average, OCF/PAT has been 102% till FY21 and OCF/EBITDA
has been 87% till FY21.
Exhibit 385: Cash conversion cycle has improved over the years

140 70
120 60
100 50
80 40
Days
Days

60 30
40 20
20 10
0 -
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Debtor days Inventory days Payable days Cash conversion cycle


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Dabur India (DABUR) 16 September 2021

Exhibit 386: OCF/PAT Exhibit 387: OCF/EBITDA


140 120
120 100
100
80
80
60

%
%

60
40
40
20 20

0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady improvement in free cash flows: Over FY12-21, cumulative cash from operating activities was Rs123.4bn, while capex
was Rs27.2bn, translating into cumulative FCF of Rs96.3bn. DABUR increased capacities in Tezpur and Indore to produce a
range of ayurvedic products. Further, it has been able to lower its tax outgo due to tax benefits availed in Tezpur on account
of MAT credit.
Exhibit 388: FCF has improved steadily
25 FY20: Added capacity for
20 Chyawanprash and Honey
FY17: Tezpur factory;
15 Rs2.5bn
Rs bn

10
5
0
-5
-10 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 389: Return ratios (%)


50

40

30
%

20

10

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE RoCE
Source: Company, Centrum Broking

Healthy return ratios: Overall return ratios have been healthy, but lower than peers due to higher investments in inventory.
Over FY12-21, average dividend payout has been 41.5%.
Exhibit 390: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Payout (%) 37.5 34.2 33.4 33.0 31.6 31.0 97.5 30.5 36.7 49.5
Source: Company, Centrum Broking

Exhibit 391: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 5,969 8,695 10,983 10,472 11,870 12,269 10,915 14,991 16,136 21,147
Cash Flow from Investing Activities -2,605 -6,241 -1,073 -8,762 -7,296 -8,069 -5,400 3,369 -5,168 -14,058
Cash from Financing Activities -1,985 -2,340 -8,037 -4,168 -3,743 -3,390 -5,771 -18,882 -10,430 -6,134
Net increase/ (decrease) in Cash and Cash Equivalents 1,380 115 1,873 -2,458 831 811 -256 -522 538 955
Closing Cash & Cash Equivalent 4,184 1,250 3,132 677 356 1,158 892 377 917 1,888
Source: Company, Centrum Broking

Centrum Institutional Research 143


Dabur India (DABUR) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 84,373 86,059 94,544 106,315 120,771 Equity share capital 1,766 1,767 1,767 1,767 1,767
Operating Expense 56,331 57,374 62,997 70,238 78,894 Reserves & surplus 54,551 64,290 74,868 83,881 95,979
Employee cost 9,379 9,477 10,335 11,219 12,489 Shareholders fund 56,317 66,058 76,635 85,648 97,746
Others 2,225 2,261 2,258 2,511 2,816 Minority Interest 314 365 367 378 390
EBITDA 16,438 16,947 18,954 22,348 26,573 Total debt 8,519 6,927 7,222 4,333 3,833
Depreciation & Amortisation 1,769 2,205 2,401 2,367 2,566 Non Current Liabilities 641 676 647 726 822
EBIT 14,669 14,742 16,553 19,980 24,006 Def tax liab. (net) 231 174 139 139 139
Interest expenses 596 495 308 256 191 Total liabilities 66,022 74,199 85,010 91,224 102,930
Other income 3,919 4,030 4,326 4,864 5,278 Gross block 27,946 32,906 34,396 37,321 40,613
PBT 17,993 18,277 20,570 24,588 29,094 Less: acc. Depreciation (11,614) (13,736) (15,324) (17,692) (20,258)
Taxes 2,786 2,797 3,611 5,099 5,938 Net block 16,332 19,170 19,072 19,629 20,356
Effective tax rate (%) 15.5 15.3 17.6 20.7 20.4 Capital WIP 638 1,466 1,473 1,473 1,473
PAT 15,206 15,479 16,960 19,489 23,156 Net fixed assets 20,331 23,995 23,905 24,462 25,189
Minority/Associates (30) (30) (10) (11) (12) Non Current Assets 1,842 6,653 2,674 2,958 3,360
Recurring PAT 15,177 15,450 16,950 19,478 23,144 Investments 0 0 0 0 0
Extraordinary items (753) (1,000) 0 0 0 Inventories 13,005 13,796 17,343 18,337 20,533
Reported PAT 14,423 14,450 16,950 19,478 23,144 Sundry debtors 8,336 8,139 5,616 5,150 5,552
Cash & Cash Equivalents 36,869 36,116 54,887 63,021 74,088
Ratios Loans & advances 375 157 174 196 222
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 3,608 4,684 3,874 4,356 4,948
Growth (%) Trade payables 14,554 14,822 19,153 22,411 25,458
Revenue 9.9 2.0 9.9 12.5 13.6 Other current liab. 2,488 2,864 2,430 2,733 3,104
EBITDA 6.1 3.1 11.8 17.9 18.9 Provisions 1,302 1,655 1,878 2,112 2,399
Adj. EPS 10.9 1.5 9.7 14.9 18.8 Net current assets 43,849 43,551 58,432 63,803 74,381
Margins (%) Total assets 66,022 74,199 85,010 91,224 102,930
Gross 48.9 49.3 49.3 49.3 49.5
EBITDA 19.5 19.7 20.0 21.0 22.0 Cashflow
EBIT 17.4 17.1 17.5 18.8 19.9 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 18.0 18.0 17.9 18.3 19.2 Profit Before Tax 17,249 17,276 20,560 24,588 29,094
Returns (%) Depreciation & Amortisation 1,769 2,205 2,401 2,367 2,566
ROE 26.8 25.2 23.8 24.0 25.2 Net Interest (2,002) (2,001) (2,300) (3,558) (4,266)
ROCE 23.8 23.0 21.8 22.6 24.2 Net Change – WC (181) (579) 3,884 2,514 184
ROIC 46.0 38.1 41.0 55.9 69.2 Direct taxes (3,507) (3,089) (3,213) (5,099) (5,938)
Turnover (days) Net cash from operations 14,991 16,136 21,147 20,812 21,641
Gross block turnover ratio (x) 3.0 2.6 2.7 2.8 3.0 Capital expenditure (2,250) (4,005) (3,063) (2,925) (3,293)
Debtors 33 35 27 18 16 Acquisitions, net 0 0 0 0 0
Inventory 108 112 119 121 116 Investments 3,175 (3,646) (13,611) 0 0
Creditors 121 123 129 141 143 Others 2,444 2,482 2,616 3,815 4,456
Net working capital 190 185 226 219 225 Net cash from investing 3,369 (5,168) (14,058) 890 1,163
Solvency (x) FCF 18,360 10,968 7,089 21,702 22,804
Net debt-equity (0.5) (0.4) (0.6) (0.7) (0.7) Issue of share capital 5 1 0 0 0
Interest coverage ratio 27.6 34.2 61.5 87.1 139.5 Increase/(decrease) in debt (2,402) (3,580) 369 (2,889) (500)
Net debt/EBITDA (1.7) (1.7) (2.5) (2.6) (2.6) Dividend paid (15,970) (6,178) (5,921) (9,897) (11,046)
Per share (Rs) Interest paid (515) (673) (582) (256) (191)
Adjusted EPS 8.6 8.7 9.6 11.0 13.1 Others 0 0 0 0 0
BVPS 32.0 37.4 43.4 48.5 55.3 Net cash from financing (18,882) (10,430) (6,134) (13,043) (11,737)
CEPS 9.6 10.0 10.9 12.4 14.5 Net change in Cash (522) 538 955 8,658 11,068
DPS 2.5 3.0 4.8 5.6 6.3 Source: Company, Centrum Broking
Dividend payout (%) 30.5 36.7 49.5 50.8 47.7
Valuation (x)
P/E 74.3 73.3 66.8 58.1 48.9
P/BV 20.0 17.1 14.8 13.2 11.6
EV/EBITDA 67.1 65.1 57.2 48.0 40.0
Dividend yield (%) 0.4 0.5 0.7 0.9 1.0
Source: Company, Centrum Broking

Centrum Institutional Research 144


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Emami
Emami reported 9.1% revenue CAGR and 8.2% PAT CAGR over FY12-21. Operating Market data
profits have been healthy and have grown consistently, largely driven by 1,340bp Current price: Rs594
expansion in gross margins. Though the Kesh King acquisition in FY16 helped Emami Bloomberg: HMN IN
to expand its hair oil business, it took three years for Emami to digest. Over FY12-21, 52-week H/L: Rs622/334
cumulative profit before WC has been Rs62.1bn (tax paid: Rs7.5bn) and cash flow
Market cap: Rs264bn
from operating activities has been Rs55.3bn. On an average, OCF/PAT has been 108%
till FY21 (FY21: 138%) and OCF/EBITDA has been 94% till FY21 (FY21: 104%). Free float: 46.1%
Cumulative capex has been Rs29bn and Emami has generated cumulative FCF of Avg. daily vol. 3mth: 788,633
Rs26.3bn over FY12-21. Average dividend payout has been 56.5%. Source: Bloomberg

Robust cash flows from operations: Operating profits have grown consistently over the last 10 years. Working capital intensity
in the business has been low to moderate, and the company has been generating healthy operating cash flows over the years.
Over FY12-21, cumulative profit before WC has been Rs62.1bn (of which tax paid: Rs7.5bn) and cash flow from operating
activities has been Rs55.3bn. The improvement has occurred on the back of strong gross margin expansion of ~1,340bp.
Exhibit 392: Cash flows from operations have improved over the last decade
10

6
Rs bn

-2 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: Emami has been able to increase its payable days from 32 to 133 days over FY12-21, which
is commendable, resulting in improvement in cash conversion cycle from 65 days in FY12 to 9 days in FY21. However, its
inventory days have been increasing over the period due to erratic seasonality effect. On an average, OCF/PAT has been 108%
till FY21 and OCF/EBITDA has been 94%.
Exhibit 393: Cash conversion cycle has improved, driven by increase in payable days
140 80
120 60
100
40
80
Days
Days

20
60
-
40
20 -20

0 -40
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Debtor days Inventory days Payable days Cash conversion cycle


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Emami 16 September 2021

Exhibit 394: OCF/PAT Exhibit 395: OCF/EBITDA


160 140
140 120
120 100
100
80
80

%
$

60
60
40
40
20 20

0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady free cash flows: Over FY12-21, cumulative cash from operating activities was Rs55.3bn, while capex was Rs29bn,
translating to FCF of Rs26.3bn. In FY16, the company acquired the Kesh King brand for Rs16.8bn.
Exhibit 396: Cash flows have grown consistently, except for FY16, when Emami acquired Kesh King
15
FY16: Kesh King brand
10
acquired for Rs16.8bn
5
0
Rs bn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-5
-10
-15
-20
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 397: Return ratios (%)


60
50
40
30
%

20
10
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE RoCE
Source: Company, Centrum Broking

Average dividend payout of 56.5%: In terms of cash flows from financing activities, major chunk of outflows has been towards
dividend and repayment of borrowings. It has also been receiving export credit facilities. Over FY12-21, average dividend
payout has been 56.5%.
Exhibit 398: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Payout (%) 23.8 44.6 54.9 37.3 18.8 52.3 29.8 55.1 179.8 68.9
Source: Company, Centrum Broking

Exhibit 399: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 3,605 3,229 4,282 5,340 5,616 7,296 5,878 5,537 5,307 9,215
Cash Flow from Investing Activities -1,327 -1,236 -1,419 -2,337 -13,064 -2,975 -2,791 -234 -2,277 -2,270
Cash from Financing Activities -1,449 -1,885 -3,013 -2,154 5,018 -4,958 -3,237 -4,277 -4,054 -6,882
Net increase/ (decrease) in Cash and Cash Equivalents 829 108 -149 850 -2,430 -637 -150 1,027 -1,023 64
Closing Cash & Cash Equivalent 2,759 2,809 2,680 3,498 1,005 284 162 1,165 108 198
Source: Company, Centrum Broking

Centrum Institutional Research 146


Emami 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 26,589 26,549 28,805 32,419 36,786 Equity share capital 454 453 445 445 445
Operating Expense 14,655 13,472 13,874 15,361 17,497 Reserves & surplus 20,307 17,787 17,182 20,303 24,089
Employee cost 2,797 2,995 3,092 3,535 3,995 Shareholders fund 20,761 18,240 17,627 20,748 24,533
Others 2,221 3,176 3,009 3,475 3,701 Minority Interest (2) (9) (9) 0 0
EBITDA 6,915 6,905 8,831 10,047 11,593 Total debt 1,099 2,102 919 1,034 1,174
Depreciation & Amortisation 3,253 3,363 3,670 1,981 1,971 Non Current Liabilities 505 601 536 497 468
EBIT 3,662 3,542 5,161 8,066 9,622 Def tax liab. (net) 160 35 42 47 53
Interest expenses 214 210 133 86 97 Total liabilities 22,523 20,969 19,114 22,326 26,228
Other income 706 571 703 973 1,104 Gross block 28,779 29,935 30,324 31,465 32,493
PBT 4,154 3,903 5,731 8,953 10,629 Less: acc. Depreciation (11,967) (15,330) (19,000) (20,981) (22,952)
Taxes 1,009 713 1,142 1,791 2,126 Net block 16,812 14,605 11,325 10,485 9,541
Effective tax rate (%) 24.3 18.3 19.9 20.0 20.0 Capital WIP 352 69 58 57 56
PAT 3,145 3,190 4,589 7,162 8,503 Net fixed assets 17,164 14,674 11,383 10,542 9,597
Minority/Associates (15) (54) (42) 0 0 Non Current Assets 775 899 882 979 1,096
Recurring PAT 4,963 5,253 6,692 7,962 9,303 Investments 1,791 881 1,664 1,664 1,664
Extraordinary items (249) (1,117) 614 0 0 Inventories 2,217 2,447 3,005 3,381 2,620
Reported PAT 2,881 2,020 5,161 7,162 8,503 Sundry debtors 2,164 3,080 2,318 2,478 2,671
Cash & Cash Equivalents 2,113 1,873 4,493 8,498 14,679
Ratios Loans & advances 47 663 30 32 34
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,953 2,269 1,423 1,521 1,554
Growth (%) Trade payables 2,914 3,244 3,507 3,870 4,397
Revenue 6.8 (0.2) 8.5 12.5 13.5 Other current liab. 1,634 1,118 1,147 1,291 1,465
EBITDA 1.9 (0.1) 27.9 13.8 15.4 Provisions 1,153 1,455 1,429 1,608 1,824
Adj. EPS (49.8) 6.0 29.9 19.0 16.8 Net current assets 2,793 4,515 5,185 9,141 13,871
Margins (%) Total assets 22,523 20,969 19,114 22,326 26,228
Gross 65.3 67.0 67.7 68.1 68.2
EBITDA 26.0 26.0 30.7 31.0 31.5 Cashflow
EBIT 13.8 13.3 17.9 24.9 26.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 18.7 19.8 23.2 22.1 23.1 Profit Before Tax 4,034 3,736 5,689 8,953 10,629
Returns (%) Depreciation & Amortisation 3,253 3,363 3,670 1,981 1,971
ROE 24.3 26.9 37.3 41.5 41.1 Net Interest 32 (83) (38) (973) (1,104)
ROCE 14.6 15.9 24.2 35.9 36.1 Net Change – WC (739) (800) 1,088 (81) 1,311
ROIC 14.8 16.3 27.6 53.8 73.4 Direct taxes (927) (760) (865) (1,791) (2,126)
Turnover (days) Net cash from operations 5,513 5,274 9,241 8,176 10,779
Gross block turnover ratio (x) 0.9 0.9 0.9 1.0 1.1 Capital expenditure (1,329) (1,481) (320) (1,140) (1,027)
Debtors 26 36 34 27 26 Acquisitions, net (25) (20) (15) 0 0
Inventory 82 97 107 113 94 Investments 945 (879) (2,253) 0 0
Creditors 105 128 133 130 129 Others 175 103 319 973 1,104
Net working capital 38 62 66 103 138 Net cash from investing (234) (2,277) (2,270) (167) 77
Solvency (x) FCF 5,279 2,997 6,971 8,008 10,856
Net debt-equity 0.0 0.0 (0.2) (0.4) (0.6) Issue of share capital 0 (625) (1,756) 0 0
Interest coverage ratio 32.3 32.9 66.5 117.1 119.5 Increase/(decrease) in debt (2,160) 970 (1,247) 115 139
Net debt/EBITDA (0.1) 0.0 (0.4) (0.7) (1.2) Dividend paid (1,902) (4,191) (3,747) (4,032) (4,717)
Per share (Rs) Interest paid (214) (207) (133) (86) (97)
Adjusted EPS 10.9 11.6 15.1 17.9 20.9 Others 0 0 0 0 0
BVPS 45.7 40.2 39.7 46.7 55.2 Net cash from financing (4,277) (4,054) (6,882) (4,003) (4,675)
CEPS 18.1 19.0 23.3 22.4 25.4 Net change in Cash 1,003 (1,056) 90 4,005 6,181
DPS 3.5 8.0 8.0 9.1 10.6 Source: Company, Centrum Broking
Dividend payout (%) 55.1 179.8 68.9 56.3 55.5
Valuation (x)
P/E 54.3 51.2 39.4 33.2 28.4
P/BV 13.0 14.8 15.0 12.7 10.8
EV/EBITDA 38.0 38.3 29.5 25.5 21.6
Dividend yield (%) 0.6 1.3 1.3 1.5 1.8
Source: Company, Centrum Broking

Centrum Institutional Research 147


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Godfrey Phillips India (GP)


Over the last 10 years, GP has delivered 4.4% revenue CAGR and 7.9% PAT CAGR, Market data
though growth has been volatile, as the cigarette industry is highly regulated and Current price: Rs1,050
driven by frequent policy interventions and taxation changes. Operating profits have Bloomberg: GP IN
been moderated due to investments in 24Seven retail business. Over FY12-21, 52-week H/L: Rs1,110/832
cumulative profit before WC has been Rs38.4bn (tax paid: Rs8.9bn) and cash flow
Market cap: Rs54.6bn
from operating activities has been Rs28.6bn. On an average, OCF/PAT has been 145%
till FY21 (FY21: 84%) and OCF/EBITDA has been 95% till FY21 (FY21: 60%). Cumulative Free float: 41.4%
capex has been Rs12.2bn and GP has generated cumulative FCF of Rs16.4bn over Avg. daily vol. 3mth: 143,111
FY12-21. Average dividend payout has been 26.6%. Source: Bloomberg

Robust cash flows from operations: Operating profits have been moderated, as GP invested heavily in 24Seven retail business.
Working capital intensity in the cigarette business has been moderate. Over FY12-21, cumulative profit before WC has been
Rs38.4bn (of which tax paid: Rs8.9bn) and cash flow from operating activities has been Rs28.6bn.
Exhibit 400: Robust cash flows from operations
8

6 FY15: Increase FY18: Increase in


in inventories trade payables
4
Rs bn

-2
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-4 Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: Over the years, GP has significantly improved its inventory and debtor days (except FY21),
which has reflected in optimization of its cash conversion cycle. On an average, OCF/PAT has been 145% till FY21 and
OCF/EBITDA has been 95%. These ratios were abnormally low in FY15 due to low OCF (increase in inventory) and abnormally
high in FY18 due to high OCF (increase in trade payables).
Exhibit 401: Cash conversion cycle improved consistently over FY16-20
300 250

250 200
200
150
Days
Days

150
100
100

50 50

0 -
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtor days Inventory days Payable days Cash conversion cycle
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Godfrey Phillips India (GP) 16 September 2021

Exhibit 402: OCF/PAT Exhibit 403: OCF/EBITDA


350 250
300
200
250
200 150

%
%

150 100
100
50
50
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Free cash flows: Over FY12-21, cumulative cash from operating activities was Rs28.6bn, while capex was Rs12.2bn, translating
to cumulative FCF of Rs16.4bn. Capex was primarily for addition of cigarette and chewing product capacity.
Exhibit 404: Cumulative FCF of Rs16.4bn over FY12-21

7
FY12: Rabale, FY16: Mumbai Metro
5 Ghaziabad, Bazpur, (Cigarettes)
Kolkata and Ongole
3
Rs bn

-1
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-3
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 405: Return ratios (%)


25

20
High CoGS impacted margins in FY17 and
15 FY18, which in turn impacted return ratios
%

10

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE RoCE
Source: Company, Centrum Broking

Return ratios improving since FY18: The Indian tobacco industry is heavily regulated; therefore, business volumes tend to be
volatile. High CoGS impacted margins in FY17 and FY18, which in turn impacted return ratios. However, return ratios have been
improving since then. Over FY12-21, average dividend payout has been 26.6%.
Exhibit 406: Cash flow summary
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 2,059 1,837 2,897 631 3,260 2,481 5,138 3,515 3,766 2,996
Cash Flow from Investing Activities -2,251 -785 -1,350 -315 -1,262 -1,314 -4,088 -3,119 -704 -3,180
Cash from Financing Activities 39 -1,059 -1,578 -306 -1,996 -1,200 -961 -394 -2,991 72
Net increase/ (decrease) in Cash and Cash Equivalents -153 -7 -30 10 3 -33 89 2 72 -112
Closing Cash & Cash Equivalent 118 110 80 90 93 78 167 169 241 128
Source: Company Centrum Broking

Centrum Institutional Research 149


Godfrey Phillips India (GP) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 24,494 28,274 24,686 27,055 29,926 Equity share capital 104 104 104 104 104
Operating Expense 16,106 17,866 15,691 17,299 18,945 Reserves & surplus 18,859 20,505 24,060 26,865 30,234
Employee cost 2,516 2,500 2,355 2,502 2,831 Shareholders fund 18,963 20,609 24,164 26,969 30,338
Others 2,344 2,246 1,687 1,894 2,172 Minority Interest 0 0 0 0 0
EBITDA 3,528 5,662 4,954 5,360 5,978 Total debt 412 3,557 3,346 3,346 3,346
Depreciation & Amortisation 959 1,524 1,385 1,585 1,698 Non Current Liabilities 213 245 260 260 260
EBIT 2,569 4,139 3,569 3,775 4,281 Def tax liab. (net) 21 24 70 70 70
Interest expenses 9 301 307 313 319 Total liabilities 19,608 24,435 27,840 30,645 34,014
Other income 1,066 1,322 1,387 1,787 2,073 Gross block 10,431 15,006 15,839 17,686 18,817
PBT 3,626 5,159 4,649 5,248 6,034 Less: acc. Depreciation (3,782) (5,187) (5,852) (7,437) (9,135)
Taxes 1,217 1,280 1,080 1,323 1,521 Net block 6,649 9,819 9,986 10,249 9,682
Effective tax rate (%) 33.6 24.8 23.2 25.2 25.2 Capital WIP 143 165 262 262 262
PAT 2,410 3,879 3,569 3,926 4,514 Net fixed assets 6,793 9,984 10,248 10,510 9,944
Minority/Associates 0 0 0 0 0 Non Current Assets 731 768 501 501 501
Recurring PAT 2,410 3,879 3,569 3,926 4,514 Investments 0 0 0 0 0
Extraordinary items (18) (102) (14) 0 0 Inventories 5,690 6,140 6,706 6,152 6,756
Reported PAT 2,391 3,777 3,556 3,926 4,514 Sundry debtors 670 667 1,237 904 1,000
Cash & Cash Equivalents 11,708 12,267 15,022 19,343 22,592
Ratios Loans & advances 13 14 15 15 15
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 837 1,132 1,455 893 988
Growth (%) Trade payables 2,909 2,506 2,393 2,723 2,832
Revenue 7.4 15.4 (12.7) 9.6 10.6 Other current liab. 3,818 3,882 4,754 4,754 4,754
EBITDA 55.1 60.5 (12.5) 8.2 11.5 Provisions 105 151 197 197 197
Adj. EPS 71.2 61.0 (8.0) 10.0 15.0 Net current assets 12,084 13,682 17,091 19,634 23,569
Margins (%) Total assets 19,608 24,435 27,840 30,645 34,014
Gross 56.3 55.7 50.6 55.0 55.4
EBITDA 14.4 20.0 20.1 19.8 20.0 Cashflow
EBIT 10.5 14.6 14.5 14.0 14.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 9.8 13.7 14.5 14.5 15.1 Profit Before Tax 4,102 6,082 5,328 5,360 5,978
Returns (%) Depreciation & Amortisation 0 0 0 0 0
ROE 13.4 19.6 15.9 15.4 15.8 Net Interest 0 0 0 0 0
ROCE 13.2 18.9 14.7 14.4 14.9 Net Change – WC 690 (1,092) (1,341) 1,778 (686)
ROIC 21.8 31.8 22.5 24.1 29.0 Direct taxes (1,277) (1,225) (991) (1,323) (1,521)
Turnover (days) Net cash from operations 3,515 3,766 2,996 5,815 3,771
Gross block turnover ratio (x) 2.3 1.9 1.6 1.5 1.6 Capital expenditure (1,238) (1,150) (1,267) (1,117) (1,131)
Debtors 12 9 14 14 12 Acquisitions, net (55) (48) (242) 0 0
Inventory 184 172 192 193 177 Investments (1,871) 392 (1,710) 0 0
Creditors 79 79 73 77 76 Others 44 102 38 1,787 2,073
Net working capital 180 177 253 265 287 Net cash from investing (3,119) (704) (3,180) 670 942
Solvency (x) FCF 396 3,062 (184) 6,485 4,713
Net debt-equity (0.6) (0.4) (0.5) (0.6) (0.6) Issue of share capital 0 0 0 0 0
Interest coverage ratio 411.0 18.8 16.1 17.1 18.7 Increase/(decrease) in debt 145 (604) 384 (253) (253)
Net debt/EBITDA (3.2) (1.5) (2.4) (3.0) (3.2) Dividend paid (498) (2,087) (25) (1,248) (1,248)
Per share (Rs) Interest paid (41) (299) (287) (313) (319)
Adjusted EPS 46.3 74.6 68.6 75.5 86.8 Others 0 0 0 0 0
BVPS 364.7 396.4 464.8 518.7 583.5 Net cash from financing (394) (2,991) 72 (1,814) (1,821)
CEPS 64.8 103.9 95.3 106.0 119.5 Net change in Cash 2 72 (112) 4,671 2,892
DPS 10.0 24.0 24.0 31.0 35.0 Source: Company, Centrum Broking
Dividend payout (%) 21.7 33.0 35.1 41.1 40.3
Valuation (x)
P/E 22.7 14.1 15.3 13.9 12.1
P/BV 2.9 2.7 2.3 2.0 1.8
EV/EBITDA 12.3 8.1 8.7 7.2 5.9
Dividend yield (%) 1.0 2.3 2.3 3.0 3.3
Source: Company, Centrum Broking

Centrum Institutional Research 150


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

Hindustan Unilever (HUVR)


HUVR reported 8.8% revenue CAGR and 13.2% PAT CAGR over FY12-21. Operating Market data
profits have been healthy and have consistently expanded. Gross margins improved Current price: Rs2,768
600bp from 47% in FY12 to 53% in FY21. Over FY12-21, cumulative profit before WC Bloomberg: HUVR IN
has been Rs660bn (tax paid: Rs178.9bn) and cash flow from operating activities has 52-week H/L: Rs2,825/2,000
been Rs502.3bn. Importantly, over the decade, HUVR could cut its inventory from 83
Market cap: Rs6504.3bn
days to 51 days, with investment in IT. On an average, OCF/PAT has been 101% till
FY21 (FY21: 112%) and OCF/EBITDA has been 78% (FY21: 79%). Cumulative capex has Free float: 34.5%
been Rs97.9bn and HUVR has generated cumulative FCF of Rs404.4bn over FY12-21. Avg. daily vol. 3mth: 1,537,602
Average dividend payout has been 83.3%. Source: Bloomberg

Robust cash flows from operations: Operating profits have grown consistently over the last 10 years, driven by 600bp gross
margin expansion. Working capital intensity in the business has been low to moderate, and the company has been ensuring
sufficient liquidity. Over FY12-21, cumulative profit before WC has been Rs660.0bn (of which tax paid: Rs178.9bn) and cash
flow from operating activities has been Rs502.3bn.
Exhibit 407: Consistent growth in cash flows from operations
120
100
80
Rs bn

60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: HUVR has been able to reduce its inventory days from 83 days in FY12 to 51 days in FY21,
with investment in supply chain, IT infrastructure and distributor sales management (DMS). Cash conversion cycle has
improved from -54 days in FY12 to -74 days in FY21. On an average, OCF/PAT has been 101% till FY21 and OCF/EBITDA has
been 78% – one of the healthiest across the FMCG universe.
Exhibit 408: Cash conversion cycle has improved over the years
160 -
140
-20
120
100 -40
Days

Days

80
60 -60
40
-80
20
0 -100
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtor days Inventory days Payable days Cash conversion cycle
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Hindustan Unilever (HUVR) 16 September 2021

Exhibit 409: OCF/PAT Exhibit 410: OCF/EBITDA


120 100

100 80
80
60

%
60
%

40
40
20
20

0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady improvement in free cash flows, aided by strong M&A: Over FY12-21, cumulative cash from operating activities was
Rs502.3bn, while capex was Rs97.9bn, translating to cumulative FCF of Rs404.4bn. In FY17, HUVR completed the acquisition of
Indulekha for Rs3.3bn and further deferred payments (10% of turnover) based on performance for five years (entered deal in
FY16). In FY19, it acquired Aditya Milks for an upfront consideration of Rs0.65bn and a deferred consideration of Rs0.18bn. In
FY20, it acquired GSK CH nutrition business (Rs30.5bn) and entered into an agreement to acquire the intimate hygiene brand
VWash from Glenmark Pharmaceuticals for a cash consideration of Rs2.86bn and a deferred contingent consideration of
Rs0.12bn (deal effect of both seen in FY21).
Exhibit 411: Free cash flows have improved steadily
FY20: Acquired GSK
100 FY19: Acquired CH and VWash
FY17: Completed Aditya Milks
acquisition of Indulekha
50
Rs bn

-50 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 412: Return ratios (%)


140
120
100
80
%

60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE RoCE
Source: Company, Centrum Broking

Average dividend payout of 83.3%: In terms of cash flows from financing activities, major chunk of outflows has been on
dividend and some portion on working capital needs. The company can avail cash credit and working capital loans on demand.
Over FY12-21, average dividend payout has been 83.3%.
Exhibit 413: Cash flow summary
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 28,724 35,296 37,242 32,719 39,740 49,530 59,130 57,280 73,050 89,570
Cash Flow from Investing Activities -4,525 343 -5,132 2,799 -510 -7,520 -12,610 -2,640 19,260 -13,670
Cash from Financing Activities -17,252 -41,604 -29,168 -34,504 -40,080 -42,640 -46,510 -54,620 -66,760 -92,800
Net increase/ (decrease) in Cash and Cash Equivalents 6,948 -5,965 2,942 1,014 -850 -630 10 20 25,550 -16,900
Closing Cash & Cash Equivalent 9,229 3,264 6,206 7,220 6,350 5,720 5,730 5,750 31,300 17,400
Source: Company, Centrum Broking

Centrum Institutional Research 152


Hindustan Unilever (HUVR) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 376,600 382,730 453,110 489,501 533,339 Equity share capital 2,160 2,160 2,350 2,350 2,350
Operating Expense 270,710 269,070 315,760 330,203 358,904 Reserves & surplus 74,430 78,150 471,990 548,178 578,771
Employee cost 17,470 16,910 22,290 27,152 29,116 Shareholders fund 76,590 80,310 474,340 550,528 581,121
Others 7,690 5,870 8,670 12,997 14,705 Minority Interest 0 0 0 0 0
EBITDA 86,370 96,000 113,240 126,266 137,271 Total debt 0 0 0 0 0
Depreciation & Amortisation 5,240 9,380 10,120 9,253 9,684 Non Current Liabilities 18,530 24,670 98,410 101,345 109,279
EBIT 81,130 86,620 103,120 117,013 127,588 Def tax liab. (net) 0 0 0 0 0
Interest expenses 280 1,060 1,080 605 265 Total liabilities 95,120 104,980 572,750 651,873 690,400
Other income 6,640 7,330 5,130 17,100 17,716 Gross block 54,760 68,820 88,640 135,805 177,159
PBT 87,490 92,890 107,170 133,509 145,039 Less: acc. Depreciation (15,690) (22,570) (30,780) (43,827) (53,510)
Taxes 24,860 23,540 25,360 34,577 37,556 Net block 39,070 46,250 57,860 91,978 123,649
Effective tax rate (%) 28.4 25.3 23.7 25.9 25.9 Capital WIP 3,730 5,130 6,230 6,356 6,356
PAT 62,630 69,350 81,810 98,932 107,483 Net fixed assets 47,160 55,690 516,500 550,795 582,466
Minority/Associates 0 0 0 0 0 Non Current Assets 11,800 16,120 25,140 27,600 29,558
Recurring PAT 62,630 69,350 81,810 98,932 107,483 Investments 2,560 2,520 3,120 3,120 3,120
Extraordinary items (2,300) (2,860) (2,060) 0 0 Inventories 24,220 26,360 33,830 34,713 36,121
Reported PAT 60,330 66,490 79,750 98,932 107,483 Sundry debtors 16,730 10,460 16,480 17,716 18,214
Cash & Cash Equivalents 63,810 62,650 70,040 117,344 129,289
Ratios Loans & advances 8,940 19,430 15,880 16,213 17,348
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 40 180 170 1,940 2,406
Growth (%) Trade payables 70,700 73,990 86,270 89,963 97,407
Revenue 11.0 1.6 18.4 8.0 9.0 Other current liab. 7,820 12,870 17,230 21,978 24,249
EBITDA 18.7 11.1 18.0 11.5 8.7 Provisions 5,010 4,180 4,910 6,766 7,604
Adj. EPS 18.2 10.7 8.7 20.9 8.6 Net current assets 30,210 28,040 27,990 69,219 74,118
Margins (%) Total assets 95,120 104,980 572,750 651,873 690,400
Gross 53.8 54.8 53.7 57.6 54.4
EBITDA 22.6 24.8 24.6 25.4 25.4 Cashflow
EBIT 21.2 22.3 22.4 23.6 23.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 16.4 17.9 17.8 19.9 19.9 Profit Before Tax 85,220 90,920 104,900 133,509 145,039
Returns (%) Depreciation & Amortisation 5,240 9,380 10,690 9,253 9,684
ROE 85.0 88.4 29.5 19.3 19.0 Net Interest (3,980) (4,900) (3,440) (16,496) (17,451)
ROCE 85.3 89.4 29.8 19.4 19.0 Net Change – WC (2,610) 2,970 (560) 780 13,023
ROIC 720.1 510.0 37.8 20.9 21.5 Direct taxes (26,850) (24,650) (23,670) (34,577) (37,556)
Turnover (days) Net cash from operations 57,280 73,050 89,570 92,469 112,738
Gross block turnover ratio (x) 6.9 5.6 5.1 3.6 3.0 Capital expenditure (7,240) (7,130) (39,540) (39,044) (41,354)
Debtors 13 13 11 13 12 Acquisitions, net 0 0 0 0 0
Inventory 49 52 51 58 52 Investments 620 22,140 22,330 0 0
Creditors 143 148 135 150 137 Others 3,980 4,250 3,540 17,100 17,716
Net working capital 29 27 23 52 51 Net cash from investing (2,640) 19,260 (13,670) (21,944) (23,639)
Solvency (x) FCF 54,640 92,310 75,900 70,525 89,099
Net debt-equity (0.8) (0.8) (0.1) (0.2) (0.2) Issue of share capital 0 0 0 0 0
Interest coverage ratio 308.5 90.6 104.9 208.8 518.8 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (0.7) (0.7) (0.6) (0.9) (0.9) Dividend paid (54,590) (62,440) (88,110) (78,171) (76,889)
Per share (Rs) Interest paid (30) (4,320) (4,690) (605) (265)
Adjusted EPS 28.9 32.0 34.8 42.1 45.7 Others 0 0 0 0 0
BVPS 35.4 37.1 201.8 234.3 247.3 Net cash from financing (54,620) (66,760) (92,800) (78,776) (77,154)
CEPS 31.3 36.4 39.1 46.0 49.9 Net change in Cash 20 25,550 (16,900) (8,250) 11,945
DPS 22.0 25.0 37.5 28.0 31.0 Source: Company, Centrum Broking
Dividend payout (%) 78.9 81.4 110.5 66.5 67.8
Valuation (x)
P/E 95.7 86.4 79.5 65.8 60.5
P/BV 78.2 74.6 13.7 11.8 11.2
EV/EBITDA 74.6 67.1 56.8 50.6 46.4
Dividend yield (%) 0.8 0.9 1.4 1.0 1.1
Source: Company, Centrum Broking

Centrum Institutional Research 153


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

ITC
ITC reported 7.9% revenue CAGR and 10.3% PAT CAGR over FY12-21. Operating profits Market data
have been healthy and have consistently expanded, with cigarette business the Current price: Rs231
dominant contributor to profitability. Over FY12-21, cumulative profit before WC has Bloomberg: ITC IN
been Rs1.43tn (tax paid: Rs430.8bn) and cash flow from operating activities has been 52-week H/L: Rs239/163
Rs979.1bn. On an average, OCF/PAT has been 95% till FY21 (FY21: 87%) and
Market cap: Rs2840.5bn
OCF/EBITDA has been 71% (FY21: 76%). As the company invested heavily in
Hotel/FMCG businesses over FY12-21, cumulative capex has been Rs239.9bn and FCF Free float: 56.4%
has been Rs739.2bn. Average dividend payout has been 65.1%. Avg. daily vol. 3mth: 19,552,500
Source: Bloomberg

Robust cash flows from operations: Operating profits have grown consistently, with stable gross margin of ~60% over the last
10 years, despite disruptions in cigarette revenues on account of unpredicted taxation. Working capital intensity in the business
has been low, and the company has been ensuring sufficient liquidity. Over FY12-21 cumulative profit before WC has been
Rs1.43tn (of which tax paid: Rs430.8bn) and cash flow from operating activities has been Rs979.1bn.
Exhibit 414: Cash flows from operations have grown over the last decade
200

150

100
Rs bn

50

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: ITC has been able to reduce its inventory days from 207 to 160 days over FY12-21, resulting
in improvement in cash conversion cycle from 167 days in FY12 to 108 days in FY21. Its payable days have been increasing
mainly due to change in product mix and it may take some time for ITC to gain buyer power. On an average, OCF/PAT has been
95% till FY21 and OCF/EBITDA has been 71%.
Exhibit 415: Cash conversion cycle has improved over the years
250 200

200
150
150
Days
Days

100
100
50
50

0 -
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtor days Inventory days Payable days Cash conversion cycle
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
ITC 16 September 2021
Exhibit 416: OCF/PAT Exhibit 417: OCF/EBITDA
120 90
80
100
70
80 60
50
60
%

%
40
40 30
20
20
10
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady free cash flows: Over FY12-21, cumulative cash from operating activities was Rs979.1bn, while capex was Rs239.9bn,
translating to cumulative FCF of Rs739.2bn. In FY15, ITC acquired Savlon and Shower to Shower brands from Johnson &
Johnson. In FY16, it acquired Technico Agri Sciences Ltd (TASL) for Rs1.2bn. In FY19, paperboards capacity was augmented in
VAP segment at Bhadrachalam. Domestic manufacturing capacity for agarbatti (incense sticks) was enhanced through
technology upgradation and standardization of processes. In FY21, Sunrise Foods Private Ltd was acquired for Rs21.5bn.
Exhibit 418: Generated cumulative FCF of Rs739.2bn over FY12-21
150 FY15: Savlon and Shower FY16: Technico FY21: Sunrise Foods
to Shower Agri Sciences Ltd
100
Rs bn

50

-50 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Cash From Operating Activities CAPEX FCF


Source: Company, Centrum Broking

Exhibit 419: Return ratios (%)


40

30

20
%

10

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE RoCE
Source: Company Centrum Broking

Average dividend payout of 65.1%: In terms of cash flows from financing activities, major chunk of the outflows has been for
dividend and some portion has been for repayment of borrowings. Effective FY20, the company revised its dividend payout
policy, expecting to pay 80-85% of its earnings as dividend. Over FY12-21, average dividend payout has been 65.1%.
Exhibit 420: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Payout (%) 57.1 55.9 54.3 52.1 73.3 56.6 56.0 55.0 90.7 99.7
Source: Company, Centrum Broking

Exhibit 421: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 60,156 67,099 69,623 93,089 92,119 1,00,020 1,26,509 1,17,491 1,38,062 1,14,940
Cash Flow from Investing Activities -25,442 -35,808 -28,233 -48,226 -37,109 -27,803 -66,912 -50,818 -55,167 64,979
Cash from Financing Activities -32,466 -32,326 -41,739 -45,736 -54,651 -71,376 -60,199 -66,006 -78,909 -1,83,789
Net increase/ (decrease) in Cash and Cash Equivalents 2,249 -1,034 -348 -873 359 841 -602 667 3,986 -3,871
Closing Cash & Cash Equivalent 2,593 1,559 1,211 363 722 1,563 960 1,627 5,614 2,312
Source: Company, Centrum Broking

Centrum Institutional Research 155


ITC 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 444,327 451,361 451,118 489,180 554,632 Equity share capital 12,259 12,292 12,309 12,309 12,309
Operating Expense 173,052 172,351 199,746 185,292 210,083 Reserves & surplus 567,239 627,999 577,737 601,557 628,261
Employee cost 27,284 26,582 28,210 30,590 34,405 Shareholders fund 579,498 640,292 590,046 613,866 640,570
Others 76,566 78,221 71,671 85,712 98,047 Minority Interest 0 0 0 0 0
EBITDA 167,425 174,206 151,492 187,587 212,097 Total debt 79 3,298 3,290 3,290 3,290
Depreciation & Amortisation 13,117 15,633 15,618 15,730 18,292 Non Current Liabilities 1,745 2,343 3,964 4,299 4,874
EBIT 154,308 158,574 135,873 171,858 193,805 Def tax liab. (net) 20,441 16,177 17,277 17,277 17,277
Interest expenses 342 557 475 475 475 Total liabilities 601,764 662,108 614,577 638,732 666,011
Other income 30,475 34,973 36,243 37,777 41,153 Gross block 221,765 255,847 265,633 281,427 297,521
PBT 184,442 192,989 171,642 209,159 234,483 Less: acc. Depreciation (42,309) (55,866) (69,700) (85,429) (103,721)
Taxes 59,798 40,308 41,325 50,358 56,455 Net block 179,457 199,981 195,933 195,997 193,800
Effective tax rate (%) 32.4 20.9 24.1 24.1 24.1 Capital WIP 33,915 27,763 33,300 33,300 33,300
PAT 124,643 152,682 130,316 158,801 178,028 Net fixed assets 218,878 232,978 255,083 255,147 252,950
Minority/Associates 0 0 0 0 0 Non Current Assets 27,518 19,751 13,064 13,128 13,236
Recurring PAT 124,643 152,682 130,316 158,801 178,028 Investments 47,030 36,736 32,397 32,397 32,397
Extraordinary items 3,626 (15,139) 2,463 0 0 Inventories 75,872 80,381 94,709 83,531 93,948
Reported PAT 128,269 137,542 132,779 158,801 178,028 Sundry debtors 36,462 20,920 20,904 28,643 32,095
Cash & Cash Equivalents 271,617 338,003 277,589 304,754 331,185
Ratios Loans & advances 13,653 15,108 11,999 13,012 14,753
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 6,949 8,477 10,061 10,910 12,369
Growth (%) Trade payables 33,683 34,467 41,195 37,690 43,113
Revenue 10.4 1.6 (0.1) 8.4 13.4 Other current liab. 62,280 54,599 58,342 63,265 71,730
EBITDA 10.4 4.1 (13.0) 23.8 13.1 Provisions 252 1,179 1,691 1,833 2,078
Adj. EPS 13.6 22.5 (14.6) 21.9 12.1 Net current assets 308,338 372,643 314,033 338,061 367,429
Margins (%) Total assets 601,764 662,108 614,577 638,732 666,011
Gross 61.1 61.8 55.7 62.1 62.1
EBITDA 37.7 38.6 33.6 38.3 38.2 Cashflow
EBIT 34.7 35.1 30.1 35.1 34.9 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 28.1 33.8 28.9 32.5 32.1 Profit Before Tax 184,442 191,668 171,642 209,159 234,483
Returns (%) Depreciation & Amortisation 13,117 15,633 15,618 15,730 18,292
ROE 22.8 25.0 21.2 26.4 28.4 Net Interest (16,243) (19,343) (19,013) (20,399) (22,170)
ROCE 22.8 25.0 21.1 26.3 28.3 Net Change – WC (4,997) 4,180 (3,948) 3,408 (2,470)
ROIC 41.3 47.4 37.4 46.3 52.5 Direct taxes (54,859) (46,501) (39,566) (50,358) (56,455)
Turnover (days) Net cash from operations 117,491 138,062 114,940 157,541 171,679
Gross block turnover ratio (x) 2.0 1.8 1.7 1.7 1.9 Capital expenditure (27,595) (21,136) (15,794) (15,794) (16,094)
Debtors 25 23 17 18 20 Acquisitions, net 0 0 0 0 0
Inventory 156 165 160 176 154 Investments (38,514) (53,945) 61,508 0 0
Creditors 71 72 69 78 70 Others 15,291 19,914 19,265 20,873 22,645
Net working capital 253 301 254 252 242 Net cash from investing (50,818) (55,167) 64,979 5,079 6,551
Solvency (x) FCF 66,673 82,895 179,918 162,620 178,230
Net debt-equity (0.5) (0.5) (0.5) (0.5) (0.5) Issue of share capital 9,691 6,253 2,907 0 0
Interest coverage ratio 489.7 312.6 319.1 395.2 446.8 Increase/(decrease) in debt 39 (44) 389 0 0
Net debt/EBITDA (1.6) (1.9) (1.8) (1.6) (1.5) Dividend paid (74,869) (84,222) (186,153) (134,981) (151,324)
Per share (Rs) Interest paid (867) (896) (931) (475) (475)
Adjusted EPS 10.1 12.4 10.6 12.9 14.5 Others 0 0 0 0 0
BVPS 47.1 52.1 48.0 49.9 52.1 Net cash from financing (66,006) (78,909) (183,789) (135,456) (151,798)
CEPS 11.2 13.7 11.9 14.2 16.0 Net change in Cash 667 3,986 (3,871) 27,164 26,432
DPS 5.7 10.1 10.8 11.0 12.3 Source: Company, Centrum Broking
Dividend payout (%) 55.0 90.7 99.7 85.0 85.0
Valuation (x)
P/E 22.8 18.6 21.8 17.9 15.9
P/BV 4.9 4.4 4.8 4.6 4.4
EV/EBITDA 15.3 14.4 16.9 13.5 11.8
Dividend yield (%) 2.5 4.4 4.7 4.8 5.3
Source: Company, Centrum Broking

Centrum Institutional Research 156


16 September 20211

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

V-Mart Retail (VMART)


VMART has reported 17.5% revenue CAGR and 21.5% EBITDA CAGR over FY12-21. In Market data
FY21, Covid derailed growth for the company; its inventory days rose to 229, Current price: Rs3,494
impacting return ratios. Operating profits have been healthy and have consistently Bloomberg: VMART IN
expanded with scale of operations. Over FY12-21, cumulative profit before WC has 52-week H/L: Rs4,085/1,878
been Rs10.1bn (tax paid: Rs1.8bn) and cash flow from operating activities has been
Market cap: Rs69bn
Rs5.6bn. On an average, OCF/PAT has been 118% till FY20 (VMART reported PAT loss
in FY21 owing to lower scale of operations) and OCF/EBITDA has been 58% till FY21 Free float: 53.1%
(FY21: 114%). Cumulative capex has been Rs3.5bn and FCF has been Rs2.1bn. Avg. daily vol. 3mth: 59,414
Source: Bloomberg

History of steady improvement of cash flows from operations: Operating profits have grown consistently over the last 10
years, led by 360bp improvement in gross margin. Working capital intensity has been high due to the nature of the industry.
VMART has consistently generated healthy operating cash flows over the years (FY21 an exception). Over FY12-21, cumulative
profit before WC has been Rs10.1bn (of which tax paid: Rs1.8bn) and cash flow from operating activities has been Rs5.6bn.
Exhibit 422: Consistent improvement in cash flows from operations over the last decade
2.5 FY20: High inventory
2
1.5
1
Rs bn

0.5
0
-0.5
-1
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1.5
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: VMART does not have debtors, as it operates on cash sales. Cash conversion cycle improved
from 85 days in FY13 to 60 days in FY19, but worsened in to 75 days in FY20 and 131 days in FY21. OCF/PAT improved from
158% in FY12 to 175% in FY20 (loss in FY21) and OCF/EBITDA improved from 61% in FY12 to 114% in FY21. On an average,
OCF/PAT has been 118% till FY20 and OCF/EBITDA has been 52% till FY20 (58% till FY21).
Exhibit 423: After improving from 85 days in FY13 to 60 days in FY19, cash conversion cycle worsened to 131 days in FY21
250 FY21: Covid impact 140
120
200
100
150 80
Days
Days

100 60
40
50
20
0 -
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtor days Inventory days Payable days Cash conversion cycle
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
V-Mart Retail (VMART) 16 September 20211

Exhibit 424: OCF/PAT Exhibit 425: OCF/EBITDA


500 120
0 100
-500 80

-1000 60
%

%
-1500 40

-2000 20

-2500 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Steady free cash flows: Over FY12-21, cumulative cash from operating activities has been Rs5.6bn, while capex has been
Rs3.5bn, translating to cumulative FCF of Rs2.1bn. Capex is primarily for store expansion and refurbishment. VMART raised
Rs3.75bn in Q4FY21 for setting up warehouse and other expansion plans. In Q2FY22, it announced the acquisition of the
Unlimited brand for Rs1.5bn.
Exhibit 426: Consistent growth in FCF
2
1.5
1
Rs bn

0.5
0
-0.5
-1
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities CAPEX FCF
Source: Company, Centrum Broking

Exhibit 427: Return ratios (%)


30

20
%

10

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-10
RoE RoCE
Source: Company, Centrum Broking

Return ratios healthy except for FY20 and FY21: Overall return ratios have been healthy, except for FY20 and FY21. Covid-led
disruptions have derailed store expansion and impacted non-essential purchases.
Exhibit 428: Leverage ratios
Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity (x) 0.7 -0.1 0.1 0.1 0.0 -0.1 -0.1 -0.2 1.1 0.3
Net Debt/EBITDA (x) 1.4 -0.2 0.4 0.2 0.1 -0.4 -0.4 -0.5 2.4 1.7
Source: Company, Centrum Broking

In terms of cash flows from financing activities, VMART targets aggressive store rollout. It does not pay much dividends. Further,
the company has been able to draw working capital loans on demand from its lenders.
Exhibit 429: Cash flow summary
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 168 98 110 399 461 687 577 763 863 1,493
Cash Flow from Investing Activities -137 -622 -271 -191 -372 -728 -84 -734 5 -4,188
Cash from Financing Activities -35 666 23 -199 -96 49 -384 -44 -943 2,869
Net increase/ (decrease) in Cash and Cash Equivalents -4 143 -137 10 -6 8 109 -14 -75 174
Closing Cash & Cash Equivalent 11 153 16 26 20 29 137 123 48 222
Source: Company, Centrum Broking

Centrum Institutional Research 158


V-Mart Retail (VMART) 16 September 20211

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 14,322 16,616 10,739 17,488 27,254 Equity share capital 181 182 197 197 197
Operating Expense 11,136 12,223 7,776 12,469 19,584 Reserves & surplus 3,911 4,408 8,055 8,082 9,144
Employee cost 1,257 1,536 1,169 1,997 2,761 Shareholders fund 4,093 4,589 8,252 8,279 9,341
Others 615 724 498 789 1,390 Minority Interest 0 0 0 0 0
EBITDA 1,329 2,138 1,312 2,249 3,537 Total debt 0 5,167 5,678 6,677 8,831
Depreciation & Amortisation 276 939 1,030 1,123 1,540 Non Current Liabilities 111 61 73 73 73
EBIT 1,053 1,198 282 1,126 1,997 Def tax liab. (net) 0 0 0 0 0
Interest expenses 16 548 589 470 609 Total liabilities 4,204 9,818 14,004 15,029 18,246
Other income 59 45 210 231 139 Gross block 2,296 2,674 2,835 3,441 5,000
PBT 1,096 695 (97) 887 1,527 Less: acc. Depreciation (641) (925) (1,050) (1,497) (2,247)
Taxes 382 202 (35) 223 385 Net block 1,655 1,749 1,785 1,944 2,752
Effective tax rate (%) 34.8 29.0 35.8 25.2 25.2 Capital WIP 40 25 22 22 22
PAT 714 493 (62) 663 1,142 Net fixed assets 1,695 6,695 6,987 6,697 8,824
Minority/Associates 0 0 0 0 0 Non Current Assets 191 172 170 170 170
Recurring PAT 714 493 (62) 663 1,142 Investments 98 33 36 36 36
Extraordinary items (102) 0 (3) 0 0 Inventories 3,290 4,779 4,283 6,012 8,993
Reported PAT 613 493 (65) 663 1,142 Sundry debtors 0 0 0 0 0
Cash & Cash Equivalents 700 96 3,428 3,667 3,201
Ratios Loans & advances 1 0 5 5 5
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 225 301 1,102 1,102 1,102
Growth (%) Trade payables 1,483 1,968 1,917 2,569 3,994
Revenue 17.3 16.0 (35.4) 62.8 55.8 Other current liab. 535 354 224 224 224
EBITDA 0.1 60.8 (38.6) 71.4 57.3 Provisions 97 97 121 121 121
Adj. EPS (8.2) (30.9) nm nm 72.2 Net current assets 2,101 2,757 6,558 7,873 8,963
Margins (%) Total assets 4,204 9,818 14,004 15,029 18,246
Gross 32.4 32.2 32.8 32.8 32.9
EBITDA 9.3 12.9 12.2 12.8 13.0 Cashflow
EBIT 7.3 7.2 2.6 6.4 7.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 5.0 3.0 (0.6) 3.8 4.2 Profit Before Tax 1,095 1,257 316 1,126 1,997
Returns (%) Depreciation & Amortisation 276 939 1,030 1,123 1,540
ROE 18.9 11.4 (1.0) 8.0 13.0 Net Interest 0 0 0 0 0
ROCE 19.1 12.7 2.7 7.0 9.6 Net Change – WC (275) (1,091) 182 (1,077) (1,556)
ROIC 20.8 12.9 1.8 7.7 11.3 Direct taxes (332) (241) (35) (223) (385)
Turnover (days) Net cash from operations 763 863 1,493 948 1,597
Gross block turnover ratio (x) 6.2 6.2 3.8 5.1 5.5 Capital expenditure (407) (546) 1,981 (606) (1,558)
Debtors 0 0 0 0 0 Acquisitions, net 0 0 0 0 0
Inventory 120 131 229 160 150 Investments (338) 551 (6,179) 0 0
Creditors 59 56 98 70 65 Others 11 1 11 231 139
Net working capital 54 61 223 164 120 Net cash from investing (734) 5 (4,188) (375) (1,419)
Solvency (x) FCF 30 868 (2,695) 574 177
Net debt-equity (0.2) 1.1 0.3 0.4 0.6 Issue of share capital 19 13 3,713 0 0
Interest coverage ratio 82.4 3.9 2.2 4.8 5.8 Increase/(decrease) in debt (3) 8 (11) 0 0
Net debt/EBITDA (0.5) 2.4 1.7 1.3 1.6 Dividend paid (44) (37) 0 (46) (80)
Per share (Rs) Interest paid (16) (548) (589) (41) (145)
Adjusted EPS 39.4 27.2 (3.1) 33.7 58.0 Others 0 (379) (244) (332) (418)
BVPS 225.7 253.1 418.8 420.1 474.0 Net cash from financing (44) (943) 2,869 (419) (643)
CEPS 54.6 79.0 49.1 90.6 136.1 Net change in Cash (14) (75) 174 154 (466)
DPS 1.7 0.0 0.0 2.4 4.1 Source: Company, Centrum Broking
Dividend payout (%) 5.0 0.0 nm 7.0 7.0
Valuation (x)
P/E 88.7 128.4 nm 103.8 60.3
P/BV 15.5 13.8 8.3 8.3 7.4
EV/EBITDA 51.3 34.6 54.3 32.0 21.1
Dividend yield (%) 0.0 0.0 0.0 0.1 0.1
Source: Company, Centrum Broking

Centrum Institutional Research 159


16 September 2021

Institutional Research
Shirish Pardeshi
Research Analyst, Consumer
+91-22-4215 9634
[email protected]
SECTOR: CONSUMER

VST Industries (VST)


VST’s operating profits have been healthy and have expanded over the last 10 years Market data
despite regulatory headwinds faced by the cigarette industry. The company focuses Current price: Rs3,566
on the entry-point cigarette category and has been able to establish a new brand in Bloomberg: VST IN
the capsule segment, with dominant share. It manages its operations efficiently. Over 52-week H/L: Rs4,538/3,125
FY12-21, cumulative profit before WC has been Rs28.2bn (tax paid: Rs8.6bn) and cash
Market cap: Rs55.1bn
flow from operating activities has been Rs21.2bn. On an average, OCF/PAT has been
111% till FY21 and OCF/EBITDA has been 74%. Cumulative cash from operating Free float: 61.1%
activities has been Rs21.2bn and capex has been Rs3.7bn, translating to cumulative Avg. daily vol. 3mth: 15,076
FCF of Rs17.5bn. Over FY12-21, average dividend payout has been 67.6%. Source: Bloomberg

History of steady improvement of cash flows from operations: Over the last 10 years, VST has reported 6.7% revenue CAGR
and 11.6% EBITDA CAGR. Operating profits have been healthy and have constantly expanded. Being a single category business,
working capital intensity has been moderate, though in FY18, there was an increase in customer advances and other statutory
liabilities (tax matters), resulting in high cash inflows. The company has been consistently generating incremental operating
cash flows over the years. Over FY12-21, cumulative profit before WC has been Rs28.2bn (of which tax paid: Rs8.6bn) and cash
flow from operating activities has been Rs21.2bn, driven by ~610bp expansion in gross margin.
Exhibit 430: Cash flows from operations grew meaningfully post GST implementation in FY17
5

3
Rs bn

-1
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Profit Before Changes In working Capital Net Changes In working Capital Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital cycle: VST has been able to increase its payable days (+51 days) over the years by strengthening its
network/better negotiations and has had tight control over its inventory days (cut by 54 days) as well (FY21 being an exception).
Cash conversion cycle has improved considerably from 233 days in FY12 to 127 days in FY21. While OCF/PAT has improved
from 106% in FY12 to 92% in FY21, OCF/EBITDA has improved from 73% to 70%. On an average, OCF/PAT has been 111% till
FY21 and OCF/EBITDA has been 74%.
Exhibit 431: Cash conversion cycle has improved over the years

350 300
300 250
250
200
200
Days

Days

150
150
100
100
50 50
0 -
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Debtor days Inventory days Payable days Cash conversion cycle


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
VST Industries (VST) 16 September 2021

Exhibit 432: OCF/PAT Exhibit 433: OCF/EBITDA


160
250
140
200 120
100
150

%
80
%

100 60
40
50
20
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

GST implementation boosted FCF: Over FY12-21, cumulative cash from operating activities was Rs21.2bn, while capex was
Rs3.7bn, translating to cumulative FCF of Rs17.5bn. Though growth improved once the cigarette industry was brought under
GST in FY17, the FY12-17 period saw frequent changes in taxation, adversely impacting its operations. The company has been
able to reap benefits from its newly-launched capsule brand, Total at higher end of the DSFT segment, driving profitability.
Exhibit 434: Cash flows grew meaningfully post GST implementation in FY17
5

3
Rs bn

-1
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Cash From Operating Activities CAPEX FCFF


Source: Company, Centrum Broking

Exhibit 435: Return ratios (%)


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE (%) 51.4 42.5 47.5 45.1 42.7 33.3 32.5 36.4 41.9 36.0
RoCE (%) 51.4 42.5 47.5 45.1 42.7 33.3 32.5 36.4 41.9 36.0
Source: Company, Centrum Broking

Healthy return ratios: Despite lower sales CAGR of ~8% over FY12-21, return ratios have been healthy. The company maintains
high dividend payout, resulting in steady RoE/RoCE. Being a net cash company, VST has enough liquidity. As its leverage ratios
are favorable, it can access debt easily and quickly. In terms of cash flows from financing activities, there have been outflows
only towards dividend payments. VST follows the SLR (Safety, Liquidity and Return) model in deployment of surplus funds. The
company predominantly deploys money in debt funds of reputed mutual funds and tax-free bonds issued by government
bodies, ensuring sufficient liquidity to meet its liabilities. In the last 3-4 years, dividend payout was on declining trend; however,
over FY12-21, average dividend payout has been 74.5%.
Exhibit 436: Dividend payout (%)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Pay-out (%) 70.4 76.4 72.0 71.0 70.6 76.4 65.8 64.7 52.3 56.6
Source: Company, Centrum Broking

Exhibit 437: Cash flow summary


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash From Operating Activities 1,507 1,184 1,298 1,175 1,321 1,457 4,201 2,902 3,314 2,862
Cash Flow from Investing Activities -634 87 -183 31 -240 -178 -2,641 -1,480 -1,548 -1,440
Cash from Financing Activities -808 -1,167 -1,129 -1,265 -1,301 -1,301 -1,394 -1,443 -1,769 -1,591
Net increase/ (decrease) in Cash and Cash Equivalents 65 104 -14 -59 -219 -22 166 -21 -2 -169
Closing Cash & Cash Equivalent 328 432 419 360 141 119 285 264 262 94
Source: Company, Centrum Broking

Centrum Institutional Research 161


VST Industries (VST) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 10,976 12,381 11,098 12,318 13,388 Equity share capital 154 154 154 154 154
Operating Expense 5,727 6,267 5,037 6,214 6,728 Reserves & surplus 6,486 7,717 9,250 10,678 12,291
Employee cost 923 1,024 1,144 1,022 1,105 Shareholders fund 6,640 7,871 9,404 10,832 12,445
Others 810 955 822 833 878 Minority Interest 0 0 0 0 0
EBITDA 3,517 4,134 4,094 4,249 4,677 Total debt 0 0 0 0 0
Depreciation & Amortisation 413 418 351 363 419 Non Current Liabilities 185 199 221 221 221
EBIT 3,104 3,716 3,743 3,886 4,259 Def tax liab. (net) (310) (264) (252) (252) (252)
Interest expenses 0 0 0 0 0 Total liabilities 6,515 7,805 9,373 10,801 12,414
Other income 403 487 430 549 507 Gross block 3,295 3,443 3,643 4,209 4,886
PBT 3,507 4,203 4,173 4,435 4,766 Less: acc. Depreciation (1,162) (1,572) (1,916) (2,279) (2,697)
Taxes 1,238 1,162 1,065 1,132 1,217 Net block 2,133 1,871 1,727 1,930 2,188
Effective tax rate (%) 35.3 27.6 25.5 25.5 25.5 Capital WIP 3 127 333 333 333
PAT 2,268 3,041 3,108 3,303 3,550 Net fixed assets 2,137 1,998 2,060 2,263 2,521
Minority/Associates 0 0 0 0 0 Non Current Assets 11 52 10 10 10
Recurring PAT 2,268 3,041 3,108 3,303 3,550 Investments 24 19 28 28 28
Extraordinary items 0 0 0 0 0 Inventories 2,818 2,977 2,972 3,574 3,942
Reported PAT 2,268 3,041 3,108 3,303 3,550 Sundry debtors 143 154 152 247 259
Cash & Cash Equivalents 5,994 7,774 9,053 9,501 10,901
Ratios Loans & advances 0 0 0 0 0
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 630 535 331 367 399
Growth (%) Trade payables 830 1,428 1,315 840 921
Revenue 16.0 12.8 (10.4) 11.0 8.7 Other current liab. 4,413 4,275 3,918 4,349 4,727
EBITDA 20.1 17.5 (1.0) 3.8 10.1 Provisions 0 0 0 0 0
Adj. EPS 24.7 34.1 2.2 6.3 7.5 Net current assets 4,343 5,737 7,275 8,500 9,854
Margins (%) Total assets 6,515 7,805 9,373 10,801 12,414
Gross 49.9 51.7 56.8 51.5 51.7
EBITDA 32.0 33.4 36.9 34.5 34.9 Cashflow
EBIT 28.3 30.0 33.7 31.5 31.8 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 20.7 24.6 28.0 26.8 26.5 Profit Before Tax 3,558 4,163 4,117 4,249 4,677
Returns (%) Depreciation & Amortisation 0 0 0 0 0
ROE 36.4 41.9 36.0 32.6 30.5 Net Interest 0 0 0 0 0
ROCE 36.4 41.9 36.0 32.6 30.5 Net Change – WC 631 206 (181) (777) 46
ROIC 201.3 768.9 1,389.1 355.6 225.0 Direct taxes (1,287) (1,054) (1,075) (1,132) (1,217)
Turnover (days) Net cash from operations 2,902 3,314 2,862 2,340 3,507
Gross block turnover ratio (x) 3.3 3.6 3.0 2.9 2.7 Capital expenditure (258) (217) (464) (566) (677)
Debtors 7 4 5 6 7 Acquisitions, net 0 0 0 0 0
Inventory 177 177 227 200 212 Investments (1,223) (1,333) (977) 0 0
Creditors 47 69 105 66 50 Others 1 2 1 549 507
Net working capital 144 169 239 252 269 Net cash from investing (1,480) (1,548) (1,440) (17) (169)
Solvency (x) FCF 1,421 1,767 1,422 2,323 3,337
Net debt-equity (0.9) (1.0) (1.0) (0.9) (0.9) Issue of share capital 0 0 0 0 0
Interest coverage ratio 0.0 0.0 0.0 0.0 0.0 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (1.7) (1.9) (2.2) (2.2) (2.3) Dividend paid (1,443) (1,769) (1,591) (1,760) (1,937)
Per share (Rs) Interest paid 0 0 0 0 0
Adjusted EPS 146.9 196.9 201.3 213.9 229.9 Others 0 0 0 0 0
BVPS 430.0 509.7 609.0 701.5 805.9 Net cash from financing (1,443) (1,769) (1,591) (1,761) (1,937)
CEPS 173.7 224.0 224.0 237.4 257.0 Net change in Cash (21) (2) (169) 563 1,400
DPS 95.0 103.0 114.0 125.4 139.4 Source: Company, Centrum Broking
Dividend payout (%) 64.7 52.3 56.6 58.6 60.6
Valuation (x)
P/E 24.3 18.1 17.7 16.7 15.5
P/BV 8.3 7.0 5.9 5.1 4.4
EV/EBITDA 13.9 11.4 11.2 10.7 9.4
Dividend yield (%) 2.7 2.9 3.2 3.5 3.9
Source: Company, Centrum Broking

Centrum Institutional Research 162


16 September 2021

Institutional Research
Chirag Muchhala
Research Analyst, Consumer Electricals
+91 22 4215 9203
[email protected]
SECTOR: CONSUMER ELECTRICALS
Rahulkumar Mishra
Research Associate, Consumer Electricals

Bajaj Electricals +91-22-4215 9265


[email protected]

Bajaj Electricals operates with higher ex-cash NWC cycle (average of 84 days in the Market data
past 10 years) compared to peers. Debtor days remain elevated at an average of 136 Current price: Rs1,443
days due to the presence of EPC business. Creditor days have declined sharply from Bloomberg: BJE IN
an average of 103 days over FY11-15 to an average of 61 days over FY16-21 and are 52-week H/L: Rs1,458/442
lower than peers. In absolute terms, the total OCF generated over FY12-21 is low at
Market cap: Rs165.4bn
Rs16.2bn, of which ~30% was spent on capex while conversion to FCF was Rs11.4bn.
Fixed asset turn is above-industry (at 8.5x in FY21) due to low share of in-house Free float: 37.8%
manufacturing. Return ratios are lower than peers (RoE/pre-tax RoCE of ~12%/~15% Avg. daily vol. 3mth: 2,553,14.5
in FY21) due to the presence of EPC projects. Source: Bloomberg

OCF positive except in FY18 and FY19: Over FY12-17, Bajaj Electricals posted positive OCF. In that six-year period, three years
saw cumulative working capital deployment of Rs3bn, which was largely offset by cumulative working capital release of
Rs2.5bn in the remaining three years. However, FY18 and FY19 were adversely affected due to the impact of UP
electrification project, which led to incremental working capital deployment of Rs4.1bn/Rs8.6bn in FY18/FY19, leading to
negative OCF of Rs1bn/Rs6bn. A turnaround was witnessed in FY20 and FY21, with positive working capital change of
Rs4.5bn and Rs3.3bn, leading to positive OCF of Rs6.3bn and Rs6.6bn, respectively.
Exhibit 438: Cash flows from operations – positive except in FY18 and FY19
10,000

Impact of UP Electrification Project


5,000

0
(Rsmn)

-5,000

-10,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Op profit before Wk cap change (Rsmn) Wk cap change (Rsmn) OCF (Rsmn)
Source: Company, Centrum Broking

Ex-cash NWC higher than peers due to presence in EPC projects business: Ex-cash NWC (in days of sales) was 55-70 days
over FY12-15, but increased to 80-120 days over FY16-19. While it has declined from 120 days in FY19 to 110/98 days in
FY20/FY21, it still remains elevated compared to peers, largely due to the presence of EPC projects business. Inventory has
traditionally remained at 40-50 days, but in FY21, it increased to 78 days. Debtors have remained elevated at an average of
120 days over FY12-17 and increased to more than 150 days over FY18-21 due to projects business. Creditor days declined
from an average of 100 days over FY12-14 to an average of 60 days over FY16-21. Other current liabilities increased from an
average of 30 days in the initial five years (FY12-16) to an average of 85 days in the past five years (FY17-21). Other current
liabilities have outweighed other current assets which have largely remained at 30-60 days.
Exhibit 439: Working capital movement
200

150
Days of sales

100

50

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventories Debtors Other current assets Creditors Other current liabilities Ex-cash NWC
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Bajaj Electricals 16 September 2021

Exhibit 440: OCF/PAT Exhibit 441: OCF/EBITDA

600% 400%

400% 300%
200%
200%
NA
0%
100%
-200%
0%
-400%
FY13
FY12

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY19

FY20
FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY21
-100%
-600%

-800% -200%

Source: Company, Centrum Broking Source: Company, Centrum Broking

Healthy conversion of operating cash to free cash except in FY18 and FY19: Capex intensity has been low over the years,
with an average capex outlay of Rs500mn in plant and equipment over the past ten years. As against total OCF of Rs16.2bn
over FY12-21, total capex incurred was Rs4.8bn, while total FCF generation was Rs11.4bn. Both OCF and FCF were negative in
FY18 and FY19 due to working capital elongation on account of UP electrification projects.
Exhibit 442: OCF, capex intensity and free cash flows
8000 Impact of UP Electrification Project
6000
4000
2000
(Rsmn)

0
-2000
-4000
-6000
-8000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF (Rsmn) Capex (Rsmn) FCF (Rsmn)
Source: Company, Centrum Broking

Low in-house manufacturing keeps fixed asset turn high: Bajaj Electricals operates with a very low in-house manufacturing
share of ~20% for the consumer electrical business. In addition, the EPC projects business does not need high gross block.
Hence, the fixed asset turn has been higher at an average of ~11x over FY12-19. In FY20 and FY21, it declined to 8.5x due to
deliberate downsizing of rural electrification projects.
Exhibit 443: Fixed asset turn – deliberate downsizing of rural electrification projects led to decline in FY20 and FY21
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Fixed Asset turn (x) 11.4 10.3 10.8 9.8 10.1 11.6 11.5 14.5 8.6 8.5
Source: Company, Centrum Broking

Leverage reducing, return ratios lower than peers: Net D/E ratio had increased to 1.4x in FY19, but it has been brought
under control at 0.1x in FY21, with repayment of debt over the past two years. Prior to FY19, net D/E ratio averaged around
0.5x over FY12-17. The return ratios are lower than peers due to the impact of EPC projects. RoE was 12% in FY21 and has not
exceeded 19% in the past ten years. Similarly, pre-tax RoCE has exceeded 20% only thrice in the past ten years, with the
highest being 29.4% in FY21.
Exhibit 444: Leverage ratios – net D/E, which had surged to 1.4x in FY19, declined to 0.1x in FY21
Leverage ratio (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.21 0.15 0.41 0.51 1.01 0.55 0.73 1.45 0.46 0.12
Source: Company Data, Centrum Broking

Exhibit 445: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 18.0 7.2 (0.7) (2.0) 15.3 13.2 19.0 16.5 (0.0) 12.3
RoCE (Pre-tax) 29.4 12.6 7.4 7.9 21.5 16.6 20.3 17.4 8.0 15.3
RoIC (Pre-tax) 26.4 11.5 5.7 5.7 15.6 15.7 15.9 11.7 6.9 12.9
Source: Company Data, Centrum Broking

Centrum Institutional Research 164


Bajaj Electricals 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Revenues 49,293 45,731 52,375 60,386 68,649 Equity share capital 228 229 229 229 229
Operating Expense 36,420 32,402 37,553 42,391 47,986 Reserves & surplus 13,565 15,818 17,184 20,021 23,581
Employee cost 3,960 3,883 4,190 4,348 4,805 Shareholders fund 13,793 16,047 17,413 20,250 23,810
Others 7,321 6,430 7,574 8,199 9,068 Minority Interest 0 0 0 0 0
EBITDA 2,069 3,015 3,058 5,449 6,789 Total debt 7,375 2,588 1,788 1,288 788
Depreciation & Amortisation 680 693 618 665 709 Non Current Liabilities 0 0 0 0 0
EBIT 1,389 2,323 2,440 4,783 6,080 Def tax liab. (net) 0 0 0 0 0
Interest expenses 1,692 756 656 308 228 Total liabilities 21,167 18,635 19,201 21,538 24,598
Other income 526 727 654 693 742 Gross block 5,743 5,396 5,846 6,246 6,646
PBT 224 2,412 2,437 5,169 6,594 Less: acc. Depreciation (1,685) (1,970) (2,588) (3,253) (3,962)
Taxes 225 575 613 1,301 1,660 Net block 4,058 3,426 3,258 2,993 2,684
Effective tax rate (%) 100.6 23.9 25.2 25.2 25.2 Capital WIP 94 100 50 50 50
PAT (1) 1,836 1,824 3,868 4,934 Net fixed assets 4,151 3,527 3,308 3,043 2,734
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT (1) 1,836 1,824 3,868 4,934 Investments 529 1,639 1,639 1,639 1,639
Extraordinary items 0 0 0 0 0 Inventories 6,908 9,710 9,774 10,104 10,517
Reported PAT (1) 1,836 1,824 3,868 4,934 Sundry debtors 25,365 19,162 21,667 24,816 27,836
Cash & Cash Equivalents 1,047 616 2,155 4,343 7,306
Ratios Loans & advances 419 1,448 1,048 1,208 1,373
YE Mar FY20A FY21A FY22E FY23E FY24E
Other current assets 6,714 5,875 6,809 7,971 9,268
Growth (%) Trade payables 9,003 9,441 11,112 12,775 14,724
Revenue (25.7) (7.2) 14.5 15.3 13.7 Other current liab. 14,318 13,319 15,451 18,116 20,595
EBITDA (40.6) 45.7 1.4 78.2 24.6 Provisions 1,097 1,106 1,161 1,219 1,280
Adj. EPS nm nm (0.7) 112.1 27.6 Net current assets 16,034 12,945 13,729 16,332 19,701
Margins (%) Total assets 21,167 18,635 19,201 21,538 24,598
Gross 27.1 29.1 28.3 29.8 30.1
EBITDA 4.2 6.6 5.8 9.0 9.9 Cashflow
EBIT 2.8 5.1 4.7 7.9 8.9 YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Adjusted PAT 0.0 4.0 3.5 6.4 7.2 Profit Before Tax 224 2,412 2,437 5,169 6,594
Returns (%) Depreciation & Amortisation 680 693 618 665 709
ROE 0.0 12.3 10.9 20.5 22.4 Net Interest 1,692 756 656 308 228
ROCE 0.0 11.7 12.2 20.1 22.1 Net Change – WC 6,944 2,658 755 (414) (406)
ROIC 0.0 9.8 11.5 23.1 29.2 Direct taxes (225) (575) (613) (1,301) (1,660)
Turnover (days) Net cash from operations 9,314 5,943 3,854 4,427 5,466
Gross block turnover ratio (x) 8.6 8.5 9.0 9.7 10.3 Capital expenditure (1,515) (68) (400) (400) (400)
Debtors 208 178 142 140 140 Acquisitions, net 0 0 0 0 0
Inventory 76 94 95 86 78 Investments (21) (1,110) 0 0 0
Creditors 100 104 100 103 105 Others 0 0 0 0 0
Net working capital 119 103 96 99 105 Net cash from investing (1,537) (1,178) (400) (400) (400)
Solvency (x) FCF 7,778 4,765 3,454 4,027 5,066
Net debt-equity 0.5 0.1 0.0 (0.2) (0.3) Issue of share capital 23 2 0 0 0
Interest coverage ratio 1.2 4.0 4.7 17.7 29.7 Increase/(decrease) in debt (8,401) (4,787) (800) (500) (500)
Net debt/EBITDA 3.1 0.7 (0.1) (0.6) (1.0) Dividend paid 0 0 (458) (1,031) (1,374)
Per share (Rs) Interest paid (1,692) (756) (656) (308) (228)
Adjusted EPS 0.0 16.0 15.9 33.8 43.1 Others 3,178 345 0 0 0
BVPS 121.2 140.1 152.0 176.8 207.9 Net cash from financing (6,891) (5,196) (1,914) (1,838) (2,103)
CEPS 6.0 22.1 21.3 39.6 49.3 Net change in Cash 887 (431) 1,539 2,188 2,963
DPS 0.0 0.0 4.0 9.0 12.0 Source: Company, Centrum Broking
Dividend payout (%) nm 0.0 25.1 26.6 27.9
Valuation (x)
P/E nm 90.0 90.6 42.7 33.5
P/BV 11.9 10.3 9.5 8.2 6.9
EV/EBITDA 83.0 55.5 54.0 29.8 23.4
Dividend yield (%) 0.0 0.0 0.3 0.6 0.8
Source: Company, Centrum Broking

Centrum Institutional Research 165


16 September 2021

Institutional Research
Chirag Muchhala
Research Analyst, Consumer Electricals
+91 22 4215 9203
[email protected]
SECTOR: CONSUMER ELECTRICALS
Rahulkumar Mishra

Crompton Greaves Consumer Electricals Research Associate, Consumer Electricals


+91-22-4215 9265
[email protected]

Crompton operates at least working capital intensity among peers, with negative ex- Market data
cash NWC (in days of sales) in four out of the past five years. Total OCF/EBITDA over Current price: Rs490.35
FY17-21 is in line with the industry at 74%. In value terms, Crompton has generated Bloomberg: CROMPTON IN
healthy OCF of Rs21.6bn over FY17-21, from which conversion to FCF is strong at 52-week H/L: Rs513/253
Rs20.5bn due to minimal capex at an average of only Rs230mn per year. With high
Market cap: Rs307.8bn
share of outsourcing and suppressed base on gross block (recognized at fully
depreciated value on demerger), fixed asset turn (22.5x in FY21) and return ratios Free float: 87.6%
(RoE/pre-tax RoCE of ~36%/~40% in FY21) are the highest in the industry. Avg. daily vol. 3mth: 1,511,565
Source: Bloomberg

Cash flows from operations healthy: Operating profits have consistently expanded over the past five years. Working capital
intensity in the business is low, with ex-cash net working capital being negative in four out of the past five years. Over FY17-
20, incremental working capital was deployed in the business every year. However, in FY21, higher payables led to a positive
change in working capital, as its total deployment reduced by Rs1.4bn. OCF has been healthy over the past five years, with a
sharp rise in FY21.
Exhibit 446: Cash flows from operations healthy, with a sharp rise in FY21
10,000

8,000

6,000
(Rsmn)

4,000

2,000

-2,000 FY17 FY18 FY19 FY20 FY21


Op profit before Wk cap change (Rsmn) Wk cap change (Rsmn) OCF (Rsmn)
Source: Company, Centrum Broking

Analysis of working capital movement: Ex-cash NWC (in days of sales) was negative in four of the last five years (barring
FY20). Inventory days have risen consistently from 26 in FY17 to 39 in FY21. However, debtor days have reduced from 45+
over FY17-19 to 37 each in FY20 and FY21. After declining in FY19 and FY20, creditor days in FY21 rose to 66, similar to FY17.
Other current liabilities (23 days in FY21) largely outweighed other current assets (19 days in FY21) over the past five years.
Exhibit 447: Working capital movement – ex-cash NWC negative in four of the last five years
80

60
Days of Sales

40

20

FY17 FY18 FY19 FY20 FY21


-20
Inventories Debtors Other current assets Creditors Other current liabilities Ex-cash NWC

Source: Company, Centrum Broking


xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Crompton Greaves Consumer Electricals 16 September 2021

Exhibit 448: OCF/PAT Exhibit 449: OCF/EBITDA


Has been 80-100% over FY17-20, but rose to 135% in FY21 Has been 50-70% over FY17-20, but rose to 115% in FY21
160% 140%
140% 120%
120% 100%
100%
80%
80%
60%
60%
40% 40%

20% 20%
0% 0%

FY21
FY17

FY18

FY19

FY20

FY21

FY17

FY18

FY19

FY20
Source: Company, Centrum Broking Source: Company, Centrum Broking

Robust conversion of operating cash to free cash: Capex intensity has been low over the years, as Crompton has relied on
outsourcing instead of in-house manufacturing. Capex on plant & equipment during the past five years has averaged only
Rs230mn. Consequently, conversion of OCF to FCF has been robust – against total OCF of Rs21.6bn over FY17-21, total FCF
was Rs20.5bn.
Exhibit 450: Low capex leads to robust conversion of OCF to FCF
10000

8000

6000
(Rsmn)

4000

2000

0
FY17 FY18 FY19 FY20 FY21
-2000
OCF (Rsmn) Capex (Rsmn) FCF (Rsmn)
Source: Company, Centrum Broking

Fixed asset turn: Crompton operates at outsourcing share of 50%. Fixed asset turn was very high at 45x in FY17, since the
new legal entity that took over the consumer business of erstwhile Crompton Greaves started with fully depreciated gross
block of only Rs760mn and a high goodwill (towards brand) of Rs7.8bn. Over the past five years, the fixed asset turn has
rationalized to 22.5x (due to rise in gross block), but it still remains the highest in the industry.
Exhibit 451: Fixed asset turn – halved over FY17-21, but still the highest in the industry
FY17 FY18 FY19 FY20 FY21
Fixed Asset turn (x) 45.0 42.8 41.2 25.3 22.5
Source: Company, Centrum Broking

Reducing leverage; strong return ratios: Leverage on the balance sheet has reduced considerably from net D/E ratio of 1.12x
in FY17 (debt of Rs6.5bn at the time of company formation) to net D/E of (0.16) in FY21, as Crompton became a net-cash
company. The return ratios are highest in the industry, with RoE of 36% and RoCE of 40% in FY21. In the initial years of FY17
and FY18, RoE was inflated due to lower base of net worth when the company was newly formed.
Exhibit 452: Leverage ratios – consistent reduction; now a net-cash company
Leverage ratios (x) FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 1.12 0.60 0.19 0.09 (0.16)
Source: Company, Centrum Broking

Exhibit 453: Return ratios – highest in the industry


Return Ratios (%) FY17 FY18 FY19 FY20 FY21
RoE 54.7 49.5 42.5 38.7 36.3
RoCE (Pre-tax) 42.3 42.2 42.9 40.8 39.5
RoIC (Pre-tax) 43.2 44.0 44.6 39.4 42.8
Source: Company, Centrum Broking

Centrum Institutional Research 167


Crompton Greaves Consumer Electricals 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Revenues 45,203 48,035 56,013 63,610 71,805 Equity share capital 1,255 1,255 1,256 1,256 1,256
Operating Expense 30,703 32,672 38,761 43,446 48,612 Reserves & surplus 13,429 18,059 20,826 24,122 28,062
Employee cost 3,110 3,366 3,753 4,135 4,452 Shareholders fund 14,684 19,314 22,081 25,377 29,318
Others 5,399 4,792 5,737 6,793 7,973 Minority Interest 0 0 0 0 0
EBITDA 5,991 7,205 7,762 9,237 10,769 Total debt 1,797 2,988 2,988 0 0
Depreciation & Amortisation 268 297 342 375 439 Non Current Liabilities 0 0 0 0 0
EBIT 5,723 6,908 7,420 8,862 10,330 Def tax liab. (net) 0 0 0 0 0
Interest expenses 407 429 318 288 116 Total liabilities 16,481 22,302 25,069 25,377 29,318
Other income 591 758 790 865 925 Gross block 1,790 2,138 2,747 3,257 3,767
PBT 5,907 7,236 7,892 9,439 11,139 Less: acc. Depreciation (539) (810) (1,152) (1,528) (1,966)
Taxes 943 1,070 1,986 2,376 2,804 Net block 1,251 1,328 1,594 1,729 1,800
Effective tax rate (%) 16.0 14.8 25.2 25.2 25.2 Capital WIP 199 109 10 10 10
PAT 4,964 6,167 5,906 7,063 8,335 Net fixed assets 9,289 9,259 9,427 9,561 9,632
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 4,964 6,167 5,906 7,063 8,335 Investments 5,408 7,697 7,697 7,697 7,697
Extraordinary items 0 0 0 0 0 Inventories 4,636 5,186 6,053 6,547 7,059
Reported PAT 4,964 6,167 5,906 7,063 8,335 Sundry debtors 4,635 4,912 5,678 6,274 6,885
Cash & Cash Equivalents 481 6,040 6,782 7,182 11,248
Ratios Loans & advances 0 0 0 0 0
YE Mar FY20A FY21A FY22E FY23E FY24E
Other current assets 2,563 2,494 3,081 4,135 4,667
Growth (%) Trade payables 6,436 8,647 9,558 10,356 11,321
Revenue 0.9 6.3 16.6 13.6 12.9 Other current liab. 2,756 2,962 2,241 3,624 4,308
EBITDA 2.5 20.3 7.7 19.0 16.6 Provisions 1,846 2,262 2,437 2,625 2,828
Adj. EPS 23.6 24.1 (4.2) 19.6 18.0 Net current assets 1,277 4,761 7,360 7,533 11,403
Margins (%) Total assets 16,481 22,302 25,069 25,377 29,318
Gross 32.1 32.0 30.8 31.7 32.3
EBITDA 13.3 15.0 13.9 14.5 15.0 Cashflow
EBIT 12.7 14.4 13.2 13.9 14.4 YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Adjusted PAT 11.0 12.8 10.5 11.1 11.6 Profit Before Tax 5,907 7,236 7,892 9,439 11,139
Returns (%) Depreciation & Amortisation 268 297 342 375 439
ROE 38.7 36.3 28.5 29.8 30.5 Net Interest 407 429 318 288 116
ROCE 34.3 33.7 25.9 28.9 30.8 Net Change – WC (2,416) 2,075 (1,856) 226 196
ROIC 52.8 61.5 58.0 62.9 74.1 Direct taxes (847) (1,149) (1,986) (2,376) (2,804)
Turnover (days) Net cash from operations 3,318 8,888 4,710 7,953 9,086
Gross block turnover ratio (x) 25.3 22.5 20.4 19.5 19.1 Capital expenditure (922) (284) (510) (510) (510)
Debtors 42 36 35 34 33 Acquisitions, net 0 0 0 0 0
Inventory 49 55 53 53 51 Investments 4 (2,289) 0 0 0
Creditors 78 84 86 84 81 Others 0 0 0 0 0
Net working capital 10 36 48 43 58 Net cash from investing (918) (2,573) (510) (510) (510)
Solvency (x) FCF 2,400 6,316 4,200 7,443 8,576
Net debt-equity 0.1 (0.2) (0.2) (0.3) (0.4) Issue of share capital 1 1 0 0 0
Interest coverage ratio 14.7 16.8 24.4 32.1 92.8 Increase/(decrease) in debt (1,695) 1,191 0 (2,988) 0
Net debt/EBITDA 0.2 (0.4) (0.5) (0.8) (1.0) Dividend paid 0 (3,452) (3,139) (3,767) (4,395)
Per share (Rs) Interest paid (407) (429) (318) (288) (116)
Adjusted EPS 7.9 9.8 9.4 11.3 13.3 Others (1,248) 1,933 0 0 0
BVPS 23.4 30.8 35.2 40.4 46.7 Net cash from financing (3,349) (757) (3,457) (7,043) (4,511)
CEPS 8.3 10.3 10.0 11.8 14.0 Net change in Cash (949) 5,558 743 400 4,065
DPS 0.0 5.5 5.0 6.0 7.0 Source: Company, Centrum Broking
Dividend payout (%) 0.0 56.0 53.2 53.3 52.7
Valuation (x)
P/E 62.1 49.9 52.1 43.6 36.9
P/BV 20.9 15.9 13.9 12.1 10.5
EV/EBITDA 51.6 42.3 39.2 32.6 27.5
Dividend yield (%) 0.0 1.1 1.0 1.2 1.4
Source: Company, Centrum Broking

Centrum Institutional Research 168


16 September 2021

Institutional Research
Chirag Muchhala
Research Analyst, Consumer Electricals
+91 22 4215 9203
[email protected]
SECTOR: CONSUMER ELECTRICALS
Rahulkumar Mishra

Havells India Research Associate, Consumer Electricals


+91-22-4215 9265
[email protected]

With healthy operating profits (led by superior margin profile) and low ex-cash NWC Market data
at an average of 7 days over the past 10 years, Havells India has generated the Current price: Rs1,453
highest OCF within the sector at Rs72.8bn over FY12-21. Total OCF/EBITDA stands at Bloomberg: HAVL IN
79% over the 10-year period. With a higher focus on in-house manufacturing (93% of 52-week H/L: Rs1,477/645
sales ex-Lloyd) and the acquisition of Lloyd, capex over the past 10 years is also the
Market cap: Rs910.1bn
highest among peers at Rs38.6bn (53% of total OCF), leading to FCF conversion of
Rs33.9bn. With high in-house manufacturing, fixed asset turn is low at 2.7x in FY21 Free float: 47.1%
(industry average is 5x), while return ratios are decent (RoE/pre-tax RoCE of Avg. daily vol. 3mth: 2,123,740
~22%/~31% in FY21). Source: Bloomberg

Positive OCF in past 10 years; rise in working capital in recent years: Operating profit over the past ten years has been
healthy and on a rising trend since FY15. In six out of the past 10 years, working capital change was negative while in the
remaining four years, it was positive. The deployment of working capital was high in FY19 at Rs4.7bn (likely due to Lloyd
acquisition in the previous year) and in FY21 at Rs7bn (likely due to lockdown impact). This led to lower conversion of
operating profit to OCF in FY19 and FY21. Except for these two years, OCF has been healthy.
Exhibit 454: Cash flows from operations – healthy except in FY19 and FY21

Sylvania Exit Lloyd


15,000
acquisition
10,000

5,000
(Rsmn)

-5,000

-10,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Op profit before Wk cap change (Rsmn) Wk cap change (Rsmn) OCF (Rsmn)
Source: Company, Centrum Broking

Analysis of working capital movement: Ex-cash NWC (in days of sales) is one of the lowest in the industry and has averaged
only 7 days over the past 10 years. It was negative in three years (FY14, FY15 and FY18) and exceeded 20 days only twice
(FY13 and FY21) in the past 10 years. The key reason for the lower NWC is low debtor days due to channel financing. Debtor
days have reduced from an average of 40 over FY12-15 to an average of 15 over FY16-21. Inventory has largely remained at
60-70 days, except in FY16 (when it was lower at 40) and in FY21 (when it was higher at 91 due to lockdown impact). Creditor
days have largely remained at 50-55 days. Other current liabilities (largely in 30-35 days range) outweigh other current assets
(largely in 10-15 days range).
Exhibit 455: Working capital movement – ex-cash NWC has averaged at 7 days over the decade
100

80

60
Days of Sales

40

20

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20
Inventories Debtors Other current assets Creditors Other current liabilities Ex-cash NWC

Source: Company, Centrum Broking


xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Havells India 16 September 2021

Exhibit 456: OCF/PAT Exhibit 457: OCF/EBITDA


250% 140%

200% 120%
100%
150%
80%

100% 60%
40%
50%
20%
0% 0%

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY12

FY14

FY16

FY18

FY20
FY13

FY15

FY17

FY19

FY21
Source: Company, Centrum Broking Source: Company Centrum Broking

Capex and Lloyd acquisition took away more than half of OCF earned over the past ten years: Havells’ capex intensity has
been higher than peers, as it prefers in-house manufacturing (~93% of sales ex-Lloyd) to outsourcing. Over the past 10 years
(excluding FY18 when it acquired Lloyd), its average capex outlay has been Rs2.5bn per annum in plant and equipment. In
FY18, Lloyd acquisition led to total capital outlay of Rs16bn. Investment in subsidiaries was Rs356mn towards the residual
value of Sylvania. Over FY12-21, Havells has generated total OCF of Rs72.8bn and has spent 53% of this towards capex and
Lloyd acquisition totalling to Rs38.6bn. Consequently, it generated total FCF of Rs33.9bn over FY12-21.
Exhibit 458: OCF, capex intensity and free cash flows
12,000 Sylvania exit impact Lloyd acquisition
8,000
4,000
(Rsmn)

-
-4,000
-8,000
-12,000
-16,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF (Rsmn) Capex (Rsmn) Investments (Rsmn) FCF (Rsmn)
Source: Company, Centrum Broking

Fixed asset turn higher than peers due to higher share of in-house manufacturing: As Havells operates with a higher share
of in-house manufacturing (~93% ex-Lloyd), it has lower fixed asset turn than peers. Over FY12-15, fixed asset turn was ~2.5x.
In FY16 and FY17, it looks higher due to restatement of gross block as per IndAS in FY16. Post Lloyd acquisition in FY18, fixed
asset turn has settled in the 2.5-3x range.
Exhibit 459: Fixed asset turn – settled at 2.5-3x post Lloyd acquisition in FY18
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Fixed Asset turn (x) 2.4 2.4 2.6 2.8 5.7 4.2 2.9 3.2 2.5 2.7
Source: Company, Centrum Broking

Net-cash company since FY14; decent return ratios: Since FY14, Havells has been a net-cash company. Its gross debt has
declined from Rs10.2bn in FY12 to nil in FY20. In FY21, it had a gross debt of Rs3.9bn, likely as a cushion in lockdown, but this
is far outweighed by the cash balance of Rs16.5bn. Return ratios are decent with RoE profile of 20-22% and RoCE (pre-tax)
profile of 28-31%.
Exhibit 460: Leverage ratio – a net-cash company since FY14
Leverage ratio (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.83 0.35 (0.03) (0.26) (0.45) (0.54) (0.39) (0.30) (0.26) (0.24)
Source: Company, Centrum Broking

Exhibit 461: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 46.0 48.5 28.7 22.1 53.7 15.3 19.2 19.8 17.2 22.0
RoCE (Pre-tax) 32.2 26.9 27.2 27.5 27.1 25.2 27.9 28.7 21.6 30.6
RoIC (Pre-tax) 32.6 29.4 34.3 39.1 40.6 41.2 43.9 35.9 24.1 34.3
Source: Company, Centrum Broking

Centrum Institutional Research 170


Havells India 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Revenues 94,292 104,279 127,927 148,426 171,150 Equity share capital 626 626 626 626 626
Operating Expense 58,351 64,748 81,362 93,212 105,942 Reserves & surplus 42,422 51,019 58,995 68,524 80,162
Employee cost 8,996 8,853 10,234 11,577 13,007 Shareholders fund 43,048 51,645 59,621 69,150 80,788
Others 16,671 15,024 17,511 21,484 25,719 Minority Interest 0 0 0 0 0
EBITDA 10,274 15,654 18,820 22,153 26,481 Total debt 0 3,937 2,437 937 0
Depreciation & Amortisation 2,179 2,489 2,550 2,767 3,147 Non Current Liabilities 0 0 0 0 0
EBIT 8,095 13,165 16,270 19,386 23,334 Def tax liab. (net) 2,865 3,391 3,391 3,391 3,391
Interest expenses 197 726 508 305 168 Total liabilities 45,913 58,972 65,448 73,478 84,180
Other income 1,120 1,878 1,590 2,020 2,425 Gross block 25,099 26,527 32,090 37,090 41,590
PBT 9,017 14,317 17,352 21,101 25,592 Less: acc. Depreciation (6,104) (7,920) (10,470) (13,237) (16,384)
Taxes 1,687 3,919 4,367 5,311 6,441 Net block 18,994 18,607 21,620 23,853 25,205
Effective tax rate (%) 18.7 27.4 25.2 25.2 25.2 Capital WIP 828 863 500 500 500
PAT 7,330 10,397 12,984 15,790 19,150 Net fixed assets 34,356 33,802 36,452 38,685 40,038
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 7,330 10,397 12,984 15,790 19,150 Investments 16 3,079 3,079 3,079 3,079
Extraordinary items 0 0 0 0 0 Inventories 18,719 26,199 28,978 31,156 33,959
Reported PAT 7,330 10,397 12,984 15,790 19,150 Sundry debtors 2,489 5,636 6,309 6,913 7,502
Cash & Cash Equivalents 11,069 16,247 20,847 26,466 35,333
Ratios Loans & advances 3,124 2,573 3,838 5,195 6,675
YE Mar FY20A FY21A FY22E FY23E FY24E
Other current assets 706 665 773 896 1,033
Growth (%) Trade payables 14,141 15,968 19,839 22,473 25,542
Revenue (6.3) 10.6 22.7 16.0 15.3 Other current liab. 7,969 10,103 11,513 12,616 13,692
EBITDA (13.2) 52.4 20.2 17.7 19.5 Provisions 2,456 3,160 3,476 3,823 4,206
Adj. EPS (6.9) 41.8 24.9 21.6 21.3 Net current assets 11,542 22,091 25,917 31,714 41,062
Margins (%) Total assets 45,913 58,972 65,448 73,478 84,180
Gross 38.1 37.9 36.4 37.2 38.1
EBITDA 10.9 15.0 14.7 14.9 15.5 Cashflow
EBIT 8.6 12.6 12.7 13.1 13.6 YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Adjusted PAT 7.8 10.0 10.1 10.6 11.2 Profit Before Tax 9,017 14,317 17,352 21,101 25,592
Returns (%) Depreciation & Amortisation 2,179 2,489 2,550 2,767 3,147
ROE 17.3 22.0 23.3 24.5 25.5 Net Interest 197 726 508 305 168
ROCE 17.5 22.2 22.7 24.2 25.6 Net Change – WC 783 (5,563) 773 (177) (482)
ROIC 21.4 28.0 32.7 36.9 42.1 Direct taxes (1,989) (3,394) (4,367) (5,311) (6,441)
Turnover (days) Net cash from operations 10,187 8,575 16,816 18,685 21,983
Gross block turnover ratio (x) 3.8 3.9 4.0 4.0 4.1 Capital expenditure (5,345) (2,136) (5,200) (5,000) (4,500)
Debtors 13 14 17 16 15 Acquisitions, net 0 0 0 0 0
Inventory 119 127 124 118 112 Investments 0 (3,063) 0 0 0
Creditors 93 85 80 83 83 Others 0 0 0 0 0
Net working capital 45 77 74 78 88 Net cash from investing (5,344) (5,199) (5,200) (5,000) (4,500)
Solvency (x) FCF 4,843 3,376 11,616 13,685 17,483
Net debt-equity (0.3) (0.2) (0.3) (0.4) (0.4) Issue of share capital 0 0 0 0 0
Interest coverage ratio 52.1 21.5 37.0 72.6 157.8 Increase/(decrease) in debt (405) 3,937 (1,500) (1,500) (937)
Net debt/EBITDA (1.1) (0.8) (1.0) (1.2) (1.3) Dividend paid (3,018) (4,069) (5,008) (6,260) (7,512)
Per share (Rs) Interest paid (197) (726) (508) (305) (168)
Adjusted EPS 11.7 16.6 20.7 25.2 30.6 Others (3,031) 2,661 0 0 0
BVPS 68.8 82.5 95.2 110.5 129.1 Net cash from financing (6,651) 1,802 (7,017) (8,065) (8,616)
CEPS 15.2 20.6 24.8 29.6 35.6 Net change in Cash (1,808) 5,178 4,599 5,619 8,866
DPS 4.0 6.5 8.0 10.0 12.0 Source: Company, Centrum Broking
Dividend payout (%) 34.1 39.1 38.6 39.6 39.2
Valuation (x)
P/E 124.1 87.5 70.1 57.6 47.5
P/BV 21.1 17.6 15.3 13.2 11.3
EV/EBITDA 87.5 57.4 47.4 39.9 33.0
Dividend yield (%) 0.3 0.4 0.6 0.7 0.8
Source: Company, Centrum Broking

Centrum Institutional Research 171


16 September 2021

Institutional Research
Chirag Muchhala
Research Analyst, Consumer Electricals
+91 22 4215 9203
[email protected]
SECTOR: CONSUMER ELECTRICALS
Rahulkumar Mishra

Orient Electric Research Associate, Consumer Electricals


+91-22-4215 9265
[email protected]

Orient Electric has seen the best improvement in working capital cycle among peers, Market data
led by channel financing and improved credit terms from vendors. Its ex-cash NWC Current price: Rs359
has declined from 60 days in FY18 to 51/40 days in FY19/FY20 and to negative 2 days Bloomberg: ORIENTEL IN
in FY21 (four-year average of 37 days). This led to a sharp rise in OCF to Rs4.2bn in 52-week H/L: Rs368/174
FY21, which was 4x FY18 levels. Its total OCF/EBITDA ratio is the highest among
Market cap: Rs76.1bn
peers at 116% over FY18-21. Over FY18-21, the conversion of OCF (Rs7.8bn) to FCF
(Rs6.6bn) has been healthy due to low capex intensity (annual average of Free float: 61.6%
~Rs300mn). Fixed asset turn is in line with the industry (5.7x in FY21) and return Avg. daily vol. 3mth: 704,044
ratios are strong (RoE/pre-tax RoCE of 29%/39% in FY21). Source: Bloomberg

Healthy cash flows from operations: Operating profits have consistently expanded over the past four years, led by margin
expansion. Working capital intensity in the business has consistently reduced over the past four years led by increased
channel financing, improved collections and favorable credit terms with the vendors. FY21 witnessed a sharp positive change
in working capital, as its total deployment reduced by Rs2.2bn. The OCF of Rs4.2bn in FY21 was 4x FY18 levels.
Exhibit 462: Cash flow from operations – consistent improvement in last four years
5,000

4,000

3,000
Rsmn

2,000

1,000

-1,000 FY18 FY19 FY20 FY21


Op profit before Wk cap change (Rsmn) Wk cap change (Rsmn) OCF (Rsmn)
Source: Company, Centrum Broking

Analysis of working capital movement: Ex-cash NWC (in days of sales) has consistently reduced from 60 days in FY18 to
51/40 days in FY19/FY20, and further to negative 2 days in FY21. This has been led by strong focus on improving collections,
with debtor days declining from 88 in FY18 to 69 in FY21. Inventory days have sustained at 45-50. Creditor days have
increased from 63 in FY18 to 93 in FY21, indicating favorable credit terms the company managed to command from its
vendors. Other current liabilities (17-20 days) have largely outweighed other current assets (9-10 days) over the past four
years.
Exhibit 463: Working capital movement – consistent reduction in ex-cash NWC days
100

80

60
Days of sales

40

20

-
FY18 FY19 FY20 FY21
-20 Inventories Debtors Other current assets Creditors Other current liabilities Ex-cash NWC

Source: Company, Centrum Broking


xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Orient Electric 16 September 2021

Exhibit 464: OCF/PAT Exhibit 465: OCF/EBITDA


Sharp improvement in FY21 Sharp improvement in FY21
400% 250%
350%
200%
300%
250% 150%
200%
100%
150%
100% 50%
50%
0% 0%
FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Low capex outlay aids in healthy free cash flow generation: Capex intensity has been lower over the past four years, with an
average outlay of only Rs300mn towards plant & equipment. Hence, the conversion of OCF to FCF has been robust. As
against the total OCF of Rs7.8bn over FY18-21, the total FCF conversion was strong at Rs6.6bn.
Exhibit 466: Healthy conversion from OCF to FCF
5,000

4,000

3,000
(Rsmn)

2,000

1,000

-
FY18 FY19 FY20 FY21
-1,000
OCF (Rsmn) Capex (Rsmn) FCF (Rsmn)
Source: Company, Centrum Broking

Fixed asset turn – in line with industry average: In FY18/FY19, Orient Electric operated at a healthy fixed asset turnover of
8.1x/8.3x, respectively and had 55% share of in-house manufacturing in total sales. With revenue growth being impacted in
FY20/FY21 due to Covid-linked lockdown and rise in gross block, fixed asset turn reduced to 6.3x in FY20 and 5.7x in FY21, but
remains in line with industry average.
Exhibit 467: Fixed asset turn – declined in FY20 and FY21, but in line with industry average of 5x
FY18 FY19 FY20 FY21
Fixed asset turn (x) 8.1 8.3 6.3 5.7
Source: Company, Centrum Broking

Reducing leverage; strong return ratios: Leverage on the balance sheet has reduced considerably, with gross debt declining
from Rs1.6bn in FY18 to Rs153mn in FY21. This has led to reduction in net D/E ratio from 0.51x in FY18 to 0.53x in FY21, as
Orient Electric became a net-cash company in FY21. Return ratios are healthy and on a rising trend. In FY21, RoE was ~29%
and RoCE was ~39%.
Exhibit 468: Leverage ratios – became a net-cash company in FY21
FY18 FY19 FY20 FY21
Net Debt/Equity (x) 0.51 0.30 0.24 (0.53)
Source: Company, Centrum Broking

Exhibit 469: Return ratios


Return Ratios (%) FY18 FY19 FY20 FY21
RoE (%) 24.3 24.3 23.6 29.4
RoCE (%) (Pre-tax) 28.6 29.7 31.7 39.5
RoIC (%) (Pre-tax) 31.4 31.4 33.8 57.6
Source: Company, Centrum Broking

Centrum Institutional Research 173


Orient Electric 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Revenues 20,618 20,326 23,630 27,114 30,910 Equity share capital 212 212 212 212 212
Operating Expense 14,094 14,210 16,825 18,709 21,111 Reserves & surplus 3,382 4,344 5,119 6,204 7,546
Employee cost 1,985 1,792 2,127 2,305 2,596 Shareholders fund 3,594 4,557 5,332 6,416 7,758
Others 2,776 2,130 2,381 3,039 3,474 Minority Interest 0 0 0 0 0
EBITDA 1,764 2,195 2,298 3,062 3,728 Total debt 947 153 1,335 1,035 635
Depreciation & Amortisation 401 432 467 565 642 Non Current Liabilities 0 0 0 0 0
EBIT 1,363 1,764 1,832 2,497 3,086 Def tax liab. (net) (214) (263) (263) (263) (263)
Interest expenses 261 207 298 273 242 Total liabilities 4,327 4,446 6,404 7,189 8,130
Other income 41 63 69 76 83 Gross block 3,290 3,545 3,921 5,901 6,331
PBT 1,143 1,619 1,603 2,300 2,927 Less: acc. Depreciation (1,452) (1,830) (2,296) (2,861) (3,503)
Taxes 357 422 403 579 737 Net block 1,838 1,716 1,625 3,040 2,828
Effective tax rate (%) 31.2 26.0 25.2 25.2 25.2 Capital WIP 35 26 830 30 25
PAT 786 1,197 1,199 1,721 2,191 Net fixed assets 2,003 1,972 2,685 3,301 3,083
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 786 1,197 1,199 1,721 2,191 Investments 0 0 0 0 0
Extraordinary items 0 0 0 0 0 Inventories 2,865 2,492 3,411 3,690 4,107
Reported PAT 786 1,197 1,199 1,721 2,191 Sundry debtors 3,889 3,838 4,273 4,828 5,335
Cash & Cash Equivalents 75 2,576 2,209 2,367 3,445
Ratios Loans & advances 85 103 118 136 185
YE Mar FY20A FY21A FY22E FY23E FY24E
Other current assets 474 380 473 597 742
Growth (%) Trade payables 3,305 5,191 4,840 5,484 6,189
Revenue 10.6 (1.4) 16.3 14.7 14.0 Other current liab. 1,295 1,183 1,347 1,627 1,916
EBITDA 24.9 24.4 4.7 33.2 21.8 Provisions 464 540 578 618 662
Adj. EPS 13.4 52.3 0.2 43.5 27.3 Net current assets 2,324 2,474 3,719 3,888 5,047
Margins (%) Total assets 4,327 4,446 6,404 7,189 8,130
Gross 31.6 30.1 28.8 31.0 31.7
EBITDA 8.6 10.8 9.7 11.3 12.1 Cashflow
EBIT 6.6 8.7 7.8 9.2 10.0 YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Adjusted PAT 3.8 5.9 5.1 6.3 7.1 Profit Before Tax 1,143 1,619 1,603 2,300 2,927
Returns (%) Depreciation & Amortisation 401 432 467 565 642
ROE 23.6 29.4 24.3 29.3 30.9 Net Interest 261 207 298 273 242
ROCE 21.8 29.2 25.0 27.3 29.9 Net Change – WC 346 2,350 (1,611) (12) (81)
ROIC 22.2 39.5 41.6 39.2 46.0 Direct taxes (374) (471) (403) (579) (737)
Turnover (days) Net cash from operations 1,777 4,137 353 2,547 2,994
Gross block turnover ratio (x) 6.3 5.7 6.0 4.6 4.9 Capital expenditure (1,110) (301) (1,180) (1,180) (425)
Debtors 70 69 63 61 60 Acquisitions, net 0 0 0 0 0
Inventory 71 69 64 69 67 Investments 0 0 0 0 0
Creditors 88 109 109 101 101 Others 0 0 0 0 0
Net working capital 41 44 57 52 60 Net cash from investing (1,110) (301) (1,180) (1,180) (425)
Solvency (x) FCF 667 3,836 (827) 1,367 2,569
Net debt-equity 0.2 (0.5) (0.2) (0.2) (0.4) Issue of share capital 0 0 0 0 0
Interest coverage ratio 6.8 10.6 7.7 11.2 15.4 Increase/(decrease) in debt (303) (794) 1,183 (300) (400)
Net debt/EBITDA 0.5 (1.1) (0.4) (0.4) (0.8) Dividend paid (272) (424) (424) (637) (849)
Per share (Rs) Interest paid (261) (207) (298) (273) (242)
Adjusted EPS 3.7 5.6 5.7 8.1 10.3 Others (71) 90 0 0 0
BVPS 16.9 21.5 25.1 30.2 36.6 Net cash from financing (908) (1,336) 461 (1,209) (1,491)
CEPS 5.6 7.7 7.9 10.8 13.3 Net change in Cash (241) 2,501 (367) 158 1,078
DPS 1.1 2.0 2.0 3.0 4.0 Source: Company, Centrum Broking
Dividend payout (%) 31.0 35.4 35.4 37.0 38.7
Valuation (x)
P/E 96.9 63.6 63.5 44.2 34.7
P/BV 21.2 16.7 14.3 11.9 9.8
EV/EBITDA 43.6 33.6 32.7 24.4 19.7
Dividend yield (%) 0.3 0.6 0.6 0.8 1.1
Source: Company, Centrum Broking

Centrum Institutional Research 174


16 September 2021

Institutional Research
Chirag Muchhala
Research Analyst, Consumer Electricals
+91 22 4215 9203
[email protected]
SECTOR: CONSUMER ELECTRICALS
Rahulkumar Mishra

Polycab India Research Associate, Consumer Electricals


+91-22-4215 9265
[email protected]

Polycab India has demonstrated healthy operating profit trend but operates at Market data
higher working capital cycle, with ex-cash NWC at an average of 82 days over FY17- Current price: Rs2,442
21. In absolute terms, it has generated robust OCF of Rs33.7bn over the past five Bloomberg: POLYCAB IN
years, with total OCF/EBITDA ratio of 76%. With more than a third of total OCF being 52-week H/L: Rs2,503/795
spent on capex (Rs2.5bn annual average), the conversion of OCF to FCF (Rs21.2bn)
Market cap: Rs364.3bn
has been decent. Fixed asset turn is lower than industry at 3.4x in FY21 (industry
average is 5x) due to highest share of in-house manufacturing (95% of total sales). Free float: 24.6%
Return ratios are decent (RoE/pre-tax RoCE of ~21%/~25% in FY21). Avg. daily vol. 3mth: 456,541
Source: Bloomberg

Cash flows from operations: Operating profit has consistently expanded over the past five years. Trend in working capital
intensity has been inconsistent. FY19 had a positive change in working capital, with reduction in working capital deployment.
However, FY20 witnessed an even higher amount being ploughed back in working capital (partly due to Covid lockdown
impact in March 2020). In FY21, working capital again saw a minor positive change. OCF has remained positive in the past five
years, with FY19 and FY21 being strong years.
Exhibit 470: Cash flows from operations – FY19 and FY21 the best years
15,000

10,000

5,000
Rsmn

-5,000
FY17 FY18 FY19 FY20 FY21
-10,000
Op profit before Wk cap change (Rsmn) Wk cap change (Rsmn) OCF (Rsmn)
Source: Company, Centrum Broking

Analysis of working capital movement: Ex-cash NWC (in days of sales) was high at 95-100 days in FY17 and FY18, but
reduced sharply in FY19 to 57 days, largely due to rise in other current liabilities (from 20 days of sales to 46 days of sales).
With Covid lockdowns, ex-cash NWC again rose to 82/77 days in FY20/FY21, respectively. Inventory days reduced from 101 in
FY17 to 80 in each of FY20 and FY21. Debtor days declined from 75-85 in FY17-18 to ~65 days in each of FY19, FY20, and
FY21. Creditor days were higher at 90 in FY17, but have largely remained at 55 in the past two years. Other current liabilities
(largely at 20-25 days) outweigh other current assets (largely at 13-18 days).
Exhibit 471: Working capital movement
120

100
Days of Sales

80

60

40

20

-
FY17 FY18 FY19 FY20 FY21
Inventories Debtors Other current assets Creditors Other current liabilities Ex-cash NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Polycab India 16 September 2021

Exhibit 472: OCF/PAT Exhibit 473: OCF/EBITDA

300% 140%

250% 120%
100%
200%
80%
150%
60%
100%
40%
50% 20%
0% 0%
FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Higher capex intensity among peers: Polycab has higher capex intensity among peers averaging at Rs2.5bn per annum over
the past five years. The capex is towards cables & wires (capacity expansion as well as diversification in specialty cables) and
setting up greenfield manufacturing plants for FMEG products (fans, lights, switchgears). Against the OCF of Rs33.7bn over
FY17-21, total capex incurred was Rs12.5bn, more than one-third of total OCF. This led to total FCF generation of Rs21.2bn
over FY17-21.
Exhibit 474: OCF, capex intensity and free cash flows
15,000

10,000
(Rsmn)

5,000

-5,000
FY17 FY18 FY19 FY20 FY21
OCF (Rsmn) Capex (Rsmn) FCF (Rsmn)
Source: Company, Centrum Broking

Fixed asset turn: Polycab has consistently operated at fixed asset turn of 4x-4.5x over FY17-20. With higher capex outlay and
revenue growth impacted in FY21 due to lockdown, fixed asset turn temporarily reduced to 3.4x in FY21. Polycab has one of
the highest shares of in-house manufacturing at ~95% of total sales, and unlike peers, does not depend on outsourcing.
Exhibit 475: Fixed asset turn
FY17 FY18 FY19 FY20 FY21
Fixed Asset turn (x) 4.1 4.4 4.5 4.4 3.4
Source: Company, Centrum Broking

Low leverage; decent return ratios: Polycab’s leverage position has reduced over the past five years, with gross debt
declining from Rs8.2bn in FY17 to Rs1.9bn in FY21. This has turned Polycab into a net-cash company from FY19 compared to
a net D/E ratio of 0.39x in FY17. The return ratios are decent, with RoE of ~21% and RoCE of ~25% in FY21.
Exhibit 476: Leverage ratios
Leverage ratios (x) FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.39 0.30 (0.04) (0.04) (0.07)
Source: Company, Centrum Broking

Exhibit 477: Return ratios


Return Ratios (%) FY17 FY18 FY19 FY20 FY21
RoE 23.3 16.5 19.2 22.7 20.5
RoCE (Pre-tax) 30.4 22.4 28.6 30.4 24.8
RoIC (Pre-tax) 25.1 19.9 27.6 30.1 24.0
Source: Company, Centrum Broking

Centrum Institutional Research 176


Polycab India 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Revenues 88,300 89,265 110,147 125,248 141,268 Equity share capital 1,489 1,491 1,491 1,491 1,491
Operating Expense 63,686 66,065 82,941 93,309 104,114 Reserves & surplus 36,875 46,048 52,913 61,318 71,027
Employee cost 3,657 3,604 3,965 4,509 5,086 Shareholders fund 38,364 47,539 54,404 62,810 72,518
Others 9,606 7,926 10,163 11,104 13,229 Minority Interest 150 188 188 188 188
EBITDA 11,350 11,670 13,078 16,325 18,839 Total debt 1,221 1,926 1,226 826 476
Depreciation & Amortisation 1,609 1,866 2,108 2,277 2,459 Non Current Liabilities 0 0 0 0 0
EBIT 9,741 9,804 10,970 14,048 16,380 Def tax liab. (net) 165 418 418 418 418
Interest expenses 495 531 478 454 409 Total liabilities 39,900 50,072 56,237 64,242 73,601
Other income 928 1,282 1,154 1,292 1,447 Gross block 20,451 26,627 29,877 33,127 36,377
PBT 10,174 10,652 11,646 14,886 17,418 Less: acc. Depreciation (6,248) (8,024) (10,133) (12,410) (14,869)
Taxes 2,444 1,791 2,931 3,747 4,384 Net block 14,203 18,602 19,744 20,717 21,508
Effective tax rate (%) 24.0 16.8 25.2 25.2 25.2 Capital WIP 2,412 991 750 500 300
PAT 7,730 8,861 8,714 11,139 13,034 Net fixed assets 16,632 19,687 20,588 21,311 21,902
Minority/Associates (140) (40) (60) (50) (45) Non Current Assets 0 0 0 0 0
Recurring PAT 7,591 8,821 8,654 11,089 12,989 Investments 655 6,349 6,349 6,349 6,349
Extraordinary items 0 0 0 0 0 Inventories 19,250 19,879 23,860 25,564 27,669
Reported PAT 7,591 8,821 8,654 11,089 12,989 Sundry debtors 15,997 15,641 18,710 20,589 22,448
Cash & Cash Equivalents 2,813 5,313 6,601 11,669 18,179
Ratios Loans & advances 298 208 330 376 494
YE Mar FY20A FY21A FY22E FY23E FY24E
Other current assets 3,962 3,069 4,406 5,636 6,781
Growth (%) Trade payables 13,537 13,480 16,361 17,895 19,967
Revenue 10.6 1.1 23.4 13.7 12.8 Other current liab. 5,675 6,108 7,710 8,767 9,606
EBITDA 19.1 2.8 12.1 24.8 15.4 Provisions 494 487 535 589 648
Adj. EPS 44.1 16.0 (1.9) 28.1 17.1 Net current assets 22,613 24,036 29,300 36,582 45,350
Margins (%) Total assets 39,900 50,072 56,237 64,242 73,601
Gross 27.9 26.0 24.7 25.5 26.3
EBITDA 12.9 13.1 11.9 13.0 13.3 Cashflow
EBIT 11.0 11.0 10.0 11.2 11.6 YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Adjusted PAT 8.6 9.9 7.9 8.9 9.2 Profit Before Tax 10,174 10,652 11,646 14,886 17,418
Returns (%) Depreciation & Amortisation 1,609 1,866 2,108 2,277 2,459
ROE 22.7 20.5 17.0 18.9 19.2 Net Interest 495 531 478 454 409
ROCE 23.1 20.6 17.2 19.2 19.5 Net Change – WC (7,242) 1,077 (3,976) (2,214) (2,257)
ROIC 23.4 22.0 20.3 23.7 26.0 Direct taxes (2,510) (1,537) (2,931) (3,747) (4,384)
Turnover (days) Net cash from operations 2,527 12,589 7,325 11,656 13,645
Gross block turnover ratio (x) 4.3 3.4 3.7 3.8 3.9 Capital expenditure (3,555) (4,920) (3,010) (3,000) (3,050)
Debtors 63 65 57 57 56 Acquisitions, net 0 0 0 0 0
Inventory 112 108 96 97 93 Investments (361) (5,695) 0 0 0
Creditors 82 75 66 67 66 Others 0 0 0 0 0
Net working capital 93 98 97 107 117 Net cash from investing (3,916) (10,615) (3,010) (3,000) (3,050)
Solvency (x) FCF (1,389) 1,974 4,315 8,656 10,595
Net debt-equity 0.0 (0.1) (0.1) (0.2) (0.2) Issue of share capital 77 2 0 0 0
Interest coverage ratio 22.9 22.0 27.3 35.9 46.1 Increase/(decrease) in debt (699) 705 (700) (400) (350)
Net debt/EBITDA (0.1) (0.3) (0.4) (0.7) (0.9) Dividend paid (1,256) (1,491) (1,789) (2,684) (3,281)
Per share (Rs) Interest paid (495) (531) (478) (454) (409)
Adjusted EPS 51.0 59.2 58.0 74.4 87.1 Others 3,410 1,841 (60) (50) (45)
BVPS 257.7 318.8 364.8 421.2 486.3 Net cash from financing 1,036 526 (3,028) (3,589) (4,085)
CEPS 61.8 71.7 72.2 89.6 103.6 Net change in Cash (353) 2,500 1,287 5,068 6,510
DPS 7.0 10.0 12.0 18.0 22.0 Source: Company, Centrum Broking
Dividend payout (%) 13.7 16.9 20.7 24.2 25.3
Valuation (x)
P/E 47.9 41.3 42.1 32.8 28.0
P/BV 9.5 7.7 6.7 5.8 5.0
EV/EBITDA 32.0 30.9 27.4 21.7 18.4
Dividend yield (%) 0.3 0.4 0.5 0.7 0.9
Source: Company, Centrum Broking

Centrum Institutional Research 177


16 September 2021

Institutional Research
Chirag Muchhala
Research Analyst, Consumer Electricals
+91 22 4215 9203
[email protected]
SECTOR: CONSUMER ELECTRICALS
Rahulkumar Mishra

V-Guard Industries Research Associate, Consumer Electricals


+91-22-4215 9265
[email protected]

V-Guard has demonstrated a decent operating profit trend but has higher working Market data
capital cycle than peers, with an average ex-cash NWC of 68 days over FY12-21. The Current price: Rs255
working capital cycle is higher due to lower creditor days (10-year average of 44 Bloomberg: VGRD IN
days). Thus, its OCF over the past 10 years is low in absolute terms at Rs11.1bn. Total 52-week H/L: Rs285/162
OCF/EBITDA ratio over the past 10 years is also lower than peers at 61%. The
Market cap: Rs109.7bn
conversion of OCF to FCF (Rs6.7bn) has been decent, with ~40% of total OCF being
spent on capex. Fixed asset turn (5.8x in FY21) is in line with the industry and return Free float: 39%
ratios are decent (RoE/pre-tax RoCE of ~18%/~26% in FY21). Avg. daily vol. 3mth: 985,565
Source: Bloomberg

OCF healthy but consistent deployment of working capital every year: Operating profits have consistently expanded over
the past 10 years. However, V-Guard has consistently deployed working capital in the past seven years. Over the past ten
years, the average working capital deployed stands at Rs400mn per annum. While the amount is small and manageable, a
positive change in working capital is missing. OCF has always remained positive in the past 10 years, as the negative impact of
working capital change has been adequately offset by improvement in operating profits.
Exhibit 478: Cash flows from operations
3000

2000

1000
Rsmn

-1000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-2000
Op profit before Wk cap change (Rsmn) Wk cap change (Rsmn) OCF (Rsmn)
Source: Company, Centrum Broking

Analysis of working capital movement: Ex-cash NWC (in days of sales) has largely remained at 60-75 days over the past ten
years. Inventory, which was in excess of 60 days over FY12-14, reduced to 50 days or lower over FY16-19, but increased to
70/85 days in FY20/FY21 due to lockdown impact. Debtors have largely remained steady at 50-55 days. Creditor days used to
be below 40 up to FY17, but increased to above 50 in FY18 and FY19, and were even higher at 64 days in FY21. Other current
assets and other current liabilities largely negated each other at ~20 days of sales in FY20 and FY21.
Exhibit 479: Working capital movement
100
Ex-cash NWC largely remained at 60-75 days over the last 10 years
80
Days of Sales

60

40

20

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Inventories Debtors Other current assets Creditors Other current liabilities Ex-cash NWC

Source: Company, Centrum Broking


xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
V-Guard Industries 16 September 2021

Exhibit 480: OCF/PAT Exhibit 481: OCF/EBITDA

180% 100%
160% 90%
140% 80%
120% 70%
60%
100%
50%
80%
40%
60% 30%
40% 20%
20% 10%
0% 0%
FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Healthy conversion of operating cash to free cash: Capex intensity has been low over the years. Over FY12-16, average
annual capex was only Rs230mn. Over FY17-21, the average annual capex rose to Rs570mn, as V-Guard set up a greenfield
manufacturing plant in Sikkim. In the past 10 years, there were two instances of investments in subsidiaries / associate firms,
albeit small in value. V-Guard invested Rs88mn in FY18 (for 74% stake in Guts Electromech, a maker of MCB and RCCB) and
Rs334mn in FY21 (for 18.7% stake in a battery start-up, Gegadyne). Against the OCF of Rs11.1bn over FY12-21, total capex
incurred was Rs4bn. This led to total FCF generation of Rs6.7bn over FY12-21.
Exhibit 482: Capex intensity, investments and free cash flows
2500
2000
1500
1000
Rsmn

500
0
-500
-1000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

OCF (Rsmn) Capex (Rsmn) Investments (Rsmn) FCF (Rsmn)


Source: Company, Centrum Broking

Asset turn: V-Guard operates with in-house manufacturing share of 40% and fixed asset turn in the range of 6x to 7x. Fixed
asset turn looks higher from FY16 to FY19 due to restatement of gross block as per IndAS in FY16.
Exhibit 483: Fixed asset turn
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Fixed Asset turn (x) 5.9 7.1 6.6 7.2 11.5 11.3 9.8 9.7 7.2 5.8
Source: Company, Centrum Broking

Unleveraged balance sheet; decent return ratios: V-Guard’s gross debt has reduced from Rs1bn in FY12 to only Rs100mn for
the past three years. The company is net cash positive for the past five years compared to net D/E ratio of 0.5x in FY12. The
return ratios are decent, with RoE profile of 18%-20% and RoCE profile of ~26% over the past four years. In the past two
years, a cash build-up of Rs1.1bn/Rs2.8bn in FY20/FY21 has been impacting return ratios while RoIC has risen to ~29%.
Exhibit 484: Leverage ratios
Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.50 0.57 0.33 0.15 0.02 (0.02) (0.01) (0.08) (0.10) (0.22)
Source: Company, Centrum Broking

Exhibit 485: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
RoE 26.6 26.7 24.3 20.4 26.1 26.1 19.2 20.0 19.6 18.1
RoCE (Pre-tax) 27.3 27.4 27.1 28.4 36.5 36.4 25.8 26.0 26.0 26.1
RoIC (Pre-tax) 26.6 26.6 26.0 26.9 34.7 34.4 24.4 25.1 26.2 29.5
Source: Company, Centrum Broking

Centrum Institutional Research 179


V-Guard Industries 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Revenues 24,820 26,990 32,013 36,836 41,917 Equity share capital 428 430 430 430 430
Operating Expense 16,582 18,487 22,185 25,122 28,336 Reserves & surplus 9,509 11,648 13,264 15,301 17,730
Employee cost 2,068 2,247 2,529 2,947 3,353 Shareholders fund 9,938 12,078 13,694 15,731 18,160
Others 3,637 3,191 4,055 4,764 5,496 Minority Interest 0 0 0 0 0
EBITDA 2,533 3,065 3,244 4,003 4,731 Total debt 100 100 0 0 0
Depreciation & Amortisation 281 373 438 485 536 Non Current Liabilities 0 0 0 0 0
EBIT 2,252 2,692 2,806 3,518 4,195 Def tax liab. (net) (22) (27) (27) (27) (27)
Interest expenses 37 56 59 62 65 Total liabilities 10,015 12,151 13,668 15,705 18,134
Other income 240 211 218 243 265 Gross block 3,441 4,660 5,656 6,466 7,276
PBT 2,454 2,847 2,965 3,700 4,396 Less: acc. Depreciation (766) (1,123) (1,561) (2,046) (2,582)
Taxes 603 857 746 931 1,106 Net block 2,675 3,538 4,095 4,420 4,694
Effective tax rate (%) 24.6 30.1 25.2 25.2 25.2 Capital WIP 669 196 10 10 10
PAT 1,852 1,990 2,219 2,768 3,289 Net fixed assets 3,343 3,733 4,105 4,430 4,704
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 1,852 1,990 2,219 2,768 3,289 Investments 451 425 425 425 425
Extraordinary items 0 0 0 0 0 Inventories 4,764 6,287 6,686 6,883 7,142
Reported PAT 1,852 1,990 2,219 2,768 3,289 Sundry debtors 3,218 3,847 4,385 4,743 5,168
Cash & Cash Equivalents 1,115 2,811 3,508 4,750 6,401
Ratios Loans & advances 86 37 112 184 210
YE Mar FY20A FY21A FY22E FY23E FY24E
Other current assets 1,403 1,431 1,761 2,136 2,515
Growth (%) Trade payables 3,007 4,731 5,470 5,782 6,133
Revenue (3.3) 8.7 18.6 15.1 13.8 Other current liab. 898 1,152 1,281 1,473 1,677
EBITDA 15.4 21.0 5.9 23.4 18.2 Provisions 460 537 564 592 622
Adj. EPS 11.5 7.0 11.5 24.8 18.8 Net current assets 6,221 7,992 9,137 10,849 13,004
Margins (%) Total assets 10,015 12,151 13,668 15,705 18,134
Gross 33.2 31.5 30.7 31.8 32.4
EBITDA 10.2 11.4 10.1 10.9 11.3 Cashflow
EBIT 9.1 10.0 8.8 9.6 10.0 YE Mar (Rs mn) FY20A FY21A FY22E FY23E FY24E
Adjusted PAT 7.5 7.4 6.9 7.5 7.8 Profit Before Tax 2,454 2,847 2,965 3,700 4,396
Returns (%) Depreciation & Amortisation 281 373 438 485 536
ROE 19.6 18.1 17.2 18.8 19.4 Net Interest 37 56 59 62 65
ROCE 19.6 18.3 17.5 19.1 19.7 Net Change – WC 33 (76) (448) (470) (504)
ROIC 21.5 21.6 22.5 25.9 28.7 Direct taxes (647) (861) (746) (931) (1,106)
Turnover (days) Net cash from operations 2,158 2,339 2,268 2,845 3,386
Gross block turnover ratio (x) 7.2 5.8 5.7 5.7 5.8 Capital expenditure (1,412) (763) (810) (810) (810)
Debtors 57 48 47 45 43 Acquisitions, net 0 0 0 0 0
Inventory 93 109 107 99 90 Investments 471 26 0 0 0
Creditors 72 76 84 82 77 Others 0 0 0 0 0
Net working capital 91 108 104 108 113 Net cash from investing (941) (737) (810) (810) (810)
Solvency (x) FCF 1,217 1,602 1,458 2,035 2,576
Net debt-equity (0.1) (0.2) (0.3) (0.3) (0.4) Issue of share capital 1 2 0 0 0
Interest coverage ratio 67.8 54.8 55.2 64.9 73.0 Increase/(decrease) in debt 0 0 (100) 0 0
Net debt/EBITDA (0.4) (0.9) (1.1) (1.2) (1.4) Dividend paid (465) (516) (602) (731) (860)
Per share (Rs) Interest paid (37) (56) (59) (62) (65)
Adjusted EPS 4.3 4.6 5.2 6.4 7.6 Others (447) 664 0 0 0
BVPS 23.2 28.1 31.8 36.6 42.2 Net cash from financing (948) 94 (761) (793) (925)
CEPS 5.0 5.5 6.2 7.6 8.9 Net change in Cash 269 1,696 697 1,242 1,651
DPS 0.9 1.2 1.4 1.7 2.0 Source: Company, Centrum Broking
Dividend payout (%) 20.8 25.9 27.1 26.4 26.2
Valuation (x)
P/E 59.0 55.1 49.4 39.6 33.3
P/BV 11.0 9.1 8.0 7.0 6.0
EV/EBITDA 42.9 34.9 32.7 26.2 21.8
Dividend yield (%) 0.4 0.5 0.5 0.7 0.8
Source: Company, Centrum Broking

Centrum Institutional Research 180


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah
Research Associate, Infrastructure

Adani Ports and SEZ (APSEZ) +91 22 4215 9815


[email protected]

APSEZ’s operating profits have consistently expanded over the last 10 years. Working Market data
capital intensity in the business has been declining since FY19. Loans/ICDs (including Current price: Rs770
to group companies) too have materially reduced over the last five years. APSEZ has Bloomberg: ADSEZ IN
rapidly expanded capacity at its existing ports, developed new greenfield ports, and 52-week H/L: Rs901/312
acquired large operating ports and logistics assets over the last decade. Against CFO
Market cap: Rs1571.4bn
of Rs354bn over FY12-21, it incurred capex of Rs286bn and invested Rs241bn in
acquiring new assets. This has led to negative FCF of Rs173bn over this period, which Free float: 36.2%
has been funded entirely by debt. Avg. daily vol. 3mth: 14,340,360
Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have been robust and have consistently
expanded over the last 10 years. Working capital intensity in the business had increased substantially over FY13-18 but there
has been significant unwinding since then, resulting in release of ~Rs14bn cash. Loans/ICDs (including to group companies)
have been a major contributor historically, but have reduced sharply in the last five years. Operating cash flows have
remained positive led by strong growth and sustained profitability and have particularly strengthened since FY17.
Exhibit 486: Operating cash flows have strengthened in recent years
100
80 80
75
60
48 52
Rs bn

40 36
26
20 7 8 7 14
0
-20
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before wcap changes (Rsbn) Wcap changes (Rsbn) CFO (Rsbn)
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital levels in the ports business should be inherently low. APSEZ’s NWC
levels however had risen due to increased debtors from group companies and others. Debtors from group companies have
declined from Rs24.6bn in FY18 to Rs7.4bn in FY21. Accrued interest declined from Rs12.4bn in FY19 to Rs4.4bn in FY21,
leading to sharp reduction in working capital levels.
Exhibit 487: Working capital, while elevated historically, is on a declining trend since FY19
200

150
days

100

50

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Current liabilities NWC (ex-cash and ex L&A to subs/JVs)
Source: Company, Centrum Broking

Exhibit 488: EBITDA to CFO conversion moderate at 72% over FY12-21


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
CFO/PAT 65% 50% 39% 113% 48% 93% 132% 130% 198% 160% 118%
CFO/EBITDA 41% 34% 25% 67% 31% 64% 69% 79% 126% 92% 72%
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Adani Ports and SEZ (APSEZ) 16 September 2021
Rapid capacity expansions and acquisitions have led to weak conversion of operating cash to free cash: Over the last
decade, APSEZ has rapidly expanded capacity at its existing ports, developed new greenfield ports, and acquired large
operating ports and logistics assets. Against CFO of Rs354bn over FY12-21, APSEZ has incurred capex of Rs286bn and invested
Rs241bn in acquiring new assets. This has led to negative FCF of Rs173bn over this period, which has been funded by debt.
Exhibit 489: Capex intensity and acquisitions have resulted in negative FCF of Rs173bn over FY12-21
100

50

0
Rs bn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50

-100 Acquisition of AALL & Acquisition of


Acquisition of Dhamra Kattupalli Krishnapatnam
-150

CFO (Rsbn) Capex (Rsbn) Acquisitions and Investments (Rsbn) Net FCF (Rsbn)

Source: Company, Centrum Broking

Acquisitions gave strategic advantage but returns yet to kick in: The performance of Dhamra, which was acquired in FY15,
has been below expectations, as the cargo ramp-up has taken longer than expected and APSEZ also had to invest
considerable capital to improve its operating efficiency. Kattupalli was acquired as a near greenfield asset in FY18 with
negligible cargo volume and is still scaling up. KPCL, acquired in FY21, had low RoCE historically due to low capacity
utilization, lower pricing, and higher cost structure. There have been pricing increases and cost reductions post takeover,
which along with cargo growth should improve returns going forward.
Exhibit 490: Returns from acquisitions yet to pick up
Dhamra Kattupalli Krishnapatnam
Acquired in FY15 FY18 FY21
RoCE of the asset (past 3 years) 7.6% 3.2% 7.2%
RoCE at acquisition price (past 3 years) 5.4% 3.0% 5.1%
Source: Company, Centrum Broking

Exhibit 491: Gap in FCF funded predominantly by borrowings (no equity raise on net basis)
Rs bn FY12* FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF (27) (45) (31) (7) (30) 13 11 (10) 31 (78) (173)
Inflow from equity raise/Outflow from dividend/Buyback (1) (2) 8 (2) (5) (0) (3) (5) (28) (0) (40)
Increase/ (decrease) in net debt 29 47 23 9 36 (13) (7) 15 (3) 78 213
Source: Company, Centrum Broking *net of impact of discontinued operations of Abbott Point

Exhibit 492: Leverage in check led by strong operating performance; improved capacity utilization to improve return ratios
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
Net Debt/Equity 3.4 1.7 1.4 1.6 1.6 1.1 0.9 0.9 0.9 1.0 1.4
Net Debt/EBITDA 4.0 4.5 4.4 4.4 4.6 3.6 2.7 3.1 3.0 3.4 3.8
RoE 26.5% 28.4% 24.1% 23.0% 23.3% 25.9% 21.1% 17.6% 15.2% 17.8% 22.3%
RoCE pre-tax 8.9% 10.1% 13.3% 13.7% 12.9% 15.1% 17.0% 13.8% 11.3% 13.8% 13.0%
RoCE 8.2% 9.4% 11.7% 12.7% 11.7% 14.1% 12.3% 10.9% 10.1% 11.1% 11.2%
Source: Company, Centrum Broking

Profitability has improved, but return ratios under pressure due to rapid expansions and acquisitions
APSEZ’s RoE has declined over the past decade, mainly on account of its sharp inorganic growth. While the quality of the
acquired assets is good, these are long-gestation assets and take time to generate returns. Also, many of these have been
acquired at a premium. Once the utilization levels of these assets improve, return ratios should also improve.
Exhibit 493: Profitability has consistently improved; capacity utilization has room to increase
FY16 FY17 FY18 FY19 FY20 FY21
APSEZ Capacity (mt) 335 335 378 380 396 472
Total volume (mt) 151 169 180 208 223 247
Capacity Utilization 45% 51% 48% 55% 56%^ 57%^
EBITDA/MT (Rs/MT)* 252 269 290 291 316 305
Source: Company, Centrum Broking; *: Port EBITDA ex forex loss/gain; ^: utilization computed on annualized volume of cargo in case of new assets

Centrum Institutional Research 182


Adani Ports and SEZ (APSEZ) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 109,254 118,731 125,496 172,716 210,034 Equity share capital 4,170 4,089 4,089 4,250 4,250
Operating Expense 27,608 30,973 32,595 49,402 56,218 Reserves & surplus 241,212 252,146 302,194 405,102 464,283
Employee cost 5,298 5,465 6,151 6,889 7,715 Shareholders fund 245,382 256,235 306,283 409,352 468,533
Others 10,433 22,903 (236) 11,356 8,067 Minority Interest 9,657 9,198 21,030 10,649 11,216
EBITDA 65,916 59,390 86,987 105,069 138,033 Total debt 275,457 300,758 349,403 419,133 392,982
Depreciation & Amortisation 13,735 16,803 21,073 25,683 30,992 Non Current Liabilities 0 0 0 0 0
EBIT 52,181 42,587 65,913 79,386 107,041 Def tax liab. (net) (8,124) (9,227) 3,214 5,233 9,467
Interest expenses 14,283 18,131 22,553 23,440 26,394 Total liabilities 522,372 556,964 679,931 844,367 882,198
Other income 13,623 18,614 19,702 15,396 14,713 Gross block 299,844 362,512 549,682 653,533 683,922
PBT 51,521 43,069 63,063 71,341 95,361 Less: acc. Depreciation (51,309) (68,229) (108,676) (149,801) (180,793)
Taxes 10,815 4,594 12,433 14,268 20,026 Net block 248,535 294,283 441,005 503,732 503,129
Effective tax rate (%) 21.0 10.7 19.7 20.0 21.0 Capital WIP 44,835 32,163 36,971 9,613 15,225
PAT 40,707 38,476 50,630 57,073 75,335 Net fixed assets 326,049 359,308 518,341 651,861 656,868
Minority/Associates (545) (258) (687) (188) (1,108) Non Current Assets 0 0 0 0 0
Recurring PAT 40,161 38,218 49,943 56,885 74,227 Investments 7,823 11,780 22,362 15,001 15,001
Extraordinary items (258) (586) 0 0 0 Inventories 8,067 2,883 9,919 12,285 14,940
Reported PAT 39,903 37,631 49,943 56,885 74,227 Sundry debtors 27,897 32,021 29,257 36,239 41,866
Cash & Cash Equivalents 59,673 73,139 47,008 76,287 96,537
Ratios Loans & advances 27,672 31,173 20,691 22,191 24,191
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 97,811 99,637 96,844 101,844 106,844
Growth (%)
Trade payables 0 0 0 0 0
Revenue (3.5) 8.7 5.7 37.6 21.6
Other current liab. 31,588 51,831 63,266 69,657 72,001
EBITDA (6.7) (9.9) 46.5 20.8 31.4 Provisions 1,032 1,145 1,224 1,685 2,049
Adj. EPS (1.9) (3.0) 30.7 9.6 30.5 Net current assets 188,500 185,876 139,229 177,505 210,329
Margins (%) Total assets 522,372 556,964 679,931 844,367 882,198
Gross 74.7 73.9 74.0 71.4 73.2
EBITDA 60.3 50.0 69.3 60.8 65.7 Cashflow
EBIT 47.8 35.9 52.5 46.0 51.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 36.8 32.2 39.8 32.9 35.3 Profit Before Tax 56,022 58,747 55,910 75,228 95,361
Returns (%) Depreciation & Amortisation 13,735 16,803 21,073 25,683 30,992
ROE 17.6 15.2 17.8 15.9 16.9 Net Interest 14,283 18,131 22,553 23,440 26,394
ROCE 10.7 10.0 11.1 10.0 11.2 Net Change – WC (10,769) 16,090 20,516 (8,998) (12,573)
ROIC 9.5 8.1 9.7 9.4 11.2 Direct taxes (8,622) (6,040) (7,325) (12,020) (15,423)
Turnover (days) Net cash from operations 64,649 103,731 112,728 103,334 124,751
Gross block turnover ratio (x) 0.4 0.3 0.2 0.3 0.3 Capital expenditure (67,629) (50,062) (23,517) (33,000) (36,000)
Debtors 119 92 89 69 68 Acquisitions, net 0 0 (119,250) (144,240) 0
Inventory 88 65 72 82 88 Investments 2,966 (3,957) (10,582) 7,360 0
Creditors 0 0 0 0 0 Others (576) (555) (656) (1,482) (540)
Net working capital 630 571 405 375 366 Net cash from investing (65,239) (54,575) (154,005) (171,362) (36,540)
Solvency (x) FCF (590) 49,156 (41,276) (68,028) 88,211
Net debt-equity 0.8 0.9 0.9 0.8 0.6 Issue of share capital 28 0 0 161 0
Interest coverage ratio 4.6 3.3 3.9 4.5 5.2 Increase/(decrease) in debt 48,656 9,038 55,798 65,843 (26,151)
Net debt/EBITDA 3.3 3.8 3.5 3.3 2.1 Dividend paid (4,556) (6,502) (10,159) (9,470) (15,047)
Per share (Rs) Interest paid (14,283) (18,131) (22,553) (23,440) (26,394)
Adjusted EPS 19.4 18.8 24.6 26.9 35.1 Others 770 (495) 1,151 291 291
BVPS 118.5 126.1 150.7 193.8 221.8 Net cash from financing 30,615 (16,091) 24,237 33,385 (67,301)
CEPS 26.0 27.1 35.0 39.1 49.8 Net change in Cash 30,026 33,066 (17,040) (34,643) 20,911
DPS 2.2 3.2 5.0 4.5 7.1 Source: Company, Centrum Broking
Dividend payout (%) 11.4 17.3 20.3 16.6 20.3
Valuation (x)
P/E 18.9 20.3 16.9 28.6 21.9
P/BV 3.1 3.0 2.8 4.0 3.5
EV/EBITDA 14.8 16.9 13.2 18.2 13.5
Dividend yield (%) 0.6 0.8 1.2 0.6 0.9
Source: Company, Centrum Broking

Centrum Institutional Research 183


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

Ahluwalia Contracts (ACIL) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

Ahluwalia Contracts’ (ACIL) cash flow analysis indicates significant improvement in Market data
working capital management and cash generation since FY15. ACIL faced substantial Current price: Rs388
stress over FY12-14 due to execution delays and cost escalations. Starting FY15, ACIL Bloomberg: AHLU IN
re-oriented its business mix towards government contracts, which helped stabilize 52-week H/L: Rs430/202
execution and margins. While revenue/profit growth has been weak, working capital
Market cap: Rs26bn
levels have been moderate at 60-80 days and operating cash flows have been
consistently positive since FY15. Capex intensity has been low, which helped ACIL Free float: 42.0%
unwind its leverage to become net cash. Return ratios were strong since FY15, but Avg. daily vol. 3mth: 59,083
weakened in FY20 and FY21 due to provisions related to legacy contracts. Source: Bloomberg

Sustained improvement in operating cash flows: Operating cash flows during FY12-14 had turned negative due to delays in
project execution and increase in raw material costs in fixed price contracts. Private sector orders comprised ~80% of the
order backlog during this period. With a change in strategy to focus on government contracts, margins and cash flows began
to improve from FY15.
Exhibit 494: Steady improvement in cash flow from operations, led by tight control on working capital
3,000
Sharp rise in Lower receivables, higher
Execution delays government orders mobilization advances
2,000 & cost increase

1,000

(1,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital levels have been stable: ACIL’s working capital has remained largely stable over the years at 60-80 days, in
sync with industry standards. However, in FY21, it declined sharply to 40 days due to sharp reduction in receivables and rise
in mobilization advances.
Exhibit 495: NWC has remained stable and in line with industry standards
200

150

100 72 75 73 77 69
66 70
62
46 40
50

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex cash ex L&A)
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Ahluwalia Contracts (ACIL) 16 September 2021

Exhibit 496: Healthy conversion of EBITDA into CFO Exhibit 497: CFO/PAT consistently strong over FY15-21
200% 162%
350% 324%
150%
300%
100% 60% 66% 65%
37% 35% 38% 250%
50%
NM 1% 200%
0% 155%
150% 132%
-50% 107%
100% 70% 66% 71%
-100%
50%
-150% NM NM 3%
0%
-200% -180%

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY13*
FY12*
FY12

FY13*

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking; *: both CFO and EBITDA were negative Source: Company, Centrum Broking; *: both CFO and PAT were negative

Free cash flows improved consistently since FY15: ACIL has consistently generated strong operating cash flows, which have
helped the company to completely fund its capex requirements. Against CFO of Rs6.8bn over FY12-21, ACIL has incurred
capex of only Rs2.7bn, which led to positive FCF generation of Rs4bn over this period. ACIL follows an asset-light model,
which limits capex investments and improves cash flow generation.
Exhibit 498: Disciplined working capital management and low capex intensity led to consistent FCF
3,000

2,000

1,000

-1,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO (Rs mn) Capex (Rs mn) Acquisitions and Investments (Rs mn) Net FCF (Rs mn)
Source: Company, Centrum Broking

Exhibit 499: Strong cash flows have helped ACIL repay debt
Rs mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF (994) (467) (166) 427 376 937 584 535 637 2,148 4,016
Inflow from equity raise/dividend outflow - - - 499 - - - (24) (24) - 450
Increase/ (decrease) in net debt 994 467 166 (926) (376) (937) (584) (511) (613) (2,148) (4,467)
Source: Company, Centrum Broking Issue of 4.2m shares to promoters on
preferential basis @Rs118/share to repay debt
Exhibit 500: Leverage has been reducing since FY15
Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 average
Net Debt/Equity 0.6 0.8 0.8 0.3 0.1 (0.1) (0.2) (0.2) (0.2) (0.5) 0.1
Net Debt*/EBITDA 9.2 (15.6) 9.3 2.5 1.6 0.7 0.0 (0.0) 0.1 (0.5) 0.7
Source: Company, Centrum Broking; *: includes mobilization advances

Exhibit 501: Return ratios declined over last two years due to elevated provisions
Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 average
RoE -13.5% -31.8% 3.5% 22.7% 22.2% 18.6% 20.5% 17.3% 8.4% 9.2% 7.7%
RoCE pre-tax* -3.0% -7.8% 6.8% 15.8% 21.4% 21.2% 27.2% 24.1% 13.5% 13.1% 13.2%
RoCE -3.0% -7.8% 6.7% 15.2% 15.2% 14.0% 18.0% 15.7% 9.0% 9.8% 9.3%
Source: Company, Centrum Broking; *: Capital employed includes mobilization advances

Execution delays and Provisions for disputes in


cost escalations legacy contracts

Centrum Institutional Research 185


Ahluwalia Contracts (ACIL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 17,547 18,849 19,822 23,786 29,019 Equity share capital 134 134 134 134 134
Operating Expense 13,500 15,038 15,869 18,444 22,490 Reserves & surplus 7,250 7,906 8,666 10,391 12,623
Employee cost 1,433 1,543 1,534 1,918 2,206 Shareholders fund 7,384 8,040 8,800 10,525 12,757
Others 449 738 876 523 638 Minority Interest 0 0 0 0 0
EBITDA 2,165 1,530 1,542 2,901 3,685 Total debt 609 470 160 150 100
Depreciation & Amortisation 276 319 304 380 422 Non Current Liabilities 0 0 0 0 0
EBIT 1,889 1,211 1,238 2,521 3,263 Def tax liab. (net) (283) (236) (231) (231) (231)
Interest expenses 192 350 426 454 472 Total liabilities 7,709 8,275 8,729 10,444 12,626
Other income 98 104 223 238 191 Gross block 2,613 3,275 3,666 3,966 4,466
PBT 1,795 966 1,035 2,305 2,983 Less: acc. Depreciation (751) (1,067) (1,371) (1,751) (2,172)
Taxes 621 322 263 580 751 Net block 1,862 2,208 2,295 2,215 2,294
Effective tax rate (%) 34.6 33.3 25.4 25.2 25.2 Capital WIP 4 2 4 4 4
PAT 1,174 644 772 1,725 2,232 Net fixed assets 1,866 2,210 2,299 2,219 2,298
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 1,174 644 772 1,725 2,232 Investments 63 63 63 63 63
Extraordinary items 0 0 0 0 0 Inventories 1,481 2,208 2,972 2,274 2,773
Reported PAT 1,174 644 772 1,725 2,232 Sundry debtors 5,950 5,973 4,349 7,820 9,541
Cash & Cash Equivalents 2,092 2,439 4,175 3,258 4,323
Ratios Loans & advances 73 80 49 58 71
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 3,056 4,392 6,479 5,865 6,758
Growth (%)
Trade payables 4,285 5,231 6,402 5,811 7,702
Revenue 6.6 7.4 5.2 20.0 22.0
Other current liab. 2,514 3,766 5,171 5,107 5,180
EBITDA (1.3) (29.3) 0.8 88.1 27.0 Provisions 71 93 83 196 318
Adj. EPS 1.7 (45.1) 19.9 123.3 29.4 Net current assets 5,780 6,002 6,368 8,162 10,265
Margins (%) Total assets 7,709 8,275 8,729 10,444 12,626
Gross 23.1 20.2 19.9 22.5 22.5
EBITDA 12.3 8.1 7.8 12.2 12.7 Cashflow
EBIT 10.8 6.4 6.2 10.6 11.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 6.7 3.4 3.9 7.3 7.7 Profit Before Tax 1,795 966 1,035 2,305 2,983
Returns (%) Depreciation & Amortisation 276 319 304 380 422
ROE 17.3 8.4 9.2 17.9 19.2 Net Interest 192 350 426 454 472
ROCE 15.3 8.8 9.6 16.3 18.4 Net Change – WC (540) 125 1,372 (2,712) (1,038)
ROIC 18.2 10.5 11.5 21.2 24.0 Direct taxes (692) (471) (317) (580) (751)
Turnover (days) Net cash from operations 1,030 1,289 2,820 (153) 2,087
Gross block turnover ratio (x) 6.7 5.8 5.4 6.0 6.5 Capital expenditure (285) (362) (353) (300) (500)
Debtors 132 115 95 93 109 Acquisitions, net 0 0 0 0 0
Inventory 46 45 60 52 41 Investments 0 0 0 0 0
Creditors 109 115 134 121 110 Others 6 (67) 6 0 0
Net working capital 120 116 117 125 129 Net cash from investing (279) (429) (347) (300) (500)
Solvency (x) FCF 750 859 2,473 (453) 1,587
Net debt-equity (0.2) (0.2) (0.5) (0.3) (0.3) Issue of share capital 0 0 0 0 0
Interest coverage ratio 11.3 4.4 3.6 6.4 7.8 Increase/(decrease) in debt 311 (138) (310) (10) (50)
Net debt/EBITDA (0.7) (1.3) (2.6) (1.1) (1.1) Dividend paid (24) (24) 0 0 0
Per share (Rs) Interest paid (192) (350) (426) (454) (472)
Adjusted EPS 17.5 9.6 11.5 25.7 33.3 Others 0 0 0 0 0
BVPS 110.2 120.0 131.4 157.1 190.4 Net cash from financing 94 (512) (736) (465) (522)
CEPS 21.6 14.4 16.1 31.4 39.6 Net change in Cash 845 347 1,737 (918) 1,066
DPS 0.3 0.3 0.0 0.0 0.0 Source: Company, Centrum Broking
Dividend payout (%) 1.7 3.1 0.0 0.0 0.0
Valuation (x)
P/E 18.6 31.6 20.5 15.1 11.6
P/BV 3.0 2.5 1.8 2.5 2.0
EV/EBITDA 9.4 12.0 7.6 7.9 5.9
Dividend yield (%) 0.1 0.1 0.0 0.0 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 186


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

Ashoka Buildcon (ABL) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

Ashoka Buildcon’s (ABL) operating cash flows (standalone basis) have been healthy, Market data
though there have been a few large dips, intermittently. Operating cash flow of Current price: Rs101
Rs21.8bn has funded 88% of capital commitments over this period (capex of Rs6.1bn Bloomberg: ASBL IN
and net equity investments of Rs18.5bn in BOT/HAM assets). Working capital 52-week H/L: Rs119/60
intensity has remained low, with higher debtor levels being compensated by higher Market cap: Rs28.3bn
payables, mobilization advances and other liabilities. Return ratios moderated after Free float: 45.5%
fresh equity capital raise in FY16, but have since bounced back to historical levels.
Avg. daily vol. 3mth: 2,356,418
Part of this recovery is due to growth rebound in FY19 and higher margins while the
Source: Bloomberg
balance is also on account of interest income from SPVs, 78% of which is accrued.

Cash generation healthy but with significant cyclicality: Operating profits have consistently risen over the last 10 years.
Working capital cycle has been low to moderate through this period, which has helped generate positive operating cash
flows in 7 out of the 10 years. Having said that, there have been some sharp swings in working capital, led in part by higher
inventories/WIP and higher T&D receivables.
Exhibit 502: Generated operating cash flow^ of Rs21.8bn over 10 years though with significant cyclicality
8,000 Release of working capital
Sharp rise in NWC levels led by fall in share of T&D
6,000 from a very low base revenue
4,000
2,000
Rs mn

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(2,000)
(4,000)
Normalization in
(6,000) working capital from
very low levels
Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking ^standalone basis

Working capital levels have remained low: Working capital levels have largely remained low to moderate. The sharp
increase in NWC to 113 days in FY16 was driven by surge in inventories/WIP for new projects and a sharp increase in share of
T&D revenue, leading also to higher receivables. This was also followed by a sharp reduction to 31 days over FY17. Over the
years, ABL’s NWC has exhibited a pattern of higher debtors balanced by higher creditors.
Exhibit 503: Net working capital^ levels remain low with higher payables balancing higher receivables
180
150
120
90
Days

60
30
-
(30) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(60)
Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex cash ex L&A)
Source: Company, Centrum Broking ^standalone basis

Higher inventories and T&D Higher debtors offset by higher


receivables, with share of T&D creditors, customer advances
revenue at 45% in FY16 and other liabilities

Please see Appendix for analyst certifications and all other important disclosures.
Ashoka Buildcon (ABL) 16 September 2021

Exhibit 504: EBITDA to CFO conversion of 67% over 10 years Exhibit 505: PAT to CFO conversion of 105% over 10 years

200%
350%
150%
250%
100%
150%
50%
50%
0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -50% FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50%

-100% -150%

-150% -250%

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex and investments largely funded by CFO: ABL has generated total operating cash flows of Rs21.8bn over FY12-21,
which have funded 88% of its total capital commitments – capex of Rs6.1bn and net equity investment of Rs18.5bn in
BOT/HAM assets. FCF over this period has been negative Rs2.8bn.
Exhibit 506: CFO^ funded 88% of capital commitments; negative FCF of Rs2.8bn over 10 years
8,000

4,000
Rs mn

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-4,000

-8,000
CFO (Rs mn) Capex (Rs mn) Acquisitions and Investments (Rs mn) Net FCF (Rs mn)
Source: Company, Centrum Broking ^standalone basis

Exhibit 507: Deficit in FCF largely funded by equity


Standalone (Rs mn) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF 202 620 704 (2,226) (4,228) 2,541 1,211 (6,168) 6,069 (1,572) (2,848)
Inflow from equity raise/dividend outflow (189) (176) (221) (197) 4,503 (150) (158) (150) - - 3,262
Increase/ (decrease) in net debt (13) (443) (484) 2,423 (276) (2,390) (1,053) 6,318 (6,069) 1,572 (414)
Source: Company, Centrum Broking

Exhibit 508: Leverage has been consistently low


Leverage ratios (x)^ FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
Net Debt/Equity 0.4 0.3 0.2 0.4 0.2 0.1 0.0 0.3 0.1 0.1 0.2
Net Debt*/EBITDA 3.2 2.9 3.4 3.2 3.1 2.8 2.4 2.7 0.9 1.1 2.6
Source: Company, Centrum Broking; *: includes mobilization advances ^standalone basis

Exhibit 509: Return ratios normalized post equity raise in FY16; bounced backed to historical levels over FY19-21
Return Ratios (%)^ FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
RoE 14.1% 15.7% 13.3% 13.9% 10.6% 10.3% 13.0% 16.1% 16.1% 14.6% 13.8%
RoCE pre-tax* 13.9% 14.4% 13.0% 14.2% 12.7% 10.5% 12.3% 16.6% 16.8% 16.7% 14.1%
RoCE* 10.6% 10.8% 9.2% 10.4% 8.9% 8.5% 10.1% 11.9% 12.2% 12.5% 10.5%
Source: Company, Centrum Broking; *: Capital employed includes mobilization advances ^-standalone basis

Equity raise of FY16 followed by low


Recovery led by strong growth in
earnings growth led to dip in RoE in FY16
FY19 + higher margins + surge in
interest income from SPVs (78%
of which is accrued)

Centrum Institutional Research 188


Ashoka Buildcon (ABL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 38,206 39,374 38,175 44,318 51,772 Equity share capital 1,404 1,404 1,404 1,404 1,404
Operating Expense 30,300 29,975 29,791 35,567 41,766 Reserves & surplus 20,717 24,586 28,664 32,643 37,147
Employee cost 1,490 1,820 1,685 1,849 2,038 Shareholders fund 22,120 25,989 30,067 34,047 38,551
Others 1,265 1,723 1,505 1,593 1,753 Minority Interest 0 0 0 0 0
EBITDA 5,152 5,856 5,195 5,309 6,215 Total debt 7,883 4,335 4,396 5,168 3,868
Depreciation & Amortisation 763 1,111 872 769 928 Non Current Liabilities 1,899 2,074 2,074 2,074 2,074
EBIT 4,389 4,745 4,323 4,540 5,287 Def tax liab. (net) (518) (475) (515) (515) (515)
Interest expenses 907 855 772 771 888 Total liabilities 31,385 31,923 36,023 40,774 43,978
Other income 1,157 1,449 1,921 1,924 1,995 Gross block 7,079 7,596 6,716 7,216 8,066
PBT 4,639 5,340 5,472 5,693 6,394 Less: acc. Depreciation (3,280) (4,105) (3,862) (4,732) (5,661)
Taxes 1,307 1,468 1,391 1,433 1,609 Net block 3,799 3,491 2,854 2,484 2,406
Effective tax rate (%) 28.2 27.5 25.4 25.2 25.2 Capital WIP 55 95 17 17 17
PAT 3,332 3,871 4,081 4,260 4,785 Net fixed assets 3,854 3,586 2,871 2,501 2,423
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 3,332 3,871 4,081 4,260 4,785 Investments 13,640 14,112 14,585 14,585 14,585
Extraordinary items (470) 0 0 0 0 Inventories 1,527 1,534 1,717 2,064 2,411
Reported PAT 2,862 3,871 4,081 4,260 4,785 Sundry debtors 15,513 14,440 14,200 16,635 19,432
Cash & Cash Equivalents 550 2,911 1,364 1,522 1,352
Ratios Loans & advances 14,563 13,232 16,356 18,805 21,278
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 2,920 2,830 3,263 4,764 6,409
Growth (%)
Trade payables 15,516 11,591 11,358 12,606 14,638
Revenue 56.1 3.1 (3.0) 16.1 16.8
Other current liab. 4,967 8,228 6,101 6,678 8,510
EBITDA 75.6 13.7 (11.3) 2.2 17.1 Provisions 700 903 875 818 764
Adj. EPS 40.6 16.2 5.4 4.4 12.3 Net current assets 13,889 14,225 18,567 23,688 26,970
Margins (%) Total assets 31,384 31,923 36,023 40,774 43,978
Gross 20.7 23.9 22.0 19.7 19.3
EBITDA 13.5 14.9 13.6 12.0 12.0 Cashflow
EBIT 11.5 12.1 11.3 10.2 10.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 8.7 9.8 10.7 9.6 9.2 Profit Before Tax 4,169 5,340 5,472 5,693 6,394
Returns (%) Depreciation & Amortisation 763 1,111 872 769 928
ROE 16.1 16.1 14.6 13.3 13.2 Net Interest 907 855 772 771 888
ROCE 12.4 12.7 12.9 12.0 12.2 Net Change – WC (2,941) 2,654 (3,364) (2,412) (1,694)
ROIC 17.7 17.3 16.5 14.0 13.9 Direct taxes (1,307) (1,468) (1,391) (1,433) (1,609)
Turnover (days) Net cash from operations 1,749 8,667 2,361 3,388 4,907
Gross block turnover ratio (x) 5.4 5.2 5.7 6.1 6.4 Capital expenditure (2,146) (557) (159) (500) (850)
Debtors 122 139 137 127 127 Acquisitions, net 0 0 0 0 0
Inventory 18 19 20 19 20 Investments (5,529) (1,101) (2,997) (2,551) (1,757)
Creditors 170 165 141 123 119 Others 1,117 (173) 0 0 0
Net working capital 133 132 178 195 190 Net cash from investing (6,558) (1,831) (3,156) (3,051) (2,607)
Solvency (x) FCF (4,809) 6,835 (795) 337 2,300
Net debt-equity 0.3 0.1 0.1 0.1 0.1 Issue of share capital 0 0 0 0 0
Interest coverage ratio 5.7 6.9 6.7 6.9 7.0 Increase/(decrease) in debt 6,284 (3,549) 62 772 (1,300)
Net debt/EBITDA 1.4 0.2 0.6 0.7 0.4 Dividend paid 0 0 0 (281) (281)
Per share (Rs) Interest paid (907) (855) (772) (771) (888)
Adjusted EPS 11.9 13.8 14.5 15.2 17.0 Others 0 0 0 0 0
BVPS 78.8 92.6 107.1 121.3 137.3 Net cash from financing 5,377 (4,403) (710) (280) (2,469)
CEPS 14.6 17.7 17.6 17.9 20.4 Net change in Cash 568 2,432 (1,505) 57 (170)
DPS 0.0 0.0 0.0 1.0 1.0 Source: Company, Centrum Broking
Dividend payout (%) 0.0 0.0 0.0 6.6 5.9
Valuation (x)
P/E 11.7 7.9 5.1 6.6 5.9
P/BV 1.8 1.2 0.7 0.8 0.7
EV/EBITDA 9.0 5.5 4.6 6.0 5.0
Dividend yield (%) 0.0 0.0 0.0 1.0 1.0
Source: Company, Centrum Broking

Centrum Institutional Research 189


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

G R Infraprojects (GRIL) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

GRIL’s operating profits have consistently expanded over the last 10 years. Working Market data
capital intensity has increased over the last 2-3 years, but is still under control and in Current price: Rs1,586
line with industry standards. Strong operating cash flow generation has helped GRIL Bloomberg: GRINFRA IN
to fund 77% of its capex requirements and equity investments (net of monetization) 52-week H/L: Rs1,839/1,543
over FY12-21. Against CFO of Rs23.6bn over FY12-21, GRIL has incurred capex of
Market cap: Rs153.4bn
Rs19.8bn and invested Rs10.8bn of equity in assets (net of monetization). Given its
strong cash flow generation, better working capital control and prudent capital Free float: 13.5%
allocation, GRIL has remained thinly levered and has generated strong return ratios Avg. daily vol. 3mth: -
over FY12-21. Source: Bloomberg

History of robust and consistent cash generation: Operating profits for GRIL have been robust and have grown substantially
over the last 10 years. While working capital intensity has increased over the last 2-3 years given the significant scale-up in
operations, it is well under control and in line with the industry standards. Consequently, GRIL’s cash flow from operations
has remained strong and consistent for a large part of FY12-21.
Exhibit 510: Cash flow from operations

11,000 Rise in working capital intensity


Cash generation, while consistent, was low, given resulted in moderation of
8,000 the scale of operations of GRIL during FY12-15 operating cash flows in FY21

5,000
Rs mn

2,000

(1,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(4,000)

(7,000)
Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Analysis of working capital movement: After a sharp rise over FY12-14 due to rise in receivables and loans to subsidiaries,
NWC levels declined materially in FY17, led by reduction in receivables. Having said that, working capital is still under control
and in sync with industry standards (typically 90-120 days).
Exhibit 511: NWC has risen in last 2-3 years, but under control and in line with industry standards
100 Higher inventories + GST receivables and lower
mobilization advances from SPVs
86 86
75 82
67 72
69
days

50 51
48

31 31
25

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex-cash ex-L&A days)

Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
G R Infraprojects (GRIL) 16 September 2021

Exhibit 512: EBITDA to CFO conversion moderate at 44% Exhibit 513: PAT to CFO conversion at 70% over FY12-21

150% 127% 400%


115% 288%
100% 192%
63% 60% 60% 200% 102% 108%
86%
29% 35% 60% 49%
50% 21% 29%
0%
0% FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -10%
-200%
-50% -7%

-100% -400%
-402%
-150% -133% -600%
Source: Company, Centrum Broking Source: Company, Centrum Broking

Strong CFO generation meets 77% of the capex and net investment requirements: Over the last decade, GRIL has
consistently generated operating cash flows, which have helped the company to fund 77% of its total capex requirements
and investments (net of monetization) despite scale-up in operations. GRIL also benefitted from monetization of two PPP
assets, namely Shillong e-way and Jodhpur-Pali e-way in FY17 at a premium valuation of 1.8x P/B, resulting in cash inflows of
Rs3bn (net gain of Rs1.4bn). Against CFO of Rs23.6bn over FY12-21, GRIL has incurred capex of Rs19.8bn and invested
Rs10.8bn of equity in assets (net of monetization).
Exhibit 514: Strong operating cash flow has funded 77% of the capex and equity commitments over FY12-21
9,000

5,000
Rs mn

1,000

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(3,000)

(7,000) CFO (Rs mn) Capex (Rs mn) Investments (Rs mn) Net FCF (Rs mn)
Source: Company, Centrum Broking

Exhibit 515: Strong operating cash flows along with monetization proceeds have kept GRIL’s leverage in check
Rs mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF (458) (55) (1,941) 356 (159) 5,196 (6,107) (1,220) 2,407 (5,008) (6,988)
Inflow from equity raise/dividend outflow - - - - - - (41) - - (14) (55)
Increase/ (decrease) in net debt 458 55 1,941 (356) 159 (5,196) 6,148 1,220 (2,407) 5,022 7,043
Source: Company, Centrum Broking

Exhibit 516: GRIL continued to be thinly levered over FY12-21


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
Net Debt/Equity 0.1 0.1 0.6 0.5 0.4 (0.1) 0.2 0.2 0.1 0.2 0.2
Net Debt*/EBITDA 0.6 1.1 4.5 3.8 2.2 0.6 1.1 1.0 0.5 0.8 1.6
Source: Company, Centrum Broking; *: includes mobilization advances

Exhibit 517: Strong return ratio profile; recent moderation due to inefficiencies of scale/diversification
Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
RoE 26.4% 15.9% 7.6% 9.0% 27.9% 46.7% 30.7% 32.4% 27.7% 24.3% 24.9%
RoCE pre-tax* 23.9% 18.9% 10.0% 9.2% 20.2% 33.3% 26.5% 31.4% 28.4% 25.0% 22.7%
RoCE* 16.9% 12.8% 6.4% 7.6% 17.7% 29.5% 22.1% 22.5% 19.5% 18.2% 17.3%
Source: Company, Centrum Broking; *: Capital employed includes mobilization advances

Centrum Institutional Research 191


G R Infraprojects (GRIL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 49,502 60,278 72,445 77,269 103,740 Equity share capital 485 485 483 483 483
Operating Expense 35,329 42,703 53,841 57,774 78,718 Reserves & surplus 20,919 27,785 35,561 43,124 53,778
Employee cost 3,472 4,466 4,548 5,230 6,015 Shareholders fund 21,404 28,270 36,044 43,607 54,261
Others 626 695 952 1,095 1,357 Minority Interest 0 0 0 0 0
EBITDA 10,074 12,413 13,104 13,170 17,650 Total debt 10,607 10,740 13,511 11,883 17,253
Depreciation & Amortisation 1,381 1,868 2,268 2,837 3,229 Non Current Liabilities 0 0 0 0 0
EBIT 8,693 10,545 10,835 10,333 14,420 Def tax liab. (net) (685) 646 638 638 638
Interest expenses 1,057 1,452 1,396 1,614 1,990 Total liabilities 31,326 39,656 50,193 56,128 72,152
Other income 674 938 1,275 1,388 1,807 Gross block 12,197 15,289 20,585 24,085 27,585
PBT 8,310 10,030 10,715 10,107 14,237 Less: acc. Depreciation (3,172) (4,967) (7,134) (9,970) (13,200)
Taxes 2,353 3,142 2,908 2,544 3,584 Net block 9,025 10,322 13,451 14,115 14,385
Effective tax rate (%) 28.3 31.3 27.1 25.2 25.2 Capital WIP 433 280 555 555 555
PAT 5,957 6,888 7,806 7,563 10,654 Net fixed assets 9,458 10,601 14,006 14,670 14,940
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 5,957 6,888 7,806 7,563 10,654 Investments 2,569 2,550 3,670 5,039 9,779
Extraordinary items 0 0 0 0 0 Inventories 6,136 7,684 10,584 10,288 14,018
Reported PAT 5,957 6,888 7,806 7,563 10,654 Sundry debtors 8,778 8,218 8,676 10,585 14,211
Cash & Cash Equivalents 6,064 8,403 5,416 6,280 6,275
Ratios Loans & advances 4,239 6,795 10,495 13,045 17,785
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 6,912 7,655 10,731 10,373 14,779
Growth (%)
Trade payables 5,189 5,570 7,283 7,123 9,705
Revenue 59.3 21.8 20.2 6.7 34.3
Other current liab. 7,641 6,680 6,101 7,029 9,932
EBITDA 72.6 23.2 5.6 0.5 34.0 Provisions 0 0 0 0 0
Adj. EPS 45.4 15.6 13.7 (3.1) 40.9 Net current assets 19,299 26,505 32,517 36,419 47,433
Margins (%) Total assets 31,326 39,656 50,193 56,128 72,152
Gross 28.6 29.2 25.7 25.2 24.1
EBITDA 20.4 20.6 18.1 17.0 17.0 Cashflow
EBIT 17.6 17.5 15.0 13.4 13.9 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 12.0 11.4 10.8 9.8 10.3 Profit Before Tax 8,310 10,030 10,715 10,107 14,237
Returns (%) Depreciation & Amortisation 1,381 1,868 2,268 2,837 3,229
ROE 32.4 27.7 24.3 19.0 21.8 Net Interest 1,057 1,452 1,396 1,614 1,990
ROCE 21.8 19.5 18.5 15.7 17.9 Net Change – WC (2,375) (2,414) (5,355) (488) (6,278)
ROIC 25.8 23.6 20.9 17.0 19.9 Direct taxes (1,859) (1,752) (2,914) (2,544) (3,584)
Turnover (days) Net cash from operations 7,102 8,930 6,075 11,526 9,595
Gross block turnover ratio (x) 4.1 3.9 3.5 3.2 3.8 Capital expenditure (4,653) (2,838) (5,673) (3,500) (3,500)
Debtors 57 51 43 45 44 Acquisitions, net 0 0 0 0 0
Inventory 47 59 62 66 56 Investments (2,657) (2,433) (3,591) (5,100) (9,480)
Creditors 44 46 44 46 39 Others 0 0 0 0 0
Net working capital 142 160 164 172 167 Net cash from investing (7,310) (5,271) (9,264) (8,600) (12,980)
Solvency (x) FCF 550 4,656 (2,173) 4,135 (1,896)
Net debt-equity 0.2 0.1 0.2 0.1 0.2 Issue of share capital 0 0 0 0 0
Interest coverage ratio 9.5 8.5 9.4 8.2 8.9 Increase/(decrease) in debt 4,458 133 2,771 (1,628) 5,370
Net debt/EBITDA 0.5 0.2 0.5 0.4 0.6 Dividend paid 0 0 0 0 0
Per share (Rs) Interest paid (1,057) (1,452) (1,396) (1,614) (1,990)
Adjusted EPS 61.4 71.0 80.7 78.2 110.2 Others 0 0 0 0 0
BVPS 220.7 291.6 372.8 451.0 561.2 Net cash from financing 3,402 (1,320) 1,376 (3,243) 3,380
CEPS 75.7 90.3 104.2 107.6 143.6 Net change in Cash 3,194 2,339 (1,814) (316) (4)
DPS 0.0 0.0 0.0 0.0 0.0 Source: Company, Centrum Broking
Dividend payout (%) 0.0 0.0 0.0 0.0 0.0
Valuation (x)
P/E 0.0 0.0 0.0 20.3 14.4
P/BV 0.0 0.0 0.0 3.5 2.8
EV/EBITDA 0.0 0.0 0.0 12.1 9.3
Dividend yield (%) 0.0 0.0 0.0 0.0 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 192


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

Gujarat Pipavav Port (GPPL) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

Over the last 10 years, GPPL has emerged from its previous phase of financial stress. Market data
Operating profits and cash flows, though consistent have been stagnant since FY15. Current price: Rs104
Working capital levels have been negative, in line with the characteristics of the Bloomberg: GPPV IN
ports business. Total operating cash flow of Rs33bn has fully funded capex of 52-week H/L: Rs124/76
Rs10.9bn, leading to FCF of Rs22.2bn over this period. This FCF and QIP proceeds of
Market cap: Rs50.2bn
Rs3.5bn in CY12 have been used for debt repayment of Rs8bn and dividend
distribution of Rs11.3bn, with the rest being accumulated as surplus cash in the Free float: 56.0%
balance sheet (Rs7.3bn in Mar-21). RoE has stagnated at 10-11% despite the high Avg. daily vol. 3mth: 1135,,147
dividend distribution due to sluggish growth in cargo and earnings. Source: Bloomberg

Cash generation consistent but stagnant: Cash flow from operations, while consistent has been stagnant. Ports as such is a
negative working capital business; so, there has been no material impact of any working capital changes. Cash from
operations has declined or stagnated due to reduced volume of containers and bulk cargo.
Exhibit 518: Operating cash flows of Rs33bn over the last 10 years
5,000

4,000

3,000
Rs mn

2,000

1,000

-
CY11 CY12 CY13 15MFY15 FY16 FY17 FY18 FY19 FY20 FY21
(1,000)
Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital remains negative: Except the storage charges for dry bulk cargo, GPPL receives its entire billing before the
departure of the vessel. The storage income for dry bulk cargo is paid at the time of evacuation of the cargo, depending upon
the duration for which the cargo has been stored at the port. As a result, working capital for port operations is negative.
Exhibit 519: Working capital levels negative, in line with the nature of port operations
150

100

50
Days

(50) CY11 CY12 CY13 15MFY15 FY16 FY17 FY18 FY19 FY20 FY21

(100)

(150)
Trade receivables (days) Trade payables (days) NWC days (ex cash ex MAT credit)
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Gujarat Pipavav Port (GPPL) 16 September 2021

Exhibit 520: EBITDA to CFO conversion of 94% in 10 years Exhibit 521: PAT to CFO conversion of 160% over 10 years
150% 300%

250%
120%
200%
90%
150%
60%
100%

30% 50%

15MFY15
CY13
CY11

CY12

CY13

15MFY15

CY11

CY12
FY16

FY17

FY18

FY19

FY20

FY21

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

FCF generation has been strong: Total operating cash flow of Rs33bn over CY11-FY21 has fully funded capex of Rs10.9bn,
leading to FCF of Rs22.2bn over this period. This FCF and QIP proceeds of Rs3.4bn (totalling to Rs25.5bn) have been used for
payment of dividend of Rs11.3bn and debt reduction of Rs8bn, with the rest accruing as surplus cash in the balance sheet.
GPPL had net cash of Rs7.3bn as at Mar-21.
Exhibit 522: Strong cash flows and low capex have led to consistent FCF
5,000

2,500
Rs mn

-
CY11 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(2,500)

(5,000)
CFO (Rs mn) Capex (Rs mn) Investments (Rs mn) Net FCF (Rs mn)
Source: Company, Centrum Broking

Exhibit 523: FCF used to repay debt and maintain consistent dividends
Rs mn CY11 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 CY11-FY21
FCF 538 290 1,691 3,472 461 2,791 2,718 2,933 3,562 3,744 22,200
Inflow from equity raise/dividend outflow - 3,448 - - - (2,268) (2,034) (1,977) (2,272) (2,705) (7,807)
Increase / (decrease) in net debt (538) (3,738) (1,691) (3,472) (461) (523) (684) (956) (1,291) (1,039) (14,393)
Source: Company, Centrum Broking

Exhibit 524: Leverage has been consistently low or non-existent


Leverage ratios (x) CY11 CY12 CY13 15MFY15 FY16 FY17 FY18 FY19 FY20 FY21 CY11-FY21 Average
Net Debt/Equity 0.7 0.2 0.1 (0.1) (0.1) (0.2) (0.2) (0.3) (0.3) (0.4) (0.1)
Net Debt/EBITDA 3.0 1.6 0.4 (0.5) (0.8) (0.8) (1.2) (1.4) (1.5) (1.7) (0.3)
Source: Company, Centrum Broking

Exhibit 525: Return ratios have stagnated due to absence of growth


Return Ratios (%) CY11 CY12 CY13 15MFY15 FY16 FY17 FY18 FY19 FY20 FY21 CY11-FY21 Average
RoE 7.2% 5.2% 12.5% 24.1% 9.6% 12.4% 9.5% 10.2% 11.3% 10.2% 11.2%
RoCE pre-tax 9.5% 8.7% 13.1% 26.2% 15.9% 16.1% 14.3% 15.7% 17.4% 15.6% 15.3%
RoCE 9.5% 8.7% 13.1% 26.2% 9.9% 11.6% 9.1% 10.1% 11.3% 10.1% 12.0%
Source: Company, Centrum Broking

Centrum Institutional Research 194


Gujarat Pipavav Port (GPPL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 7,020 7,354 7,335 8,138 9,581 Equity share capital 4,834 4,834 4,834 4,834 4,834
Operating Expense 3,131 2,888 3,113 3,591 4,021 Reserves & surplus 15,376 16,014 15,488 15,644 15,999
Employee cost 597 567 672 745 805 Shareholders fund 20,210 20,848 20,322 20,478 20,833
Others 750 719 746 784 865 Minority Interest 0 0 0 0 0
EBITDA 3,889 4,466 4,221 4,547 5,560 Total debt 0 0 0 0 0
Depreciation & Amortisation 1,128 1,315 1,335 1,366 1,353 Non Current Liabilities 0 0 0 0 0
EBIT 2,760 3,152 2,887 3,181 4,206 Def tax liab. (net) 462 494 1,007 1,505 1,518
Interest expenses 4 74 63 63 63 Total liabilities 20,672 21,342 21,329 21,983 22,351
Other income 452 509 442 385 608 Gross block 20,076 21,314 21,495 22,356 22,556
PBT 3,209 3,587 3,266 3,503 4,751 Less: acc. Depreciation (4,175) (5,488) (6,823) (8,188) (9,542)
Taxes 1,153 1,264 1,161 1,234 1,197 Net block 15,901 15,825 14,673 14,168 13,014
Effective tax rate (%) 35.9 35.3 35.6 35.2 25.2 Capital WIP 454 57 528 200 200
PAT 2,056 2,322 2,104 2,269 3,554 Net fixed assets 16,354 15,882 15,200 14,368 13,214
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 2,056 2,322 2,104 2,269 3,554 Investments 830 830 830 830 830
Extraordinary items 0 602 80 (71) 0 Inventories 84 76 105 86 79
Reported PAT 2,056 2,924 2,184 2,198 3,554 Sundry debtors 510 459 441 557 656
Cash & Cash Equivalents 5,337 6,495 7,254 8,427 9,768
Ratios Loans & advances 5 5 5 5 5
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 574 510 585 585 585
Growth (%)
Trade payables 325 298 339 371 416
Revenue 8.2 4.8 (0.3) 11.0 17.7
Other current liab. 2,696 2,616 2,752 2,504 2,372
EBITDA 5.6 14.9 (5.5) 7.7 22.3 Provisions 0 0 0 0 0
Adj. EPS 6.8 12.9 (9.4) 7.8 56.7 Net current assets 3,488 4,630 5,298 6,785 8,307
Margins (%) Total assets 20,672 21,342 21,329 21,983 22,351
Gross 74.6 78.2 76.9 74.7 75.5
EBITDA 55.4 60.7 57.6 55.9 58.0 Cashflow
EBIT 39.3 42.9 39.4 39.1 43.9 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 29.3 31.6 28.7 27.0 37.1 Profit Before Tax 3,209 3,587 3,266 3,503 4,751
Returns (%) Depreciation & Amortisation 1,128 1,315 1,335 1,366 1,353
ROE 10.2 11.3 10.2 11.1 17.2 Net Interest 4 74 63 63 63
ROCE 10.2 11.5 10.4 11.3 17.4 Net Change – WC (338) 16 90 (314) (180)
ROIC 12.2 14.8 14.4 17.6 29.3 Direct taxes (691) (1,269) (1,180) (736) (1,185)
Turnover (days) Net cash from operations 3,312 3,722 3,574 3,882 4,803
Gross block turnover ratio (x) 0.3 0.3 0.3 0.4 0.4 Capital expenditure 294 841 653 533 200
Debtors 20 24 22 22 23 Acquisitions, net 0 0 0 0 0
Inventory 23 18 19 17 13 Investments 0 0 0 0 0
Creditors 62 71 69 63 61 Others (11) 1,611 76 0 0
Net working capital (96) (93) (97) (74) (56) Net cash from investing 283 2,452 728 533 200
Solvency (x) FCF 3,018 2,881 2,921 3,349 4,603
Net debt-equity (0.3) (0.3) (0.4) (0.4) (0.5) Issue of share capital 0 0 0 0 0
Interest coverage ratio 1,065.4 60.5 66.9 72.1 88.1 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (1.4) (1.5) (1.7) (1.9) (1.8) Dividend paid (1,982) (3,260) (2,175) (2,042) (3,199)
Per share (Rs) Interest paid (4) (74) (63) (63) (63)
Adjusted EPS 4.3 4.8 4.4 4.7 7.4 Others 0 0 0 0 0
BVPS 41.8 43.1 42.0 42.4 43.1 Net cash from financing (1,985) (3,333) (2,239) (2,105) (3,262)
CEPS 6.6 7.5 7.1 7.5 10.2 Net change in Cash 1,610 2,840 2,064 2,310 1,741
DPS 3.4 5.6 4.5 4.2 6.6 Source: Company, Centrum Broking
Dividend payout (%) 79.9 92.6 99.6 92.9 90.0
Valuation (x)
P/E 25.3 17.3 19.0 22.2 14.1
P/BV 2.6 1.9 2.0 2.5 2.4
EV/EBITDA 12.0 7.5 7.7 9.2 7.3
Dividend yield (%) 3.2 6.8 5.5 4.1 6.4
Source: Company, Centrum Broking

Centrum Institutional Research 195


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

HG Infra Engineering (HG) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

HG Infra’s (HG) cash flows during its scale-up phase since FY17 indicate a fair degree Market data
of resilience after an initial spike in working capital levels. Working capital averaged Current price: Rs658
at a moderate level of 58 days over FY13-21, though it spiked intermittently during Bloomberg: HGINFRA IN
FY18-20. Operating cash flow of Rs8bn has funded 77% of its capex of Rs7.7bn and 52-week H/L: Rs680/151
investments of Rs2.6bn in HAM assets. FCF of (-) Rs2.3bn has been funded by IPO
Market cap: Rs42.9bn
proceeds, and as a result, net debt remained largely unchanged. While FCF has
recovered since FY20, HG needs to sustain the improvement to cement credentials. Free float: 25.5%
Return ratios have been strong, with average RoE of 22.4% over FY13-21. Avg. daily vol. 3mth: 529,285
Source: Bloomberg

Operating cash flows marginal in the past; on an improving trend since FY20: HG’s operating profits have picked up in the
last 3-4 years along with strong scale-up in revenue. Operating cash flows, while positive, were miniscule till FY17. HG saw
significant expansion in working capital levels in FY18 and FY19 due to delayed collections in certain contracts. Since FY20,
there has been significant release in working capital, leading to a surge in operating cash flow.
Exhibit 526: Operating cash flows seeing a pick-up since FY20
5,000

3,750

2,500
Rs mn

1,250

(1,250)

(2,500)
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital levels improving after witnessing a surge: HG has maintained an average working capital cycle of 58 days
over FY13-21, which is well within the industry standards. NWC levels, however, had surged to about 80 days during FY18-20
due to rise in receivables from its Rajasthan PWD contracts as well as from some private developers. In FY21, NWC of just 46
days has been led by unwinding of ~Rs2bn delayed receivables from Rajasthan PWD and increase in mobilization advances.
We note that such low levels are not sustainable and one should expect a reversion to mean, going forward.
Exhibit 527: Average NWC levels low at 58 days; FY21 levels of 46 days too low and are bound to increase
150

100 77 82 81
days

60
47 46
39
45 43
50

-
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex cash ex L&A)
Source: Company, Centrum Broking
Unwinding of ~Rs2bn delayed receivables from
Rajasthan PWD and higher mobilization advances

Please see Appendix for analyst certifications and all other important disclosures.
HG Infra Engineering (HG) 16 September 2021

Exhibit 528: EBITDA to CFO conversion moderate at 50% Exhibit 529: PAT to CFO conversion high at 113% in FY13-21

125% 116% 240% 225%

100% 180% 148% 148%


75% 125%
61%
50% 120% 90%
50% 38% 60%
31% 46%
23% 60% 38%
25% 14% 15%

0% 0%
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-25% -60%
-21% -51%
Source: Company, Centrum Broking Source: Company, Centrum Broking

FCF seeing recovery; needs to sustain improvement to cement credentials: Since FY13, HG’s operating cash flow has been
Rs8bn, which has funded 77% of its capex of Rs7.7bn and investments of Rs2.6bn in HAM assets. Recent improvement in
operating cash flows over FY20-21 has materially aided this track record. However, we note that HG will need to sustain the
improvement in cash generation in the coming years to cement its credentials among peers.
Exhibit 530: Operating cash flows have funded 78% of the capex and equity commitments over FY13-21
6,000

4,500

3,000
Rs mn

1,500

(1,500)

(3,000)
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Investments Net FCF


Source: Company, Centrum Broking

Exhibit 531: FCF of (-) Rs2.3bn funded by IPO proceeds; net debt has remained largely unchanged
Rs mn FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13-21
FCF (101) 245 (29) (424) (607) (2,956) (1,028) 383 2,201 (2,316)
Inflow from equity raise/ dividend outflow 30 - - 28 - 2,806 (39) (39) - 2,785
Increase/ (decrease) in net debt 71 (245) 29 396 607 151 1,067 (344) (2,201) (468)
Source: Company, Centrum Broking

Exhibit 532: Leverage has improved, led by equity raise and improved cash generation since FY20
Leverage ratios (x) FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13-21 Average
Net Debt/Equity 0.2 0.2 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2
Net Debt/EBITDA 1.8 1.4 1.7 1.8 1.4 1.6 1.2 1.3 0.9 1.5
Source: Company, Centrum Broking

Exhibit 533: Return ratios have been strong; average RoE of 22.4%
Return Ratios (%) FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY13-21 Average
RoE 19.6% 21.5% 10.9% 24.6% 35.7% 23.5% 20.6% 22.4% 22.8% 22.4%
ROCE pre-tax* 21.0% 25.4% 18.8% 27.6% 29.5% 21.1% 21.6% 22.3% 22.5% 23.3%
RoCE* 14.1% 16.9% 12.8% 18.1% 18.9% 15.0% 14.0% 16.2% 16.8% 15.9%
Source: Company, Centrum Broking; *: includes mobilization advances

Growth and margin profile intact.


Moderation due to equity raise of
Rs2.8bn through IPO.

Centrum Institutional Research 197


HG Infra Engineering (HG) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 20,098 21,961 25,275 33,110 38,077 Equity share capital 652 652 652 652 652
Operating Expense 15,585 17,064 19,808 26,091 30,233 Reserves & surplus 5,940 7,564 9,670 12,549 15,723
Employee cost 1,191 1,114 1,093 1,311 1,442 Shareholders fund 6,592 8,216 10,322 13,201 16,375
Others 290 360 267 430 495 Minority Interest 0 0 0 0 0
EBITDA 3,032 3,424 4,107 5,278 5,907 Total debt 3,803 3,674 2,890 4,000 4,000
Depreciation & Amortisation 755 756 844 902 1,042 Non Current Liabilities 0 0 0 0 0
EBIT 2,278 2,668 3,262 4,376 4,864 Def tax liab. (net) (84) 0 0 0 0
Interest expenses 490 524 596 626 720 Total liabilities 10,312 11,890 13,212 17,201 20,375
Other income 115 141 154 167 184 Gross block 6,147 6,976 7,656 8,356 9,356
PBT 1,902 2,285 2,821 3,917 4,329 Less: acc. Depreciation (1,527) (2,152) (2,826) (3,728) (4,770)
Taxes 667 623 712 986 1,090 Net block 4,620 4,824 4,831 4,629 4,587
Effective tax rate (%) 35.0 27.3 25.2 25.2 25.2 Capital WIP 0 111 18 18 18
PAT 1,236 1,662 2,110 2,931 3,239 Net fixed assets 4,620 4,936 4,849 4,647 4,605
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 1,236 1,662 2,110 2,931 3,239 Investments 200 908 2,612 4,129 6,130
Extraordinary items 0 0 0 0 0 Inventories 1,161 1,055 1,680 2,216 2,568
Reported PAT 1,236 1,662 2,110 2,931 3,239 Sundry debtors 6,244 8,111 6,575 10,885 12,518
Cash & Cash Equivalents 1,002 1,144 2,584 2,055 2,341
Ratios Loans & advances 0 0 0 0 0
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 2,371 4,531 3,361 4,989 5,738
Growth (%)
Trade payables 3,992 5,437 4,984 6,076 7,041
Revenue 44.3 9.3 15.1 31.0 15.0
Other current liab. 1,295 3,358 3,465 5,644 6,485
EBITDA 45.7 12.9 19.9 28.5 11.9 Provisions 0 0 0 0 0
Adj. EPS 46.7 34.5 27.0 38.9 10.5 Net current assets 5,492 6,046 5,751 8,425 9,640
Margins (%) Total assets 10,312 11,890 13,212 17,201 20,375
Gross 22.5 22.3 21.6 21.2 20.6
EBITDA 15.1 15.6 16.2 15.9 15.5 Cashflow
EBIT 11.3 12.1 12.9 13.2 12.8 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 6.1 7.6 8.3 8.9 8.5 Profit Before Tax 1,902 2,285 2,821 3,917 4,329
Returns (%) Depreciation & Amortisation 755 756 844 902 1,042
ROE 20.6 22.4 22.8 24.9 21.9 Net Interest 490 524 596 626 720
ROCE 14.0 16.2 16.8 18.3 16.8 Net Change – WC (1,542) (413) 1,735 (3,203) (928)
ROIC 15.8 17.6 21.1 25.4 23.9 Direct taxes (689) (624) (685) (986) (1,090)
Turnover (days) Net cash from operations 916 2,528 5,311 1,256 4,073
Gross block turnover ratio (x) 3.3 3.1 3.3 4.0 4.1 Capital expenditure (1,163) (1,072) (758) (700) (1,000)
Debtors 96 119 106 96 112 Acquisitions, net 0 0 0 0 0
Inventory 26 24 25 27 29 Investments (200) (708) (1,704) (1,517) (2,001)
Creditors 85 101 96 77 79 Others 0 0 0 0 0
Net working capital 100 100 83 93 92 Net cash from investing (1,363) (1,780) (2,461) (2,217) (3,001)
Solvency (x) FCF (446) 748 2,849 (961) 1,072
Net debt-equity 0.4 0.3 0.0 0.1 0.1 Issue of share capital 0 0 0 0 0
Interest coverage ratio 6.2 6.5 6.9 8.4 8.2 Increase/(decrease) in debt (237) (129) (785) 1,110 0
Net debt/EBITDA 0.9 0.7 0.1 0.4 0.3 Dividend paid (39) (39) 0 (52) (65)
Per share (Rs) Interest paid (490) (524) (596) (626) (720)
Adjusted EPS 19.0 25.5 32.4 45.0 49.7 Others (75) 86 (29) 0 0
BVPS 101.2 126.1 158.4 202.6 251.3 Net cash from financing (841) (606) (1,410) 432 (785)
CEPS 30.5 37.1 45.3 58.8 65.7 Net change in Cash (1,287) 142 1,440 (529) 287
DPS 0.5 0.5 0.8 0.8 1.0 Source: Company, Centrum Broking
Dividend payout (%) 2.6 2.0 2.5 1.8 2.0
Valuation (x)
P/E 13.1 9.3 6.5 14.6 13.2
P/BV 2.5 1.9 1.3 3.2 2.6
EV/EBITDA 6.3 5.3 3.4 8.5 7.5
Dividend yield (%) 0.2 0.2 0.4 0.1 0.2
Source: Company, Centrum Broking

Centrum Institutional Research 198


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

KEC International (KEC) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

After a brief period over FY13-15, when KEC’s operating performance was impacted Market data
amid diversification into several new verticals, impacting margins, KEC’s operating Current price: Rs428
profits have expanded since FY16. Net working capital intensity has remained Bloomberg: KECI IN
elevated but stable at 80-100 days during FY12-21. Having said that, KEC has 52-week H/L: Rs486/299
generated FCF of Rs6.6bn after completely meeting its capex requirements. FCF was
Market cap: Rs110bn
also propelled by increase in acceptances and monetization of land (inflow of
Rs2.1bn from Thane land sale). Against CFO of Rs14.6bn over FY12-21, KEC has Free float: 48.2%
incurred capex of Rs8.6bn. Given its strong cash flow generation in the recent past Avg. daily vol. 3mth: 469,415
and better control over working capital, KEC’s leverage has improved over FY16-21. Source: Bloomberg

Operating cash flows healthy, but cyclical: Over FY13-15, KEC’s financial performance was impacted due to moderation in
margins in the SAE business and adverse revenue mix, as diversification into newer businesses yielded poor margins. Since
then, its operating profits have improved. Working capital levels, while elevated, have remained at 87-110 days in recent
years. Overall, KEC’s operating cashflow has been aided by increase in acceptances from Rs9.7bn in FY15 to Rs15.3bn in FY21.
Exhibit 534: Cash flow from operations
15,000
12,500 Release of wcap led by
10,000 rise in acceptances and
mobilization advances
7,500
5,000
Rs mn

2,500
-
(2,500) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(5,000)
(7,500)
(10,000)
Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Analysis of working capital movement: KEC’s net working capital cycle has remained elevated but stable at 80-100 days over
the last decade, as trade receivables and payables have remained in sync. Power T&D and Railways, which accounted for
majority revenue share, are characterised by longer payment cycles, leading to working capital cycle of 80-100 days.
Exhibit 535: NWC has remained elevated but stable at 80-100 days over the last decade
250

200

150
110 110
days

98 87 98 101
87
100 67 80
55
50

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex-cash ex-L&A days)
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
KEC International (KEC) 16 September 2021

Exhibit 536: EBITDA - CFO conversion weak at 18% in FY12-21 Exhibit 537: PAT to CFO conversion at 50% over FY12-21
200% 600%

150% 400%

100% 200%

50% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
0% -200%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50% -400%

-100% -600%
Source: Company, Centrum Broking Source: Company, Centrum Broking

FCF of Rs6.6bn driven by low capex intensity: KEC has generated operating cash flows of Rs14.6bn over FY12-21, which have
been adequate to fund its capex requirements of Rs8.6bn. Inflows of Rs2.1bn from sale of Thane land parcel in FY15 have
aided FCF of Rs6.6bn over FY12-21.
Exhibit 538: Capex requirements largely met by operating cashflows
15,000 Proceeds of Rs574mn from
Includes proceeds of Rs2.1bn
12,500 sale of subsidiary
from monetization of Thane
10,000 land parcel

7,500
Rs mn

5,000
2,500
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-2,500
-5,000
CFO (Rs mn) Capex (Rs mn) Acquisitions and Investments (Rs mn) Net FCF (Rs mn)
Source: Company, Centrum Broking

Exhibit 539: Recovery in FCF led to reduction in debt levels


Rs mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF 3,437 (4,059) (4,075) (275) (3,696) 13,421 3,391 (1,541) (3,801) 3,791 6,594
Inflow from equity raise/dividend outflow (355) (357) (150) (175) (575) (11) (411) (614) (1,558) (5) (4,211)
Increase/ (decrease) in net debt (3,082) 4,416 4,224 450 4,271 (13,410) (2,980) 2,155 5,359 (3,786) (2,383)
Source: Company, Centrum Broking

Exhibit 540: KEC’s leverage has declined gradually, driven by improved cash flows
Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 average
Net Debt/Equity 0.9 1.3 1.7 1.4 1.5 1.2 0.8 0.6 0.8 0.5 1.1
Net Debt*/EBITDA 3.6 5.1 4.5 7.0 5.7 4.7 4.1 3.8 3.8 4.0 4.6
Source: Company, Centrum Broking; *: includes mobilization advances and acceptances

Exhibit 541: Strong return ratios; moderation in FY14-16 due to losses in new businesses
Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 average
RoE 20.5% 5.8% 7.3% 2.1% 10.4% 19.7% 25.6% 21.9% 21.6% 18.0% 15.3%
RoCE pre-tax* 16.4% 10.7% 12.6% 9.9% 10.6% 12.6% 15.0% 15.5% 14.7% 12.8% 13.1%
RoCE* 10.8% 4.8% 6.3% 2.1% 5.4% 8.4% 10.2% 10.3% 10.6% 9.4% 7.8%
Source: Company, Centrum Broking; *: Capital employed includes mobilization advances and acceptances

Moderation due to losses


in SAE business

Centrum Institutional Research 200


KEC International (KEC) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 110,005 119,654 131,142 145,812 162,554 Equity share capital 1,382 1,382 1,382 1,382 1,382
Operating Expense 80,578 84,963 96,040 107,070 116,565 Reserves & surplus 22,969 26,594 32,215 36,958 43,885
Employee cost 8,322 11,044 11,151 12,322 13,554 Shareholders fund 24,351 27,976 33,597 38,340 45,266
Others 9,606 11,304 12,539 14,581 16,255 Minority Interest 0 0 0 0 0
EBITDA 11,499 12,344 11,412 11,840 16,180 Total debt 18,395 23,733 19,282 18,282 17,282
Depreciation & Amortisation 1,171 1,472 1,525 1,720 1,977 Non Current Liabilities 0 0 0 0 0
EBIT 10,328 10,872 9,887 10,120 14,203 Def tax liab. (net) 1,497 527 (68) (668) (1,068)
Interest expenses 3,119 3,080 2,627 2,650 2,845 Total liabilities 44,243 52,236 52,811 55,954 61,480
Other income 226 111 299 242 212 Gross block 14,274 17,202 19,473 21,473 23,973
PBT 7,435 7,903 7,559 7,712 11,571 Less: acc. Depreciation (5,608) (6,790) (8,315) (10,035) (12,011)
Taxes 2,571 2,248 2,032 1,928 3,124 Net block 11,824 13,518 13,975 14,255 14,778
Effective tax rate (%) 34.6 28.4 26.9 25.0 27.0 Capital WIP 73 840 179 179 179
PAT 4,864 5,655 5,527 5,784 8,447 Net fixed assets 11,897 14,357 14,154 14,434 14,957
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 4,864 5,655 5,527 5,784 8,447 Investments 132 225 11 11 11
Extraordinary items 93 0 0 0 0 Inventories 6,410 7,758 8,422 9,389 10,222
Reported PAT 4,958 5,655 5,527 5,784 8,447 Sundry debtors 48,753 54,448 55,668 63,119 69,475
Cash & Cash Equivalents 2,762 1,637 2,492 1,620 1,546
Ratios Loans & advances 424 1,130 1,129 799 1,336
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 46,568 48,992 57,985 61,521 69,030
Growth (%)
Trade payables 48,009 50,073 61,840 66,882 74,091
Revenue 9.4 8.8 9.6 11.2 11.5
Other current liab. 24,190 25,477 24,419 27,179 30,027
EBITDA 14.3 7.3 (7.5) 3.7 36.7 Provisions 503 761 790 878 979
Adj. EPS 6.1 16.3 (2.3) 4.7 46.0 Net current assets 32,214 37,654 38,647 41,509 46,512
Margins (%) Total assets 44,243 52,236 52,811 55,954 61,480
Gross 26.8 29.0 26.8 26.6 28.3
EBITDA 10.5 10.3 8.7 8.1 10.0 Cashflow
EBIT 9.4 9.1 7.5 6.9 8.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 4.4 4.7 4.2 4.0 5.2 Profit Before Tax 7,528 7,903 7,559 7,712 11,571
Returns (%) Depreciation & Amortisation 1,171 1,472 1,525 1,720 1,977
ROE 21.9 21.6 18.0 16.1 20.2 Net Interest 3,119 3,080 2,627 2,650 2,845
ROCE 12.0 12.4 11.1 11.1 13.8 Net Change – WC (5,416) (6,565) (138) (3,734) (5,077)
ROIC 17.4 16.9 14.3 14.5 18.1 Direct taxes (2,519) (2,854) (2,088) (2,528) (3,524)
Turnover (days) Net cash from operations 3,883 3,035 9,486 5,819 7,791
Gross block turnover ratio (x) 7.7 7.0 6.7 6.8 6.8 Capital expenditure (690) (3,642) (1,137) (2,000) (2,500)
Debtors 165 157 153 149 149 Acquisitions, net 0 0 0 0 0
Inventory 29 30 31 30 31 Investments 261 (93) 214 0 0
Creditors 214 211 213 219 221 Others (5) (901) 399 0 0
Net working capital 107 115 108 104 104 Net cash from investing (434) (4,636) (524) (2,000) (2,500)
Solvency (x) FCF 3,449 (1,601) 8,962 3,819 5,291
Net debt-equity 1.1 1.2 1.0 0.9 0.8 Issue of share capital 0 0 0 0 0
Interest coverage ratio 3.7 4.0 4.3 4.5 5.7 Increase/(decrease) in debt 732 5,338 (4,451) (1,000) (1,000)
Net debt/EBITDA 2.4 2.7 2.8 2.8 2.1 Dividend paid (614) (1,558) (1,028) (1,041) (1,520)
Per share (Rs) Interest paid (3,119) (3,080) (2,627) (2,650) (2,845)
Adjusted EPS 19.3 22.0 21.5 22.5 32.9 Others 0 0 0 0 0
BVPS 94.7 108.8 130.7 149.1 176.1 Net cash from financing (3,000) 700 (8,107) (4,691) (5,365)
CEPS 23.8 27.7 27.4 29.2 40.5 Net change in Cash 449 (901) 855 (871) (74)
DPS 2.7 3.4 4.0 4.0 5.9 Source: Company, Centrum Broking
Dividend payout (%) 14.0 15.5 18.6 18.0 18.0
Valuation (x)
P/E 16.6 13.3 14.8 19.0 12.9
P/BV 3.3 2.7 2.4 2.9 2.4
EV/EBITDA 8.4 7.9 8.6 10.6 7.7
Dividend yield (%) 0.9 1.2 1.3 0.9 1.4
Source: Company, Centrum Broking

Centrum Institutional Research 201


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

KNR Constructions (KNR) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

KNR’s 10-year financials exemplify how a difficult business like construction can also Market data
generate value if run well. Operating cash flows have been positive for 9 out of 10 Current price: Rs309
years and have more than adequately funded capex and equity investments in Bloomberg: KNRC IN
BOT/HAM assets. Working capital intensity has remained low-to-moderate, with the 52-week H/L: Rs344/114
recent increase driven by post-Covid rise in receivables for Telangana irrigation Market cap: Rs86.9bn
projects. Leverage has consistently remained low, reflecting efficient project Free float: 46.8%
management and disciplined capital allocation. RoE has normalized from its peak,
Avg. daily vol. 3mth: 1,607,253
led partly by discontinuation of MAT regime, but remains remunerative at 15-16%.
Source: Bloomberg

Consistent cash generation: KNR’s operating profits have been robust and have consistently expanded over the last 10 years.
While working capital intensity has increased over the last 2-3 years, it is well under control and in line with industry
standards. KNR’s cash flow from operations has remained strong and consistent for large part of FY12-21.
Exhibit 542: Generated positive cash flow from operations in 9 out of 10 years
6,000 Higher irrigation
receivables
4,500

3,000
Rs mn

1,500

(1,500)

(3,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital levels remained low to moderate: Working capital levels declined materially starting FY16, led by fall in
receivables and sharp rise in advances from clients. However, since FY19, we have seen a rise in the share of irrigation
revenues (~23% in FY18 to ~30% in FY21), primarily from the Telangana government, which typically come without
mobilization advances. KNR also delays or avoids taking mobilization advances from its HAM project SPVs in order to save IDC
in the assets and it also uses its strong liquidity position at the parent level. Receivables from Telangana irrigation projects
have remained elevated post Covid (Rs5bn in Mar-21), though intermittent payments keep overall exposure within control.
Exhibit 543: Working capital levels have normalised from very low levels; remain in control
94
100 86
79
74
75 60
51
42 44
days

50

25 11
5
-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex-cash ex-L&A days)
Source: Company, Centrum Broking

Rise in share of irrigation revenue to 30% in FY21 from


23% in FY18 - no mobilization advances and elongated
receivables leads to rise in working capital levels

Please see Appendix for analyst certifications and all other important disclosures.
KNR Constructions (KNR) 16 September 2021

Exhibit 544: EBITDA to CFO conversion of 68% in FY12-21 Exhibit 545: PAT to CFO conversion of 118% over 10 years
191% 190%
200% 200%
170%
159% 151%
150% 130% 150%
110%
90% 93%
100% 82% 100% 84%
75%
52% 50% 53%
44% 37%
50% 50%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-8% -19%
-50% -50%

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex and investments funded by internal cash generation: Total operating cash flows of Rs18.4bn over FY12-21 have
adequately funded capex of Rs10.6bn and equity investment of Rs4.9bn in BOT/HAM assets (net of monetization proceeds of
Rs3.1bn). This has led to positive FCF generation of Rs2.9bn over this period.
Exhibit 546: Capital commitments fully funded by operating cash flows, leading to deleveraging
4,000

3,000

2,000

1,000
Rs mn

-1,000

-2,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-3,000 Proceeds of Rs3.1bn from
CFO (Rs mn) Capex (Rs mn) Acquisitions and Investments (Rs mn) Net FCF (Rs mn) sale of Walayar BOT asset
Source: Company, Centrum Broking

Exhibit 547: Strong cash flows and asset monetization proceeds have helped KNR become debt free
Rs mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF 560 (691) 392 324 (133) (188) (487) (678) 697 3,133 2,930
Inflow from equity raise/ dividend outflow (65) (33) (33) (33) (68) - (85) (68) (153) - (537)
Increase/ (decrease) in net debt (495) 724 (359) (291) 200 188 571 746 (545) (3,133) (2,393)
Source: Company, Centrum Broking

Exhibit 548: Leverage has been consistently low


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 average
Net Debt/Equity 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 (0.1) 0.1
Net Debt*/EBITDA 0.9 1.7 1.3 1.1 1.8 1.7 1.0 0.8 0.7 0.1 1.1
Source: Company, Centrum Broking; *: includes mobilization advances

Exhibit 549: Return ratios normalized from peak levels, but strong, nevertheless
Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 average
RoE 13.8% 12.1% 12.6% 13.3% 16.9% 20.6% 26.5% 20.7% 13.5% 15.7% 16.6%
RoCE pre-tax* 16.5% 13.1% 12.5% 11.9% 15.5% 16.7% 20.2% 19.4% 16.7% 22.1% 16.4%
RoCE* 11.1% 10.2% 11.4% 12.0% 14.0% 16.1% 20.5% 17.6% 12.9% 15.5% 14.1%
Source: Company, Centrum Broking; *: Capital employed includes mobilization advances

Strong revenue growth, Discontinuation of MAT,


higher asset turn and high capex/lower asset turn
margin improvement

Centrum Institutional Research 203


KNR Constructions (KNR) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 21,373 22,210 27,027 31,081 42,581 Equity share capital 281 281 562 562 562
Operating Expense 15,796 15,720 19,581 23,078 31,893 Reserves & surplus 13,862 15,958 18,116 21,006 25,493
Employee cost 929 1,252 1,390 1,473 1,768 Shareholders fund 14,143 16,239 18,678 21,569 26,055
Others 379 549 622 715 979 Minority Interest 0 0 0 0 0
EBITDA 4,270 4,690 5,434 5,815 7,940 Total debt 2,641 2,297 7 0 0
Depreciation & Amortisation 1,681 1,918 1,444 1,344 1,666 Non Current Liabilities 0 0 0 0 0
EBIT 2,589 2,771 3,991 4,471 6,274 Def tax liab. (net) 0 0 0 0 0
Interest expenses 291 474 487 355 372 Total liabilities 16,785 18,536 18,685 21,569 26,055
Other income 634 348 496 359 409 Gross block 10,751 12,701 13,731 15,231 17,231
PBT 2,931 2,646 4,000 4,475 6,311 Less: acc. Depreciation (6,412) (8,237) (9,680) (11,025) (12,691)
Taxes 273 601 1,176 1,514 1,588 Net block 4,339 4,464 4,051 4,207 4,541
Effective tax rate (%) 9.3 22.7 29.4 33.8 25.2 Capital WIP 0 102 24 24 24
PAT 2,658 2,045 2,823 2,961 4,722 Net fixed assets 4,339 4,566 4,075 4,231 4,564
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 2,658 2,045 2,823 2,961 4,722 Investments 6,200 7,149 4,898 8,344 11,275
Extraordinary items (25) 208 (306) 0 0 Inventories 951 1,232 1,480 1,345 1,844
Reported PAT 2,633 2,252 2,518 2,961 4,722 Sundry debtors 2,344 4,761 8,632 5,194 6,650
Cash & Cash Equivalents 130 330 1,173 1,479 994
Ratios Loans & advances 65 57 105 105 105
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 6,932 7,474 7,357 10,218 13,999
Growth (%)
Trade payables 2,236 2,511 2,397 3,767 5,164
Revenue 10.6 3.9 21.7 15.0 37.0
Other current liab. 3,516 5,899 7,780 6,460 8,997
EBITDA 10.6 9.8 15.9 7.0 36.5 Provisions 164 232 344 255 350
Adj. EPS (2.3) (23.1) 38.1 4.9 59.5 Net current assets 4,506 5,212 8,226 7,860 9,081
Margins (%) Total assets 16,785 18,536 18,685 21,569 26,055
Gross 26.1 29.2 27.5 25.7 25.1
EBITDA 20.0 21.1 20.1 18.7 18.6 Cashflow
EBIT 12.1 12.5 14.8 14.4 14.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 12.4 9.2 10.4 9.5 11.1 Profit Before Tax 2,906 2,853 3,694 4,475 6,311
Returns (%) Depreciation & Amortisation 1,681 1,918 1,444 1,344 1,666
ROE 20.7 13.5 15.7 14.7 19.8 Net Interest 291 474 487 355 372
ROCE 17.6 12.9 15.8 14.6 19.1 Net Change – WC (1,992) (530) (2,111) 596 (1,872)
ROIC 22.2 18.2 21.3 21.2 31.0 Direct taxes (551) (844) (787) (1,163) (1,588)
Turnover (days) Net cash from operations 2,336 3,872 2,727 5,608 4,889
Gross block turnover ratio (x) 2.0 1.7 2.0 2.0 2.5 Capital expenditure (2,086) (2,145) (939) (1,500) (2,000)
Debtors 40 58 90 81 51 Acquisitions, net 0 0 0 0 0
Inventory 19 25 25 22 18 Investments (844) (949) 2,250 (3,446) (2,931)
Creditors 51 55 46 49 51 Others 158 306 (336) 76 0
Net working capital 77 86 111 92 78 Net cash from investing (2,773) (2,787) 975 (4,870) (4,931)
Solvency (x) FCF (437) 1,085 3,703 738 (42)
Net debt-equity 0.2 0.1 (0.1) (0.1) 0.0 Issue of share capital 0 0 0 0 0
Interest coverage ratio 14.7 9.9 11.2 16.4 21.3 Increase/(decrease) in debt 523 (344) (2,290) (7) 0
Net debt/EBITDA 0.6 0.4 (0.2) (0.3) (0.1) Dividend paid (59) (66) (82) (70) (70)
Per share (Rs) Interest paid (291) (474) (487) (355) (372)
Adjusted EPS 9.5 7.3 10.0 10.5 16.8 Others 0 0 0 0 0
BVPS 50.3 57.7 66.4 76.7 92.6 Net cash from financing 173 (884) (2,859) (432) (443)
CEPS 15.4 14.1 15.2 15.3 22.7 Net change in Cash (264) 200 843 306 (485)
DPS 0.2 0.3 0.3 0.3 0.8 Source: Company, Centrum Broking
Dividend payout (%) 2.1 3.1 2.8 2.4 5.0
Valuation (x)
P/E 12.2 17.3 13.8 29.4 18.4
P/BV 2.3 2.2 2.1 4.0 3.3
EV/EBITDA 8.2 8.0 7.0 14.7 10.8
Dividend yield (%) 0.1 0.1 0.1 0.1 0.3
Source: Company, Centrum Broking

Centrum Institutional Research 204


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

Larsen & Toubro (L&T) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

L&T’s standalone operating cash flows, while growing at a muted pace over the last Market data
10 years, have been consistently positive. Working capital levels have ranged from Current price: Rs1,721
80 to 100 days, within the average range for the industry. FCF has shown an Bloomberg: LT IN
improving trend since FY15, led by L&T’s decision to not invest in PPP assets as well 52-week H/L: Rs1,729/826
as due to monetization of several existing investments. Acquisition of 60% stake in
Market cap: Rs2417.2bn
Mindtree in FY20 was the only exception to this trend. Leverage has remained under
control throughout the period on the back of consistent cash generation. Return Free float: 68.6%
ratios though have moderated post FY14 owing to moderation in margins and drag Avg. daily vol. 3mth: 2,430,782
due to investments in Hyderabad Metro, power generation and forgings business. Source: Bloomberg

Analysis of operating cash flows: Operating profits have grown at a muted 2.3% CAGR over FY12-21. Operating cash flows,
however, rose fairly consistently or at least remained steady till FY19, with working capital remaining within the range of 80-
100 days. FY20 saw a sharp deterioration in operating cash flows due to sharp rise in unbilled revenue with the impact on
execution caused by outbreak of Covid in Mar-21. FY21, on the other hand, saw a significant release of working capital,
leading to sharp rebound in operating cash flow. CFO over FY12-21 was Rs349bn.
Exhibit 550: Operating cash flows (standalone) had been weakening since FY18 but witnessed a strong rebound in FY21
90

60

30
Rs bn

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(30)

(60) Sharp drop in receivables +


higher creditors
(90)

Operating profit before wcap changes (Rsbn) Wcap changes (Rsbn) CFO (Rsbn)

Source: Company, Centrum Broking

Analysis of working capital movement: Over FY12-16, L&T’s working capital increased sharply from very low levels of 27
days in FY12 to 101 days in FY16. After remaining benign in FY17 at 84 days, it again climbed back to 114/103 days in FY20/21
owing to rise in advances to contractors, as L&T extended support to its vendors before and during the pandemic.
Exhibit 551: NWC (standalone) has risen in last 2-3 years, but under control and in line with industry standards
200 Increase in payables and
Sharp rise in unbilled revenue, retentions
and advances to contractors customer advances
150
Days

100 87 103
84 114
96 101
81 86
50
50
27
-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex-cash ex-L&A days)
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Larsen & Toubro (L&T) 16 September 2021
Exhibit 552: EBITDA to CFO conversion moderate at 52% over FY12-21
Standalone Rs bn CFO PAT EBITDA CFO/PAT CFO/EBITDA
FY12-21 349 613 667 57% 52%
Source: Company, Centrum Broking

Analysis of free cash flow: L&T has generated CFO of Rs349bn over FY12-21, which has completely funded the capex and
investments of Rs168bn (capex of Rs93bn and net investments/acquisitions of Rs75bn). This resulted in positive FCF
generation of Rs181bn over FY12-21.
Exhibit 553: CFO of Rs349bn over FY12-21 sufficed for capex and investment (net of monetization) requirements
200
Sale of electrical business
150 resulted in post tax cash
100 inflow of Rs109bn

50
Rsbn

0
-50 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-100 Acquisition of
-150 Mindtree for Rs96bn

CFO (Rsbn) Capex (Rsbn) Acquisitions and Investments (Rsbn) Net FCF (Rsbn)

Source: Company, Centrum Broking

Exhibit 554: Free cash generation of Rs181bn utilized to pay dividends consistently over FY12-21
Rsbn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF (17) (3) (29) 10 11 76 28 63 (123) 165 181
Inflow from capital raise/ (dividend outflow) (8) (10) (11) (13) (16) (18) (22) (26) (41) (36) (201)
Increase/ (decrease) in net debt 26 13 40 3 4 (58) (6) (37) 164 (129) 20
Source: Company, Centrum Broking

Exhibit 555: Leverage under control throughout the last 10 years


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
Net Debt/Equity 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.3 0.0 0.1
Net Debt*/EBITDA 1.8 2.0 2.0 2.3 3.1 2.1 2.3 2.1 4.5 2.1 2.4
Source: Company, Centrum Broking; *: includes mobilization advances and acceptances

Exhibit 556: Return ratios have moderated post FY14 owing to weak margins and slower growth
Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
RoE 18.8% 15.8% 16.1% 13.3% 11.0% 10.2% 10.4% 11.8% 11.8% 10.3%^ 13.0%
RoCE (pre-tax)* 18.8% 14.7% 15.7% 13.7% 11.1% 10.3% 11.5% 13.5% 11.1% 10.1% 13.1%
RoCE* 13.2% 10.7% 11.5% 10.1% 8.6% 8.0% 8.4% 9.4% 9.3% 7.8% 9.7%
Source: Company, Centrum Broking; *: Capital employed includes mobilization advances and acceptances ^adjusted for gain from E&A sale net of other impairments

Exhibit 557: Performance of key subsidiaries


Loans and Investments Profit/(Loss)
Rsbn
FY21 FY21 FY20
Mindtree 95.7 11.1 6.3
LTI 1.1 17.9 15.5
LTTS 8.1 6.7 7.9
LTFH 53.8 1.2 2.7
Power development 22.8 (5.6) (1.1)
L&T Metro Rail (Hyderabad) Limited 53.8 (17.7) (3.8)
L&T Seawoods Limited 16.5 0.5 0.4
L&T Hydrocarbon Engineering Limited 15.0 8.3 9.4
L&T Uttaranchal Hydropower Limited 8.4 (7.4) (0.1)
L&T Infrastructure Development Projects Limited 10.2 (0.5) (0.2)
L&T Special Steels and Heavy Forgings - (12.0) (2.2)
Total of the above 285.4 2.4 34.7
Source: Company, Centrum Broking

Centrum Institutional Research 206


Larsen & Toubro (L&T) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 1,352,203 1,454,524 1,359,790 1,564,905 1,768,934 Equity share capital 2,806 2,825 2,825 2,825 2,825
Operating Expense 956,330 973,627 867,009 999,104 1,163,885 Reserves & surplus 620,943 664,424 755,876 816,478 893,701
Employee cost 174,664 231,140 247,620 286,001 286,001 Shareholders fund 623,748 667,249 758,701 819,303 896,526
Others 67,912 86,467 88,920 98,720 101,287 Minority Interest 68,261 95,208 120,515 137,648 159,386
EBITDA 153,296 163,290 156,241 181,079 217,761 Total debt 1,255,552 1,410,071 1,326,053 1,270,322 1,260,322
Depreciation & Amortisation 19,230 24,623 29,042 30,111 33,123 Non Current Liabilities 0 0 0 0 0
EBIT 134,066 138,667 127,199 150,968 184,637 Def tax liab. (net) (31,078) (23,935) (15,183) (19,183) (24,183)
Interest expenses 18,026 27,967 39,134 33,340 33,840 Total liabilities 1,916,483 2,148,593 2,190,085 2,208,089 2,292,050
Other income 18,365 23,609 34,294 30,689 30,114 Gross block 390,357 555,464 592,660 630,379 655,379
PBT 142,862 143,142 148,803 148,317 180,911 Less: acc. Depreciation (196,687) (221,309) (250,351) (280,462) (313,586)
Taxes 43,433 34,919 65,552 47,045 55,308 Net block 193,670 334,155 342,308 349,917 341,793
Effective tax rate (%) 30.4 24.4 44.1 31.7 30.6 Capital WIP 139,195 55,376 25,219 7,500 7,500
PAT 99,428 108,223 83,251 101,273 125,604 Net fixed assets 351,134 469,645 448,197 438,086 429,963
Minority/Associates (13,325) (12,733) (12,626) (14,533) (18,638) Non Current Assets 913,246 963,246 888,246 888,246 918,246
Recurring PAT 86,104 95,490 70,625 86,739 106,965 Investments 211,203 200,465 396,266 396,266 403,766
Extraordinary items 2,948 0 45,204 0 0 Inventories 64,139 57,467 58,205 61,619 66,712
Reported PAT 89,051 95,490 115,829 86,739 106,965 Sundry debtors 426,868 472,731 481,795 487,153 512,718
Cash & Cash Equivalents 117,262 151,178 162,415 144,840 172,553
Ratios Loans & advances 146,344 97,925 102,665 113,665 123,665
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 526,880 586,607 547,918 537,023 603,146
Growth (%)
Trade payables 429,948 436,439 455,046 410,343 449,118
Revenue 12.8 7.6 (6.5) 15.1 13.0
Other current liab. 410,646 414,231 440,576 448,467 489,600
EBITDA 13.0 6.5 (4.3) 15.9 20.3 Provisions 0 0 0 0 0
Adj. EPS 18.7 11.6 (26.1) 22.8 23.3 Net current assets 440,900 515,237 457,376 485,491 540,075
Margins (%) Total assets 1,916,483 2,148,593 2,190,085 2,208,089 2,292,050
Gross 29.3 33.1 36.2 36.2 34.2
EBITDA 11.3 11.2 11.5 11.6 12.3 Cashflow
EBIT 9.9 9.5 9.4 9.6 10.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 6.4 6.6 5.2 5.5 6.0 Profit Before Tax 145,809 143,142 194,007 148,317 180,911
Returns (%) Depreciation & Amortisation 19,230 24,623 29,042 30,111 33,123
ROE 14.6 14.8 9.9 11.0 12.5 Net Interest 18,026 27,967 39,134 33,340 33,840
ROCE 5.4 5.6 3.9 5.2 6.1 Net Change – WC 18,255 (39,802) 53,304 (45,690) (26,872)
ROIC 5.5 5.6 3.8 5.7 6.8 Direct taxes (37,312) (29,618) (40,901) (43,045) (50,308)
Turnover (days) Net cash from operations 164,007 126,311 274,588 123,034 170,695
Gross block turnover ratio (x) 3.5 2.6 2.3 2.5 2.7 Capital expenditure (50,128) (143,133) (7,595) (20,000) (25,000)
Debtors 111 113 128 113 103 Acquisitions, net 0 0 0 0 0
Inventory 21 23 24 22 20 Investments (58,090) 10,738 (195,802) 0 (7,500)
Creditors 154 162 188 158 135 Others (154,159) (70,798) 101,225 (5,350) (37,350)
Net working capital 119 129 123 113 111 Net cash from investing (262,377) (203,193) (102,171) (25,350) (69,850)
Solvency (x) FCF (98,370) (76,882) 172,417 97,684 100,845
Net debt-equity 1.6 1.7 1.3 1.2 1.0 Issue of share capital (1,101) 13,514 12,537 0 0
Interest coverage ratio 8.5 5.8 4.0 5.4 6.4 Increase/(decrease) in debt 180,311 154,520 (84,019) (55,731) (10,000)
Net debt/EBITDA 5.0 5.2 5.0 4.3 3.7 Dividend paid (25,878) (29,270) (50,564) (26,137) (29,743)
Per share (Rs) Interest paid (18,026) (27,967) (39,134) (33,340) (33,840)
Adjusted EPS 61.0 68.0 50.3 61.8 76.2 Others 0 0 0 0 0
BVPS 441.7 475.3 540.2 583.3 638.3 Net cash from financing 135,307 110,797 (161,180) (115,208) (73,583)
CEPS 75.1 85.6 71.0 83.2 99.7 Net change in Cash 36,937 33,915 11,237 (17,525) 27,262
DPS 15.9 18.0 36.0 18.6 21.2 Source: Company, Centrum Broking
Dividend payout (%) 25.1 26.5 43.7 30.1 27.8
Valuation (x)
P/E 21.7 19.8 21.4 27.9 22.6
P/BV 3.0 2.8 2.0 3.0 2.7
EV/EBITDA 13.2 12.9 11.5 19.6 16.1
Dividend yield (%) 1.0 1.1 2.2 1.1 1.2
Source: Company, Centrum Broking

Centrum Institutional Research 207


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

NCC Ltd (NCC) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

NCC’s 10-year cash flows reflect the burden of its legacy investments in land and Market data
power plant. They also reflect the stress faced by construction companies during Current price: Rs83
2010-2014 due to delayed approvals and cost increases. Operating cash flow, and Bloomberg: NJCC IN
hence, FCF has largely remained weak, though we have seen an improvement in 52-week H/L: Rs100/30
these over the last two years. Negative FCF has been almost entirely funded through
Market cap: Rs50.6bn
equity issuances, leading to leverage remaining in control. Working capital levels are
elevated due to sticky exposures (Sembcorp arbitration and AP unpaid dues) while Free float: 80.3%
incremental execution is supported by regular payments. Net debt declined Rs3.4bn Avg. daily vol. 3mth: 5,273,902
over FY20-21, led partly by equity infusion by promoters in FY20. Source: Bloomberg

Cash conversion weak historically; some improvement lately: NCC witnessed considerable stress during FY11-14, led by
sluggish execution and cost increases, leading to weak operating profits. Operating profits have recovered since, but cash
conversion was weak. FY20 and FY21 witnessed improved cash conversion on incremental execution, but we are still to see
any material release of older working capital, despite lower revenue and operating profits.
Exhibit 558: Operating cash flows have been weak until recently

10,000

6,000
Rs mn

2,000

(2,000) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(6,000)

(10,000)
Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital levels have been moderate to high: Working capital levels have remained largely at elevated levels, with
intermediate moderation in some years. Specifically, working capital levels remain impacted by (i) encashment of BG,
overdue receivables, and retentions related to dispute with Sembcorp totalling to ~Rs7bn, (ii) outstanding exposure of
Rs7.1bn in AP projects, and (iii) decline in revenue by 40% from peak revenue of Rs121bn in FY21.
Exhibit 559: Working capital levels have spiked due to large sticky receivables amid sharp drop in revenue
220
205
163 167
160
119 137
Days

115 108 117


108
94
100 84

40
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Trade receivables (days) Trade payables (days) Mobilization advances (days) NWC (ex cash ex L&A)
Source: Company, Centrum Broking

BG of Rs3.4bn encashed Unpaid AP exposure of


by Sembcorp + Rs4bn of Rs7.1bn (Mar-21) and
receivables & retentions sharp drop in revenue

Please see Appendix for analyst certifications and all other important disclosures.
NCC Ltd (NCC) 16 September 2021

Exhibit 560: EBITDA to CFO conversion weak Exhibit 561: PAT to CFO conversion of 42% over 11 years
200% 150%

150% 120%

100% 90%

50% 60%

0% 30%
FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
-50% 0%

FY11*

FY12*

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
-100% -30%

-150% -60%

Source: Company, Centrum Broking Source: Company, Centrum Broking; *: values not included as they were out of range

Free cash flows weak due to low CFO amid capex and investments: Total operating cash flow of Rs10.1bn over FY12-21 has
been hugely inadequate to fund capex of Rs17.4bn and equity investment (net) of Rs4.8bn in BOT and Power assets as well as
in real estate subsidiaries. This has led to negative FCF of Rs12.1bn over this period, which was largely funded with fresh
equity raise of Rs12.7bn. Net debt over this period reduced by Rs540mn.
Exhibit 562: FCF in the negative zone historically, but seeing some reversal in recent years
7,500

5,000

2,500

-
Rs mn

FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(2,500)

(5,000)

(7,500)

(10,000)
CFO (Rs mn) Capex (Rs mn) Investments (Rs mn) Net FCF (Rs mn)
Source: Company, Centrum broking

Exhibit 563: Negative FCF of Rs12.1bn was almost entirely funded with fresh equity raise
Rs mn FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY11-21
FCF (9,908) 2,230 334 (6,208) (648) 2,411 2,406 (2,814) (3,555) 978 2,697 (12,077)
Inflow from equity raise/dividend outflow (389) (298) (89) 3,600 5,881 (263) (402) 5,145 (450) (263) 143 12,617
Increase/ (decrease) in debt 10,297 (1,932) (245) 2,609 (5,234) (2,148) (2,004) (2,331) 4,005 (716) (2,840) (540)
Source: Company, Centrum broking

Exhibit 564: Leverage has remained low-to-moderate, despite weak cash flows due to timely fund raise
Leverage ratios (x) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY11-21 Average
Net Debt/Equity 1.0 0.9 0.9 1.0 0.6 0.5 0.4 0.3 0.4 0.3 0.3 0.6
Net Debt*/EBITDA 6.2 8.2 6.6 9.1 5.2 3.7 3.4 3.7 2.5 3.2 3.7 5.0
Source: Company, Centrum broking; *: includes mobilization advances and acceptances

Exhibit 565: Return ratios remained weak, led by lower margins, impairments and burden of unproductive investments
Return Ratios (%) FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY11-21 Average
RoE 7.1% 1.5% 2.6% 1.6% 4.2% 9.2% 7.5% 10.3% 13.8% 6.9% 5.0% 6.4%
RoCE pre-tax* 8.7% 7.7% 8.8% 7.8% 11.6% 14.0% 12.0% 13.1% 17.8% 11.8% 9.1% 11.1%
RoCE* 5.4% 5.2% 5.7% 5.2% 8.1% 10.9% 9.7% 10.8% 11.9% 8.2% 7.1% 8.0%
Source: Company, Centrum broking; *: includes mobilization advances and acceptances

Revenue/margin expansion with NWC/CE RoE remained low due to equity issuances Surge in operations led by AP
remaining flat. Rise in income from loans (used for debt repayment), rise in tax projects followed by a very
to subsidiaries (but low cash conversion). rates, and impairments. sharp dip.

Centrum Institutional Research 209


NCC Ltd (NCC) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 120,798 82,188 72,557 100,128 130,167 Equity share capital 1,201 1,220 1,220 1,220 1,256
Operating Expense 99,305 64,949 58,725 82,876 108,260 Reserves & surplus 46,367 49,837 52,475 56,510 63,199
Employee cost 4,393 4,352 3,494 3,738 4,187 Shareholders fund 47,568 51,056 53,694 57,730 64,455
Others 2,870 2,586 1,794 2,242 2,736 Minority Interest 0 0 0 0 0
EBITDA 14,230 10,302 8,545 11,271 14,984 Total debt 19,930 19,101 17,889 18,889 18,889
Depreciation & Amortisation 1,494 1,772 1,741 1,891 2,043 Non Current Liabilities 0 0 0 0 0
EBIT 12,736 8,529 6,804 9,380 12,941 Def tax liab. (net) (1,726) (2,055) (411) (411) (411)
Interest expenses 4,513 5,179 4,578 4,514 5,014 Total liabilities 65,771 68,102 71,172 76,208 82,933
Other income 1,183 1,513 1,156 824 890 Gross block 21,802 22,565 24,567 26,567 28,567
PBT 9,406 4,863 3,382 5,690 8,817 Less: acc. Depreciation (8,705) (9,968) (11,709) (13,600) (15,644)
Taxes 3,178 1,444 771 1,432 2,219 Net block 13,098 12,597 12,858 12,966 12,923
Effective tax rate (%) 33.8 29.7 22.8 25.2 25.2 Capital WIP 132 148 215 215 215
PAT 6,228 3,419 2,611 4,258 6,598 Net fixed assets 13,229 12,745 13,073 13,182 13,138
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 6,228 3,419 2,611 4,258 6,598 Investments 9,193 8,887 9,907 9,907 9,907
Extraordinary items (589) 403 0 0 0 Inventories 5,129 5,148 5,268 5,933 7,702
Reported PAT 5,639 3,823 2,611 4,258 6,598 Sundry debtors 31,542 26,180 26,602 31,330 36,002
Cash & Cash Equivalents 2,990 3,169 4,349 6,068 4,949
Ratios Loans & advances 4,965 5,947 3,001 3,001 3,001
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 62,812 63,574 64,378 73,549 93,317
Growth (%)
Trade payables 44,923 39,830 37,134 47,460 61,615
Revenue 59.8 (32.0) (11.7) 38.0 30.0
Other current liab. 18,548 16,860 17,252 18,084 21,892
EBITDA 66.5 (27.6) (17.1) 31.9 32.9 Provisions 617 857 1,021 1,217 1,578
Adj. EPS 54.5 (45.1) (23.6) 58.4 55.0 Net current assets 43,349 46,470 48,191 53,119 59,887
Margins (%) Total assets 65,771 68,102 71,172 76,208 82,933
Gross 17.8 21.0 19.1 17.2 16.8
EBITDA 11.8 12.5 11.8 11.3 11.5 Cashflow
EBIT 10.5 10.4 9.4 9.4 9.9 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 5.2 4.2 3.6 4.3 5.1 Profit Before Tax 8,817 5,267 3,382 5,690 8,817
Returns (%) Depreciation & Amortisation 1,494 1,772 1,741 1,891 2,043
ROE 13.8 6.9 5.0 7.6 10.8 Net Interest 4,513 5,179 4,578 4,514 5,014
ROCE 11.5 8.1 6.9 8.3 10.4 Net Change – WC (7,985) (1,952) (3,311) (3,209) (7,887)
ROIC 12.3 8.0 7.0 9.1 11.6 Direct taxes (3,087) (1,731) (74) (1,432) (2,219)
Turnover (days) Net cash from operations 3,751 8,534 6,316 7,454 5,768
Gross block turnover ratio (x) 5.5 3.6 3.0 3.8 4.6 Capital expenditure (5,638) (1,288) (1,516) (2,000) (2,000)
Debtors 118 128 133 106 94 Acquisitions, net 0 0 0 0 0
Inventory 41 29 32 25 23 Investments 2,313 (684) 1,750 0 0
Creditors 147 238 239 186 184 Others 574 (1,049) 0 0 0
Net working capital 131 206 242 194 168 Net cash from investing (2,751) (3,021) 234 (2,000) (2,000)
Solvency (x) FCF 1,000 5,513 6,551 5,454 3,768
Net debt-equity 0.4 0.3 0.3 0.2 0.2 Issue of share capital 0 1,098 0 266 797
Interest coverage ratio 3.2 2.0 1.9 2.5 3.0 Increase/(decrease) in debt 6,930 (829) (1,212) 1,000 0
Net debt/EBITDA 1.2 1.5 1.6 1.1 0.9 Dividend paid (1,086) (147) (488) (488) (669)
Per share (Rs) Interest paid (4,513) (5,179) (4,578) (4,514) (5,014)
Adjusted EPS 10.2 5.6 4.3 6.8 10.5 Others 0 0 0 0 0
BVPS 78.0 83.7 88.0 91.9 102.7 Net cash from financing 1,331 (5,057) (6,277) (3,737) (4,887)
CEPS 12.9 8.6 7.1 10.1 14.0 Net change in Cash 2,331 456 273 1,718 (1,119)
DPS 1.5 0.2 0.8 0.8 1.1 Source: Company, Centrum Broking
Dividend payout (%) 16.0 3.2 18.7 11.5 10.1
Valuation (x)
P/E 9.2 11.7 10.4 12.2 7.9
P/BV 1.2 0.8 0.5 0.9 0.8
EV/EBITDA 5.2 5.4 4.8 5.6 4.3
Dividend yield (%) 1.6 0.3 1.8 1.0 1.3
Source: Company, Centrum Broking

Centrum Institutional Research 210


16 September 2021

Institutional Research
Ashish Shah
Research Analyst, Infrastructure
+91 22 4215 9021
SECTOR: INFRASTRUCTURE [email protected]
Vaibhav Shah

PNC Infratech (PNC) Research Associate, Infrastructure


+91 22 4215 9815
[email protected]

PNC’s cash flows over last 10 years reflect its good project management skills along Market data
with its focus on conserving balance sheet integrity. Operating profits have grown Current price: Rs370
consistently and working capital levels have been maintained at an average of 83 Bloomberg: PNCL IN
days over this period. Operating cash flows of Rs26.8bn have completely funded the 52-week H/L: Rs389/147
capex requirements and equity investments. Balance sheet has remained thinly-
Market cap: Rs95bn
levered throughout this period with average Net Debt/Equity at 0.1x and Net
Debt/EBITDA at 1.3x. Average RoE has been 13.8% over the 10-year cycle, with FY21 Free float: 43.9%
RoE at 13.3% being impacted due to adverse impact of Covid on execution. Avg. daily vol. 3mth: 1,212,496
Source: Bloomberg

Operating cash flows have been strong: Led by fairly consistent growth in operating profits, PNC’s cash flows from
operations have been strong, especially during the last 3-4 years. There was considerable release of working capital in end-
FY20 due to the government’s liquidity push in response to Covid. Over FY12-21, PNC’s cumulative operating profits were
Rs27.6bn while CFO was Rs26.8bn with working capital absorption of Rs836m.
Exhibit 566: Operating cash flows of Rs26.8bn over FY12-21
10,000 Liquidity stimulus in
7,500 response to Covid

5,000
Rs mn

2,500

-
(2,500)
(5,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before wcap changes (Rs mn) Wcap changes (Rs mn) CFO (Rs mn)
Source: Company, Centrum Broking

Working capital management has been good: PNC’s working capital cycle has been at 83 days on an average over FY12-21,
in line with the industry standard of 80-100 days. However, over the last three years, NWC has declined sharply. Particularly,
in FY20, NWC came down to 16 days, led by substantial release of liquidity by government clients in Mar-21 as a Covid relief
measure and also due to draw down of mobilization advances in several projects. Share of EPC revenue from HAM projects
increased to an average of 45% during FY18-20 vis-à-vis 8% in FY17, giving better ability to control NWC levels.
Exhibit 567: Historical NWC levels in line with industry standards
150
Decline aided by
120 Covid relief measures
in Mar-20
90
69
days

51 48 49 53
60 43
39
24 19 19
30

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Trade receivables (days) Trade payables (days) Mobilization (days) NWC (ex cash ex L&A)
Source: Company, Centrum Broking
EPC revenue from own HAMs at
45% (8% in FY17), giving better
control on NWC

Please see Appendix for analyst certifications and all other important disclosures.
PNC Infratech (PNC) 16 September 2021

Exhibit 568: EBITDA to CFO conversion at 80% over FY12-21 Exhibit 569: PAT to CFO conversion at 124% in FY12-21
139% 294%
150% 300%
117% 121% 123% 239%
99% 204%
100% 200%
154%
139%

42% 45% 47% 88%


50% 100%
48% 47%
14% 30%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-26% -51%
-50% -100%

Source: Company, Centrum Broking Source: Company, Centrum Broking

Growth funded by operating cash flows: PNC generated operating cash flows of Rs26.8bn over FY12-21, which completely
funded its total capex requirements (Rs11.4bn) and equity investments (Rs13.2bn) in assets. FCF stood at Rs2.1bn over this
period. Net debt declined by Rs5.3bn from Rs627m (net debt) in Mar-11 to net cash of Rs4.7bn in Mar-21.
Exhibit 570: Operating cash flows completely funded capital commitments; FCF at Rs2.1bn over FY12-21
10,000
8,000
6,000
4,000
Rs mn

2,000
-
(2,000)
(4,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO (Rs mn) Capex (Rs mn) Investments (Rs mn) Net FCF (Rs mn)
Source: Company, Centrum Broking

Exhibit 571: Positive FCF and IPO proceeds helped unwinding of debt
Rs mn FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21
FCF (1,701) 209 406 (1,478) (142) (1,866) 1,467 (274) 5,703 (213) 2,110
Inflow from equity raise/dividend outflow - (35) - (93) 4,079 (161) (161) (155) (309) - 3,166
Increase/ (decrease) in net debt 1,701 (175) (406) 1,571 (3,937) 2,027 (1,306) 429 (5,393) 213 (5,276)
Source: Company, Centrum Broking

Exhibit 572: PNC has always remained thinly-levered


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
Net Debt/Equity 0.5 0.4 0.3 0.4 (0.1) 0.1 0.0 0.0 (0.2) (0.1) 0.1
Net Debt*/EBITDA 2.4 1.9 2.8 2.4 0.7 1.4 0.4 1.1 0.4 (0.2) 1.3
Source: Company, Centrum Broking; *: includes mobilization advances

Exhibit 573: Average RoE of 13.8% over FY12-21


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12-21 Average
RoE 17.3% 14.5% 11.2% 14.8% 18.5% 12.5% 9.5% 12.3% 14.1% 13.3% 13.8%
ROCE pre-tax* 19.8% 15.2% 12.4% 16.2% 16.0% 12.0% 10.4% 15.4% 18.0% 17.8% 15.3%
RoCE* 13.2% 10.2% 8.1% 11.0% 16.1% 11.4% 9.5% 11.7% 12.6% 11.6% 11.5%
Source: Company, Centrum Broking; *: Capital employed includes mobilization advances

Centrum Institutional Research 212


PNC Infratech (PNC) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 30,716 47,689 49,254 59,598 71,040 Equity share capital 6,414 6,414 6,414 6,414 6,414
Operating Expense 21,140 33,710 34,965 42,195 50,439 Reserves & surplus 14,738 19,052 22,671 27,254 32,690
Employee cost 1,923 2,651 2,791 3,237 3,885 Shareholders fund 21,152 25,466 29,085 33,668 39,104
Others 3,333 4,775 4,771 5,960 7,104 Minority Interest 0 0 0 0 0
EBITDA 4,320 6,553 6,728 8,205 9,613 Total debt 3,747 3,266 3,975 3,975 3,975
Depreciation & Amortisation 922 1,264 1,124 1,338 1,492 Non Current Liabilities 0 0 0 0 0
EBIT 3,398 5,289 5,604 6,867 8,120 Def tax liab. (net) (5) 0 0 (125) (125)
Interest expenses 641 1,144 771 810 957 Total liabilities 24,894 28,732 33,060 37,518 42,954
Other income 430 529 752 665 619 Gross block 8,640 9,524 11,325 12,575 14,075
PBT 3,187 4,675 5,585 6,721 7,782 Less: acc. Depreciation (2,486) (3,644) (4,768) (6,106) (7,599)
Taxes 773 1,391 1,966 2,010 2,218 Net block 6,155 5,880 6,557 6,469 6,477
Effective tax rate (%) 24.3 29.8 35.2 29.9 28.5 Capital WIP 62 0 34 34 34
PAT 2,414 3,283 3,619 4,712 5,564 Net fixed assets 6,217 5,880 6,592 6,503 6,511
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 2,414 3,283 3,619 4,712 5,564 Investments 5,730 7,355 8,469 11,290 14,480
Extraordinary items 835 1,321 0 0 0 Inventories 4,036 2,673 3,536 4,008 4,792
Reported PAT 3,249 4,604 3,619 4,712 5,564 Sundry debtors 6,154 8,035 8,392 11,430 12,846
Cash & Cash Equivalents 3,094 7,401 7,683 3,222 3,923
Ratios Loans & advances 4,196 5,988 6,829 5,408 5,408
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 7,723 6,770 7,067 9,797 11,678
Growth (%)
Trade payables 4,737 4,675 7,194 5,077 6,230
Revenue 70.8 55.3 3.3 21.0 19.2
Other current liab. 7,402 10,588 8,077 8,776 10,111
EBITDA 65.8 51.7 2.7 22.0 17.2 Provisions 117 108 238 287 343
Adj. EPS 50.5 36.0 10.2 30.2 18.1 Net current assets 12,947 15,496 17,998 19,725 21,963
Margins (%) Total assets 24,894 28,732 33,060 37,518 42,954
Gross 31.2 29.3 29.0 29.2 29.0
EBITDA 14.1 13.7 13.7 13.8 13.5 Cashflow
EBIT 11.1 11.1 11.4 11.5 11.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 7.9 6.9 7.3 7.9 7.8 Profit Before Tax 4,022 5,996 5,585 6,721 7,782
Returns (%) Depreciation & Amortisation 922 1,264 1,124 1,338 1,492
ROE 12.3 14.1 13.3 15.0 15.3 Net Interest 641 1,144 771 810 957
ROCE 11.7 12.6 11.6 13.6 13.9 Net Change – WC 507 3,549 (1,379) (7,608) (1,537)
ROIC 14.9 18.1 18.0 20.4 20.3 Direct taxes (753) (1,486) (1,998) (2,135) (2,218)
Turnover (days) Net cash from operations 5,340 10,467 4,103 (873) 6,477
Gross block turnover ratio (x) 3.6 5.0 4.3 4.7 5.0 Capital expenditure (2,858) (822) (1,820) (1,250) (1,500)
Debtors 78 54 61 61 62 Acquisitions, net 0 0 0 0 0
Inventory 50 36 32 33 32 Investments (1,992) (2,793) (1,574) (1,400) (3,190)
Creditors 81 51 62 53 41 Others (121) (142) 144 0 0
Net working capital 154 119 133 121 113 Net cash from investing (4,970) (3,758) (3,249) (2,650) (4,690)
Solvency (x) FCF 370 6,709 854 (3,523) 1,787
Net debt-equity 0.0 (0.2) (0.1) 0.0 0.0 Issue of share capital 0 0 0 0 0
Interest coverage ratio 6.7 5.7 8.7 10.1 10.0 Increase/(decrease) in debt 2,047 (482) 709 0 0
Net debt/EBITDA 0.2 (0.6) (0.6) 0.1 0.0 Dividend paid (155) (154) (128) (128) (128)
Per share (Rs) Interest paid (641) (1,144) (771) (810) (957)
Adjusted EPS 9.4 12.8 14.1 18.4 21.7 Others 0 0 0 0 0
BVPS 82.5 99.3 113.4 131.2 152.4 Net cash from financing 1,252 (1,780) (190) (939) (1,086)
CEPS 13.0 17.7 18.5 23.6 27.5 Net change in Cash 1,621 4,930 664 (4,461) 702
DPS 0.5 0.5 0.5 0.5 0.5 Source: Company, Centrum Broking
Dividend payout (%) 3.9 2.8 3.5 2.7 2.3
Valuation (x)
P/E 16.1 14.1 11.9 20.2 17.1
P/BV 1.8 1.8 1.5 2.8 2.4
EV/EBITDA 9.2 6.4 5.9 11.7 9.9
Dividend yield (%) 0.3 0.3 0.3 0.1 0.1
Source: Company, Centrum Broking

Centrum Institutional Research 213


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari
Research Associate, Metals & Mining

APL Apollo (APAT) +91 22 4215 9375


[email protected]

APAT has consistently grown (capacity expanded at 20% CAGR over FY12-21) and Market data
gained leadership in the structural tubes industry, with >50% market share. Despite Current price: Rs956
consistent volume growth, its operating cash flows have fluctuated through the Bloomberg: APAT IN
commodity cycle. Shift towards value-added products from FY20 has helped 52-week H/L: Rs1,050/230
operating cash flows to improve. APAT changed from credit to cash sales model from
Market cap: Rs238.9bn
FY21 and improved inventory management, which led to a decline in net working
capital from an average of 46 days over FY12-21 to 18 days in FY21. It has mastered Free float: 63.1%
turning around acquired assets, though its last acquisition was expensive. Return Avg. daily vol. 3mth: 626,170
ratios have remained robust, with average RoE of 19.7% and RoCE of 20.9% (FY12-21). Source: Bloomberg

Operating cash flows have fluctuated with commodity cycle: Despite consistent growth in sales volumes, we observe OCF has
fluctuated with commodity cycle. In FY21, we observe a shift in profitability owing to premiumization and better cost control,
which may lead to higher cash flows. We observe consistent reduction in working capital, with better control on inventory,
changing business model from credit to cash sales, and increasing payable days with increasing business size.
Exhibit 574: Operating cash flows fluctuate with commodity cycle

VAP volume growth, premiumization,


Despite increasing volume over FY12-19, OCF movement and cost control led to OCF growth
6000 has been directed by steel cyclicality
5,096
4000
3,576
3,148 3,154
Rs in mn

2000
373 256 1,327 113
41 914
0

-2000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-4000
Operating profit before Wcap Changes W Cap Changes CFO
Source: Company, Centrum Broking

Consistent decline in working capital over FY12-21: Net working capital (NWC) has been on a downward trend since FY12.
Receivables were largely under control (average at 28 days over FY12-19), and with change from credit sales to cash sales,
NWC fell further to 13 days in FY21. APAT has also cut inventory from 49 days in FY17 to 33 days in FY21. With increasing
business size, it has gained some influence over creditors too, which allows higher credit steel HRC purchases. As a result, NWC
declined from an average of 34 days over FY17-21 to 18 days in FY21.
Exhibit 575: NWC days on a downward trend
80 74 Inventory, which had spiked to 49 days in
68 FY17, reduced to 33 days in FY21 Change from credit to cash sales and low
70 65
inventory resulted in lower NWC in FY21
60
No of Days

50 45
37 47 40
40
35
30 30
20 17
10
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventories Receivables Payable Net Working capital
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
APL Apollo (APAT) 16 September 2021

Exhibit 576: OCF/EBITDA has fluctuated widely Exhibit 577: OCF/PAT

200 600
173
494
160 500

107 400
120 95 91
81 300
%

241

%
225 207
80 199
200
32 25 76
40 16 100 58
37
4 4 8 11
0 0

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Capacity expansions and acquisitions led to poor conversion of operating cash to free cash: APAT expanded capacity by 5.3x
to 2.6mtpa over FY12-21, leading to largely negative free cash flows. From FY19, APAT decided to expand only via internal
accruals, which helped in debt peaking in FY19. Despite acquiring Apollo Tricoat and Taurus Value Steel & Pipes in FY20, we
observe positive free cash flows during FY19-21. Against OCF of Rs20.6bn over FY12-21, APAT incurred capex of Rs17.8bn and
invested Rs2.2bn in acquisition. This was funded by a mix of internal accruals, debt and equity. Net debt increased from Rs3bn
in FY12 to Rs8bn in FY19, which later reduced to Rs1.7bn in FY21.
Exhibit 578: On a continuous capex mode, with balance sheet under control
10000
8000 Capex spend for 5.3x capacity expansion over Since FY19, capex funded through internal
FY12-18 led to largely negative FCF accruals and higher OCF led to positive FCF
6000 6,279
Rs in mn

4000
2000
645 657 193 816
0
(560)
-2000 (738) (1,023) (1,839) (1,585)

-4000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Change in Invesment Net FCF
Source: Company, Centrum Broking

Acquisition of assets remunerative: APAT acquired Apollo Tricoat (55.8% stake as at March 2021) in FY20. With the
integration of a high-margin business, APAT’s overall profitability improved. The acquisition is value-accretive.
Exhibit 579: Acquisition of Apollo Tricoat turned out to be value-accretive
FY19 FY20 FY21
ROCE (%) 2.0 26.6 45.4
APL share in ROIC (%) 1.0 30.0 40.6
Source: Company, Centrum Broking

Leverage under control despite continuous capex; return ratios superior: Despite continuous expansion via
organic/inorganic route, APAT’s average Net Debt/Equity and Net Debt/EBITDA were comfortable at 0.9x and 2.1x,
respectively. However, with sharp increase in profitability in FY21, Net Debt/EBITDA fell to 0.3x. APAT has managed
its return ratios well. Over FY12-21, average return ratios remained robust, with RoE at 19.7% and RoCE at 20.9%.
Exhibit 580: Net Debt/EBITDA at 0.3x in FY21 against 10-year average of 2.1x
Leverage Ratio (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA 2.7 2.7 3.0 2.6 2.3 1.8 2.1 2.1 1.7 0.3 2.1
Source: Company, Centrum Broking

Exhibit 581: Over FY12-21, average return ratios remained robust, with RoE at 19.7% and RoCE at 20.9%
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 18.5 20.8 14.9 13.9 23.7 23.9 20.5 16.5 20.5 23.6 19.7
ROCE 19.5 20.9 17.2 17.2 23.5 22.9 22.4 19.8 19.7 26.3 20.9
Source: Company, Centrum Broking *ROCE is pre tax

Centrum Institutional Research 214


APL Apollo (APAT) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 71,523 77,232 84,998 125,023 125,689 Equity share capital 239 249 250 500 500
Operating Expense 63,077 65,786 71,648 106,667 105,619 Reserves & surplus 9,402 13,313 16,697 21,585 27,898
Employee cost 1,079 1,422 1,296 1,400 1,512 Shareholders fund 9,641 13,562 16,947 22,085 28,398
Others 3,439 5,252 5,266 7,411 7,203 Minority Interest 0 954 1,383 1,383 1,383
EBITDA 3,928 4,773 6,787 9,545 11,354 Total debt 8,581 8,338 5,203 3,203 3,203
Depreciation & Amortisation 643 959 1,028 1,118 1,262 Non Current Liabilities 584 842 930 930 930
EBIT 3,286 3,814 5,759 8,427 10,092 Def tax liab. (net) 1,200 1,012 1,112 1,112 1,112
Interest expenses 1,134 1,072 661 410 313 Total liabilities 20,005 24,707 25,574 28,713 35,026
Other income 117 222 359 350 514 Gross block 11,626 18,131 19,326 21,326 24,576
PBT 2,269 2,964 5,458 8,367 10,293 Less: acc. Depreciation (1,548) (2,449) (3,363) (4,480) (5,743)
Taxes 787 403 1,381 2,106 2,591 Net block 10,078 15,681 15,964 16,846 18,833
Effective tax rate (%) 34.7 13.6 25.3 25.2 25.2 Capital WIP 275 101 1,077 1,327 327
PAT 1,482 2,560 4,077 6,261 7,702 Net fixed assets 10,611 17,185 18,434 19,566 20,553
Minority/Associates 0 (180) (475) (649) (756) Non Current Assets 1,744 960 1,550 2,126 2,135
Recurring PAT 1,482 2,380 3,602 5,612 6,946 Investments 494 15 15 15 15
Extraordinary items 0 0 0 0 0 Inventories 7,835 7,842 7,599 11,989 12,052
Reported PAT 1,482 2,380 3,602 5,612 6,946 Sundry debtors 5,433 4,764 1,306 1,921 1,931
Cash & Cash Equivalents 478 456 3,579 3,017 8,309
Ratios Loans & advances 13 13 13 13 13
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,131 1,426 1,494 2,182 2,194
Growth (%)
Trade payables 6,989 7,644 7,859 11,559 11,621
Revenue 34.1 8.0 10.1 47.1 0.5
Other current liab. 736 298 544 544 544
EBITDA 5.9 21.5 42.2 40.6 19.0 Provisions 8 11 12 12 12
Adj. EPS (6.7) 54.0 50.6 (22.1) 23.8 Net current assets 7,156 6,547 5,576 7,006 12,322
Margins (%) Total assets 20,005 24,707 25,574 28,713 35,026
Gross 11.8 14.8 15.7 14.7 16.0
EBITDA 5.5 6.2 8.0 7.6 9.0 Cashflow
EBIT 4.6 4.9 6.8 6.7 8.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 2.1 3.1 4.2 4.5 5.5 Profit Before Tax 2,269 2,963 5,458 8,367 10,293
Returns (%) Depreciation & Amortisation 643 959 1,028 1,118 1,262
ROE 16.5 20.5 23.6 28.8 27.5 Net Interest 1,105 1,073 661 0 0
ROCE 12.9 17.0 19.7 26.2 26.6 Net Change – WC 287 1,017 4,121 (2,568) (34)
ROIC 12.9 16.6 20.3 28.9 31.3 Direct taxes (673) (816) (1,195) (2,106) (2,591)
Turnover (days) Net cash from operations 3,576 5,096 9,771 4,811 8,931
Gross block turnover ratio (x) 6.2 4.3 4.4 5.9 5.1 Capital expenditure (2,369) (3,092) (2,869) (2,250) (2,250)
Debtors 25 24 13 5 6 Acquisitions, net 0 0 0 0 0
Inventory 35 37 33 29 35 Investments (390) (1,423) (462) 0 0
Creditors 28 35 33 28 34 Others 121 167 (3,137) 0 0
Net working capital 37 31 24 20 36 Net cash from investing (2,639) (4,349) (6,468) (2,250) (2,250)
Solvency (x) FCF 1,207 2,003 6,902 2,561 6,681
Net debt-equity 0.8 0.5 0.1 0.0 (0.2) Issue of share capital 56 1,775 154 0 0
Interest coverage ratio 3.5 4.5 10.3 23.3 36.3 Increase/(decrease) in debt 830 (949) (3,111) (2,000) 0
Net debt/EBITDA 2.1 1.7 0.2 0.0 (0.4) Dividend paid (332) (411) 0 (1,122) (1,389)
Per share (Rs) Interest paid (1,014) (1,187) (623) 0 0
Adjusted EPS 12.4 19.1 28.8 22.5 27.8 Others (68) (6) (6) 0 0
BVPS 80.8 109.1 135.7 88.4 113.6 Net cash from financing (528) (778) (3,586) (3,122) (1,389)
CEPS 17.8 26.9 37.1 26.9 32.8 Net change in Cash 410 (32) (283) (562) 5,292
DPS 2.8 2.7 0.0 4.5 5.6 Source: Company, Centrum Broking
Dividend payout (%) 22.6 14.3 0.0 20.0 20.0
Valuation (x)
P/E 78.7 51.1 33.9 43.5 35.2
P/BV 12.1 9.0 7.2 11.1 8.6
EV/EBITDA 10.8 8.1 24.0 25.6 21.1
Dividend yield (%) 0.3 0.3 0.0 0.5 0.6
Source: Company, Centrum Broking

Centrum Institutional Research 215


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Coal India (COAL) Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

COAL, being a cash-rich company, has been recording moderate cash flows except for Market data
the last two years, when debtors surged. Net working capital has largely been Current price: Rs162
negative till FY19. Cash conversion ratio has remained moderate in the last decade, Bloomberg: COAL IN
with average CFO/EBITDA of 67% during FY12-21. The entire capex of ~Rs609bn 52-week H/L: Rs165/110
during FY12-21 has been funded via internal cash flows and COAL has not raised any
Market cap: Rs1000.2bn
equity. The company has been continuously paying high dividend (cumulatively paid
Rs218/share during FY12-21), which led net cash to decline to Rs24/share in FY21 Free float: 33.9%
from Rs93/share in FY12. Due to higher dividend payout and better profitability, Avg. daily vol. 3mth: 10,962,410
return ratios were high, with average RoE of 56% and RoCE of 72% over FY12-21. Source: Bloomberg

Operating cash flows hit by higher debtors in last two years: COAL’s continuous volume growth and stable profitability (except
for the last two years) helped it to generate moderate OCF throughout the cycle. Its cash flows were hit in FY20 due to higher
receivables from power discoms. Due to absence of debt and negative working capital (except for last two years), it generated
~Rs1,387bn OCF during FY12-21. Cash conversion ratio remained moderate (average CFO/EBITDA of 67% during FY12-21).
Exhibit 582: Moderate operating cash flows

COAL generated moderate OCF throughout the cycle,


400
but was hit in FY20-21 due to higher recievables
300
211
200 164
Rs in bn

198 145 144 167


91 114
100 41 113

-100

-200
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before Wcap Changes W Cap Changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital (NWC) has largely been negative till FY19 due to other financial
liabilities and provisions. However, cash conversion cycle is on the higher side (average 51 days during FY12-21). Due to delay
in payments from state discoms, working capital got hit from FY20. Inventory has largely been stable at an average of 30 days.
Exhibit 583: Negative net working capital till FY19, post which higher debtors adversely impacted working capital

NWC negative till FY19, though cash Due to delay in payments from power
conversion cycle averaged at 51 days. discoms, NWC got hit from FY20.

80 69
48 56 53
60 42 41 47 40 38
40 26 22
No of Days

20
0 4
1 4 -3
-20 -1
-19
-40 -30 -35 -40
-60
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Coal India (COAL) 16 September 2021

Exhibit 584: OCF/EBITDA Exhibit 585: OCF/PAT

120 109 105 160


137
96 140
100 119
120 108
80 69 68 100
79 82 80
53 56 56 74
60 80 67

%
%

40
60 44
40
40
15 18
20 20
0 0

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Low capex, no acquisition led to healthy free cash flows till FY19: During FY12-21, COAL spent ~Rs609bn to expand its mining
capacity, which includes land acquisition, machinery, etc. It has accelerated capex from FY21 to improve evacuation facilities
along with expanding capacities. The entire capex has been funded via internal accruals. As it has not acquired any company,
it generated high cash flows till FY19. However, cash flows were hit during FY20-21 on account of high debtors and lower
profits. It generated net free cash flows of Rs777bn during FY12-21.
Exhibit 586: Low capex till FY19; accelerating now
300 COAL generated high FCF till FY19, post which FCF
was hit due to high capex and recievables.
164
200 125
104
Rs in bn

95 78 93
66 59
100
(11) 4
0

-100

-200
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition & Investments Net FCF
Source: Company, Centrum Broking

No equity raised in last 10 years; dividend payout higher than FCF – net cash has declined: COAL has not raised any equity
from the market. Being cash rich, it has been continuously paying higher dividend (even higher than free cash flows in many
years). During FY12-21, it paid ~Rs1,366bn dividend (Rs218/share), much higher than free cash flows of ~Rs777bn. This led net
cash to decline from Rs587bn (Rs93/share) in FY12 to Rs151bn (Rs24/share) in FY21, down Rs436bn.
Exhibit 587: High dividend-paying company Exhibit 588: Net cash/share has declined due to high dividend
300 700 120
250 242 208 600 100
Net Cash declined due
200 156 197 500 100 to dividend paid > FCF
93 80
89 generated
Rs/share

164 123
Rs in bn

150 112 400


77
Rs in bn

79 60
100 97 300
95 125 61
104 77 40
50 66 78 93 200 46 49 50
74 59 4
100 36 20
0
24
(11) 0 0
-50
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
FCF Dividend Paid Net cash (Rs bn - LHS) Net cash (Rs/share - RHS)
Source: Company, Centrum Broking Source: Company, Centrum Broking
Return ratios healthy: COAL’s return ratios remain healthy (average RoCE of ~72% and RoE of 56% over FY12-21) due to
higher operating profits and higher dividend payout.
Exhibit 589: Return ratios are healthy
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 49.9 46.2 40.5 42.0 45.0 40.3 79.6 96.6 75.9 41.2 56.0
ROCE 65.1 61.7 56.8 60.5 63.6 54.8 87.8 127.0 88.5 49.1 72.0
Source: Company, Centrum Broking *ROCE is pre tax

Centrum Institutional Research 217


Coal India (COAL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 928,961 893,733 827,103 949,772 1,027,982 Equity share capital 61,627 61,627 61,627 61,627 61,627
Operating Expense 241,245 226,294 251,198 297,566 325,396 Reserves & surplus 192,549 262,926 306,530 342,179 406,155
Employee cost 387,701 393,841 386,977 412,711 414,288 Shareholders fund 264,539 321,569 365,174 400,822 464,798
Others 66,040 66,042 61,847 77,028 84,924 Minority Interest 4,068 3,941 4,411 4,411 4,411
EBITDA 300,483 274,627 200,238 235,052 280,315 Total debt 22,099 64,338 58,831 58,831 58,831
Depreciation & Amortisation 34,504 34,508 37,089 45,970 52,810 Non Current Liabilities 585,737 670,135 697,682 688,575 721,969
EBIT 265,980 240,119 163,149 189,082 227,506 Def tax liab. (net) 0 0 7,221 7,221 7,221
Interest expenses 2,750 5,029 6,447 5,883 5,883 Total liabilities 876,443 1,059,982 1,133,318 1,159,859 1,257,229
Other income 58,737 61,042 37,924 29,522 29,021 Gross block 400,845 468,263 559,866 649,866 739,866
PBT 321,967 296,132 194,626 212,721 250,643 Less: acc. Depreciation (115,455) (145,240) (182,329) (228,299) (281,109)
Taxes 96,625 73,710 53,071 53,818 63,413 Net block 285,391 323,024 377,537 421,567 458,757
Effective tax rate (%) 30.0 24.9 27.3 25.3 25.3 Capital WIP 96,616 82,711 104,037 164,037 224,037
PAT 225,342 222,422 141,555 158,903 187,231 Net fixed assets 422,726 451,119 528,951 632,981 730,171
Minority/Associates 0 0 0 0 0 Non Current Assets 154,364 162,134 177,827 184,688 189,062
Recurring PAT 225,342 222,422 141,555 158,903 187,231 Investments 14,210 18,732 23,176 23,176 23,176
Extraordinary items 0 0 0 0 0 Inventories 55,839 66,189 89,475 65,053 70,410
Reported PAT 225,342 222,422 141,555 158,903 187,231 Sundry debtors 54,986 144,082 196,231 143,116 112,656
Cash & Cash Equivalents 328,742 285,465 209,429 145,092 194,012
Ratios Loans & advances 5,023 5,027 5,013 5,013 5,013
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 248,606 334,358 347,101 409,244 408,019
Growth (%)
Trade payables 68,155 101,076 76,376 78,063 84,492
Revenue 14.6 (3.8) (7.5) 14.8 8.2
Other current liab. 311,226 271,255 343,444 346,376 366,732
EBITDA 50.0 (8.6) (27.1) 17.4 19.3 Provisions 71,364 67,903 64,659 64,659 64,659
Adj. EPS 27.7 (1.3) (36.4) 12.3 17.8 Net current assets 242,451 394,889 362,770 278,420 274,225
Margins (%) Total assets 876,443 1,059,982 1,133,318 1,159,859 1,257,229
Gross 98.3 100.7 102.2 98.9 98.6
EBITDA 30.2 28.6 22.2 23.0 25.4 Cashflow
EBIT 26.7 25.0 18.1 18.5 20.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 22.6 23.1 15.7 15.5 16.9 Profit Before Tax 271,255 240,725 180,092 212,721 250,643
Returns (%) Depreciation & Amortisation 34,504 34,508 37,089 45,970 52,810
ROE 96.6 75.9 41.2 41.5 43.3 Net Interest (31,320) (29,642) (9,154) 0 0
ROCE 88.9 66.5 35.7 36.6 38.6 Net Change – WC (48,918) (123,268) (56,552) 73,050 85,282
ROIC (230.8) 1,079.8 84.3 57.5 56.0 Direct taxes (95,329) (119,463) (56,630) (53,818) (63,413)
Turnover (days) Net cash from operations 166,955 41,465 105,599 271,061 320,948
Gross block turnover ratio (x) 2.3 1.9 1.5 1.5 1.4 Capital expenditure (73,393) (52,056) (108,525) (150,000) (150,000)
Debtors 22 38 69 61 42 Acquisitions, net 0 0 0 0 0
Inventory 22 23 32 28 22 Investments (40,675) 24,871 96,392 0 0
Creditors 25 32 36 28 27 Others 31,410 30,508 15,522 11,522 11,021
Net working capital 95 161 160 107 97 Net cash from investing (82,658) 3,324 3,389 (138,478) (138,979)
Solvency (x) FCF 93,561 (10,590) (2,927) 121,061 170,948
Net debt-equity (1.1) (0.7) (0.4) (0.2) (0.3) Issue of share capital 0 0 0 0 0
Interest coverage ratio 109.3 54.6 31.1 40.0 47.6 Increase/(decrease) in debt 6,718 22,776 (5,508) 0 0
Net debt/EBITDA (1.0) (0.8) (0.8) (0.4) (0.5) Dividend paid (112,110) (96,760) (77,064) (123,255) (123,255)
Per share (Rs) Interest paid (96) (686) (1,982) (5,883) (5,883)
Adjusted EPS 36.6 36.1 23.0 25.8 30.4 Others 3,972 5,169 0 0 0
BVPS 42.9 52.2 59.3 65.0 75.4 Net cash from financing (101,516) (69,502) (84,554) (129,138) (129,138)
CEPS 42.2 41.7 29.0 33.2 39.0 Net change in Cash (17,220) (24,712) 24,433 3,445 52,831
DPS 13.2 12.5 16.0 20.0 20.0 Source: Company, Centrum Broking
Dividend payout (%) 36.0 34.6 69.7 77.6 65.8
Valuation (x)
P/E 4.4 4.5 7.1 6.3 5.3
P/BV 3.8 3.1 2.7 2.5 2.2
EV/EBITDA 3.9 2.3 3.2 3.6 2.5
Dividend yield (%) 8.1 7.7 9.9 12.3 12.3
Source: Company, Centrum Broking

Centrum Institutional Research 218


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Hindalco (HNDL) Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

HNDL shifted its focus to value addition (with Novelis acquisition), giving it Market data
sustainable and increasing operating cash flows after FY15. Working capital intensity Current price: Rs483
reduced over the period. With no major expansion in India since FY15 and Novelis Bloomberg: HNDL IN
generating consistent free cash flows, HNDL recorded positive free cash flows since 52-week H/L: Rs488/154
FY16 till it acquired Aleris in FY21, generating ~2.5% RoCE in FY21. Balance sheet is
Market cap: Rs1085.1bn
under control with consistent decline in leverage. It spent ~Rs846bn over FY12-21,
largely funded via debt and raised equity of ~Rs49bn via warrants and QIP. Though Free float: 65.4%
Novelis has generated ~14% RoCE during FY17-21, HNDL’s consolidated return ratios Avg. daily vol. 3mth: 12,769,480
remain poor (average RoCE of ~10% over FY17-21) due to low aluminum prices. Source: Bloomberg

Consistent improvement in CFO since FY16: With consistent improvement in Novelis’ operations since FY17 and cost control
at Indian operations, we observe consistent increase in HNDL’s operating profits, despite fluctuating aluminium prices. Until
FY16, Indian operations had a higher share in profits – as Indian operations have higher exposure to aluminium prices, cash
flow from operations (CFO) kept fluctuating. Working capital intensity too has reduced since FY16 and cash conversion ratio
improved to an average of 62% during FY16-21.
Exhibit 590: Consistent improvement in cash flows from operations since FY16
Until FY16, domestic operations had FY17 onwards, consistent improvement in
200
higher share. As a result, amid higher Novelis operations provided stable growth
exposure to aluminum prices, OCF kept in operating profits
150 142
fluctuating
Rs in bn

100 84 86
67 66 70
50 47 31 19
(7)
0

-50
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before Wcap Changes W Cap Changes CFO
Source: Company, Centrum Broking

NWC on downward trend: HNDL’s net working capital (NWC) has been on a downward trend since FY16. Though debtors and
inventory days have largely been stable, other avenues of working capital financing aided the decline in NWC. Against an
average of 36 days over FY12-21, NWC stood at 25 days in FY21.
Exhibit 591: Net working capital on downward trend

NWC remained stable throughout cycle;


80 while since FY17 improved further
70
60
48 50
No of days

50 43
39 43
40 32
31
30 22 25
25
20
10
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

xxx

Please see Appendix for analyst certifications and all other important disclosures.
Hindalco (HNDL) 16 September 2021
Capacity expansions and acquisitions led to poor conversion of operating cash to free cash: HNDL expanded aluminum
capacity in India till FY16 (aluminium capacity by 718ktpa and alumina capacity by 1.6mtpa), leading to negative free cash flows
during FY12-15. With focus turning to capacity expansion in Novelis through its internal accurals, we observe positive free cash
flows during FY16-20. In FY21, it acquired Aleris, leading to negative free cash flows. Against CFO of Rs607bn over FY12-21,
HNDL incurred capex of Rs672bn and invested Rs195bn in acquiring new assets. This led to negative FCF of Rs240bn over this
period, which was funded by debt. Net debt increased by Rs149bn from Rs329bn in FY12 to Rs478bn in FY21.
Exhibit 592: Capacity expansions and acquisitions led to poor conversion of operating cash to free cash flows
200 Until FY17, moderate CFO and high
150 expansion and acquisition cost resulted
100 in negative FCF
61.5
26.5 3…
50 24.3
Rs bn

0 19.4
-50 (38.6)
(76.5) (62.0)
-100 FCF remained positive since FY16, but Aleris (108.1)
(124.1)
-150 acquisition in FY21 led to negative FCF
-200
-250
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition Net FCF
Source: Company, Centrum Broking

Returns from acquisitions weak: Novelis acquired Aleris (similar business model) at an EV of ~USD2.6bn, which generated an
EBITDA of ~USD200mn (calculated EBIT of ~USD60mn) in FY21, the first year of acquisition. It thereby generated ~2.5% RoCE,
which is much lower than the average RoCE of ~14% generated by Novelis.
Exhibit 593: Besides internal accruals, capex largely debt-funded
200 Raised Rs22bn via warrants Purchased Aleris in FY21 at
Raised Rs33bn via QIP USD2.6bn
143 to promoters
150 @Rs189.45/share in FY17
@Rs144.35/share in FY14 113
90
Rs in bn

100 57
49
50 28

0
-50 (25) (14)
(36)
-100
-150 (123)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
FCF Increase/Decrease in Debt Inflow from equity raise/Outflow from buyback
Source: Company, Centrum Broking

Raised equity twice in last 10 years; Net Debt/EBITDA peaked in FY16: HNDL has raised equity of ~Rs49bn since FY14 (Rs16bn
by issuing warrants to promoters in FY14 and ~Rs33bn via QIP in FY17). The gap in free cash flows was largely funded via debt,
but we observe Net Debt/EBITDA peaked out in FY16. Novelis continues to generate free cash flows despite organic expansion,
except in FY21, when it bought Aleris.
Exhibit 594: Net Debt/EBITDA peaked at 6.3x in FY16 and has declined to 2.7x in FY21
Leverage Ratio (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA 4.1 5.9 6.4 6.5 6.3 3.7 2.9 2.5 2.7 2.7 4.4
Source: Company, Centrum Broking

Return ratios poor due to low aluminum prices: HNDL’s consolidated return ratios remain poor (average RoCE of ~10% over
FY17-21 and 8.3% over FY12-21) due to low aluminum prices, though Novelis generated average RoCE of ~14% during FY17-
21, with improved profitability.
Exhibit 595: Standalone return ratios poor due to low aluminum prices
Standalone (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 8.0 6.0 5.0 3.6 2.9 3.1 4.8 5.1 2.1 2.8 4.4
ROCE 7.1 4.7 4.6 5.1 4.8 6.0 6.2 5.1 3.9 4.4 5.2
Source: Company, Centrum Broking *ROCE is pre tax

Exhibit 596: Novelis pulls up overall consolidated return ratios


Consolidated (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 12.5 8.9 6.9 3.9 -1.0 4.4 8.5 9.8 7.0 9.1 7.0
ROCE 9.6 7.2 5.8 5.9 5.0 8.4 10.0 11.4 9.3 10.1 8.3
Source: Company, Centrum Research; *ROCE is pre tax

Centrum Institutional Research 220


Hindalco (HNDL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 1,305,423 1,181,440 1,319,850 1,643,342 1,790,670 Equity share capital 2,220 2,220 2,220 2,220 2,220
Operating Expense 883,075 779,660 852,280 1,101,119 1,216,105 Reserves & surplus 572,795 580,950 663,111 751,509 850,082
Employee cost 90,431 88,320 107,820 121,122 130,599 Shareholders fund 575,015 583,170 665,331 753,729 852,302
Others 176,919 169,400 183,270 182,598 191,016 Minority Interest 95 100 100 100 100
EBITDA 154,998 144,060 176,480 238,503 252,950 Total debt 524,153 672,570 659,780 607,784 555,788
Depreciation & Amortisation 47,662 51,910 67,400 71,223 73,965 Non Current Liabilities 87,535 109,340 111,850 111,850 111,850
EBIT 107,335 92,150 109,080 167,281 178,985 Def tax liab. (net) 45,260 46,710 44,930 44,930 44,930
Interest expenses 37,780 41,970 37,380 33,963 32,657 Total liabilities 1,232,057 1,411,890 1,481,991 1,518,394 1,564,970
Other income 11,271 11,900 12,220 18,703 16,201 Gross block 1,031,410 1,106,960 1,206,930 1,265,212 1,328,494
PBT 80,826 62,080 83,920 152,021 162,529 Less: acc. Depreciation (389,560) (446,290) (498,440) (563,178) (630,352)
Taxes 25,881 21,570 27,230 46,534 49,899 Net block 641,850 660,670 708,490 702,034 698,142
Effective tax rate (%) 32.0 34.7 32.4 30.6 30.7 Capital WIP 39,750 76,100 100,130 117,130 132,130
PAT 54,945 40,510 56,690 105,486 112,631 Net fixed assets 899,782 969,570 1,105,170 1,115,714 1,126,822
Minority/Associates 5 40 50 50 50 Non Current Assets 28,240 22,880 29,970 28,290 30,770
Recurring PAT 54,950 40,550 56,740 105,536 112,681 Investments 51,357 30,910 76,700 76,700 76,700
Extraordinary items 0 2,840 4,920 0 0 Inventories 221,940 223,840 306,680 343,894 346,157
Reported PAT 54,950 43,390 61,660 105,536 112,681 Sundry debtors 113,890 93,450 129,590 151,566 147,213
Cash & Cash Equivalents 136,423 278,480 182,260 168,560 232,199
Ratios Loans & advances 577 550 470 470 470
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 67,512 66,500 57,280 62,190 66,477
Growth (%)
Trade payables 207,244 183,000 282,800 287,086 310,352
Revenue 13.3 (9.5) 11.7 24.5 9.0
Other current liab. 16,340 10,770 16,880 27,844 32,368
EBITDA 11.3 (7.1) 22.5 35.1 6.1 Provisions 72,840 89,620 115,320 122,932 127,990
Adj. EPS 28.0 (26.2) 39.9 86.0 6.8 Net current assets 243,918 379,430 261,280 288,819 321,807
Margins (%) Total assets 1,232,057 1,411,890 1,481,991 1,518,394 1,564,970
Gross 39.7 42.2 42.0 39.5 38.5
EBITDA 11.9 12.2 13.4 14.5 14.1 Cashflow
EBIT 8.2 7.8 8.3 10.2 10.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 4.2 3.4 4.3 6.4 6.3 Profit Before Tax 80,831 59,240 79,050 152,021 162,529
Returns (%) Depreciation & Amortisation 47,770 50,910 66,280 64,738 67,174
ROE 9.8 7.0 9.1 14.9 14.0 Net Interest 32,350 41,970 37,380 0 0
ROCE 7.4 5.8 6.3 9.6 9.8 Net Change – WC (16,865) (11,780) 14,040 (22,781) 59,769
ROIC 8.1 6.5 7.3 10.6 11.2 Direct taxes (18,883) (1,020) (12,560) (46,534) (49,899)
Turnover (days) Net cash from operations 119,795 126,650 179,120 147,444 239,574
Gross block turnover ratio (x) 1.3 1.1 1.1 1.3 1.3 Capital expenditure (59,719) (67,070) (55,170) (75,282) (78,282)
Debtors 30 32 31 31 30 Acquisitions, net 0 0 (195,240) 0 0
Inventory 61 69 73 72 70 Investments (3,136) (15,780) (27,750) 0 0
Creditors 58 60 64 63 61 Others 8,263 (160) 21,790 0 0
Net working capital 68 117 72 64 66 Net cash from investing (54,592) (83,010) (256,370) (75,282) (78,282)
Solvency (x) FCF 60,076 59,580 (71,290) 72,162 161,292
Net debt-equity 0.7 0.7 0.7 0.6 0.4 Issue of share capital 61 70 50 0 0
Interest coverage ratio 4.1 3.4 4.7 7.0 7.7 Increase/(decrease) in debt (14,443) 112,800 56,920 (51,996) (51,996)
Net debt/EBITDA 2.5 2.7 2.7 1.8 1.3 Dividend paid (3,229) (3,200) (2,220) (6,660) (6,660)
Per share (Rs) Interest paid (35,766) (40,160) (36,780) 0 0
Adjusted EPS 24.8 18.3 25.6 47.5 50.8 Others (1,236) (3,410) (66,790) 0 0
BVPS 259.0 262.7 299.7 339.5 383.9 Net cash from financing (54,613) 66,100 (48,820) (58,656) (58,656)
CEPS 46.2 41.6 55.9 79.6 84.1 Net change in Cash 10,590 109,740 (126,070) 13,506 102,636
DPS 1.2 1.0 3.0 3.0 3.0 Source: Company, Centrum Broking
Dividend payout (%) 4.8 5.1 10.8 6.3 5.9
Valuation (x)
P/E 19.5 26.5 18.9 10.2 9.5
P/BV 1.9 1.8 1.6 1.4 1.3
EV/EBITDA 5.5 4.2 7.3 6.3 5.5
Dividend yield (%) 0.2 0.2 0.6 0.6 0.6
Source: Company, Centrum Broking

Centrum Institutional Research 221


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Hindustan Zinc (HZ) Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

HZ, being a cash rich company, recorded robust OCF in the last decade, thanks to low Market data
cost of production for zinc. Net working capital has been negative since FY16, with Current price: Rs335
tight control on inventories and very low debtors. Cash conversion ratio has been Bloomberg: HZ IN
good in the last decade, with average OCF/EBITDA of 79% during FY12-21. The entire 52-week H/L: Rs362/197
capex of ~Rs224bn during FY12-21 has been funded via cash flows and HZ has not
Market cap: Rs1415.1bn
raised any equity. HZ started paying higher dividend (sometimes higher than free cash
flows) from FY16, which led net cash to decline to Rs36/share in FY21 from Rs42/share Free float: 5.5%
in FY12 and Rs83/share in FY16. Due to higher profitability, return ratios were high, Avg. daily vol. 3mth: 1,185,589
with average RoE of 22% and RoCE of 26% over FY12-21. Source: Bloomberg

Robust cash flows from operations in last 10 years: HZ’s focus on cost control helped it to consistently improve OCF, despite
fluctuating commodity prices (zinc, lead and silver). Due to absence of debt and tight control on working capital, it generated
OCF of ~Rs689bn during FY12-21. Cash conversion ratio has remained high in the last decade (average of 79% over FY12-21).
Exhibit 597: Robust cash flows from operations due to low cost of production for zinc
140 Consistent improvement in OCF, barring FY20,
hit by lower prices
120
100 96 103
86
Rs in bn

74
80 65
55 64
60 54
45 48
40
20
0
-20 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before Wcap Changes W Cap Changes CFO


Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital (NWC) has been negative since FY16. Tight control on debtors,
stable inventory days, coupled with other short-term financing helped maintain consistent negative working capital since FY16.
Exhibit 598: Negative net working capital since FY16; 10-year average NWC at -67 days
50

0 5
10 6
FY12 4 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -43
No of Days

-50
-65 -56
-100
-117
-150
-167
-200

-250 -248

-300
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Hindustan Zinc (HZ) 16 September 2021

Exhibit 599: OCF/EBITDA - Robust cash conversion ratio Exhibit 600: OCF/PAT at an average of 90% over FY12-21
120
97 140 129
100 88
79 80 120 106 108
74 74 76 78 95
80 73 73 89
100
81 79 79
60 80 69 67
%

%
60
40
40
20 20
0 0
FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Low capex, no acquisition led to healthy free cash flows over FY12-21: During FY12-21, HZ spent ~Rs224bn to expand zinc
mine capacity from 1mtpa to 1.2mtpa and silver capacity from ~180ktpa to 800ktpa. The entire capex was funded by internal
accruals. In the absence of acquisitions, it generated high cash flows. It generated free cash flows of Rs465bn during FY12-21.
Exhibit 601: Low capex, no acquisition led to healthy free cash flows
120 Increasing OCF helped to fund capex from internal accruals and generate high FCF throughout the decade
100 79
68
80 54 52
49
60 37 39
Rs in bn

28 30 28
40
20
0
-20
-40
-60
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Acquisition & Investments Net FCF


Source: Company, Centrum Broking

No equity raised in last 10 years; higher dividend from FY16 to support parent – net cash has declined: HZ has not raised any
equity from the market ever. Being cash rich, it started paying higher dividend from FY16 to support the ultimate parent
company, Vedanta Resources. During FY12-21, it paid ~Rs660bn dividend (Rs136.4/share), of which Rs593bn (Rs123/share)
was paid during FY16-21. This led net cash to decline to Rs159bn (Rs38/share) in FY21 from Rs179bn (Rs42/share) in FY12 and
Rs353bn (Rs83/share) in FY16.
Exhibit 602: High dividend payout since FY16 to support parent Exhibit 603: Net cash/share has declined
200 100
83
80 73
150 60 57
60 51 53 51
Rs/share

42
Rs in bn

100 40 36
40
50 20

0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Dividend Paid FCF Net cash/share (Rs)
Source: Company, Centrum Broking Source: Company, Centrum Broking
Return ratios healthy: HZ’s return ratios remain healthy (average RoCE of ~26% and RoE of 22% over FY12-21) due to higher
operating profits, which in turn were due to low cost of zinc production and higher average zinc prices (USD2,293/t during
FY12-21) coupled with increase in silver production.
Exhibit 604: Return ratios healthy – 10-year average RoE at 22%, RoCE at 26.2%
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 22.4 23.3 19.8 20.1 19.9 24.4 27.1 22.9 18.4 22.0 22.0
ROCE* 28.2 26.5 23.0 23.5 21.1 27.3 33.5 29.3 22.1 27.3 26.2
Source: Company, Centrum Broking, *ROCE is pre tax

Centrum Institutional Research 223


Hindustan Zinc (HZ) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 211,180 185,610 226,290 276,140 273,415 Equity share capital 8,451 8,450 8,450 8,450 8,450
Operating Expense 48,990 42,500 52,760 63,002 61,980 Reserves & surplus 327,600 394,650 314,680 330,246 344,203
Employee cost 9,050 6,890 7,600 7,980 8,379 Shareholders fund 336,051 403,100 323,130 338,696 352,653
Others 46,440 47,750 49,160 49,336 47,935 Minority Interest 0 0 0 0 0
EBITDA 106,700 88,470 116,770 155,821 155,121 Total debt 25,380 6,110 71,770 71,770 71,770
Depreciation & Amortisation 18,830 22,790 25,310 26,322 27,639 Non Current Liabilities 9,640 10,900 10,440 10,440 10,440
EBIT 87,870 65,680 91,460 129,499 127,482 Def tax liab. (net) 0 0 0 0 0
Interest expenses 1,130 1,120 3,860 3,600 3,300 Total liabilities 371,071 420,110 405,340 420,906 434,863
Other income 17,820 19,340 18,190 14,500 14,500 Gross block 256,580 292,790 318,470 355,820 367,420
PBT 104,560 83,900 105,790 140,399 138,682 Less: acc. Depreciation (109,900) (130,620) (154,000) (180,322) (207,961)
Taxes 25,000 15,850 25,940 40,327 40,218 Net block 146,680 162,170 164,470 175,498 159,459
Effective tax rate (%) 23.9 18.9 24.5 28.7 29.0 Capital WIP 22,540 24,890 19,220 4,220 19,220
PAT 79,560 68,050 79,850 100,072 98,464 Net fixed assets 170,320 189,580 187,300 183,328 182,289
Minority/Associates 0 0 0 0 0 Non Current Assets 19,291 13,820 13,710 19,464 19,277
Recurring PAT 79,560 68,050 79,850 100,072 98,464 Investments 0 0 0 0 0
Extraordinary items 0 0 0 (1,340) 0 Inventories 15,440 18,350 14,250 19,670 19,476
Reported PAT 79,560 68,050 79,850 98,732 98,464 Sundry debtors 1,960 4,010 4,060 3,783 3,745
Cash & Cash Equivalents 195,110 222,470 223,330 228,626 243,921
Ratios Loans & advances 30 20 20 20 20
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 3,180 3,280 4,020 4,020 4,020
Growth (%)
Trade payables 11,740 14,880 15,450 12,105 11,985
Revenue (4.4) (12.1) 21.9 22.0 (1.0)
Other current liab. 39,580 32,440 33,960 33,960 33,960
EBITDA (13.0) (17.1) 32.0 33.4 (0.4) Provisions 2,190 2,320 2,520 2,520 2,520
Adj. EPS (12.0) (14.5) 17.3 25.3 (1.6) Net current assets 162,210 198,490 193,750 207,534 222,717
Margins (%) Total assets 371,071 420,110 405,340 420,906 434,863
Gross 100.3 101.6 98.9 100.0 100.0
EBITDA 50.5 47.7 51.6 56.4 56.7 Cashflow
EBIT 41.6 35.4 40.4 46.9 46.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 37.7 36.7 35.3 35.8 36.0 Profit Before Tax 104,560 83,900 105,740 140,399 138,682
Returns (%) Depreciation & Amortisation 18,830 22,790 25,310 26,322 27,639
ROE 22.9 18.4 22.0 30.2 28.5 Net Interest (6,880) (8,760) (5,550) 0 0
ROCE 22.3 17.9 20.6 25.5 24.1 Net Change – WC 6,710 (11,170) 6,380 (14,242) 299
ROIC 44.0 30.2 38.5 52.2 50.0 Direct taxes (25,600) (11,350) (17,550) (27,812) (27,736)
Turnover (days) Net cash from operations 87,810 66,210 105,670 124,668 138,883
Gross block turnover ratio (x) 0.8 0.6 0.7 0.8 0.7 Capital expenditure (33,410) (36,180) (24,270) (22,350) (26,600)
Debtors 3 6 7 5 5 Acquisitions, net 0 0 0 0 0
Inventory 25 33 26 22 26 Investments 19,960 4,510 71,930 0 0
Creditors 18 26 24 18 16 Others 2,530 5,230 (72,010) 0 0
Net working capital 280 390 313 274 297 Net cash from investing (10,920) (26,440) (24,350) (22,350) (26,600)
Solvency (x) FCF 54,400 30,030 81,400 102,318 112,283
Net debt-equity (0.5) (0.5) (0.5) (0.5) (0.5) Issue of share capital 0 0 0 0 0
Interest coverage ratio 94.4 79.0 30.3 43.3 47.0 Increase/(decrease) in debt 25,360 (19,240) 65,240 0 0
Net debt/EBITDA (1.6) (2.4) (1.3) (1.0) (1.1) Dividend paid (119,580) 0 (159,717) (84,506) (84,506)
Per share (Rs) Interest paid (2,080) (1,700) (2,440) 0 0
Adjusted EPS 18.8 16.1 18.9 23.7 23.3 Others 0 (40) (50) 0 0
BVPS 79.5 95.4 76.5 80.2 83.5 Net cash from financing (96,300) (20,980) (96,967) (84,506) (84,506)
CEPS 23.3 21.5 24.9 29.9 29.8 Net change in Cash (19,410) 18,790 (15,647) 17,811 27,776
DPS 20.0 0.0 37.8 20.0 20.0 Source: Company, Centrum Broking
Dividend payout (%) 106.2 0.0 200.0 85.6 85.8
Valuation (x)
P/E 17.8 20.8 17.7 14.1 14.4
P/BV 4.2 3.5 4.4 4.2 4.0
EV/EBITDA 9.4 5.0 10.2 8.1 8.0
Dividend yield (%) 6.0 0.0 11.3 6.0 6.0
Source: Company, Centrum Broking

Centrum Institutional Research 224


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Jindal Stainless (JDSL) Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

JDSL, after being debt trapped while expanding capacities post FY08, narrowly Market data
escaped bankruptcy by restructuring debt twice (partly converted into equity) during Current price: Rs167
FY10-15 and demerging its businesses. Finally, with improving financials, it came out Bloomberg: JDSL IN
of corporate debt restructuring (CDR) in FY20. It managed its financials well since 52-week H/L: Rs174/39
FY18, with improving OCF and no major capex. Improving macro, efficient working
Market cap: Rs81.4bn
capital management, cost rationalization, and debt restructuring helped it to
overcome the crisis. Consistent deleveraging via free cash flows and equity raising Free float: 31.9%
helped reduce net debt to Rs30.6bn (Net Debt/EBITDA: 2.2x) in FY21 from Rs58.4bn Avg. daily vol. 3mth: 4,573,207
(Net Debt/EBITDA: 5.1x) in FY17. Average return ratios, however, have been poor. Source: Bloomberg

OCF improves from FY18 after restructuring of businesses: While it generated negative OCF during FY12-15, JDSL’s businesses
were demerged into different entities in FY16 as part of asset monetization plan, which was to help JDSL to get out of CDR. We
have seen consistent improvement in OCF from FY18 onwards, with debottlenecking of capacities and improvement in working
capital. Average cash conversion ratio (OCF/EBITDA) has improved since FY18 (average of 68% during FY18-21).
Exhibit 605: OCF improved from FY18 after demerger of businesses into different entities

50000 42,515 50,000

40000 40,000

30000 30,000
Rs in mn

20000 20,000
8,198 9,574 9,674
6,788
10000 10,000

0 0
-4,247 -1,680 -2,337 -3,939 75
-10000 -10,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before Wcap Changes W Cap Changes CFO
Source: Company, Centrum Broking

Consistent decline in working capital from FY18: JDSL has managed its working capital well since FY18. It took measures such
as reducing receivables (focusing more on domestic sales) and inventory days (reducing scrap purchases from US and Europe,
and focusing on sourcing from South East Asia), which helped keep net working capital low (average 16 days over FY18-21).
Exhibit 606: Working capital cycle has consistently improved since FY17
300 274

250 210
200
Days

150
99
67 64
100 60
50 22 18 12 13

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

ource: Co mpany, C ent rum Researchxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Jindal Stainless (JDSL) 16 September 2021
Exhibit 607: Cash conversion cycle has improved since FY17
400 369.6

300

200
62.5 82.2 59.6 67.9
100
1.3
0

-100 (44.8) (23.7) (23.1)


(108.3)
-200
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF/EBITDA (%)
Source: Company, Centrum Broking

With no major expansion, JDSL turned free cash flow positive from FY18: JDSL’s FY17 financials depicted the effect of
demerger. It started receiving benefits of fully ramped up SS capacity from FY18. Since then, with incremental OCF and limited
capex, it used its entire free cash flows for debt reduction. Post demerger, almost its entire capex was for maintenance (Rs7.5bn
during FY18-21). As a result, it has generated positive free cash flows of Rs27bn during FY18-21, which was used to deleverage
the balance sheet. JDSL also raised equity by issuing warrants to promoters and Kotak Special Situation Fund in FY21. Net debt
decreased from Rs58bn in FY17 to Rs30.7bn in FY21 (down ~Rs28bn).
Exhibit 608: Capex intensity has moderated; positive free cash flows after demerger of businesses in FY16
50000 41,931
40000
30000
Rs in mn

20000
6,176 7,517 8,050
10000 5,043

0
-10000 -2,449 -3,911 -3,916 -1,600

-20000 -13,288
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition Net FCF
Source: Company, Centrum Broking

Debt peaked in FY17; deleveraging since then: As JDSL demerged its businesses into different entities, restructured its loans
by partly converting into equity, the debt on its book was Rs58bn at FY17-end. It started receiving benefits of fully ramped up
SS capacity from FY18. Since then, with incremental CFO and limited capex on maintenance only, it used its entire free cash
flows for debt reduction. Net debt decreased from Rs58bn in FY17 to Rs30.7bn in FY21 (down ~Rs28bn).
Exhibit 609: On course of deleveraging since FY17; against a 10-year average of 10.5x, Net Debt/EBITDA was 2.2x in FY21
Leverage Ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA 10.3 16.0 11.4 30.8 18.0 5.1 3.8 3.7 3.4 2.2 10.5
Source: Company, Centrum Broking

Return ratios poor in last 10 years: JDSL was a loss-making company during FY13-16. Post restructuring of businesses, it started
generating profits, but return ratios have been poor and depend on macro conditions.
Exhibit 610: Return ratios improving; profit-making company since FY17
Consolidated (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 2.3 (38.5) (135.5) (81.4) (26.2) 3.2 15.8 5.6 2.5 10.7 -24.1
ROCE* 4.8 0.0 2.7 0.1 2.2 8.8 14.0 11.7 11.1 16.3 7.2
Source: Company, Centrum Broking, *ROCE is pre-tax

Centrum Institutional Research 226


Jindal Stainless (JDSL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 134,008 127,584 119,870 163,384 157,536 Equity share capital 958 975 975 1,051 1,051
Operating Expense 101,173 96,031 86,559 122,271 118,496 Reserves & surplus 24,950 26,198 31,077 43,952 53,780
Employee cost 2,119 2,045 1,779 1,853 1,931 Shareholders fund 25,908 27,172 32,051 45,003 54,831
Others 20,636 20,038 19,305 21,283 21,870 Minority Interest 117 130 133 133 133
EBITDA 11,646 11,395 14,242 20,429 17,635 Total debt 43,877 39,029 31,817 26,817 21,817
Depreciation & Amortisation 3,515 4,252 4,030 4,035 4,329 Non Current Liabilities 3,773 4,433 4,058 4,058 4,058
EBIT 8,131 7,143 10,212 16,393 13,306 Def tax liab. (net) 1,323 1,903 4,610 4,610 4,610
Interest expenses 6,369 5,855 4,801 3,323 2,948 Total liabilities 74,998 72,668 72,669 80,620 85,449
Other income 326 399 409 386 386 Gross block 77,997 80,548 81,374 84,124 86,874
PBT 2,088 1,687 5,821 13,457 10,743 Less: acc. Depreciation (14,845) (19,064) (23,094) (27,129) (31,457)
Taxes 766 926 2,702 4,714 3,764 Net block 63,152 61,484 58,281 56,996 55,417
Effective tax rate (%) 36.7 54.9 46.4 35.0 35.0 Capital WIP 235 126 527 527 527
PAT 1,322 760 3,118 8,743 6,979 Net fixed assets 63,739 61,956 59,136 57,851 56,272
Minority/Associates 97 (92) 50 50 50 Non Current Assets 1,067 2,097 2,472 2,472 2,472
Recurring PAT 1,419 669 3,168 8,792 7,029 Investments 4,534 4,460 4,552 4,604 4,656
Extraordinary items 7 44 1,024 0 0 Inventories 24,146 27,390 27,886 29,489 33,411
Reported PAT 1,426 713 4,192 8,792 7,029 Sundry debtors 9,194 7,052 9,339 9,683 10,971
Cash & Cash Equivalents 456 712 1,169 12,207 17,750
Ratios Loans & advances 79 52 32 32 32
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 3,931 3,058 2,759 3,593 4,420
Growth (%)
Trade payables 24,883 26,596 26,319 31,259 35,416
Revenue 16.7 (4.8) (6.0) 36.3 (3.6)
Other current liab. 7,259 7,503 8,335 8,029 9,096
EBITDA (11.2) (2.2) 25.0 43.4 (13.7) Provisions 6 9 22 22 22
Adj. EPS (58.1) (53.7) 373.7 157.3 (20.1) Net current assets 5,658 4,156 6,509 15,693 22,049
Margins (%) Total assets 74,998 72,668 72,669 80,620 85,449
Gross 32.7 34.3 36.5 33.0 33.0
EBITDA 8.6 8.8 11.7 12.3 11.0 Cashflow
EBIT 6.0 5.5 8.4 9.9 8.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 1.0 0.5 2.6 5.3 4.4 Profit Before Tax 2,217 1,653 6,897 13,457 10,743
Returns (%) Depreciation & Amortisation 3,515 4,252 4,030 4,035 4,329
ROE 5.6 2.5 10.7 22.8 14.1 Net Interest 6,261 5,632 4,587 0 0
ROCE 7.4 5.0 8.7 16.0 12.0 Net Change – WC 3,150 (59) (1,806) 2,993 (1,052)
ROIC 7.6 5.1 9.2 18.8 15.8 Direct taxes (27) 49 115 (1,645) (967)
Turnover (days) Net cash from operations 14,187 11,804 13,078 18,840 13,053
Gross block turnover ratio (x) 1.7 1.6 1.5 1.9 1.8 Capital expenditure (2,058) (1,746) (1,625) (2,750) (2,750)
Debtors 25 23 25 21 24 Acquisitions, net 0 0 0 0 0
Inventory 65 73 83 63 72 Investments 0 (211) (67) 0 0
Creditors 62 73 79 63 76 Others 133 79 172 0 0
Net working capital 15 12 20 35 51 Net cash from investing (1,925) (1,878) (1,520) (2,750) (2,750)
Solvency (x) FCF 12,129 10,058 11,453 16,090 10,303
Net debt-equity 1.7 1.4 1.0 0.3 0.1 Issue of share capital 0 286 537 1,088 0
Interest coverage ratio 1.8 1.9 3.0 6.1 6.0 Increase/(decrease) in debt (7,759) (5,138) (8,320) (5,000) (5,000)
Net debt/EBITDA 3.7 3.4 2.2 0.7 0.2 Dividend paid 0 0 0 0 0
Per share (Rs) Interest paid (4,612) (5,015) (3,403) 0 0
Adjusted EPS 3.0 1.4 6.5 16.7 13.4 Others 0 (40) 0 0 0
BVPS 54.1 55.8 65.8 85.6 104.3 Net cash from financing (12,372) (9,908) (11,186) (3,912) (5,000)
CEPS 10.3 10.1 14.8 24.4 21.6 Net change in Cash (110) 18 372 12,178 5,303
DPS 0.0 0.0 0.0 0.0 0.0 Source: Company, Centrum Broking
Dividend payout (%) 0.0 0.0 0.0 0.0 0.0
Valuation (x)
P/E 56.5 122.0 25.7 10.0 12.5
P/BV 3.1 3.0 2.5 2.0 1.6
EV/EBITDA 5.4 4.4 4.5 5.0 5.2
Dividend yield (%) 0.0 0.0 0.0 0.0 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 227


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Jindal Steel and Power (JSP) Research Associate, Metals & Mining
+91 22 4215 9375
[email protected]

JSP’s business dynamics changed post FY15, with de-allocation of its captive coal Market data
block. It managed its financials well and narrowly escaped bankruptcy. Efficient Current price: Rs395
working capital management, cost rationalization and debt restructuring helped it to Bloomberg: JSP IN
overcome the crisis. Consistent deleveraging via free cash flows, equity raising in FY18 52-week H/L: Rs502/160
and sale of its overseas subsidiaries in FY21 helped it to reduce net debt to Rs221bn
Market cap: Rs403bn
(Net Debt/EBITDA: 1.5x) in FY21 from Rs461bn (Net Debt/EBITDA: 13.6x) in FY16.
While its investment in Indian assets is remunerative, its investments in overseas Free float: 39.5%
mining assets remain a drag on profitability. After recording net losses from FY16 to Avg. daily vol. 3mth: 10,542,120
FY20, it came back to profits in FY21 and now has a strong balance sheet. Source: Bloomberg

OCF has improved after falling sharply in FY15: As JSP’s captive coal was de-allocated by GoI and penalty got imposed, it
recorded negative OCF in FY15. It was on the verge of bankruptcy, as it was expanding then. With continuous release of working
capital (like lower inventory, debtors, issuing export advances, etc), it narrowly escaped bankruptcy. Thereafter, OCF improved
consistently, with incremental volumes from FY19. The crisis could have been of lower magnitude, but JSP was also adversely
affected by its overseas operations and power business. Cash conversion ratio (OCF/EBITDA) has improved since FY17 (average
of 61% during FY17-21).
Exhibit 611: OCF has improved consistently, with incremental volumes from FY19
150 Incremental volumes from FY19 led to
During FY15, JSP's captive coal was
consistent improvement in CFO
deallocated and penalty was imposed,
100 which resulted in negative CFO 97
Rs in bn

52
50 45
31 38 27 30
14 7
0

-23
-50
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before Wcap Changes W Cap Changes CFO
Source: Company, Centrum Broking

Consistent decline in working capital since FY17: JSP has managed its working capital well since FY17. It took measures such
as buying its major raw material, coking coal on credit, taking export advances to sell steel, etc. These have helped keep net
working capital low (<20 days) for JSP in the last two years.
Exhibit 612: Working capital cycle improving since FY17
140
130 SInce FY17, JSP managed to keep NWC
120 123 low (FY20 and FY21 <20 days)
100 108
94 92
No of Days

80
60 61 60
40 30
20 17 17
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Recievable Days Inventory Days Payable Days NWC


Source: Company, Centrum Broking

xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Jindal Steel and Power (JSP) 16 September 2021
Exhibit 613: Cash conversion ratio has improved in the second half of the decade
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF/EBITDA (%) 46 23 70 -42 22 62 47 54 76 67
Source: Company, Centrum Broking

With no major expansion, JSP turned free cash flow positive since FY16; overseas mining investment a drag: JSP’s 5mtpa
Angul plant was commissioned in phases, with full commissioning in December 2018. Since then, with incremental CFO and
limited capex, it used its entire free cash flows for debt reduction. During FY12-21, it incurred capex of Rs470bn to set up a
2,400MW merchant power plant and a 5mtpa steel plant. As a result, it has generated negative free cash flows of Rs151bn
during FY12-21 (positive free cash flows of Rs162bn during FY17-21). JSP’s Indian entity has been servicing overseas debt for
years and had debt of ~Rs65bn in overseas subsidiaries in FY21. JSP has funded its capex via debt and internal cash flows and
raised ~Rs12bn in FY18 via QIP. Net debt increased from Rs169bn in FY12 to Rs221bn in FY21 (up ~Rs52bn).
Exhibit 614: Capex intensity has moderated; no acquisitions in last 10 years – positive free cash flows since FY16

Incremental OCF from FY17 and


FCF until FY16 remained negative limited capex helped FCF to turn
150 owing to high capex to set up steel positive 100
88
100 and power plant
36 50
30
50 2 5
0 0
Rs in bn

-50 -50
-100 -34 -32
-70 -74
-104 -100
-150
-200 -150
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition Net FCF (RHS)
Source: Company, Centrum Broking

Overseas acquisitions non-remunerative: JSP acquired a steel business in Oman in CY20 at USD500mn. It developed the plant
and put up a 2mtpa long steel mill, and finally sold it to a group company at ~USD750mn in FY21. This business was financially
self-sustainable but could not add value to JSP. Besides this, JSP’s investment in mining assets overseas (Australia, South Africa,
Mozambique) remains a drag, with nil contribution to operating earnings.
Debt peaked in FY16; on course of deleveraging since then: The de-allocation of coal blocks and penalty of Rs295/t on coal
extracted till September 2014 (~Rs30.9bn) by the Supreme Court hit JSP’s profitability in FY15. It narrowly escaped
bankruptcy. Since then, JSP’s focus has been to deleverage the balance sheet, which it has managed to do by improving cash
flows, restricting capex, and monetizing the Oman business in FY21.
Exhibit 615: Debt peaked in FY16 – against 10-year average of 6.3x, Net Debt/EBITDA was 1.5x in FY21
Leverage Ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA 2.5 4.1 6.5 7.9 13.6 10.4 6.6 4.7 5.3 1.5 6.3
Source: Company, Centrum Broking

Return ratios poor in last 10 years: JSP has revalued its assets and inflated equity by ~Rs165bn in FY15. In addition to that, it
was making losses till FY19 and started generating profits only from FY20. No operating earnings from overseas subsidiaries
and underutilization of power assets (operating at <50% PLF) drag its overall return ratios.
Exhibit 616: Return ratios (%)
Consolidated FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 25.3 15.2 8.6 1.0 -8.3 -6.9 -3.4 3.6 0.0 14.9 5.0
ROCE* 17.4 11.2 6.9 4.1 -0.6 0.9 3.5 5.9 4.9 18.0 7.2
Source: Company, Centrum Broking, *ROCE is pre-tax

Centrum Institutional Research 229


Jindal Steel and Power (JSP) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 392,202 304,646 389,886 498,410 402,106 Equity share capital 968 1,020 1,020 1,020 1,020
Operating Expense 276,345 205,555 236,445 298,680 264,856 Reserves & surplus 319,879 320,351 317,127 412,705 476,744
Employee cost 10,719 9,133 8,999 8,540 8,894 Shareholders fund 320,847 321,371 318,147 413,725 477,764
Others 22,602 21,812 0 23,986 12,157 Minority Interest (5,261) (7,764) (8,777) (8,777) (8,777)
EBITDA 82,537 68,147 144,443 167,204 116,199 Total debt 395,590 368,244 293,095 173,095 97,095
Depreciation & Amortisation 41,938 34,289 34,533 24,384 25,064 Non Current Liabilities 7,507 16,190 11,542 11,542 11,542
EBIT 40,599 33,858 109,909 142,820 91,135 Def tax liab. (net) 53,643 56,226 62,394 66,169 66,169
Interest expenses 42,642 37,679 30,933 18,215 4,747 Total liabilities 772,326 754,267 676,401 655,753 643,792
Other income 1,676 262 5,389 0 0 Gross block 840,996 883,559 764,653 675,653 703,653
PBT (367) (3,559) 84,365 124,605 86,388 Less: acc. Depreciation (171,086) (211,373) (245,906) (270,290) (295,355)
Taxes (3,902) 1,085 17,687 32,802 22,349 Net block 669,910 672,186 518,747 405,363 408,298
Effective tax rate (%) 1,062.6 30.5 21.0 26.3 25.9 Capital WIP 29,055 19,745 8,903 32,903 64,903
PAT 3,535 (4,643) 66,678 91,803 64,039 Net fixed assets 730,668 725,071 560,612 471,228 506,164
Minority/Associates 7,662 4,645 (18,934) 0 0 Non Current Assets 14,788 11,009 13,159 15,989 13,478
Recurring PAT 11,196 2 47,744 91,803 64,039 Investments 1,452 1,430 1,443 1,443 1,443
Extraordinary items (27,650) (1,094) (11,409) 0 0 Inventories 65,095 63,687 59,426 81,930 62,795
Reported PAT (16,453) (1,092) 36,336 91,803 64,039 Sundry debtors 30,285 35,493 27,944 35,503 28,643
Cash & Cash Equivalents 4,266 9,438 71,635 109,153 82,700
Ratios Loans & advances 4,612 4,226 3,463 4,427 3,572
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 38,843 47,066 40,723 59,941 49,387
Growth (%) Trade payables 52,043 55,671 40,383 51,623 41,649
Revenue 40.4 (22.3) 28.0 27.8 (19.3) Other current liab. 64,422 86,506 60,799 71,417 61,918
EBITDA 28.3 (17.4) 112.0 15.8 (30.5)
Provisions 1,218 976 822 822 822
Adj. EPS nm (100.0) NM 92.3 (30.2)
Net current assets 25,418 16,756 101,187 167,094 122,708
Margins (%)
Total assets 772,326 754,267 676,401 655,753 643,792
Gross 29.5 32.5 39.4 40.1 34.1
EBITDA 21.0 22.4 37.0 33.5 28.9 Cashflow
EBIT 10.4 11.1 28.2 28.7 22.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 2.9 0.0 12.2 18.4 15.9 Profit Before Tax (28,017) (4,652) 72,956 124,605 86,388
Returns (%) Depreciation & Amortisation 54,804 34,289 34,533 24,384 25,064
ROE 3.6 0.0 14.9 25.1 14.4 Net Interest 42,642 37,679 30,933 0 0
ROCE (56.4) 3.4 14.2 17.8 11.8 Net Change – WC 4,654 18,204 (26,846) (31,219) 20,443
ROIC (54.6) 3.4 14.5 21.1 14.2 Direct taxes 296 861 515 (29,027) (22,349)
Turnover (days) Net cash from operations 90,269 88,143 119,609 92,518 109,546
Gross block turnover ratio (x) 0.5 0.3 0.5 0.7 0.6 Capital expenditure (14,333) (15,403) (8,581) (30,000) (60,000)
Debtors 23 39 30 23 29 Acquisitions, net 0 0 0 0 0
Inventory 53 77 58 52 66 Investments (159) (1,252) (10,311) 0 0
Creditors 44 65 45 34 42 Others 6,171 1,899 50 95,000 0
Net working capital 24 20 95 122 111 Net cash from investing (8,321) (14,756) (18,842) 65,000 (60,000)
Solvency (x) FCF 75,936 72,740 111,028 62,518 49,546
Net debt-equity 1.2 1.1 0.7 0.2 0.0 Issue of share capital 0 77 0 0 0
Interest coverage ratio 1.9 1.8 4.7 9.2 24.5 Increase/(decrease) in debt (36,897) (37,199) (22,660) (120,000) (76,000)
Net debt/EBITDA 4.7 5.3 1.5 0.4 0.1 Dividend paid (18) (18) 0 0 0
Per share (Rs) Interest paid (45,699) (36,268) (22,735) (18,215) (4,747)
Adjusted EPS 11.6 0.0 46.8 90.0 62.8 Others 0 0 0 0 0
BVPS 331.5 315.1 311.9 405.6 468.4 Net cash from financing (82,614) (73,408) (45,394) (138,215) (80,747)
CEPS 54.9 33.6 80.7 113.9 87.4 Net change in Cash (666) (21) 55,373 19,304 (31,201)
DPS 0.0 0.0 0.0 0.0 0.0 Source: Company, Centrum Broking
Dividend payout (%) nm nm 0.0 0.0 0.0
Valuation (x)
P/E 34.1 nm 8.4 4.4 6.3
P/BV 1.2 1.3 1.3 1.0 0.8
EV/EBITDA 6.8 6.5 4.0 2.8 3.6
Dividend yield (%) 0.0 0.0 0.0 0.0 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 230


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
[email protected]
SECTOR: METALS & MINING
Kunal Kothari
Research Associate, Metals & Mining

JSW Steel (JSTL) +91 22 4215 9375


[email protected]

JSTL’s cost efficiencies, superior working capital management, and low capex cost/t Market data
have helped it to grow despite the absence of raw material integration. It has been Current price: Rs689
aggressive in capacity building and almost its entire expansion of ~16mtpa has been Bloomberg: JSTL IN
funded by internal cash flows and debt – it has had negative free cash flows 52-week H/L: Rs777/258
throughout the decade. Though JSTL’s debt remains on the higher side, it has
Market cap: Rs1666.6bn
managed its debt well and has not defaulted even during downturns in the last 10
years. Low cost expansion has kept its return ratios superior to its Indian competitors. Free float: 55.9%
Its incremental overseas exposure (US, Italy) has not succeeded so far, but as less Avg. daily vol. 3mth: 7,192,022
capital is involved, it is not significantly impacting overall return ratios. Source: Bloomberg

OCF fluctuates due to cyclicality: JSTL’s operating cash flows fluctuate with steel prices. However, with improvement in cost
efficiencies and volume growth, JSTL has been able to keep increasing OCF in the last decade, despite being a non-integrated
steel producer. Working capital management is strong – most of its coking coal purchases is via creditors, which has helped
keep its net working capital negative in most years during the last decade.
Exhibit 617: OCF fluctuates due to cyclicality

During FY12-21, OCF fluctuated amid steel price


200 volatility, but remained positive throughout the 160
cycle with consistent volume growth 144 140
150
120
108
100 100
Rs in bn

89 83 80
50 60
53
43 38 43 40
0
24 20
-50 2 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before Wcap Changes W Cap Changes CFO


Source: Company, Centrum Broking

Negative working capital, thanks to higher acceptances: JSTL manages its working capital well. It buys most of its major raw
material, coking coal, on credit. It buys coking coal from its group company, JSW International Trade Corp, which in turn buys
from global coking coal producers. Buying on credit helps keep working capital negative for JSTL.
Exhibit 618: Negative working capital cycle; 10-year average NWC at -22 days
150 JSTL managed NWC best in the industry. During FY12-21, NWC remained largely negative.

100
No of Days

50

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50 -27 -25 3 8 -4
-42 -41 -14 -33
-43
-100
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
JSW Steel (JSTL) 16 September 2021

Exhibit 619: OCF/EBITDA Exhibit 620: OCF/PAT

74 350 325
80 72
68 288
70 300
59 60 57
57 229
60 250
201
50 40 174 181
200
35
40 139 144

%
%

150 125
30
20 100
10 2 50 8
0 0
FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Growth-focused; negative free cash flows amid continuous capex: JSTL has been continuously expanding its steel capacities.
In the last 10 years, it has added steel capacity of ~16mtpa via organic/inorganic route. All its organic expansion (11.5mtpa)
has been brownfield; hence, capital cost has been low. On inorganic expansions, its strategy is to acquire companies under a
JV, ramp up profitability, and then merge it with itself. Therefore, acquisitions do not bloat JSTL’s balance sheet. It recently
acquired Monnet Ispat (~Rs29bn) and Bhushan Power and Steel (at Rs193bn) in a JV. Over FY12-21, it spent ~Rs770bn in
maintenance, capacity expansion and acquisitions via JV. With continuous expansion, JSTL delivered negative free cash flows
of ~Rs143bn during FY12-21. Net debt increased from Rs169bn in FY12 to Rs523bn in FY21, an increase of ~Rs353bn.
Exhibit 621: Negative free cash flows amid continuous capex
200
Despite improving OCF, JSTL’s continuous
150 expansion has resulted in negative FCF
100
38
50
Rs in bn

0
-50 -13 -12 -14 -2 -8 -14
-17
-56 -46
-100
-150
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Acquisition Net FCF


Source: Company, Centrum Broking

Overseas acquisitions a drag, Indian acquisitions remunerative: JSTL’s major acquisition after Ispat Industries in December
2010 is the acquisition of Bhushan Power & Steel (NCLT case) in March 2021. Ispat Industries’ profitability got into sync with
JSTL’s overall profitability and the acquisition has proved to be value accretive. However, its overseas acquisitions (US, Italy)
remain a drag and need continuous support from Indian operations.
Leverage has remained high: The fluctuating steel cycle, continuous expansion via organic/inorganic route, and support to
overseas operations have kept JSTL’s leverage high. While average Net Debt/Equity has been comfortable at 1.5x, Net
Debt/EBITDA has remained high throughout the decade. However, with sharp increase in profitability in FY21, Net Debt/EBITDA
fell to a comfortable level of 2.5x.
Exhibit 622: Leverage remains high; 10-year average Net Debt/EBITDA at 3.6x
Leverage Ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA 2.9 3.1 3.8 4.1 6.4 3.4 2.6 2.4 4.5 2.5 3.6
Source: Company, Centrum Broking

Return ratios higher than peers: JSTL has managed its return ratios well and RoE has been relatively high (11-25%) in the last
five years. Its continuous debt-funded capex keeps its RoCE low, but better than its peers.
Exhibit 623: Return ratios higher than peers; 10-year average RoE at 14.1%, RoCE at 12.7%
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 8.5 7.9 11.3 8.9 8.4 16.7 25.2 24.0 11.5 19.2 14.1
ROCE* 12.2 11.4 12.7 10.3 5.3 14.0 17.4 19.8 8.1 15.5 12.7
Source: Company, Centrum Broking, *ROCE is pre-tax

Centrum Institutional Research 232


JSW Steel (JSTL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 824,990 711,160 780,590 1,324,357 1,263,337 Equity share capital 2,417 2,400 2,410 2,410 2,410
Operating Expense 502,110 455,180 452,320 868,085 863,531 Reserves & surplus 346,203 374,860 469,030 684,082 847,298
Employee cost 24,890 28,390 25,060 47,678 47,815 Shareholders fund 347,950 365,990 467,640 682,692 845,908
Others 131,050 130,960 119,600 37,797 44,959 Minority Interest (4,500) (5,750) (6,190) (6,190) (6,190)
EBITDA 189,520 111,570 201,410 388,597 326,030 Total debt 514,750 624,170 620,810 570,810 520,810
Depreciation & Amortisation 40,410 42,460 46,790 55,200 55,790 Non Current Liabilities 9,320 27,140 36,000 36,000 36,000
EBIT 149,110 69,110 154,620 333,397 270,240 Def tax liab. (net) 38,940 16,770 35,090 58,383 76,359
Interest expenses 39,170 42,650 39,570 47,970 50,770 Total liabilities 906,460 1,028,320 1,153,350 1,341,695 1,472,887
Other income 2,040 5,460 5,920 5,730 5,230 Gross block 763,520 795,270 846,630 1,071,630 1,251,630
PBT 111,980 31,920 120,970 291,157 224,700 Less: acc. Depreciation (147,480) (182,980) (219,900) (275,100) (330,890)
Taxes 36,440 (9,060) 41,420 87,347 67,410 Net block 616,040 612,290 626,730 796,530 920,740
Effective tax rate (%) 32.5 28.4 34.2 30.0 30.0 Capital WIP 115,400 268,570 324,330 224,330 224,330
PAT 75,540 40,980 79,550 203,810 157,290 Net fixed assets 745,330 891,850 974,830 1,044,630 1,168,840
Minority/Associates (300) 210 390 15,883 7,976 Non Current Assets 48,970 48,090 64,090 64,090 64,090
Recurring PAT 75,240 41,190 79,940 219,693 165,266 Investments 18,120 12,570 85,730 75,357 70,981
Extraordinary items 0 (890) (830) 0 0 Inventories 145,480 138,640 142,490 250,358 238,823
Reported PAT 75,240 40,300 79,110 219,693 165,266 Sundry debtors 71,600 45,050 44,860 79,824 76,146
Cash & Cash Equivalents 62,690 120,050 128,210 213,047 228,537
Ratios Loans & advances 5,610 7,420 6,220 6,220 6,220
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 50,170 54,530 36,740 52,017 50,302
Growth (%)
Trade payables 161,590 179,180 152,430 258,614 246,699
Revenue 17.7 (13.8) 9.8 69.7 (4.6)
Other current liab. 79,750 109,090 174,650 174,650 174,650
EBITDA 28.1 (41.1) 80.5 92.9 (16.1) Provisions 1,340 1,610 2,740 10,584 9,704
Adj. EPS 18.0 (44.9) 93.3 174.8 (24.8) Net current assets 92,870 75,810 28,700 157,618 168,976
Margins (%) Total assets 906,460 1,028,320 1,153,350 1,341,695 1,472,887
Gross 50.8 47.8 60.9 50.9 48.5
EBITDA 22.4 15.4 25.2 29.0 25.4 Cashflow
EBIT 17.6 9.5 19.4 24.8 21.1 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 8.9 5.7 10.0 16.4 12.9 Profit Before Tax 111,680 30,130 120,150 291,157 224,700
Returns (%) Depreciation & Amortisation 40,410 42,460 46,790 55,200 55,790
ROE 24.0 11.5 19.2 38.2 21.6 Net Interest 34,480 34,850 32,640 0 0
ROCE 13.4 5.8 10.2 20.4 14.8 Net Change – WC (15,810) 16,390 12,640 (20,788) 22,108
ROIC 14.2 6.1 11.8 25.5 18.7 Direct taxes (26,300) (11,550) (19,300) (64,054) (49,434)
Turnover (days) Net cash from operations 146,330 127,850 187,890 261,514 253,164
Gross block turnover ratio (x) 1.1 0.9 0.9 1.2 1.0 Capital expenditure (101,620) (127,670) (92,070) (125,000) (180,000)
Debtors 26 29 21 17 22 Acquisitions, net (14,270) (640) (66,620) 0 0
Inventory 58 71 64 53 70 Investments 2,510 2,490 60 0 0
Creditors 69 86 76 56 72 Others (490) (70,040) 77,440 0 0
Net working capital 41 39 13 43 49 Net cash from investing (113,870) (195,860) (81,190) (125,000) (180,000)
Solvency (x) FCF 30,440 (460) 29,200 136,514 73,164
Net debt-equity 1.3 1.4 1.1 0.5 0.3 Issue of share capital 0 0 0 0 0
Interest coverage ratio 4.8 2.6 5.1 8.1 6.4 Increase/(decrease) in debt 66,540 114,700 16,740 0 0
Net debt/EBITDA 2.4 4.5 2.4 0.9 0.9 Dividend paid (9,330) (11,950) (4,830) (12,050) (12,050)
Per share (Rs) Interest paid (38,150) (45,200) (43,400) 0 0
Adjusted EPS 31.1 17.2 33.2 91.2 68.6 Others (1,530) (5,660) 390 0 0
BVPS 143.9 152.5 194.0 283.3 351.0 Net cash from financing 17,530 51,890 (31,100) (12,050) (12,050)
CEPS 47.8 34.9 52.6 114.1 91.7 Net change in Cash 49,990 (16,120) 75,600 124,464 61,114
DPS 4.1 2.0 6.5 5.0 5.0 Source: Company, Centrum Broking
Dividend payout (%) 13.2 11.9 19.8 5.5 7.3
Valuation (x)
P/E 22.1 40.2 20.8 7.6 10.1
P/BV 4.8 4.5 3.6 2.4 2.0
EV/EBITDA 6.1 7.7 7.7 5.2 6.0
Dividend yield (%) 0.6 0.3 0.9 0.7 0.7
Source: Company, Centrum Broking

Centrum Institutional Research 233


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

NMDC Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

NMDC, a net cash company, has been generating moderate to low operating cash Market data
flows over FY12-21 due to cyclicality. Cash conversion ratio remained moderate Current price: Rs152
throughout the decade, with average OCF/EBITDA of 60%. We observe, NWC days Bloomberg: NMDC IN
turn better during an upturn and worsen in a downturn. The entire capex of ~Rs214bn 52-week H/L: Rs213/76
(~85% on steel plant) during FY12-21 was funded via internal cash flows. NMDC has
Market cap: Rs445.7bn
been continuously paying higher dividend (paid Rs82.6/share during FY12-21), which
led net cash to decline to Rs19.8/share from Rs51/share in FY12. High statutory Free float: 31.7%
duties, high iron ore CoP and investment in steel plant led to its return ratios being Avg. daily vol. 3mth: 19,715,900
low (for a miner), with average RoE of 19% and RoCE of ~29% during FY12-21. Source: Bloomberg

Moderate cash flows from operations during FY12-21; hit by higher debtors since FY16: NMDC’s muted volume growth and
fluctuating profitability amid cyclicality (except for FY21), led it to generate moderate to low OCF throughout the cycle. We
observe NWC turns poor in a downturn (FY12-16) compared to an upturn (FY17-21). Receivables have remained relatively high
since FY16. Cash conversion ratio remained moderate in the last decade, with average OCF/EBITDA of 60% during FY12-21.
Exhibit 624: OCF has remained moderate throughout the decade
OCF remained moderate to low amid muted
100
volume growth and cyclicality throughout FY12-21
80
73.1
60
45.9 40.1 40.1
Rs in bn

40 37.2 33.1 33.4


30.9
21.1
20 20.4

-20
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-40
Operating profit before Wcap Changes W Cap Changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Due to delay in payments from RINL, NMDC’s receivable days were elevated
throughout FY13-21. Inventory has largely been stable at an average of 21 days. However, net working capital is on the higher
side (average 55 days during FY12-21).
Exhibit 625: Net working capital remains lumpy amid cyclicality; 10-year average NWC at 55 days

120 111
97 96 NWC turns poor in commodity downturn
100 (FY12-16) and improves in upturn (FY17-21)
No of Days

80
54 57 53
60 49 46 52
40 44 40
38 35 38
40 26 31
20 17
20 10

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
NMDC 16 September 2021

Exhibit 626: OCF/EBITDA Exhibit 627: OCF/PAT

140
120 140
120 114 117
120
100 100 91 86
83 82
80 80
59 63 58 61
58
%

58

%
51 52 55
60 48 60 49
42
34 40
40
20
20
0
0

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Capex on steel plant led to poor free cash flows: During FY12-21, NMDC incurred capex of ~Rs214bn, of which ~Rs180bn was
spent on upcoming 3mtpa steel plant, which is yet to be commissioned. Almost the entire capex has been funded via internal
accruals. As a result, while it generated OCF of Rs375bn, net free cash flow during FY12-21 was Rs161bn.
Exhibit 628: Capex on steel plant led to poor free cash flows
80 Moderate OCF, steel capex funded through internal accruals; FCF
remained low for most of FY12-21, barring FY21 57.2
60
Rs in bn

40 30.8
14.4 13.6 20.1
20 11.1 12.9
6.6
(2.0) (3.6)
0

-20

-40
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition & Investments Net FCF
Source: Company, Centrum Broking

No equity raised in last 10 years; dividend/buyback payout higher than FCF – net cash has declined: NMDC has not raised
any equity from the market. Being a net cash company, it has been continuously rewarding shareholders with higher dividend
and buybacks (even higher than free cash flows over the entire decade, except FY12 and FY21). Overall, it paid ~Rs297.7bn
dividend (Rs82.6/share) and did buyback worth Rs102.5bn, much higher than free cash flows of ~Rs161.1bn. This led net cash
to decline from Rs202bn (Rs51.1/share) in FY12 to Rs58bn (Rs19.8/share) in FY21, down Rs144.5bn.
Exhibit 629: Dividend/buyback payout higher than FCF Exhibit 630: Net cash/share has declined
100 60
90.0 51.1 53.0
50 47.1 46.5
80
58.0 37.2
60 58.7 57.2 40
Rs/share
Rs in bn

40 30.8 31.4 39.7 30


34.5 19.8
25.3 19.5
20 13.6 6.6 23.9 20 16.7 17.2 15.0
19.1 11.1 20.1
14.4 12.9 7.8
0 10
(2.0)
(3.6)
-20 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
FCF Dividend & Buyback payout Net cash (Rs/share)
Source: Company, Centrum Broking Source: Company, Centrum Broking
Return ratios poor for a mining company: Though NMDC’s return ratios seem good (average RoCE of ~28.8% and RoE of 19%
over FY12-21), these are poor for a mining company.
Exhibit 631: Return ratios (10-year average RoE of 19%, RoCE of 28.8%) poor for a mining company
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 33.5 24.4 22.2 21.0 9.4 10.0 15.6 18.5 13.9 21.8 19.0
ROCE 49.6 36.5 33.8 31.7 13.8 16.2 25.6 28.3 22.9 29.8 28.8
Source: Company, Centrum Broking *ROCE is pre tax

Centrum Institutional Research 235


NMDC 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 121,198 116,686 153,395 253,468 249,648 Equity share capital 3,062 3,062 2,931 2,931 2,931
Operating Expense 24,003 26,524 34,259 94,823 68,225 Reserves & surplus 256,453 272,278 294,631 356,011 378,958
Employee cost 10,368 10,468 10,818 11,359 11,927 Shareholders fund 259,515 275,340 297,562 358,942 381,889
Others 17,856 19,896 20,665 29,292 91,242 Minority Interest 0 0 0 0 0
EBITDA 69,300 60,104 87,959 118,301 78,561 Total debt 3,642 5,656 19,945 5,945 5,945
Depreciation & Amortisation 2,789 2,944 2,278 2,324 13,503 Non Current Liabilities 0 55 46 46 46
EBIT 66,511 57,160 85,680 115,977 65,058 Def tax liab. (net) 0 0 0 0 0
Interest expenses 403 99 168 136 357 Total liabilities 263,157 281,050 317,552 364,932 387,880
Other income 5,883 5,138 3,499 5,402 5,162 Gross block 32,789 35,896 38,779 238,779 258,779
PBT 71,991 62,199 89,011 121,243 69,864 Less: acc. Depreciation (7,244) (9,728) (12,006) (14,330) (27,833)
Taxes 25,565 25,126 26,485 30,553 17,606 Net block 25,545 26,168 26,773 224,449 230,946
Effective tax rate (%) 35.5 40.4 29.8 25.2 25.2 Capital WIP 137,925 154,716 170,767 5,767 20,767
PAT 46,425 37,073 62,527 90,690 52,258 Net fixed assets 165,131 185,179 202,466 235,142 256,639
Minority/Associates 0 0 0 0 0 Non Current Assets 29,863 30,755 36,959 40,000 40,000
Recurring PAT 46,425 37,073 62,527 90,690 52,258 Investments 9,393 9,856 9,849 9,849 9,849
Extraordinary items 0 964 0 0 0 Inventories 6,662 7,235 9,217 13,905 30,816
Reported PAT 46,425 38,038 62,527 90,690 52,258 Sundry debtors 14,245 22,237 21,399 31,287 34,240
Cash & Cash Equivalents 46,077 23,923 58,060 59,131 51,207
Ratios Loans & advances 7,965 8,662 9,012 9,012 9,012
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 12,656 19,622 16,805 18,759 18,684
Growth (%)
Trade payables 2,027 2,256 3,603 5,948 17,120
Revenue 4.9 (3.7) 31.5 65.2 (1.5)
Other current liab. 24,539 17,630 36,263 38,240 37,664
EBITDA 19.3 (13.3) 46.3 34.5 (33.6) Provisions 8,097 10,504 10,432 12,047 11,866
Adj. EPS 31.0 (20.1) 76.2 45.0 (42.4) Net current assets 52,942 51,290 64,196 75,858 77,309
Margins (%) Total assets 263,157 281,050 317,552 364,932 387,880
Gross 100.5 100.4 101.0 99.9 100.0
EBITDA 57.0 51.4 57.2 46.6 31.4 Cashflow
EBIT 54.7 48.9 55.7 45.7 26.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 38.2 31.7 40.7 35.7 20.9 Profit Before Tax 71,984 61,224 89,016 121,243 69,864
Returns (%) Depreciation & Amortisation 2,789 2,944 2,278 2,324 13,503
ROE 18.5 13.9 21.8 27.6 14.1 Net Interest 403 99 168 0 0
ROCE 18.2 13.6 20.9 26.6 14.0 Net Change – WC (8,629) (21,433) 5,277 (13,633) (9,374)
ROIC 21.8 15.0 24.2 31.8 15.6 Direct taxes (26,024) (23,047) (24,877) (30,553) (17,606)
Turnover (days) Net cash from operations 40,469 20,529 73,305 79,380 56,386
Gross block turnover ratio (x) 3.7 3.3 4.0 1.1 1.0 Capital expenditure (19,972) (23,990) (15,981) (35,000) (35,000)
Debtors 44 57 52 38 48 Acquisitions, net 0 0 0 0 0
Inventory 19 22 20 17 33 Investments (1,529) (463) (30,347) 0 0
Creditors 5 7 7 7 17 Others 14,114 21,680 2,412 0 0
Net working capital 159 160 153 109 113 Net cash from investing (7,387) (2,773) (43,915) (35,000) (35,000)
Solvency (x) FCF 20,497 (3,461) 57,325 44,380 21,386
Net debt-equity (0.2) (0.1) (0.1) (0.1) (0.1) Issue of share capital (10,067) 0 (17,006) 0 0
Interest coverage ratio 171.9 608.3 523.3 872.6 220.3 Increase/(decrease) in debt (1,359) 2,014 13,993 0 0
Net debt/EBITDA (0.6) (0.3) (0.4) (0.4) (0.6) Dividend paid (21,321) (19,525) (22,733) (29,310) (29,310)
Per share (Rs) Interest paid (401) (97) (166) 0 0
Adjusted EPS 15.2 12.1 21.3 30.9 17.8 Others 190 77 0 0 0
BVPS 84.8 89.9 101.5 122.5 130.3 Net cash from financing (32,959) (17,531) (25,912) (29,310) (29,310)
CEPS 16.1 13.1 22.1 31.7 22.4 Net change in Cash 124 225 3,478 15,070 (7,924)
DPS 5.5 5.3 7.8 10.0 10.0 Source: Company, Centrum Broking
Dividend payout (%) 36.4 42.6 36.4 32.3 56.1
Valuation (x)
P/E 10.0 12.6 7.1 4.9 8.5
P/BV 1.8 1.7 1.5 1.2 1.2
EV/EBITDA 4.0 3.8 4.1 3.7 5.7
Dividend yield (%) 3.6 3.5 5.1 6.6 6.6
Source: Company, Centrum Broking

Centrum Institutional Research 236


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Steel Authority of India (SAIL) Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

SAIL’s high cost base and inefficiency has led to lower operating profits. This along Market data
with poor working capital management and delays in capacity expansion caused a Current price: Rs120
deterioration in the company’s balance sheet in the last decade – so much so that it Bloomberg: SAIL IN
was on the verge of default in FY17. SAIL remained FCF negative over FY12-20 till its 52-week H/L: Rs151/33
major expansion program was completed. Gradual ramp-up and a favorable steel
Market cap: Rs494bn
cycle has led to its highest-ever positive FCF of Rs166bn in FY21. One or two years of
good steel cycle in a decade can offset the poor free cash flows of earlier years. This Free float: 35.0%
happened for SAIL in FY21, as it deleveraged its balance sheet significantly, with Net Avg. daily vol. 3mth: 53,884,560
Debt/EBITDA at 2.9x, and is now preparing itself for the next phase of expansion. Source: Bloomberg

OCF muted due to cyclicality and inefficiency: During FY12-21, SAIL recorded negative OCF in FY17 and FY20 amid weak steel
prices. High cost structure and poor volume uptick kept its OCF dependent on steel prices. Moreover, higher working capital
requirements pulled down OCF further throughout the last decade. OCF averaged at Rs33bn over FY12-21. Yet, it recorded OCF
of Rs205bn in FY21, suggesting one or two years of good steel cycle in a decade can offset the poor cash flows of earlier years.
Exhibit 632: OCF muted – has averaged at Rs33bn over the decade
150 250
Muted operating performance due to high 205
100 CoP and high working capital resulted in poor 200
OCF generation
150
50
Rs bn

100
0
50
-50 50
33 39 0
4 17 13 15
-100 -4 -50
-43
-150 -100
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before Wcap changes Change in WC CFO
Source: Company, Centrum Broking

Working capital cycle stretched due to multiple plant locations, high proportion of sales to government entities: Except for
FY17-19, when its NWC averaged 14 days, SAIL’s average NWC during FY12-21 was 44 days. This was largely on account of high
inventory days, which averaged at four months over FY12-21 due to multiple plant locations and poor inventory management.
Its receivable days too remained high relative to industry due to higher proportion of sales to government entities.
Exhibit 633: Working capital cycle stretched – has averaged at 44 days over the decade
NWC remained high on account of poor inventory management due to multi-plant locations, high receivables
149
150 130 128
122 122 125
114
No. of Days

99 104 99
100

50

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-50 Inventories Receivables Payable Net Working Capital cycle


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Steel Authority of India (SAIL) 16 September 2021

Exhibit 634: OCF/EBITDA Exhibit 635: OCF/PAT

250 226 600 540

200 161 400 327


150 127 154 193
200 70 59
100 76 11 14
0
%

41

%
36 28
50 7
-200 -37
0
-50 -400

-100 -52 -436


-83 -600
FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY21
Source: Company, Centrum Broking Source: Company, Centrum Broking

Poor operating cash flows, continuous capex led to negative free cash flows during FY12-20; FY21 a game changer: During
FY12-21, SAIL added steel capacity of ~7.5mtpa via brownfield expansion. Due to this, it delivered negative free cash flows
during FY12-20 (-Rs488bn), though in FY21, it delivered positive free cash flows of Rs166bn. Against OCF of Rs329bn over FY12-
21, SAIL incurred maintenance and expansion capex of Rs651bn. Its expansions have proved to be both costly and time
consuming – the capacity additions have cost Rs86.8bn/t and have taken a decade. SAIL has funded its capex via debt and
internal cash flows, and has not raised any equity from the market. Net Debt increased from Rs99bn (Net Debt/EBITDA: 1.6x)
in FY12 to Rs367bn (Net Debt/EBITDA: 2.9x) in FY21, an increase of ~Rs268bn.
Exhibit 636: Capex intensity high, but no acquisitions over the years – negative free cash flows till FY20
250
200 166
Low OCF, time delays and costly capex led to negative FCF during FY12-20
150
100
Rs in bn

50
0
-50 (0)
(39) (34)
-100 (50) (52) (59)
(90) (75) (90)
-150
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition & Investment FCF
Source: Company, Centrum Broking

Leverage has remained high: Fluctuating steel cycle, continuous expansion via organic route, and inefficient working capital
management have kept SAIL’s leverage high. Average Net Debt/Equity has been comfortable at below 1x, but Net Debt/EBITDA
has remained high throughout the decade. With sharp increase in profitability in FY21, though, Net Debt/EBITDA fell to 2.9x.
Exhibit 637: Leverage high; 10-year average Net Debt/EBITDA of 5.7x
(x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA 1.6 3.8 5.7 6.2 -12.0 -229.8 10.3 4.6 10.3 2.9 5.7
Source: Company, Centrum Broking

Return ratios poor: SAIL’s RoE has been very low, as profitability depends on steel prices. RoE has fluctuated between -9.7%
and +9.9% over FY12-21 and has averaged at 1.6%. Also, RoCE has been low, with average of 2.9% over FY12-21 due to low
operating profits and continuous expansion and modernization.
Exhibit 638: Return ratios poor in last decade; 10-year average RoE at 1.6%, RoCE at 4.3%
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 9.9 5.8 3.6 5.2 -9.7 -7.5 -2.1 7.0 -5.7 9.1 1.6
ROCE* 10.8 7.0 4.7 5.5 -6.3 -3.1 2.3 8.4 2.7 11.1 4.3
Source: Company, Centrum Broking, *ROCE is pre-tax

Centrum Institutional Research 238


Steel Authority of India (SAIL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 662,673 610,249 684,744 979,400 924,600 Equity share capital 41,305 41,305 41,305 41,305 41,305
Operating Expense 405,778 393,709 386,589 513,153 531,274 Reserves & surplus 340,210 356,469 393,644 557,862 632,073
Employee cost 88,303 87,813 104,459 115,500 118,965 Shareholders fund 381,516 397,774 434,949 599,167 673,378
Others 78,250 83,288 72,772 77,220 86,121 Minority Interest 0 0 0 0 0
EBITDA 97,342 51,796 127,281 279,884 194,597 Total debt 450,416 538,032 373,534 273,534 213,534
Depreciation & Amortisation 33,847 37,551 41,020 42,770 43,770 Non Current Liabilities 58,792 58,086 61,969 81,445 77,823
EBIT 63,495 14,245 86,261 237,114 150,827 Def tax liab. (net) 0 0 12,532 12,532 12,532
Interest expenses 31,549 34,868 28,171 18,441 14,612 Total liabilities 890,724 993,892 882,984 966,678 977,267
Other income 5,328 9,852 10,117 5,517 5,517 Gross block 995,269 1,107,552 1,134,521 1,189,521 1,229,521
PBT 37,274 (10,770) 68,206 224,189 141,732 Less: acc. Depreciation (396,196) (431,807) (472,827) (515,597) (559,367)
Taxes 11,591 11,491 30,290 56,047 35,716 Net block 599,073 675,745 661,694 673,924 670,154
Effective tax rate (%) 31.1 106.7 44.4 25.0 25.2 Capital WIP 160,135 87,527 88,785 88,785 128,785
PAT 25,683 (22,261) 37,916 168,142 106,015 Net fixed assets 773,727 777,706 764,782 777,012 813,242
Minority/Associates 0 0 0 0 0 Non Current Assets 23,326 27,448 28,740 28,740 28,740
Recurring PAT 25,683 (22,261) 37,916 168,142 106,015 Investments 15,848 15,850 15,950 15,950 15,950
Extraordinary items (3,894) (7,718) 584 0 0 Inventories 194,418 237,472 195,083 295,162 278,647
Reported PAT 21,789 (29,979) 38,500 168,142 106,015 Sundry debtors 44,951 88,124 71,240 67,082 63,329
Cash & Cash Equivalents 2,194 3,633 6,805 80,575 66,007
Ratios Loans & advances 532 497 505 505 505
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 80,398 79,459 88,491 112,868 106,562
Growth (%)
Trade payables 72,648 63,204 70,144 101,965 96,260
Revenue 16.5 (7.9) 12.2 43.0 (5.6)
Other current liab. 177,918 170,334 198,070 250,741 240,945
EBITDA 122.9 (46.8) 145.7 119.9 (30.5) Provisions 23,088 23,549 20,398 20,398 20,398
Adj. EPS nm nm nm 343.5 (36.9) Net current assets 48,839 152,098 73,511 183,087 157,446
Margins (%) Total assets 890,724 993,892 882,984 966,678 977,267
Gross 56.4 54.1 60.9 63.3 58.6
EBITDA 14.5 8.4 18.4 28.4 20.9 Cashflow
EBIT 9.5 2.3 12.5 24.1 16.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 3.8 (3.6) 5.5 17.1 11.4 Profit Before Tax 33,379 31,707 68,790 224,189 141,732
Returns (%) Depreciation & Amortisation 33,847 37,551 41,020 42,770 43,770
ROE 7.0 (5.7) 9.1 32.5 16.7 Net Interest 29,865 31,608 23,938 0 0
ROCE 5.8 (0.2) 6.1 21.6 13.3 Net Change – WC (26,258) (106,806) 100,367 (16,331) 7,451
ROIC 5.4 (0.1) 5.6 22.8 14.3 Direct taxes 357 (871) (224) (17,935) (35,716)
Turnover (days) Net cash from operations 73,016 (6,506) 234,004 232,693 157,237
Gross block turnover ratio (x) 0.7 0.6 0.6 0.8 0.8 Capital expenditure (39,791) (46,723) (38,273) (55,000) (80,000)
Debtors 23 39 42 26 26 Acquisitions, net 0 0 0 0 0
Inventory 99 128 114 91 112 Investments (457) (133) 72 0 0
Creditors 40 40 35 32 39 Others 2,691 4,494 4,292 0 0
Net working capital 27 91 39 68 62 Net cash from investing (37,557) (42,361) (33,908) (55,000) (80,000)
Solvency (x) FCF 33,225 (53,229) 195,731 177,693 77,237
Net debt-equity 1.2 1.3 0.8 0.3 0.2 Issue of share capital 0 0 0 0 0
Interest coverage ratio 3.1 1.5 4.5 15.2 13.3 Increase/(decrease) in debt (2,387) 89,074 (163,350) (100,000) (60,000)
Net debt/EBITDA 4.6 10.3 2.9 0.7 0.8 Dividend paid 0 (2,481) (4,131) (42,035) (31,805)
Per share (Rs) Interest paid (33,521) (36,538) (29,421) 0 0
Adjusted EPS 6.2 (5.4) 9.2 40.7 25.7 Others 0 0 0 0 0
BVPS 92.4 96.3 105.3 145.1 163.0 Net cash from financing (35,908) 50,055 (196,901) (142,035) (91,805)
CEPS 14.4 3.7 19.1 51.1 36.3 Net change in Cash (449) 1,188 3,194 35,657 (14,568)
DPS 0.5 0.0 2.8 10.2 7.7 Source: Company, Centrum Broking
Dividend payout (%) 9.5 nm 30.0 25.0 30.0
Valuation (x)
P/E 19.2 nm 13.0 2.9 4.7
P/BV 1.3 1.2 1.1 0.8 0.7
EV/EBITDA 6.9 12.2 5.4 2.5 3.3
Dividend yield (%) 0.4 0.0 2.3 8.5 6.4
Source: Company, Centrum Broking

Centrum Institutional Research 239


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Tata Steel (TATA) Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

TATA’s incremental focus on its fully-integrated Indian operations over the last 10 Market data
years helped it to tide over business cyclicality. It managed its working capital well, Current price: Rs1,437
keeping average net working capital below 30 days. It expanded domestic steel Bloomberg: TATA IN
capacity by ~12mtpa during FY12-21, funding the expansion through debt and equity 52-week H/L: Rs1,535/343
in the ratio 2:1. The Indian entity continues to support European operations (bought
Market cap: Rs1728.4bn
in FY07), dragging overall return ratios. However, the acquisition of Bhushan Steel
assets in FY19 is proving to be remunerative. A year or two of good steel cycle in a Free float: 65.6%
decade offsets the poor free cash flows of earlier years. This happened for TATA in Avg. daily vol. 3mth: 12,916,900
FY21, when it significantly reduced its Net Debt/EBITDA to 2.7x. Source: Bloomberg

Despite cyclicality, TATA has history of robust cash flows from operations: Due to 100% iron ore integration in domestic
business, focus on domestic operations, and reducing exposure to Europe, we observe average annual operating cash flows of
Rs70bn during FY12-18. In the last three years (FY19-21), besides higher operating profits, efficient working capital
management (receiving export advances, reducing debtors) led to strong operating cash flows.
Exhibit 639: Despite cyclicality, has robust cash flows from operations
Improvement in steel prices, focus on
400 India operations led to improved CFO 375
300 since FY19

200 106
76 92 65 60 182 127
100 61 29
Rs in bn

0
-100
-200
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating profit before Wcap Changes W Cap Changes CFO


Source: Company, Centrum Broking

Working capital movement – cash outflow in 3 out of 10 years: During FY12-21, we observe sizeable reduction in debtors (20
days in FY21 v/s average of 35 days over FY12-21), which could be due to incremental focus on domestic operations, where
debtor days are low. We have not seen any material change in inventory (75 days in FY21 v/s average of 72 days over FY12-21)
and payable days (55 days in FY21 v/s average of 56 days). During the 10-year period, we witnessed cash outflow due to working
capital only in three years (FY14, FY17 and FY18). TATA managed its working capital well throughout the cycle, keeping average
net working capital below 30 days.
Exhibit 640: NWC on downward trend

TATA managed its working capital well throughout


100
the cycle, keeping average NWC at ~25 days
80
No of Days

60
34 30 33 30
40 27 26 25 25
21
20
3
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Tata Steel (TATA) 16 September 2021
Exhibit 641: Cash conversion cycle fluctuates
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF/EBITDA 62 86 56 51 75 36 13 62 72 123
Source: Company, Centrum Broking

Continuous expansion led to negative free cash flows during FY12-20; FY21 was a game changer: During FY12-21, TATA
expanded steel capacity by ~12mtpa via organic/inorganic route. Due to this, it delivered negative free cash flows during FY12-
FY20. As against CFO of Rs1,173bn over FY12-21, TATA incurred capex of Rs1,051bn and invested Rs412bn in acquiring new
assets. This led to negative FCF of Rs291bn over this period, despite FY21 recording positive free cash flows of Rs310bn. TATA
has essentially funded its capex via debt and internal cash flows over time, but has also raised equity of ~Rs182bn since FY11.
As a result, Net Debt increased from Rs499bn in FY12 to Rs836bn in FY21, up Rs337bn.
Exhibit 642: Capex intensity high, on acquisition spree since FY19
FY20: Acquisition of
FY19: Acquisition of Usha Martin
600
FY13: Completion of FY16: Completion of Bhushan Steel @Rs44bn (1mtpa)
400 3mtpa Jamshedpur KPO Phase 1 @Rs352bn (5.6mtpa)
expansion (3mtpa) expansion
Rs in bn

200

-200

-400
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition & Investments Net FCF
Source: Company, Centrum Broking

Corus acquisition poor, but acquisition of Bhushan Steel assets remunerative: We observe that TATA’s decision to acquire
Corus in FY07 (near the peak of the cycle in a mature market) still drags overall profits and return ratios. However, the
acquisition of Bhushan Steel assets in FY19 at an EV of ~Rs352bn has proven to be remunerative. The performance of Bhushan
Steel has improved significantly since TATA acquired it – in FY21, it generated ~11% RoCE (pre-tax) for TATA.
Exhibit 643: Tata Steel BSL (renamed Bhushan Steel) – significant RoCE expansion in FY21
FY19 FY20 FY21
ROCE (%) 7 2.8 12.1
TATA's ROCE on acquisition price (%) 0.5 2.0 11.2
Source: Company, Centrum Broking

Leverage remained high till FY20; steel upcycle helped reduce it to <3x in FY21: The fluctuating steel cycle, continuous
expansion via organic/inorganic route, and support to European operations kept TATA’s leverage high till FY20. The steel
upcycle and controlled capex helped to reduce leverage significantly in FY21. While average Net Debt/Equity was comfortable
at 1.5x, Net Debt/EBITDA remained high till FY20. With strong free cash flows in FY21, Net Debt/EBITDA fell to comfortable
level of 2.7x.
Exhibit 644: Leverage ratios remain high; 10-year average Net Debt/EBITDA at 4.8x
(x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA 4.0 4.7 4.4 5.5 9.2 4.4 3.3 3.3 6.0 2.7 4.8
Source: Company, Centrum Broking

Return ratios low due to loss in European operations: TATA’s RoE was very low during FY12-16 (0-5%), but improved since
then (10-17%). However, as profitability depends on steel prices, RoE keeps fluctuating. Also, RoCE has been low (2.5-15%) due
to continuous expansion and drag from European operations.
Exhibit 645: Return ratios fluctuate; higher in second half of the decade than in the first half
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 5.2 0.9 9.7 0.0 -4.5 10.4 16.9 16.6 9.4 11.8 7.6
ROCE* 9.3 6.9 9.6 5.9 2.5 9.5 12.0 14.4 6.0 12.1 8.8
Source: Company, Centrum Broking; Note: *ROCE is pre-tax

Centrum Institutional Research 241


Tata Steel (TATA) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 1,546,918 1,461,060 1,533,084 2,309,041 1,879,938 Equity share capital 11,449 11,449 11,976 12,780 12,780
Operating Expense 1,013,931 1,050,024 987,172 1,042,736 936,949 Reserves & surplus 655,051 701,564 722,662 1,199,115 1,405,293
Employee cost 187,589 191,522 199,088 180,562 185,889 Shareholders fund 666,501 713,013 734,638 1,211,895 1,418,073
Others 81,336 69,896 71,639 333,516 322,615 Minority Interest 23,645 25,866 32,697 57,697 75,197
EBITDA 293,833 178,276 305,043 768,228 450,485 Total debt 1,030,912 1,186,032 966,148 808,398 733,398
Depreciation & Amortisation 73,418 87,077 92,336 93,339 95,339 Non Current Liabilities 84,561 92,293 104,869 136,497 119,007
EBIT 220,415 91,199 212,706 674,889 355,146 Def tax liab. (net) 124,599 92,614 92,414 92,414 92,414
Interest expenses 76,601 75,807 76,067 64,445 59,445 Total liabilities 1,930,218 2,109,818 1,930,766 2,306,902 2,438,089
Other income 14,206 18,220 8,956 8,577 8,577 Gross block 1,690,019 1,868,926 2,019,523 2,069,523 2,119,523
PBT 158,020 33,612 145,595 619,022 304,278 Less: acc. Depreciation (505,509) (588,388) (734,979) (828,317) (923,656)
Taxes 67,184 (25,529) 56,539 110,618 66,151 Net block 1,184,510 1,280,538 1,284,545 1,241,206 1,195,867
Effective tax rate (%) 42.5 76.0 38.8 17.9 21.7 Capital WIP 179,565 188,621 181,287 251,287 321,287
PAT 90,836 59,141 89,056 508,404 238,128 Net fixed assets 1,430,831 1,540,475 1,547,826 1,574,487 1,599,148
Minority/Associates 13,209 5,721 (3,722) (20,100) (13,500) Non Current Assets 302,179 369,545 295,054 309,593 301,553
Recurring PAT 104,044 64,861 85,334 488,304 224,628 Investments 12,904 6,848 9,874 9,874 9,874
Extraordinary items (1,210) (49,296) (10,432) 0 0 Inventories 316,561 310,687 332,764 499,765 406,891
Reported PAT 102,835 15,565 74,902 488,304 224,628 Sundry debtors 118,110 78,849 95,398 143,683 116,982
Cash & Cash Equivalents 58,662 114,866 130,011 388,172 521,559
Ratios Loans & advances 18,518 21,482 19,845 19,845 19,845
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 78,059 61,443 24,101 35,003 28,974
Growth (%)
Trade payables 217,170 213,809 259,675 322,633 262,676
Revenue 26.9 (5.6) 4.9 50.6 (18.6)
Other current liab. 175,950 163,932 217,178 303,635 256,808
EBITDA 37.1 (39.3) 71.1 151.8 (41.4) Provisions 12,487 16,637 47,253 47,253 47,253
Adj. EPS 30.6 (37.7) 25.8 436.2 (54.0) Net current assets 184,303 192,950 78,013 412,947 527,514
Margins (%) Total assets 1,930,218 2,109,818 1,930,766 2,306,902 2,438,089
Gross 62.6 58.4 64.8 61.2 57.6
EBITDA 18.6 12.0 19.5 33.0 23.8 Cashflow
EBIT 14.0 6.1 13.6 29.0 18.7 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 6.6 4.4 5.5 21.0 11.8 Profit Before Tax 158,071 (13,804) 138,437 619,022 304,278
Returns (%) Depreciation & Amortisation 75,793 87,077 92,336 93,339 95,339
ROE 16.6 9.4 11.8 50.2 17.1 Net Interest 67,040 75,807 76,067 64,445 59,445
ROCE 8.3 1.4 7.4 29.5 13.2 Net Change – WC 25,905 41,962 164,913 (59,685) 9,371
ROIC 8.6 1.3 7.7 33.9 16.5 Direct taxes (50,942) (21,059) (7,043) (110,618) (66,151)
Turnover (days) Net cash from operations 253,360 201,687 443,267 606,503 402,282
Gross block turnover ratio (x) 0.9 0.8 0.8 1.1 0.9 Capital expenditure (86,243) (100,123) (65,340) (120,000) (120,000)
Debtors 28 24 20 19 25 Acquisitions, net (352,825) (44,327) 0 0 0
Inventory 69 77 75 65 87 Investments 0 0 0 0 0
Creditors 49 53 55 46 56 Others 140,394 (853) (27,889) 0 0
Net working capital 43 48 19 65 102 Net cash from investing (298,673) (145,304) (93,229) (120,000) (120,000)
Solvency (x) FCF (185,708) 57,237 377,927 486,503 282,282
Net debt-equity 1.4 1.4 1.1 0.3 0.1 Issue of share capital 0 1,875 32,390 0 0
Interest coverage ratio 3.8 2.4 4.0 11.9 7.6 Increase/(decrease) in debt 79,418 86,363 (308,766) (150,000) (75,000)
Net debt/EBITDA 3.3 6.0 2.7 0.5 0.5 Dividend paid (11,862) (18,152) (11,505) (31,950) (31,950)
Per share (Rs) Interest paid (71,519) (74,193) (68,037) (64,445) (59,445)
Adjusted EPS 90.9 56.7 71.3 382.1 175.8 Others (2,763) (12,840) (14,978) 0 0
BVPS 582.1 622.8 613.4 948.3 1,109.6 Net cash from financing (6,727) (16,946) (370,897) (246,395) (166,395)
CEPS 155.0 132.7 148.4 455.1 250.4 Net change in Cash (52,041) 39,438 (20,859) 240,108 115,887
DPS 13.0 10.0 25.0 25.0 25.0 Source: Company, Centrum Broking
Dividend payout (%) 14.5 73.6 40.0 6.5 14.2
Valuation (x)
P/E 15.8 25.4 20.2 3.8 8.2
P/BV 2.5 2.3 2.3 1.5 1.3
EV/EBITDA 5.3 7.7 2.7 0.5 0.5
Dividend yield (%) 0.9 0.7 1.7 1.7 1.7
Source: Company, Centrum Broking

Centrum Institutional Research 242


16 September 2021

Institutional Research
Ashish Kejriwal
Research Analyst, Metals & Mining
+91 22 4215 9855
SECTOR: METALS & MINING [email protected]
Kunal Kothari

Vedanta (VEDL) Research Associate, Metals & Mining


+91 22 4215 9375
[email protected]

VEDL’s low cost status and presence across commodities helped improve OCF since Market data
FY14 (business in current form, as Sterlite merged with Sesa Goa in FY14; Current price: Rs309
subsequently, Cairn India got merged in VEDL in FY17), largely due to HZ. Net working Bloomberg: VEDL IN
capital was negative throughout the decade. Cash conversion ratio remained 52-week H/L: Rs341/91
moderate. Though consolidated debt is at the lower end (Net Debt/EBITDA of 1.3x
Market cap: Rs1149bn
during FY14-21), ex-HZ, net debt remains high (ex-HZ Net Debt/EBITDA of 4.2x during
FY14-21) due to continuous capex in oil and aluminum. It spent ~Rs592bn over FY14- Free float: 34.8%
21, largely funded via internal accruals. It has not raised any equity in the last decade. Avg. daily vol. 3mth: 15,760,620
VEDL can access HZ’s cash only via dividend payout. Source: Bloomberg

Robust cash flows from operations from FY14: VEDL’s focus on cost control across commodities helped it to consistently
improve OCF from FY14, despite fluctuating commodity prices. On an average, ~55% of OCF has been generated by HZ. VEDL
maintained tight control on working capital, and as a result, it had negative net working capital cycle throughout the decade.
Cash conversion ratio has remained moderate during the last decade (average of 65% during FY14-21).
Exhibit 646: Robust cash flow from operations since FY14
250 On an average, HZ contributed 55% of VEDL's OCF, which helped maintain
consistency in OCF throughout the cycle from FY14
200 177
186
146 140
150 115 119 124
109
Rs in bn

100

50
20 (2)
0

-50
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-100
Operating profit before Wcap Changes W Cap Changes CFO
Source: Company, Centrum Broking
Note: Financials before FY14 only for Sesa Goa; hence, not comparable

Analysis of working capital movement: Net working capital (NWC) has been negative throughout the cycle. Tight control on
debtors and stable inventory days coupled with short-term financing helped VEDL to consistently maintain negative working
capital (negative 52 days on an average during FY14-21). Moreover, consistent high dividend payout from HZ also helped.
Exhibit 647: Negative net working capital; 10-year average NWC of -78 days
200

100
No of Days

-100 (26) (38) (37) (43)


(50) (61) (62) (55)
(79)
-200
Net working capital negative throughout the cycle
-300 (333)

-400
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Recievable Days Inventory Days Payable Days NWC
Source: Company, Centrum Broking

xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Vedanta (VEDL) 16 September 2021
Exhibit 648: Moderate cash conversion ratio
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
OCF/EBITDA 58 (51) 56 52 96 56 50 77 68 68
Source: Company, Centrum Broking; Note: *ROCE is pre-tax; Financials before FY14 only for Sesa Goa; hence, not comparable

Almost 90% of free cash flows over FY14-21 due to HZ: VEDL has 64.9% stake in HZ, which generated consistent free cash
flows (Rs407bn during FY14-21). This helped VEDL to generate free cash flows of Rs465bn over the same period. VEDL’s
expansion across business segments (international zinc, aluminum, oil, etc) coupled with closure of Goa’s iron ore and copper
smelter, and interest servicing led to only ~Rs58bn free cash flows over FY14-21 for VEDL ex-HZ. Continuous high dividend from
HZ helped net debt ex-HZ to decrease by Rs135bn from Rs553bn in FY14 to Rs418bn in FY21.
Exhibit 649: 90% of free cash flows over FY14-21 due to HZ
300

200
Rs in bn

92 65 63 119
100 37 42 39
12 (11) 9
0

-100

-200
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Acquisition & Investments Net FCF
Source: Company, Centrum Broking; Note: Financials before FY14 only for Sesa Goa; hence, not comparable

Returns from Cairn India acquisition weak: VEDL successfully turned around HZ (bought in 2002; generated average margins
of 22% during FY12-21) and improved financials of Electrosteel Steel (bought in NCLT in FY19; generated ~7% RoCE in FY21).
Cairn India was acquired by its parent company, Vedanta Resources, and group company, Sesa Goa (acquired 58.5% stake in
December 2011 at ~Rs420bn), and finally merged with VEDL. This acquisition has generated 7-8% RoCE over the last six years
and needs continuous capex to maintain profitability.
Exhibit 650: High dividend payout since FY17 to meet parent, Vedanta Resources’ debt obligations
25 200
20 19
20 20 150

15 100
10
10 7 50
4 4
5 2 3 0
0
0 -50
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
DPS (Rs - LHS) Div payout (%)
Source: Company, Centrum Broking
Note: Financials before FY14 only for Sesa Goa; hence, not comparable
No equity raised in last 10 years; dividend payout high since FY17; net debt ex-HZ remains high: VEDL passes on the dividend
received from HZ to its shareholders, largely to meet its parent’s debt obligation (also benefiting minority shareholders). It has
not raised any equity from the market in the last 10 years. Capex has largely been funded via internal accruals, but VEDL has
not had sufficient free cash flows to deleverage (ex-HZ Net Debt/EBITDA was 4.4x in FY20, the same level as in FY14, before
falling to 2.7x in FY21).
Exhibit 651: Net Debt/EBITDA (VEDL ex-HZ) remains high; 10-year average at 2.2x
Leverage Ratio (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
Net Debt/EBITDA -8.1 -4.3 4.4 3.9 6.3 3.7 4.2 4.4 4.4 3.0 2.2
Source: Company, Centrum Broking; Note: Financials before FY14 only for Sesa Goa; hence, not comparable

Return ratios healthy due to HZ: VEDL’s consolidated return ratios remain healthy (average RoCE of ~12% over FY14-21) due
to higher profitability of HZ (average RoCE of 26%) and improvement in aluminum operations since FY21.
Exhibit 652: Return ratios healthy; 10-year average RoE at 18.9%, RoCE at 13.5%
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Average
ROE 35.7 14.1 14.3 9.8 41.9 11.1 11.6 10.7 18.3 21.0 18.9
ROCE 37.8 1.6 14.1 9.6 6.5 12.4 14.3 12.7 9.7 16.7 13.5
Source: Company, Centrum Broking; Note: *ROCE is pre-tax; Financials before FY14 only for Sesa Goa; hence, not comparable

Centrum Institutional Research 244


Vedanta (VEDL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 920,480 844,470 880,210 1,069,607 1,112,543 Equity share capital 3,718 3,720 3,720 3,720 3,720
Operating Expense 442,940 388,950 373,560 412,472 430,007 Reserves & surplus 598,831 512,900 588,160 655,850 738,104
Employee cost 30,230 26,720 28,610 31,471 34,618 Shareholders fund 622,968 546,350 622,780 690,470 772,724
Others 216,280 221,930 204,860 210,774 217,926 Minority Interest 152,270 171,120 151,380 197,003 242,205
EBITDA 231,030 206,870 273,180 414,890 429,992 Total debt 743,420 681,320 650,110 627,287 591,181
Depreciation & Amortisation 81,920 90,930 76,380 84,540 86,478 Non Current Liabilities 86,730 89,440 89,800 89,800 89,800
EBIT 149,110 115,940 196,800 330,350 343,514 Def tax liab. (net) 44,840 28,850 22,150 22,150 22,150
Interest expenses 56,890 49,770 52,100 47,442 43,686 Total liabilities 1,650,228 1,517,080 1,536,220 1,626,711 1,718,060
Other income 40,180 25,100 34,210 19,476 18,972 Gross block 2,131,860 2,289,670 2,365,780 2,427,130 2,439,730
PBT 132,400 91,270 178,910 302,384 318,800 Less: acc. Depreciation (1,176,710) (1,409,450) (1,471,490) (1,556,030) (1,642,508)
Taxes 38,620 (35,160) 21,800 77,470 79,745 Net block 955,150 880,220 894,290 871,100 797,222
Effective tax rate (%) 29.2 38.5 12.2 25.6 25.0 Capital WIP 222,360 168,370 138,800 211,750 314,700
PAT 93,780 126,430 157,110 224,914 239,055 Net fixed assets 1,213,560 1,074,890 1,067,840 1,117,600 1,146,672
Minority/Associates (26,330) (19,200) (34,300) (45,623) (45,201) Non Current Assets 124,700 116,290 167,050 167,050 167,050
Recurring PAT 67,450 107,230 122,810 179,290 193,854 Investments 48,910 950 1,560 1,560 1,560
Extraordinary items (3,200) 173,860 6,780 0 0 Inventories 131,980 113,350 99,230 120,582 125,422
Reported PAT 64,250 281,090 129,590 179,290 193,854 Sundry debtors 39,820 26,970 34,910 42,422 44,125
Cash & Cash
365,660 371,600 331,330 389,724 456,006
Ratios Equivalents
YE Mar FY19A FY20A FY21A FY22E FY23E Loans & advances 820 850 20,190 20,190 20,190
Growth (%) Other current assets 60,230 62,430 76,260 76,260 76,260
Revenue 0.2 (8.3) 4.2 21.5 4.0 Trade payables 92,360 80,270 78,920 95,901 99,751
EBITDA (7.1) (10.5) 32.1 51.9 3.6 Other current liab. 273,973 235,320 238,300 267,845 274,543
Adj. EPS (6.0) 58.9 14.5 46.0 8.1 Provisions 3,870 3,550 3,530 3,530 3,530
Margins (%) Net current assets 228,308 256,060 241,170 281,901 344,178
Gross 71.6 73.4 73.1 72.5 72.4 Total assets 1,650,228 1,517,080 1,536,220 1,626,711 1,718,060
EBITDA 25.1 24.5 31.0 38.8 38.6
EBIT 16.2 13.7 22.4 30.9 30.9 Cashflow
YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 7.3 12.7 14.0 16.8 17.4
Returns (%) Profit Before Tax 135,600 (82,590) 172,130 302,384 318,800

ROE 10.7 18.3 21.0 27.3 26.5 Depreciation & Amortisation 82,200 91,520 76,620 84,540 86,478
ROCE 9.0 5.9 14.4 17.7 17.4 Net Interest 41,460 48,740 51,230 0 0
ROIC 9.6 6.7 16.3 22.2 22.7 Net Change – WC 21,280 (9,390) (15,710) 17,663 4,004
Turnover (days) Direct taxes (26,130) (11,350) (21,080) (77,470) (79,745)
Gross block turnover ratio (x) 0.4 0.4 0.4 0.4 0.5 Net cash from operations 237,540 192,980 239,800 327,117 329,538
Debtors 16 14 13 13 14 Capital expenditure (88,170) (76,690) (67,180) (134,300) (115,550)
Inventory 50 53 44 38 40 Acquisitions, net (50,750) (330) (450) 0 0
Creditors 35 37 33 30 32 Investments 230 49,810 81,700 0 0
Net working capital 91 111 100 96 113 Others 32,750 (31,730) (81,570) 0 0
Solvency (x) Net cash from investing (105,940) (58,940) (67,500) (134,300) (115,550)
Net debt-equity 0.5 0.4 0.4 0.3 0.1 FCF 98,620 115,960 172,170 192,817 213,988
Interest coverage ratio 4.1 4.2 5.2 8.7 9.8 Issue of share capital 40 0 0 0 0
Net debt/EBITDA 1.6 1.5 1.2 0.6 0.3 Increase/(decrease) in debt 76,990 29,060 73,720 (22,823) (36,106)
Per share (Rs) Dividend paid (117,920) (14,440) (35,190) (111,600) (111,600)
Adjusted EPS 18.1 28.8 33.0 48.2 52.1 Interest paid (60,090) (53,220) (53,480) 0 0
BVPS 167.6 146.9 167.4 185.6 207.7 Others (1,440) (117,180) (160,700) 0 0
CEPS 40.2 53.3 53.5 70.9 75.4 Net cash from financing (102,420) (155,780) (175,650) (134,423) (147,706)
DPS 18.8 3.9 9.5 30.0 30.0 Net change in Cash 29,180 (21,740) (3,350) 58,394 66,282
Dividend payout (%) 109.0 5.2 27.3 62.2 57.6 Source: Company, Centrum Broking
Valuation (x)
P/E 17.0 10.7 9.4 6.4 5.9
P/BV 1.8 2.1 1.8 1.7 1.5
EV/EBITDA 4.6 2.7 1.2 0.6 0.3
Dividend yield (%) 6.1 1.3 3.1 9.7 9.7
Source: Company, Centrum Broking

Centrum Institutional Research 245


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

BPCL
BPCL has seen the scope and scale of profitability, and hence, cash flows improve Market data
dramatically post FY15, when the subsidy regime was completely done away with. Current price: Rs439
Since then, its annual OCF (pre WC) has nearly doubled to ~Rs127bn vs ~Rs73bn over Bloomberg: BPCL IN
FY12-15. Working capital has also shown the same trend, negative over FY12-14 due 52-week H/L: Rs503/325
to higher liabilities from the government and then turning positive from FY15.
Market cap: Rs952.4bn
Cumulative CFO of Rs1,138bn has been used for capex of Rs683.5bn and investments
of Rs23bn – we note that the investments number is supressed by the large NRL Free float: 40.2%
divestment done in FY21 (~Rs98bn), excluding which investments total Rs71-75bn. Avg. daily vol. 3mth: 5,131,573
Source: Bloomberg

Operating profits have picked up sharply post FY15: Operating profits, and hence, operating cash flows have picked up
dramatically post FY15, with the removal of the subsidy regime. Working capital has also followed a largely similar route from
FY15 onwards, boosting overall CFO vs being a drag over FY12-15. FY20 saw the metrics slip again due to weak profitability,
but the trend has picked up again FY21 onwards.
Exhibit 653: Cash flows from operations – a structural change post FY15

Scale and scope of the business changed dramatically post FY15, when the
250,000 subsidy system was done away with

200,000

150,000
Rsmn

100,000

50,000

-50,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally been a drag on the business cash flows pre-FY15,
with large subsidy-related receivables impacting NWC. Over the last decade, NWC has stayed at an average of 15-20 days.
Exhibit 654: On an average, NWC was at 15-20 days over the last decade – FY21 has seen a spike

NWC days have been volatile, but absolute impact of working


60 capital on cash flows has not been material post FY15 35
50 30
40 25
# of days

# of days

20
30
15
20 10
10 5
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC

Source: Company, Centrum Broking


xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
BPCL 16 September 2021

Exhibit 655: OCF/PAT averaged at ~2x over FY12-21 Exhibit 656: OCF/EBITDA at ~1x over FY12-21

5.0 3.0
4.5
2.5
4.0
3.5 2.0
3.0
2.5 1.5

x
x

2.0
1.0
1.5
1.0 0.5
0.5
0.0 0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Step change in operations post FY15 reflects in FCF, though trends remain volatile: In the initial years of our review period,
FCF conversion was weak, with capex outweighing core OCF. In the later years, while both capex and investments increased
dramatically, FCF still rose over FY15-18, before dipping once again, as capex jumped even more and investments in various
JVs/other business segments ramped up.
Exhibit 657: Capex intensity, acquisitions and free cash flows – upstream entry, JV refineries key investments over FY12-21
NRL divestment to facilitate the
Bina Refinery equity contribution ramped up
divestment process of BPCL
250,000 300,000
200,000 250,000
150,000 200,000
100,000 150,000
Rsmn

Rsmn
50,000 100,000
0 50,000
-50,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0
-100,000 -50,000
-150,000 Initiating purchase of Mozambique Area 1 -100,000
CFO Capex Acquisition/Investments FCF
Source: Company, Centrum Broking

Return ratios have steadily improved, barring a weak FY20: While BPCL’s RoE/RoCE have consistently improved (barring a
weak FY20), leverage has been relatively more volatile, fluctuating in line with capex and investment trends. Overall FCF
conversion has been weak, particularly over the last three years after growing at a healthy pace over FY15-18.
Exhibit 658: Return ratios and leverage trends – FY20 a bad year, FY21 has seen a recovery
BPCL’s return ratios have consistently improved post FY15, barring FY20, when large inventory losses dragged down profitability
6.0 35.0%
5.0 30.0%
25.0%
4.0
20.0%
3.0
x

15.0%
2.0
10.0%
1.0 5.0%
0.0 0.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 248


BPCL 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 2,989,781 2,848,396 2,361,787 3,197,790 3,378,673 Equity share capital 19,669 19,669 20,929 20,929 20,929
Operating Expense 2,795,919 2,695,999 2,110,766 2,974,495 3,126,345 Reserves & surplus 347,708 312,475 524,516 573,983 631,451
Employee cost 36,642 36,915 44,772 40,295 43,115 Shareholders fund 367,377 332,144 545,446 594,912 652,380
Others 27,256 31,110 32,946 34,593 36,323 Minority Interest 0 0 0 0 0
EBITDA 129,964 84,373 173,304 148,408 172,891 Total debt 290,993 476,663 288,676 198,676 191,348
Depreciation & Amortisation 31,893 37,869 39,781 40,974 43,023 Non Current Liabilities 3,405 4,357 6,080 6,383 6,703
EBIT 98,072 46,504 133,523 107,434 129,868 Def tax liab. (net) 61,690 59,673 44,716 40,887 37,250
Interest expenses 13,190 21,819 13,284 5,960 5,740 Total liabilities 723,465 872,837 884,917 840,859 887,681
Other income 29,836 30,813 43,445 40,106 40,356 Gross block 561,555 701,821 811,062 916,062 1,016,062
PBT 104,396 26,710 226,176 141,580 164,484 Less: acc. Depreciation (93,043) (128,343) (168,124) (209,098) (252,120)
Taxes 33,076 (122) 35,759 22,384 26,005 Net block 468,512 573,477 642,939 706,965 763,942
Effective tax rate (%) 31.7 22.5 15.8 15.8 15.8 Capital WIP 67,026 91,081 70,948 70,948 70,948
PAT 71,320 26,832 190,417 119,196 138,478 Net fixed assets 535,539 664,558 713,886 777,912 834,890
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 71,320 31,502 145,274 119,196 138,478 Investments 124,711 121,174 121,561 108,495 108,495
Extraordinary items 0 (4,670) 45,142 0 0 Inventories 215,447 204,211 267,568 316,793 317,977
Reported PAT 71,320 26,832 190,417 119,196 138,478 Sundry debtors 66,707 51,643 78,275 97,553 103,071
Cash & Cash Equivalents 51,713 53,243 138,478 144,500 226,259
Ratios Loans & advances 162,156 169,860 86,278 96,278 106,278
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 397,685 357,474 478,279 655,681 762,046
Revenue 26.6 (4.7) (17.1) 35.4 5.7 Other current liab. 0 0 0 0 0
EBITDA 9.2 (35.1) 105.4 (14.4) 16.5 Provisions 35,123 34,379 42,849 44,992 47,241
Adj. EPS (10.6) (55.8) 361.2 (18.0) 16.2 Net current assets 63,215 87,104 49,469 (45,549) (55,703)
Margins (%) Total assets 723,465 872,837 884,917 840,859 887,681
Gross 10.9 10.0 15.8 11.0 11.4
EBITDA 4.3 3.0 7.3 4.6 5.1 Cashflow
EBIT 3.3 1.6 5.7 3.4 3.8 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 2.4 1.1 6.2 3.7 4.1 Profit Before Tax 104,396 26,710 226,176 141,580 164,484
Returns (%) Depreciation & Amortisation 31,893 37,869 39,781 40,974 43,023
ROE 20.1 9.0 33.1 20.9 22.2 Net Interest 13,190 21,819 13,284 (34,146) (34,616)
ROCE 14.2 8.2 18.1 15.3 17.5 Net Change – WC (34,577) 5,081 35,716 101,345 92,232
ROIC 15.2 6.5 18.6 16.2 20.8 Direct taxes (20,711) (15,454) (28,338) (26,213) (29,642)
Turnover (days) Net cash from operations 76,449 63,578 201,284 223,540 235,481
Gross block turnover ratio (x) 5.3 4.1 2.9 3.5 3.3 Capital expenditure (90,168) (94,332) (61,070) (105,000) (100,000)
Debtors 7 8 10 10 11 Acquisitions, net 0 0 0 0 0
Inventory 29 30 43 37 39 Investments (236) 991 (9,793) 13,066 0
Creditors 51 54 77 73 86 Others 15,039 702 91,577 34,146 34,616
Net working capital 8 11 8 (5) (6) Net cash from investing (75,366) (92,640) 20,714 (57,788) (65,384)
Solvency (x) FCF (13,720) (30,755) 140,215 118,540 135,481
Net debt-equity 0.7 1.3 0.3 0.1 (0.1) Issue of share capital 0 0 55,195 0 0
Interest coverage ratio 9.9 3.9 13.0 24.9 30.1 Increase/(decrease) in debt 51,762 106,150 (149,911) (90,000) (7,328)
Net debt/EBITDA 1.8 5.0 0.9 0.4 (0.2) Dividend paid (41,883) (57,378) (42,613) (69,730) (81,010)
Per share (Rs) Interest paid (10,753) (13,266) (12,306) 0 0
Adjusted EPS 34.1 15.1 69.4 57.0 66.2 Others (1,079) (6,239) (6,588) 0 0
BVPS 175.5 158.7 260.6 284.3 311.7 Net cash from financing (1,954) 29,266 (156,223) (159,730) (88,338)
CEPS 49.3 33.1 88.4 76.5 86.7 Net change in Cash (871) 204 65,776 6,023 81,759
DPS 19.7 17.1 79.0 28.5 33.1 Source: Company, Centrum Broking
Dividend payout (%) 57.8 133.4 86.8 50.0 50.0
Valuation (x)
P/E 12.9 29.2 6.3 7.7 6.6
P/BV 2.5 2.8 1.7 1.5 1.4
EV/EBITDA 9.2 16.3 6.4 6.8 5.3
Dividend yield (%) 4.5 3.9 18.0 6.5 7.5
Source: Company, Centrum Broking

Centrum Institutional Research 249


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

GAIL India (GAIL)


GAIL’s cash flows have been variable, with both profitability and volatile working Market data
capital impacting operating cash flow generation. Overall, net OCF has steadily Current price: Rs157
grown at a CAGR of 5% over FY12-21. Cumulative OCF of Rs727bn has been utilized Bloomberg: GAIL IN
in capex of Rs413bn and investments/acquisitions of Rs39bn, leaving FCF of Rs353bn 52-week H/L: Rs170/81
over the period. Steadily improving profitability, reflecting in higher cash flows, has
Market cap: Rs697.8bn
reflected in lower leverage (Net DER down to 0.1x in FY21 from 0.2x in FY12) but a
steady expansion in asset base has led to moderation in return ratios. Free float: 41.2%
Avg. daily vol. 3mth: 12,618,670
Source: Bloomberg

History of steady improvement in cash flows: Operating profits have been robust and have mostly expanded over the last 10
years. Working capital intensity in the business has been high, but the cumulative impact of working capital on cash flows has
been positive (cumulative positive impact of Rs6bn over FY12-21). As a result, the company has generated strong operating
cash flows, albeit the trend has been a bit inconsistent.
Exhibit 659: Cash flows from operations
120,000
A one-way trend for cash flows barring FY15-16, when KG D6 decline was not completely offset by higher LNG volumes
100,000
80,000
60,000
Rsmn

40,000
20,000
0
(20,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(40,000)
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, with net
working capital (NWC) sustaining at an average of 15-18 days over most of the last decade. The company has seen average
working capital levels mostly favoring on the upside, helping boost net operating cash flows.
Exhibit 660: NWC has varied between 10 and 15 days post FY15
40 NWC has varied between 10 and 15 days post FY15, but has not been a material component of OCF 25
35
20
30
25
# of days

# of days

15
20
15 10
10
5
5
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
GAIL India (GAIL) 16 September 2021

Exhibit 661: OCF/PAT Exhibit 662: OCF/EBITDA

300% 160%
140%
250%
120%
200%
100%
150% 80%
%

%
60%
100%
40%
50%
20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been volatile: Conversion of OCF to FCF has been patchy, with steadily rising
organic capex and the need to fund multiple subsidiaries specially in the CGD/LNG/Petchem spaces, dragging down the net
FCF to CFO ratio (particularly, GAIL Gas and BCPL have dragged). FCF as a % of OCF has ranged wildly from -10% to as high as
80% over the last decade.
Exhibit 663: Capex intensity, acquisitions and free cash flows
150,000 Investments in GAIL Additional equity in GAIL Gas/ 80,000
Additional equity in GAIL
Gas/BCPL/OPAL and fresh investments in Konkan
Gas and BCPL
Ratnagiri Power LNG/Ramgundam Fertilizer
100,000 60,000

50,000 40,000
Rsmn

Rsmn
10,455 4,134 4,563 6,720 3,418 6,000
886 685 1,811 0
0 20,000

-50,000 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-100,000 CFO Capex Acquisition/Investments FCF -20,000

Source: Company, Centrum Broking

Return ratios have moderated somewhat; leverage remains a non-issue: Sustained improvement in profitability and mostly
positive working capital impact have meant that the balance sheet has consistently remained relatively free of leverage over
the last decade. With capex intensity higher over FY12-21, return ratios have moderated somewhat.
Exhibit 664: Return ratios and leverage trends

2.0 Leverage has been a non-issue post FY17 and reflects in improving return ratios over the last five years 20.0%

1.5
15.0%

1.0
10.0%
x

0.5

5.0%
0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-0.5 0.0%
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 251


GAIL India (GAIL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 748,983 720,570 567,302 684,142 672,348 Equity share capital 22,551 45,101 44,404 44,404 44,404
Operating Expense 588,642 573,605 451,597 544,607 535,219 Reserves & surplus 418,379 394,610 421,708 469,572 522,238
Employee cost 17,784 15,193 16,256 17,394 18,611 Shareholders fund 440,930 439,711 466,112 513,976 566,642
Others 49,287 46,218 34,997 18,131 2,435 Minority Interest 0 0 0 0 0
EBITDA 93,271 85,554 64,451 104,009 116,083 Total debt 10,011 54,118 55,656 57,177 72,023
Depreciation & Amortisation 15,502 18,360 19,079 21,325 23,045 Non Current Liabilities 34,384 44,860 56,056 57,738 59,470
EBIT 77,769 67,194 45,373 82,684 93,038 Def tax liab. (net) 59,477 44,972 45,022 44,396 43,744
Interest expenses 1,385 1,085 1,559 3,035 3,827 Total liabilities 544,801 583,661 622,846 673,287 741,879
Other income 15,448 14,168 20,045 18,757 19,067 Gross block 369,602 413,331 460,939 495,939 535,939
PBT 90,848 79,434 63,858 98,406 108,278 Less: acc. Depreciation (58,741) (76,881) (95,960) (117,285) (140,330)
Taxes 30,592 13,227 14,956 24,769 27,254 Net block 310,861 336,450 364,979 378,654 395,609
Effective tax rate (%) 33.7 16.7 23.4 25.2 25.2 Capital WIP 92,025 105,819 119,034 154,034 209,034
PAT 60,257 66,206 48,902 73,637 81,024 Net fixed assets 402,886 442,269 484,014 532,688 604,643
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 60,916 59,320 48,902 73,637 81,024 Investments 106,204 84,013 96,273 96,273 96,273
Extraordinary items (659) 6,887 0 0 0 Inventories 23,219 29,601 26,038 31,401 30,860
Reported PAT 60,257 66,206 48,902 73,637 81,024 Sundry debtors 50,743 55,759 44,858 54,097 53,164
Cash & Cash Equivalents 12,147 8,039 13,618 9,058 5,016
Ratios Loans & advances 48,587 65,655 68,304 68,304 68,304
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 39,612 41,284 43,264 49,913 47,859
Revenue 39.6 (3.8) (21.3) 20.6 (1.7) Other current liab. 45,120 47,544 53,395 53,609 53,725
EBITDA 22.2 (8.3) (24.7) 61.4 11.6 Provisions 14,253 12,847 13,600 15,013 14,797
Adj. EPS 32.4 (2.6) (17.6) 50.6 10.0 Net current assets 35,711 57,379 42,559 44,325 40,963
Margins (%) Total assets 544,801 583,661 622,846 673,287 741,879
Gross 21.4 20.4 20.4 20.4 20.4
EBITDA 12.5 11.9 11.4 15.2 17.3 Cashflow
EBIT 10.4 9.3 8.0 12.1 13.8 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 8.1 8.2 8.6 10.8 12.1 Profit Before Tax 90,848 79,434 63,858 98,406 108,278
Returns (%) Depreciation & Amortisation 15,502 18,360 19,079 21,325 23,045
ROE 14.4 13.5 10.8 15.0 15.0 Net Interest (3,066) (2,027) (6,305) (2,020) (1,228)
ROCE 14.1 14.4 9.9 13.9 13.9 Net Change – WC (3,282) 3,073 22,210 (6,490) (849)
ROIC 16.6 15.3 8.5 14.1 13.9 Direct taxes (20,764) (19,555) (12,754) (25,395) (27,904)
Turnover (days) Net cash from operations 78,763 68,881 80,639 78,327 93,842
Gross block turnover ratio (x) 2.0 1.7 1.2 1.4 1.3 Capital expenditure (72,022) (54,345) (49,767) (70,000) (95,000)
Debtors 22 27 32 26 29 Acquisitions, net 0 0 0 0 0
Inventory 13 17 22 19 21 Investments 0 0 0 0 0
Creditors 24 26 34 31 33 Others 17,656 (13,944) 11,158 12,719 12,723
Net working capital 17 29 27 24 22 Net cash from investing (54,366) (68,289) (38,609) (57,281) (82,277)
Solvency (x) FCF 6,741 14,536 30,872 8,327 (1,158)
Net debt-equity 0.0 0.1 0.1 0.1 0.1 Issue of share capital 0 0 (12,810) 0 0
Interest coverage ratio 67.3 78.9 41.3 34.3 30.3 Increase/(decrease) in debt (11,348) 45,196 4,564 1,521 14,846
Net debt/EBITDA 0.0 0.5 0.7 0.5 0.6 Dividend paid (20,886) (39,421) (22,371) (25,773) (28,358)
Per share (Rs) Interest paid (1,417) (1,132) (3,199) (3,035) (3,827)
Adjusted EPS 13.7 13.4 11.0 16.6 18.2 Others (3,894) (9,344) (1,575) 1,682 1,732
BVPS 99.3 99.0 105.0 115.8 127.6 Net cash from financing (37,544) (4,700) (35,391) (25,605) (15,607)
CEPS 17.2 17.5 15.3 21.4 23.4 Net change in Cash (13,147) (4,109) 6,639 (4,560) (4,042)
DPS 3.9 6.5 5.0 5.8 6.4 Source: Company, Centrum Broking
Dividend payout (%) 28.8 43.6 45.4 35.0 35.0
Valuation (x)
P/E 11.5 11.8 14.3 9.5 8.6
P/BV 1.6 1.6 1.5 1.4 1.2
EV/EBITDA 7.5 8.7 11.5 7.2 6.6
Dividend yield (%) 2.5 4.1 3.2 3.7 4.1
Source: Company, Centrum Broking

Centrum Institutional Research 252


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

Gujarat Gas (GGL)


GGL’s cash flows have closely approximated fluctuations in operating profits, with Market data
very little impact of working capital on the company’s cash flow generation. Barring Current price: Rs682
a couple of weak years over FY16-17, operating cash flows have averaged ~Rs12bn Bloomberg: GUJGA IN
over FY14-21 (company was merged and formed only in FY14). Cumulative OCF of 52-week H/L: Rs787/281
Rs89bn has been utilized in capex of Rs41bn and investments/acquisitions of
Market cap: Rs469.6bn
Rs4.6bn, leaving FCF of Rs43.5bn. Steadily improving profitability, reflecting in higher
cash flows, has reflected in lower leverage (Net DER down to 0.1x in FY21 from 2x in Free float: 25%
FY14) and higher return ratios (RoE up 830bp in 7 years, RoCE up 1,280bp). Avg. daily vol. 3mth: 2,326,603
(*Period under review FY14 onwards, as consolidated data for the entity post merger with GSPC Gas Source: Bloomberg
only available from then)

History of robust and consistent cash flows from operations: Operating profits have been robust and have consistently
expanded over the last 8 years, barring FY16-17. Working capital intensity in the business has been low, and over the last two
years, there has been a very sharp expansion in cash flows, driven by higher profitability. As a result, the company has
consistently generated strong operating cash flow.
Exhibit 665: OCF has consistently expanded over the last 8 years
25,000

20,000

15,000
Rsmn

10,000

5,000

0
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-5,000
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, with net
working capital (NWC) being in the range of -1 to +8 days over the period under observation. This trend has remained fairly
constant despite a marked change in the scale of operations.
Exhibit 666: NWC has been in the range of -1 to +8 days
35 10
30 8

25 6
No of Days

4
# of days

20
2
15
0
10 -2
5 -4
0 -6
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Gujarat Gas (GGL) 16 September 2021

Exhibit 667: OCF/PAT Exhibit 668: OCF/EBITDA

400% 115%
350% 110%
300%
105%
250%
100%

%
200%
%

150% 95%
100%
90%
50%
0% 85%
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been steady: The initial years of operations pre-merger of erstwhile Gujarat
Gas with GSPC Gas (FY14-15) are not really representative of normal business operations. Post the initial adjustments,
conversion of OCF to FCF has been relatively unobtrusive and steady. Capex has been going up over the last few years, as
GGL has been aggressively expanding its operations; hence, FCF as a % of OCF has reduced materially over FY19-21.
Exhibit 669: Capex intensity, acquisitions and free cash flows
25,000
20,000
15,000
10,000
Rsmn

5,000
0
-5,000
-10,000
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-15,000
CFO Capex Acquisition/Investments FCF
Source: Company, Centrum Broking

Return ratios have expanded steadily; leverage has reduced materially: The sustained improvement in profitability and no
material impact of working capital-related issues has meant that return ratios have expanded meaningfully over the last 8
years. Balance sheet has also seen a steady improvement in leverage over this period.
Exhibit 670: Return ratios and leverage trends
6 40%
35%
5
30%
4
25%
3 20%
x

15%
2
10%
1
5%
0 0%
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 254


Gujarat Gas (GGL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 77,544 1,03,003 98,543 1,53,211 1,77,333 Equity share capital 1,377 1,377 1,377 1,377 1,377
Operating Expense 60,830 78,818 69,898 1,16,576 1,35,252 Reserves & surplus 20,463 31,529 43,450 58,809 76,724
Employee cost 1,600 1,754 1,775 2,307 2,769 Shareholders fund 21,840 32,906 44,827 60,186 78,101
Others 5,268 5,929 5,992 7,302 8,310 Minority Interest 0 0 0 0 0
EBITDA 9,846 16,503 20,878 27,026 31,002 Total debt 22,131 19,983 7,700 2,700 2,200
Depreciation & Amortisation 2,880 3,180 3,408 3,765 4,114 Non Current Liabilities 0 0 0 0 0
EBIT 6,966 13,323 17,470 23,260 26,888 Def tax liab. (net) 10,816 8,005 8,063 8,063 8,063
Interest expenses 1,962 1,922 1,163 243 198 Total liabilities 54,787 60,895 60,589 70,948 88,363
Other income 1,113 837 740 1,193 1,547 Gross block 68,417 74,263 81,470 89,970 98,470
PBT 5,939 12,078 17,047 24,210 28,238 Less: acc. Depreciation (15,526) (18,416) (21,824) (25,589) (29,703)
Taxes 1,768 145 4,292 6,095 7,110 Net block 52,891 55,847 59,646 64,381 68,767
Effective tax rate (%) 29.8 1.2 25.2 25.2 25.2 Capital WIP 4,885 5,686 6,876 6,876 6,876
PAT 4,170 11,933 12,755 18,115 21,128 Net fixed assets 57,776 61,533 66,522 71,257 75,643
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 4,290 9,158 12,755 18,115 21,128 Investments 2,496 2,448 3,163 5,663 8,163
Extraordinary items (120) 2,776 0 0 0 Inventories 694 463 522 812 940
Reported PAT 4,170 11,933 12,755 18,115 21,128 Sundry debtors 5,103 5,101 7,831 10,958 11,415
Cash & Cash Equivalents 3,092 6,919 3,187 16,119 29,456
Ratios Loans & advances 1,481 1,436 1,420 1,704 2,044
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 634 1,074 1,849 1,942 2,039
Growth (%) Trade payables 16,008 17,495 23,142 36,666 40,413
Revenue 25.6 32.8 (4.3) 55.5 15.7 Other current liab. 0 0 0 0 0
EBITDA 10.0 67.6 26.5 29.4 14.7 Provisions 480 583 763 839 923
Adj. EPS 47.2 113.5 39.3 42.0 16.6 Net current assets (5,484) (3,086) (9,097) (5,972) 4,557
Margins (%) Total assets 54,787 60,894 60,589 70,948 88,363
Gross 21.6 23.5 29.1 23.9 23.7
EBITDA 12.7 16.0 21.2 17.6 17.5 Cashflow
EBIT 9.0 12.9 17.7 15.2 15.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 5.5 8.9 12.9 11.8 11.9 Profit Before Tax 5,939 12,078 17,047 24,210 28,238
Returns (%) Depreciation & Amortisation 2,880 3,180 3,408 3,765 4,114
ROE 21.3 33.5 32.8 34.5 30.6 Net Interest 976 1,341 747 243 198
ROCE 13.2 28.9 25.9 31.7 29.7 Net Change – WC (289) 413 (537) 9,808 2,809
ROIC 12.9 32.1 29.1 39.9 48.0 Direct taxes 0 (2,801) (4,166) (6,095) (7,110)
Turnover (days) Net cash from operations 9,561 14,220 16,552 30,738 26,701
Gross block turnover ratio (x) 1.1 1.4 1.2 1.7 1.8 Capital expenditure (5,304) (5,955) (7,512) (8,500) (8,500)
Debtors 21 18 24 22 23 Acquisitions, net 0 0 0 0 0
Inventory 4 3 3 2 2 Investments (1,696) 711 998 (2,500) (2,500)
Creditors 89 78 106 94 104 Others 958 576 431 1,193 1,547
Net working capital (26) (11) (34) (14) 9 Net cash from investing (6,042) (4,668) (6,083) (9,807) (9,453)
Solvency (x) FCF 4,257 8,266 9,040 22,238 18,201
Net debt-equity 0.9 0.4 0.1 (0.2) (0.3) Issue of share capital 0 0 0 0 0
Interest coverage ratio 5.0 8.6 18.0 111.2 156.6 Increase/(decrease) in debt (1,139) (2,322) (11,150) (5,000) (500)
Net debt/EBITDA 1.9 0.8 0.2 (0.5) (0.9) Dividend paid (408) (837) (863) (2,755) (3,214)
Per share (Rs) Interest paid (1,947) (1,864) (1,163) (243) (198)
Adjusted EPS 6.2 13.3 18.5 26.3 30.7 Others 0 0 0 0 0
BVPS 31.7 47.8 65.1 87.4 113.5 Net cash from financing (3,494) (5,024) (13,177) (7,998) (3,912)
CEPS 10.4 17.9 23.5 31.8 36.7 Net change in Cash 25 4,528 (2,708) 12,933 13,337
DPS 1.2 1.5 2.0 4.0 4.7 Source: Company, Centrum Broking
Dividend payout (%) 19.9 8.4 10.8 15.2 15.2
Valuation (x)
P/E 109.5 51.3 36.8 25.9 22.2
P/BV 21.5 14.3 10.5 7.8 6.0
EV/EBITDA 49.6 29.2 22.7 16.9 14.3
Dividend yield (%) 0.2 0.2 0.3 0.6 0.7
Source: Company, Centrum Broking

Centrum Institutional Research 255


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

Gujarat State Petronet (GSPL)


GSPL’s cash flows have closely approximated fluctuations in operating profits, with Market data
relatively little impact of working capital on the company’s cash flow generation Current price: Rs335
(FY17 an exception). Operating cash flows have consistently grown at a CAGR of 5% Bloomberg: GUJS IN
over FY12-21. Cumulative OCF of Rs114bn has been utilized in capex of Rs20.4bn and 52-week H/L: Rs383/177
investments/acquisitions of Rs52bn, leaving FCF of Rs49bn over the period. Steadily
Market cap: Rs189bn
improving profitability, leading to higher cash flows, has reflected in lower leverage
(Net DER down to 0.1x in FY21 from 0.4x in FY12), but a steady expansion in the Free float: 39.9%
asset base has reflected in moderating return ratios over the period. Avg. daily vol. 3mth: 1,220,073
Source: Bloomberg

History of steady improvement in cash flows: Operating profits have been robust and have mostly expanded over the last 10
years. Working capital intensity in the business has been low, except in FY17. There has been a very sharp expansion in cash
flows, driven by higher profitability. As a result, the company has consistently generated strong operating cash flows.
Exhibit 671: OCF has improved steadily over the last decade
Rising demand for gas in Gujarat and access to LNG drive cash flows higher
20000

15000

10000
Rsmn

5000

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-5000
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, with net
working capital (NWC) days steadily declining post FY16, as operational scale transformed. This trend has steadily solidified
over the last 4-5 years, with a consistent decline in net working capital days over FY16-21.
Exhibit 672: NWC days have consistently declined over FY16-21
Contrary to usual trends, higher scale of operations has reduced working capital intensity
100 120

80 100
80
# of days

# of days

60
60
40
40
20 20
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Gujarat State Petronet (GSPL) 16 September 2021

Exhibit 673: OCF/PAT Exhibit 674: OCF/EBITDA

2.5 1.4
1.2
2
1
1.5 0.8
x

x
1 0.6
0.4
0.5
0.2
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been volatile: Conversion of OCF to FCF has been patchy, despite relatively
moderate capex. This is due to consistent investments in various subsidiaries to fund their requirements and the acquisition
of a controlling stake in Gujarat Gas from parent, GSPC Group in FY18, acquisition of Swan LNG in FY20 and increase of stake
in Sabarmati Gas in FY16. GSPL has also been annually increasing equity contribution to subsidiaries, GSPL India Gasnet and
GSPL India Transco.
Exhibit 675: Capex intensity, acquisitions and free cash flows
20,000 20,000
10,000
10,000
0
-10,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0
Rsmn

Rsmn
-20,000 -10,000
-30,000 GSPL distribution
network equity -20,000
-40,000 Sabarmati Gas
stake increase Controlling stake
-50,000 in Gujarat Gas -30,000

CFO Capex Acquisition/Investments FCF


Source: Company, Centrum Broking

Return ratios have moderated somewhat; leverage remains a non-issue: The sustained improvement in profitability and no
material impact of working capital-related issues has meant that balance sheet has consistently remained free of leverage
over the last decade. With capex intensity higher over FY12-17, return ratios have moderated somewhat.
Exhibit 676: Return ratios and leverage trends
Similar to GAIL, volumes and profitability took a hit, as KG started to decline from FY14 – higher LNG
2.5 volumes post FY17 helped 25.0%

2
20.0%

1.5
15.0%
1
x

10.0%
0.5

5.0%
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-0.5 0.0%
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 257


Gujarat State Petronet (GSPL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 18,773 23,693 20,794 22,508 23,807 Equity share capital 5,640 5,641 5,642 5,642 5,642
Operating Expense 2,452 7,063 5,195 5,629 5,855 Reserves & surplus 51,800 61,584 69,808 78,608 88,048
Employee cost 645 619 592 639 690 Shareholders fund 57,440 67,226 75,450 84,250 93,690
Others 249 261 274 288 303 Minority Interest 0 0 0 0 0
EBITDA 15,426 15,749 14,733 15,951 16,959 Total debt 23,660 16,303 7,499 5,499 3,499
Depreciation & Amortisation 1,800 1,966 2,030 2,127 2,295 Non Current Liabilities 457 975 1,101 1,112 1,123
EBIT 13,626 13,783 12,703 13,824 14,664 Def tax liab. (net) 5,226 4,081 4,218 4,229 4,201
Interest expenses 2,192 1,645 929 546 403 Total liabilities 86,784 88,585 88,268 95,089 1,02,513
Other income 594 649 693 727 764 Gross block 43,245 44,848 45,688 49,188 53,188
PBT 12,028 12,786 12,467 14,005 15,024 Less: acc. Depreciation (7,170) (8,990) (11,020) (13,147) (15,443)
Taxes 4,081 1,699 3,160 3,529 3,786 Net block 36,075 35,857 34,668 36,041 37,745
Effective tax rate (%) 33.9 13.3 25.3 25.2 25.2 Capital WIP 4,194 2,372 2,215 2,215 2,215
PAT 7,947 11,087 9,307 10,476 11,238 Net fixed assets 40,269 38,229 36,883 38,256 39,960
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 7,947 11,113 9,371 10,476 11,238 Investments 43,684 47,159 51,101 55,669 60,236
Extraordinary items 0 (25) (64) 0 0 Inventories 1,279 1,261 1,296 1,403 1,484
Reported PAT 7,947 11,087 9,307 10,476 11,238 Sundry debtors 2,081 1,637 1,586 1,717 1,816
Cash & Cash Equivalents 1,583 957 877 1,382 2,235
Ratios Loans & advances 604 1,785 1,985 2,191 2,364
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 238 410 620 671 710
Revenue 41.0 26.2 (12.2) 8.2 5.8 Other current liab. 2,262 1,757 4,533 4,533 4,533
EBITDA 34.4 2.1 (6.5) 8.3 6.3 Provisions 216 276 307 324 340
Adj. EPS 18.9 39.8 (15.7) 11.8 7.3 Net current assets 2,831 3,197 284 1,165 2,316
Margins (%) Total assets 86,784 88,585 88,268 95,089 1,02,513
Gross 100.0 100.0 100.0 100.0 100.0
EBITDA 82.2 66.5 70.9 70.9 71.2 Cashflow
EBIT 72.6 58.2 61.1 61.4 61.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 42.3 46.9 45.1 46.5 47.2 Profit Before Tax 12,028 12,786 12,382 14,005 15,024
Returns (%) Depreciation & Amortisation 1,800 1,966 2,048 2,127 2,295
ROE 14.7 17.8 13.1 13.1 12.6 Net Interest 1,983 1,491 837 546 403
ROCE 11.6 15.2 12.0 12.6 12.3 Net Change – WC (955) 893 684 (376) (298)
ROIC 25.5 33.6 28.6 32.5 32.5 Direct taxes (3,639) (3,082) (3,025) (3,519) (3,814)
Turnover (days) Net cash from operations 10,882 13,602 12,412 12,783 13,611
Gross block turnover ratio (x) 0.4 0.5 0.5 0.5 0.4 Capital expenditure (2,118) (1,066) (1,119) (3,500) (4,000)
Debtors 32 29 28 27 27 Acquisitions, net 0 0 0 0 0
Inventory 187 66 90 87 90 Investments 1,476 (2,594) (3,846) (4,568) (4,568)
Creditors 32 17 36 42 43 Others 563 558 586 0 0
Net working capital 55 49 5 19 36 Net cash from investing (80) (3,102) (4,379) (8,068) (8,568)
Solvency (x) FCF 8,764 12,536 11,293 9,283 9,611
Net debt-equity 0.4 0.2 0.1 0.0 0.0 Issue of share capital 12 8 8 0 0
Interest coverage ratio 7.0 9.6 15.9 29.2 42.0 Increase/(decrease) in debt (6,912) (7,344) (6,047) (1,989) (1,989)
Net debt/EBITDA 1.4 1.0 0.4 0.3 0.1 Dividend paid (1,128) (1,283) (1,128) (1,676) (1,798)
Per share (Rs) Interest paid (2,299) (1,678) (924) (546) (403)
Adjusted EPS 14.1 19.7 16.6 18.6 19.9 Others 0 0 0 0 0
BVPS 101.8 119.2 133.8 149.4 166.1 Net cash from financing (10,328) (10,297) (8,091) (4,211) (4,190)
CEPS 17.3 23.2 20.2 22.3 24.0 Net change in Cash 475 203 (57) 504 853
DPS 2.0 2.0 2.0 3.0 3.2 Source: Company, Centrum Broking
Dividend payout (%) 14.0 10.0 12.1 16.0 16.0
Valuation (x)
P/E 23.8 17.0 20.1 18.0 16.8
P/BV 3.3 2.8 2.5 2.2 2.0
EV/EBITDA 13.7 13.0 13.3 12.1 11.2
Dividend yield (%) 0.6 0.6 0.6 0.9 1.0
Source: Company, Centrum Broking

Centrum Institutional Research 258


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

HPCL
HPCL has seen the scope and scale of profitability, and hence, cash flows improve Market data
dramatically post FY15, when the subsidy regime was completely done away with. Current price: Rs283
Since then, annual OCF (pre WC) has doubled to ~Rs117bn vs Rs55-56bn over FY12- Bloomberg: HPCL IN
15. Working capital has also shown a similar trend – negative over FY12-14 due to 52-week H/L: Rs312/163
higher liabilities from the government and then turning positive from FY15 onwards.
Market cap: Rs400.7bn
Cumulatively, OCF of Rs1,014bn has been utilized for capex of Rs694bn and
investments of Rs66.5bn. We note that the trajectory of both capex and investments Free float: 41.7%
has picked up sharply over FY19-21, dragging down FCF. Avg. daily vol. 3mth: 4,200,257
Source: Bloomberg

Operating profits have picked up sharply post FY15: Operating profits, and hence, operating cash flows have picked up
dramatically post FY15, with the removal of the subsidy regime. Working capital has also followed a largely similar trend from
FY15 onwards, boosting overall OCF vs being a drag over FY12-15.
Exhibit 677: Since FY15, WC changes have not been a drag on OCF
250,000 Working capital has become a non-material part of cash flows post FY15

200,000

150,000
Rsmn

100,000

50,000

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50,000
Operating Cash flow before WCAP changes WCAP changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally been a drag on the business cash flows pre-FY15,
with large subsidy-related outstanding impacting NWC. Over the last decade, NWC has stayed at an average of 15-20 days.
Exhibit 678: NWC has stayed at an average of 15-20 days over the last decade
60 35

50 30

25
40
# of days

# of days

20
30
15
20
10
10 5

0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking
nxxxxx

Please see Appendix for analyst certifications and all other important disclosures.
HPCL 16 September 2021

Exhibit 679: OCF/PAT Exhibit 680: OCF/EBITDA

1000% 450%
900% 400%
800% 350%
700% 300%
600%
250%
500%
%

%
200%
400%
300% 150%
200% 100%
100% 50%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been volatile: In the initial years of our review period, FCF conversion was
weak, with capex outweighing core OCF. In the later years, while both capex and investments increased dramatically, FCF still
rose over FY15-18 before dipping again, as capex jumped even more and investments in various JVs/other business segments
ramped up.
Exhibit 681: Capex intensity, acquisitions and free cash flows
250,000 FY17-18 saw bigger CGD investments and start of work at Ramp up of Rajasthan refinery equity funding 200,000
200,000 the Rajasthan Barmer refinery and HMEL refinery expansion by 1.7mt
150,000
150,000
100,000 100,000
Rs,mn

50,000

Rsmn
50,000
0
-50,000 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-100,000
-50,000
-150,000
FY12-13 saw HMEL Bhatinda refinery set up
-200,000 -100,000
CFO Capex Acquisition/Investments FCF
Source: Company, Centrum Broking

Return ratios have improved: While RoE has consistently improved for HPCL (barring a weak FY20), leverage has been far
more volatile, fluctuating in line with capex and investment trends. Overall FCF conversion has been weak, particularly over
the last three years after growing at a healthy pace over FY15-18.
Exhibit 682: Return ratios and leverage trends

RoE has expanded steadily over FY15-20 and has improved in FY21 as well post the FY20 weakness
7 40.0%
6 35.0%

5 30.0%
25.0%
4
20.0%
x

3
15.0%
2 10.0%
1 5.0%
0 0.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 260


HPCL 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 2,751,974 2,687,664 2,329,968 3,716,020 3,752,365 Equity share capital 15,242 15,242 14,524 14,524 14,524
Operating Expense 2,602,861 2,571,691 2,185,872 3,539,748 3,518,923 Reserves & surplus 266,506 274,382 347,337 376,155 422,302
Employee cost 29,385 31,935 31,884 34,435 37,189 Shareholders fund 281,748 289,624 361,861 390,679 436,826
Others 20,804 25,957 38,287 39,053 39,834 Minority Interest 0 0 0 0 0
EBITDA 120,589 62,267 159,254 102,785 156,418 Total debt 272,397 427,642 418,891 443,891 493,891
Depreciation & Amortisation 30,126 33,044 35,527 39,079 42,987 Non Current Liabilities 1,242 2,122 3,709 3,969 4,247
EBIT 90,463 29,223 123,728 63,705 113,431 Def tax liab. (net) 71,648 54,915 55,111 58,084 60,174
Interest expenses 7,259 10,817 9,147 8,878 9,878 Total liabilities 627,035 774,303 839,572 896,622 995,138
Other income 16,352 18,382 27,887 26,482 26,652 Gross block 515,890 617,505 662,736 687,736 712,736
PBT 93,387 15,726 142,468 81,309 130,205 Less: acc. Depreciation (106,097) (134,600) (170,127) (209,206) (252,193)
Taxes 33,100 (10,647) 35,829 20,448 32,745 Net block 409,793 482,904 492,609 478,530 460,543
Effective tax rate (%) 35.4 30.7 25.1 25.1 25.1 Capital WIP 94,959 171,437 240,533 365,533 490,533
PAT 60,287 26,373 106,639 60,861 97,460 Net fixed assets 504,752 654,341 733,141 844,062 951,075
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 60,287 18,397 106,639 60,861 97,460 Investments 67,349 71,667 143,143 143,143 143,143
Extraordinary items 0 7,976 0 0 0 Inventories 201,934 191,412 285,922 432,523 436,367
Reported PAT 60,287 26,373 106,639 60,861 97,460 Sundry debtors 56,526 39,227 68,563 77,788 58,860
Cash & Cash Equivalents 51,794 54,580 56,548 89,926 88,064
Ratios Loans & advances 155,154 128,881 25,075 30,075 35,075
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 188,767 112,952 176,973 314,493 343,323
Revenue 25.5 (2.3) (13.3) 59.5 1.0 Other current liab. 199,435 222,867 263,882 358,297 325,579
EBITDA 13.2 (48.4) 155.8 (35.5) 52.2 Provisions 22,272 29,986 31,965 48,106 48,545
Adj. EPS (5.2) (69.5) 479.7 (42.9) 60.1 Net current assets 54,934 48,295 (36,712) (90,583) (99,080)
Margins (%) Total assets 627,035 774,303 839,572 896,622 995,138
Gross 9.9 8.3 14.0 7.5 9.1
EBITDA 4.3 2.3 6.6 2.8 4.2 Cashflow
EBIT 3.3 1.1 5.1 1.7 3.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 2.2 0.7 4.4 1.6 2.6 Profit Before Tax 93,387 15,726 142,468 81,309 130,205
Returns (%) Depreciation & Amortisation 30,126 33,044 35,527 39,079 42,987
ROE 23.1 6.4 32.7 16.2 23.6 Net Interest 3,460 7,154 5,348 (17,604) (16,774)
ROCE 13.7 5.2 15.2 8.4 11.9 Net Change – WC (24,776) 8,607 28,182 87,249 6,636
ROIC 15.3 3.9 15.8 8.1 13.1 Direct taxes (20,823) (17,229) (31,852) (17,476) (30,655)
Turnover (days) Net cash from operations 84,497 54,533 177,223 172,558 132,400
Gross block turnover ratio (x) 5.3 4.4 3.5 5.4 5.3 Capital expenditure (112,571) (137,847) (111,770) (150,000) (150,000)
Debtors 7 6 8 7 7 Acquisitions, net 0 0 0 0 0
Inventory 28 29 42 38 46 Investments (7,387) (9,319) (22,450) 0 0
Creditors 25 22 25 26 35 Others 6,125 5,509 6,938 17,604 16,774
Net working capital 7 7 (6) (9) (10) Net cash from investing (113,834) (141,657) (127,282) (132,396) (133,226)
Solvency (x) FCF (28,074) (83,314) 65,453 22,558 (17,600)
Net debt-equity 0.8 1.3 1.0 0.9 0.9 Issue of share capital 0 0 (19,135) 0 0
Interest coverage ratio 16.6 5.8 17.4 11.6 15.8 Increase/(decrease) in debt 51,336 114,340 5,693 25,000 50,000
Net debt/EBITDA 1.8 6.0 2.3 3.4 2.6 Dividend paid (16,533) (17,251) (14,844) (32,043) (51,313)
Per share (Rs) Interest paid (7,895) (12,306) (15,644) 0 0
Adjusted EPS 41.5 12.7 73.4 41.9 67.1 Others (8,401) 2,517 0 260 278
BVPS 194.0 199.4 249.1 269.0 300.8 Net cash from financing 18,506 87,299 (43,930) (6,784) (1,035)
CEPS 62.3 35.4 97.9 68.8 96.7 Net change in Cash (10,830) 175 6,011 33,378 (1,861)
DPS 16.7 10.2 22.8 18.9 30.2 Source: Company, Centrum Broking
Dividend payout (%) 40.2 56.3 31.0 45.0 45.0
Valuation (x)
P/E 6.8 22.3 3.8 6.7 4.2
P/BV 1.5 1.4 1.1 1.1 0.9
EV/EBITDA 5.2 12.4 4.8 7.3 5.2
Dividend yield (%) 5.9 3.6 8.1 6.7 10.7
Source: Company, Centrum Broking

Centrum Institutional Research 261


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

IOCL
IOCL has seen the scope and scale of profitability, and hence, cash flows improve Market data
dramatically post FY15, when the subsidy regime was completely done away with. Current price: Rs118
Since then, annual OCF (pre WC) has nearly doubled to ~Rs282bn vs ~Rs152bn over Bloomberg: IOCL IN
FY12-15. However, working capital has remained a drag on cash flows (post a brief 52-week H/L: Rs119/71
period of improvement over FY14-16), given the requirement of higher inventories
Market cap: Rs1,114.2bn
due to its landlocked refineries in the North/North East. Cumulatively, OCF of
Rs2,572bn has been used for capex of Rs1,676bn and investments of Rs247bn, Free float: 17.3%
leaving FCF of Rs649.2bn. Avg. daily vol. 3mth: 11,300,610
Source: Bloomberg

Operating profits have picked up sharply post FY15: Operating profits, and hence, operating cash flows have picked up
dramatically post FY15, with the removal of the subsidy regime. Working capital also followed a largely similar trend over
FY14-16, but has been a drag owing to much higher inventory days post FY16.
Exhibit 683: Cash flows from operations
Scale and scope of business changed dramatically post FY15, when the subsidy system was done away
with. NWC has still gone up due to higher inventory days driven by landlocked refinery requirements.
500,000 600,000
400,000 500,000
300,000 400,000
200,000 300,000
Rsmn

Rsmn
100,000 200,000
0 100,000
-100,000 0
-200,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -100,000
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Average net working capital days have been increasing steadily despite the
elimination of subsidies from FY15, largely due to steady ramp-up of capacity utilization at the Panipat and North East
refineries, which being landlocked, require higher inventories.
Exhibit 684: NWC has remained high due to higher inventory requirements
100 Despite the reduction of subsidy, NWC has remained at high levels owing to higher inventory 70
requirements across IOCL's refining portfolio
90
60
80
70 50
60
# of days

# of days

40
50
40 30
30 20
20
10
10
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Inventory Trade receivables Trade payables NWC RHS


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
IOCL 16 September 2021

Exhibit 685: OCF/PAT averaged 204% over FY12-21 Exhibit 686: OCF/EBITDA averaged at 109%
1400% 500%
1200% 450%
400%
1000%
350%
800% 300%
250%
600%
200%
400% 150%
200% 100%
50%
0%
0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-200% -50% FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Aggressive capex and investments in subsidiaries have kept FCF at low levels: The sharply higher levels of profitability and
cash flows have been utilized for aggressive buildout of refining, petchem and marketing infrastructure, as well as
investments in multiple associated businesses like LNG/upstream assets and even renewables. As a result, FCF conversion has
been fairly weak over the review period.
Exhibit 687: Capex intensity, acquisitions and free cash flows

600,000 CFO Russian Taas and Vankor 400,000


Investment ramped up in LNG
Capex asset investments
subsidiary
Acquisition/Investments 300,000
400,000
FCF 200,000
200,000 100,000
Rsmn

Rsmn
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -100,000
-200,000
E&P investment in Pacific North West LNG
-200,000
Project, Canada, and in Lower Zakum, Abu Dhabi Additional investment in CPCL
-400,000 -300,000
Source: Company, Centrum Broking

Return ratios have steadily improved barring a weak FY19-20: While IOCL’s RoE/RoCE have consistently improved (barring a
weak FY19-20), leverage has been relatively more volatile, fluctuating in line with capex and investment trends. Overall FCF
conversion has been weak, particularly over the last three years, after growing at a healthy pace over FY15-18.
Exhibit 688: Return ratios and leverage trends
7 25.0%
Consistent reduction in leverage, and thus,
6 improvement in return ratios post FY15, barring weak
performance in FY19-20 20.0%
5
4 15.0%
x

3 10.0%
2
5.0%
1
0 0.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Net Debt/Equity Net Debt/EBITDA ROE ROCE

Source: Company, Centrum Broking

Centrum Institutional Research 263


IOCL 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 52,76,927 48,54,055 37,80,576 69,77,760 68,43,119 Equity share capital 91,810 91,810 91,810 91,810 91,810
Operating Expense 47,77,632 45,43,026 32,48,234 64,49,236 62,85,593 Reserves & surplus 9,94,765 8,45,878 10,13,190 10,54,554 10,96,489
Employee cost 98,357 87,927 1,07,120 1,15,690 1,24,945 Shareholders fund 10,86,575 9,37,689 11,05,000 11,46,364 11,88,300
Others 80,148 1,07,870 88,112 96,923 1,04,677 Minority Interest 0 0 0 0 0
EBITDA 3,50,903 1,79,337 3,92,586 3,15,911 3,27,904 Total debt 8,63,587 11,65,450 9,65,808 10,85,808 12,05,808
Depreciation & Amortisation 75,143 87,661 98,043 1,03,926 1,10,161 Non Current Liabilities 22,141 28,321 34,236 35,948 37,745
EBIT 2,75,760 91,676 2,94,543 2,11,985 2,17,743 Def tax liab. (net) 1,58,231 1,14,131 1,29,647 1,40,833 1,52,019
Interest expenses 43,110 59,795 30,939 25,645 28,645 Total liabilities 21,30,534 22,45,591 22,34,692 24,08,953 25,83,872
Other income 31,285 35,714 45,507 48,693 49,180 Gross block 14,53,173 16,89,513 18,43,863 21,09,278 23,69,693
PBT 2,51,269 (36,941) 2,97,157 2,35,033 2,38,278 Less: acc. Depreciation (2,51,710) (3,36,659) (4,34,702) (5,38,627) (6,48,788)
Taxes 82,328 (50,073) 78,796 62,323 63,183 Net block 12,01,463 13,52,855 14,09,161 15,70,651 17,20,905
Effective tax rate (%) 32.8 14.8 26.5 26.5 26.5 Capital WIP 2,21,605 2,81,341 3,16,006 3,16,006 3,16,006
PAT 1,68,942 13,132 2,18,360 1,72,710 1,75,094 Net fixed assets 14,23,068 16,34,196 17,25,168 18,86,657 20,36,911
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 1,60,426 74,887 2,09,576 1,72,710 1,75,094 Investments 4,66,764 3,83,871 5,15,524 5,15,524 5,15,524
Extraordinary items 8,515 (61,754) 8,785 0 0 Inventories 7,14,704 6,36,776 7,81,880 12,46,586 12,22,533
Reported PAT 1,68,942 13,132 2,18,360 1,72,710 1,75,094 Sundry debtors 1,54,480 1,28,441 1,33,977 2,24,285 2,30,956
Cash & Cash Equivalents 85,072 86,755 1,07,285 23,965 1,46,244
Ratios Loans & advances 3,12,990 2,40,867 76,707 64,707 52,707
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 3,86,790 2,52,516 3,38,746 5,83,284 6,17,791
Revenue 25.3 (8.0) (22.1) 84.6 (1.9) Other current liab. 5,29,538 5,07,934 6,65,128 8,12,043 8,48,118
EBITDA (4.9) (48.9) 118.9 (19.5) 3.8 Provisions 1,10,216 1,04,865 1,01,975 1,57,445 1,55,094
Adj. EPS (30.8) (53.3) 179.9 (17.6) 1.4 Net current assets 2,40,702 2,27,524 (6,000) 6,772 31,436
Margins (%) Total assets 21,30,534 22,45,591 22,34,692 24,08,953 25,83,872
Gross 15.5 13.6 22.0 11.2 12.1
EBITDA 6.6 3.6 10.2 4.5 4.8 Cashflow
EBIT 5.2 1.9 7.7 3.0 3.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 3.0 1.5 5.5 2.5 2.6 Profit Before Tax 2,51,269 (36,941) 2,97,157 2,35,033 2,38,278
Returns (%) Depreciation & Amortisation 75,143 87,661 98,043 1,03,926 1,10,161
ROE 14.7 7.4 20.5 15.3 15.0 Net Interest 26,146 40,622 21,609 (23,048) (20,534)
ROCE 11.4 5.4 12.0 8.9 8.5 Net Change – WC (1,43,945) 35,303 1,07,680 (96,092) 97,615
ROIC 14.7 5.2 14.1 9.9 9.3 Direct taxes (54,595) (18,067) (39,271) (51,137) (51,998)
Turnover (days) Net cash from operations 1,34,895 86,394 4,90,958 1,68,681 3,73,522
Gross block turnover ratio (x) 3.6 2.9 2.1 3.3 2.9 Capital expenditure (2,23,556) (2,96,970) (2,12,585) (2,65,415) (2,60,415)
Debtors 9 10 12 9 12 Acquisitions, net 0 0 0 0 0
Inventory 56 58 86 60 75 Investments (30,299) (8,256) (44,663) 0 0
Creditors 29 27 36 27 36 Others 35,465 36,452 35,709 23,048 20,534
Net working capital 17 17 (1) 0 2 Net cash from investing (2,18,390) (2,68,774) (2,21,540) (2,42,368) (2,39,881)
Solvency (x) FCF (88,661) (2,10,576) 2,78,373 (96,734) 1,13,107
Net debt-equity 0.7 1.2 0.8 0.9 0.9 Issue of share capital 0 0 0 0 0
Interest coverage ratio 8.1 3.0 12.7 12.3 11.4 Increase/(decrease) in debt 2,81,899 2,98,393 (1,43,218) 1,20,000 1,20,000
Net debt/EBITDA 2.2 6.0 2.2 3.4 3.2 Dividend paid (1,16,353) (58,023) (83,832) (1,31,346) (1,33,159)
Per share (Rs) Interest paid (37,773) (53,017) (44,588) 0 0
Adjusted EPS 17.5 8.2 22.8 18.8 19.1 Others (44,199) 5 0 1,712 1,797
BVPS 118.3 102.1 120.4 124.9 129.4 Net cash from financing 83,574 1,87,358 (2,71,638) (9,634) (11,362)
CEPS 25.7 17.7 33.5 30.1 31.1 Net change in Cash 79 4,978 (2,219) (83,320) 1,22,279
DPS 10.5 4.2 12.0 12.2 12.4 Source: Company, Centrum Broking
Dividend payout (%) 57.2 297.1 50.5 65.0 65.0
Valuation (x)
P/E 6.8 14.5 5.2 6.3 6.2
P/BV 1.0 1.2 1.0 0.9 0.9
EV/EBITDA 5.4 12.2 5.0 6.9 6.6
Dividend yield (%) 8.9 3.6 10.1 10.3 10.5
Source: Company, Centrum Broking

Centrum Institutional Research 264


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

Indraprastha Gas (IGL)


IGL’s cash flows have closely approximated fluctuations in operating profits, with Market data
relatively little impact of working capital on the company’s cash flow generation Current price: Rs571
(FY21 an exception). Operating cash flows have averaged ~Rs11.5bn over FY12-21. Bloomberg: IGL IN
Cumulative OCF of Rs115bn has been utilized in capex of Rs49.4bn and 52-week H/L: Rs604/364
investments/acquisitions of Rs26.7bn, leaving FCF of Rs38.8bn over the period.
Market cap: Rs399.6bn
Steadily improving profitability, reflecting in higher cash flows, has reflected in lower
leverage (Net DER down to negative 0.2x in FY21 from 0.2x in FY12), albeit return Free float: 42.9%
ratios have moderated somewhat owing to gradually higher capex over FY12-21. Avg. daily vol. 3mth: 2,914,322
Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have been robust and have consistently
expanded over the last 10 years. Working capital intensity in the business has been low, and over the last two years, there
has been a very sharp expansion in cash flows, driven by higher profitability. As a result, the company has consistently
generated strong operating cash flow. FY21 has seen some additional benefits from payables, driving large negative NWC.
Exhibit 689: OCF has consistently expanded over the last decade
20000

16000

12000
Rsmn

8000

4000

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows with net
working capital (NWC) being in the negative territory for most years in our reference period. This trend has remained fairly
constant despite a marked change in the scale of operations. In fact, FY21 saw a sharp expansion in payable days, helping to
boost cash flows for the year.
Exhibit 690: NWC negative for most of the decade

80 10
70
0
60
-10
50
# of days
Days #

40 -20
30
-30
20
-40
10
0 -50
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC

Source: Company, Centrum Broking


xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Indraprastha Gas (IGL) 16 September 2021

Exhibit 691: OCF/PAT Exhibit 692: OCF/EBITDA

250% 140%
120%
200%
100%
150% 80%
%

%
100% 60%
40%
50%
20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been volatile: Conversion of OCF to FCF has been volatile, with the last
material inorganic investment being the 50% stake taken in Central UP Gas (FY14) and 50% stake taken in Maharashtra
Natural Gas (MNGL) in FY15. Since FY16, there has not been any meaningful acquisition or investment in any subsidiary;
hence, FCF is a direct function of OCF less capex for the period.
Exhibit 693: Capex intensity, acquisitions and free cash flows
20000 CUGL MNGL
acquisition acquisition
15000

10000

5000
Rsmn

-5000

-10000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-15000
CFO Capex Acquisition/ Asset investment FCF
Source: Company, Centrum Broking

Return ratios have moderated somewhat; leverage has reduced materially: The sustained improvement in profitability and
no material impact of working capital-related issues has meant that balance sheet has consistently remained free of leverage
over the last decade. However, the higher capex intensity over FY18-21 has reflected in return ratios relatively moderating
over the last five years.
Exhibit 694: Return ratios and leverage trends
1.0 30.0%
20.0%
0.5
10.0%
0.0 0.0%
-10.0%
x

-0.5 -20.0%
-30.0%
-1.0
-40.0%
-1.5 -50.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Net Debt/Equity Net Debt/EBITDA ROE ROCE


Source: Company, Centrum Broking

Centrum Institutional Research 266


Indraprastha Gas (IGL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21E FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21E FY22E FY23E
Revenues 57,648 64,853 49,408 62,781 75,305 Equity share capital 1,400 1,400 1,400 1,400 1,400
Operating Expense 33,973 36,794 22,295 28,473 35,821 Reserves & surplus 39,899 49,224 57,319 66,985 77,705
Employee cost 0 0 0 0 0 Shareholders fund 41,299 50,624 58,719 68,385 79,105
Others 11,105 12,863 12,283 14,704 17,113 Minority Interest 0 0 0 0 0
EBITDA 12,570 15,196 14,830 19,605 22,371 Total debt 4 782 836 836 836
Depreciation & Amortisation 2,011 2,523 2,904 3,203 4,203 Non Current Liabilities 10 9 120 124 128
EBIT 10,559 12,674 11,926 16,402 18,168 Def tax liab. (net) 2,678 2,119 2,423 2,423 2,423
Interest expenses 21 81 113 105 105 Total liabilities 43,991 53,533 62,097 71,767 82,492
Other income 1,462 1,564 1,502 2,170 2,417 Gross block 35,184 43,946 54,489 66,149 76,309
PBT 12,000 14,157 13,315 18,468 20,480 Less: acc. Depreciation (6,416) (8,377) (11,281) (14,484) (18,686)
Taxes 4,133 2,791 3,258 4,617 5,120 Net block 28,769 35,569 43,209 51,666 57,623
Effective tax rate (%) 34.4 19.7 24.5 25.0 25.0 Capital WIP 4,781 7,767 8,469 8,469 8,469
PAT 7,867 11,365 10,057 13,851 15,360 Net fixed assets 33,549 43,336 51,678 60,135 66,092
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 7,867 11,365 10,057 13,851 15,360 Investments 3,406 3,276 3,104 3,104 3,104
Extraordinary items 0 0 0 0 0 Inventories 509 511 456 521 562
Reported PAT 7,867 11,365 10,057 13,851 15,360 Sundry debtors 2,215 1,704 2,607 2,981 3,219
Cash & Cash Equivalents 6,071 21,799 11,323 18,475 28,936
Ratios Loans & advances 153 154 213 271 325
YE Mar FY19A FY20A FY21E FY22E FY23E
Other current assets 13,591 942 16,493 16,493 16,493
Growth (%) Trade payables 15,279 15,382 20,051 25,479 30,561
Revenue 27.1 12.5 (23.8) 27.1 19.9 Other current liab. 0 0 0 0 0
EBITDA 12.7 20.9 (2.4) 32.2 14.1 Provisions 224 2,808 3,727 4,735 5,680
Adj. EPS 17.3 44.5 (11.5) 37.7 10.9 Net current assets 7,036 6,921 7,314 8,528 13,295
Margins (%) Total assets 43,991 53,533 62,097 71,767 82,492
Gross 41.1 43.3 54.9 54.6 52.4
EBITDA 21.8 23.4 30.0 31.2 29.7 Cashflow
EBIT 18.3 19.5 24.1 26.1 24.1 YE Mar (Rs mn) FY19A FY20A FY21E FY22E FY23E
Adjusted PAT 13.6 17.5 20.4 22.1 20.4 Profit Before Tax 12,000 14,157 13,315 18,468 20,480
Returns (%) Depreciation & Amortisation 2,011 2,523 2,904 3,203 4,203
ROE 20.6 24.7 18.4 21.8 20.8 Net Interest (1,242) (1,275) (948) (2,066) (2,312)
ROCE 20.6 24.7 18.3 21.6 20.7 Net Change – WC 2,642 1,720 3,473 5,943 5,699
ROIC 23.8 35.0 25.2 26.5 28.5 Direct taxes (3,688) (3,442) (2,895) (4,617) (5,120)
Turnover (days) Net cash from operations 11,572 13,608 15,460 20,931 22,949
Gross block turnover ratio (x) 1.6 1.5 0.9 0.9 1.0 Capital expenditure (6,807) (9,632) (8,829) (11,660) (10,160)
Debtors 14 11 16 16 15 Acquisitions, net 0 0 0 0 0
Inventory 6 5 8 6 6 Investments (4,891) 3,973 (10,783) 0 0
Creditors 145 152 290 292 286 Others 490 452 1,349 2,170 2,417
Net working capital 45 39 54 50 64 Net cash from investing (11,208) (5,207) (18,264) (9,490) (7,743)
Solvency (x) FCF 4,764 3,975 6,631 9,271 12,789
Net debt-equity (0.1) (0.4) (0.2) (0.3) (0.4) Issue of share capital 0 0 0 0 0
Interest coverage ratio 613.2 187.1 130.8 187.6 214.0 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (0.5) (1.4) (0.7) (0.9) (1.3) Dividend paid (1,685) (2,025) (1,960) (4,184) (4,640)
Per share (Rs) Interest paid (4) 0 0 (105) (105)
Adjusted EPS 11.2 16.2 14.4 19.8 21.9 Others 0 (409) (1,010) 0 0
BVPS 59.0 72.3 83.9 97.7 113.0 Net cash from financing (1,688) (2,435) (2,970) (4,289) (4,745)
CEPS 14.1 19.8 18.5 24.4 27.9 Net change in Cash (1,325) 5,966 (5,774) 7,152 10,461
DPS 2.4 2.8 3.6 5.0 5.5 Source: Company, Centrum Broking
Dividend payout (%) 21.4 17.2 25.1 25.1 25.1
Valuation (x)
P/E 50.8 35.1 39.7 28.8 26.0
P/BV 9.7 7.9 6.8 5.8 5.1
EV/EBITDA 31.3 24.9 26.2 19.5 16.6
Dividend yield (%) 0.4 0.5 0.6 0.9 1.0
Source: Company, Centrum Broking

Centrum Institutional Research 267


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

Mahanagar Gas (MGL)


MAHGL’s cash flows have closely approximated fluctuations in operating profits, Market data
with relatively little impact of working capital on the company’s cash flow Current price: Rs1,175
generation (FY21 an exception). Operating cash flows have consistently grown at a Bloomberg: MAHGL IN
CAGR of 7% over FY12-21. Cumulative OCF of Rs76bn has been utilized in capex of 52-week H/L: Rs1,284/780
Rs27bn and investments/acquisitions of Rs9.5bn, leaving FCF of Rs39.7bn. Steadily
Market cap: Rs116bn
improving profitability, reflecting in higher cash flows, has reflected in lower
leverage (Net DER down to negative 0.5x in FY21 from negative 0.3x in FY12), albeit Free float: 41.2%
return ratios have moderated somewhat due to gradually higher capex over FY12-21. Avg. daily vol. 3mth: 526,861
Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have been robust and have consistently
expanded over the last 10 years. Working capital intensity in the business has been low, and over the last 3-4 years, there has
been a very sharp expansion in cash flows, driven by higher profitability. As a result, the company has consistently generated
strong operating cash flow. FY21 has seen some additional benefits from payables, driving large negative NWC.
Exhibit 695: OCF has consistently expanded over the last decade
14,000
12,000
10,000
8,000
Rsmn

6,000
4,000
2,000
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, with net
working capital (NWC) being in the negative territory for most years in our reference period. This trend has remained fairly
constant, despite a marked change in the scale of operations. In fact, FY21 saw a sharp expansion in payable days, helping
boost cash flows for the year.
Exhibit 696: NWC has been negative for most of the decade – has reduced sharply over the last 2-3 years

80 20
70 10
60 0
50
# of days

-10
# days

40
-20
30
20 -30

10 -40
0 -50
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Mahanagar Gas (MGL) 16 September 2021

Exhibit 697: OCF/PAT Exhibit 698: OCF/EBITDA


2.5 1.25

2 1.2

1.5 1.15

x
x

1 1.1

0.5 1.05

0 1
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been volatile: Conversion of OCF to FCF has been >60% for most years, with
limited acquisitions made by the company during the last decade. Since FY16, there has not been any meaningful acquisition
or investment in any subsidiary; hence, FCF is a direct function of OCF less capex for the period.
Exhibit 699: Capex intensity, acquisitions and free cash flows
15,000 10,000

10,000 8,000

5,000 6,000
Rsmn

Rsmn
0 4,000

-5,000 2,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

-10,000 0
CFO Capex Acquisition/Investments FCF
Source: Company, Centrum Broking

Return ratios have moderated somewhat; leverage remains a non-issue: Sustained improvement in profitability and no
material impact of working capital-related issues has meant that balance sheet has consistently remained free of leverage
over the last decade. However, the higher capex intensity over FY18-21 has reflected in return ratios relatively moderating
over the last five years.
Exhibit 700: Return ratios and leverage trends
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
0 35.0%

30.0%
-0.5
25.0%

20.0%
-1
x

15.0%

10.0%
-1.5
5.0%

-2 Net Debt/Equity Net Debt/EBITDA ROE ROCE 0.0%

Source: Company, Centrum Broking

Centrum Institutional Research 269


Mahanagar Gas (MGL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 27,708 29,510 21,360 29,225 33,438 Equity share capital 988 988 988 988 988
Operating Expense 16,452 16,157 9,461 13,065 15,341 Reserves & surplus 23,001 28,539 31,336 35,864 40,996
Employee cost 709 806 875 963 1,011 Shareholders fund 23,989 29,527 32,324 36,851 41,984
Others 1,895 2,229 1,850 2,312 2,544 Minority Interest 0 0 0 0 0
EBITDA 8,855 10,528 9,340 13,052 14,711 Total debt 0 0 0 0 0
Depreciation & Amortisation 1,259 1,617 1,737 2,137 2,467 Non Current Liabilities 18 496 581 581 581
EBIT 7,595 8,911 7,603 10,915 12,244 Def tax liab. (net) 2,048 1,607 1,773 1,773 1,773
Interest expenses 3 65 72 50 50 Total liabilities 26,055 31,629 34,677 39,205 44,338
Other income 777 990 805 892 1,134 Gross block 21,740 26,178 29,116 35,616 41,116
PBT 8,369 9,835 8,336 11,757 13,328 Less: acc. Depreciation (4,106) (5,686) (7,423) (9,560) (12,027)
Taxes 2,905 1,900 2,140 3,019 3,422 Net block 17,634 20,492 21,693 26,056 29,089
Effective tax rate (%) 34.7 19.3 25.7 25.7 25.7 Capital WIP 3,697 4,865 5,603 5,603 5,603
PAT 5,464 7,935 6,196 8,739 9,906 Net fixed assets 21,331 25,357 27,296 31,659 34,692
Minority/Associates 0 0 0 0 0 Non Current Assets 1,321 871 1,172 1,172 1,172
Recurring PAT 5,464 7,369 6,196 8,739 9,906 Investments 0 0 0 0 0
Extraordinary items 0 566 0 0 0 Inventories 191 186 222 144 169
Reported PAT 5,464 7,935 6,196 8,739 9,906 Sundry debtors 995 684 1,275 801 916
Cash & Cash Equivalents 9,529 13,510 15,368 11,155 14,174
Ratios Loans & advances 775 501 505 505 505
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 269 176 173 173 173
Growth (%) Trade payables 8,143 9,393 10,985 6,054 7,115
Revenue 24.9 6.5 (27.6) 36.8 14.4 Other current liab. 0 0 0 0 0
EBITDA 13.5 18.9 (11.3) 39.8 12.7 Provisions 212 263 350 350 350
Adj. EPS 14.3 34.9 (15.9) 41.0 13.4 Net current assets 3,404 5,401 6,209 6,374 8,473
Margins (%) Total assets 26,055 31,629 34,677 39,205 44,338
Gross 50.2 54.0 65.8 64.6 63.5
EBITDA 31.7 35.4 43.4 44.4 43.8 Cashflow
EBIT 27.2 30.0 35.3 37.1 36.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 19.6 24.8 28.8 29.7 29.5 Profit Before Tax 8,369 9,835 8,336 11,757 13,328
Returns (%) Depreciation & Amortisation 1,259 1,617 1,737 2,137 2,467
ROE 24.3 27.5 20.0 25.3 25.1 Net Interest (264) (264) (312) 50 50
ROCE 24.3 29.9 20.2 25.4 25.2 Net Change – WC 418 1,374 602 (4,378) 920
ROIC 35.9 47.2 34.3 38.0 34.0 Direct taxes (2,708) (2,380) (2,065) (3,019) (3,422)
Turnover (days) Net cash from operations 6,844 9,826 8,055 5,655 12,208
Gross block turnover ratio (x) 1.3 1.1 0.7 0.8 0.8 Capital expenditure (3,622) (4,232) (3,395) (6,500) (5,500)
Debtors 12 10 17 13 9 Acquisitions, net 0 0 0 0 0
Inventory 6 5 10 6 5 Investments 473 (4,316) 1,287 (1,025) (1,127)
Creditors 200 232 498 295 194 Others (1,234) 1,026 (2,331) 892 1,134
Net working capital 45 67 106 80 92 Net cash from investing (4,383) (7,522) (4,439) (6,633) (5,494)
Solvency (x) FCF 3,222 5,594 4,660 (845) 6,708
Net debt-equity (0.4) (0.5) (0.5) (0.3) (0.3) Issue of share capital 0 0 0 0 0
Interest coverage ratio 2,743.0 161.2 129.9 261.0 294.2 Increase/(decrease) in debt (12) 0 0 0 0
Net debt/EBITDA (1.1) (1.3) (1.6) (0.9) (1.0) Dividend paid (2,330) (2,183) (3,221) (4,211) (4,773)
Per share (Rs) Interest paid (3) (16) (5) (50) (50)
Adjusted EPS 55.3 74.6 62.7 88.5 100.3 Others 0 (216) (262) 0 0
BVPS 242.8 298.9 327.2 373.1 425.0 Net cash from financing (2,346) (2,416) (3,488) (4,261) (4,823)
CEPS 68.1 91.0 80.3 110.1 125.3 Net change in Cash 115 (112) 128 (5,238) 1,892
DPS 20.0 20.0 23.0 35.4 40.1 Source: Company, Centrum Broking
Dividend payout (%) 36.2 24.9 36.7 40.0 40.0
Valuation (x)
P/E 21.2 15.7 18.7 13.3 11.7
P/BV 4.8 3.9 3.6 3.1 2.8
EV/EBITDA 12.0 9.7 10.8 8.0 6.9
Dividend yield (%) 1.7 1.7 2.0 3.0 3.4
Source: Company, Centrum Broking

Centrum Institutional Research 270


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

ONGC
ONGC’s cash flows have closely approximated fluctuations in crude prices, with Market data
working capital intensity having reduced post FY15, as the participation in subsidy Current price: Rs129
for fuels was eliminated from Q4FY15, thus reducing receivables from the Bloomberg: ONGC IN
government. Post the one year of adjustment due to that, working capital has 52-week H/L: Rs131/64
benefited OCF in most years. Cumulatively, OCF of Rs4,437bn has been utilized for
Market cap: Rs1619.1bn
capex of Rs2,783bn and significant investments of Rs334bn, leaving net FCF at just
Rs1,320bn or 30% of OCF. This low conversion has reflected in weakening return Free float: 18.7%
ratios as well, with both RoE/RoCE seeing a steady decline over the last decade. Avg. daily vol. 3mth: 18,722,480
Source: Bloomberg

Cash flows have fluctuated in line with crude prices and government policy: Given its upstream operations, ONGC’s
operating profits have followed crude price trends (adjusting for materially high government subsidies till FY15). Over FY12-
15, average crude prices dipped from USD114/bbl to USD85/bbl, driving OCF from Rs492.5bn in FY12 to Rs426bn in FY15.
Since FY16, while average crude prices have declined, removal of subsidy has helped support cash flows.
Exhibit 701: Since FY16, removal of subsidy has helped support operating cash flows
700,000 700,000
600,000 600,000
500,000
500,000
400,000
300,000 400,000
Rsmn

Rsmn
200,000 300,000
100,000
200,000
0
-100,000 100,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-200,000 0
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, with net
working capital (NWC) being at a steady 70-75 days for most years. FY15 saw unusual movement in inventory and receivables
due to changes in policy on subsidy and/or sharp changes in crude prices.
Exhibit 702: NWC largely steady at 70-75 days for most of the decade
140 Shock in FY15 owing to change in subsidy regime; 160
120 steady pattern to NWC, thereafter 140

100 120
100
# of days

80
80
60
60
40 40
20 20
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
ONGC 16 September 2021

Exhibit 703: OCF/PAT at high levels, barring FY20-21 Exhibit 704: OCF/EBITDA comfortably >5x in most years

100 8
7
80
6
60
5
40 4

x
x

20 3

0 2
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 1
-20
0
-40 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been weak, driven by aggressive acquisitions: Conversion of OCF to FCF has
reduced considerably, as both ONGC and Oil India have aggressively pursued the Indian government’s policy to reduce
dependence on imports by acquiring stake in upstream assets globally while also aggressively incurring capex just to maintain
production from 2-3 decade old wells. Given the relatively longer gestation of some of these projects and adverse tax
structure (Russia assets), cash flows from these projects have come with a lag, driving weak FCF conversion in the period.
Exhibit 705: Capex intensity, acquisitions and free cash flows
800,000 Acquisition of participating 350,000
Vankorneft acquisition
interest in Area 1, Mozambique 300,000
600,000
250,000
400,000
200,000
Rsmn

Rsmn
200,000 150,000
100,000
0
50,000
-200,000
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-400,000 -50,000
CFO Capex Acquisition/Investments FCF
Source: Company, Centrum Broking

Return ratios have reduced sharply: Owing to the relatively weaker earnings profile and sharply higher investment and capex
spends, return ratios have declined steadily over the last decade.
Exhibit 706: Return ratios and leverage trends
1 Aggressive acquisition/capex strategy with back-ended returns and older assets combined to 45.0%
steadily reduce return profile of the business 40.0%
0.8
35.0%
0.6
30.0%
0.4 25.0%
x

0.2 20.0%
15.0%
0
10.0%
-0.2 5.0%
-0.4 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 0.0%

net Debt/Equity net Debt/EBITDA ROE ROCE

Source: Company, Centrum Broking

Centrum Institutional Research 272


ONGC 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 10,96,546 9,62,136 6,81,411 9,98,514 10,30,506 Equity share capital 62,902 62,902 62,901 62,901 62,901
Operating Expense 2,65,004 2,25,708 1,64,237 2,51,424 2,59,051 Reserves & surplus 19,54,994 18,80,479 19,82,684 21,22,089 22,64,370
Employee cost 1,20,639 1,24,258 1,29,229 1,34,398 1,39,774 Shareholders fund 20,17,896 19,43,381 20,45,586 21,84,990 23,27,271
Others 1,16,213 1,19,300 59,818 1,01,911 98,898 Minority Interest 0 0 0 0 0
EBITDA 5,94,689 4,92,869 3,28,127 5,10,781 5,32,782 Total debt 2,17,443 1,91,964 2,77,517 2,57,517 2,37,517
Depreciation & Amortisation 2,42,129 2,73,005 2,27,129 2,49,777 2,72,388 Non Current Liabilities 0 0 0 0 0
EBIT 3,52,560 2,19,864 1,00,998 2,61,004 2,60,394 Def tax liab. (net) 2,74,261 2,63,441 2,74,734 2,77,734 2,80,734
Interest expenses 24,921 28,237 22,145 20,344 16,888 Total liabilities 25,09,600 23,98,786 25,97,837 27,20,241 28,45,522
Other income 72,653 61,050 71,425 72,139 75,746 Gross block 17,78,192 20,83,140 22,19,689 24,59,689 27,23,689
PBT 4,00,291 2,03,687 1,64,028 3,12,800 3,19,253 Less: acc. Depreciation (5,58,835) (8,06,149) (9,12,691) (11,68,848) (14,41,236)
Taxes 1,32,645 69,241 51,564 98,331 1,00,360 Net block 12,19,357 12,76,991 13,06,998 12,90,841 12,82,453
Effective tax rate (%) 33.1 34.0 31.4 31.4 31.4 Capital WIP 3,50,502 3,62,255 4,09,491 4,39,491 4,72,491
PAT 2,67,647 1,34,445 1,12,464 2,14,469 2,18,893 Net fixed assets 15,69,860 16,39,246 17,16,488 17,30,332 17,54,944
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 2,67,647 1,67,269 1,03,252 2,14,469 2,18,893 Investments 10,29,741 9,45,822 10,47,351 10,78,772 11,11,135
Extraordinary items 0 (32,824) 9,213 0 0 Inventories 77,039 85,666 84,745 1,24,186 1,28,165
Reported PAT 2,67,647 1,34,445 1,12,464 2,14,469 2,18,893 Sundry debtors 1,93,878 1,69,394 2,26,170 3,31,433 3,42,052
Cash & Cash Equivalents 5,041 9,682 3,026 1,44,342 2,13,836
Ratios Loans & advances 1,21,522 1,16,997 1,06,756 1,07,819 1,08,882
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 0 0 0 0 0
Growth (%) Trade payables 2,10,687 2,10,748 2,02,846 2,97,254 3,06,778
Revenue 29.0 (12.3) (29.2) 46.5 3.2 Other current liab. 24,689 66,906 64,643 94,729 97,765
EBITDA 34.1 (17.1) (33.4) 55.7 4.3 Provisions 2,52,104 2,90,367 3,19,210 4,04,659 4,08,950
Adj. EPS 34.2 (37.5) (38.3) 107.7 2.1 Net current assets (90,001) (1,86,283) (1,66,003) (88,862) (20,557)
Margins (%) Total assets 25,09,600 23,98,785 25,97,837 27,20,241 28,45,522
Gross 100.0 100.0 100.0 100.0 100.0
EBITDA 54.2 51.2 48.2 51.2 51.7 Cashflow
EBIT 32.2 22.9 14.8 26.1 25.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 24.4 17.4 15.2 21.5 21.2 Profit Before Tax 4,00,291 2,03,687 1,64,028 3,12,800 3,19,253
Returns (%) Depreciation & Amortisation 2,23,616 2,56,126 2,09,884 2,43,269 2,65,750
ROE 13.5 8.4 5.2 10.1 9.7 Net Interest 8,978 15,338 11,534 (51,795) (58,859)
ROCE 12.8 8.5 5.3 9.6 9.2 Net Change – WC (63,610) 1,26,655 (24,091) 64,176 1,189
ROIC 19.9 12.2 5.6 14.4 14.5 Direct taxes (1,12,076) (66,646) (28,349) (95,331) (97,360)
Turnover (days) Net cash from operations 4,23,038 5,77,853 2,76,651 4,43,444 4,00,300
Gross block turnover ratio (x) 0.6 0.5 0.3 0.4 0.4 Capital expenditure (2,63,191) (3,33,247) (2,44,911) (3,00,000) (3,30,000)
Debtors 53 69 106 102 119 Acquisitions, net (7,721) (4,374) 2,964 0 0
Inventory 69 86 139 108 129 Investments 8,159 (7,018) 6,880 (31,421) (32,363)
Creditors 195 223 337 258 308 Others 41,878 (4,944) 28,497 1,27,743 1,34,806
Net working capital (30) (71) (89) (32) (7) Net cash from investing (2,20,876) (3,49,583) (2,06,570) (2,03,677) (2,27,557)
Solvency (x) FCF 1,59,847 2,44,606 31,741 1,43,444 70,300
Net debt-equity 0.1 0.1 0.1 0.1 0.0 Issue of share capital (40,220) 0 0 0 0
Interest coverage ratio 23.9 17.5 14.8 25.1 31.5 Increase/(decrease) in debt (44,608) (82,247) 12,860 (20,000) (20,000)
Net debt/EBITDA 0.4 0.4 0.8 0.2 0.0 Dividend paid (1,09,595) (87,504) (22,053) (75,064) (76,613)
Per share (Rs) Interest paid (7,799) (5,120) (2,125) (3,386) (6,636)
Adjusted EPS 21.3 13.3 8.2 17.0 17.4 Others (5,027) (48,757) (65,420) 0 0
BVPS 160.4 154.5 162.6 173.7 185.0 Net cash from financing (2,07,249) (2,23,628) (76,738) (98,450) (1,03,248)
CEPS 40.5 35.0 26.3 36.9 39.1 Net change in Cash (5,086) 4,642 (6,657) 1,41,316 69,495
DPS 7.0 5.0 3.6 6.0 6.1 Source: Company, Centrum Broking
Dividend payout (%) 32.9 46.8 40.3 35.0 35.0
Valuation (x)
P/E 6.0 9.7 15.7 7.5 7.4
P/BV 0.8 0.8 0.8 0.7 0.7
EV/EBITDA 3.1 3.7 5.8 3.4 3.1
Dividend yield (%) 5.4 3.9 2.8 4.6 4.7
Source: Company, Centrum Broking

Centrum Institutional Research 273


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

Oil India (OIL)


OIL’s cash flows have closely approximated fluctuations in crude prices, with working Market data
capital intensity having reduced post FY15, as participation in subsidy for fuels was Current price: Rs212
eliminated from Q4FY15, thus reducing receivables from the government. Barring Bloomberg: OINL IN
the one year of adjustment due to that, NWC has averaged at 80 days during the 52-week H/L: Rs213/83
decade and has had limited impact on net OCF. Expansions have been the bigger
Market cap: Rs229.4bn
absorber of available OCF over the period – cumulative OCF of Rs391bn has been
used for organic capex of Rs224bn and for acquisitions (mostly overseas upstream Free float: 21.6%
assets) of Rs216bn, driving negative FCF of Rs50bn and very low return ratios. Avg. daily vol. 3mth: 1,620,343
Source: Bloomberg

Cash flows have fluctuated in line with crude prices and government policy: Given its upstream operations, operating
profits have followed crude price trends (adjusting for materially high government subsidies till FY15). Over FY12-15, average
crude prices dipped from USD114/bbl to USD85/bbl, driving OCF from Rs46bn in FY12 to Rs38.86bn in FY15. Since FY16, while
average crude prices have declined, removal of subsidy has helped support CF. Working capital has been relatively small,
except for FY15 and FY18.
Exhibit 707: Cash flow from operations
OCF has largely followed crude price trends and working capital has been a relatively small component
80,000 except for FY15-16, when subsidy was done away with

60,000

40,000
Rsmn

20,000

-20,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating Cash flow before WCAP changes WCAP changes CFO


Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, with net
working capital (NWC) being at a steady 80 days for most years. FY15 saw unusual movement in inventory and receivables
due to changes in policy on subsidy and/or sharp changes in crude prices.
Exhibit 708: NWC days have remained fairly steady for most of the decade
140 Barring FY15, NWC days have remained fairly steady at 80-90 days for most years 160
120 140
100 120
100
# of days

# of days

80
80
60
60
40 40
20 20
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Inventory Trade receivables Trade payables NWC


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Oil India (OIL) 16 September 2021

Exhibit 709: OCF/PAT Exhibit 710: OCF/EBITDA


700% 140%
600% 120%
500% 100%
400% 80%
%

%
300% 60%

200% 40%

100% 20%

0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been weak, driven by aggressive acquisitions: Conversion of OCF to FCF has
reduced considerably, as both ONGC and OIL India have aggressively pursued the Indian Government’s policy to reduce
dependence on imports by acquiring stake in upstream assets globally while also aggressively spending capex just to maintain
production from 2-3 decade old wells. Given the relatively long gestation of some of these projects and adverse tax structure
(Russia assets), cash flows from these projects have come with a lag, driving negative FCF for the period. FY21 put additional
pressure on FCF, driven by government-mandated purchase of NRL stake from BPCL to facilitate the BPCL divestment
process.
Exhibit 711: Capex intensity, acquisitions and free cash flows
100,000

50,000
Rsmn

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-50,000
Purchase of Area 1, TAAS and Vankor assets of Russia Purchase of NRL stake
-100,000 Mozambique acquired; US operations started from BPCL

CFO Capex Acquisition/Investments FCF


Source: Company, Centrum Broking

Return ratios have reduced sharply: Owing to the relatively weaker earnings profile and the sharply higher investment and
capex spends, return ratios have steadily declined over the last decade.
Exhibit 712: Return ratios have steadily declined over the last decade
12 Acquisitions of Russian upstream assets (FY19) and refiner NRL (FY21) have 25.0%
10 materially impacted leverage and return ratios
20.0%
8
15.0%
6
4 10.0%
x

2
5.0%
0
0.0%
-2
-4 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 -5.0%
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 275


Oil India (OIL) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 137,350 121,285 86,184 129,756 132,373 Equity share capital 10,844 10,844 10,844 10,844 10,844
Operating Expense 51,506 44,946 39,309 53,084 53,205 Reserves & surplus 266,608 233,023 251,262 259,917 269,610
Employee cost 15,765 18,994 19,451 20,034 20,635 Shareholders fund 277,452 243,867 262,106 270,761 280,455
Others 12,821 14,303 13,571 12,000 12,500 Minority Interest 0 0 0 0 0
EBITDA 57,258 43,043 13,853 44,638 46,032 Total debt 74,146 91,589 159,701 189,701 194,701
Depreciation & Amortisation 17,383 18,764 16,575 21,681 21,720 Non Current Liabilities 0 0 0 0 0
EBIT 39,875 24,280 (2,723) 22,957 24,312 Def tax liab. (net) 34,127 24,929 25,279 25,279 25,279
Interest expenses 4,795 4,988 4,987 9,958 10,955 Total liabilities 385,724 360,385 447,086 485,741 500,434
Other income 4,083 1,910 14,940 8,037 10,206 Gross block 171,383 195,267 210,009 241,724 276,081
PBT 39,162 21,201 7,231 21,036 23,563 Less: acc. Depreciation (50,103) (67,057) (82,434) (100,614) (118,660)
Taxes 13,261 (4,640) (10,185) 5,301 5,938 Net block 121,280 128,210 127,575 141,110 157,422
Effective tax rate (%) 33.9 21.9 140.9 25.2 25.2 Capital WIP 12,674 20,253 23,877 23,877 23,877
PAT 25,901 25,841 17,416 15,735 17,625 Net fixed assets 133,954 148,463 151,452 164,986 181,298
Minority/Associates 0 0 0 0 0 Non Current Assets 9,468 5,066 3,608 3,608 3,608
Recurring PAT 32,781 8,734 8,839 15,735 17,625 Investments 217,502 177,782 260,324 260,324 260,324
Extraordinary items (6,879) 17,107 8,577 0 0 Inventories 12,199 12,750 12,580 18,941 19,323
Reported PAT 25,901 25,841 17,416 15,735 17,625 Sundry debtors 13,135 10,748 11,738 17,673 18,029
Cash & Cash Equivalents 63,885 41,875 14,487 9,356 6,218
Ratios Loans & advances 351 387 352 530 541
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 24,160 31,343 51,702 77,841 79,411
Growth (%) Trade payables 6,415 6,047 7,440 8,755 8,881
Revenue 28.9 (11.7) (28.9) 50.6 2.0 Other current liab. 58,541 41,151 36,246 42,654 43,267
EBITDA 33.3 (24.8) (67.8) 222.2 3.1 Provisions 23,973 20,831 15,472 16,110 16,171
Adj. EPS 17.2 (73.4) 1.2 78.0 12.0 Net current assets 24,801 29,074 31,702 56,822 55,204
Margins (%) Total assets 385,724 360,385 447,086 485,741 500,434
Gross 90.4 90.3 81.1 87.0 87.3
EBITDA 41.7 35.5 16.1 34.4 34.8 Cashflow
EBIT 29.0 20.0 (3.2) 17.7 18.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 23.9 7.2 10.3 12.1 13.3 Profit Before Tax 39,162 21,201 7,231 21,036 23,563
Returns (%) Depreciation & Amortisation 15,192 15,065 15,317 18,181 18,045
ROE 11.8 3.4 3.5 5.9 6.4 Net Interest (7) (3,105) 648 (8,037) (10,206)
ROCE 8.2 6.0 (1.3) 5.3 5.5 Net Change – WC 3,893 2,989 (10,368) (30,251) (1,520)
ROIC 31.8 20.4 0.8 10.2 9.1 Direct taxes (9,631) (3,805) 8,929 (5,301) (5,938)
Turnover (days) Net cash from operations 50,688 53,038 18,013 (872) 27,619
Gross block turnover ratio (x) 0.8 0.6 0.4 0.5 0.5 Capital expenditure (24,941) (27,771) (25,411) (35,215) (38,032)
Debtors 36 36 48 41 49 Acquisitions, net (223) (34) 0 0 0
Inventory 320 386 284 342 415 Investments 5,243 (14,654) (63,222) 0 0
Creditors 166 193 151 175 191 Others 12,475 13,420 16,310 8,037 10,206
Net working capital 66 87 134 160 152 Net cash from investing (7,446) (29,039) (72,323) (27,178) (27,826)
Solvency (x) FCF 25,747 25,267 (7,398) (36,087) (10,413)
Net debt-equity 0.0 0.2 0.6 0.7 0.7 Issue of share capital (10,923) (8) 0 0 0
Interest coverage ratio 11.9 8.6 2.8 4.5 4.2 Increase/(decrease) in debt 21,268 (35,018) 70,706 30,000 5,000
Net debt/EBITDA 0.2 1.2 10.5 4.0 4.1 Dividend paid (12,979) (14,042) (5,523) (7,081) (7,931)
Per share (Rs) Interest paid (3,918) (4,818) (4,298) 0 0
Adjusted EPS 30.2 8.1 8.2 14.5 16.3 Others (1,224) (1,659) (1,066) 0 0
BVPS 255.9 224.9 241.7 249.7 258.6 Net cash from financing (7,775) (55,544) 59,819 22,919 (2,931)
CEPS 46.3 25.4 23.4 34.5 36.3 Net change in Cash 35,467 (31,545) 5,510 (5,131) (3,138)
DPS 10.3 10.6 5.0 6.5 7.3 Source: Company, Centrum Broking
Dividend payout (%) 42.9 44.5 31.1 45.0 45.0
Valuation (x)
P/E 7.0 26.3 26.0 14.6 13.0
P/BV 0.8 0.9 0.9 0.8 0.8
EV/EBITDA 4.2 6.5 27.0 9.2 9.1
Dividend yield (%) 4.8 5.0 2.4 3.1 3.5
Source: Company, Centrum Broking

Centrum Institutional Research 276


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

Petronet LNG (PLNG)


PLNG’s cash flows have closely approximated fluctuations in operating profits, with Market data
relatively little impact of working capital on the company’s cash flow generation Current price: Rs233
(FY16 an exception). Operating cash flows have consistently grown at a CAGR of 11% Bloomberg: PLNG IN
over FY12-21. Cumulative OCF of Rs273bn has been utilized in capex of Rs56bn and 52-week H/L: Rs,275/201
investments/acquisitions of just Rs0.7bn, leaving FCF of Rs216bn over the period.
Market cap: Rs349.2bn
Steadily improving profitability, reflecting in higher cash flows, has reflected in lower
leverage (Net DER down to negative 0.5x in FY21 from 0.7x in FY12), with return Free float: 46%
ratios also staying strong over the period. Avg. daily vol. 3mth: 3,682,083
Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have been robust and have mostly expanded
over the last 10 years. Working capital intensity in the business has been low, and over the last 3-4 years, there has been a
very sharp expansion in cash flows, driven by higher profitability. As a result, the company has consistently generated strong
operating cash flows.
Exhibit 713: Consistent generation of strong operating cash flows
50,000 Sudden change in volume mix in favor of long-term volumes
from third party due to renegotiation with RasGas
40,000

30,000
Rsmn

20,000

10,000

-10,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company; Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, with net
working capital (NWC) being in the negative territory for most years in our reference period. This trend has remained fairly
constant despite a marked change in the scale of operations. FY16 saw the renegotiation of volumes/pricing arrangements
with RasGas, which led to long-term volumes shooting up in Q4FY16 and helped drive sharply higher positive WC.
Exhibit 714: Net working capital has ranged between 10 days and 15 days
35 NWC days have ranged between 10 and 15 days in most years – not a material impact on net OCF 20
30
25 15
# of days

# of days

20
10
15
10 5
5
0 0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC
Source: Company; Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Petronet LNG (PLNG) 16 September 2021

Exhibit 715: OCF/PAT Exhibit 716: OCF/EBITDA

4.5 2.5
4.0
3.5 2.0
3.0
1.5
2.5

x
x

2.0
1.0
1.5
1.0 0.5
0.5
0.0 0.0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company; Centrum Broking Source: Company; Centrum Broking

Conversion of operating cash flow to FCF has been volatile: Conversion of OCF to FCF was weak due to very high capex over
FY13-17, but has improved sharply since then. Except for FY17, there has not been any meaningful acquisition or investment
in any subsidiary; hence, FCF is a direct function of OCF less capex for the period.
Exhibit 717: Capex intensity, acquisitions and free cash flows

50,000 Early years of building the gas grid in Gujarat dragged FCF down; monetization of the same has 50,000
helped deliver stronger numbers post FY16
40,000
40,000
30,000
20,000 30,000
Rsmn

Rsmn
10,000 20,000
0
10,000
-10,000
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20,000 0
CFO Capex Acquisition/Investments FCF
Source: Company; Centrum Broking

Return ratios have strengthened, leverage has declined since FY16: The sustained improvement in profitability and no
material impact of working capital-related issued has meant that balance sheet has consistently remained free of leverage
over the last decade. With capex intensity reducing post FY17, return ratios have improved post a weak period over FY14-16.
Exhibit 718: Pick-up in profitability from FY16 reflecting in lower leverage, stronger return ratios

Profitability has picked up sharply post FY16, reflecting in lower leverage and stronger return ratios
2.0 35.0%
1.5 30.0%
1.0 25.0%
0.5 20.0%
X

0.0 15.0%
-0.5 10.0%
-1.0 5.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1.5 0.0%
Net Debt/Equity Net Debt/EBITDA ROE ROCE
Source: Company; Centrum Broking

Centrum Institutional Research 278


Petronet LNG (PLNG) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 383,954 354,520 260,229 373,647 381,721 Equity share capital 15,000 15,000 15,000 15,000 15,000
Operating Expense 344,170 304,959 206,815 317,916 320,972 Reserves & surplus 85,661 94,530 101,495 114,605 128,812
Employee cost 1,259 1,258 1,471 1,618 1,780 Shareholders fund 100,661 109,530 116,495 129,605 143,812
Others 5,591 6,529 4,948 5,640 5,979 Minority Interest 0 0 0 0 0
EBITDA 32,935 41,774 46,995 48,473 52,991 Total debt 7,334 1,012 230 0 0
Depreciation & Amortisation 4,112 7,761 7,841 8,427 9,405 Non Current Liabilities 10,861 43,548 42,742 32,057 24,043
EBIT 28,823 34,013 39,154 40,045 43,585 Def tax liab. (net) 13,360 8,883 8,806 8,806 8,806
Interest expenses 989 4,032 3,360 0 0 Total liabilities 132,216 162,973 168,273 170,468 176,661
Other income 4,503 3,726 3,882 4,507 2,706 Gross block 91,640 134,606 133,696 143,698 160,371
PBT 32,336 31,106 39,676 44,552 46,291 Less: acc. Depreciation (14,989) (22,724) (30,565) (38,992) (48,397)
Taxes 10,782 4,131 10,183 16,442 17,084 Net block 76,651 111,882 103,131 104,706 111,973
Effective tax rate (%) 33.3 13.3 25.7 36.9 36.9 Capital WIP 3,482 47 255 255 204
PAT 21,555 26,976 29,494 28,110 29,207 Net fixed assets 80,133 111,929 103,386 104,960 112,177
Minority/Associates 0 0 0 0 0 Non Current Assets 0 0 0 0 0
Recurring PAT 21,555 24,462 29,494 28,110 29,207 Investments 1,644 1,644 1,644 1,644 1,644
Extraordinary items 0 2,514 0 0 0 Inventories 5,694 4,809 3,372 5,287 5,338
Reported PAT 21,555 26,976 29,494 28,110 29,207 Sundry debtors 13,825 16,026 18,745 38,394 30,172
Cash & Cash Equivalents 37,852 46,167 57,275 46,036 53,411
Ratios Loans & advances 9,965 3,330 3,040 3,046 3,051
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,737 3,085 1,864 2,937 3,000
Growth (%) Trade payables 18,354 23,687 20,070 30,852 31,148
Revenue 25.5 (7.7) (26.6) 43.6 2.2 Other current liab. 0 0 0 0 0
EBITDA (0.6) 26.8 12.5 3.1 9.3 Provisions 278 330 983 983 983
Adj. EPS 3.7 13.5 20.6 (4.7) 3.9 Net current assets 50,439 49,400 63,243 63,863 62,840
Margins (%) Total assets 132,216 162,973 168,273 170,468 176,661
Gross 10.4 14.0 20.5 14.9 15.9
EBITDA 8.6 11.8 18.1 13.0 13.9 Cashflow
EBIT 7.5 9.6 15.0 10.7 11.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 5.6 6.9 11.3 7.5 7.7 Profit Before Tax 32,336 31,107 39,677 44,552 46,291
Returns (%) Depreciation & Amortisation 4,112 7,761 7,841 8,427 9,405
ROE 21.8 23.3 26.1 22.8 21.4 Net Interest (466) 1,271 1,332 0 0
ROCE 20.2 30.0 28.2 22.8 21.4 Net Change – WC (4,523) (3,964) (1,746) (11,860) 8,399
ROIC 29.5 45.0 48.3 36.2 32.2 Direct taxes (8,133) (9,576) (9,949) (16,442) (17,084)
Turnover (days) Net cash from operations 21,459 28,631 35,592 20,171 44,305
Gross block turnover ratio (x) 4.2 2.6 1.9 2.6 2.4 Capital expenditure (1,628) (408) (728) (10,002) (16,622)
Debtors 14 15 24 28 33 Acquisitions, net 0 0 0 0 0
Inventory 6 6 7 5 6 Investments 867 7,294 (11,588) 0 0
Creditors 21 25 39 29 35 Others 1 2,524 3,043 4,507 2,706
Net working capital 48 51 89 62 60 Net cash from investing (760) 9,410 (9,273) (5,495) (13,916)
Solvency (x) FCF 19,832 28,223 34,864 10,169 27,683
Net debt-equity (0.3) (0.4) (0.5) (0.4) (0.4) Issue of share capital 0 0 0 0 0
Interest coverage ratio 33.3 10.4 14.0 0.0 0.0 Increase/(decrease) in debt (6,202) (6,322) (368) (10,916) (8,014)
Net debt/EBITDA (0.9) (1.1) (1.2) (0.9) (1.0) Dividend paid (18,083) (18,083) (22,452) (15,000) (15,000)
Per share (Rs) Interest paid (1,191) (4,265) (3,360) 0 0
Adjusted EPS 14.4 16.3 19.7 18.7 19.5 Others 0 (1,876) (1,407) 0 0
BVPS 67.1 73.0 77.7 86.4 95.9 Net cash from financing (25,476) (30,547) (27,586) (25,916) (23,014)
CEPS 17.1 21.5 24.9 24.4 25.7 Net change in Cash (4,777) 7,494 (1,267) (11,240) 7,375
DPS 10.0 12.5 11.5 10.0 10.0 Source: Company, Centrum Broking
Dividend payout (%) 69.6 69.5 58.5 53.4 51.4
Valuation (x)
P/E 16.2 14.3 11.8 12.4 12.0
P/BV 3.5 3.2 3.0 2.7 2.4
EV/EBITDA 9.7 7.3 6.2 6.3 5.6
Dividend yield (%) 4.3 5.4 4.9 4.3 4.3
Source: Company, Centrum Broking

Centrum Institutional Research 279


16 September 2021

Institutional Research
Probal Sen
Research Analyst, Oil & Gas
+91 22 4215 9001
[email protected]
SECTOR: OIL & GAS

RIL
RIL has seen its core annual OCF grow to more than 2x FY12 levels by FY21, with OCF Market data
of Rs710bn on an average over FY17-21 vs Rs374bn over FY12-16. Aggressive Current price: Rs2,428
expansion outside of its traditional downstream and upstream oil & gas focus, Bloomberg: RIL IN
coupled with near doubling of petchem capacity has reflected in earnings and cash 52-week H/L: Rs2,480/1,746
flows. However, the relentless growth in balance sheet size with a combination of
Market cap: Rs15393.4bn
core capex and non-core investments (Retail + Telecom) has meant that overall FCF
has remained negative, implying weak return ratios. Cumulative OCF of Rs5.4tn has Free float: 43.7%
been exceeded by capex of Rs6.1tn and investments of Rs3tn, with RoE/RoCE Avg. daily vol. 3mth: 7,466,889
compressing by 330bp/26bp over FY17-21. Source: Bloomberg

Operating profits have picked up sharply over the last decade: Operating profits, and hence, operating cash flows have
picked up dramatically over the last decade, particularly after FY14-15, as the second refinery (RPL) started delivering and the
KG D6 asset also performed well till FY14. Also, post that, the Telecom/Retail segments have also gradually supported
earnings/cash flows. Working capital has not been a major component barring FY19 and FY21, when sharp movement in
payables caused a material WC impact on cash flows.
Exhibit 719: WC has been a drag on OCF in only two of the 10 years due to higher payables
1,000 1,200
800
1,000
600
800
400
Rsbn

Rsbn
200 600
0
400
-200
200
-400
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-600 0
Operating Cash flow before WCAP changes WCAP changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Working capital has traditionally not been a drag on the business cash flows, except
for FY19/21 when a large jump in creditors (including supplier advances) led to large negative working capital impact on OCF.
Exhibit 720: Barring a few years, NWC has been a negative 16-17 days
140 30
120 20
10
100
0
# of days

# of days

80 -10
60 -20
-30
40
-40
20 -50
0 -60
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Inventory Trade receivables Trade payables NWC

Source: Company, Centrum Broking


nxxxxx

Please see Appendix for analyst certifications and all other important disclosures.
RIL 16 September 2021

Exhibit 721: OCF/EBITDA Exhibit 722: OCF/PAT

160% 250%
140%
200%
120%
100% 150%
80%
%

%
60% 100%

40%
50%
20%
0% 0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Source: Company, Centrum Broking Source: Company, Centrum Broking

Conversion of operating cash flow to FCF has been weak: The last decade saw weak FCF conversion, with capex +
investments outweighing core OCF. In the later years, while both capex and investments increased dramatically, FCF
compressed even more, with FY21 finally seeing a big jump in the other direction post value unlocking in Retail and Telecom
subsidiaries.
Exhibit 723: Capex intensity, acquisitions and free cash flows
1,500 Significant jump in JIO Infocomm/Additional JIO Fiber and Retail investment ramp up 500.0
debentures also subscribed to
1,000 -
500
(500.0)

Rsbn
Rsbn

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 (1,000.0)
-500

-1,000 (1,500.0)
First big jump in JIO Organic capex on downstream capacity and
-1,500 investments petcoke gasifier over FY17-20 (2,000.0)
CFO Capex Acquisition/Investments FCF
Source: Company, Centrum Broking

Return ratios have been declining: Aggressive investment in multiple business expansions and the relatively longer term
gestation of the various business ventures have meant that return ratios have been subdued. Leverage, however, after
reaching very high levels over FY15-17, has shown a sustained improvement in the last four years.
Exhibit 724: Return ratios and leverage trends

4.0 Return ratios subdued due to aggressive investment in multiple business expansions 45.0%
3.5 40.0%

3.0 35.0%
30.0%
2.5
25.0%
2.0
X

20.0%
1.5
15.0%
1.0 10.0%
0.5 5.0%
0.0 0.0%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
net Debt/Equity net Debt/EBITDA ROE ROCE
Source: Company, Centrum Broking

Centrum Institutional Research 281


RIL 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 5,692,090 5,967,430 4,669,240 6,003,208 6,561,764 Equity share capital 59,260 63,390 64,450 64,450 64,450
Operating Expense 4,773,290 4,990,950 3,790,249 4,880,897 5,234,001 Reserves & surplus 3,811,860 4,469,920 6,937,270 7,423,924 8,045,496
Employee cost 124,880 140,750 182,975 237,868 309,228 Shareholders fund 3,871,120 4,533,310 7,001,720 7,488,374 8,109,946
Others (47,750) (46,440) (111,354) (47,657) (102,853) Minority Interest 82,800 80,160 992,600 992,600 992,600
EBITDA 841,670 882,170 807,370 932,101 1,121,388 Total debt 3,013,490 3,295,250 2,646,670 2,516,670 2,386,670
Depreciation & Amortisation 209,340 222,030 265,720 274,961 307,175 Non Current Liabilities 0 0 0 0 0
EBIT 632,330 660,140 541,650 657,141 814,213 Def tax liab. (net) 451,470 512,230 370,010 366,388 363,671
Interest expenses 164,950 220,270 211,890 143,917 136,767 Total liabilities 7,418,880 8,420,950 11,011,000 11,364,031 11,852,886
Other income 83,860 139,560 163,270 183,065 185,409 Gross block 5,845,250 7,335,290 7,687,480 9,120,549 9,863,733
PBT 551,240 534,990 549,450 696,288 862,854 Less: acc. Depreciation (1,981,480) (2,111,300) (2,377,020) (2,651,981) (2,959,156)
Taxes 153,900 137,260 17,220 132,295 163,942 Net block 3,863,770 5,223,990 5,310,460 6,468,569 6,904,577
Effective tax rate (%) 27.9 25.7 3.1 19.0 19.0 Capital WIP 1,794,630 1,091,060 1,259,530 515,111 360,577
PAT 397,340 397,730 532,230 563,994 698,912 Net fixed assets 5,778,370 6,417,640 6,672,110 7,085,800 7,367,275
Minority/Associates 1,030 1,070 5,160 5,000 5,000 Non Current Assets 176,760 374,070 661,240 661,240 661,240
Recurring PAT 398,370 452,230 500,773 568,994 703,912 Investments 1,646,120 2,038,520 2,123,820 2,123,820 2,123,820
Extraordinary items 0 (53,430) 54,652 0 0 Inventories 675,610 739,030 816,720 833,607 894,308
Reported PAT 398,370 398,800 537,390 568,994 703,912 Sundry debtors 300,890 196,560 190,140 246,707 256,178
Cash & Cash
Ratios 821,040 1,038,350 1,698,430 1,392,636 1,555,896
Equivalents
YE Mar FY19A FY20A FY21A FY22E FY23E Loans & advances 162,800 498,350 636,730 815,467 890,708
Growth (%) Other current assets 414,710 327,630 412,930 433,577 455,255
Revenue 45.3 4.8 (21.8) 28.6 9.3 Trade payables 1,083,090 967,990 1,088,970 1,094,109 1,207,316
EBITDA 31.2 4.8 (8.5) 15.4 20.3 Other current liab. 1,432,510 2,204,410 1,060,860 1,075,911 1,075,911
Adj. EPS 12.9 13.5 10.7 13.6 23.7 Provisions 41,820 36,800 51,290 58,802 68,568
Margins (%) Net current assets (182,370) (409,280) 1,553,830 1,493,172 1,700,552
Gross 25.7 28.1 30.2 30.1 31.4 Total assets 7,418,880 8,420,950 11,011,000 11,364,031 11,852,886
EBITDA 14.8 14.8 17.3 15.5 17.1
EBIT 11.1 11.1 11.6 10.9 12.4 Cashflow
YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 7.0 7.6 10.7 9.5 10.7
Returns (%) Profit Before Tax 552,270 536,060 554,610 696,288 862,854
ROE 11.7 10.8 8.7 7.9 9.0 Depreciation & Amortisation 209,340 222,030 265,720 274,961 307,175
ROCE 8.6 8.0 7.4 6.3 7.2 Net Interest 115,390 115,630 106,610 34,291 28,295
ROIC 10.5 10.5 9.0 7.4 8.6 Net Change – WC (287,820) 219,040 (507,310) (245,136) (44,120)
Turnover (days) Direct taxes (121,910) (83,860) (32,130) (135,917) (166,659)
Gross block turnover ratio (x) 1.0 0.8 0.6 0.7 0.7 Net cash from operations 423,460 980,740 261,850 559,752 919,573
Debtors 15 15 15 13 14 Capital expenditure (927,770) (755,530) (1,035,180) (688,650) (588,650)
Inventory 55 60 87 72 70 Acquisitions, net 0 0 0 0 0
Creditors 93 87 115 95 93 Investments (38,240) (17,290) (465,420) 60,122 63,129
Net working capital (12) (25) 121 91 95 Others 14,730 15,650 84,260 114,239 113,315
Solvency (x) Net cash from investing (951,280) (757,170) (1,416,340) (514,289) (412,206)
Net debt-equity 0.6 0.5 0.1 0.1 0.1 FCF (504,310) 225,210 (773,330) (128,898) 330,923
Interest coverage ratio 5.1 4.0 3.8 6.5 8.2 Issue of share capital 2,320 1,300 2,135,970 0 0
Net debt/EBITDA 2.6 2.6 1.2 1.2 0.7 Increase/(decrease) in debt 832,940 314,910 (884,120) (130,000) (130,000)
Per share (Rs) Dividend paid (42,820) (45,920) (39,210) (77,340) (77,340)
Adjusted EPS 61.8 70.2 77.7 88.3 109.2 Interest paid (233,380) (285,080) (183,400) (143,917) (136,767)
BVPS 600.6 703.4 1,086.4 1,161.9 1,258.3 Others 0 (10,620) (10,220) 0 0
CEPS 94.3 104.6 118.9 130.9 156.9 Net cash from financing 559,060 (25,410) 1,019,020 (351,257) (344,107)
DPS 5.5 6.0 7.0 10.0 10.0 Net change in Cash 31,240 198,160 (135,470) (305,794) 163,260
Dividend payout (%) 8.9 9.7 8.4 11.3 9.2 Source: Company, Centrum Broking
Valuation (x)
P/E 39.3 34.6 31.3 27.5 22.2
P/BV 4.0 3.5 2.2 2.1 1.9
EV/EBITDA 21.5 20.6 20.9 18.3 14.9
Dividend yield (%) 0.2 0.2 0.3 0.4 0.4
Source: Company, Centrum Broking

Centrum Institutional Research 282


16 September, 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Aarti Drugs (ARTD)


Operating cash flows have grown at a CAGR of 17% over the last 10 years. Net working Market data
capital days have by-and-large been within a range of 80-100 days since FY15. Current price: Rs617
Inventory volatility in FY18 and FY21 was driven by industry-wide raw material supply Bloomberg: ARTD IN
chain disruption. ARTD has been consistently incurring capex of about Rs750mn per 52-week H/L: Rs1,027/580
year on an average. While capex intensity has reduced amid the pandemic, the
Market cap: Rs57.1bn
management has announced Rs6bn capex, which it intends to finance through
internal accruals. Return ratios have averaged at about 20% over the decade. Free float: 35.1%
Avg. daily vol. 3mth: 287,836
Source: Bloomberg

Operating cash flows have grown at a CAGR of 17% over FY12-21: ARTD’s operating profits have been improving consistently
over 10 years. Working capital has been inconsistent due to raw material inventories, which take 1-2 years to normalize. While
there have been dips in FY18 and FY21, operating cash flows have grown at a CAGR of 17% over FY12-21.
Exhibit 725: OCF has grown at a CAGR of 17% over FY12-21, despite high working capital
4,000

3,000

2,000
Rs in mn

1,000

(1,000)

(2,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(3,000) Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Rising share of exports in the API business has led to higher debtor days. Inventory
levels have stretched amid the pandemic to sustain demand dynamics. Net working capital days have been at similar levels for
the last four years.
Exhibit 726: Working capital cycle impacted by high debtor days
120

100

80
Days

60

40

20

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Aarti Drugs (ARTD) 16 September 2021

Exhibit 727: Cash conversion ratios


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT 2% 28% 47% 381% 194% 214% 85% 170% 182% 55% 136%
OCF/EBITDA 2% 37% 32% 84% 75% 91% 35% 68% 94% 35% 55%
Source: Company, Centrum Broking

Rapid capacity expansion has subdued conversion of operating cash to free cash: ARTD has consistently spent on capacity
expansion. The API business needs to sustain capex. While capex intensity is lower amid the pandemic, the management has
announced Rs6bn capex.
Exhibit 728: High capex spend has affected FCF generation
3,000
2,500
2,000
1,500
Rs in mn

1,000
500
-
(500)
(1,000)
(1,500) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
CFO Capex Net FCF
Source: Company, Centrum Broking

Exhibit 729: Asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 1.6 1.6 1.5 1.2 1.1 1.0 1.0 1.1 1.2 1.3
Source: Company, Centrum Broking

Deployment of FCF: ARTD has repaid debt whenever possible from the FCF generated and unlocked value for the shareholders
via buyback.
Exhibit 730: Deployment of FCF
2,500
2,000
1,500
1,000
Rs in mn

500
-
(500) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(1,000)
(1,500)
(2,000) FCF Inflow from equity raise/Outflow from Buyback Increase/ (decrease) in debt
Source: Company, Centrum Broking

Exhibit 731: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 12.67 23.48 26.56 9.8 20.7 21.3 19.0 16.9 23.0 35.8 20.1
RoCE 12.67 23.47 26.92 13.8 17.6 17.5 16.3 15.5 19.4 32.1 19.5
Source: Company, Centrum Broking

Exhibit 732: Leverage ratios


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 1.5 1.4 1.3 1.3 1.3 1.1 1.1 0.9 0.5 0.3
Net Debt/EBITDA 0.2 1.0 1.2 3.3 2.6 2.4 2.6 2.3 1.3 0.7
Source: Company, Centrum Broking

Centrum Institutional Research 284


Aarti Drugs (ARTD) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 15,609 18,061 21,548 25,441 32,947 Equity share capital 236 233 932 932 932
Operating Expense 12,810 14,612 16,372 18,824 24,172 Reserves & surplus 5,199 6,292 8,202 11,388 15,843
Employee cost 609 694 805 966 1,159 Shareholders fund 5,434 6,525 9,134 12,320 16,775
Others 81 100 0 636 824 Minority Interest 0 0 0 0 0
EBITDA 2,109 2,655 4,371 5,015 6,792 Total debt 4,822 3,527 3,157 2,557 1,957
Depreciation & Amortisation 426 488 499 620 677 Non Current Liabilities 197 236 217 349 451
EBIT 1,684 2,168 3,872 4,395 6,115 Def tax liab. (net) 898 807 771 771 771
Interest expenses 435 374 230 141 117 Total liabilities 11,351 11,095 13,279 15,997 19,955
Other income 24 15 45 38 49 Gross block 6,674 6,838 7,094 8,900 10,416
PBT 1,273 1,808 3,688 4,293 6,047 Less: acc. Depreciation (426) (488) (499) (620) (677)
Taxes 436 439 886 1,043 1,482 Net block 6,249 6,351 6,595 8,280 9,739
Effective tax rate (%) 34.3 24.3 24.0 24.3 24.5 Capital WIP 327 122 193 193 193
PAT 837 1,369 2,802 3,250 4,566 Net fixed assets 6,576 6,473 6,788 8,473 9,932
Minority/Associates 0 0 0 0 0 Non Current Assets 85 118 132 160 160
Recurring PAT 837 1,369 2,802 3,250 4,566 Investments 124 134 173 173 173
Extraordinary items 30 36 2 0 0 Inventories 2,466 3,254 4,150 3,779 4,778
Reported PAT 874 1,414 2,804 3,250 4,566 Sundry debtors 4,585 4,886 5,552 4,531 5,867
Cash & Cash Equivalents 56 76 98 3,073 4,371
Ratios Loans & advances 0 120 128 139 181
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 736 703 641 558 722
Growth (%) Trade payables 2,426 3,295 3,300 3,746 4,756
Revenue 25.5 15.7 19.3 18.1 29.5 Other current liab. 829 1,328 1,054 1,115 1,444
EBITDA 4.5 25.9 64.6 14.7 35.4 Provisions 22 46 28 28 28
Adj. EPS 1.7 65.6 104.6 16.0 40.5 Net current assets 4,566 4,370 6,187 7,191 9,690
Margins (%) Total assets 11,351 11,095 13,279 15,997 19,955
Gross 32.1 34.7 38.7 36.5 37.4
EBITDA 13.5 14.7 20.3 19.7 20.6 Cashflow
EBIT 10.8 12.0 18.0 17.3 18.6 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 5.4 7.6 13.0 12.8 13.9 Profit Before Tax 1,310 1,853 3,690 4,293 6,047
Returns (%) Depreciation & Amortisation 426 488 499 620 677
ROE 16.8 22.9 35.8 30.3 31.4 Net Interest 435 374 230 141 117
ROCE 11.2 16.3 26.6 24.7 27.7 Net Change – WC (292) 338 (1,856) 2,103 (1,099)
ROIC 11.2 16.5 26.9 28.1 35.8 Direct taxes (347) (530) (922) (1,043) (1,482)
Turnover (days) Net cash from operations 1,532 2,523 1,640 6,114 4,261
Gross block turnover ratio (x) 2.3 2.6 3.0 2.9 3.2 Capital expenditure (693) (384) (814) (2,305) (2,136)
Debtors 97 96 88 72 58 Acquisitions, net 0 0 0 0 0
Inventory 90 89 102 90 76 Investments (17) (9) (39) 0 0
Creditors 86 89 91 80 75 Others 0 (87) 28 (28) 0
Net working capital 107 88 105 103 107 Net cash from investing (710) (481) (825) (2,334) (2,136)
Solvency (x) FCF 822 2,042 816 3,780 2,125
Net debt-equity 0.9 0.5 0.3 0.0 (0.1) Issue of share capital 0 (3) 699 0 0
Interest coverage ratio 4.8 7.1 19.0 35.7 57.9 Increase/(decrease) in debt (380) (1,295) (370) (600) (600)
Net debt/EBITDA 2.3 1.3 0.7 (0.1) (0.4) Dividend paid (28) (56) (112) (112) (112)
Per share (Rs) Interest paid (435) (374) (230) (141) (117)
Adjusted EPS 8.9 14.7 30.1 34.9 49.0 Others 34 (293) (781) 49 2
BVPS 57.6 70.0 98.0 132.2 180.0 Net cash from financing (809) (2,021) (795) (804) (828)
CEPS 13.4 19.9 35.4 41.5 56.3 Net change in Cash 13 21 21 2,975 1,298
DPS (0.3) (0.3) (1.0) (1.0) (1.0) Source: Company, Centrum Broking
Dividend payout (%) (2.7) (1.6) (3.3) (2.9) (2.0)
Valuation (x)
P/E 69.5 42.0 20.5 17.7 12.6
P/BV 10.7 8.8 6.3 4.7 3.4
EV/EBITDA 29.3 22.8 13.8 11.3 8.1
Dividend yield (%) 0.0 0.0 -0.2 -0.2 -0.2
Source: Company, Centrum Broking

Centrum Institutional Research 285


16 September, 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Abbott
Abbott remains a cash flow compounder; its operating cash flows have grown Market data
consistently at a CAGR of 20% over the last decade. Its strong marketing platform Current price: Rs21,004
enables its domestic business to grow at 2.5x IMP on an average. Given the domestic Bloomberg: BOOT IN
market presence, working capital remains in favor of the company. Expansion of 52-week H/L: Rs21,870/13,835
products and consistent cost efficiencies have driven operating leverage and
Market cap: Rs446.3bn
consistent margin expansion. With minimal capex, almost all its operating cash flows
are converted to free cash flows. On an average, RoE has been 24% and RoCE has been Free float: 23.4%
21%. Abbott has increased dividend payout, and given its stellar cash flows, dividends Avg. daily vol. 3mth: 17,048
should continue to increase. Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have grown at a CAGR of ~20% over the last
decade. With very low working capital adjustment, this has translated to cash flow from operations.
Exhibit 733: Consistent growth in cash flow from operations
14,000
12,000
10,000
8,000
Rs in mn

6,000
4,000
2,000
-
(2,000) CY11 CY12 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(4,000)
Operating profit before wcap changes (Rsbn) Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Favorable payable and debtor days along with strong control on inventory have helped
Abbott to maintain a short working capital cycle. This trend has been observed with all the domestic players.
Exhibit 734: Working capital cycle has improved over the years
100

80

60
Days

40

20

0
CY11 CY12 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-20
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Abbott 16 September 2021

With minimal capex, almost the entire OCF is converted to FCF: Abbott has not incurred any major capex over the last decade.
The little capex it has incurred can be majorly attributed to debottlenecking and upkeep of existing facilities.
Exhibit 735: Almost 100% conversion of OCF to FCF
14,000
12,000
10,000
8,000
Rs in mn

6,000
4,000
2,000
-
CY11 CY12 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(2,000)
CFO Capex Net FCF
Source: Company, Centrum Broking

Dividend distribution: The company has consistently been distributing dividends to its shareholders from the free cash
available. In FY21, it distributed a dividend of Rs275/share.
Exhibit 736: Dividend distributed has grown at a CAGR of 36% over the last decade to Rs275/share
15,000

10,000

5,000
Rs in mn

-
CY11 CY12 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(5,000)

(10,000)
FCF Dividend/buyback
Source: Company, Centrum Broking

Exhibit 737: Earnings and dividend per share


(Rs/share) CY11 CY12 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash EPS 64 77 104 115 127 138 196 220 307 350
Dividend yield 1.2 1.1 1.3 0.8 0.7 0.9 1.0 0.9 1.6 1.8
Dividend per share 17 17 23 31 35 40 55 65 250 275
Source: Company, Centrum Broking

Exhibit 738: Return ratios


Return Ratios (%) CY12 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 24.3 29.4 26.5 21.4 19.9 23.7 22.4 24.3 26.3 24.2
RoCE 36.1 25.1 23.1 18.8 17.4 19.4 18.9 21.1 24.5 21.0
RoIC 76.1 29.1 25.1 24.2 62.2 142.2 271.1 376.9 125.9
Source: Company, Centrum Broking

Exhibit 739: Cash conversion ratios


(%) CY12 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 AVG
OCF/PAT 5% 7% 8% 180% 213% 226% 140% 225% 183% 136%
OCF/EBITDA 5% 8% 8% 135% 149% 157% 107% 167% 143% 101%
Source: Company, Centrum Broking

Centrum Institutional Research 287


Abbott 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 36,786 40,931 43,000 50,431 57,344 Equity share capital 213 213 213 213 213
Operating Expense 25,137 27,695 28,035 31,275 35,363 Reserves & surplus 19,873 24,105 25,809 30,080 35,189
Employee cost 4,356 4,761 4,927 5,598 6,308 Shareholders fund 20,086 24,317 26,022 30,292 35,402
Others 1,245 911 924 1,866 1,720 Minority Interest 0 0 0 0 0
EBITDA 6,048 7,564 9,115 11,693 13,953 Total debt 0 0 0 0 0
Depreciation & Amortisation 169 596 581 620 620 Non Current Liabilities 754 2,240 2,074 2,074 2,074
EBIT 5,878 6,968 8,533 11,073 13,333 Def tax liab. (net) 0 0 0 0 0
Interest expenses 23 85 183 96 109 Total liabilities 20,840 26,557 28,096 32,367 37,476
Other income 1,133 1,144 809 1,513 1,720 Gross block 1,219 1,607 1,630 1,551 1,551
PBT 6,989 8,027 9,160 12,490 14,944 Less: acc. Depreciation (169) (596) (581) (620) (620)
Taxes 2,485 2,112 2,315 3,210 3,841 Net block 1,050 1,011 1,048 931 931
Effective tax rate (%) 35.6 26.3 25.3 25.7 25.7 Capital WIP 7 16 7 7 7
PAT 4,503 5,915 6,845 9,280 11,104 Net fixed assets 1,057 1,028 1,055 938 938
Minority/Associates 0 0 0 0 0 Non Current Assets 528 530 466 691 786
Recurring PAT 4,503 5,915 6,845 9,280 11,104 Investments 0 0 0 0 0
Extraordinary items 0 0 0 0 0 Inventories 6,068 5,272 7,176 9,721 10,573
Reported PAT 4,503 5,915 6,845 9,280 11,104 Sundry debtors 2,761 3,179 2,502 3,316 3,771
Cash & Cash Equivalents 16,843 21,974 24,090 25,817 30,311
Ratios Loans & advances 73 61 50 0 0
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,949 3,280 2,888 1,658 1,885
Growth (%) Trade payables 6,635 6,578 7,627 7,270 8,283
Revenue 11.2 11.3 5.1 17.3 13.7 Other current liab. 894 826 1,019 1,019 1,019
EBITDA 15.3 25.1 20.5 28.3 19.3 Provisions 1,040 1,508 1,663 1,663 1,663
Adj. EPS 12.2 31.3 15.7 35.6 19.7 Net current assets 19,125 24,855 26,397 30,560 35,575
Margins (%) Total assets 20,840 26,557 28,096 32,367 37,476
Gross 43.2 43.4 44.4 46.7 46.7
EBITDA 16.4 18.5 21.2 23.2 24.3 Cashflow
EBIT 16.0 17.0 19.8 22.0 23.3 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 12.2 14.5 15.9 18.4 19.4 Profit Before Tax 6,989 8,027 9,160 12,490 14,944
Returns (%) Depreciation & Amortisation 169 596 581 620 620
ROE 24.3 26.6 27.2 33.0 33.8 Net Interest 23 85 183 96 109
ROCE 24.4 26.9 27.7 33.2 34.1 Net Change – WC 3,577 884 473 (2,661) (616)
ROIC 76.9 183.8 298.4 256.8 207.1 Direct taxes (2,470) (2,126) (2,348) (3,210) (3,841)
Turnover (days) Net cash from operations 8,288 7,466 8,048 7,335 11,217
Gross block turnover ratio (x) 30.2 25.5 26.4 32.5 37.0 Capital expenditure (391) (567) (609) (503) (620)
Debtors 27 26 24 21 23 Acquisitions, net 0 0 0 0 0
Inventory 104 89 95 115 121 Investments 0 0 0 0 0
Creditors 100 104 108 101 93 Others 0 0 0 0 0
Net working capital 190 222 224 221 226 Net cash from investing (391) (567) (609) (503) (620)
Solvency (x) FCF 7,897 6,900 7,440 6,832 10,597
Net debt-equity (0.8) (0.9) (0.9) (0.9) (0.9) Issue of share capital 0 0 0 0 0
Interest coverage ratio 268.8 88.7 49.9 122.0 128.1 Increase/(decrease) in debt 0 0 0 0 0
Net debt/EBITDA (2.8) (2.9) (2.6) (2.2) (2.2) Dividend paid (1,658) (1,658) (7,013) (5,011) (5,996)
Per share (Rs) Interest paid (23) (85) (183) (96) (109)
Adjusted EPS 211.9 278.3 322.1 436.7 522.5 Others 312 (26) 1,872 2 2
BVPS 945.2 1,144.3 1,224.5 1,425.5 1,666.0 Net cash from financing (1,368) (1,769) (5,323) (5,105) (6,103)
CEPS 219.9 306.4 349.5 465.9 551.7 Net change in Cash 6,529 5,131 2,117 1,727 4,494
DPS 65.0 65.0 275.0 196.5 235.1 Source: Company, Centrum Broking
Dividend payout (%) 30.7 23.4 85.4 45.0 45.0
Valuation (x)
P/E 99.1 75.5 65.2 48.1 40.2
P/BV 22.2 18.4 17.2 14.7 12.6
EV/EBITDA 71.0 56.1 46.3 36.0 29.8
Dividend yield (%) 0.3 0.3 1.3 0.9 1.1
Source: Company, Centrum Broking

Centrum Institutional Research 288


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Aurobindo Pharma (ARBP)


ARBP has seen consistent improvement in cash flow generation from FY18. In the last Market data
two years, its cash flows have been well ahead of the historical range, as the business’ Current price: Rs755
ability to generate cash has improved. Net working capital has been steady for the Bloomberg: ARBP IN
last five years, though inventory cycle remains heavy. The nature of the business 52-week H/L: Rs1,064/660
necessitates high working capital, but its size now ensures significant cash flow
Market cap: Rs442.2bn
generation. The stark improvement in balance sheet from leverage-driven to net-
cash, also aided by Natrol divestment, is a key highlight. Return ratios indicate better Free float: 43.4%
asset utilization, with the 10-year average at ~20%. ARBP’s return ratios have been Avg. daily vol. 3mth: 3,199,356
better than peers, with better acquisitions. R&D spend is controlled, at ~4% of sales. Source: Bloomberg

History of robust and consistent operating profits: ARBP’s cash flows from operations have grown at a CAGR of 29% in the last
decade. In the last five years, operating profit before working capital changes has grown at 13%, whereas cash flows from
operations have been almost flat.
Exhibit 740: Cash flows from operations have grown at a CAGR of 29% over FY12-21
50,000

40,000

30,000
Rs in mn

20,000

10,000

(10,000)

(20,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: We observe an improvement in working capital cycle over the decade, led by decrease
in debtor days, though inventory days remain high. Since FY18, the working capital cycle has been flattish at ~35 days.
Exhibit 741: Working capital cycle has been improving over the decade
200

150
Days

100

50

0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Aurobindo Pharma (ARBP) 16 September 2021

Exhibit 742: Cash conversion ratios


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT -128% 454% 55% 75% 71% 142% 81% 70% 155% 103% 108%
OCF/EBITDA 68% 44% 30% 48% 45% 95% 52% 42% 91% 62% 58%
Source: Company, Centrum Broking

Rapid capacity expansions and acquisitions from operating cash: Historically, FCF generation has been poor due to higher
capex and frequent acquisitions. In the past two years, FCF generation has increased significantly.
Exhibit 743: Capex intensity, acquisitions and free cash flows
50,000 79 products Natrol sale: USD50mn
Acquired Generis from Magnum Capital: EUR135mn
from TEVA
40,000 and Shreya Life's Russia business: USD100mn
30,000
20,000
Rs in mn

10,000
-
(10,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)
(30,000) Dermatology & oral solid brands acquired from Novartis: USD900mn+
CFO Capex Acquisitions Net FCF 7 oncology drugs from Sectrum Pharma: USD160mn
Generic drug business from Mallinckrodt PLC: USD900mn
Source: Company, Centrum Broking

Exhibit 744: Asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
Asset turn (x) 0.8 0.9 1.0 1.1 1.0 0.9 0.9 0.8 0.8 0.8 0.9
Source: Company, Centrum Broking

Dividend distribution: The company has been consistently distributing dividends to its shareholders.
Exhibit 745: Consistently distributing dividends to shareholders
50,000

40,000

30,000
Rs in mn

20,000

10,000

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(10,000)
FCF Dividend/buyback
Source: Company, Centrum Broking

Exhibit 746: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE -10.6 2.4 36.9 35.9 31.8 27.6 23.0 18.5 18.4 16.6 20.1
RoCE 6.6 7.4 26.9 27.7 29.0 26.1 23.0 18.4 17.9 18.5 20.2
Source: Company, Centrum Broking

Exhibit 747: Leverage ratios


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 1.1 1.2 0.9 0.6 0.5 0.3 0.3 0.3 0.2 (0.0)
Net Debt/EBITDA 5.2 5.1 1.6 1.3 1.1 0.7 0.9 1.2 0.6 (0.1)
Source: Company, Centrum Broking

Exhibit 748: Cumulative R&D spend of Rs56bn (4% of sales) over FY14-21
(Rs in mn) FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
R&D 2,750 3,460 4,640 5,430 6,670 8,680 9,580 15,100 -
% of sales 3.4 2.9 3.4 3.7 4.0 4.4 4.1 6.1 4.01
Source: Company, Centrum Broking

Centrum Institutional Research 290


Aurobindo Pharma (ARBP) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 195,636 230,985 247,747 266,274 298,664 Equity share capital 586 586 586 586 586
Operating Expense 105,286 120,662 120,933 136,576 155,219 Reserves & surplus 138,322 167,518 218,713 250,388 288,838
Employee cost 25,849 32,192 35,350 37,278 40,320 Shareholders fund 138,908 168,104 219,299 250,974 289,424
Others 24,982 29,841 38,129 31,791 35,120 Minority Interest 16 1 (9) (9) (9)
EBITDA 39,519 48,290 53,335 60,628 68,005 Total debt 67,532 56,867 52,373 34,373 34,373
Depreciation & Amortisation 6,680 9,667 10,554 11,196 13,104 Non Current Liabilities 465 1,622 2,507 2,758 3,034
EBIT 32,840 38,623 42,781 49,432 54,901 Def tax liab. (net) 2,926 3,025 1,219 1,219 1,219
Interest expenses 2,626 1,598 745 619 687 Total liabilities 209,847 229,619 275,389 289,315 328,041
Other income 1,553 862 3,808 2,088 2,083 Gross block 83,103 94,472 100,001 86,188 92,032
PBT 31,767 37,887 45,844 50,902 56,297 Less: acc. Depreciation (6,680) (9,667) (10,554) (11,196) (13,104)
Taxes 7,269 9,135 20,098 13,743 15,200 Net block 76,423 84,805 89,447 74,992 78,927
Effective tax rate (%) 22.9 24.1 43.8 27.0 27.0 Capital WIP 16,685 19,859 30,615 30,615 30,615
PAT 24,499 28,752 25,747 37,158 41,097 Net fixed assets 101,433 113,824 124,351 109,896 113,832
Minority/Associates 27 (152) (554) (554) (554) Non Current Assets 5,864 5,768 7,115 7,265 7,431
Recurring PAT 24,526 28,600 25,193 36,605 40,543 Investments 3,602 5,547 4,312 4,312 4,312
Extraordinary items (881) (261) 28,146 0 0 Inventories 72,456 76,999 90,266 91,717 90,790
Reported PAT 23,645 28,339 53,339 36,605 40,543 Sundry debtors 34,138 43,152 35,033 42,312 45,004
Cash & Cash Equivalents 19,572 28,422 54,743 64,732 98,260
Ratios Loans & advances 14,083 695 1,272 1,459 1,637
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 13,397 14,858 16,922 16,922 15,324
Growth (%) Trade payables 26,771 25,450 27,947 18,564 17,750
Revenue 18.6 18.1 7.3 7.5 12.2 Other current liab. 26,117 30,028 28,958 28,958 28,958
EBITDA 4.8 22.2 10.4 13.7 12.2 Provisions 1,809 4,166 1,719 1,779 1,840
Adj. EPS 1.2 16.6 (11.9) 45.3 10.8 Net current assets 98,948 104,481 139,611 167,841 202,466
Margins (%) Total assets 209,847 229,619 275,389 289,315 328,041
Gross 55.5 57.9 60.0 59.6 59.8
EBITDA 20.2 20.9 21.5 22.8 22.8 Cashflow
EBIT 16.8 16.7 17.3 18.6 18.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 12.5 12.4 10.2 13.7 13.6 Profit Before Tax 30,887 37,626 73,990 50,902 56,297
Returns (%) Depreciation & Amortisation 6,680 9,667 10,554 11,196 13,104
ROE 19.2 18.6 13.0 15.6 15.0 Net Interest 2,626 1,598 745 619 687
ROCE 14.4 13.9 10.5 13.5 13.7 Net Change – WC (16,704) 4,216 (6,603) (18,142) (2,584)
ROIC 15.4 15.7 11.9 16.8 18.3 Direct taxes (6,801) (9,036) (21,904) (13,743) (15,200)
Turnover (days) Net cash from operations 16,687 44,070 56,782 30,832 52,304
Gross block turnover ratio (x) 2.4 2.4 2.5 3.1 3.2 Capital expenditure (27,075) (22,058) (21,081) 3,259 (17,040)
Debtors 61 61 58 53 53 Acquisitions, net 0 0 0 0 0
Inventory 274 280 308 309 278 Investments (487) (1,945) (363) 0 1,598
Creditors 106 98 98 79 55 Others (740) 354 (1,070) 0 0
Net working capital 185 165 206 230 247 Net cash from investing (28,301) (23,649) (22,514) 3,259 (15,442)
Solvency (x) FCF (11,614) 20,421 34,268 34,090 36,862
Net debt-equity 0.3 0.2 0.0 (0.1) (0.2) Issue of share capital 1 3 0 0 0
Interest coverage ratio 15.0 30.2 71.6 98.0 98.9 Increase/(decrease) in debt 22,706 (10,665) (4,494) (18,000) 0
Net debt/EBITDA 1.2 0.6 0.0 (0.5) (0.9) Dividend paid (1,317) (2,093) (2,093) (2,093) (2,093)
Per share (Rs) Interest paid (2,626) (1,598) (745) (619) (687)
Adjusted EPS 41.9 48.8 43.0 62.5 69.2 Others (200) 2,781 (615) (3,390) (554)
BVPS 237.1 286.9 374.3 428.4 494.0 Net cash from financing 18,564 (11,571) (7,947) (24,101) (3,334)
CEPS 53.3 65.3 61.0 81.6 91.6 Net change in Cash 6,949 8,850 26,321 9,989 33,528
DPS 1.9 3.0 3.0 3.0 3.0 Source: Company, Centrum Broking
Dividend payout (%) 4.7 6.2 3.3 4.8 4.3
Valuation (x)
P/E 18.0 15.5 17.6 12.1 10.9
P/BV 3.2 2.6 2.0 1.8 1.5
EV/EBITDA 12.4 9.7 8.2 6.8 5.6
Dividend yield (%) 0.3 0.4 0.4 0.4 0.4
Source: Company, Centrum Broking

Centrum Institutional Research 291


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Biocon
Rs

Biocon is the only meaningful play in the biosimilar space. Its cash flows from Market data
operations have grown at a CAGR of 8% over the last decade. It has been in heavy Current price: Rs377
investment mode, with cumulative capex of Rs99bn over the last 10 years. To fund its Bloomberg: BIOS IN
capex, besides internal accruals, Biocon has also relied on debt and has recently raised 52-week H/L: Rs488/328
equity (Rs13bn in FY20/21). Being present in first wave biosimilar launches, Biocon’s
Market cap: Rs452.3bn
FCF generation has been lagging and its return ratios are constrained. R&D spend has
been extensive at five-year average of 9% of sales. Cash flow improvement is Free float: 36.6%
dependent on market share gains in the developed market for key products and Avg. daily vol. 3mth: 2,303,194
partner commercial strategy. Insulin glargine interchangeability is one hope. Source: Bloomberg

Improving cash flows from operations: In the past decade, cash flows from operations grew at a CAGR of 8%, with a negative
growth of 10% in the first five years. Since FY15, cash flows from operations have grown at a CAGR of ~33%.
Exhibit 749: Cash flows from operations have grown at a CAGR of 8% over the decade
20,000

15,000

10,000
CAGR FY12-16: -10%
Rs in mn

5,000

(5,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(10,000)
Operating profit before wcap changes Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Biocon’s working capital cycle decreased from 84 days in FY12 to 61 days in FY21. Over
the last four years, working capital cycle has been maintained at ~60 days.
Exhibit 750: Working capital cycle maintained at ~60 days since FY17
120
100
80
Days

60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Debtors Inventory Payable Net working capital


Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Biocon 16 September 2021

Exhibit 751: Cash conversion ratios


(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT 167% 142% 136% 48% 70% 105% 141% 157% 209% 85% 126%
OCF/EBITDA 109% 89% 82% 29% 58% 65% 101% 103% 102% 76% 81%
Source: Company, Centrum Broking

Exhibit 752: High capex spend constrained FCF generation


15,000
10,000
5,000
Rs in mn

-
(5,000)
(10,000)
(15,000)
(20,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Investing in Subsidary/ Acquistion Net FCF


Source: Company, Centrum Broking

Exhibit 753: Asset turn


FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
Asset turn (x) 0.6 0.5 0.4 0.4 0.4 0.5 0.5 0.4 0.5
Source: Company, Centrum Broking

Exhibit 754: Negative FCF funded by debt and by raising equity capital
25,000
20,000
15,000
Rs in mn

10,000
5,000
-
(5,000)
(10,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

FCF Inflow from equity raise/Outflow from Buyback Increase/ (decrease) in debt

Source: Company, Centrum Broking

Exhibit 755: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 15.0 13.3 14.5 13.8 14.5 13.9 9.4 12.9 9.2 18.7 13.5
RoCE 13.1 12.3 13.3 11.7 9.6 11.2 7.9 11.8 11.1 10.2 11.2
Source: Company, Centrum Broking

Exhibit 756: Leverage ratios


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity - (0.3) (0.2) (0.0) 0.0 0.0 0.1 0.1 0.1 0.1
Net Debt/EBITDA - (1.7) (0.9) (0.1) 0.1 0.2 0.4 0.5 0.6 0.7
Source: Company, Centrum Broking

Exhibit 757: Cumulative R&D spend of Rs31bn (7.4% of sales) during the decade
(Rs in mn) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
R&D 1,366 1,640 1,310 1,688 1,310 4,019 3,804 4,796 5,270 6,270 -
% of sales 7.1% 6.8% 4.6% 5.6% 4.0% 10.5% 9.6% 8.9% 8.5% 8.7% 7.4%
Source: Company, Centrum Broking

Centrum Institutional Research 293


Biocon 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 53,811 62,115 71,847 85,628 111,242 Equity share capital 3,000 6,000 6,000 6,000 6,000
Operating Expense 23,785 27,122 28,679 29,890 39,688 Reserves & surplus 57,980 61,058 70,269 75,007 90,388
Employee cost 11,653 14,588 17,410 21,171 25,407 Shareholders fund 60,980 67,058 76,269 81,007 96,388
Others 8,468 9,378 11,950 13,128 15,485 Minority Interest 6,089 6,773 8,807 8,807 8,807
EBITDA 11,238 12,584 15,165 21,440 30,663 Total debt 17,868 18,898 35,558 35,258 34,958
Depreciation & Amortisation 1,779 2,064 3,644 7,409 8,188 Non Current Liabilities 9,214 18,007 28,107 7,632 9,666
EBIT 9,459 10,520 11,521 14,031 22,475 Def tax liab. (net) 0 298 323 0 0
Interest expenses 709 660 577 1,622 1,573 Total liabilities 94,151 111,034 149,064 132,703 149,820
Other income 1,444 1,614 2,545 1,165 2,498 Gross block 44,306 56,028 59,217 69,825 74,416
PBT 10,194 11,474 13,489 13,574 23,399 Less: acc. Depreciation (1,779) (2,064) (3,644) (7,409) (8,188)
Taxes 2,123 3,151 1,966 3,461 5,967 Net block 42,527 53,964 55,573 62,416 66,228
Effective tax rate (%) 20.8 27.5 14.6 25.5 25.5 Capital WIP 12,869 15,765 22,535 22,535 22,535
PAT 8,071 8,323 11,523 10,113 17,433 Net fixed assets 64,130 80,562 91,893 98,736 102,548
Minority/Associates (715) (2,173) 2,145 (1,450) (1,450) Non Current Assets 910 1,844 2,678 1,145 1,145
Recurring PAT 7,356 6,150 13,668 8,663 15,983 Investments 1,394 943 5,637 5,637 5,637
Extraordinary items 1,946 675 0 0 0 Inventories 10,316 14,359 18,666 14,815 17,688
Reported PAT 9,302 6,825 13,668 8,663 15,983 Sundry debtors 12,918 12,237 12,173 7,378 7,700
Cash & Cash Equivalents 10,572 9,954 20,167 18,623 37,518
Ratios Loans & advances 1,665 1,774 3,276 570 570
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 15,079 16,668 25,008 18,659 19,520
Growth (%) Trade payables 11,983 13,251 15,139 10,864 14,139
Revenue 35.3 15.4 15.7 19.2 29.9 Other current liab. 2,193 3,098 3,366 1,057 1,264
EBITDA 71.7 12.0 20.5 41.4 43.0 Provisions 13,597 17,055 17,654 26,664 32,829
Adj. EPS 57.0 (58.2) 122.2 (36.6) 84.5 Net current assets 22,777 21,588 43,131 21,461 34,765
Margins (%) Total assets 94,151 111,034 149,064 132,703 149,820
Gross 67.2 69.5 71.1 71.9 72.6
EBITDA 20.4 19.8 20.7 25.0 27.6 Cashflow
EBIT 17.2 16.5 15.7 16.4 20.2 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 13.3 9.7 18.7 10.1 14.4 Profit Before Tax 12,140 12,149 13,489 13,574 23,399
Returns (%) Depreciation & Amortisation 1,779 2,064 3,644 7,409 8,188
ROE 13.0 9.6 19.1 11.0 18.0 Net Interest 709 660 577 1,622 1,573
ROCE 10.7 9.9 11.3 9.2 14.0 Net Change – WC (3,308) 59 (8,516) 19,526 5,591
ROIC 11.1 9.9 11.1 10.7 16.9 Direct taxes (4,747) (4,010) (1,569) (3,784) (5,967)
Turnover (days) Net cash from operations 6,573 10,922 7,625 38,347 32,785
Gross block turnover ratio (x) 1.2 1.1 1.2 1.2 1.5 Capital expenditure (16,516) (21,118) (9,644) (15,561) (12,000)
Debtors 78 72 61 42 25 Acquisitions, net 0 0 0 0 0
Inventory 169 219 273 254 194 Investments (3,573) 168 (8,205) 0 0
Creditors 212 224 235 197 150 Others 2,996 187 (355) 0 0
Net working capital 154 127 219 91 114 Net cash from investing (17,093) (20,763) (18,204) (15,561) (12,000)
Solvency (x) FCF (10,520) (9,841) (10,579) 22,786 20,785
Net debt-equity 0.1 0.1 0.2 0.2 0.0 Issue of share capital 139 2,067 381 0 0
Interest coverage ratio 15.9 19.1 26.3 13.2 19.5 Increase/(decrease) in debt (1,335) 1,030 16,660 (300) (300)
Net debt/EBITDA 0.6 0.7 1.0 0.8 (0.1) Dividend paid (351) (702) (600) 0 (600)
Per share (Rs) Interest paid (709) (660) (577) (1,622) (1,573)
Adjusted EPS 12.3 5.1 11.4 7.2 13.3 Others 10,120 7,488 4,928 (22,408) 584
BVPS 101.6 55.9 63.6 67.5 80.3 Net cash from financing 7,864 9,223 20,792 (24,330) (1,890)
CEPS 15.2 6.8 14.4 13.4 20.1 Net change in Cash (2,656) (618) 10,213 (1,544) 18,895
DPS (0.5) (0.5) (0.5) (0.5) (0.5) Source: Company, Centrum Broking
Dividend payout (%) (3.2) (8.8) (4.4) (6.9) (3.8)
Valuation (x)
P/E 30.7 73.4 33.1 52.2 28.3
P/BV 3.7 6.7 5.9 5.6 4.7
EV/EBITDA 20.8 18.7 15.9 11.3 7.3
Dividend yield (%) (0.1) (0.1) (0.1) (0.1) (0.1)
Source: Company, Centrum Broking

Centrum Institutional Research 294


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Cipla
Cipla’s cash flows from operations have grown at a CAGR of 9% over FY12-21. Market data
However, in the first half of the decade, there was little growth. Growth improved Current price: Rs954
from FY19, driven by key inhaler asset monetization in the US market. Domestically, Bloomberg: CIPLA IN
its strong Covid drugs basket is aiding growth well ahead of the IPM. The company is 52-week H/L: Rs997/706
focusing on the Indian market and the inhaler pipeline in the US. Net working capital
Market cap: Rs769.5bn
is on an improving trajectory from FY19. The Invagen acquisition in FY16 at USD550mn
saw meaningful impairment of ~Rs8.5bn in FY17/18. RoE has been steady at ~10% for Free float: 58.6%
the last five years. R&D spend at 7% of sales is in line with peers. Avg. daily vol. 3mth: 2,742,953
Source: Bloomberg

Cash flows from operations have grown at a CAGR of 36% over FY18-21: Cash flows from operations have grown at a CAGR
of 9% over FY12-21. However, the trend was flattish in the first half of the decade. Over FY18-21, cash flows from operations
have grown at a CAGR of 36%.
Exhibit 758: Cash flows from operations have grown at a CAGR of 9% over FY12-21
40,000

30,000
CAGR FY12-16: 0%
20,000
Rs mn

10,000

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(10,000)
Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: We observe an improving trend in working capital cycle, aided largely by a decline in
inventory days.
Exhibit 759: Working capital cycle has by-and-large improved over the decade
160
140
120
100
Days

80
60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Debtors Inventory Payable Net working capital


Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Cipla 16 September 2021

Exhibit 760: Cash conversion ratios


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT 133% 92% 113% 99% 126% 187% 109% 108% 198% 156% 132%
OCF/EBITDA 95% 64% 73% 54% 70% 96% 52% 54% 96% 88% 74%
Source: Company, Centrum Broking

Rapid capacity expansions and acquisitions from operating cash: The company periodically acquires brands from other players
to improve its foothold in the market. In FY16, it acquired InvaGen Pharmaceuticals and Exelan Pharmaceuticals for USD550mn.
The acquisitions were impaired over the next two years to the extent of Rs8.5bn.
Exhibit 761: FCF consistently improving from FY17
50,000 Brands Vysov & Vysov M for Rs308mn
40,000 Brands CPink, CDense, Productiv and Folinine under WHC for Rs829mn
30,000
20,000
Rs mn

10,000
-
(10,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)
(30,000) InvaGen Pharma and Exelan Pharmac for 100% stake in Mirren (an OTC
OTC brand
(40,000) USD550mn through debt funding manufacturer and distributor in SA)
Dentopain for
Rs654mn
CFO Capex Investment in subsidary/ Acquisition Net FCF
Source: Company, centrum

Exhibit 762: Asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.8 0.8 0.8 0.8 0.7 0.7 0.7 0.7 0.7 0.8
Source: Company, centrum

Exhibit 763: Consistently paying dividends to shareholders


40,000
30,000
20,000
10,000
Rs mn

-
(10,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)
(30,000)
(40,000) FCF Dividend/buyback
Source: Centrum, company

Exhibit 764: Return ratios


(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 18.0 18.2 14.6 11.4 12.5 10.6 10.1 10.7 10.1 14.1 13.0
RoCE 21.1 22.8 18.3 14.7 12.4 7.7 10.2 11.6 11.9 17.2 14.8
Source: Company, Centrum Broking

Exhibit 765: Leverage ratios


(x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity (0.1) (0.1) 0.1 0.1 0.3 0.2 0.1 0.1 0.1 (0.1)
Net Debt/EBITDA (0.6) (0.6) 0.3 0.3 1.5 1.1 0.7 0.5 0.2 (0.5)
Source: Centrum, company

Exhibit 766: R&D spend for the decade was Rs83bn, 6.3% of sales
(Rs in mn) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
R&D spend 3,238 4,251 5,292 6,789 8,906 10,853 10,473 11,819 11,750 9,240 -
% of sales 4.6% 5.3% 5.4% 6.2% 6.6% 7.6% 7.1% 7.4% 7.0% 6.0% 6.3%
Source: Centrum, company

Centrum Institutional Research 296


Cipla 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 159,710 166,949 189,885 211,113 235,768 Equity share capital 1,611 1,613 1,613 1,613 1,613
Operating Expense 77,297 79,408 90,857 102,588 114,547 Reserves & surplus 148,511 156,018 181,652 205,539 236,229
Employee cost 28,205 30,270 32,518 35,467 38,194 Shareholders fund 150,123 157,630 183,265 207,152 237,842
Others 26,789 29,582 25,696 28,250 29,064 Minority Interest 3,320 2,943 2,591 2,591 2,591
EBITDA 31,333 32,060 42,525 46,579 55,713 Total debt 43,162 28,164 15,375 9,875 4,375
Depreciation & Amortisation 13,263 11,747 10,677 10,821 12,064 Non Current Liabilities 5,922 4,777 4,754 4,754 4,754
EBIT 18,070 20,313 31,848 35,758 43,649 Def tax liab. (net) 2,239 1,254 (181) 2,500 2,500
Interest expenses 1,684 1,974 1,607 1,481 656 Total liabilities 204,766 194,768 205,804 226,871 252,061
Other income 4,766 3,442 2,660 2,073 2,614 Gross block 83,488 78,800 75,141 79,656 81,800
PBT 21,151 21,782 32,901 36,350 45,607 Less: acc. Depreciation (13,263) (11,747) (10,677) (10,821) (12,064)
Taxes 5,695 6,312 8,888 9,633 12,086 Net block 70,225 67,054 64,464 68,835 69,737
Effective tax rate (%) 26.9 29.0 27.0 26.5 26.5 Capital WIP 3,311 4,210 5,708 3,000 3,000
PAT 15,456 15,470 24,014 26,717 33,521 Net fixed assets 102,227 100,604 100,245 101,908 102,809
Minority/Associates 181 (5) 36 49 63 Non Current Assets 6,224 7,547 7,196 7,534 7,635
Recurring PAT 15,637 15,465 24,049 26,766 33,584 Investments 4,902 9,015 8,836 9,036 9,236
Extraordinary items 0 0 0 0 0 Inventories 39,648 43,776 46,692 51,215 56,485
Reported PAT 15,637 15,465 24,049 26,766 33,584 Sundry debtors 41,507 38,913 34,457 37,595 41,986
Cash & Cash Equivalents 6,188 10,039 14,012 29,804 49,878
Ratios Loans & advances 63 56 26 289 323
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 36,860 24,278 36,908 40,709 42,793
Growth (%) Trade payables 19,480 22,818 20,668 29,107 34,390
Revenue 8.3 4.5 13.7 11.2 11.7 Other current liab. 6,006 7,160 11,117 10,122 11,304
EBITDA 10.9 2.3 32.6 9.5 19.6 Provisions 7,368 9,482 10,783 11,990 13,391
Adj. EPS 5.0 (1.2) 55.5 11.3 25.5 Net current assets 91,413 77,602 89,527 108,394 132,381
Margins (%) Total assets 204,766 194,768 205,804 226,871 252,061
Gross 66.2 66.7 62.2 62.1 63.8
EBITDA 19.1 18.7 22.2 21.9 23.5 Cashflow
EBIT 11.0 11.9 16.6 16.8 18.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 9.6 9.0 12.6 12.6 14.1 Profit Before Tax 21,151 21,782 32,901 36,350 45,607
Returns (%) Depreciation & Amortisation 13,263 11,747 10,677 10,821 12,064
ROE 10.7 10.1 14.1 13.7 15.1 Net Interest 1,684 1,974 1,607 1,481 656
ROCE 8.7 8.8 12.9 13.2 14.6 Net Change – WC (10,679) 6,658 4,570 (3,412) (4,015)
ROIC 7.3 8.1 13.4 14.6 17.5 Direct taxes (2,758) (7,297) (10,323) (6,952) (12,086)
Turnover (days) Net cash from operations 22,662 34,863 39,432 38,288 42,226
Gross block turnover ratio (x) 1.9 2.1 2.5 2.7 2.9 Capital expenditure (5,641) (9,475) (9,585) (12,484) (12,965)
Debtors 81 86 70 62 61 Acquisitions, net 0 0 0 0 0
Inventory 253 254 225 219 225 Investments (13,561) 6,979 (12,519) (200) (200)
Creditors 128 129 108 111 133 Others (2,326) (1,293) 357 0 0
Net working capital 209 170 172 187 205 Net cash from investing (21,528) (3,789) (21,747) (12,684) (13,165)
Solvency (x) FCF 1,134 31,075 17,685 25,604 29,061
Net debt-equity 0.2 0.1 0.0 (0.1) (0.2) Issue of share capital 326 276 0 0 0
Interest coverage ratio 18.6 16.2 26.5 31.4 84.9 Increase/(decrease) in debt 2,183 (14,998) (12,790) (5,500) (5,500)
Net debt/EBITDA 1.2 0.6 0.0 (0.4) (0.8) Dividend paid (2,828) (4,717) (2,831) (2,831) (2,831)
Per share (Rs) Interest paid (1,684) (1,974) (1,607) (1,481) (656)
Adjusted EPS 19.4 19.2 29.8 33.2 41.6 Others (2,597) (5,811) 3,515 0 0
BVPS 186.3 195.5 227.2 256.9 294.9 Net cash from financing (4,602) (27,224) (13,711) (9,812) (8,987)
CEPS 35.9 33.8 43.1 46.6 56.6 Net change in Cash (3,468) 3,851 3,973 15,792 20,074
DPS 3.0 5.0 3.0 3.0 3.0 Source: Company, Centrum Broking
Dividend payout (%) 15.5 26.1 10.1 9.0 7.2
Valuation (x)
P/E 49.1 49.7 32.0 28.7 22.9
P/BV 5.1 4.9 4.2 3.7 3.2
EV/EBITDA 25.7 24.6 18.1 16.1 13.0
Dividend yield (%) 0.3 0.5 0.3 0.3 0.3
Source: Company, Centrum Broking

Centrum Institutional Research 297


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Dr Reddy’s Laboratories (DRRD)


After a declining trend over FY16-18, driven by the US generic business, DRRD’s cash Market data
flows from operations have grown at a strong CAGR of 26% over FY18-21. Working Current price: Rs4,932
capital cycle has stabilized at 130-135 days. RoCE has averaged at ~16% over the Bloomberg: DRRD IN
decade and has been on an improving trajectory in the last three years. R&D spends 52-week H/L: Rs5,650/4,135
have rationalized to 8-9% of sales from a peak of 13-14%, driven by management
Market cap: Rs820.4bn
focus on better R&D productivity. DRRD has impaired nearly the entire Teva-Actavis
brand basket acquisition, including brands like Nuvaring and Suboxone. The recent Free float: 67.3%
acquisition of Wockhardt is on faster sales ramp-up, with better strategic fit. Key Avg. daily vol. 3mth: 704,454
management change has firmed well for shareholders. Source: Bloomberg

Cash flows from operations have grown at a CAGR of 9% over FY12-21: Cash flows from operations have grown consistently
over the past decade, barring FY17 and FY18. After the decline over FY16-18, driven by the US generic business, cash flows
from operations have grown at a strong CAGR of 26% over FY18-21, aided by lower working capital.
Exhibit 767: After a declining trend over FY16-18, cash flows from operations grew at a CAGR of 26% over FY18-21
50,000
40,000
30,000
Rs in mn

20,000
10,000
-
(10,000)
(20,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: Net working capital days increased in the first half of the decade, with a significant rise
in FY17, and have stagnated thereafter at 130-135 days. The increase in working capital cycle has largely been led by rising
inventory days.
Exhibit 768: NWC has been rising, led by increase in inventory
160
140
120
100
Days

80
60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Dr Reddy’s Laboratories (DRRD) 16 September 2021

Exhibit 769: Cash conversion ratios


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT 105% 86% 95% 119% 145% 178% 158% 153% 117% 146% 130%
OCF/EBITDA 66% 49% 61% 72% 76% 85% 76% 87% 82% 78% 73%
Source: Company, Centrum Broking

Large expansions/acquisitions have impacted FCF generation: DRRD has been spending a significant part of its cash from
operations to expand either organically or inorganically. It has periodically acquired brands/companies to fuel growth. In FY21,
it acquired some brands from Wockhardt to expand its domestic business. Other notable acquisitions include brands from Teva
(Actavis acquisition fallout), brands from Glenmark for CIS markets in FY20, and brands from UCB in FY15.
Exhibit 770: Capex intensity, acquisitions and free cash flows
40,000 OctoPlus acquisition: Brands from Glenmark for CIS markets
Rs1.8bn
20,000

-
Rs in mn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)

Brands from UCB: Brands from


(40,000)
Rs8bn Wockhardt for India
and Nepal: Rs18.5bn
(60,000)
CFO Capex Acquisitions Net FCF
Source: Company, Centrum Broking

Exhibit 771: Asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.9 0.9 0.8 0.8 0.8 0.7 0.6 0.7 0.8 0.8
Source: Company, Centrum Broking

Dividend distribution: DRRD has been consistently paying dividends to its shareholders.
Exhibit 772: Consistently paying dividends to shareholders
30,000

20,000

10,000
Rs in mn

(10,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(20,000)
FCF Dividend/buyback
(30,000)
Source: Company, Centrum Broking

Exhibit 773: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 29.6% 24.5% 25.4% 21.1% 18.8% 9.5% 9.1% 14.1% 17.3% 14.8% 18.4%
RoCE 25.1% 22.8% 21.4% 19.4% 18.5% 7.6% 6.4% 11.1% 12.8% 16.7% 16.2%
Source: Company, Centrum Broking

Exhibit 774: Leverage ratios


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.2 0.2 0.1 0.0 (0.1) 0.3 0.2 0.1 (0.0) (0.0)
Net Debt/EBITDA 0.6 0.5 0.3 0.1 (0.1) 1.2 1.3 0.4 (0.1) (0.1)
Source: Company, Centrum Broking

Exhibit 775: Cumulative R&D spend of Rs147mn (10% of sales) in the last decade
(Rs in mn) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
R&D spend 5,910 7,670 12,400 17,450 17,830 19,550 18,260 15,610 15,410 16,540 -
% of sales 6.0% 7.0% 9.4% 11.8% 11.5% 13.9% 12.9% 10.1% 8.8% 8.7% 10%
Source: Company, Centrum Broking

Centrum Institutional Research 299


Dr Reddy’s Laboratories (DRRD) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 153,851 174,600 189,722 218,091 249,119 Equity share capital 830 831 831 831 831
Operating Expense 122,728 142,298 144,949 163,350 185,967 Reserves & surplus 139,367 154,157 175,586 203,815 236,213
Employee cost 0 0 0 0 0 Shareholders fund 140,197 154,988 176,417 204,646 237,044
Others 0 0 0 0 0 Minority Interest 0 0 0 0 0
EBITDA 33,078 36,592 45,755 55,941 64,352 Total debt 34,125 17,745 29,444 24,318 19,195
Depreciation & Amortisation 12,190 12,472 12,796 14,612 16,691 Non Current Liabilities 2,920 2,860 2,125 2,141 2,158
EBIT 20,888 24,120 32,959 41,329 47,661 Def tax liab. (net) 610 275 289 295 301
Interest expenses (2,280) (2,461) (2,636) (1,882) (1,523) Total liabilities 177,852 175,868 208,275 231,400 258,697
Other income (725) (917) (503) (1,532) (2,141) Gross block 110,645 92,463 104,905 103,869 103,154
PBT 22,443 25,664 35,092 41,679 47,043 Less: acc. Depreciation (12,190) (12,472) (12,796) (14,612) (16,691)
Taxes 3,648 (1,466) 9,175 9,294 10,491 Net block 98,455 79,991 92,109 89,257 86,463
Effective tax rate (%) 16.3 5.7 26.1 22.3 22.3 Capital WIP 0 0 0 0 0
PAT 18,795 27,130 25,917 32,384 36,552 Net fixed assets 98,455 79,991 92,109 89,257 86,463
Minority/Associates 0 0 0 0 0 Non Current Assets 4,961 6,575 6,792 6,840 6,889
Recurring PAT 18,795 27,130 25,917 32,384 36,552 Investments 3,342 3,091 8,333 8,004 8,679
Extraordinary items 0 (7,671) (6,768) 0 0 Inventories 33,579 35,066 45,412 41,590 47,507
Reported PAT 18,795 19,459 19,149 32,384 36,552 Sundry debtors 39,869 50,278 49,641 59,751 68,252
Cash & Cash Equivalents 2,228 2,053 14,829 26,687 36,577
Ratios Loans & advances 3,760 5,484 1,218 1,242 1,267
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 35,065 37,489 34,403 39,818 46,169
Growth (%) Trade payables 14,553 16,659 18,109 16,730 19,110
Revenue 8.3 13.5 8.7 15.0 14.2 Other current liab. 28,856 35,914 34,769 33,877 33,229
EBITDA 40.0 10.6 25.0 22.3 15.0 Provisions 4,166 3,800 5,015 5,015 5,015
Adj. EPS 91.7 44.2 (4.5) 25.0 12.9 Net current assets 66,926 73,997 87,610 113,466 142,417
Margins (%) Total assets 177,852 175,868 208,275 231,400 258,697
Gross 60.9 56.3 59.3 59.0 59.1
EBITDA 21.2 20.5 24.0 25.5 25.7 Cashflow
EBIT 13.4 13.5 17.3 18.8 19.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 12.1 15.2 13.6 14.8 14.6 Profit Before Tax 22,443 17,993 28,324 41,679 47,043
Returns (%) Depreciation & Amortisation 12,190 12,472 12,796 14,612 16,691
ROE 14.1 18.4 15.6 17.0 16.6 Net Interest (1,117) (983) (1,653) (183) 785
ROCE 9.6 12.6 12.7 14.2 14.6 Net Change – WC (467) (6,579) (784) (10,049) (14,323)
ROIC 10.3 13.5 13.9 18.5 18.5 Direct taxes (5,657) (6,523) (9,563) (9,691) (10,900)
Turnover (days) Net cash from operations 27,392 16,380 29,120 36,368 39,296
Gross block turnover ratio (x) 1.4 1.9 1.8 2.1 2.4 Capital expenditure (8,111) 5,992 (24,914) (11,760) (13,897)
Debtors 94 92 96 91 93 Acquisitions, net 0 0 0 0 0
Inventory 184 155 188 175 158 Investments (2,888) (907) (1,299) (3,620) (5,413)
Creditors 90 71 81 70 63 Others (1,023) (3,000) 405 (1,747) (2,357)
Net working capital 159 155 169 190 209 Net cash from investing (12,022) 2,085 (25,808) (17,127) (21,667)
Solvency (x) FCF 15,370 18,465 3,312 19,241 17,629
Net debt-equity 0.2 0.1 0.1 0.0 (0.1) Issue of share capital 421 285 (8,495) 0 0
Interest coverage ratio (14.5) (14.9) (17.4) (29.7) (42.3) Increase/(decrease) in debt (16,430) (16,380) 11,699 (5,126) (5,123)
Net debt/EBITDA 1.0 0.4 0.3 0.0 (0.3) Dividend paid (3,320) (3,324) (4,155) (4,155) (4,155)
Per share (Rs) Interest paid 2,280 2,461 2,636 1,882 1,523
Adjusted EPS 113.2 163.2 155.9 194.9 219.9 Others 1,269 (1,682) 7,779 16 17
BVPS 844.6 932.5 1,061.5 1,231.3 1,426.3 Net cash from financing (15,780) (18,640) 9,464 (7,383) (7,739)
CEPS 186.7 238.3 232.9 282.8 320.4 Net change in Cash (410) (175) 12,776 11,858 9,890
DPS 20.0 20.0 25.0 25.0 25.0 Source: Company, Centrum Broking
Dividend payout (%) 17.7 17.1 21.7 12.8 11.4
Valuation (x)
P/E 43.6 30.2 31.6 25.3 22.4
P/BV 5.8 5.3 4.6 4.0 3.5
EV/EBITDA 25.8 22.8 18.3 14.6 12.5
Dividend yield (%) 0.4 0.4 0.5 0.5 0.5
Source: Company, Centrum Broking

Centrum Institutional Research 300


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

FDC
Operating cash flow generation has improved over the last two years. Working capital Market data
intensity has been steady, though it was marginally impacted by raw material Current price: Rs365
inflation in the recent past. FDC has a fast-moving working capital cycle despite being Bloomberg: FDCLT IN
inventory-heavy. Free cash flow generation has also improved significantly over the 52-week H/L: Rs405/255
last two years. Domestic business revival and focus along with niche profitable
Market cap: Rs61.7bn
ophthalmic US business has aided cash flow generation. The company has been a
consistent dividend payer and recently adopted a combination of buyback and Free float: 30.5%
dividend to reward shareholders. Return ratios have been steady. Avg. daily vol. 3mth: 403,222
Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have significantly expanded in the last two
years. Working capital intensity in the business has been moderate, given the dominance of domestic market. The company
has been consistently generating operating cash flows in a similar range. The spurt in cash flows from operations in the last
two years is on account of increased export business and domestic growth.
Exhibit 776: Cash flows from operations have grown at a CAGR of 8% over FY12-21
4,000

3,000

2,000
Rs in mn

1,000

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1,000
Net profit Working capital changes Cash From Operating Activities
Source: Company, Centrum Broking

Analysis of working capital movement: FDC has a fast-moving working capital cycle despite being inventory-heavy. It has been
able to maintain its payable days and receivable days over the years. The company enjoys a long credit period from its suppliers.
Exhibit 777: Fast-moving working capital cycle despite being inventory-heavy
70
60
50
40
Days

30
20
10
0
-10 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Receivable days Inventory days Payable days Net working capital


Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
FDC 16 September 2021

Exhibit 778: Cash conversion ratios


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/EBITDA 96% 91% 79% 74% 76% 63% 66% 49% 85% 85% 76%
OCF/APAT 117% 105% 120% 101% 103% 82% 86% 66% 104% 94% 98%
Source: Company, Centrum Broking

Exhibit 779: High capex has led to poor conversion of OCF to FCF
4,000
3,000
2,000
1,000
Rs in mn

-
-1,000 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-2,000
-3,000
-4,000 Cash From Operating Activities CAPEX FCF

Source: Company, Centrum Broking

Dividend distribution/buybacks: In terms of cash flows from financing activities, major chunk of the outflows has been towards
dividend payments or buybacks.
Exhibit 780: FDC has been creating value through buybacks and dividend distribution
2,500 2.2mn shares bought
3.4mn shares bought back
2,000 at Rs350/share back at Rs450/share
1,500
1,000
Rs in mn

500
-
-500 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
-1,000
-1,500 FCF Buy Back of Equity Shares Capital
3.4mn shares bought back at
Equity Dividend Paid Increase / (Decrease) in Loan Funds Rs350/share

Source: Company, Centrum Broking

Exhibit 781: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 19.9 20.4 20.6 16.6 19.4 19.0 16.3 15.3 18.8 20.9 18.7
RoCE 18.7 19.4 15.3 14.2 16.7 16.0 13.6 12.5 16.0 18.4 16.1
RoIC 29.4 27.0 20.5 19.8 23.8 25.6 22.5 21.2 28.4 34.2 25.2
Source: Company, Centrum Broking

Exhibit 782: Leverage ratios


Leverage ratios FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Net Debt/Equity (x) -0.5 -0.4 -0.4 -0.3 -0.3 -0.3 -0.3 -0.4 -0.3 -0.3 -0.3 -0.3

Net Debt/EBITDA (x) -1.4 -1.8 -1.7 -1.2 -1.3 -1.7 -1.3 -1.9 -1.9 -1.8 -1.8 -1.7
Source: Company, Centrum Broking

Exhibit 783: Earnings and dividend per share


(Rs/share) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash EPS 8.3 10.1 9.0 10.5 11.4 12.6 12.0 11.8 16.3
Dividend yield (%) 2.6 2.4 1.8 1.5 1.2 0 0 0 0.4 0.4
Dividend per share 366 404 400 400 400 137
Source: Company, Centrum Broking

Centrum Institutional Research 302


FDC 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 10,907 13,442 13,332 16,091 19,607 Equity share capital 175 171 169 169 169
Operating Expense 5,543 6,504 7,029 7,422 9,098 Reserves & surplus 14,277 15,303 17,171 20,509 24,768
Employee cost 2,256 2,775 2,963 3,318 3,750 Shareholders fund 14,452 15,474 17,340 20,678 24,937
Others 798 1,234 0 1,126 1,431 Minority Interest 0 0 0 0 0
EBITDA 2,310 2,929 3,341 4,224 5,328 Total debt 5 3 2 2 2
Depreciation & Amortisation 332 375 378 586 614 Non Current Liabilities 18 96 72 74 75
EBIT 1,978 2,555 2,962 3,638 4,714 Def tax liab. (net) 133 92 109 109 109
Interest expenses 14 34 34 20 20 Total liabilities 14,608 15,666 17,522 20,863 25,123
Other income 435 689 970 1,116 1,283 Gross block 7,154 6,985 7,122 10,151 11,975
PBT 2,398 3,210 3,898 4,734 5,977 Less: acc. Depreciation (332) (375) (378) (586) (614)
Taxes 668 801 865 1,231 1,751 Net block 6,822 6,610 6,744 9,564 11,360
Effective tax rate (%) 27.9 24.9 22.2 26.0 29.3 Capital WIP 124 239 192 192 192
PAT 1,730 2,409 3,033 3,503 4,226 Net fixed assets 6,946 6,849 6,936 9,756 11,552
Minority/Associates 0 0 0 0 0 Non Current Assets 204 325 549 423 431
Recurring PAT 1,730 2,409 3,033 3,503 4,226 Investments 1,849 1,685 2,740 1,587 1,934
Extraordinary items (32) (10) (21) 0 0 Inventories 1,738 2,100 2,149 2,357 2,788
Reported PAT 1,698 2,399 3,012 3,503 4,226 Sundry debtors 875 1,237 1,105 1,543 1,880
Cash & Cash Equivalents 213 323 316 1,988 3,590
Ratios Loans & advances 7 12 14 44 54
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 4,567 5,599 5,753 5,623 5,687
Growth (%) Trade payables 776 1,179 773 1,153 1,383
Revenue 0.7 23.2 (0.8) 20.7 21.9 Other current liab. 767 946 909 909 928
EBITDA 1.9 26.8 14.0 26.5 26.1 Provisions 248 339 358 397 483
Adj. EPS (0.3) 42.7 27.5 15.5 20.7 Net current assets 5,609 6,808 7,298 9,096 11,205
Margins (%) Total assets 14,608 15,666 17,522 20,863 25,123
Gross 68.4 68.3 68.9 69.2 69.8
EBITDA 21.2 21.8 25.1 26.3 27.2 Cashflow
EBIT 18.1 19.0 22.2 22.6 24.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 15.9 17.9 22.8 21.8 21.6 Profit Before Tax 2,366 3,200 3,877 4,734 5,977
Returns (%) Depreciation & Amortisation 332 375 378 586 614
ROE 12.7 16.1 18.5 18.4 18.5 Net Interest 14 34 34 20 20
ROCE 12.8 16.3 18.6 18.5 18.6 Net Change – WC (506) (241) (480) 1 (514)
ROIC 11.9 12.6 16.6 17.2 18.3 Direct taxes (715) (847) (863) (1,231) (1,751)
Turnover (days) Net cash from operations 1,492 2,520 2,947 4,110 4,347
Gross block turnover ratio (x) 1.5 1.9 1.9 1.6 1.6 Capital expenditure (413) (277) (465) (3,407) (2,410)
Debtors 28 29 32 30 32 Acquisitions, net 0 0 0 0 0
Inventory 177 165 187 166 159 Investments (1,137) (798) (1,282) 1,153 (347)
Creditors 92 84 86 71 78 Others 0 0 0 0 0
Net working capital 188 185 200 206 209 Net cash from investing (1,549) (1,076) (1,747) (2,253) (2,757)
Solvency (x) FCF (57) 1,444 1,200 1,857 1,590
Net debt-equity 0.0 0.0 0.0 (0.1) (0.1) Issue of share capital (7) (4) (2) 0 0
Interest coverage ratio 160.6 85.8 97.3 211.2 266.4 Increase/(decrease) in debt (1) (1) (1) 0 0
Net debt/EBITDA (0.1) (0.1) (0.1) (0.5) (0.7) Dividend paid 0 (141) (164) (164) (164)
Per share (Rs) Interest paid (14) (34) (34) (20) (20)
Adjusted EPS 9.9 14.1 18.0 20.8 25.0 Others (1) (1,153) (1,005) 0 197
BVPS 82.5 90.5 102.7 122.5 147.7 Net cash from financing (23) (1,333) (1,207) (184) 12
CEPS 11.8 16.3 20.2 24.2 28.7 Net change in Cash (80) 111 (7) 1,672 1,602
DPS 0.0 0.8 0.8 0.8 0.8 Source: Company, Centrum Broking
Dividend payout (%) 0.0 5.7 4.6 3.9 3.2
Valuation (x)
P/E 37.0 25.9 20.3 17.6 14.6
P/BV 4.4 4.0 3.6 3.0 2.5
EV/EBITDA 26.6 20.9 18.4 14.1 10.9
Dividend yield (%) 0.0 0.2 0.2 0.2 0.2
Source: Company, Centrum Broking

Centrum Institutional Research 303


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst , Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

GlaxoSmithKline Pharmaceuticals (GLXO)


GLXO’s cash flows from operations grew at a CAGR of 6% over the last decade, lower Market data
than peers. However, post the Augmentin impact, cash flows from operations have Current price: Rs1,573
steadily grown at a CAGR of 24% over FY17-21. The company had invested Rs10.8bn Bloomberg: GLXO IN
in its Vemgal plant, which was sold to Hetero Labs at Rs1.8bn before 52-week H/L: Rs1,803/1,376
commercialization, as the key product Ranitidine was globally withdrawn by the
Market cap: Rs266.5bn
parent. The Ranitidine impact did not affect cash flows due to land sale. After
FY16/17, return ratios have revived and have continued to improve to 32% in FY21. Free float: 18.6%
GLXO has consistently paid dividends, often exceeding earnings / FCF for the year and Avg. daily vol. 3mth: 72,198
payout has been higher than peers. Source: Bloomberg

Cash flows from operations bounced back in the second half of the decade: Operating profits have been robust and have
consistently expanded over the last five years. Working capital intensity in the business has been low to moderate due to
favorable payable days. As a result, the company has consistently generated strong operating cash flows over FY17-21.
Exhibit 784: Cash flows from operations bounced back from FY16; have grown at a CAGR of 6% in the last decade
6,000
5,000
4,000
3,000
Rs in mn

2,000
1,000
-
(1,000)
CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(2,000)
Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: The company enjoys higher payable days than debtor days, which helps maintain low
working capital days, despite high inventory turnover time.
Exhibit 785: Significantly higher payable days than debtor days helps to keep net working capital days in control
100

80

60
Days

40

20

0
CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
GlaxoSmithKline Pharmaceuticals (GLXO) 16 September 2021

Exhibit 786: Cash conversion ratios


CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT 40% 34% 62% 64% 37% 64% 140% 98% 106% 75%
OCF/EBITDA 43% 38% 53% 53% 29% 48% 93% 68% 74% 58%
Source: Company, Centrum Broking

Exhibit 787: Capex intensity, acquisitions and free cash flows


8,000

6,000

4,000
Rs in mn

2,000

(2,000)
CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(4,000)

(6,000) Vemgal capex at Rs10.8bn; sold to Hetreo Labs for Rs1.8bn


CFO Capex Net FCF
Source: Company, Centrum Broking

Exhibit 788: Asset turn


CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.8 0.8 0.8 0.9 1.0 0.8 0.8 0.9 1.0
Source: Company, Centrum broking

Dividend distribution: The company has been consistently distributing dividends to its shareholders from the free cash
available. In FY21, it declared a special dividend of Rs5/share along with normal dividend of Rs30/share.
Exhibit 789: Dividend payouts have often been higher than FCF for the year
6,000

4,000

2,000
Rs in mn

-
CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(2,000)

(4,000)

(6,000)

(8,000) FCF Dividend/buyback

Source: Company, Centrum Broking

Exhibit 790: Return ratios


Return Ratios (%) CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
ROE (%) 45.0 22.4 19.1 16.2 17.4 16.6 19.9 23.3 32.2 23.6
ROIC (%) 529.4 246.9 90.7 41.1 29.7 27.7 35.8 40.2 72.8 123.8
ROCE (%) 43.5 31.1 26.0 22.2 22.7 22.7 27.3 28.7 37.3 29.1
Source: Company, Centrum Broking

Exhibit 791: Dividend has often exceeded earnings for the year
CY11 CY12 CY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash EPS 27 34 30 30 24 21 23 29 10 26
Dividend yield 2.3 2.3 1.7 1.8 1.3 1.1 1.7 1.5 3.2 2.1
Dividend 45 50 50 62.5 50 30 35 20 40 35
Source: Company, Centrum Broking

Centrum Institutional Research 305


GlaxoSmithKline Pharmaceuticals (GLXO) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 31,285 32,244 31,989 34,913 39,215 Equity share capital 1,694 1,694 1,694 1,694 1,694
Operating Expense 16,620 16,298 15,514 17,791 19,233 Reserves & surplus 19,704 16,512 13,304 15,740 16,214
Employee cost 5,372 6,286 6,147 6,372 6,863 Shareholders fund 21,398 18,206 14,991 17,428 17,901
Others 3,281 3,088 3,374 2,617 3,339 Minority Interest 0 0 0 0 0
EBITDA 6,026 6,611 6,953 8,133 9,780 Total debt 3,172 2,907 2,819 3,273 3,674
Depreciation & Amortisation 486 827 793 422 812 Non Current Liabilities 0 0 0 0 0
EBIT 5,540 5,784 6,161 7,711 8,968 Def tax liab. (net) 0 0 0 0 0
Interest expenses 6 63 0 0 0 Total liabilities 24,570 21,113 17,809 20,701 21,575
Other income 1,009 762 1,106 1,029 1,262 Gross block 4,786 7,999 4,323 2,002 2,338
PBT 6,544 6,483 7,266 8,740 10,230 Less: acc. Depreciation (486) (827) (793) (422) (812)
Taxes 2,373 1,877 1,924 2,237 2,619 Net block 4,300 7,173 3,530 1,580 1,525
Effective tax rate (%) 36.3 29.0 26.5 25.6 25.6 Capital WIP 10,026 1,201 132 132 132
PAT 4,171 4,606 5,343 6,503 7,611 Net fixed assets 14,326 8,767 3,975 2,025 1,970
Minority/Associates 0 0 0 0 0 Non Current Assets 923 622 622 632 704
Recurring PAT 4,171 4,606 5,343 6,503 7,611 Investments 17 15 14 14 14
Extraordinary items 287 (3,415) (1,726) 0 13,192 Inventories 4,865 4,830 5,467 2,259 2,416
Reported PAT 4,458 1,191 3,617 6,503 20,803 Sundry debtors 1,205 998 2,156 1,052 1,182
Cash & Cash Equivalents 11,713 10,832 11,580 14,096 15,411
Ratios Loans & advances 900 310 257 3,782 4,248
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,412 779 2,567 2,471 2,553
Growth (%) Trade payables 4,058 3,576 4,645 3,178 3,558
Revenue 8.0 3.1 (0.8) 9.1 12.3 Other current liab. 9,561 3,898 6,138 4,312 7,471
EBITDA 18.6 9.7 5.2 17.0 20.3 Provisions 924 2,768 2,542 3,104 859
Adj. EPS 24.4 10.4 16.0 21.7 17.0 Net current assets 5,551 7,506 8,702 13,065 13,922
Margins (%) Total assets 24,570 21,113 17,809 20,701 21,575
Gross 56.6 59.6 59.0 59.0 60.8
EBITDA 19.3 20.5 21.7 23.3 24.9 Cashflow
EBIT 17.7 17.9 19.3 22.1 22.9 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 13.3 14.3 16.7 18.6 53.0 Profit Before Tax 6,831 3,068 5,540 8,740 23,422
Returns (%) Depreciation & Amortisation 486 827 793 422 812
ROE 19.9 23.3 32.2 40.1 43.1 Net Interest (1,003) (699) (1,106) (1,029) (1,262)
ROCE 17.4 20.4 27.5 33.8 36.0 Net Change – WC (551) (3,318) 1,622 (194) (1,856)
ROIC 30.3 35.6 55.0 89.6 104.7 Direct taxes (2,066) (2,328) (2,217) (2,706) (2,619)
Turnover (days) Net cash from operations 3,696 (2,450) 4,633 5,233 18,497
Gross block turnover ratio (x) 6.5 4.0 7.4 17.4 16.8 Capital expenditure (2,355) 4,732 4,000 1,528 (758)
Debtors 16 12 18 17 10 Acquisitions, net 0 0 0 0 0
Inventory 133 135 143 98 55 Investments 1 1 (1,799) 0 0
Creditors 122 107 114 100 80 Others 1,057 939 790 983 1,194
Net working capital 65 85 99 137 130 Net cash from investing (1,297) 5,673 2,991 2,511 437
Solvency (x) FCF 2,399 3,222 7,624 7,744 18,934
Net debt-equity (0.4) (0.4) (0.6) (0.6) (0.7) Issue of share capital 0 0 (7) 0 0
Interest coverage ratio 1,087.2 104.9 0.0 0.0 0.0 Increase/(decrease) in debt (4) (2) 0 0 0
Net debt/EBITDA (1.4) (1.2) (1.3) (1.3) (1.2) Dividend paid (4,072) (8,053) (6,076) (5,026) (17,619)
Per share (Rs) Interest paid (6) (63) 0 0 0
Adjusted EPS 24.5 27.1 31.4 38.3 44.8 Others 432 4,013 (793) (203) 0
BVPS 251.7 214.2 176.4 205.0 210.6 Net cash from financing (3,650) (4,104) (6,876) (5,228) (17,619)
CEPS 54.8 63.9 72.2 81.5 99.1 Net change in Cash (1,251) (882) 748 2,516 1,315
DPS 39.9 79.7 59.8 39.9 199.3 Source: Company, Centrum Broking
Dividend payout (%) 76.0 569.0 140.5 52.1 81.4
Valuation (x)
P/E 60.0 224.5 73.9 41.1 12.9
P/BV 6.2 7.3 8.9 7.7 7.5
EV/EBITDA 0.6 0.5 0.4 0.4 0.4
Dividend yield (%) 0.0 0.0 0.0 0.0 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 306


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst , Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Granules India (GRAN)


GRAN’s cash flows from operations have grown at a CAGR of 37% over FY12-21, with Market data
a significant dip in FY18. FY18 was largely impacted by raw material inflation and Current price: Rs333
supply challenges from China, followed by higher receivables. After FY18, working Bloomberg: GRAN IN
capital cycle has improved with better receivables management. In FY21, inventory 52-week H/L: Rs438/295
cycle was impacted again amid supply shortages and raw material inflation. Return
Market cap: Rs82.5bn
ratios have improved since FY19 along with debt reduction. The management has
announced capex of Rs10bn over the coming three years, which should largely be Free float: 55.9%
internally-funded. Avg. daily vol. 3mth: 4,295,496
Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits before working capital have been growing
consistently over the last decade. With very low working capital adjustments, cash flows from operations have moved in line
with operating profits except in FY18 and FY21. Cash flows from operations have grown at a CAGR of 37% over the decade with
a significant dip in FY18.
Exhibit 792: Cash flows from operations grew at a CAGR of 37% over the last decade
8,000

6,000

4,000
Rs in mn

2,000

(2,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(4,000)
Operating profit before wcap changes Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: Working capital cycle has been volatile over the years, with a decline in FY12-15
followed by a sharp rise over FY16-18 due to sharp rise in debtors. Post FY18, working capital cycle has improved aided by
better debtor management.
Exhibit 793: Working capital cycle has been improving since FY18 aided by better receivables management
140
120
100
80
Days

60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Granules India (GRAN) 16 September 2021

Exhibit 794: Cash conversion ratios


(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 Avg
OCF/PAT 86% 279% 143% 165% 125% 115% 0% 111% 133% 124%
OCF/EBITDA 32% 107% 68% 72% 55% 63% 0% 68% 91% 61%
Source: Company, Centrum Broking

Rapid capacity expansions led to poor conversion of operating cash to FCF: Over the last decade, GRAN has periodically
invested in capacity expansion, leading to negative free cash flows for most of the decade.
Exhibit 795: Capex intensity, acquisitions and free cash flows
6,000
OmniChem JV divestment
4,000

2,000
Rs in mn

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(2,000)

(4,000) Granules-Biocause JV
divestment: Rs1.11bn
(6,000)
CFO Capex Acquisitions Net FCF

Source: Company, Centrum Broking

Exhibit 796: Asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 1.3 1.2 1.3 1.2 1.0 0.8 0.7 0.8 0.8 0.9
Source: Company, Centrum Broking

FCF utilization: With FCF being negative for most part of the decade, GRAN has had to rely on capital raising and borrowings.
In the last two years, the company has generated positive FCF and utilized it primarily to repay debt and buy back shares.
Exhibit 797: Has used positive FCF in the last two years to repay debt and buy back shares
4,000

2,000

-
Rs in mn

(2,000)
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(4,000)

(6,000)
FCF Inflow from equity raise/(Outflow from Buyback) Increase/ (decrease) in debt
Source: Company, Centrum Broking

Exhibit 798: Return ratios


Return Ratios (%) FY12 FY13 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 12.9 12.6 23.9 23.1 22.2 20.9 11.8 16.7 21.2 19.2
RoCE 14.6 12.6 19.6 18.7 20.0 16.5 10.8 12.5 16.2 16.8
Source: Company, Centrum Broking

Exhibit 799: Leverage ratios


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.6 0.8 1.0 0.9 0.6 0.6 0.6 0.6 0.3 0.2
Net Debt/EBITDA 1.9 2.5 2.3 1.8 1.5 1.8 3.0 2.2 1.0 0.6
Source: Company, Centrum Broking

Centrum Institutional Research 308


Granules India (GRAN) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 22,792 25,986 32,375 39,050 48,813 Equity share capital 254 254 248 248 248
Operating Expense 12,556 12,809 13,913 18,354 22,454 Reserves & surplus 15,040 18,183 21,485 26,776 34,333
Employee cost 2,098 2,590 4,082 4,686 5,858 Shareholders fund 15,295 18,437 21,733 27,024 34,581
Others 4,298 5,334 5,829 6,639 8,298 Minority Interest 0 0 0 0 0
EBITDA 3,840 5,253 8,552 9,372 12,203 Total debt 9,330 7,932 7,504 6,904 6,304
Depreciation & Amortisation 1,055 1,370 1,515 2,025 2,422 Non Current Liabilities 126 215 248 214 267
EBIT 2,786 3,884 7,037 7,347 9,781 Def tax liab. (net) 655 482 11 11 11
Interest expenses 285 270 263 193 177 Total liabilities 25,405 27,067 29,496 34,153 41,164
Other income 0 0 0 0 0 Gross block 8,530 11,257 12,227 16,195 18,910
PBT 2,768 3,979 7,043 7,553 10,212 Less: acc. Depreciation (1,055) (1,370) (1,515) (2,025) (2,422)
Taxes 891 1,157 1,549 1,964 2,655 Net block 7,476 9,888 10,712 14,169 16,487
Effective tax rate (%) 32.2 29.1 22.0 26.0 26.0 Capital WIP 3,235 1,481 1,848 1,848 1,848
PAT 1,877 2,822 5,494 5,590 7,557 Net fixed assets 14,402 14,982 15,711 19,168 21,486
Minority/Associates 0 0 0 0 0 Non Current Assets 500 821 1,264 861 912
Recurring PAT 2,364 3,571 5,494 5,590 7,557 Investments 2,104 193 190 190 190
Extraordinary items 487 532 0 0 0 Inventories 3,842 4,384 7,822 5,694 6,981
Reported PAT 2,364 3,354 5,494 5,590 7,557 Sundry debtors 6,735 7,352 7,654 9,629 12,036
Cash & Cash Equivalents 890 2,839 2,710 4,001 6,079
Ratios Loans & advances 32 79 100 107 134
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 1,323 2,364 1,684 1,498 1,872
Growth (%) Trade payables 3,235 4,300 5,410 5,603 6,788
Revenue 34.9 14.0 24.6 20.6 25.0 Other current liab. 1,136 1,532 2,008 1,284 1,605
EBITDA 39.1 36.8 62.8 9.6 30.2 Provisions 52 117 220 107 134
Adj. EPS 81.4 51.1 57.9 1.7 35.2 Net current assets 8,400 11,070 12,332 13,934 18,576
Margins (%) Total assets 25,405 27,067 29,496 34,153 41,164
Gross 44.9 50.7 57.0 53.0 54.0
EBITDA 16.8 20.2 26.4 24.0 25.0 Cashflow
EBIT 12.2 14.9 21.7 18.8 20.0 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 10.4 13.7 17.0 14.3 15.5 Profit Before Tax 3,255 4,511 7,043 7,553 10,212
Returns (%) Depreciation & Amortisation 1,055 1,370 1,515 2,025 2,422
ROE 16.7 21.2 27.4 22.9 24.5 Net Interest 285 270 263 193 177
ROCE 8.8 11.8 20.5 18.2 20.6 Net Change – WC (349) (679) (1,429) (312) (2,563)
ROIC 9.1 12.2 22.1 19.4 22.5 Direct taxes (779) (1,330) (2,020) (1,964) (2,655)
Turnover (days) Net cash from operations 3,466 4,142 5,371 7,496 7,593
Gross block turnover ratio (x) 2.7 2.3 2.6 2.4 2.6 Capital expenditure (2,545) (1,949) (2,244) (5,483) (4,740)
Debtors 103 99 85 81 81 Acquisitions, net 0 0 0 0 0
Inventory 97 117 160 134 103 Investments (529) 1,880 40 0 0
Creditors 84 107 127 110 101 Others (59) (334) (440) 403 (51)
Net working capital 135 155 139 130 139 Net cash from investing (3,133) (403) (2,644) (5,080) (4,791)
Solvency (x) FCF 333 3,739 2,727 2,416 2,802
Net debt-equity 0.6 0.3 0.2 0.1 0.0 Issue of share capital 10 0 (7) 0 0
Interest coverage ratio 13.5 19.4 32.5 48.5 69.1 Increase/(decrease) in debt (252) (1,398) (428) (600) (600)
Net debt/EBITDA 2.2 1.0 0.6 0.3 0.0 Dividend paid (305) (306) (298) (298) 0
Per share (Rs) Interest paid (285) (270) (263) (193) (177)
Adjusted EPS 9.3 14.0 22.2 22.6 30.5 Others 233 184 (1,860) (34) 53
BVPS 60.2 72.5 87.7 109.1 139.6 Net cash from financing (599) (1,790) (2,856) (1,126) (723)
CEPS 13.4 19.4 28.3 30.7 40.3 Net change in Cash (266) 1,949 (129) 1,290 2,079
DPS 1.0 1.0 1.0 1.0 0.0 Source: Company, Centrum Broking
Dividend payout (%) 10.7 7.6 4.5 4.4 0.0
Valuation (x)
P/E 35.8 23.7 15.0 14.8 10.9
P/BV 5.5 4.6 3.8 3.1 2.4
EV/EBITDA 23.7 16.7 10.2 9.1 6.8
Dividend yield (%) 0.3 0.3 0.3 0.3 0.0
Source: Company, Centrum Broking

Centrum Institutional Research 309


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst , Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Lupin
Cash flows from operations have been inconsistent, peaking in FY17, with peak US Market data
sales at USD1.2bn. While cash flows from operations have grown at a CAGR of 14% Current price: Rs968
over the decade, they have been flat in the last four years. Working capital cycle has Bloomberg: LPC IN
been increasing. EBITDA to OCF conversion is the lowest among peers. The Gavis 52-week H/L: Rs1,268/855
acquisition at USD880mn (9x sales) in FY16 was later impaired to the extent of
Market cap: Rs439.4bn
USD560mn in two tranches. Lupin divested the Japanese business (Kyowa) in FY20 at
~2x sales. Acquisitions and investments in speciality brands have been the least Free float: 43.2%
productive. Return ratios have been stuck at ~9% over the last four years compared Avg. daily vol. 3mth: 1,654,846
to 20%+ earlier. R&D investments have averaged at 10.1% of sales over the decade. Source: Bloomberg

Cash flows from operations have been inconsistent: Over FY12-15, cash flows from operations grew linearly, followed by a
drastic fall in FY16 and an extraordinary jump in FY17. Cash flows from operations have been more-or-less flat since FY18.
Exhibit 800: Cash flows from operations have grown at a CAGR of 14% over FY12-21, but with large swings in between
50,000
40,000
1% CAGR FY18-21
30,000
20,000
Rs in mn

10,000
-
(10,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)
(30,000)
(40,000)
Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Rising working capital: During the decade, the working capital cycle has been increasing due to rising debtors.
Exhibit 801: Working capital cycle has risen over the decade
160
140
120
100
Day

80
60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking
xxxxx

Please see Appendix for analyst certifications and all other important disclosures.
Lupin 16 September 2021

Exhibit 802: Cash conversion ratios


(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT 65% 95% 109% 114% -17% 161% 132% 176% 136% 150% 117%
OCF/EBITDA 39% 55% 67% 76% -10% 92% 56% 58% 61% 71% 58%
Source: Company, Centrum Broking

Rapid capacity expansions and acquisitions from operating cash: FCF generation has been poor historically on account of
heavy capex and periodic costly acquisitions that not have been very profitable for the company.
Exhibit 803: Dampened FCF due to capex and acquisitions

Gavis & Novel 21 products


in Japan for Gavis Stake sale in Kyowa
60,000 acquisition: USD880mn
USD90mn impairment Criticare: Rs12.2bn
40,000 Rs15.8bn gain
20,000
Rs in mn

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)
(40,000)
Gavis Symbiomix Therapeutics
(60,000) acquisition and Solosec
impairment
(80,000) Rs14.6bn brand: USD150mn

CFO Capex Acquisitions Net FCF

Source: Company, Centrum Broking

Exhibit 804: Asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 1.0 1.1 1.2 1.1 0.8 0.7 0.6 0.6 0.6 0.6
Source: Company, Centrum Broking

Dividend distribution: The company has been consistent in distributing dividends.


Exhibit 805: Consistent dividend distribution policy
40,000

20,000

-
Rs in mn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)

(40,000)

(60,000)

(80,000)
FCF Dividend/buyback
Source: Company, Centrum Broking

Exhibit 806: Return ratios


Return Ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 23.8 28.5 30.3 29.8 22.2 20.7 9.8 6.9 8.2 9.2 18.9
RoCE 22.9 30.8 38.7 38 23.3 17.9 10.2 9.8 8.8 9 20.9
Source: Company, Centrum Broking

Exhibit 807: Leverage ratios


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity 0.3 0.2 (0.1) (0.2) 0.6 0.4 0.4 0.4 0.1 0.1
Net Debt/EBITDA 0.9 0.3 (0.1) (0.4) 1.7 1.1 1.7 1.9 0.7 0.5
Source: Company, Centrum Broking

Exhibit 808: 10-year R&D spend at Rs130mn, 10% of sales


(Rs in mn) FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
R&D spend 7,096 9,313 10,962 16,097 23,101 18,509 15,731 15,538 14,324 -
% of sales 7.5% 8.4% 8.7% 11.7% 13.5% 11.9% 9.7% 10.3% 9.6% 10.1%
Source: Company, Centrum Broking

Centrum Institutional Research 311


Lupin 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 161,591 151,428 149,270 164,844 187,746 Equity share capital 905 906 907 905 905
Operating Expense 79,367 74,050 69,303 83,070 89,507 Reserves & surplus 136,517 124,460 137,124 134,905 151,001
Employee cost 31,513 29,868 28,259 31,073 35,484 Shareholders fund 137,422 125,366 138,031 135,810 151,906
Others 27,479 26,650 28,399 25,257 27,414 Minority Interest 469 445 550 550 550
EBITDA 28,822 23,178 25,669 29,407 38,298 Total debt 82,219 42,860 30,656 22,230 16,230
Depreciation & Amortisation 10,850 9,702 8,874 9,650 10,782 Non Current Liabilities 11,004 11,847 10,704 11,239 11,801
EBIT 17,972 13,476 16,795 19,757 27,516 Def tax liab. (net) (5,736) 1,949 (828) (828) (828)
Interest expenses 3,078 3,629 1,406 (121) (246) Total liabilities 225,378 182,466 179,112 169,000 179,658
Other income 3,640 4,837 1,363 1,617 1,693 Gross block 97,914 70,569 68,058 65,477 62,576
PBT 18,534 14,684 16,751 21,494 29,454 Less: acc. Depreciation (10,850) (9,702) (8,874) (9,650) (10,782)
Taxes 9,017 11,571 4,485 7,064 8,247 Net block 87,064 60,866 59,183 55,826 51,794
Effective tax rate (%) 48.7 78.8 26.8 32.9 28.0 Capital WIP 10,186 7,582 8,515 8,515 8,515
PAT 9,517 3,113 12,266 14,430 21,207 Net fixed assets 127,264 88,777 89,470 88,113 86,081
Minority/Associates 38 39 (101) 0 0 Non Current Assets 3,073 3,640 1,496 3,691 3,989
Recurring PAT 9,466 9,996 12,165 14,430 21,207 Investments 1,856 361 781 781 781
Extraordinary items (3,400) (7,521) 0 3,734 0 Inventories 38,368 34,569 40,920 48,721 50,425
Reported PAT 6,155 (4,368) 12,165 18,164 21,207 Sundry debtors 51,498 54,459 44,743 49,411 56,276
Cash & Cash Equivalents 9,872 24,541 17,424 6,667 15,118
Ratios Loans & advances 248 0 0 153 169
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 38,253 40,561 36,776 36,776 36,776
Growth (%) Trade payables 24,982 24,123 20,144 27,246 26,749
Revenue 3.9 (6.3) (1.4) 10.4 13.9 Other current liab. 12,798 31,242 24,510 30,797 35,939
EBITDA (8.4) (19.6) 10.7 14.6 30.2 Provisions 7,275 9,077 7,844 7,270 7,270
Adj. EPS (28.7) 5.6 21.7 18.6 47.0 Net current assets 93,185 89,688 87,365 76,416 88,807
Margins (%) Total assets 225,378 182,466 179,112 169,000 179,658
Gross 67.3 65.7 65.7 65.1 66.2
EBITDA 17.2 15.1 16.9 17.4 20.1 Cashflow
EBIT 10.8 8.8 11.1 11.7 14.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 5.7 6.5 8.0 10.8 11.1 Profit Before Tax 15,134 7,163 16,751 25,228 29,454
Returns (%) Depreciation & Amortisation 10,850 9,702 8,874 9,650 10,782
ROE 6.9 7.6 9.2 10.5 14.7 Net Interest 3,078 3,629 1,406 (121) (246)
ROCE 5.2 2.0 7.9 8.8 12.9 Net Change – WC (2,081) 1,596 (1,164) 15,343 (5,148)
ROIC 4.6 1.6 8.3 8.8 13.0 Direct taxes (9,831) (3,886) (7,262) (7,064) (8,247)
Turnover (days) Net cash from operations 13,510 13,367 17,244 41,420 24,902
Gross block turnover ratio (x) 1.7 2.1 2.2 2.5 3.0 Capital expenditure (9,194) 23,496 (8,458) (8,293) (8,750)
Debtors 113 126 119 102 101 Acquisitions, net 0 0 0 0 0
Inventory 234 245 257 266 272 Investments (20,339) (788) (806) 0 0
Creditors 158 165 151 141 148 Others 3,038 3,957 3,710 (1,245) 1,394
Net working capital 210 216 214 169 173 Net cash from investing (26,496) 26,665 (5,553) (9,538) (7,356)
Solvency (x) FCF (12,986) 40,032 11,691 31,882 17,546
Net debt-equity 0.5 0.1 0.1 0.1 0.0 Issue of share capital 516 532 713 (2) 0
Interest coverage ratio 9.4 6.4 18.3 (243.3) (155.8) Increase/(decrease) in debt 13,457 (39,359) (12,205) (8,426) (6,000)
Net debt/EBITDA 2.5 0.8 0.5 0.5 0.0 Dividend paid (2,215) (2,730) (2,730) 0 (3,730)
Per share (Rs) Interest paid (3,078) (3,629) (1,406) 121 246
Adjusted EPS 20.9 22.1 26.9 31.9 46.9 Others 98 19,823 (3,180) (34,332) 389
BVPS 303.7 277.1 305.0 300.1 335.7 Net cash from financing 8,777 (25,363) (18,808) (42,639) (9,095)
CEPS 44.9 43.5 46.5 53.2 70.7 Net change in Cash (4,208) 14,669 (7,117) (10,757) 8,451
DPS 4.2 5.0 5.0 6.8 9.4 Source: Company, Centrum Broking
Dividend payout (%) 30.8 nm 18.6 17.0 20.0
Valuation (x)
P/E 46.3 43.8 36.0 30.4 20.7
P/BV 3.2 3.5 3.2 3.2 2.9
EV/EBITDA 17.8 19.7 17.6 15.5 11.5
Dividend yield (%) 0.4 0.5 0.5 0.7 1.0
Source: Company, Centrum Broking

Centrum Institutional Research 312


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Pfizer
Pfizer has maintained consistent performance and its operating cash flows have Market data
expanded at a CAGR of 37% over the last decade. Being a domestic-focused Current price: Rs6,011
established brand-driven business, cash flow generation has been favorable. The Bloomberg: PFIZ IN
business has yielded better margins with stringent cost controls driving operating 52-week H/L: Rs6,175/4,196
leverage, leading to highest EBITDA margins from domestic segment. Working capital
Market cap: Rs275bn
intensity in the business has been negative to moderate due to favorable payable
days. Dividend payments have grown significantly in the last two years post the tax Free float: 29.1%
regime change. The business has low capex needs and its robust cash flow generation Avg. daily vol. 3mth: 82,532
enables the company to pay high dividends. Source: Bloomberg

History of robust cash flows from operations: Operating profits have been robust and have consistently expanded over the
last 10 years. Working capital intensity in the business has been negative to moderate due to favorable payable days. As a
result, the company has generated strong operating cash flows.
Exhibit 809: Cash flows from operations have grown at a CAGR of 37% over the last decade
6,000

4,000

2,000
Rs in mn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(2,000)

(4,000) Operating profit before wcap changes Wcap changes CFO

Source: Company, Centrum Broking

Analysis of working capital movement: The company enjoys higher payable days than debtor days, which helps maintain
lower working capital duration, despite high inventory turnover time.
Exhibit 810: Tight control over working capital cycle due to favorable payable days
150

100
Days

50

-
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(50)
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Pfizer 16 September 2021

Exhibit 811: Cash conversion ratios


FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT -17% 57% 63% 117% 159% 92% 23% 63% 86% 72%
OCF/EBITDA -200% 1656% 87% 597% 523% 500% 137% 313% 391% 445%
Source: Company, Centrum Broking

High conversion of operating cash to free cash: Over the last decade, Pfizer has not done any major capex. Its capital
expenditure can be majorly attributed to debottlenecking and upkeep of existing facilities.
Exhibit 812: High OCF to FCF conversion due to low capex
6,000
5,000
4,000
Rs in mn

3,000
2,000
1,000
-
(1,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

CFO Capex Net FCF


Source: Company, Centrum Broking

Exhibit 813: Asset turn


FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 1.8 2.0 2.1 2.0 2.3 2.1 2.4
Source: Company, Centrum Broking

Dividend distribution: The company has been consistently distributing dividends to its shareholders. It declared a dividend of
Rs330/share for FY20 and Rs35/share for FY21. In FY14, the company had declared total dividend of Rs360/share on account
of sale of animal healthcare division.
Exhibit 814: Has consistently paid dividends to shareholders
10,000

5,000

-
Rs in mn

FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(5,000)

(10,000) Declared a dividend of Declared a dividend of Rs330/share for FY20


Rs360/share for FY14
(15,000)

(20,000)
FCF Dividend/buyback
Source: Company, Centrum Broking

Exhibit 815: Return ratios


(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 14.9 12.1 19.1 11.5 14.6 11.1 14.1 15.1 15.9 17.2 14.6
RoCE 22.0 18.5 28.6 22.9 21.0 15.9 20.3 22.5 19.9 22.7 21.4
Source: Company, Centrum Broking

Exhibit 816: Earnings and dividend per share


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Cash EPS 65.1 171.3 76.7 43.9 79.3 87.4 93.2 109.4 133.9 132.7
Dividend per share 12.5 32.5 360 12.5 15 20 20 22.5 330 35
Dividend yield 1.0 3.1 28.5 0.6 0.8 1.1 0.9 0.7 8.2 0.8
Source: Company, Centrum Broking

Centrum Institutional Research 314


Pfizer 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 20,815 21,517 22,386 26,475 28,491 Equity share capital 457 457 457 457 457
Operating Expense 9,723 9,899 11,654 11,202 12,665 Reserves & surplus 29,656 33,497 23,473 24,291 29,246
Employee cost 3,238 3,645 3,611 4,183 4,188 Shareholders fund 30,113 33,955 23,930 24,748 29,703
Others 2,202 2,247 0 2,216 2,302 Minority Interest 0 0 0 0 0
EBITDA 5,652 5,726 7,121 8,874 9,336 Total debt 0 0 0 0 0
Depreciation & Amortisation 714 1,032 1,094 1,056 1,056 Non Current Liabilities 347 1,366 985 985 985
EBIT 4,938 4,693 6,027 7,818 8,280 Def tax liab. (net) 22 0 0 0 0
Interest expenses 13 109 151 109 109 Total liabilities 30,483 35,320 24,916 25,734 30,688
Other income 1,674 1,840 811 1,438 1,675 Gross block 9,576 10,761 10,037 7,925 7,925
PBT 6,599 6,425 6,687 9,147 9,846 Less: acc. Depreciation (714) (1,032) (1,094) (1,056) (1,056)
Taxes 2,309 1,334 1,711 2,369 2,550 Net block 8,862 9,729 8,943 6,869 6,869
Effective tax rate (%) 35.0 20.8 25.6 25.9 25.9 Capital WIP 137 359 379 379 379
PAT 4,291 5,091 4,976 6,778 7,296 Net fixed assets 8,999 10,088 9,322 7,249 7,249
Minority/Associates 0 0 0 0 0 Non Current Assets 3,371 3,829 4,307 4,307 4,307
Recurring PAT 4,291 5,091 4,976 6,778 7,296 Investments 0 0 0 0 0
Extraordinary items 0 0 0 0 0 Inventories 3,867 4,306 4,351 5,267 5,465
Reported PAT 4,291 5,091 4,976 6,778 7,296 Sundry debtors 1,717 1,720 1,297 2,183 2,349
Cash & Cash Equivalents 19,142 22,199 11,151 14,969 20,053
Ratios Loans & advances 54 35 86 145 156
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 2,251 1,871 2,011 2,011 2,011
Growth (%) Trade payables 4,359 4,268 2,837 4,901 4,988
Revenue 5.7 3.4 4.0 18.3 7.6 Other current liab. 3,934 3,889 4,100 4,785 5,149
EBITDA 13.0 1.3 24.4 24.6 5.2 Provisions 624 577 806 710 764
Adj. EPS 19.2 18.7 (2.3) 36.2 7.6 Net current assets 18,113 21,397 11,152 14,178 19,133
Margins (%) Total assets 30,483 35,320 24,916 25,734 30,688
Gross 64.1 63.2 64.4 66.1 65.2
EBITDA 27.2 26.6 31.8 33.5 32.8 Cashflow
EBIT 23.7 21.8 26.9 29.5 29.1 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 20.6 23.7 22.2 25.6 25.6 Profit Before Tax 6,599 6,425 6,687 9,147 9,846
Returns (%) Depreciation & Amortisation 714 1,032 1,094 1,056 1,056
ROE 15.1 15.9 17.2 27.8 26.8 Net Interest (1,661) (1,732) (660) (1,329) (1,566)
ROCE 15.1 16.2 17.6 28.2 27.1 Net Change – WC (1,456) (554) (1,200) 791 130
ROIC 31.9 32.7 36.6 51.4 63.2 Direct taxes (3,337) (1,362) (1,840) (2,234) (2,550)
Turnover (days) Net cash from operations 859 3,809 4,081 7,431 6,916
Gross block turnover ratio (x) 2.2 2.0 2.2 3.3 3.6 Capital expenditure (62) (2,122) (329) 1,018 (1,056)
Debtors 29 29 25 24 29 Acquisitions, net 0 0 0 0 0
Inventory 167 188 198 196 197 Investments 0 0 0 0 0
Creditors 227 199 163 157 182 Others 1,674 1,840 811 1,438 1,675
Net working capital 318 363 182 195 245 Net cash from investing 1,612 (282) 483 2,456 619
Solvency (x) FCF 2,471 3,528 4,564 9,887 7,535
Net debt-equity (0.6) (0.7) (0.5) (0.6) (0.7) Issue of share capital 607 0 0 0 0
Interest coverage ratio 438.1 52.8 47.1 81.4 85.7 Increase/(decrease) in debt (25) 0 0 0 0
Net debt/EBITDA (3.4) (3.9) (1.6) (1.7) (2.1) Dividend paid (1,178) (1,213) (18,192) (2,205) (2,141)
Per share (Rs) Interest paid (13) (109) (151) (109) (109)
Adjusted EPS 93.8 111.3 108.8 148.2 159.5 Others 168 850 2,732 (3,755) (200)
BVPS 658.2 742.2 523.1 541.0 649.3 Net cash from financing (440) (471) (15,612) (6,069) (2,450)
CEPS 109.4 133.9 132.7 171.2 182.6 Net change in Cash 2,031 3,056 (11,048) 3,818 5,084
DPS 22.0 22.0 330.0 40.0 40.0 Source: Company, Centrum Broking
Dividend payout (%) 23.5 19.8 303.4 27.0 25.1
Valuation (x)
P/E 64.1 54.0 55.3 40.6 37.7
P/BV 9.1 8.1 11.5 11.1 9.3
EV/EBITDA 45.3 44.2 37.0 29.3 27.3
Dividend yield (%) 0.4 0.4 5.5 0.7 0.7
Source: Company, Centrum Broking

Centrum Institutional Research 315


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Sanofi India (SANL)


SANL’s cash flows from operations have grown at a CAGR of 13% over last decade. Market data
Business mix would be changing from 70% domestic to 85% domestic, given the exit Current price: Rs8,049
of Ankleshwar facility and related export business. Cash flow generation over last two Bloomberg: SANL IN
years has been significantly higher, with domestic focus becoming more dominant. 52-week H/L: Rs9,300/7,057
The company plans to exit the nutraceutical business, further concentrating the
Market cap: Rs185.4bn
business to top 10 brands. Lantus’ entry into NLEM would be a one-time risk – as the
Indian domestic market remains the capital of diabetes, volume growth remains Free float: 34.6%
promising. Dividend payout has increased, especially in the last two years. Avg. daily vol. 3mth: 33,392
Source: Bloomberg

History of robust and consistent cash flows from operations: Operating profits have been robust and have consistently
expanded over the last 10 years. Working capital intensity in the business has been low to moderate due to favorable payable
days. As a result, the company has consistently generated strong operating cash flows.
Exhibit 817: Cash flows from operations have grown at a CAGR of 13% in the last decade
7,000
6,000
5,000
4,000
Rs in mn

3,000
2,000
1,000
-
(1,000)
(2,000) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: The company enjoys higher payable days than debtor days. Its inventory days have
consistently declined from CY14, enabling it to have a faster working capital cycle.
Exhibit 818: Working capital cycle has improved over the years
100

80

60
Days

40

20

0
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Sanofi India (SANL) 16 September 2021

Exhibit 819: Cash conversion ratios


CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20 Avg
OCF/PAT 107% 164% 103% 100% 66% 106% 133% 98% 100% 128% 111%
OCF/EBITDA 83% 93% 69% 78% 46% 60% 81% 60% 62% 86% 72%
Source: Company, Centrum Broking

Low capex aids conversion of operating cash to free cash: Over the last decade, SANL has not done any major capex. Its capital
expenditure can be majorly attributed to debottlenecking and upkeep of existing facilities.
Exhibit 820: High OCF to FCF conversion, aided by low capex
10,000

8,000

6,000
Rs in mn

4,000

2,000

(2,000)
CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
(4,000) CFO Capex Net FCF

Source: Company, Centrum Broking

Exhibit 821: Asset turn


CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Asset turn (x) 1.0 1.0 1.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9
Source: Company, Centrum Broking

Dividend distribution: The company has been consistently distributing dividends to its shareholders. In CY20, it declared a
special dividend of Rs125/share on account of sale of its Ankleshwar plant along with a normal dividend of Rs240/share.
Exhibit 822: Consistently distributing dividends to shareholders
10,000

5,000
Rs in mn

CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
(5,000)
Special dividend of Rs125/share on sale of Ankleshwar
plant along with normal dividend of Rs240/share
(10,000) FCF Dividend/buyback

Source: Company, Centrum Broking

Exhibit 823: Return ratios


Return Ratios (%) CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20 Avg
ROE (%) 18.1 15.4 19.0 14.0 14.7 16.7 16.7 17.9 20.3 22.8 17.6
ROCE (%) 25.5 22.0 27.4 20.6 22.9 24.9 24.8 26.9 26.9 30.2 25.2
ROIC (%) 21.3 20.9 24.8 17.7 19.6 22.3 22.8 25.6 32.2 42.8 25
Source: Company, Centrum Broking

Exhibit 824: Earnings and dividend per share


CY11 CY12 CY13 CY14 CY15 CY16 CY17 CY18 CY19 CY20
Cash EPS 97 116 155 156 189 184 186 210 224 243
Dividend yield (%) 1.4 1.4 1.6 1.3 1.5 1.6 1.5 1.3 5.0 4.4
Dividend 33 33 45 45 65 68 71 84 349 365
Source: Company, Centrum Broking

Centrum Institutional Research 317


Sanofi India (SANL) 16 September 2021

P&L Balance sheet


YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Revenues 25,940 28,427 29,019 28,932 31,783 Equity share capital 230 230 230 230 230
Operating Expense 14,550 16,619 14,639 16,186 17,972 Reserves & surplus 21,962 24,193 20,960 23,358 24,643
Employee cost 4,068 4,497 4,608 4,398 4,768 Shareholders fund 22,192 24,423 21,190 23,588 24,873
Others 2,855 2,937 2,641 2,245 2,424 Minority Interest 0 0 0 0 0
EBITDA 6,235 6,653 7,131 8,330 8,862 Total debt 0 0 226 226 226
Depreciation & Amortisation 1,027 999 806 812 812 Non Current Liabilities 491 541 646 646 646
EBIT 5,208 5,654 6,325 7,518 8,050 Def tax liab. (net) 921 446 302 302 302
Interest expenses 7 3 18 18 18 Total liabilities 23,604 25,410 22,364 24,762 26,047
Other income 897 941 898 1,128 1,434 Gross block 8,355 5,986 5,447 5,012 4,531
PBT 6,098 6,592 7,205 8,628 9,466 Less: acc. Depreciation (1,027) (999) (806) (812) (812)
Taxes 2,292 1,857 1,996 2,330 2,423 Net block 7,328 4,987 4,641 4,200 3,719
Effective tax rate (%) 37.6 28.2 27.7 27.0 25.6 Capital WIP 211 174 100 100 100
PAT 3,806 4,735 5,209 6,298 7,043 Net fixed assets 7,539 5,161 4,741 4,300 3,819
Minority/Associates 0 0 0 0 0 Non Current Assets 6,376 5,990 6,111 4,773 4,773
Recurring PAT 3,806 4,735 5,209 6,298 7,043 Investments 2 0 0 0 0
Extraordinary items 0 (593) (417) 4,696 0 Inventories 4,831 4,696 3,680 4,421 4,916
Reported PAT 3,806 4,142 4,792 10,994 7,043 Sundry debtors 1,584 2,240 1,480 1,671 1,841
Cash & Cash Equivalents 8,319 11,295 12,086 15,236 16,652
Ratios Loans & advances 43 15 57 67 74
YE Dec CY18A CY19A CY20A CY21E CY22E
Other current assets 1,145 3,047 1,030 1,030 1,030
Growth (%) Trade payables 3,438 3,689 3,183 3,268 3,242
Revenue 11.5 9.6 2.1 (0.3) 9.9 Other current liab. 1,513 1,963 2,153 1,998 2,195
EBITDA 16.1 6.7 7.2 16.8 6.4 Provisions 1,284 1,382 1,485 1,470 1,620
Adj. EPS 16.7 24.4 10.0 20.9 11.8 Net current assets 9,687 14,259 11,512 15,689 17,456
Margins (%) Total assets 23,604 25,410 22,364 24,762 26,047
Gross 62.6 60.6 56.8 64.4 64.8
EBITDA 22.5 21.7 24.6 26.7 26.0 Cashflow
EBIT 18.8 18.4 21.8 24.1 23.7 YE Dec (Rs mn) CY18A CY19A CY20A CY21E CY22E
Adjusted PAT 13.7 15.4 18.0 35.3 20.7 Profit Before Tax 6,098 5,999 6,788 13,324 9,466
Returns (%) Depreciation & Amortisation 1,027 999 806 812 812
ROE 17.9 20.3 22.8 28.1 29.1 Net Interest 7 3 18 18 18
ROCE 17.9 20.3 22.8 27.9 28.9 Net Change – WC (1,295) (1,230) 3,422 311 (351)
ROIC 24.2 30.1 40.7 61.3 70.4 Direct taxes (1,709) (2,332) (2,140) (2,330) (2,423)
Turnover (days) Net cash from operations 4,128 3,439 8,894 12,135 7,522
Gross block turnover ratio (x) 3.1 4.7 5.3 5.8 7.0 Capital expenditure (574) 1,379 (386) (371) (330)
Debtors 23 23 23 18 19 Acquisitions, net 0 0 0 0 0
Inventory 143 129 122 118 127 Investments 0 2 0 0 0
Creditors 107 97 100 94 88 Others 13 20 (5) 0 0
Net working capital 136 183 145 198 200 Net cash from investing (561) 1,401 (391) (371) (330)
Solvency (x) FCF 3,567 4,840 8,503 11,764 7,192
Net debt-equity (0.4) (0.5) (0.6) (0.6) (0.7) Issue of share capital 0 0 0 0 0
Interest coverage ratio 890.7 2,217.7 396.2 462.8 492.3 Increase/(decrease) in debt 0 0 226 0 0
Net debt/EBITDA (1.3) (1.7) (1.7) (1.8) (1.9) Dividend paid (1,972) (1,832) (8,038) (8,406) (5,758)
Per share (Rs) Interest paid (7) (3) (18) (18) (18)
Adjusted EPS 165.3 205.6 226.2 273.5 305.8 Others (573) (29) 118 (190) 0
BVPS 963.6 1,060.5 920.1 1,024.2 1,080.0 Net cash from financing (2,552) (1,864) (7,712) (8,614) (5,776)
CEPS 209.9 249.0 261.2 308.7 341.0 Net change in Cash 1,015 2,976 791 3,150 1,416
DPS 71.0 66.0 349.0 365.0 250.0 Source: Company, Centrum Broking
Dividend payout (%) 43.0 36.7 167.7 76.5 81.8
Valuation (x)
P/E 48.7 39.2 35.6 29.4 26.3
P/BV 8.4 7.6 8.7 7.9 7.5
EV/EBITDA 28.4 26.2 24.3 20.5 19.1
Dividend yield (%) 0.9 0.8 4.3 4.5 3.1
Source: Company, Centrum Broking

Centrum Institutional Research 318


16 September 2021

Institutional Research
Cyndrella Carvalho
Research Analyst, Pharmaceuticals
+91 22 4215 9643
SECTOR: PHARMACEUTICALS [email protected]

Sun Pharma (SUNP)


SUNP compounded its operating cash flows strongly in the initial years of the decade, Market data
enabling a 12% CAGR over the period, despite the declining trend over FY17-19. Post Current price: Rs781
the Ranbaxy acquisition, US patented basket investments, and plant compliance Bloomberg: SUNP IN
issues, cash flow generation has now stabilized in the last two years. Return ratios are 52-week H/L: Rs804/452
now back to early double digits. SUNP acquired many businesses, largely in the US
Market cap: Rs1,873.5bn
market, before the Ranbaxy acquisition and has never seen any meaningful
impairment on acquired assets. Post the Ranbaxy acquisition, speciality investment, Free float: 38.4%
Taro legal settlements, the earnings trajectory has been improving, with better Avg. daily vol. 3mth: 4,588,373
speciality sales and domestic business. R&D spend has averaged at 7%. Source: Bloomberg

Cash flows from operations have stabilized in the last two years: SUNP’s cash flows from operations have grown at a CAGR
of 12% over the decade, with strong growth till FY17. After a decline over FY17-19, operating cash flows revived in FY20 and
have been stable since then.
Exhibit 825: Cash flows from operations have grown at a CAGR of 12% over FY12-21
100,000
80,000
60,000
Rs in mn

40,000
20,000
-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)
(40,000)
Operating profit before wcap changes Wcap changes CFO
Source: Company, Centrum Broking

Analysis of working capital movement: SUNP has seen increasing inventory build-up since FY14; this combined with lower
creditor days has led to longer working capital cycle. Debtor days have also been declining in the last three years.
Exhibit 826: Net working capital days have been increasing since FY14
160
140
120
100
Days

80
60
40
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Debtors Inventory Payable Net working capital
Source: Company, Centrum Broking

Please see Appendix for analyst certifications and all other important disclosures.
Sun Pharma (SUNP) 16 September 2021
Exhibit 827: Cash conversion ratios
(%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
OCF/PAT 84% 94% 70% 124% 126% 102% 118% 60% 166% 104% 107%
OCF/EBITDA 70% 69% 57% 72% 79% 70% 70% 35% 95% 73% 69%
Source: Company, Centrum Broking

Rapid capacity expansions and acquisitions have led to poor conversion of operating cash to free cash: The company has
expanded inorganically from time to time by acquiring brands and companies to fuel its growth. Few notable acquisitions
include Ranbaxy in FY15, Dusa in FY12, URL in FY13, and Zenotech in FY18.
Exhibit 828: Capex intensity, acquisitions and free cash flows
80,000 URL generics business Zenotech Labs (INR736mn) Pola Pharma
& JV with Intrexon Baska Plant (INR10mn) INR228mn
60,000
40,000
Rs in mn

20,000
-
(20,000) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

(40,000)
Dusa Pharmalucence Ranbaxy Taro share buyback
(60,000) acquisition acquisition ~USD200mn

CFO Capex Investing in Subsidary/ Acquisition Net FCF


Source: Company, Centrum Broking

Exhibit 829: Asset turn


FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Asset turn (x) 0.6 0.6 0.7 0.7 0.6 0.5 0.4 0.4 0.5 0.5
Source: Company, Centrum Broking

Dividend distribution: SUNP has consistently paid dividends to shareholders. In FY17, it conducted a buyback program for the
shareholders of Taro, a US subsidiary.
Exhibit 830: Consistently paying dividends
60,000

40,000

20,000
Rs in mn

-
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
(20,000)

(40,000) FCF Dividend/buyback

Source: Company, Centrum Broking

Exhibit 831: Return ratios


Return ratios (%) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
RoE 24.5 26.2 33.8 20.5 18.6 20.5 8.8 9.2 9.1 12.9 17.7
RoCE 28.5 33.0 34.5 22.7 19.6 20.0 9.6 10.1 9.5 12.9 19.1
Source: Company, Centrum Broking

Exhibit 832: Leverage ratios


Leverage ratios (x) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Net Debt/Equity (0.4) (0.3) (0.4) (0.2) (0.2) (0.2) (0.1) (0.0) (0.1) (0.1)
Net Debt/EBITDA (1.5) (1.0) (1.0) (0.7) (0.8) (0.7) (0.7) (0.1) (0.5) (0.7)
Source: Company, Centrum Broking

Exhibit 833: R&D spend in the last decade was Rs167bn, ~7% of sales
Rs in bn FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Avg
R&D 7.0 10.4 19.6 23.0 23.1 22.5 19.8 19.7 21.5 -
% of sales 6.3% 6.5% 7.2% 8.3% 7.6% 8.6% 6.9% 6.1% 6.5% 7%
Source: Company, Centrum Broking

Centrum Institutional Research 320


Sun Pharma (SUNP) 16 September 2021

P&L Balance sheet


YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Revenues 290,659 328,375 334,981 368,119 408,844 Equity share capital 2,399 2,399 2,399 2,399 2,399
Operating Expense 110,327 134,993 86,901 134,147 148,549 Reserves & surplus 411,691 450,246 462,229 492,715 562,469
Employee cost 59,671 63,624 68,622 73,624 79,316 Shareholders fund 414,091 452,645 464,628 495,114 564,868
Others 58,439 60,805 94,545 62,532 66,261 Minority Interest 33,135 38,602 30,171 31,076 32,008
EBITDA 62,221 68,954 84,914 97,817 114,718 Total debt 98,934 75,783 33,430 30,536 27,909
Depreciation & Amortisation 17,533 20,526 20,800 21,813 23,069 Non Current Liabilities 10,047 13,343 10,986 14,500 15,574
EBIT 44,689 48,427 64,114 76,004 91,649 Def tax liab. (net) 1,043 581 445 423 402
Interest expenses 5,553 3,027 1,414 836 763 Total liabilities 557,250 580,954 539,660 571,649 640,762
Other income 10,255 6,359 8,355 11,130 11,798 Gross block 176,340 184,181 173,453 251,323 254,831
PBT 49,391 51,759 71,055 86,298 102,683 Less: acc. Depreciation (17,533) (20,526) (20,800) (21,813) (23,069)
Taxes 6,009 8,043 5,147 14,671 17,456 Net block 158,808 163,655 152,653 229,510 231,762
Effective tax rate (%) 12.2 15.5 7.2 17.0 17.0 Capital WIP 9,108 6,589 9,365 20,000 20,000
PAT 43,383 43,716 65,908 71,627 85,227 Net fixed assets 172,919 175,858 168,322 259,510 261,762
Minority/Associates (5,439) (4,285) 6,191 (3,563) (3,908) Non Current Assets 65,599 72,072 69,209 69,965 70,693
Recurring PAT 37,944 39,431 72,100 68,064 81,319 Investments 39,518 52,458 64,824 58,472 52,748
Extraordinary items (12,144) (2,606) (43,061) 0 0 Inventories 78,860 78,750 89,970 81,032 92,477
Reported PAT 25,800 36,825 29,038 68,064 81,319 Sundry debtors 88,842 94,212 90,614 90,769 101,332
Cash & Cash Equivalents 72,756 64,876 64,455 17,237 85,180
Ratios Loans & advances 7,578 10,777 9,319 8,068 9,007
YE Mar FY19A FY20A FY21A FY22E FY23E
Other current assets 62,656 67,927 50,062 49,750 49,497
Growth (%) Trade payables 41,479 40,937 39,737 30,912 44,588
Revenue 9.7 13.0 2.0 9.9 11.1 Other current liab. 17,617 18,911 49,653 52,136 54,743
EBITDA 10.9 10.8 23.1 15.2 17.3 Provisions 30,592 41,722 47,617 49,998 52,498
Adj. EPS 24.6 3.9 82.9 (5.6) 19.5 Net current assets 221,004 214,971 167,413 113,810 185,665
Margins (%) Total assets 557,250 580,954 539,660 571,649 640,762
Gross 72.9 71.9 74.1 74.1 74.4
EBITDA 21.4 21.0 25.3 26.6 28.1 Cashflow
EBIT 15.4 14.7 19.1 20.6 22.4 YE Mar (Rs mn) FY19A FY20A FY21A FY22E FY23E
Adjusted PAT 13.1 12.0 21.5 18.5 19.9 Profit Before Tax 37,248 49,153 27,994 86,298 102,683
Returns (%) Depreciation & Amortisation 17,533 20,526 20,800 21,813 23,069
ROE 9.5 9.1 15.7 14.2 15.3 Net Interest 5,553 3,027 1,414 836 763
ROCE 9.1 8.3 12.3 13.3 14.5 Net Change – WC (14,502) 6,235 34,156 8,792 (3,411)
ROIC 9.5 9.3 14.0 14.3 15.7 Direct taxes (15,287) (15,890) (9,580) (14,693) (17,477)
Turnover (days) Net cash from operations 30,544 63,052 74,783 103,046 105,627
Gross block turnover ratio (x) 1.6 1.8 1.9 1.5 1.6 Capital expenditure (33,341) (23,465) (13,263) (113,002) (25,321)
Debtors 105 102 101 90 86 Acquisitions, net 0 0 0 0 0
Inventory 342 312 354 327 302 Investments (7,597) (22,406) 5,307 5,726 5,085
Creditors 207 163 169 135 131 Others 577 (1,117) 834 (537) (590)
Net working capital 278 239 182 113 166 Net cash from investing (40,361) (46,988) (7,123) (107,812) (20,827)
Solvency (x) FCF (9,817) 16,063 67,660 (4,767) 84,800
Net debt-equity 0.1 0.0 (0.1) 0.0 (0.1) Issue of share capital 4 (59) 0 0 0
Interest coverage ratio 11.2 22.8 60.0 117.0 150.3 Increase/(decrease) in debt 1,416 (23,151) (42,353) (2,894) (2,627)
Net debt/EBITDA 0.4 0.2 (0.4) 0.1 (0.5) Dividend paid (14,318) (9,597) (4,799) (9,597) (9,597)
Per share (Rs) Interest paid (5,553) (3,027) (1,414) (836) (763)
Adjusted EPS 15.8 16.4 30.0 28.3 33.8 Others 1,729 11,890 (19,515) (29,125) (3,869)
BVPS 172.1 188.1 193.1 205.8 234.8 Net cash from financing (16,721) (23,944) (68,081) (42,452) (16,857)
CEPS 23.1 24.9 38.6 37.4 43.4 Net change in Cash (26,538) (7,880) (421) (47,218) 67,944
DPS 2.7 4.0 2.0 4.0 4.0 Source: Company, Centrum Broking
Dividend payout (%) 25.6 26.1 16.5 14.1 11.8
Valuation (x)
P/E 49.5 47.7 26.1 27.6 23.1
P/BV 4.5 4.2 4.0 3.8 3.3
EV/EBITDA 30.5 27.3 21.7 19.3 15.8
Dividend yield (%) 0.4 0.5 0.3 0.5 0.5
Source: Company, Centrum Broking

Centrum Institutional Research 321


The Blue Book 8 September 2021

Annexure: Annual capex over the last 10 years


Exhibit 834: Auto & Auto Components Exhibit 835: Cement
500000 60000 160000
400000 50000 140000
40000 120000
300000
Rs mn

30000 100000

Rs mn
200000 80000
20000
100000 60000
10000
40000
0 0
20000
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20
0

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20
Automobiles Auto Components
Source: Company, Centrum Broking Source: Company, Centrum Broking

Exhibit 836: Healthcare & Pharmaceuticals Exhibit 837: Metals & Mining
180000
600000
160000
140000 500000
120000 400000
Rs mn

100000 Rs mn
80000 300000
60000 200000
40000
20000 100000
0 0
FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20
Source: Company, Centrum Broking Source: Company, Centrum Broking

Exhibit 838: Oil, Gas & Consumable Fuels Exhibit 839: Chemicals
1400000 25000

1200000 20000
1000000
800000 15000
Rs mn
Rs mn

600000 10000
400000
200000 5000

0 0
FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

Source: Company, Centrum Broking Source: Company, Centrum Broking

Exhibit 840: Utilities Exhibit 841: Total (Industrial/Mfg/Healthcare)


700000 4000000
600000 3500000
3000000
500000
2500000
400000
Rs mn
Rs mn

2000000
300000
1500000
200000 1000000
100000 500000
0 0
FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

FY20

Source: Company, Centrum Broking Source: Company, Centrum Broking

Centrum Institutional Research ϯϮϮ


The Blue Book 8 September 2021
Disclaimer
Centrum Broking Limited (“Centrum”) is a full service, Stock Broking Company and a member of The Stock Exchange, Mumbai (BSE) and National Stock
Exchange of India Ltd. (NSE). Our holding company, Centrum Capital Ltd, is an investment banker and an underwriter of securities. As a group Centrum has
Investment Banking, Advisory and other business relationships with a significant percentage of the companies covered by our Research Group. Our research
professionals provide important inputs into the Group's Investment Banking and other business selection processes.
Recipients of this report should assume that our Group is seeking or may seek or will seek Investment Banking, advisory, project finance or other businesses
and may receive commission, brokerage, fees or other compensation from the company or companies that are the subject of this material/report. Our
Company and Group companies and their officers, directors and employees, including the analysts and others involved in the preparation or issuance of this
material and their dependants, may on the date of this report or from, time to time have "long" or "short" positions in, act as principal in, and buy or sell the
securities or derivatives thereof of companies mentioned herein. Centrum or its affiliates do not own 1% or more in the equity of this c ompany Our sales
people, dealers, traders and other professionals may provide oral or written market commentary or trading strateg ies to our clients that reflect opinions
that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are
inconsistent with the recommendations expressed herein. We may have earlier issued or may issue in future reports on the companies covered herein with
recommendations/ information inconsistent or different those made in this report. In reviewing this document, you should be aware that any or all of the
foregoing, among other things, may give rise to or potential conflicts of interest. We and our Group may rely on information barriers, such as "Chinese
Walls" to control the flow of information contained in one or more areas within us, or other areas, units, groups or affiliates of Centrum. Centrum or its
affiliates do not make a market in the security of the company for which this report or any report was written. Further, Centrum or its affiliates did not
make a market in the subject company’s securities at the time that the research report was published.
This report is for information purposes only and this document/material should not be construed as an offer to sell or the solicitation of an offer to buy,
purchase or subscribe to any securities, and neither this document nor anything contained herein shall form the basis of or be relied upon in connection with
any contract or commitment whatsoever. This document does not solicit any action based on the material contained herein. It i s for the general information
of the clients of Centrum. Though disseminated to clients simultaneously, not all clients may receive this report at the same time. C entrum will not treat
recipients as clients by virtue of their receiving this report. It does not constitute a personal recommendation or take into account the particular investment
objectives, financial situations, or needs of individual clients. Similarly, this document does not have regard to the specific investment objectives, financial
situation/circumstances and the particular needs of any specific person who may receive this document. The securities discussed in this report may not be
suitable for all investors. The securities described herein may not be eligible for sale in all jurisdictions or to all categ ories of investors. The countries in which
the companies mentioned in this report are organized may have restrictions on investments, voting rights or dealings in secur ities by nationals of other
countries. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives. Persons who
may receive this document should consider and independently evaluate whether it is suitable for his/ her/their particular cir cumstances and, if necessary,
seek professional/financial advice. Any such person shall be responsible for conducting his/her/their own investigation and analysis of the information
contained or referred to in this document and of evaluating the merits and risks involved in the securities forming the subject matter of this document.
The projections and forecasts described in this report were based upon a number of estimates and assumptions and are inherent ly subject to significant
uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on
which the projections and forecasts were based will not materialize or will vary significantly from actual results, and such variances will likely increase over
time. All projections and forecasts described in this report have been prepared solely by the authors of this report independently of the Company. These
projections and forecasts were not prepared with a view toward compliance with published guidelines or generally accepted a ccounting principles. No
independent accountants have expressed an opinion or any other form of assurance on these projections or forecasts. You should not regard the inclusion of
the projections and forecasts described herein as a representation or warranty by or on behalf of the Company, Centrum, the authors of this report or any
other person that these projections or forecasts or their underlying assumptions will be achieved. For these reasons, you should only consider the
projections and forecasts described in this report after carefully evaluating all of the information in this report, including the assumptions underlying such
projections and forecasts.
The price and value of the investments referred to in this document/material and the income from them may go down as well as up, and investors may
realize losses on any investments. Past performance is not a guide for future performance. Future returns are not guaranteed and a loss of original capital
may occur. Actual results may differ materially from those set forth in projections. Forwardlooking statements are not predictions and may be subject to
change without notice. Centrum does not provide tax advice to its clients, and all investors are strongly advised to consult regarding any potential
investment. Centrum and its affiliates accept no liabilities for any loss or damage of any kind arising out of the use of this repor t. Foreign currencies
denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the
investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies effectively assume currency risk. Certain
transactions including those involving futures, options, and other derivatives as well as noninvestmentgrade securities give rise to substantial risk and are
not suitable for all investors. Please ensure that you have read and understood the current risk disclosure documents before entering into any derivative
transactions.
This report/document has been prepared by Centrum, based upon information available to the public and sources, believed to be reliable. No
representation or warranty, express or implied is made that it is accurate or complete. Centr um has reviewed the report and, in so far as it includes current
or historical information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The o pinions expressed in this
document/material are subject to change without notice and have no obligation to tell you when opinions or information in this report change.
This report or recommendations or information contained herein do/does not constitute or purport to constitute investment advice in publicly accessible
media and should not be reproduced, transmitted or published by the recipient. The report is for the use and consumption of the recipient only. This
publication may not be distributed to the public used by the public media without the express written consent of Centrum. This report or any portion hereof
may not be printed, sold or distributed without the written consent of Centrum.
The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this document comes should inform
themselves about, and observe, any such restrictions. Neither Centrum nor its directors, employees, agents or representatives shall be liable for any
damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the
use of the information.
This document does not constitute an offer or invitation to subscribe for or purchase or deal in any securities and neither t his document nor anything
contained herein shall form the basis of any contract or commitment whatsoever. This document is strictly confidential and is being furnished to you solely
for your information, may not be distributed to the press or other media and may not be reproduced or redistributed to any other person. The distribution
of this report in other jurisdictions may be restricted by law and persons into whose possession this report comes should inf orm themselves about, and
observe any such restrictions. By accepting this report, you agree to be bound by the fore going limitations. No representation is made that this report is
accurate or complete.
The opinions and projections expressed herein are entirely those of the author and are given as part of the normal research a ctivity of Centrum Broking and
are given as of this date and are subject to change without notice. Any opinion estimate or projection herein constitutes a view as of the date of this report
and there can be no assurance that future results or events will be consistent with any such opinions, estimate or projection.
This document has not been prepared by or in conjunction with or on behalf of or at the instigation of, or by arrangement with the company or any of its
directors or any other person. Information in this document must not be relied upon as having been authorized or approved by the company or its directors
or any other person. Any opinions and projections contained herein are entirely those of the authors. None of the company or its directors or any other
person accepts any liability whatsoever for any loss arising from any use of this document or its contents or otherwise arising in connection therewith.

Centrum Institutional Research 323


The Blue Book 8 September 2021
Centrum and its affiliates have not managed or comanaged a public offering for the subject company in the preceding twelve months. Centrum and
affiliates have not received compensation from the companies mentioned in the report during the period preceding twelve months from the date of this
report for service in respect of public offerings, corporate finance, debt restructuring, investment banking or other advisory services in a merger/acquisition
or some other sort of specific transaction.
As per the declarations given by them, Research team and and/or any of their family members do not serve as an officer, director or any way connected to
the company/companies mentioned in this report. Further, as declared by them, they are not received any compensation from the above companies in the
preceding twelve months. They do not hold any shares by them or through their relatives or in case if holds the shares then will not to do any transactions
in the said scrip for 30 days from the date of release such report. Our entire research professionals are our employees and are paid a salary. They do not
have any other material conflict of interest of the research analyst or member of which the research analyst knows of has reason to know at the time of
publication of the research report or at the time of the public appearance.
While we would endeavour to update the information herein on a reasonable basis, Centrum, its associated companies, their directors and employees are
under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons tha t may prevent Centrum from
doing so.
Nonrated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable
regulations and/or Centrum policies, in circumstances where Centrum is acting in an advisory capacity to this company, or any certain other circumstances.
This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state,
country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subjec t Centrum
Broking Limited or its group companies to any registration or licensing requirement within such jurisdiction. Specificall y, this document does not constitute
an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any transaction to any U.S.
person unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be
distributed in Canada or used by private customers in United Kingdom. The information contained herein is not intended for pu blication or distribution or
circulation in any manner whatsoever and any unauthorized reading, dissemination, distribution or copying of this communication is prohibi ted unless
otherwise expressly authorized. Please ensure that you have read “Risk Disclosure Document for Capital Market and Derivatives Segments” as prescribed by
Securities and Exchange Board of India before investing in Indian Securities Market.

Ratings definitions
Our ratings denote the following 12month forecast returns:
Buy – The stock is expected to return above 15%.
Add – The stock is expected to return 515%.
Reduce – The stock is expected to deliver 5+5% returns.
Sell – The stock is expected to deliver <5% returns.

Disclosure of Interest Statement

1 Business activities of Centrum Broking Centrum Broking Limited (hereinafter referred to as “CBL”) is a registered member of NSE (Cash, F&O and Currency Derivatives
Limited (CBL) Segments), MCXSX (Currency Derivatives Segment) and BSE (Cash segment), Depository Participant of CDSL and a SEBI registered
Portfolio Manager.
2 Details of Disciplinary History of CBL CBL has not been debarred/ suspended by SEBI or any other regulatory authority from accessing /dealing in securities market.

3 Registration status of CBL: CBL is registered with SEBI as a Research Analyst (SEBI Registration No. INH000001469)
Member (NSE and BSE). Member MSEI (Inactive)

Single SEBI Regn No.: INZ000205331

Depository Participant (DP)


CDSL DP ID: 120 – 12200
SEBI REGD NO. : CDSL : INDPCDSL6612012

PORTFOLIO MANAGER

SEBI REGN NO.: INP000004383

Research Analyst
SEBI Registration No. INH000001469

Mutual Fund Distributor


AMFI REGN No. ARN 147569

Website: www.centrum.co.in
Investor Grievance Email ID: [email protected]

Compliance Officer Details:


Ashok D Kadambi
(022) 4215 9937; Email ID: [email protected]

Centrum Broking Ltd. (CIN :U67120MH1994PLC078125)

Corporate Office & Correspondence Address


Registered Office Address
Centrum House
Bombay Mutual Building ,
6th Floor, CST Road, Near Vidya Nagari Marg, Kalina, Santacruz (E), Mumbai
2nd Floor, Dr. D. N. Road,
400 098.
Fort, Mumbai 400 001
Tel: (022) 4215 9000 Fax: +91 22 4215 9344

Centrum Institutional Research 324

You might also like